Citrus Sinensis ID: 003628

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------
Protein Sequence
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQQRILLMILLLHSQQAEIRRGSLW
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHccccccccccccccccccccEEEEcccEEEEEEcccccccccEEEEEEcccccccEEEEEcccccccccccEEEEEEcccEEEEcccccEEEEEccccccccccEEEEcccccEEEEEcccccEEEEEccccccccccccEEEEEEccccEEEEEEcccccccccccEEEEEEcccccEEEEEEccccEEEEccccccEEEccccccEEEEEEEEEEEEccccEEEEEEEEccEEEEEEEEcccccEEEEEEEcccccccccccccccccccccccccccccccccccHHHHccccccccEEEccccccccccccccccccccEEEcccccccccEEEcccccHHHHHHHHHHccccccEEEcccccEEEEcccccEEEccccccccEEEEEEccccccccccccEEEccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHcccccccEEEcccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHcccccccccEEEcccccccEEccccccccccccccEEEcccccccccccEEEEEcccccHHHHHccccccccccccccEEEEEEEEcccccccccccccHHHHHHHHHcccccccccccccccccccHHHHHHHHHEEEEcccccccccccHHHHHHHHccccccccccccccEEEccccccccccccccEEEEEEEEEEEcHHHHHHccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHccccccccccccccccEEEccccEEEEEEEcccccccEEEEEEEEcccccEEEEEEEcccccccccEEEEEccccEEEEEEccccEEEEEccccccccccEEEEEccccEEEEEcccccEEEEEccccccccccccEEcccccccccEEEEEcccccccccccEEEEEccccccEEEEEcccEEEEEccccccEEEEcccccccccEEEEEEEEEccccEEEEEEccccEEEEEEEEcccccEEEEEEccccccccccccccccccccccccccccccccccccHHHHHccccccccEEccccccccccccccccccccEEEEccccccccccHEEcccHHHHHHHHHHcccEEEEEcccccEEEEEEcccEEEHHHccccccEEEEEEcccHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccEcHHHHHHHHccccHccccccccccccEccccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEEcccHccccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEcccccccEcccccEEccccEEEEEcccccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHccccHHHccHHHccccccHHHHHHHHHHHHHHHHccccccccHHHEEEEccccccccccccccEEEEEccccccccccccccccEEEEEEccccHHHHHccccc
Coil and Loop (DISEMBL)
MIPIALLIILLSCFCLDFAVAidssitssqlirdpdailsngsnfklgffnpadspyrymgiwydmpseKAVIWVANrdnplkdssgiitisedgnlvlvnGQKEVLWSSnvsnlvnnstsaqlldsgnlvlrdNINRAIVWEsfqeptdsflpgmhhgidqrtgkkvqltswkslsdpstgsfsaglihqnipeifvwnvsrpywrsgpwngqifigipelksvYLFRHnftfgfandwtFFALTAQGILEERIWIKWKDNWEVGFLNLRTecdvygkcgafgicnsqekpicsclegfepknaeewnrgnwtsgcirrsklqcerrnitgkvgkedgfsklnkmkvpdftewtspatedecreqclkncsciayafdggIGCMVWRSinlidiqrlpfggtdlYIRVansdvdekgkkdvfvsPLIKGMFALAICTLFLWRWIAKRKEVIAKLSAtnvntvklqdlplfqfEELATAtnnfqlssklgqggfgpvywgrlkdgQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYmpnrsldallfdplkkERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNilldeelnpkisdfgmakifggnqdqadtgrvvgtfgymspeyamegrfseksdvFSFGVLLLEIVSgrkntsffeddLTILGYAWKLWNENKILAlvdpflsessfqLDMIIRCIHVGLLCVQElvkdrpnmSTVVSMLNSeirdlpypkepafterqgaddseSFKQIQQRILLMILLLHSQQAEIRRGSLW
Flexible Loop (DISEMBL)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTsaqlldsgnLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKnaeewnrgnwtsgcirrsklqcerrnitgkvgkedgfsklnkmkvpdfteWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRvansdvdekgkKDVFVSPLIKGMFALAICTLFLWRWIAKRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRkrfniiegisrgllylhRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFggnqdqadtgrVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSgrkntsffEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNseirdlpypkEPAFTerqgaddsESFKQIQQRILLMILLLHSqqaeirrgslw
Low Complexity Region (SEG)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEvlwssnvsnlvnnsTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSESFKqiqqrillmilllhsqqAEIRRGSLW
Disordered region (IsUnstruct)
**PIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGI**********************SFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVG***GFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS******************************QIQQRILLMILLLHS***********
Disordered Region (DISOPRED)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNV**********QLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQ************EDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANS*****GKKDVFVSPLIKGMFALAICTLFLWRWIAK********************LPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF************************LLHSQQAE***GSLW
Disordered Region (DISEMBL)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFT***********KQIQQRILLMILLLHSQQAEIRRGSLW
Disordered Region (DISPRO)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNI****GKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKEVI************LQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQG*************ILLMILLLHSQQAEIRR**L*
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQQRILLMILLLHSQQAEIRRGSLW
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	807	2.2.26 [Sep-21-2011]
Q9SXB4	820	G-type lectin S-receptor-	no	no	0.944	0.929	0.530	0.0
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.939	0.900	0.525	0.0
Q9SXB5	820	G-type lectin S-receptor-	no	no	0.936	0.921	0.509	0.0
Q9LPZ9	830	G-type lectin S-receptor-	no	no	0.952	0.926	0.506	0.0
Q9SY89	842	Putative G-type lectin S-	no	no	0.947	0.908	0.450	0.0
O81906	849	G-type lectin S-receptor-	no	no	0.947	0.901	0.459	0.0
O81905	850	Receptor-like serine/thre	no	no	0.903	0.857	0.448	0.0
O64781	831	G-type lectin S-receptor-	no	no	0.947	0.920	0.436	0.0
O64783	814	G-type lectin S-receptor-	no	no	0.939	0.931	0.444	0.0
Q9S972	847	Receptor-like serine/thre	no	no	0.916	0.873	0.446	0.0

>sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1

 Score =  835 bits (2157), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 425/801 (53%), Positives = 565/801 (70%), Gaps = 39/801 (4%)

Query: 6   LLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYD 65
           + I++LSCF L  ++A + +  S +L  D + I+S+   F+ GFF+P +S  RY GIWY+
Sbjct: 11  VCILVLSCFFLSVSLAQERAFFSGKL-NDSETIVSSFRTFRFGFFSPVNSTSRYAGIWYN 69

Query: 66  MPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVN-NSTSAQL 124
             S + VIWVAN+D P+ DSSG+I++S+DGNLV+ +GQ+ VLWS+NVS   + NST A+L
Sbjct: 70  SVSVQTVIWVANKDKPINDSSGVISVSQDGNLVVTDGQRRVLWSTNVSTQASANSTVAEL 129

Query: 125 LDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK-KVQLTSWKSLSDPSTGS 183
           LDSGNLVL++  + A +WESF+ PTDS+LP M  G + R G   V +TSWKS SDPS GS
Sbjct: 130 LDSGNLVLKEASSDAYLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDPSPGS 189

Query: 184 FSAGLIHQNIPEIFVWNVS---RPYWRSGPWNGQIFIGIPELKS-VYLFRH--------N 231
           ++A L+    PE+F+ N +      WRSGPWNGQ+F G+P++ + V+L+R         +
Sbjct: 190 YTAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDDTNGS 249

Query: 232 FTFGFANDWT--FFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQ 289
            T  +AND T  +F +  +G +  R W + + NW VG     TECD Y +CG F  CN +
Sbjct: 250 VTMSYANDSTLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFATCNPR 309

Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVP 349
           + P+CSC+ GF P+N  EWN GNW+ GC RR  LQCER+N  G     DGF +L +MK+P
Sbjct: 310 KNPLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGSA---DGFLRLRRMKLP 366

Query: 350 DFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRV 409
           DF    S A+E EC   CL+ CSCIA A   G GCM+W   +L+D Q L   G DLYIR+
Sbjct: 367 DFAR-RSEASEPECLRTCLQTCSCIAAAHGLGYGCMIWNG-SLVDSQELSASGLDLYIRL 424

Query: 410 ANSDVDEKGKKDVFVSPLIKG-MFALAICTLFLWRWIAKRK---------EVIAKLSA-T 458
           A+S++  K K+ + +  ++ G +F +A C L   R + K++         ++  ++ A  
Sbjct: 425 AHSEIKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAKKKGRDAEQIFERVEALA 484

Query: 459 NVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG 518
             N  KL++LPLF+F+ LA ATNNF L +KLGQGGFGPVY G+L++GQEIAVKRLS+ASG
Sbjct: 485 GGNKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASG 544

Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 578
           QGLEE +NEV+VISKLQHRNLV+LLGCC+ GEE+ML+YE+MP +SLD  LFD  + + LD
Sbjct: 545 QGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLD 604

Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           W+ RFNII GI RGLLYLHRDSRLRIIHRDLKASNILLDE L PKISDFG+A+IF GN+D
Sbjct: 605 WKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNED 664

Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA 698
           +A+T RVVGT+GYM+PEYAM G FSEKSDVFS GV+LLEI+SGR+N+     + T+L Y 
Sbjct: 665 EANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRNS-----NSTLLAYV 719

Query: 699 WKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 758
           W +WNE +I +LVDP + +  F+ + I +CIH+GLLCVQE   DRP++STV SML+SEI 
Sbjct: 720 WSIWNEGEINSLVDPEIFDLLFEKE-IHKCIHIGLLCVQEAANDRPSVSTVCSMLSSEIA 778

Query: 759 DLPYPKEPAFTERQGADDSES 779
           D+P PK+PAF  R    ++ES
Sbjct: 779 DIPEPKQPAFISRNNVPEAES 799

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  829 bits (2142), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/801 (52%), Positives = 561/801 (70%), Gaps = 43/801 (5%)

Query: 26  ITSSQLIRDPDA--ILSNGSNFKLGFFNPADSP--YRYMGIWYDMPSEKAVIWVANRDNP 81
           IT S  I+D ++  +L     F+ GFF P +S    RY+GIWY+    + V+WVAN+D+P
Sbjct: 33  ITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVWVANKDSP 92

Query: 82  LKDSSGIITISEDGNLVLVNGQKEVLWSSNVS-NLVNNSTSAQLLDSGNLVLRDNINRA- 139
           + D+SG+I+I +DGNL + +G+  ++WS+NVS  +  N+T  QL+DSGNL+L+DN N   
Sbjct: 93  INDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMDSGNLMLQDNRNNGE 152

Query: 140 IVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVW 199
           I+WESF+ P DSF+P M  G D RTG  ++LTSW S  DPSTG+++AG+     PE+ +W
Sbjct: 153 ILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFPELLIW 212

Query: 200 NVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------TFGFAND--WTFFALTA 247
             + P WRSGPWNGQ+FIG+P + S+ LF   F          +  +AND     F L  
Sbjct: 213 KNNVPTWRSGPWNGQVFIGLPNMDSL-LFLDGFNLNSDNQGTISMSYANDSFMYHFNLDP 271

Query: 248 QGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEE 307
           +GI+ ++ W      W +G     T+CD YG+CG FG C++ E P C C++GF PKN  E
Sbjct: 272 EGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPCKCVKGFVPKNNTE 331

Query: 308 WNRGNWTSGCIRRSKLQCER-RNITGKVG--KEDGFSKLNKMKVPDFTEWTSPATEDECR 364
           WN GNW++GC+R++ LQCER RN++   G  K DGF KL KMKVP   E  S A+E  C 
Sbjct: 332 WNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPISAE-RSEASEQVCP 390

Query: 365 EQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFV 424
           + CL NCSC AYA+D GIGCM+W S +L+D+Q     G DL+IRVA+S++       V +
Sbjct: 391 KVCLDNCSCTAYAYDRGIGCMLW-SGDLVDMQSFLGSGIDLFIRVAHSELKTHSNLAVMI 449

Query: 425 S-PLIKGMFALAICTLFLWR---------------WIAKRKEVIAKLSATNVNTVKLQDL 468
           + P+I  M   A+C L   R                + KR E +   + +  N +KL++L
Sbjct: 450 AAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFKRMEALTSDNESASNQIKLKEL 509

Query: 469 PLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEV 528
           PLF+F+ LAT+T++F L +KLGQGGFGPVY G+L +GQEIAVKRLS+ SGQGLEE MNEV
Sbjct: 510 PLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEV 569

Query: 529 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
           +VISKLQHRNLV+LLGCC+EGEE+ML+YEYMP +SLDA LFDP+K++ LDW+ RFNI+EG
Sbjct: 570 VVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIMEG 629

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           I RGLLYLHRDSRL+IIHRDLKASNILLDE LNPKISDFG+A+IF  N+D+A+T RVVGT
Sbjct: 630 ICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRVVGT 689

Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF--EDDLTILGYAWKLWNENK 706
           +GYMSPEYAMEG FSEKSDVFS GV+ LEI+SGR+N+S    E++L +L YAWKLWN+ +
Sbjct: 690 YGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWKLWNDGE 749

Query: 707 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 766
             +L DP + +  F+ + I +C+H+GLLCVQE+  DRPN+S V+ ML +E   L  PK+P
Sbjct: 750 AASLADPAVFDKCFEKE-IEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSLADPKQP 808

Query: 767 AFTERQGADDSESFKQIQQRI 787
           AF  R+GA ++ES  Q  Q++
Sbjct: 809 AFIVRRGASEAESSDQSSQKV 829

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1

 Score =  795 bits (2053), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/801 (50%), Positives = 548/801 (68%), Gaps = 45/801 (5%)

Query: 8   IILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMP 67
           ++ LSCF L  ++A + ++ S  L  D + I+S+   F+ GFF+P +S  RY GIWY+  
Sbjct: 13  VLSLSCFFLSVSLAHERALFSGTL-NDSETIVSSFRTFRFGFFSPVNSTNRYAGIWYNSI 71

Query: 68  SEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVN-NSTSAQLLD 126
             + VIWVAN+D P+ DSSG+I+ISEDGNLV+ +GQ+ VLWS+NVS   + NST A+LL+
Sbjct: 72  PVQTVIWVANKDTPINDSSGVISISEDGNLVVTDGQRRVLWSTNVSTRASANSTVAELLE 131

Query: 127 SGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK-KVQLTSWKSLSDPSTGSFS 185
           SGNLVL+D    A +WESF+ PTDS+LP M  G + RTG   + +TSW + SDPS GS++
Sbjct: 132 SGNLVLKDANTDAYLWESFKYPTDSWLPNMLVGTNARTGGGNITITSWTNPSDPSPGSYT 191

Query: 186 AGLIHQNIPEIFVWNVS---RPYWRSGPWNGQIFIGIPEL-KSVYLFRHNF--------T 233
           A L+    PE+F++N +      WRSGPWNG +F G+P++   ++L+R           T
Sbjct: 192 AALVLAPYPELFIFNNNDNNATVWRSGPWNGLMFNGLPDVYPGLFLYRFKVNDDTNGSAT 251

Query: 234 FGFANDWTF--FALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
             +AND T     L  +G    R W + + NW +G     TECD+Y +CG +  CN ++ 
Sbjct: 252 MSYANDSTLRHLYLDYRGFAIRRDWSEARRNWTLGSQVPATECDIYSRCGQYTTCNPRKN 311

Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
           P CSC++GF P+N  EWN GNW+ GCIR+  LQCER+N     G  D F KL +MK+PDF
Sbjct: 312 PHCSCIKGFRPRNLIEWNNGNWSGGCIRKLPLQCERQN---NKGSADRFLKLQRMKMPDF 368

Query: 352 TEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVAN 411
               S A+E EC   CL++CSCIA+A   G GCM+W   +L+D Q L   G DL IR+A+
Sbjct: 369 AR-RSEASEPECFMTCLQSCSCIAFAHGLGYGCMIWNR-SLVDSQVLSASGMDLSIRLAH 426

Query: 412 SDVDEKGKKDVFV-SPLIKGMFALAICTLFLWRWIAKRKEVIAKLSATNVNTV------- 463
           S+   + ++ + + + L  G+F +A C L   R + K++   AK   T+   +       
Sbjct: 427 SEFKTQDRRPILIGTSLAGGIFVVATCVLLARRIVMKKR---AKKKGTDAEQIFKRVEAL 483

Query: 464 ------KLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS 517
                 KL++LPLF+F+ LATAT+NF LS+KLGQGGFGPVY G L +GQEIAVKRLS+AS
Sbjct: 484 AGGSREKLKELPLFEFQVLATATDNFSLSNKLGQGGFGPVYKGMLLEGQEIAVKRLSQAS 543

Query: 518 GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL 577
           GQGLEE + EV+VISKLQHRNLV+L GCC+ GEE+ML+YE+MP +SLD  +FDP + + L
Sbjct: 544 GQGLEELVTEVVVISKLQHRNLVKLFGCCIAGEERMLVYEFMPKKSLDFYIFDPREAKLL 603

Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
           DW  RF II GI RGLLYLHRDSRLRIIHRDLKASNILLDE L PKISDFG+A+IF GN+
Sbjct: 604 DWNTRFEIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNE 663

Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY 697
           D+A+T RVVGT+GYM+PEYAM G FSEKSDVFS GV+LLEI+SGR+N+       T+L +
Sbjct: 664 DEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRNS-----HSTLLAH 718

Query: 698 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI 757
            W +WNE +I  +VDP + +  F+ + I +C+H+ LLCVQ+   DRP++STV  ML+SE+
Sbjct: 719 VWSIWNEGEINGMVDPEIFDQLFEKE-IRKCVHIALLCVQDAANDRPSVSTVCMMLSSEV 777

Query: 758 RDLPYPKEPAFTERQGADDSE 778
            D+P PK+PAF  R    ++E
Sbjct: 778 ADIPEPKQPAFMPRNVGLEAE 798

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2

 Score =  768 bits (1983), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/809 (50%), Positives = 547/809 (67%), Gaps = 40/809 (4%)

Query: 13  CFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAV 72
           CF L   +A D  IT S   RD + ++SN S F+ GFF+P +S  RY GIW++    + V
Sbjct: 13  CFSLRLCLATDV-ITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTV 71

Query: 73  IWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNV-SNLVNNSTSAQLLDSGNLV 131
           +WVAN ++P+ DSSG+++IS++GNLV+++G+ +V WS+NV   +  N+  A+LL++GNLV
Sbjct: 72  VWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLV 131

Query: 132 LRDNINRA--IVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLI 189
           L    N    I+WESF+ P + +LP M    D +TG+ ++L SWKS  DPS G +SAGLI
Sbjct: 132 LLGTTNTGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLI 191

Query: 190 HQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELK-SVYLF--------RHNFTFGFANDW 240
               PE+ VW      WRSGPWNGQ FIG+P +   + LF        R + +  +A + 
Sbjct: 192 PLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNRGSVSMSYAGNT 251

Query: 241 TF--FALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGIC--NSQEKPICSC 296
               F L ++G + +R W      W+       T+CD Y  CG F  C  N    P C C
Sbjct: 252 LLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMC 311

Query: 297 LEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTS 356
           + GF+P++  EWN GNWT GC+R++ LQCE R+      K DGF ++ KMKVP   +  S
Sbjct: 312 IRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQ-RS 370

Query: 357 PATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDE 416
            A E +C E CLKNCSC AY+FD GIGC++W S NL+D+Q     G   YIR+A+S+  +
Sbjct: 371 GANEQDCPESCLKNCSCTAYSFDRGIGCLLW-SGNLMDMQEFSGTGVVFYIRLADSEFKK 429

Query: 417 KGKKDVFVS-PLIKGMFALA-ICTLFLWRWIAKRKEV----------IAKLSATNV---- 460
           +  + + ++  L+ G F  A    L LW+ IAK +E           +  LS+ +V    
Sbjct: 430 RTNRSIVITVTLLVGAFLFAGTVVLALWK-IAKHREKNRNTRLLNERMEALSSNDVGAIL 488

Query: 461 -NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ 519
            N  KL++LPLF+F+ LA ATNNF +++KLGQGGFG VY GRL++G +IAVKRLS+ SGQ
Sbjct: 489 VNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQ 548

Query: 520 GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW 579
           G+EEF+NEV+VISKLQHRNLVRLLG C+EGEE+ML+YE+MP   LDA LFDP+K+  LDW
Sbjct: 549 GVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDW 608

Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
           + RFNII+GI RGL+YLHRDSRL+IIHRDLKASNILLDE LNPKISDFG+A+IF GN+D+
Sbjct: 609 KTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDE 668

Query: 640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED--DLTILGY 697
             T RVVGT+GYM+PEYAM G FSEKSDVFS GV+LLEIVSGR+N+SF+ D  +  +  Y
Sbjct: 669 VSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAY 728

Query: 698 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI 757
           AWKLWN  + +ALVDP + E  F+ + I RC+HVGLLCVQ+   DRP+++TV+ ML+SE 
Sbjct: 729 AWKLWNTGEDIALVDPVIFEECFE-NEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSEN 787

Query: 758 RDLPYPKEPAFTERQGADDSESFKQIQQR 786
            +LP PK+PAF  R+G  + ES  Q   R
Sbjct: 788 SNLPEPKQPAFIPRRGTSEVESSGQSDPR 816

Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1

 Score =  700 bits (1806), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/825 (45%), Positives = 510/825 (61%), Gaps = 60/825 (7%)

Query: 2   IPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMG 61
           + +   +++    C + + +  +S T +  IR+ D+++S   +F+LGFF P +S  RY+G
Sbjct: 8   LTLVTTLLIFHQLCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVG 67

Query: 62  IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
           IWY     + V+WVANR+ PL D  G + I++DGNLV+VNGQ E +WS+NV    NN T 
Sbjct: 68  IWYKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNN-TV 126

Query: 122 AQLLDSGNLVL-RDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPS 180
           A L  +G+LVL  D+  R   WESF  PTD+FLPGM   ++   G+      WKS SDPS
Sbjct: 127 AVLFKTGDLVLCSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPS 186

Query: 181 TGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGF---- 236
            G +S G+      EI +W   +  WRSGPWN  IF GIP++    L   N+ +GF    
Sbjct: 187 PGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDM----LRFTNYIYGFKLSS 242

Query: 237 ----------------ANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKC 280
                           ++D+  F +   G+ E+  W K   NW +      TEC+ Y +C
Sbjct: 243 PPDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRC 302

Query: 281 GAFGICNSQEK---PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKE 337
           G + +C+  ++     CSC++GFEP + ++WN  +++ GC RR  L C +  +    G+E
Sbjct: 303 GNYSVCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLV---AGQE 359

Query: 338 DGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQR 397
           DGF+ L  +KVPDF         + C++ C ++CSC AYA   GIGCM+W + +LID++ 
Sbjct: 360 DGFTVLKGIKVPDFGSVVLHNNSETCKDVCARDCSCKAYALVVGIGCMIW-TRDLIDMEH 418

Query: 398 LPFGGTDLYIRVANSDVDEKGKKD----VFVSPLIKGMFALAICTLFLWRWIAKRKEVIA 453
              GG  + IR+A S +   GK++    + V  +I G F L +C   LW++    K  + 
Sbjct: 419 FERGGNSINIRLAGSKLG-GGKENSTLWIIVFSVI-GAFLLGLCIWILWKFKKSLKAFLW 476

Query: 454 KLSATNV-------------------NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGF 494
           K     V                   + V   DLP+F F+ +A+AT +F   +KLGQGGF
Sbjct: 477 KKKDITVSDIIENRDYSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGF 536

Query: 495 GPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554
           G VY G   +G+EIAVKRLS  S QGLEEF NE+++I+KLQHRNLVRLLGCC+E  EKML
Sbjct: 537 GTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKML 596

Query: 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 614
           +YEYMPN+SLD  LFD  K+  LDWRKR+ +I GI+RGLLYLHRDSRL+IIHRDLKASNI
Sbjct: 597 LYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNI 656

Query: 615 LLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVL 674
           LLD E+NPKISDFGMA+IF   QD A+T RVVGT+GYM+PEYAMEG FSEKSDV+SFGVL
Sbjct: 657 LLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVL 716

Query: 675 LLEIVSGRKNTSFF-EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGL 733
           +LEIVSGRKN SF   D  +++GYAW LW++ K   ++DP + ++   +   +RCIHVG+
Sbjct: 717 ILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTR-DVTEAMRCIHVGM 775

Query: 734 LCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSE 778
           LC Q+ V  RPNM +V+ ML S+   LP P++P F     + D E
Sbjct: 776 LCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIE 820

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  696 bits (1797), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 387/843 (45%), Positives = 524/843 (62%), Gaps = 78/843 (9%)

Query: 7   LIILLSCFCLDFAVAIDSSITSSQLIRD---PDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           L + L  F  + ++A ++ I   + +RD      ++S    F+LGFF+P  S +R++GIW
Sbjct: 11  LSLFLYFFLYESSMAANT-IRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNV--SNLVNNSTS 121
           Y    +KAV+WVANR  P+ D SG++ IS DGNLVL++G+   +WSSN+  S   NN+  
Sbjct: 70  YGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRV 129

Query: 122 AQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPST 181
             + D+GN VL +      +WESF  PTD+FLP M   ++ +TG      SW+S +DPS 
Sbjct: 130 VSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSP 189

Query: 182 GSFSAGLIHQNIPEIFVW--NVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFAND 239
           G++S G+     PEI +W  N +R  WRSG WN  IF GIP +  +  + + F      D
Sbjct: 190 GNYSLGVDPSGAPEIVLWEGNKTRK-WRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPD 248

Query: 240 WT----------------FFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAF 283
            T                 F +   G  EE  W +    W        +ECD Y +CG F
Sbjct: 249 ETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKF 308

Query: 284 GICNSQ-EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSK 342
           GIC+ +    ICSC+ G+E     + + GNW+ GC RR+ L+CER    G    ED F  
Sbjct: 309 GICDMKGSNGICSCIHGYE-----QVSVGNWSRGCRRRTPLKCERNISVG----EDEFLT 359

Query: 343 LNKMKVPDFT--EWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPF 400
           L  +K+PDF   E      ED CRE+CL+NCSC AY+  GGIGCM+W   +L+D+Q+   
Sbjct: 360 LKSVKLPDFEIPEHNLVDPED-CRERCLRNCSCNAYSLVGGIGCMIWNQ-DLVDLQQFEA 417

Query: 401 GGTDLYIRVANSDVDE--KGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKE-------- 450
           GG+ L+IR+A+S+V E  K K  V V+ L+ G+  + I  L LWR+  KRK+        
Sbjct: 418 GGSSLHIRLADSEVGENRKTKIAVIVAVLV-GVILIGIFALLLWRF--KRKKDVSGAYCG 474

Query: 451 -------VIAKLSATNVNT---------------VKLQDLPLFQFEELATATNNFQLSSK 488
                  V+A L+ +   T               V   +LP+F    +A ATN+F   ++
Sbjct: 475 KNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENE 534

Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548
           LG+GGFGPVY G L+DG+EIAVKRLS  SGQG++EF NE+++I+KLQHRNLVRLLGCC E
Sbjct: 535 LGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFE 594

Query: 549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRD 608
           GEEKML+YEYMPN+SLD  LFD  K+  +DW+ RF+IIEGI+RGLLYLHRDSRLRIIHRD
Sbjct: 595 GEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRD 654

Query: 609 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDV 668
           LK SN+LLD E+NPKISDFGMA+IFGGNQ++A+T RVVGT+GYMSPEYAMEG FS KSDV
Sbjct: 655 LKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDV 714

Query: 669 FSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKLWNENKILALVDPFLSESSFQLDMIIR 727
           +SFGVLLLEIVSG++NTS    +  +++GYAW L+   +   LVDP +  +  + +  +R
Sbjct: 715 YSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREA-LR 773

Query: 728 CIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF--TERQGADDSESFKQIQQ 785
           CIHV +LCVQ+   +RPNM++V+ ML S+   L  P++P F  T R   D + +    QQ
Sbjct: 774 CIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQ 833

Query: 786 RIL 788
            I+
Sbjct: 834 YIV 836

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/798 (44%), Positives = 500/798 (62%), Gaps = 69/798 (8%)

Query: 25  SITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKD 84
           S + S  I   + I+S G+ F+LGFF P      Y+GIWY   S++  +WVANRD PL  
Sbjct: 33  SASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPLSS 92

Query: 85  SSGIITISEDGNLVLVNGQKEVLWSSNVSNL-VNNSTSAQLLDSGNLVLRDNINRA---I 140
           S G + IS D NLV+++     +WS+N++   V +   A+LLD+GN VLRD+ N A   +
Sbjct: 93  SIGTLKIS-DSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDGV 151

Query: 141 VWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWN 200
           +W+SF  PTD+ LP M  G D +TG    + SWKS  DPS+G FS  L  +  PEIF+WN
Sbjct: 152 LWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWN 211

Query: 201 VSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFT-------FGF----ANDWTFFALTAQG 249
                +RSGPWNG  F G+PE++       NFT       + F    ++ ++  ++++ G
Sbjct: 212 RESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSG 271

Query: 250 ILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWN 309
           +L+   WI+   NW   +   + +CD Y +CG +G C+S   P+C+C++GF+P+N + W 
Sbjct: 272 LLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWG 331

Query: 310 RGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATED------EC 363
             + + GC+R++ L C         G  DGF +L KMK+PD    T+ A+ D      EC
Sbjct: 332 LRDGSDGCVRKTLLSC---------GGGDGFVRLKKMKLPD----TTTASVDRGIGVKEC 378

Query: 364 REQCLKNCSCIAYAFD----GGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGK 419
            ++CL++C+C A+A       G GC+ W    L DI+    GG DLY+R+A +D+++K  
Sbjct: 379 EQKCLRDCNCTAFANTDIRGSGSGCVTWTG-ELFDIRNYAKGGQDLYVRLAATDLEDKRN 437

Query: 420 KDVFV---SPLIKGMFALAICTLFLWRWIAKRKEVI----------------------AK 454
           +   +   S  +  +  L+    FLW+   KR  +I                      ++
Sbjct: 438 RSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSR 497

Query: 455 LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLS 514
              +  N     +LPL +FEE+A ATNNF  ++KLGQGGFG VY G+L DGQE+AVKRLS
Sbjct: 498 RHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLS 557

Query: 515 KASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK 574
           K S QG +EF NEV +I++LQH NLVRLL CCV+  EKMLIYEY+ N SLD+ LFD  + 
Sbjct: 558 KTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRN 617

Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
            +L+W+ RF+II GI+RGLLYLH+DSR RIIHRDLKASNILLD+ + PKISDFGMA+IFG
Sbjct: 618 SKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFG 677

Query: 635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF--EDDL 692
            ++ +A+T +VVGT+GYMSPEYAM+G FS KSDVFSFGVLLLEI+S ++N  F+  + DL
Sbjct: 678 RDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDL 737

Query: 693 TILGYAWKLWNENKILALVDPFLSESS--FQLDMIIRCIHVGLLCVQELVKDRPNMSTVV 750
            +LG  W+ W E K L ++DP +++SS  F+   I+RCI +GLLCVQE  +DRP MS V+
Sbjct: 738 NLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVI 797

Query: 751 SMLNSEIRDLPYPKEPAF 768
            ML SE   +P PK P +
Sbjct: 798 LMLGSESTTIPQPKAPGY 815

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64781|Y1639_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61390 OS=Arabidopsis thaliana GN=At1g61390 PE=2 SV=1

 Score =  669 bits (1726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/805 (43%), Positives = 506/805 (62%), Gaps = 40/805 (4%)

Query: 1   MIPIALLIILLSCFCLDFA-VAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRY 59
           M+  A L++L+      +A +   S ++  Q +  PD +      ++LGFF+P +S  +Y
Sbjct: 24  MVIFACLLLLIIFPTFGYADINTSSPLSIGQTLSSPDGV------YELGFFSPNNSRKQY 77

Query: 60  MGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNS 119
           +GIW+   + + V+WVANRD P+  ++  +TIS +G+L+L++G ++V+WS+  +   +N 
Sbjct: 78  VGIWFKNIAPQVVVWVANRDKPVTKTAANLTISSNGSLILLDGTQDVIWSTGEA-FTSNK 136

Query: 120 TSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDP 179
             A+LLD+GNLV+ D+++   +W+SF+   ++ LP      D   GK   LTSW+S SDP
Sbjct: 137 CHAELLDTGNLVVIDDVSGKTLWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDP 196

Query: 180 STGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLF----------- 228
           S G F+     Q  P+  +   S PYWRSGPW    F GIP + + Y+            
Sbjct: 197 SPGEFTLEFTPQVPPQGLIRRGSSPYWRSGPWAKTRFSGIPGIDASYVSPFTVLQDVAKG 256

Query: 229 RHNFTFGFANDW--TFFALTAQGILEERIWIKWKD--NWEVGFLNLRTECDVYGKCGAFG 284
             +F++    ++  ++  LT++G ++    I W D  +W++ F    + CD+Y  CG FG
Sbjct: 257 TASFSYSMLRNYKLSYVTLTSEGKMK----ILWNDGKSWKLHFEAPTSSCDLYRACGPFG 312

Query: 285 ICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKE-DGFSKL 343
           +C     P C CL+GF PK+ +EW +GNWTSGC+RR++L C   + T   GKE D F  +
Sbjct: 313 LCVRSRNPKCICLKGFVPKSDDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYHM 372

Query: 344 NKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGT 403
            ++K PD  +       ++C + CL NCSC A+A+  GIGC+VW    L+D  +    G 
Sbjct: 373 TRVKTPDLYQLAGFLNAEQCYQDCLGNCSCTAFAYISGIGCLVWNR-ELVDTVQFLSDGE 431

Query: 404 DLYIRVANSDVDEKGKKDVFVSPLIK-GMFALAICTLFL-WRWIAKRKE----VIAKLSA 457
            L +R+A+S++    +  + +   +   +F + +   +  WR+  K+ E     I     
Sbjct: 432 SLSLRLASSELAGSNRTKIILGTTVSLSIFVILVFAAYKSWRYRTKQNEPNPMFIHSSQD 491

Query: 458 TNVNTVKLQDLP---LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLS 514
                ++ QD+    LF    + TATNNF  S+KLGQGGFGPVY G+L DG+EIAVKRLS
Sbjct: 492 AWAKDMEPQDVSGVNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKRLS 551

Query: 515 KASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK 574
            +SGQG +EFMNE+ +ISKLQH+NLVRLLGCC++GEEK+LIYEY+ N+SLD  LFD   K
Sbjct: 552 SSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDSTLK 611

Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
             +DW+KRFNII+G++RGLLYLHRDSRLR+IHRDLK SNILLDE++ PKISDFG+A++  
Sbjct: 612 FEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQ 671

Query: 635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTI 694
           G Q Q +T RVVGT GYM+PEYA  G FSEKSD++SFGVLLLEI+ G K + F E+  T+
Sbjct: 672 GTQYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSEEGKTL 731

Query: 695 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 754
           L YAW+ W E K + L+D  L++SS   + + RC+ +GLLCVQ    DRPN   ++SML 
Sbjct: 732 LAYAWESWCETKGVDLLDQALADSSHPAE-VGRCVQIGLLCVQHQPADRPNTLELMSMLT 790

Query: 755 SEIRDLPYPKEPAFTERQGADDSES 779
           + I +LP PK+P FT     DDS S
Sbjct: 791 T-ISELPSPKQPTFTVHSRDDDSTS 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64783|Y1137_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61370 OS=Arabidopsis thaliana GN=At1g61370 PE=3 SV=2

 Score =  667 bits (1721), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/799 (44%), Positives = 505/799 (63%), Gaps = 41/799 (5%)

Query: 6   LLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYD 65
           LLII  SC     A+   S ++  Q +  P     NG+ ++LGFF+P +S  +Y+GIW+ 
Sbjct: 15  LLIIFPSCAFA--AITRASPLSIGQTLSSP-----NGT-YELGFFSPNNSRNQYVGIWFK 66

Query: 66  MPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLL 125
             + + V+WVANRD P+ +++  +TI+ +G+L+LV  ++ V+WS       +N   A+LL
Sbjct: 67  NITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWSIG-ETFSSNELRAELL 125

Query: 126 DSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFS 185
           ++GNLVL D ++   +WESF+   D+ L       D    KK  L+SWK+ +DPS G F 
Sbjct: 126 ENGNLVLIDGVSERNLWESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKNPTDPSPGEFV 185

Query: 186 AGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFA-------- 237
           A L  Q  P+ F+   SRPYWR GPW    F GIPE+   ++ + + +   A        
Sbjct: 186 AELTTQVPPQGFIMRGSRPYWRGGPWARVRFTGIPEMDGSHVSKFDISQDVAAGTGSLTY 245

Query: 238 ------NDWTFFALTAQGILEERIWIKWKDN--WEVGFLNLRTECDVYGKCGAFGICNSQ 289
                 ++ ++  LT+ G L+    I W +   W        + CDVY  CG FG+C   
Sbjct: 246 SLERRNSNLSYTTLTSAGSLK----IIWNNGSGWVTDLEAPVSSCDVYNTCGPFGLCIRS 301

Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCE-RRNITGKVGKEDGFSKLNKMKV 348
             P C CL+GF PK+ EEWN+ NWT GC+RR+ L C+   + T +    D F  +  +K 
Sbjct: 302 NPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDIFDIVANVKP 361

Query: 349 PDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIR 408
           PDF E+ S   E++C+++CL NCSC A+++   IGC+VW    L+D+ +   GG  L IR
Sbjct: 362 PDFYEYLSLINEEDCQQRCLGNCSCTAFSYIEQIGCLVWNR-ELVDVMQFVAGGETLSIR 420

Query: 409 VANSDVDEKGKKDVFVSPL--IKGMFALAICTLFLWRWIAKRKEVIAKLSATNVNT---- 462
           +A+S++    +  + V+ +  I     L   + + WR+ AK+ +       T+ +     
Sbjct: 421 LASSELAGSNRVKIIVASIVSISVFMILVFASYWYWRYKAKQNDSNPIPLETSQDAWREQ 480

Query: 463 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
           +K QD+  F  + + T TNNF + +KLGQGGFGPVY G L+DG+EIA+KRLS  SGQGLE
Sbjct: 481 LKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLE 540

Query: 523 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 582
           EFMNE+++ISKLQHRNLVRLLGCC+EGEEK+LIYE+M N+SL+  +FD  KK  LDW KR
Sbjct: 541 EFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKR 600

Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
           F II+GI+ GLLYLHRDS LR++HRD+K SNILLDEE+NPKISDFG+A++F G Q QA+T
Sbjct: 601 FEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANT 660

Query: 643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF--EDDLTILGYAWK 700
            RVVGT GYMSPEYA  G FSEKSD+++FGVLLLEI++G++ +SF   E+  T+L +AW 
Sbjct: 661 RRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGKTLLEFAWD 720

Query: 701 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL 760
            W E+    L+D  +S S  + + + RC+ +GLLC+Q+   DRPN++ V+SML + + DL
Sbjct: 721 SWCESGGSDLLDQDISSSGSESE-VARCVQIGLLCIQQQAGDRPNIAQVMSMLTTTM-DL 778

Query: 761 PYPKEPAFTERQGADDSES 779
           P PK+P F  +    DSES
Sbjct: 779 PKPKQPVFAMQVQESDSES 797

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  659 bits (1699), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/809 (44%), Positives = 493/809 (60%), Gaps = 69/809 (8%)

Query: 11  LSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEK 70
            S +  +F+     +I+S++ I  P  I      F+LGFFNP  S   Y+GIWY +   +
Sbjct: 23  FSVYASNFSATESLTISSNKTIISPSQI------FELGFFNPDSSSRWYLGIWYKIIPIR 76

Query: 71  AVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNL-VNNSTSAQLLDSGN 129
             +WVANRDNPL  S+G + IS D NLV+ +     +WS+N++   V +  +A+LLD GN
Sbjct: 77  TYVWVANRDNPLSSSNGTLKIS-DNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGN 135

Query: 130 LVLRDNINR---AIVWESFQEPTDSFLPGMHHGIDQRTGKKVQ-LTSWKSLSDPSTGSFS 185
            VLRD+ N      +W+SF  PTD+ L  M  G D ++G   + L SWK+  DPS+G FS
Sbjct: 136 FVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFS 195

Query: 186 AGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFT-----------F 234
             L     PE +++N     +RSGPW G  F  +P +K V    ++FT            
Sbjct: 196 TKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRV 255

Query: 235 GFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPIC 294
              N ++  +L++ G+L+   W++   +W+  + + +  CD Y +CG +G C++   PIC
Sbjct: 256 NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPIC 315

Query: 295 SCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEW 354
           +C++GFEP N +   R + + GC+R++KL C+ R         DGF +L KM++PD TE 
Sbjct: 316 NCIKGFEPMNEQAALRDD-SVGCVRKTKLSCDGR---------DGFVRLKKMRLPDTTET 365

Query: 355 T--SPATEDECREQCLKNCSCIAYA----FDGGIGCMVWRSINLIDIQRLPFGGTDLYIR 408
           +        EC E+CLK C+C A+A     +GG GC++W S  L DI+    GG DLY+R
Sbjct: 366 SVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIW-SGGLFDIRNYAKGGQDLYVR 424

Query: 409 VANSDVDEK---GKKDVFVSPLIKGMFALAICTLFLWRWIAKRKEVI------------- 452
           VA  D+++K    KK +  S  +  +  L+      W+   KR   I             
Sbjct: 425 VAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDS 484

Query: 453 --------AKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD 504
                   ++   +  N     +LPL +++ LA ATNNF   +KLGQGGFG VY G L D
Sbjct: 485 LMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLD 544

Query: 505 GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564
           G+EIAVKRLSK S QG +EFMNEV +I+KLQH NLVRLLGCCV+  EKMLIYEY+ N SL
Sbjct: 545 GKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSL 604

Query: 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624
           D+ LFD  +   L+W+KRF+II GI+RGLLYLH+DSR RIIHRDLKASN+LLD+ + PKI
Sbjct: 605 DSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKI 664

Query: 625 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN 684
           SDFGMA+IFG  + +A+T RVVGT+GYMSPEYAM+G FS KSDVFSFGVLLLEI+SG++N
Sbjct: 665 SDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRN 724

Query: 685 TSFFED--DLTILGYAWKLWNENKILALVDPF---LSESSFQLDMIIRCIHVGLLCVQEL 739
             F+    DL +LG+ W+ W E K L +VDP       S F    I+RCI +GLLCVQE 
Sbjct: 725 KGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQER 784

Query: 740 VKDRPNMSTVVSMLNSEIRDLPYPKEPAF 768
            +DRP MS+V+ ML SE   +P PK P F
Sbjct: 785 AEDRPVMSSVMVMLGSETTAIPQPKRPGF 813

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	807
224114125	832	predicted protein [Populus trichocarpa]	0.959	0.930	0.604	0.0
359496521	844	PREDICTED: G-type lectin S-receptor-like	0.950	0.908	0.614	0.0
224114137	827	predicted protein [Populus trichocarpa]	0.956	0.933	0.595	0.0
224078778	831	predicted protein [Populus trichocarpa]	0.965	0.937	0.595	0.0
147840284	827	hypothetical protein VITISV_016155 [Viti	0.933	0.910	0.596	0.0
224112032	824	predicted protein [Populus trichocarpa]	0.947	0.928	0.586	0.0
359496519	854	PREDICTED: G-type lectin S-receptor-like	0.942	0.891	0.597	0.0
224114141	824	predicted protein [Populus trichocarpa]	0.947	0.928	0.585	0.0
296084622	817	unnamed protein product [Vitis vinifera]	0.949	0.937	0.608	0.0
359496538	887	PREDICTED: G-type lectin S-receptor-like	0.929	0.845	0.604	0.0

>gi|224114125|ref|XP_002316674.1| predicted protein [Populus trichocarpa] gi|222859739|gb|EEE97286.1| predicted protein [Populus trichocarpa]

 Score =  984 bits (2544), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 494/817 (60%), Positives = 606/817 (74%), Gaps = 43/817 (5%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           I  L ++L CFCL+F  +ID+ I+ SQ IRDP+ I+S G  F+LGFF+P +S  RY+ IW
Sbjct: 9   IIALHLILYCFCLEFGASIDT-ISLSQFIRDPETIVSAGKKFELGFFSPVNSTNRYVAIW 67

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y   S    +WVANR+ PL DSSGI+TISEDGNLV++NGQKE LWSSNVS  +N+S  AQ
Sbjct: 68  YSNISITTPVWVANRNKPLNDSSGIMTISEDGNLVVLNGQKETLWSSNVSTGMNDS-RAQ 126

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           L+D GNLVL  + N   +W+SFQEP+D+++P M    + RTGKK  LTSWKS SDPS GS
Sbjct: 127 LMDDGNLVLGGSENGNSLWQSFQEPSDTYIPKMRLTANPRTGKKTPLTSWKSPSDPSIGS 186

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------T 233
           FS G+   +IPE+ +WN SRP WR+GPWNGQ+FIG+PE+ SVYL   N           +
Sbjct: 187 FSLGIDPSSIPEVVLWNDSRPIWRTGPWNGQVFIGVPEMNSVYLDGFNLADDGNGGFTLS 246

Query: 234 FGFAND--WTFFALTAQGILEERIWI-----KWKDNWEVGFLNLRTECDVYGKCGAFGIC 286
            GFA++   T F L+++G   +  W       W+  WE    +++ ECDVYGKCG+F  C
Sbjct: 247 VGFADESYITNFVLSSEGKFGQVFWDDMNEGSWRYQWE----SVQDECDVYGKCGSFASC 302

Query: 287 NSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKM 346
           +++  PICSCL+GFEPKNA+EWN  NWT GC+RR  ++CER    G++GKEDGFSKL ++
Sbjct: 303 DAKNTPICSCLKGFEPKNADEWNSRNWTHGCVRRKAMRCERIQNGGELGKEDGFSKLERV 362

Query: 347 KVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLY 406
           KVP F EW+S  TE +CR+ C  NCSCIAYA+  GI CM+W+  NL DI++   GG DLY
Sbjct: 363 KVPGFAEWSSSITEQKCRDDCWNNCSCIAYAYYTGIYCMLWKG-NLTDIKKFSSGGADLY 421

Query: 407 IRVANSDVDEK--GKKDVFVSPLIKGMFALAICTLFLWRWI-----------AKRKEVI- 452
           IR+A +++D K    K +    ++ G  A+AIC  + WRWI            KRK  I 
Sbjct: 422 IRLAYTELDNKKINMKVIISLTVVVGAIAIAICVFYSWRWIERKRTSKKVLLPKRKHPIL 481

Query: 453 --AKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAV 510
               +   N+N VKLQ+LPLF  + L  AT+NF  ++KLGQGGFGPVY G+  DGQEIA+
Sbjct: 482 LDENVIQDNLNHVKLQELPLFSLQMLIVATDNFNTANKLGQGGFGPVYKGKFPDGQEIAL 541

Query: 511 KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 570
           KRLS+ASGQG EEFM EV+VISKLQH NLVRLLGCCVEGEEKML+YEYMPNRSLDA LFD
Sbjct: 542 KRLSRASGQGQEEFMTEVVVISKLQHMNLVRLLGCCVEGEEKMLVYEYMPNRSLDAFLFD 601

Query: 571 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
           P +K+ LDW+KRFNI+EGI RGLLYLHRDSRLRIIHRDLKASNILLD+ELNPKISDFGMA
Sbjct: 602 PSRKQLLDWKKRFNIVEGICRGLLYLHRDSRLRIIHRDLKASNILLDQELNPKISDFGMA 661

Query: 631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF-- 688
           +IFG N+DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI+SGRKNTSF+  
Sbjct: 662 RIFGRNEDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIISGRKNTSFYGN 721

Query: 689 EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMST 748
           E+ L++LGYAWKLWNE  I ALVDP +S  SF  + I RC+HVGLLCVQE  KDRP + T
Sbjct: 722 EEALSLLGYAWKLWNEGNIAALVDPGISYPSFH-EEIFRCVHVGLLCVQEFAKDRPAIFT 780

Query: 749 VVSMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQQ 785
           V+SMLNSEI DLP PK+PAF+ER+   D+ S +  Q+
Sbjct: 781 VISMLNSEIVDLPTPKQPAFSERRSELDTASLQHDQR 817

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496521|ref|XP_002262970.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera]

 Score =  983 bits (2540), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 506/824 (61%), Positives = 616/824 (74%), Gaps = 57/824 (6%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           +  L++LLS  C  F  AID+ +TS++ I DP+ ++SNGS FKLGFF+ ADS  RY+GIW
Sbjct: 9   VIALLLLLSVICFGFCTAIDT-MTSTRFIEDPETLVSNGSAFKLGFFSLADSTNRYVGIW 67

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y  PS   VIWVANRD PL DSSGI+TISEDGNL+++NGQKE++WSSNVSN   NS SAQ
Sbjct: 68  YSTPSLSTVIWVANRDKPLNDSSGIVTISEDGNLLVMNGQKEIVWSSNVSNASANS-SAQ 126

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           LLDSGNLVL+DN + +I WES Q P+ S LP M    D  TG+KV LTSWKS SDPS GS
Sbjct: 127 LLDSGNLVLQDN-SGSITWESIQHPSHSLLPNMKISTDTNTGEKVVLTSWKSPSDPSIGS 185

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------- 232
           FS G+   NIP+IF+WN S PYWRSGPW+ QIFIGIP++ SVY  R  F           
Sbjct: 186 FSLGMNPLNIPQIFIWNGSHPYWRSGPWSSQIFIGIPDMDSVY--RSGFQVVDDKEGTVY 243

Query: 233 -TFGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQ 289
            TF  AN   + ++ LT+QG L +      K+ W V + + ++ECDVYG CGAFGICNS 
Sbjct: 244 ATFTEANSSIFLYYVLTSQGSLVQTDREYGKEEWGVTWRSNKSECDVYGTCGAFGICNSG 303

Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVP 349
             PICSCL G+EPK  EEW+RGNWTSGC+R++ LQCER N +G+ GK DGF +L  +KVP
Sbjct: 304 TSPICSCLRGYEPKYTEEWSRGNWTSGCVRKTTLQCERTNSSGQQGKIDGFFRLTTVKVP 363

Query: 350 DFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRV 409
           D+ +W S A EDECRE+CLKNCSCIAY++  GIGCM+W S +LID+Q+    G DLYIR+
Sbjct: 364 DYADW-SLAHEDECREECLKNCSCIAYSYYSGIGCMLW-SGSLIDLQKFTKRGADLYIRL 421

Query: 410 ANSDVDEKGKKDVFV---SPLIKGMFALAICTLFLWRWIA------KRKEVIAK------ 454
           A+S++  K K+D+ V     ++ G  A+AICT FLWRWI       K KE++        
Sbjct: 422 AHSELG-KNKRDMKVIISVTIVIGTIAIAICTYFLWRWIGRQAVKEKSKEILPSDRGHAY 480

Query: 455 ------LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI 508
                 +   NVN VKL++LPL  FE+LA ATNNF  ++KLGQGGFGPVY G L  GQ+I
Sbjct: 481 QNYDMNMLGDNVNRVKLEELPLLDFEKLAAATNNFHEANKLGQGGFGPVYRGNLPGGQKI 540

Query: 509 AVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG-C----------CVEGEEKMLIYE 557
           AVKRLS+AS QG EEFMNE++VISK+QHRNLVRLLG C          C+EG+EK+LIYE
Sbjct: 541 AVKRLSRASAQGQEEFMNEMIVISKIQHRNLVRLLGFCIEGDVRLLGFCIEGDEKLLIYE 600

Query: 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617
           YMPN+SLDA LFDPLK+E LDWR+RF+IIEGI RGLLYLHRDSRL+IIHRDLKASNILLD
Sbjct: 601 YMPNKSLDAFLFDPLKRESLDWRRRFSIIEGIGRGLLYLHRDSRLKIIHRDLKASNILLD 660

Query: 618 EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLE 677
           E+LN KISDFGMA+IFG NQDQA+T RVVGT+GYMSPEYAM G+FSEKSDVFSFGVLLLE
Sbjct: 661 EDLNAKISDFGMARIFGSNQDQANTMRVVGTYGYMSPEYAMGGQFSEKSDVFSFGVLLLE 720

Query: 678 IVSGRKNTSFFEDD--LTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLC 735
           IVSGR+NTSF  DD  +++LGYAW LW ++ I  L+D  ++E+ FQ + I RCIHVGLLC
Sbjct: 721 IVSGRRNTSFQYDDQHMSLLGYAWTLWCQHNIQELIDETIAEACFQ-EEISRCIHVGLLC 779

Query: 736 VQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSES 779
           VQE  KDRP++STV+SML+SEI  LP PK+P F E+Q A D+ES
Sbjct: 780 VQESAKDRPSISTVLSMLSSEIAHLPSPKQPPFLEKQTAIDTES 823

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224114137|ref|XP_002316677.1| predicted protein [Populus trichocarpa] gi|222859742|gb|EEE97289.1| predicted protein [Populus trichocarpa]

 Score =  966 bits (2497), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 484/813 (59%), Positives = 601/813 (73%), Gaps = 41/813 (5%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           IA L+IL  CFC +F  ++D+ ITSSQ I+DP+ I+S G+ FKLGFF+P +S  RY  IW
Sbjct: 10  IAFLLILY-CFCWEFGASVDT-ITSSQYIKDPEDIVSAGNKFKLGFFSPVNSTNRYAAIW 67

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y   S    +WVANR+ PL DSSGI+TISEDGNLV++NGQKE+LWSSNVS  +N+S  AQ
Sbjct: 68  YSNISITTPVWVANRNMPLNDSSGIMTISEDGNLVVLNGQKEILWSSNVSTGMNDS-RAQ 126

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           L+D GNLVL  + N   +W+SFQEP+D+++P M    + RTGKK  L SW S+SDPS GS
Sbjct: 127 LMDDGNLVLGGSENGNSLWQSFQEPSDTYMPKMRLTANSRTGKKTLLKSWTSVSDPSIGS 186

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHN----------FT 233
            S G+    IP+ ++WN SRP WR+GPWNGQ+FIGIPE+ SVYL   N           +
Sbjct: 187 ISGGIDPSRIPQFYIWNGSRPIWRTGPWNGQVFIGIPEMVSVYLDGFNIADEGNGTFTLS 246

Query: 234 FGFANDWTF--FALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
            GFAN+     + L+++G   + +W   + +W   +   + ECDVYGKCG+FG CN ++ 
Sbjct: 247 VGFANESLISNYILSSEGKFGKVLWDDTEGSWRYEWKFPKDECDVYGKCGSFGSCNPKDS 306

Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
           PICSCL+GFEPKNA+EWN GNWT+GC+RR +LQCER    G+VGKEDGF KL +MKVPDF
Sbjct: 307 PICSCLKGFEPKNADEWNNGNWTNGCVRRRELQCERTQNGGQVGKEDGFLKLERMKVPDF 366

Query: 352 TEWTSPATEDECREQCLK-NCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVA 410
           +EW S  +E  C+ +CL  NCSCIAY++  G GCM+WR  NL D+++ P    DLYIR+A
Sbjct: 367 SEWLSSTSEHTCKNECLNINCSCIAYSYYPGFGCMLWRG-NLTDLKKFPIKAADLYIRLA 425

Query: 411 NSDVDEK--GKKDVFVSPLIKGMFALAICTLFLWR-----------WIAKRKEVIAKLS- 456
           +S++D K    K +    ++ G  A+AIC  + WR           +++KRK     LS 
Sbjct: 426 DSELDNKKINLKVIISLTVVVGAIAIAICVFYSWRRIDRKRKSKKVFLSKRKVGYPILSD 485

Query: 457 ----ATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR 512
                 N+N VKLQ+LPLF  + L  AT+NF  ++KLGQGGFGPVY G L DGQEIAVKR
Sbjct: 486 ENMIQDNLNHVKLQELPLFSLQTLIAATDNFNTANKLGQGGFGPVYKGNLSDGQEIAVKR 545

Query: 513 LSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL 572
           LS++SGQGLEEFMNEV+VISKLQHRNLVR+LGCCVEGEEKMLIYEYMPN+SLDA LFD L
Sbjct: 546 LSRSSGQGLEEFMNEVVVISKLQHRNLVRILGCCVEGEEKMLIYEYMPNKSLDAFLFDSL 605

Query: 573 KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
           +K+ LDW+ RF I+EGI RGLLYLHRDSRLRIIHRDLKASNILLD+ELNPKISDFGMA+I
Sbjct: 606 RKQLLDWKNRFKIVEGICRGLLYLHRDSRLRIIHRDLKASNILLDQELNPKISDFGMARI 665

Query: 633 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 692
           FG ++DQA+T RVVGT+GYMSPEYAMEGRFSEKSDVFSFGVLLLE +SGRKNT++F    
Sbjct: 666 FGNHEDQANTRRVVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLETISGRKNTTYF---- 721

Query: 693 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM 752
            +   AWKLWNE  I ALVDP +S  SF  + I RC+HVGLLCVQE  KDRP + TV+SM
Sbjct: 722 -LTSQAWKLWNEGNIAALVDPGISYPSFH-EEIFRCVHVGLLCVQEFAKDRPAIFTVISM 779

Query: 753 LNSEIRDLPYPKEPAFTERQGADDSESFKQIQQ 785
           LNSEI DLP PK+PAF+ER+   D++S +  Q+
Sbjct: 780 LNSEIADLPTPKQPAFSERRSELDTKSLQHDQR 812

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224078778|ref|XP_002305625.1| predicted protein [Populus trichocarpa] gi|222848589|gb|EEE86136.1| predicted protein [Populus trichocarpa]

 Score =  948 bits (2450), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 486/816 (59%), Positives = 602/816 (73%), Gaps = 37/816 (4%)

Query: 2   IPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMG 61
           I +ALL+ L S FC++   AID+ ITS+Q ++DP+AI+SNG+ + LGFF+P +S  RY+G
Sbjct: 8   ISVALLL-LTSSFCVEIITAIDT-ITSTQFLKDPEAIVSNGNIYTLGFFSPVNSTDRYVG 65

Query: 62  IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
           IW++       IWVANR+NPL DSSGI+ IS+DG LV++NGQ+E+LWS+NVSN V+NS S
Sbjct: 66  IWFNEVPVVTAIWVANRNNPLNDSSGILAISKDGALVVLNGQQEILWSTNVSNFVSNS-S 124

Query: 122 AQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPST 181
           AQL D+GNLVLRDN N  I+WESFQ P+D+F   M    ++RTG K  +TSWKS +DPS 
Sbjct: 125 AQLSDTGNLVLRDNNNEEIMWESFQYPSDTFFSNMKLSANKRTGGKTLITSWKSATDPSI 184

Query: 182 GSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHN---------- 231
           GSFSAGL H +IPEIF+W  + PY+RSGPWN  +FIG+P + S  +   N          
Sbjct: 185 GSFSAGLNHLDIPEIFIWKDNYPYFRSGPWNRLVFIGVPYMNSAAVDGLNLVDDGEGTID 244

Query: 232 FTFGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQ 289
            TF +AN    + F LT+QG LE+  W    ++  V +     +C+ YG+CG FG CN+Q
Sbjct: 245 LTFSYANQSIMSSFVLTSQGQLEQTRWEHGMEDRIVLWSVPMFDCEFYGRCGLFGSCNAQ 304

Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCER-RNITGKVGKEDGFSKLNKMKV 348
             PICSCL GFEP N EEW  GNWT GCIRR  LQCER ++ +   GK D F KL  MKV
Sbjct: 305 ASPICSCLRGFEPNNPEEWYVGNWTGGCIRRKSLQCERVKSESEAAGKNDVFLKLGNMKV 364

Query: 349 PDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIR 408
           PD  +W S  TE EC+++CL NCSCIAYA+D GIGCM W   +LID+Q  P GG DLYIR
Sbjct: 365 PDLAQW-SRLTEIECKDKCLTNCSCIAYAYDSGIGCMSWIG-DLIDVQEFPTGGADLYIR 422

Query: 409 VANSDVDEKGKKD--VFVSPLIKGMFALAICTLFLWRWIAK-RKEVIAK----------- 454
           +A S++D   +K   V VS +I  + +  IC L  WR+++K R E +             
Sbjct: 423 MAYSELDGNHRKKVIVIVSAVIGTITSAMICALLTWRFMSKHRGEKLHSDTNEKHPSFLD 482

Query: 455 --LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR 512
             ++  +++ VKLQ+LPLF  E L  AT+ F LS+KLGQGGFGPVY G+L DG+EIAVKR
Sbjct: 483 RDMAGDSMDHVKLQELPLFSLESLTAATDGFDLSNKLGQGGFGPVYKGKLSDGKEIAVKR 542

Query: 513 LSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL 572
           LS+ASGQGL+EFMNEV VISKLQHRNLVRLLGCCVEGEEK+L+YEYMPN+SLDA L+DPL
Sbjct: 543 LSRASGQGLKEFMNEVEVISKLQHRNLVRLLGCCVEGEEKLLVYEYMPNKSLDAFLYDPL 602

Query: 573 KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
           +K+ LDW+KRFNIIEGI RGLLYLHRDSRLRIIHRDLKASNILLD EL PKISDFG A+I
Sbjct: 603 RKQLLDWKKRFNIIEGICRGLLYLHRDSRLRIIHRDLKASNILLDPELKPKISDFGAARI 662

Query: 633 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF--ED 690
           FGG++DQA+T RVVGT+GY+SPEYAMEGRFSEKSDV+SFGVLLLEIVSGR+NTSF+  E 
Sbjct: 663 FGGDEDQANTIRVVGTYGYISPEYAMEGRFSEKSDVYSFGVLLLEIVSGRRNTSFYGNEQ 722

Query: 691 DLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVV 750
            L++LG+AWKLWNE  I ALVDP +S+ S Q++ I RCIHVGLLCVQE  +DRP  STVV
Sbjct: 723 ALSLLGFAWKLWNEGNISALVDPAISDPSSQVE-IFRCIHVGLLCVQEFPEDRPTASTVV 781

Query: 751 SMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQQR 786
           SMLNSEI  L  PK+P F ER+   + E   Q +++
Sbjct: 782 SMLNSEISYLATPKQPPFAERKYHFNEERPHQNEEK 817

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147840284|emb|CAN63987.1| hypothetical protein VITISV_016155 [Vitis vinifera]

 Score =  948 bits (2450), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 486/815 (59%), Positives = 590/815 (72%), Gaps = 62/815 (7%)

Query: 12  SCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKA 71
           S  C  F  A D+ ITS+Q I+DP+ ++SNGS FK+GFF+P +S  RY GIWY+  S   
Sbjct: 17  SGLCFQFCTATDT-ITSTQFIKDPETMVSNGSLFKMGFFSPGNSTKRYFGIWYNSTSLFT 75

Query: 72  VIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLV 131
           VIW+ANR+NPL DSSGI+ +SEDGNL+++N QKE+ WSSNVSN   NS  AQLLDSGNLV
Sbjct: 76  VIWIANRENPLNDSSGIVMVSEDGNLLVLNDQKEIFWSSNVSNAALNS-RAQLLDSGNLV 134

Query: 132 LRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQ 191
           L+D  +  I W+SFQ P+ +FL  M    + +TG+K  LTSWKS SDPS GSFS G+   
Sbjct: 135 LQDKNSGRITWQSFQHPSHAFLQKMELSENMKTGEKQGLTSWKSPSDPSVGSFSTGIDPS 194

Query: 192 NIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFR----------HNFTFGFANDWT 241
           +IPEIFVWN SRP+WRSGPWNGQ  IG+P++  +  F             F   +A+   
Sbjct: 195 DIPEIFVWNGSRPFWRSGPWNGQTLIGVPDMNYLNGFHIVNDKEGNVSVTFEHAYASILW 254

Query: 242 FFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFE 301
           ++ L+ QG + E        NWE+ + + +TECDVYGKCGAFGICN++  PICSCL G+E
Sbjct: 255 YYVLSPQGTIVEIYSDDGMKNWEITWQSRKTECDVYGKCGAFGICNAKNSPICSCLRGYE 314

Query: 302 PKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATED 361
           P+N EEW+RGNWT GC+R++  QCE+ N + + G+ DGF +L  +KVPDF EW S A ED
Sbjct: 315 PRNIEEWSRGNWTGGCVRKTPFQCEKINGSMEEGEADGFIRLTTVKVPDFAEW-SLALED 373

Query: 362 ECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKD 421
           +C+E CLKNCSCIAYA+  GIGCM W S NL D+Q+    G DLYIRV  S++       
Sbjct: 374 DCKEFCLKNCSCIAYAYYTGIGCMSW-SRNLTDVQKFSSNGADLYIRVPYSEL------- 425

Query: 422 VFVSPLIKGMFALAICTLFLWRWI---------------AKRKEVIAKLSATNV-----N 461
                   G   +A+   F  RWI               + R +V   +S  N+     N
Sbjct: 426 --------GTIFVAVFIYFSRRWITKRRAKNKKRKEMLSSDRGDVHLNVSDANILGDRMN 477

Query: 462 TVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY----------WGRLKDGQEIAVK 511
            VKL++LPL  F +L TATNNF  ++KLGQGGFG VY           GRL +GQEIAVK
Sbjct: 478 QVKLEELPLVDFGKLVTATNNFDEANKLGQGGFGSVYRVMLAHLELHGGRLPEGQEIAVK 537

Query: 512 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 571
           RLS+AS QGLEEFMNEV+VISKLQHRNLVRLLGCC+EG+EKMLIYEYMP +SLDALLFDP
Sbjct: 538 RLSRASAQGLEEFMNEVVVISKLQHRNLVRLLGCCIEGDEKMLIYEYMPKKSLDALLFDP 597

Query: 572 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
           L++E LDW+KRF+IIEGI RGLLYLHRDSRLRIIHRDLKASNILLD  LNPKISDFGMA+
Sbjct: 598 LRQETLDWKKRFSIIEGIGRGLLYLHRDSRLRIIHRDLKASNILLDXNLNPKISDFGMAR 657

Query: 632 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
           IFGGNQDQA+T RVVGT+GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR+N SF+ D+
Sbjct: 658 IFGGNQDQANTIRVVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRRNNSFYHDE 717

Query: 692 --LTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTV 749
             L++LGYAWKLWNE+ I  L+D  +SE+ F  D I+RCIHVGLLCVQEL KDRP++STV
Sbjct: 718 QSLSLLGYAWKLWNEHNIETLIDGSISEACFP-DEILRCIHVGLLCVQELAKDRPSISTV 776

Query: 750 VSMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQ 784
           VSM+ SEI  LP PK+PAFTERQ + D+ES  Q Q
Sbjct: 777 VSMICSEIAXLPTPKKPAFTERQISKDTESXGQSQ 811

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224112032|ref|XP_002332843.1| predicted protein [Populus trichocarpa] gi|222833304|gb|EEE71781.1| predicted protein [Populus trichocarpa]

 Score =  944 bits (2441), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 471/803 (58%), Positives = 587/803 (73%), Gaps = 38/803 (4%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           +A L +LL CFC     A+D+ ITSSQ I+DP+A++S G+ FKLGFF+P +S  RY+GIW
Sbjct: 1   MAALRLLLCCFCWQLGAAVDT-ITSSQYIKDPEAVVSAGNKFKLGFFSPGNSTNRYVGIW 59

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y   S    +W+ANR+ PL DSSGI+TISEDGN+V+++G+KE+LWSSNVSN V+NS SAQ
Sbjct: 60  YSNISVTTPVWIANRNKPLNDSSGIMTISEDGNIVVLDGRKEILWSSNVSNGVSNS-SAQ 118

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           L D GN++LR       +W+SFQEP+D+F+  M    ++RTGKK Q+TSWKS SDPS GS
Sbjct: 119 LTDDGNVILRGGEIGNSLWQSFQEPSDTFMLKMRLTANRRTGKKTQITSWKSPSDPSVGS 178

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------T 233
           FS+G+   +IPE+FVWN SRP+WRSGPWNGQ FIGIPE+ SVYL  +N           +
Sbjct: 179 FSSGIEPSSIPEVFVWNDSRPFWRSGPWNGQAFIGIPEMNSVYLNGYNLVQDGDGTFSLS 238

Query: 234 FGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
            G AN+   T FAL+ +G   E  W    + WE        +CD+YGKCG FG CN+Q  
Sbjct: 239 VGLANESYITNFALSYEGRFGEMYWDSANERWEHKKQYPGDDCDIYGKCGPFGFCNTQNS 298

Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
            IC CL+GFEPKN++EWNR NWT+GC+RR +L+CER    G+V KED F KL+K+KVPDF
Sbjct: 299 LICRCLKGFEPKNSDEWNRRNWTNGCVRRRELKCERTQSDGQVPKEDEFLKLDKVKVPDF 358

Query: 352 TEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVAN 411
           +EW+S A+E  C+++CL NCSCIAY++  GIGCM+WR   L DI++   GG +LY+R+A+
Sbjct: 359 SEWSSSASEQNCKDECLNNCSCIAYSYHTGIGCMLWRG-KLTDIRKFSSGGANLYVRLAD 417

Query: 412 SDVDE-KGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKE-------------------- 450
            +  + +  K V    ++ G   +A+   F WR +AK +E                    
Sbjct: 418 LEFGKNRDMKAVICITVVTGAIIVAVGAFFWWRRMAKYRERKRESERILSSRRKKGYPIF 477

Query: 451 VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAV 510
               L   ++N VK Q+LPLF+ + L  AT+ F  ++KLG+GGFGPVY G L DGQEIAV
Sbjct: 478 FNGNLIQESMNQVKFQELPLFKLQMLIAATDYFDAANKLGEGGFGPVYRGNLPDGQEIAV 537

Query: 511 KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 570
           KRLS+ASGQG EEFMNEV+VIS+LQHRNLVRLLGCCVEG+EKML+YEYMPN+SLDA LFD
Sbjct: 538 KRLSRASGQGQEEFMNEVVVISELQHRNLVRLLGCCVEGDEKMLVYEYMPNKSLDASLFD 597

Query: 571 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
           P++KE LDW+KRFNI++GI RGLLYLHRDSRLRIIHRDLK SNILLD+ELNPKISDFGMA
Sbjct: 598 PVRKEVLDWKKRFNIVDGICRGLLYLHRDSRLRIIHRDLKPSNILLDQELNPKISDFGMA 657

Query: 631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF--F 688
           +IFGGN+D   T RVVGT+GYMSPEYAM GRFSEKSDVFSFGVLLLEIVSGR++T     
Sbjct: 658 RIFGGNEDHVKTRRVVGTYGYMSPEYAMHGRFSEKSDVFSFGVLLLEIVSGRRSTKIDGN 717

Query: 689 EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMST 748
           E  L +L +AWKLWNE    ALVDP L+   +    I RCIHVGLLCVQE  KDRP +ST
Sbjct: 718 EQGLNLLEFAWKLWNEGNAPALVDPALTLDQYSKVEIFRCIHVGLLCVQEFAKDRPAIST 777

Query: 749 VVSMLNSEIRDLPYPKEPAFTER 771
           ++SMLNSEI DLP P  PA+TER
Sbjct: 778 IISMLNSEIVDLPLPNNPAYTER 800

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496519|ref|XP_002263029.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera]

 Score =  944 bits (2441), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 496/830 (59%), Positives = 598/830 (72%), Gaps = 69/830 (8%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           +  L++LLS  C  F  AID+ +TS++ I DP+ ++S+GS FKLGFF+ ADS  RY+GIW
Sbjct: 9   VIALLLLLSVICFGFCTAIDT-MTSTRFIEDPETLVSDGSAFKLGFFSLADSTNRYVGIW 67

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y  PS   +IWVANRD PL DSSG++TISEDGNL+++NGQKE+ WS+NVSN   NS SAQ
Sbjct: 68  YSTPSLSTIIWVANRDKPLNDSSGLVTISEDGNLLVMNGQKEIFWSTNVSNAAANS-SAQ 126

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           LLDSGNLVLRDN  R I WES Q P+ SFLP M    D  +G+KV LTSWKS SDPS GS
Sbjct: 127 LLDSGNLVLRDNSGR-ITWESIQHPSHSFLPKMKISADTDSGEKVVLTSWKSPSDPSIGS 185

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIG-----IPELKSVYLFRHNF------ 232
           FS G+   NIP+ FVWN S PYWRSGPWNGQIFIG     +P++ SV+L    F      
Sbjct: 186 FSLGMNPLNIPQAFVWNGSHPYWRSGPWNGQIFIGQIYIGVPKMNSVFLNGFGFQVVDDK 245

Query: 233 ------TFGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFG 284
                 TF  AN   + ++ LT QG + E      K+ WEV + +  +ECDVYG CGAFG
Sbjct: 246 AGTVYETFTLANSSIFLYYVLTPQGTVVETYREDGKEEWEVTWRSNNSECDVYGTCGAFG 305

Query: 285 ICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLN 344
           ICNS   PICSCL G+EPK  EEW+RGNWTSGC+R++ LQCER N +G+ GK DGF +L 
Sbjct: 306 ICNSGNSPICSCLRGYEPKYIEEWSRGNWTSGCVRKTPLQCERTNSSGQQGKLDGFFRLT 365

Query: 345 KMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTD 404
            +KVPDF +W S A EDECREQCLKNCSC+AY++  GIGCM W S NLID+ +   GG D
Sbjct: 366 TVKVPDFADW-SLALEDECREQCLKNCSCMAYSYYSGIGCMSW-SGNLIDLGKFTQGGAD 423

Query: 405 LYIRVANSDVD-----------------EKGKKDVFVSPLIKGMFALAICTLFLWRWIAK 447
           LYIR+ANS+++                 ++  K +    ++ G  A+ I T F WRW  +
Sbjct: 424 LYIRLANSELEWNMRTPKLIKHLMATYKKRDMKAIISVTIVIGTIAIGIYTYFSWRW--R 481

Query: 448 RKEVIAKLS--------------------ATNVNTVKLQDLPLFQFEELATATNNFQLSS 487
           RK+ +   S                      N N  KL++LPL   E+L TATNNF  ++
Sbjct: 482 RKQTVKDKSKEILLSDRGDAYQIYDMNRLGDNANQFKLEELPLLALEKLETATNNFHEAN 541

Query: 488 KLGQGGFGPVY---WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           KLGQGGFGPVY    G+L  GQEIAVKRLS+AS QGLEEF NEV+VISK+QHRNLVRLLG
Sbjct: 542 KLGQGGFGPVYRVMLGKLPGGQEIAVKRLSRASAQGLEEFGNEVVVISKIQHRNLVRLLG 601

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
            C+EG+EK+LIYEYMPN+SLD+ LFDPLK++ LDWR+RFNIIEGI RGLLYLHRDSR RI
Sbjct: 602 YCIEGDEKLLIYEYMPNKSLDSFLFDPLKRDFLDWRRRFNIIEGIGRGLLYLHRDSRFRI 661

Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDLKASNILLDE+L  KISDFG+A+I GGNQDQA+T RVVGT+GYMSPEYAMEGRFSE
Sbjct: 662 IHRDLKASNILLDEDLTAKISDFGIARIVGGNQDQANTMRVVGTYGYMSPEYAMEGRFSE 721

Query: 665 KSDVFSFGVLLLEIVSGRKNTSFFEDD--LTILGYAWKLWNENKILALVDPFLSESSFQL 722
           KSDVFSFGVLLLEIVSGR+NTSF  DD  +++LGYAW LW E+ I  L+D  ++E  FQ 
Sbjct: 722 KSDVFSFGVLLLEIVSGRRNTSFQYDDQYMSLLGYAWTLWCEHNIEELIDEIIAEEGFQ- 780

Query: 723 DMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQ 772
           + I RCIHVGLL VQEL KDRP++STVVSML+SEI  LP PK+P F E+Q
Sbjct: 781 EEISRCIHVGLLAVQELAKDRPSISTVVSMLSSEIAHLPPPKQPPFLEKQ 830

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224114141|ref|XP_002316678.1| predicted protein [Populus trichocarpa] gi|222859743|gb|EEE97290.1| predicted protein [Populus trichocarpa]

 Score =  944 bits (2439), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 470/803 (58%), Positives = 587/803 (73%), Gaps = 38/803 (4%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           +A L +LL CFC     A+D+ ITSSQ I+DP+A++S G+ FKLGFF+P +S  RY+GIW
Sbjct: 1   MAALRLLLCCFCWQLGAAVDT-ITSSQYIKDPEAVVSAGNKFKLGFFSPGNSTNRYVGIW 59

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y   S    +W+ANR+ PL DSSGI+TISEDGN+V+++G+KE+LWSSNVSN V+NS SAQ
Sbjct: 60  YSNISVTTPVWIANRNKPLNDSSGIMTISEDGNIVVLDGRKEILWSSNVSNGVSNS-SAQ 118

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           L D GN++LR       +W+SFQEP+D+F+  M    ++RTGKK Q+TSWKS SDPS GS
Sbjct: 119 LTDDGNVILRGGEIGNSLWQSFQEPSDTFMLKMRLTANRRTGKKTQITSWKSPSDPSVGS 178

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------T 233
           FS+G+   +IPE+FVWN SRP+WRSGPWNGQ FIGIPE+ SVYL  +N           +
Sbjct: 179 FSSGIEPSSIPEVFVWNDSRPFWRSGPWNGQAFIGIPEMNSVYLNGYNLVQDGDGTFSLS 238

Query: 234 FGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
            G AN+   T FAL+ +G   E  W    + WE        +CD+YGKCG FG CN+Q  
Sbjct: 239 VGLANESYITNFALSYEGRFGEMYWDSANERWEHKKQYPGDDCDIYGKCGPFGFCNTQNS 298

Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
            IC CL+GFEPKN++EWNR NWT+GC+RR +L+CER    G+V KED F KL+K+KVPDF
Sbjct: 299 LICRCLKGFEPKNSDEWNRRNWTNGCVRRRELKCERTQSDGQVPKEDEFLKLDKVKVPDF 358

Query: 352 TEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVAN 411
           +EW+S A+E  C+++CL NCSCIAY++  GIGCM+WR   L DI++   GG +LY+R+A+
Sbjct: 359 SEWSSSASEQNCKDECLNNCSCIAYSYHTGIGCMLWRG-KLTDIRKFSSGGANLYVRLAD 417

Query: 412 SDVDE-KGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKE-------------------- 450
            +  + +  K V    ++ G   +A+   F WR +AK +E                    
Sbjct: 418 LEFGKNRDMKAVICITVVTGAIIVAVGAFFWWRRMAKYRERKRESERILSSRRKKGYPIF 477

Query: 451 VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAV 510
               L   ++N VK Q+LPLF+ + L  AT+ F  ++KLG+GGFGPVY G L DGQEIAV
Sbjct: 478 FNGNLIQESMNQVKFQELPLFKLQMLIAATDYFDAANKLGEGGFGPVYRGNLPDGQEIAV 537

Query: 511 KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 570
           KRLS+ASGQG EEFMNEV+VIS+LQH+NLVRLLGCCVEG+EKML+YEYMPN+SLDA LFD
Sbjct: 538 KRLSRASGQGQEEFMNEVVVISELQHKNLVRLLGCCVEGDEKMLVYEYMPNKSLDASLFD 597

Query: 571 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
           P++KE LDW+KRFNI++GI RGLLYLHRDSRLRIIHRDLK SNILLD+ELNPKISDFGMA
Sbjct: 598 PVRKEVLDWKKRFNIVDGICRGLLYLHRDSRLRIIHRDLKPSNILLDQELNPKISDFGMA 657

Query: 631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF--F 688
           +IFGGN+D   T RVVGT+GYMSPEYAM GRFSEKSDVFSFGVLLLEIVSGR++T     
Sbjct: 658 RIFGGNEDHVKTRRVVGTYGYMSPEYAMHGRFSEKSDVFSFGVLLLEIVSGRRSTKIDGN 717

Query: 689 EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMST 748
           E  L +L +AWKLWNE    ALVDP L+   +    I RCIHVGLLCVQE  KDRP +ST
Sbjct: 718 EQGLNLLEFAWKLWNEGNAPALVDPALTLDQYSKVEIFRCIHVGLLCVQEFAKDRPAIST 777

Query: 749 VVSMLNSEIRDLPYPKEPAFTER 771
           ++SMLNSEI DLP P  PA+TER
Sbjct: 778 IISMLNSEIVDLPLPNNPAYTER 800

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296084622|emb|CBI25710.3| unnamed protein product [Vitis vinifera]

 Score =  942 bits (2434), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 483/794 (60%), Positives = 597/794 (75%), Gaps = 28/794 (3%)

Query: 9   ILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPS 68
           +LL+CF   F  +   +ITS+  I+DP+ I+S+G  FKLGFF+   S  RY+GIWY+  S
Sbjct: 11  LLLTCFWFVFGCSAIDTITSTHFIKDPETIVSSGRVFKLGFFSLDGSSNRYVGIWYNTTS 70

Query: 69  EKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSG 128
              +IWVAN+D PL DSSG++TISEDGN+ ++NG+KE+LWSSNVSN    ++SAQL DSG
Sbjct: 71  LLTIIWVANKDRPLNDSSGVLTISEDGNIQVLNGRKEILWSSNVSNPAAVNSSAQLQDSG 130

Query: 129 NLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGL 188
           NLVLRD  N   VWES Q P+ SF+P M    + RT  +  LTSWKS SDPS GSF+AG+
Sbjct: 131 NLVLRDK-NGVSVWESLQNPSHSFVPQMKISTNTRTRVRKVLTSWKSSSDPSMGSFTAGV 189

Query: 189 IHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------TFGFAN 238
              NIP++F+WN SRPYWRSGPW+GQI  G+ ++K + L   N           TF    
Sbjct: 190 EPLNIPQVFIWNGSRPYWRSGPWDGQILTGV-DVKWITLDGLNIVDDKEGTVYVTFAHPE 248

Query: 239 DWTFFA--LTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSC 296
              F+A  LT +GIL E    K  ++WE  +     EC++YGKCG FG CNS++ PICSC
Sbjct: 249 SGFFYAYVLTPEGILVETSRDKRNEDWERVWTTKENECEIYGKCGPFGHCNSRDSPICSC 308

Query: 297 LEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTS 356
           L+G+EPK+ +EWNRGNWT GC+R++ LQCER     +  K DGF KL  MKVPDF E  S
Sbjct: 309 LKGYEPKHTQEWNRGNWTGGCVRKTPLQCERTKNGSEEAKVDGFLKLTNMKVPDFAE-QS 367

Query: 357 PATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDE 416
            A ED+CR+QCL+NCSCIAY++  GIGCM W S +LIDIQ+L   G +L+IRVA+S++ +
Sbjct: 368 YALEDDCRQQCLRNCSCIAYSYYTGIGCMWW-SGDLIDIQKLSSTGANLFIRVAHSELKQ 426

Query: 417 KGKKDV---FVSPLIKGMFALAICTLFLWRWIAKRKE--VIAKLS-----ATNVNTVKLQ 466
             K+D     +  +I G  A+A+CT FL RWIA+++   +I K S        VN VKL+
Sbjct: 427 DRKRDARVIVIVTVIIGTIAIALCTYFLRRWIARQRGNLLIGKFSDPSVPGDGVNQVKLE 486

Query: 467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN 526
           +LPL  F +LATATNNF  ++KLGQGGFGPVY G+L +GQ+IAVKRLS+AS QGLEEFMN
Sbjct: 487 ELPLIDFNKLATATNNFHEANKLGQGGFGPVYRGKLAEGQDIAVKRLSRASTQGLEEFMN 546

Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 586
           EV+VISKLQHRNLVRL+GCC+EG+EKMLIYE+MPN+SLDA LFDP+K++ LDWR RF II
Sbjct: 547 EVVVISKLQHRNLVRLIGCCIEGDEKMLIYEFMPNKSLDASLFDPVKRQILDWRTRFKII 606

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
           EGI RGLLYLHRDSRLRIIHRDLKASNILLDE+LNPKISDFGMA+IFG NQDQA+T RVV
Sbjct: 607 EGIGRGLLYLHRDSRLRIIHRDLKASNILLDEDLNPKISDFGMARIFGSNQDQANTKRVV 666

Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF-EDDLTILGYAWKLWNEN 705
           GT+GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN+SF+ E+  T+LGYAWKLW E+
Sbjct: 667 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNSSFYHEEYFTLLGYAWKLWKED 726

Query: 706 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKE 765
            +  L+D  + E+ FQ + I+RCIHVGLLCVQEL KDRP++STVV M+ SEI  LP PK+
Sbjct: 727 NMKTLIDGSILEACFQ-EEILRCIHVGLLCVQELAKDRPSVSTVVGMICSEIAHLPPPKQ 785

Query: 766 PAFTERQGADDSES 779
           PAFTE +   D ES
Sbjct: 786 PAFTEMRSGIDIES 799

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496538|ref|XP_002270222.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera]

 Score =  929 bits (2401), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 476/787 (60%), Positives = 587/787 (74%), Gaps = 37/787 (4%)

Query: 25  SITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKD 84
           +ITS+  I+DP+ I+S+G  FKLGFF+   S  RY+GIWY+  S   +IWVAN+D PL D
Sbjct: 88  TITSTHFIKDPETIVSSGRVFKLGFFSLDGSSNRYVGIWYNTTSLLTIIWVANKDRPLND 147

Query: 85  SSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144
           SSG++TISEDGN+ ++NG+KE+LWSSNVSN    ++SAQL DSGNLVLRD  N   VWES
Sbjct: 148 SSGVLTISEDGNIQVLNGRKEILWSSNVSNPAAVNSSAQLQDSGNLVLRDK-NGVSVWES 206

Query: 145 FQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRP 204
            Q P+ SF+P M    + RT  +  LTSWKS SDPS GSF+AG+   NIP++F+WN SRP
Sbjct: 207 LQNPSHSFVPQMKISTNTRTRVRKVLTSWKSSSDPSMGSFTAGVEPLNIPQVFIWNGSRP 266

Query: 205 YWRSGPWNGQIFIGIPELKSVYLFRHNF----------TFGFANDWTFFA--LTAQGILE 252
           YWRSGPW+GQI  G+ ++K + L   N           TF       F+A  LT +GIL 
Sbjct: 267 YWRSGPWDGQILTGV-DVKWITLDGLNIVDDKEGTVYVTFAHPESGFFYAYVLTPEGILV 325

Query: 253 ERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGN 312
           E    K  ++WE  +     EC++YGKCG FG CNS++ PICSCL+G+EPK+ +EWNRGN
Sbjct: 326 ETSRDKRNEDWERVWTTKENECEIYGKCGPFGHCNSRDSPICSCLKGYEPKHTQEWNRGN 385

Query: 313 WTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCS 372
           WT GC+R++ LQCER     +  K DGF KL  MKVPDF E  S A ED+CR+QCL+NCS
Sbjct: 386 WTGGCVRKTPLQCERTKNGSEEAKVDGFLKLTNMKVPDFAE-QSYALEDDCRQQCLRNCS 444

Query: 373 CIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDV---FVSPLIK 429
           CIAY++  GIGCM W S +LIDIQ+L   G +L+IRVA+S++ +  K+D     +  +I 
Sbjct: 445 CIAYSYYTGIGCMWW-SGDLIDIQKLSSTGANLFIRVAHSELKQDRKRDARVIVIVTVII 503

Query: 430 GMFALAICTLFLWRWIAKRKEVIAKLS----------------ATNVNTVKLQDLPLFQF 473
           G  A+A+CT FL RWIA+++    K+                    VN VKL++LPL  F
Sbjct: 504 GTIAIALCTYFLRRWIARQRAKKGKIEELLSFNRGKFSDPSVPGDGVNQVKLEELPLIDF 563

Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
            +LATATNNF  ++KLGQGGFGPVY G+L +GQ+IAVKRLS+AS QGLEEFMNEV+VISK
Sbjct: 564 NKLATATNNFHEANKLGQGGFGPVYRGKLAEGQDIAVKRLSRASTQGLEEFMNEVVVISK 623

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQHRNLVRL+GCC+EG+EKMLIYE+MPN+SLDA LFDP+K++ LDWR RF IIEGI RGL
Sbjct: 624 LQHRNLVRLIGCCIEGDEKMLIYEFMPNKSLDASLFDPVKRQILDWRTRFKIIEGIGRGL 683

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           LYLHRDSRLRIIHRDLKASNILLDE+LNPKISDFGMA+IFG NQDQA+T RVVGT+GYMS
Sbjct: 684 LYLHRDSRLRIIHRDLKASNILLDEDLNPKISDFGMARIFGSNQDQANTKRVVGTYGYMS 743

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF-EDDLTILGYAWKLWNENKILALVD 712
           PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN+SF+ E+  T+LGYAWKLW E+ +  L+D
Sbjct: 744 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNSSFYHEEYFTLLGYAWKLWKEDNMKTLID 803

Query: 713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQ 772
             + E+ FQ + I+RCIHVGLLCVQEL KDRP++STVV M+ SEI  LP PK+PAFTE +
Sbjct: 804 GSILEACFQ-EEILRCIHVGLLCVQELAKDRPSVSTVVGMICSEIAHLPPPKQPAFTEMR 862

Query: 773 GADDSES 779
              D ES
Sbjct: 863 SGIDIES 869

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	807
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.402	0.382	0.606	8.3e-177
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.374	0.358	0.638	8.4e-175
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.381	0.363	0.623	7.5e-174
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.387	0.368	0.620	2.5e-173
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.376	0.388	0.584	6.7e-173
TAIR|locus:2197664	804	AT1G61490 [Arabidopsis thalian	0.946	0.950	0.446	1.1e-172
TAIR|locus:2200888	804	AT1G61500 [Arabidopsis thalian	0.934	0.937	0.452	1.4e-172
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.390	0.374	0.621	5.4e-171
TAIR|locus:2197729	805	SD1-29 "S-domain-1 29" [Arabid	0.928	0.930	0.443	1.9e-170
TAIR|locus:2200923	802	AT1G61550 [Arabidopsis thalian	0.936	0.942	0.435	4e-170

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1000 (357.1 bits), Expect = 8.3e-177, Sum P(2) = 8.3e-177
 Identities = 202/333 (60%), Positives = 252/333 (75%)

Query:   455 LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLS 514
             +S  N NT  L+ LPL +FEE+A ATNNF  ++KLGQGGFG VY G+L DGQE+AVKRLS
Sbjct:   500 ISREN-NTDDLE-LPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLS 557

Query:   515 KASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK 574
             K S QG +EF NEV +I++LQH NLVRLL CCV+  EKMLIYEY+ N SLD+ LFD  + 
Sbjct:   558 KTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRN 617

Query:   575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
              +L+W+ RF+II GI+RGLLYLH+DSR RIIHRDLKASNILLD+ + PKISDFGMA+IFG
Sbjct:   618 SKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFG 677

Query:   635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD--L 692
              ++ +A+T +VVGT+GYMSPEYAM+G FS KSDVFSFGVLLLEI+S ++N  F+  D  L
Sbjct:   678 RDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDL 737

Query:   693 TILGYAWKLWNENKILALVDPFLSESS--FQLDMIIRCIHVGLLCVQELVKDRPNMSTVV 750
              +LG  W+ W E K L ++DP +++SS  F+   I+RCI +GLLCVQE  +DRP MS V+
Sbjct:   738 NLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVI 797

Query:   751 SMLNSEIRDLPYPKEPAFT-ERQGAD-DSESFK 781
              ML SE   +P PK P +  ER   D DS S K
Sbjct:   798 LMLGSESTTIPQPKAPGYCLERSLLDTDSSSSK 830

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1002 (357.8 bits), Expect = 8.4e-175, Sum P(2) = 8.4e-175
 Identities = 196/307 (63%), Positives = 236/307 (76%)

Query:   467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN 526
             +LPL + E LATATNNF   +KLGQGGFG VY GRL DG+EIAVKRLSK S QG +EFMN
Sbjct:   503 ELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMN 562

Query:   527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 586
             EV +I+KLQH NLVRLLGCCV+  EKMLIYEY+ N SLD+ LFD  +   L+W+KRF+II
Sbjct:   563 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 622

Query:   587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
              GI+RGLLYLH+DSR RIIHRDLKASN+LLD+ + PKISDFGMA+IFG  + +A+T RVV
Sbjct:   623 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 682

Query:   647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED--DLTILGYAWKLWNE 704
             GT+GYMSPEYAM+G FS KSDVFSFGVLLLEI+SG++N  F+    DL +LG+ W+ W E
Sbjct:   683 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE 742

Query:   705 NKILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 761
                L +VDP   +S    F    I+RCI +GLLCVQE  +DRP MS+V+ ML SE   +P
Sbjct:   743 GNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIP 802

Query:   762 YPKEPAF 768
              PK P F
Sbjct:   803 QPKRPGF 809

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 995 (355.3 bits), Expect = 7.5e-174, Sum P(2) = 7.5e-174
 Identities = 195/313 (62%), Positives = 237/313 (75%)

Query:   461 NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG 520
             N     +LPL +++ LA ATNNF   +KLGQGGFG VY G L DG+EIAVKRLSK S QG
Sbjct:   501 NKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQG 560

Query:   521 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
              +EFMNEV +I+KLQH NLVRLLGCCV+  EKMLIYEY+ N SLD+ LFD  +   L+W+
Sbjct:   561 TDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQ 620

Query:   581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
             KRF+II GI+RGLLYLH+DSR RIIHRDLKASN+LLD+ + PKISDFGMA+IFG  + +A
Sbjct:   621 KRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEA 680

Query:   641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED--DLTILGYA 698
             +T RVVGT+GYMSPEYAM+G FS KSDVFSFGVLLLEI+SG++N  F+    DL +LG+ 
Sbjct:   681 NTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFV 740

Query:   699 WKLWNENKILALVDPFLSE---SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 755
             W+ W E K L +VDP   +   S F    I+RCI +GLLCVQE  +DRP MS+V+ ML S
Sbjct:   741 WRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGS 800

Query:   756 EIRDLPYPKEPAF 768
             E   +P PK P F
Sbjct:   801 ETTAIPQPKRPGF 813

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1020 (364.1 bits), Expect = 2.5e-173, Sum P(2) = 2.5e-173
 Identities = 196/316 (62%), Positives = 250/316 (79%)

Query:   463 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
             V   +LP+F    +A ATN+F   ++LG+GGFGPVY G L+DG+EIAVKRLS  SGQG++
Sbjct:   509 VNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVD 568

Query:   523 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 582
             EF NE+++I+KLQHRNLVRLLGCC EGEEKML+YEYMPN+SLD  LFD  K+  +DW+ R
Sbjct:   569 EFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLR 628

Query:   583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
             F+IIEGI+RGLLYLHRDSRLRIIHRDLK SN+LLD E+NPKISDFGMA+IFGGNQ++A+T
Sbjct:   629 FSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANT 688

Query:   643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKL 701
              RVVGT+GYMSPEYAMEG FS KSDV+SFGVLLLEIVSG++NTS    +  +++GYAW L
Sbjct:   689 VRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYL 748

Query:   702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 761
             +   +   LVDP +  +  + + + RCIHV +LCVQ+   +RPNM++V+ ML S+   L 
Sbjct:   749 YTHGRSEELVDPKIRVTCSKREAL-RCIHVAMLCVQDSAAERPNMASVLLMLESDTATLA 807

Query:   762 YPKEPAFTE-RQGADD 776
              P++P FT  R+ + D
Sbjct:   808 APRQPTFTSTRRNSID 823

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 940 (336.0 bits), Expect = 6.7e-173, Sum P(2) = 6.7e-173
 Identities = 180/308 (58%), Positives = 238/308 (77%)

Query:   467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN 526
             +LP    + ++ AT+ F   +KLGQGGFGPVY G L  GQE+AVKRLS+ S QG+EEF N
Sbjct:   449 ELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKN 508

Query:   527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 586
             E+ +I+KLQHRNLV++LG CV+ EE+MLIYEY PN+SLD+ +FD  ++  LDW KR  II
Sbjct:   509 EIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEII 568

Query:   587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
             +GI+RG+LYLH DSRLRIIHRDLKASN+LLD ++N KISDFG+A+  GG++ +A+T RVV
Sbjct:   569 KGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVV 628

Query:   647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD--LTILGYAWKLWNE 704
             GT+GYMSPEY ++G FS KSDVFSFGVL+LEIVSGR+N  F  ++  L +LG+AW+ + E
Sbjct:   629 GTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLE 688

Query:   705 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPK 764
             +K   ++D  ++ES   +  ++R IH+GLLCVQ+  KDRPNMS VV ML+SE+  L  P+
Sbjct:   689 DKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLD-PR 747

Query:   765 EPAF-TER 771
             +P F  ER
Sbjct:   748 QPGFFNER 755

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)]

 Score = 1678 (595.7 bits), Expect = 1.1e-172, P = 1.1e-172
 Identities = 354/793 (44%), Positives = 489/793 (61%)

Query:     8 IILLSCFCLDFAVAIDSS---ITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWY 64
             I+  +C  L F V +  S   IT+   +     + S+   ++LGFF+P +S   Y+GIW+
Sbjct:     6 IVFFACLLL-FTVLLRFSYAGITTESPLSVEQTLSSSNGIYELGFFSPNNSQNLYVGIWF 64

Query:    65 DMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQL 124
                  + V+WVANR+ P  D+S  + IS +G+L+L NG K               + A+L
Sbjct:    65 KGIIPRVVVWVANRETPTTDTSANLAISSNGSLLLFNG-KHGVVWSIGENFASNGSRAEL 123

Query:   125 LDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSF 184
              D+GNLV+ DN +   +WESF+   D+ LP      +  TG+K  LTSWK+ +DPS G F
Sbjct:   124 TDNGNLVVIDNASGRTLWESFEHFGDTMLPFSSLMYNLATGEKRVLTSWKTDTDPSPGVF 183

Query:   185 SAGLIHQNIP-EIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFF 243
               G I   +P ++ +   S  Y+R+GPW    F GIP +   Y    +     AN   FF
Sbjct:   184 -VGQITPQVPSQVLIMRGSTRYYRTGPWAKTRFTGIPLMDDTYASPFSLQQD-ANGSGFF 241

Query:   244 ALTAQGILEERIWI-------KWKDN---WEVGFLNLRTECDVYGKCGAFGICNSQEKPI 293
                 +     RI I       +++ N   WE+ ++     CD+YG CG FG+C       
Sbjct:   242 TYFDRSFKLSRIIISSEGSMKRFRHNGTDWELSYMAPANSCDIYGVCGPFGLCIVSVPLK 301

Query:   294 CSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTE 353
             C CL+GF P + EEW RGNWT GC R ++L C+  N TGK    + F  +  +K+PDF E
Sbjct:   302 CKCLKGFVPHSTEEWKRGNWTGGCARLTELHCQG-NSTGK--DVNIFHPVTNVKLPDFYE 358

Query:   354 WTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSD 413
             + S    +EC + CL NCSC+A+A+  GIGC++W   NL+D  +   GG  L IR+A+S+
Sbjct:   359 YESSVDAEECHQSCLHNCSCLAFAYIHGIGCLIWNQ-NLMDAVQFSAGGEILSIRLAHSE 417

Query:   414 VD-EKGKKDVFVSPLIKGMFALAICTLF-LWRWIAKRKEVIAKLSATN-VNTVKLQDLPL 470
             +   K  K +  S +   +F +     F  WR+  K K    K +  N + + ++  L  
Sbjct:   418 LGGNKRNKIIVASTVSLSLFVILTSAAFGFWRYRVKHKAYTLKDAWRNDLKSKEVPGLEF 477

Query:   471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMV 530
             F+   + TATNNF LS+KLGQGGFG VY G+L+DG+EIAVK+LS +SGQG EEFMNE+++
Sbjct:   478 FEMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVL 537

Query:   531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
             ISKLQHRNLVR+LGCC+EGEEK+LIYE+M N+SLD  +FD  KK  +DW KRF+I++GI+
Sbjct:   538 ISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIA 597

Query:   591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
             RGLLYLHRDSRL++IHRDLK SNILLDE++NPKISDFG+A+++ G Q Q  T RVVGT G
Sbjct:   598 RGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLG 657

Query:   651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLTILGYAWKLWNENKIL 708
             YMSPEYA  G FSEKSD++SFGVLLLEI+ G K +  S+ E+  T+L YAW+ W E K +
Sbjct:   658 YMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAWESWGETKGI 717

Query:   709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF 768
              L+D  L++S   L+ + RC+ +GLLCVQ    DRPN   +++ML +   DLP PK+P F
Sbjct:   718 DLLDQDLADSCRPLE-VGRCVQIGLLCVQHQPADRPNTLELLAMLTTT-SDLPSPKQPTF 775

Query:   769 TERQGADDSESFK 781
                   D+S   K
Sbjct:   776 VVHSRDDESSLSK 788

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)]

 Score = 1677 (595.4 bits), Expect = 1.4e-172, P = 1.4e-172
 Identities = 359/794 (45%), Positives = 494/794 (62%)

Query:    10 LLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSN-FKLGFFNPADSPYRYMGIWYDMPS 68
             L + F         S++ +++        LS+ +  ++LGFF+P ++  +Y+GIW+    
Sbjct:    10 LFTMFLFTLLSGSSSAVITTESPLSMGQTLSSANEVYELGFFSPNNTQDQYVGIWFKDTI 69

Query:    69 EKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQLLDSG 128
              + V+WVANR+ P+ DS+  + IS  G+L+L+NG K                 A+L DSG
Sbjct:    70 PRVVVWVANREKPVTDSTAYLAISSSGSLLLLNG-KHGTVWSSGVTFSSSGCRAELSDSG 128

Query:   129 NLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGL 188
             NL + DN++   +W+SF    D+ L       +  T +K  LTSWKS +DPS G F  G 
Sbjct:   129 NLKVIDNVSERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGDF-LGQ 187

Query:   189 IHQNIP-EIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYL--FR-HNFTFG------FAN 238
             I   +P + FV   S PYWRSGPW    F GIP +   Y   F  H    G      F  
Sbjct:   188 ITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFTLHQDVNGSGYLTYFQR 247

Query:   239 DWTF--FALTAQGILEERIWIKWKDN---WEVGFLNLRTECDVYGKCGAFGICNSQEKPI 293
             D+      LT++G ++      ++DN   WE+ +   +  CD YG CG FG+C     P+
Sbjct:   248 DYKLSRITLTSEGSIK-----MFRDNGMGWELYYEAPKKLCDFYGACGPFGLCVMSPSPM 302

Query:   294 CSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTE 353
             C C  GF PK+ EEW RGNWT GC+R ++L C   N TG+    D F ++  +K PDF E
Sbjct:   303 CKCFRGFVPKSVEEWKRGNWTGGCVRHTELDC-LGNSTGE--DADDFHQIANIKPPDFYE 359

Query:   354 WTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSD 413
             + S    +EC ++C+ NCSC+A+A+  GIGC+VW   +L+D  +    G  L IR+A S+
Sbjct:   360 FASSVNAEECHQRCVHNCSCLAFAYIKGIGCLVWNQ-DLMDAVQFSATGELLSIRLARSE 418

Query:   414 VD-EKGKKDVFVSPLIKGMFALAICTLF-LWRWIAKRKEVIAKLSATN-VNTVKLQDLPL 470
             +D  K KK +  S +   +F +   T F +WR    R E IA +S     N +K QD+P 
Sbjct:   419 LDGNKRKKTIVASIVSLTLFMILGFTAFGVWRC---RVEHIAHISKDAWKNDLKPQDVPG 475

Query:   471 FQFEELAT---ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE 527
               F ++ T   ATNNF LS+KLGQGGFG VY G+L+DG+EIAVKRLS +SGQG EEFMNE
Sbjct:   476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535

Query:   528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
             +++ISKLQHRNLVR+LGCC+E EEK+LIYE+M N+SLD  LFD  K+  +DW KRF+II+
Sbjct:   536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595

Query:   588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
             GI+RGLLYLH DSRLR+IHRDLK SNILLDE++NPKISDFG+A+++ G + Q +T RVVG
Sbjct:   596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655

Query:   648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLTILGYAWKLWNEN 705
             T GYMSPEYA  G FSEKSD++SFGVL+LEI+SG K +  S+  +  T++ YAW+ W+E 
Sbjct:   656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSEY 715

Query:   706 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKE 765
             + + L+D  L++S   L+ + RCI +GLLCVQ    DRPN   +++ML +   DLP PK+
Sbjct:   716 RGIDLLDQDLADSCHPLE-VGRCIQIGLLCVQHQPADRPNTLELLAMLTTT-SDLPSPKQ 773

Query:   766 PAFTERQGADDSES 779
             P F      D+S S
Sbjct:   774 PTFAFHTRDDESLS 787

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 1026 (366.2 bits), Expect = 5.4e-171, Sum P(2) = 5.4e-171
 Identities = 197/317 (62%), Positives = 244/317 (76%)

Query:   463 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
             V   DLP+F F+ +A+AT +F   +KLGQGGFG VY G   +G+EIAVKRLS  S QGLE
Sbjct:   505 VDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLE 564

Query:   523 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 582
             EF NE+++I+KLQHRNLVRLLGCC+E  EKML+YEYMPN+SLD  LFD  K+  LDWRKR
Sbjct:   565 EFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKR 624

Query:   583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
             + +I GI+RGLLYLHRDSRL+IIHRDLKASNILLD E+NPKISDFGMA+IF   QD A+T
Sbjct:   625 WEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANT 684

Query:   643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKL 701
              RVVGT+GYM+PEYAMEG FSEKSDV+SFGVL+LEIVSGRKN SF   D  +++GYAW L
Sbjct:   685 IRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHL 744

Query:   702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 761
             W++ K   ++DP + ++   +   +RCIHVG+LC Q+ V  RPNM +V+ ML S+   LP
Sbjct:   745 WSQGKTKEMIDPIVKDTR-DVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLP 803

Query:   762 YPKEPAFTERQGADDSE 778
              P++P F     + D E
Sbjct:   804 PPRQPTFHSFLNSGDIE 820

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 1657 (588.4 bits), Expect = 1.9e-170, P = 1.9e-170
 Identities = 350/790 (44%), Positives = 492/790 (62%)

Query:     1 MIPIALLIILLSCFCLDFAVAIDSSITSSQL-IRDPDAILSNGSNFKLGFFNPADSPYRY 59
             M+  A L++L+      +A AI+   TSS L IR    + S G  ++LGFF+P ++  +Y
Sbjct:     3 MVLFACLLLLIIFPTCGYA-AIN---TSSPLSIRQ--TLSSPGGFYELGFFSPNNTQNQY 56

Query:    60 MGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXX 119
             +GIW+     + V+WVANRD P+  S+  +TIS +G+L+L++G K+              
Sbjct:    57 VGIWFKKIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLDG-KQDVIWSTGKAFTSNK 115

Query:   120 TSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDP 179
               A+LLD+GN V+ D+++   +W+SF+   ++ LP      D   GKK  LT+WKS SDP
Sbjct:   116 CHAELLDTGNFVVIDDVSGNKLWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSDP 175

Query:   180 STGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYL--FR-------- 229
             S G FS  +  Q   +  +   S PYWR GPW    F GI  + + Y+  F         
Sbjct:   176 SPGEFSLEITPQIPTQGLIRRGSVPYWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAAG 235

Query:   230 -HNFTFGFANDW--TFFALTAQGILEERIWIKWKD--NWEVGFLNLRTECDVYGKCGAFG 284
               +F++    ++  ++  LT +G ++    I W D  NW++        CD+YG+CG +G
Sbjct:   236 TGSFSYSTLRNYNLSYVTLTPEGKMK----ILWDDGNNWKLHLSLPENPCDLYGRCGPYG 291

Query:   285 ICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKE-DGFSKL 343
             +C   + P C CL+GF PK+ EEW +GNWTSGC+RR+KL C+ ++     GK+ D F ++
Sbjct:   292 LCVRSDPPKCECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRM 351

Query:   344 NKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGT 403
               +K PD  ++ S    ++C + CL NCSC A+A+  GIGC+VW    L D  +    G 
Sbjct:   352 TDVKTPDLHQFASFLNAEQCYQGCLGNCSCTAFAYISGIGCLVWNG-ELADTVQFLSSGE 410

Query:   404 DLYIRVANSDVDEKGKKDVFVSPLIK-GMFALAI-CTLFLWRWIAKRKEVIAK-LSATNV 460
              L+IR+A+S++    ++ + V   +   +F + +   + LWR+ AK+ +         +V
Sbjct:   411 FLFIRLASSELAGSSRRKIIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGFERQDV 470

Query:   461 NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG 520
             + V       F+   + TATNNF  S+KLGQGGFGPVY G+L DG+EI VKRL+ +SGQG
Sbjct:   471 SGVNF-----FEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQG 525

Query:   521 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
              EEFMNE+ +ISKLQHRNLVRLLG C++GEEK+LIYE+M N+SLD  +FDP  K  LDW 
Sbjct:   526 TEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWP 585

Query:   581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
             KRFNII+GI+RGLLYLHRDSRLR+IHRDLK SNILLD+ +NPKISDFG+A++F G Q Q 
Sbjct:   586 KRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQD 645

Query:   641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT--ILGYA 698
             +T RVVGT GYMSPEYA  G FSEKSD++SFGVL+LEI+SG++ + F   D +  +L Y 
Sbjct:   646 NTRRVVGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAYT 705

Query:   699 WKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 758
             W  W E     L+D  L+++  Q   + RC+ +GLLCVQ    DRPN   V+SML S   
Sbjct:   706 WDSWCETGGSNLLDRDLTDTC-QAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSAT- 763

Query:   759 DLPYPKEPAF 768
             DLP PK+P F
Sbjct:   764 DLPVPKQPIF 773

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)]

 Score = 1654 (587.3 bits), Expect = 4.0e-170, P = 4.0e-170
 Identities = 345/792 (43%), Positives = 487/792 (61%)

Query:    10 LLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSE 69
             L S   L F+ A   +IT +  +     + S    F+LGFF+P +S   Y+GIW+     
Sbjct:     8 LFSTLLLSFSYA---AITPTSPLSIGQTLSSPNGIFELGFFSPNNSRNLYVGIWFKGIIP 64

Query:    70 KAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQLLDSGN 129
             + V+WVANR+N + D++  + IS +G+L+L +G K               +SA+L DSGN
Sbjct:    65 RTVVWVANRENSVTDATADLAISSNGSLLLFDG-KHSTVWSTGETFASNGSSAELSDSGN 123

Query:   130 LVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLI 189
             L++ D ++   +W+SF+   D+ LP      +  TG+K  L+SWKS +DP  G F   + 
Sbjct:   124 LLVIDKVSGITLWQSFEHLGDTMLPYSSLMYNPGTGEKRVLSSWKSYTDPLPGEFVGYIT 183

Query:   190 HQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGF-ANDWTFFA---- 244
              Q  P+ F+   S+PYWRSGPW    F G+P     Y   H F+    AN   +F+    
Sbjct:   184 TQVPPQGFIMRGSKPYWRSGPWAKTRFTGVPLTDESYT--HPFSVQQDANGSVYFSHLQR 241

Query:   245 --------LTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSC 296
                     LT++G L  ++      +W +        CD YG CG FG+C     P C C
Sbjct:   242 NFKRSLLVLTSEGSL--KVTHHNGTDWVLNIDVPANTCDFYGVCGPFGLCVMSIPPKCKC 299

Query:   297 LEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTS 356
              +GF P+ +EEW RGNWT GC+RR++L C+  N TG+    + F  +  +K PDF E+ S
Sbjct:   300 FKGFVPQFSEEWKRGNWTGGCVRRTELLCQG-NSTGR--HVNVFHPVANIKPPDFYEFVS 356

Query:   357 PATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDE 416
               + +EC + CL NCSC+A+A+  GIGC++W    L+D+ +   GG  L IR+A+S++  
Sbjct:   357 SGSAEECYQSCLHNCSCLAFAYINGIGCLIWNQ-ELMDVMQFSVGGELLSIRLASSEMGG 415

Query:   417 KGKKDVFVSPLIK-GMFA-LAICTLFLWRWIAKRKEVIAKLSATNV--NTVKLQDLPLFQ 472
               +K   ++ ++   +F  LA      WR+  K   +++K+S      N +K +D+    
Sbjct:   416 NQRKKTIIASIVSISLFVTLASAAFGFWRYRLKHNAIVSKVSLQGAWRNDLKSEDVSGLY 475

Query:   473 FEELAT---ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVM 529
             F E+ T   ATNNF L +KLGQGGFGPVY G+L+DG+EIAVKRLS +SGQG EEFMNE++
Sbjct:   476 FFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIL 535

Query:   530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
             +ISKLQH NLVR+LGCC+EGEE++L+YE+M N+SLD  +FD  K+  +DW KRF+II+GI
Sbjct:   536 LISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPKRFSIIQGI 595

Query:   590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             +RGLLYLHRDSRLRIIHRD+K SNILLD+++NPKISDFG+A+++ G + Q +T R+VGT 
Sbjct:   596 ARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTRRIVGTL 655

Query:   650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD--LTILGYAWKLWNENKI 707
             GYMSPEYA  G FSEKSD +SFGVLLLE++SG K + F  D     +L YAW+ W EN  
Sbjct:   656 GYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEKISRFSYDKERKNLLAYAWESWCENGG 715

Query:   708 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 767
             +  +D   ++S    + + RC+ +GLLCVQ    DRPN   ++SML +   DLP PKEP 
Sbjct:   716 VGFLDKDATDSCHPSE-VGRCVQIGLLCVQHQPADRPNTLELLSMLTTT-SDLPLPKEPT 773

Query:   768 FTERQGADDSES 779
             F      D S +
Sbjct:   774 FAVHTSDDGSRT 785

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	807
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-56
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-56
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-44
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-37
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	5e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-35
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-35
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-32
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-31
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-31
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-31
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	3e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-31
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-30
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	1e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-29
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	3e-29
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-29
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-28
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-28
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-27
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-27
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-26
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-25
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-25
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-25
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-24
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-24
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	1e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-24
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-24
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-24
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-23
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-23
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-22
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-21
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-21
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-21
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-20
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-20
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-19
pfam08276	66	pfam08276, PAN_2, PAN-like domain	7e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-18
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-14
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	6e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-12
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-04
COG1718	268	COG1718, RIO1, Serine/threonine protein kinase inv	8e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	9e-04
cd00129	80	cd00129, PAN_APPLE, PAN/APPLE-like domain; present	0.001
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.004
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  192 bits (490), Expect = 6e-56
 Identities = 97/284 (34%), Positives = 141/284 (49%), Gaps = 42/284 (14%)

Query: 484 QLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHR 537
            L  KLG+G FG VY G+LK        E+AVK L + AS Q +EEF+ E  ++ KL H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+LLG C E E   ++ EYM    L + L     + +L      +    I+RG+ YL 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLE 119

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYMSPEY 656
                  IHRDL A N L+ E L  KISDFG+++ ++  +  +   G++     +M+PE 
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPES 174

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG---YAWKLWNENKILALVDP 713
             EG+F+ KSDV+SFGVLL EI +              LG   Y      E  +L  +  
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT--------------LGEQPYPGMSNEE--VLEYL-- 216

Query: 714 FLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSML 753
              ++ ++L     C      + L C  E  +DRP  S +V +L
Sbjct: 217 ---KNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  192 bits (490), Expect = 7e-56
 Identities = 83/203 (40%), Positives = 115/203 (56%), Gaps = 13/203 (6%)

Query: 485 LSSKLGQGGFGPVYWGRLKDG-----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 538
           L  KLG+G FG VY G LK        E+AVK L + AS Q +EEF+ E  ++ KL H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V+LLG C E E  M++ EYMP   L   L    + + L      +    I+RG+ YL  
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE- 120

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYMSPEYA 657
                 IHRDL A N L+ E L  KISDFG+++ ++  +  +   G++     +M+PE  
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESL 176

Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
            EG+F+ KSDV+SFGVLL EI +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  181 bits (463), Expect = 5e-52
 Identities = 80/206 (38%), Positives = 114/206 (55%), Gaps = 13/206 (6%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRL-SKASGQGLEEFMNEVMVISKLQH 536
            +L  KLG+G FG VY G LK        ++AVK L   AS +  EEF+ E  ++ KL H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
            N+VRLLG C +GE   ++ EYMP   L   L      E+L  +    +   I++G+ YL
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYL 118

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYMSPE 655
                   +HRDL A N L+ E L  KISDFG+++ I+  +  +   G  +    +M+PE
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK-WMAPE 174

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSG 681
              +G+F+ KSDV+SFGVLL EI + 
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  181 bits (461), Expect = 8e-52
 Identities = 80/205 (39%), Positives = 115/205 (56%), Gaps = 16/205 (7%)

Query: 488 KLGQGGFGPVYWGRLKDGQ----EIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRL 542
           KLG+G FG VY G+LK       E+AVK L + AS +  ++F+ E  V+ KL H N+VRL
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNIIEGISRGLLYL 596
           LG C E E   L+ EYM    L   L      F   +K  L  +   +    I++G+ YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYMSPE 655
                 + +HRDL A N L+ E+L  KISDFG+++ ++  +  +  TG  +    +M+PE
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVS 680
              +G F+ KSDV+SFGVLL EI +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (452), Expect = 4e-51
 Identities = 77/194 (39%), Positives = 111/194 (57%), Gaps = 11/194 (5%)

Query: 489 LGQGGFGPVYWGR-LKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           LG+GGFG VY  R  K G+++A+K + K  S   LEE + E+ ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
            +     L+ EY    SL  LL +   + +L   +   I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 607 RDLKASNILLDE-ELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-YAMEGRFSE 664
           RDLK  NILLD      K++DFG++K+   ++    T  +VGT  YM+PE    +G +SE
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 665 KSDVFSFGVLLLEI 678
           KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (434), Expect = 5e-48
 Identities = 75/204 (36%), Positives = 105/204 (51%), Gaps = 12/204 (5%)

Query: 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNL 539
           ++L  KLG G FG VY  + K  G+ +AVK L K     +  +    E+ ++ +L H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           VRL+    + +   L+ EY     L   L    +   L   +   I   I RGL YLH  
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS- 116

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
               IIHRDLK  NILLDE    KI+DFG+AK    +     T   VGT  YM+PE  + 
Sbjct: 117 --NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLG 172

Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
           G  +  K DV+S GV+L E+++G+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  165 bits (420), Expect = 4e-46
 Identities = 78/252 (30%), Positives = 127/252 (50%), Gaps = 18/252 (7%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLV 540
           +++  KLG+G FG VY  R K  G+ +A+K + K   +   E  + E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLYLHRD 599
           RL     + ++  L+ EY     L  LL    K+ RL     RF  +  I   L YLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARF-YLRQILSALEYLHS- 115

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
               I+HRDLK  NILLDE+ + K++DFG+A+     + +  T   VGT  YM+PE  + 
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTT--FVGTPEYMAPEVLLG 170

Query: 660 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS 719
             + +  D++S GV+L E+++G+     F  D  +L    K+          +  +S  +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK---PPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEA 227

Query: 720 FQLDMIIRCIHV 731
              D+I + +  
Sbjct: 228 --KDLIRKLLVK 237

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  159 bits (405), Expect = 5e-44
 Identities = 73/210 (34%), Positives = 114/210 (54%), Gaps = 19/210 (9%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
            +     LG+G FG VY    KD G+ +AVK   LS  S + LE    E+ ++S LQH N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 539 LVRLLGCCVEGEEKML-IY-EYMPNRSLDALL--FDPLKKERLDWRKRF--NIIEGISRG 592
           +VR  G   + E+  L I+ EY+   SL +LL  F  L +  +   +++   I+EG++  
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI---RKYTRQILEGLA-- 115

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
             YLH      I+HRD+K +NIL+D +   K++DFG AK  G  +    TG V GT  +M
Sbjct: 116 --YLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           +PE      +   +D++S G  ++E+ +G+
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  141 bits (357), Expect = 1e-37
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 21/207 (10%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           F++  K+G+GGFG VY  R  + G+E+A+K +   S +  E+ +NE+ ++ K +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRGLLY 595
             G  ++ +E  ++ E+    SL  LL            +         + + + +GL Y
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL--------KSTNQTLTESQIAYVCKELLKGLEY 113

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           LH      IIHRD+KA+NILL  +   K+ DFG++       D      +VGT  +M+PE
Sbjct: 114 LHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPE 167

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                 +  K+D++S G+  +E+  G+
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score =  133 bits (338), Expect = 5e-37
 Identities = 54/113 (47%), Positives = 68/113 (60%), Gaps = 5/113 (4%)

Query: 69  EKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSG 128
            + V+WVANR NPL DSS  + +  DGNLVL +G   V+WSSN S   +    A L D G
Sbjct: 1   NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSG-CVAVLQDDG 59

Query: 129 NLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRT-GKKVQLTSWKSLSDPS 180
           NLVL DN +  ++W+SF  PTD+ LPG          G   +LTSWKS +DPS
Sbjct: 60  NLVLYDN-SGKVLWQSFDHPTDTLLPGQ--KDGNVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 2e-35
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 17/207 (8%)

Query: 482 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQHRN 538
           N+QL   +G+G FG VY G  L+ G  +A+K++S  K   + L+  M E+ ++  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYL 596
           +V+ +G     +   +I EY  N SL  ++  F P   E L     + +++G    L YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLVAVYVYQVLQG----LAYL 115

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE- 655
           H      +IHRD+KA+NIL  ++   K++DFG+A           +  VVGT  +M+PE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
             M G  S  SD++S G  ++E+++G 
Sbjct: 171 IEMSGA-STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  134 bits (340), Expect = 2e-35
 Identities = 68/198 (34%), Positives = 105/198 (53%), Gaps = 6/198 (3%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
           F L  KLG G FG V+ G  K+   +A+K L        ++F  EV  + +L+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
              C  GE   +I E M   SL A L  P  +  L      ++   ++ G+ YL      
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
             IHRDL A NIL+ E+L  K++DFG+A++   +   +   ++   + + +PE A  G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 663 SEKSDVFSFGVLLLEIVS 680
           S KSDV+SFG+LL E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  132 bits (334), Expect = 2e-34
 Identities = 81/206 (39%), Positives = 111/206 (53%), Gaps = 13/206 (6%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLG G FG V+ G      ++AVK L K      E F+ E  ++ KL+H  LV
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           +L   C E E   ++ EYM   SL D L     KK RL   +  ++   I+ G+ YL   
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLES- 121

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYA 657
                IHRDL A NIL+ E L  KI+DFG+A++   ++  A  G     F   + +PE A
Sbjct: 122 --RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG---AKFPIKWTAPEAA 176

Query: 658 MEGRFSEKSDVFSFGVLLLEIVS-GR 682
             GRF+ KSDV+SFG+LL EIV+ GR
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (322), Expect = 5e-33
 Identities = 77/210 (36%), Positives = 111/210 (52%), Gaps = 26/210 (12%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
              +L + +G+G FG V  G  + GQ++AVK L K      + F+ E  V++ L+H NLV
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLV 63

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK-KER----LDWRKRFNIIEGISRGLLY 595
           +LLG  ++G    ++ EYM   SL     D L+ + R    L  +  F +   +  G+ Y
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSL----VDYLRSRGRAVITLAQQLGFAL--DVCEGMEY 117

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMS 653
           L        +HRDL A N+L+ E+L  K+SDFG+AK     QD        G     + +
Sbjct: 118 LEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-------SGKLPVKWTA 167

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GR 682
           PE   E +FS KSDV+SFG+LL EI S GR
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  127 bits (321), Expect = 1e-32
 Identities = 71/216 (32%), Positives = 110/216 (50%), Gaps = 17/216 (7%)

Query: 482 NFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQ 535
           + +   +LG+G FG V   R        G+++AVK L+ +   Q   +F  E+ ++  L 
Sbjct: 5   HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64

Query: 536 HRNLVRLLGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           H N+V+  G C +  G    LI EY+P+ SL   L     +++++ ++       I +G+
Sbjct: 65  HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGM 122

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGY 651
            YL      R IHRDL A NIL++ E   KISDFG+AK+   ++D            F Y
Sbjct: 123 DYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTS 686
            +PE     +FS  SDV+SFGV L E+ + G  + S
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  125 bits (315), Expect = 6e-32
 Identities = 71/228 (31%), Positives = 109/228 (47%), Gaps = 37/228 (16%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRN 538
           ++ +    LGQG  G VY  R K  G+  A+K++      +  ++ + E+  +   +   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN--IIEGISR----G 592
           +V+  G   +  E  ++ EYM   SL  LL    KK       +    ++  I+R    G
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLL----KK-----VGKIPEPVLAYIARQILKG 111

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L YLH      IIHRD+K SN+L++ +   KI+DFG++K+     DQ +T   VGT  YM
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYM 167

Query: 653 SPEYAMEGRF-----SEKSDVFSFGVLLLEIVSGR------KNTSFFE 689
           SPE     R      S  +D++S G+ LLE   G+         SFFE
Sbjct: 168 SPE-----RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  125 bits (316), Expect = 6e-32
 Identities = 75/224 (33%), Positives = 110/224 (49%), Gaps = 33/224 (14%)

Query: 482 NFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKL 534
             +   +LG+G FG VY G L           +A+K L + A  +  +EF  E  ++S L
Sbjct: 6   AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DPLKKERLDWRK 581
           QH N+V LLG C + +   +++EY+ +  L   L              D   K  LD   
Sbjct: 66  QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQA 640
             +I   I+ G+ YL   S    +HRDL A N L+ E L  KISDFG+++ I+      A
Sbjct: 126 FLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-----SA 177

Query: 641 DTGRVVGT----FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           D  RV         +M PE  + G+F+ +SD++SFGV+L EI S
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  123 bits (312), Expect = 1e-31
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 19/205 (9%)

Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           ++G+G FG VY  R   DG+   +K   LS  S +  E+ +NEV ++ KL H N+++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF---NIIE---GISRGLLYLHR 598
              E  +  ++ EY     L   +     K++    K F    I++    +   L YLH 
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKI-----KKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
            SR +I+HRD+K  NI L      K+ DFG++K+     D A T  VVGT  Y+SPE   
Sbjct: 121 -SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQ 176

Query: 659 EGRFSEKSDVFSFGVLLLEIVSGRK 683
              ++ KSD++S G +L E+ + + 
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  123 bits (311), Expect = 1e-31
 Identities = 78/206 (37%), Positives = 111/206 (53%), Gaps = 14/206 (6%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
              +L  KLG G FG V+ G      ++A+K L + S    E F+ E  ++ +LQH  LV
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEGISRGLLYLH 597
           RL    V  E   +I EYM N SL     D LK     +L   K  ++   I+ G+ ++ 
Sbjct: 65  RLYAV-VTQEPIYIITEYMENGSL----VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           R +    IHRDL+A+NIL+ E L  KI+DFG+A++   N+  A  G       + +PE  
Sbjct: 120 RKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAI 175

Query: 658 MEGRFSEKSDVFSFGVLLLEIVS-GR 682
             G F+ KSDV+SFG+LL EIV+ GR
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  124 bits (312), Expect = 2e-31
 Identities = 63/204 (30%), Positives = 112/204 (54%), Gaps = 17/204 (8%)

Query: 489 LGQGGFGPVY---WGRLKDGQEI--AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
           LG G FG VY   W    +  +I  A+K L + +  +  +E ++E  V++ + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           LG C+   +  LI + MP   L   + +   K+ +  +   N    I++G+ YL      
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYL---EEK 128

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEG 660
           R++HRDL A N+L+    + KI+DFG+AK+   ++ +  A+ G+V     +M+ E  +  
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV--PIKWMALESILHR 186

Query: 661 RFSEKSDVFSFGVLLLEIVS-GRK 683
            ++ KSDV+S+GV + E+++ G K
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 2e-31
 Identities = 75/210 (35%), Positives = 111/210 (52%), Gaps = 20/210 (9%)

Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+G FG V   R KD G+  A+K L K      + +E  + E  ++S++ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 545 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSR 601
              + EEK+ L+ EY P   L    F  L KE    + R RF   E I   L YLH    
Sbjct: 60  YAFQTEEKLYLVLEYAPGGEL----FSHLSKEGRFSEERARFYAAE-IVLALEYLHS--- 111

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
           L II+RDLK  NILLD + + K++DFG+AK       + +T    GT  Y++PE  +   
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKG 169

Query: 662 FSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
           + +  D +S GVLL E+++G+    F+ +D
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK--PPFYAED 197

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  126 bits (317), Expect = 2e-31
 Identities = 70/213 (32%), Positives = 109/213 (51%), Gaps = 17/213 (7%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH-R 537
           ++++  KLG+G FG VY    +D + +A+K L+K      + +E F+ E+ +++ L H  
Sbjct: 1   SYRILRKLGEGSFGEVY--LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+L     +     L+ EY+   SL+ LL    +K  L   +   I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 598 RDSRLRIIHRDLKASNILLDEELN-PKISDFGMAKIFGGNQ----DQADTGRVVGTFGYM 652
                 IIHRD+K  NILLD +    K+ DFG+AK+           A     VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 653 SPEYAM---EGRFSEKSDVFSFGVLLLEIVSGR 682
           +PE  +       S  SD++S G+ L E+++G 
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  123 bits (310), Expect = 2e-31
 Identities = 70/207 (33%), Positives = 114/207 (55%), Gaps = 15/207 (7%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 538
           +F++ +K+G+G FG V+    K D +  A+K+  LSK + +  EE ++E  V++KL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK---ERLDWRKRFNIIEGISRGLLY 595
           ++R     ++  +  ++ EY  N  L  LL     +   E   WR        I  GL +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR----FFIQILLGLAH 116

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           LH     +I+HRD+K+ N+ LD   N KI D G+AK+   N + A+T  +VGT  Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
              +  ++EKSDV++ GV+L E  +G+
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score =  117 bits (296), Expect = 3e-31
 Identities = 50/120 (41%), Positives = 67/120 (55%), Gaps = 4/120 (3%)

Query: 29  SQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGI 88
           S  +     ++S+GS F+LGFF        Y  I Y   S + V+WVANRDNP   SS  
Sbjct: 1   SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYK-GSSRTVVWVANRDNP-SGSSCT 58

Query: 89  ITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEP 148
           +T+  DGNLV+ +G   V+WSSN + +  N     LLD GNLVL D+    + W+SF  P
Sbjct: 59  LTLQSDGNLVIYDGSGTVVWSSNTTRVNGN-YVLVLLDDGNLVLYDSDGNFL-WQSFDYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  122 bits (308), Expect = 6e-31
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 31/215 (14%)

Query: 489 LGQGGFGPVYWGR---LKDGQE---IAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLVR 541
           LG+G FG V+ G    L+   +   +AVK L + +     + F  E  +++  QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLKKERLDWRKRFNIIEGIS 590
             G C EG+  ++++EYM +  L+  L                   L   +   I   I+
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGT- 648
            G++YL   +    +HRDL   N L+  +L  KI DFGM++ ++       D  RV G  
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-----TTDYYRVGGHT 184

Query: 649 ---FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                +M PE  M  +F+ +SDV+SFGV+L EI +
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 8e-31
 Identities = 70/206 (33%), Positives = 107/206 (51%), Gaps = 13/206 (6%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + QL  KLG G FG V+ G   +   +AVK L K      ++F+ E  ++ KL+H  L+
Sbjct: 6   TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLI 64

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 597
           +L   C   E   ++ E M   SL     + L+       K   +I+    ++ G+ YL 
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGSL----LEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
             +    IHRDL A N+L+ E    K++DFG+A++   +  +A  G       + +PE A
Sbjct: 121 AQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF-PIKWTAPEAA 176

Query: 658 MEGRFSEKSDVFSFGVLLLEIVS-GR 682
           +  RFS KSDV+SFG+LL EIV+ GR
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  120 bits (304), Expect = 1e-30
 Identities = 96/293 (32%), Positives = 135/293 (46%), Gaps = 57/293 (19%)

Query: 489 LGQGGFGPVYWG--RLKDGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           LG G FG V  G   +K G+E+  AVK L +     G +EF+ E  V+++L H  +VRL+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHRDS 600
           G C +GE  ML+ E  P   L  LL   LKK R       ++ E    ++ G+ YL    
Sbjct: 63  GVC-KGEPLMLVMELAP---LGPLL-KYLKKRRE--IPVSDLKELAHQVAMGMAYLESK- 114

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTF--GYMSPEY 656
               +HRDL A N+LL      KISDFGM++  G   D  +A T    G +   + +PE 
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKWYAPEC 169

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK---ILALVDP 713
              G+FS KSDV+S+GV L E  S                Y  K + E K   ++A++  
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS----------------YGAKPYGEMKGAEVIAML-- 211

Query: 714 FLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
              ES  +L     C      + L C +   +DRP  S + S      R  P 
Sbjct: 212 ---ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF----RRDPE 257

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 2e-30
 Identities = 70/195 (35%), Positives = 103/195 (52%), Gaps = 6/195 (3%)

Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G FG VY G LK   E+AVK         L  +F+ E  ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           V+ +   ++ E +P  SL  L F   KK RL  +K   +    + G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 607 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS 666
           RDL A N L+ E    KISDFGM++   G       G       + +PE    GR++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 667 DVFSFGVLLLEIVSG 681
           DV+S+G+LL E  S 
Sbjct: 177 DVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score =  113 bits (284), Expect = 1e-29
 Identities = 42/114 (36%), Positives = 61/114 (53%), Gaps = 19/114 (16%)

Query: 206 WRSGPWNGQIFIGIPELKSVYLFRHNF---------TFGFANDWTF--FALTAQGILEER 254
           WRSGPWNG  F GIPE++ +  + +NF         T+   N+  +    L+++G LE  
Sbjct: 1   WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60

Query: 255 IWIK----WKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKN 304
            WI     W   W       + +CDVYG+CG +G C+    P C+C++GF PKN
Sbjct: 61  TWIPNSQDWNLFWSAP----KDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  118 bits (298), Expect = 2e-29
 Identities = 58/205 (28%), Positives = 109/205 (53%), Gaps = 18/205 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            N +   K+G+G  G VY       G+E+A+K++ +   Q  E  +NE++++   +H N+
Sbjct: 22  KNLE---KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNI 77

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNIIEGISRGLLYL 596
           V      + G+E  ++ EYM   SL  ++   F  + + ++ +     +   + +GL YL
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCREVLQGLEYL 132

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H      +IHRD+K+ NILL ++ + K++DFG A      + + ++  VVGT  +M+PE 
Sbjct: 133 HS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEV 187

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSG 681
                +  K D++S G++ +E+  G
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  116 bits (294), Expect = 3e-29
 Identities = 58/201 (28%), Positives = 107/201 (53%), Gaps = 10/201 (4%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           F +  KLG+G +G VY    K+ GQ +A+K +     + L+E + E+ ++ +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
             G   +  +  ++ EY    S+  ++   +  + L   +   I+    +GL YLH    
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
            + IHRD+KA NILL+EE   K++DFG++        + +T  V+GT  +M+PE   E  
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIG 175

Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           ++ K+D++S G+  +E+  G+
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score =  112 bits (281), Expect = 3e-29
 Identities = 48/117 (41%), Positives = 66/117 (56%), Gaps = 5/117 (4%)

Query: 29  SQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGI 88
           S  +     ++S  S F+LGFF        Y  I Y   S + V+WVANRDNP+ DS   
Sbjct: 1   SNTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYK-SSSRTVVWVANRDNPVSDS-CT 57

Query: 89  ITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF 145
           +T+  DGNLVL +G   V+WSSN +   N +    LLD GNLV+ D+ +   +W+SF
Sbjct: 58  LTLQSDGNLVLYDGDGRVVWSSNTTG-ANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112

Length = 114

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  117 bits (294), Expect = 5e-29
 Identities = 75/204 (36%), Positives = 110/204 (53%), Gaps = 17/204 (8%)

Query: 487 SKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
            +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  E+ ++  LQH N+V+
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 542 LLGCCVE-GEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
             G C   G   + L+ EY+P  SL   L     +ERLD RK       I +G+ YL   
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYL--- 124

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG---TFGYMSPEY 656
              R +HRDL   NIL++ E   KI DFG+ K+   +++     R  G    F Y +PE 
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY-KVREPGESPIFWY-APES 182

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVS 680
             E +FS  SDV+SFGV+L E+ +
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  115 bits (291), Expect = 1e-28
 Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 19/214 (8%)

Query: 482 NFQLSSKLGQGGFGPVYWG----RLKDGQEIAVK---RLSKASGQGLEEFMNEVMVISKL 534
           +  L   LG G FG VY G    R  D  E+ V         S Q   +F+ E +++SK 
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 590
            H+N+VRL+G   E   + ++ E M    L + L +    P +   L  +        ++
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVV 646
           +G  YL  +     IHRD+ A N LL  +  P    KI+DFGMA+           GR +
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               +M PE  ++G F+ K+DV+SFGVLL EI S
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 2e-28
 Identities = 66/197 (33%), Positives = 101/197 (51%), Gaps = 11/197 (5%)

Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548
           LG G FG V+ G+ +   ++A+K + + +    ++F+ E  V+ KL H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRD 608
                ++ EYM N  L   L +   K   +W    ++   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 609 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEGRFSEKS 666
           L A N L+ E+   K+SDFG+A+    +Q  +  G     F   +  PE     RFS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG---TKFPVKWAPPEVFDYSRFSSKS 182

Query: 667 DVFSFGVLLLEIVSGRK 683
           DV+SFGVL+ E+ S  K
Sbjct: 183 DVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 5e-28
 Identities = 65/199 (32%), Positives = 109/199 (54%), Gaps = 14/199 (7%)

Query: 489 LGQGGFGPVYWGRLK--DGQEI--AVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           +G G FG V  GRLK    +EI  A+K L + +S +   +F+ E  ++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           G   +    M+I EYM N SLD  L +     +    +   ++ GI+ G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT--GRVVGTFGYMSPEYAMEGR 661
            +HRDL A NIL++  L  K+SDFG+++    ++    T  G++     + +PE     +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRK 184

Query: 662 FSEKSDVFSFGVLLLEIVS 680
           F+  SDV+SFG+++ E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  112 bits (282), Expect = 8e-28
 Identities = 73/203 (35%), Positives = 109/203 (53%), Gaps = 12/203 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLG G FG V+ G   +  ++AVK L K     ++ F+ E  ++  LQH  LV
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEGISRGLLYLH 597
           RL     + E   +I EYM   SL     D LK +   ++   K  +    I+ G+ Y+ 
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSL----LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           R +    IHRDL+A+N+L+ E L  KI+DFG+A++   N+  A  G       + +PE  
Sbjct: 121 RKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAI 176

Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
             G F+ KSDV+SFG+LL EIV+
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 1e-27
 Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 13/202 (6%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNL 539
           F L   +G+G FG VY    K   Q +A+K   L +A  + +E+   E+  +S+ +   +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
            +  G  ++G +  +I EY    S      D LK  +LD      I+  +  GL YLH +
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
                IHRD+KA+NILL EE + K++DFG++        + +T   VGT  +M+PE   +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172

Query: 660 GRFSEKSDVFSFGVLLLEIVSG 681
             + EK+D++S G+  +E+  G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 2e-27
 Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 21/210 (10%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF----MNEVMVISKLQHR 537
           ++  +++G+G +G VY  R  K G+ +A+K++   + +  E F    + E+ ++ KL+H 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHP 58

Query: 538 NLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRF--NIIEGISRGL 593
           N+VRL        +    +++EYM +  L  LL  P  K      K +   ++EG+    
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQ--- 114

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            YLH +    I+HRD+K SNIL++ +   K++DFG+A+ +        T RV+ T  Y  
Sbjct: 115 -YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169

Query: 654 PEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 682
           PE  +   R+  + D++S G +L E+  G+
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  111 bits (278), Expect = 4e-27
 Identities = 72/210 (34%), Positives = 111/210 (52%), Gaps = 22/210 (10%)

Query: 489 LGQGGFGPVYWGRLKD-------GQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLV 540
           LG G FG VY G   D          +AVK L K A+ Q  +EF+ E  ++S   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----LDWRKRFNIIEGISRGLLY 595
           +LLG C+  E + +I E M    L + L D  + ER     L  ++  +I   +++G +Y
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDA-RVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNP-----KISDFGMAKIFGGNQDQADTGRVVGTFG 650
           L    ++  IHRDL A N L+ E+        KI DFG+A+    +      G  +    
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           +M+PE  ++G+F+ +SDV+SFGVL+ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  108 bits (272), Expect = 2e-26
 Identities = 74/205 (36%), Positives = 111/205 (54%), Gaps = 8/205 (3%)

Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
              + QL  KLG G FG V+ G      ++AVK L K      E F+ E  ++ KL+H  
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           LV+L     E E   ++ EYM   SL   L D  +   L      ++   ++ G+ Y+ R
Sbjct: 63  LVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER 120

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
              +  IHRDL+++NIL+ + L  KI+DFG+A++   N+  A  G       + +PE A+
Sbjct: 121 ---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176

Query: 659 EGRFSEKSDVFSFGVLLLEIVS-GR 682
            GRF+ KSDV+SFG+LL E+V+ GR
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  108 bits (273), Expect = 2e-26
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)

Query: 483 FQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQHRNL 539
           +++   +G+G FG V    R  DG+ +  K +     + +  ++ ++EV ++ +L+H N+
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDAL--LFDPLKKER--LDWRKRFNIIEGISRGLLY 595
           VR     ++      +Y  M       L  L    KKER  ++    + I+  +   L  
Sbjct: 62  VRYYDRIID-RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 596 LHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            H   D    ++HRDLK +NI LD   N K+ DFG+AKI G +   A T   VGT  YMS
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMS 178

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE      + EKSD++S G L+ E+ +  
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  108 bits (272), Expect = 2e-26
 Identities = 76/205 (37%), Positives = 112/205 (54%), Gaps = 14/205 (6%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 65

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER---LDWRKRFNIIEGISRGLLYLHR 598
           L     E E   ++ EYM   SL     D LK E    L   +  ++   I+ G+ Y+ R
Sbjct: 66  LYAVVSE-EPIYIVTEYMSKGSL----LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
              +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+
Sbjct: 121 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176

Query: 659 EGRFSEKSDVFSFGVLLLEIVS-GR 682
            GRF+ KSDV+SFG+LL E+ + GR
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 3e-26
 Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 29/220 (13%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
               L  +LGQG FG VY G  K          +A+K +++ AS +   EF+NE  V+ +
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL------------FDPLKKERLDWRK 581
               ++VRLLG    G+  +++ E M    L + L              P   ++     
Sbjct: 66  FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF---- 121

Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQA 640
              +   I+ G+ YL      + +HRDL A N ++ E+L  KI DFGM + I+  +  + 
Sbjct: 122 -IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177

Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               ++    +M+PE   +G F+ KSDV+SFGV+L E+ +
Sbjct: 178 GGKGLL-PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  107 bits (269), Expect = 4e-26
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 14/213 (6%)

Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           L  ++G G FG V+ G   + +++A+K + + +    E+F+ E  V+ KL H  LV+L G
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
            C E     L++E+M +  L   L    ++ +        +   +  G+ YL   +   +
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121

Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     ++S 
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVKWSSPEVFSFSKYSS 180

Query: 665 KSDVFSFGVLLLEIVS-------GRKNTSFFED 690
           KSDV+SFGVL+ E+ S        R N+   E 
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET 213

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  107 bits (268), Expect = 9e-26
 Identities = 67/197 (34%), Positives = 103/197 (52%), Gaps = 7/197 (3%)

Query: 485 LSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NLV+LL
Sbjct: 10  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           G C       +I E+M   +L   L +   ++ ++      +   IS  + YL + +   
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 663
            IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE     +FS
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFS 183

Query: 664 EKSDVFSFGVLLLEIVS 680
            KSDV++FGVLL EI +
Sbjct: 184 IKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  107 bits (269), Expect = 9e-26
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 12/207 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLE-EFMNEVMVISKLQHRN 538
                 S+LG+G  G V   RLK+   I A+K ++      L+ + + E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 539 LVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLY 595
           +V+  G  ++     +    EY    SLD++     K+  R+  +    I E + +GL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           LH  SR +IIHRD+K SNILL  +   K+ DFG++     +      G   GT  YM+PE
Sbjct: 121 LH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPE 173

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                 +S  SDV+S G+ LLE+   R
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  107 bits (269), Expect = 1e-25
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 31/226 (13%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEF-MNEVMVISKL-Q 535
           ++F+    +G+G F  V   + K   +E A+K L K     +   ++   E  V+++L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           H  +++L     + EE +  + EY PN  L   +    K   LD +        I   L 
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN---------------QDQ 639
           YLH      IIHRDLK  NILLD++++ KI+DFG AK+   N               Q +
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 640 ADTGR---VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            +  R    VGT  Y+SPE   E    + SD+++ G ++ ++++G+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  106 bits (267), Expect = 1e-25
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 21/204 (10%)

Query: 489 LGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           LG+G +G VY  R    Q  IA+K + +   + ++    E+ + S L+HRN+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 548 EGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNII---EGISRGLLYLHRDSR 601
           E     +  E +P  SL ALL   + PLK           II   + I  GL YLH    
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKD------NEQTIIFYTKQILEGLKYLH---D 126

Query: 602 LRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            +I+HRD+K  N+L++      KISDFG +K   G     +T    GT  YM+PE   +G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTLQYMAPEVIDKG 184

Query: 661 R--FSEKSDVFSFGVLLLEIVSGR 682
              +   +D++S G  ++E+ +G+
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  106 bits (265), Expect = 1e-25
 Identities = 73/202 (36%), Positives = 112/202 (55%), Gaps = 13/202 (6%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLGQG FG V+ G      ++A+K L K      E F+ E  ++ KL+H  LV 
Sbjct: 7   SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVP 65

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK---ERLDWRKRFNIIEGISRGLLYLHR 598
           L     E E   ++ E+M   SL     D LK+   + L   +  ++   I+ G+ Y+ R
Sbjct: 66  LYAVVSE-EPIYIVTEFMGKGSL----LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
              +  IHRDL+A+NIL+ + L  KI+DFG+A++   N+  A  G       + +PE A+
Sbjct: 121 ---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176

Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
            GRF+ KSDV+SFG+LL E+V+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  106 bits (266), Expect = 2e-25
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 21/214 (9%)

Query: 485 LSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
           L  +LG+G FG V+          +D   +AVK L +AS    ++F  E  +++ LQH++
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 539 LVRLLGCCVEGEEKMLIYEYMP----NRSL-----DALLFDPLKKE---RLDWRKRFNII 586
           +VR  G C EG   ++++EYM     NR L     DA +    +     +L   +   I 
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
             I+ G++YL   + L  +HRDL   N L+ + L  KI DFGM++           GR +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               +M PE  +  +F+ +SD++SFGV+L EI +
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  106 bits (265), Expect = 2e-25
 Identities = 84/291 (28%), Positives = 146/291 (50%), Gaps = 57/291 (19%)

Query: 489 LGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLL 543
           +G G FG V  GRLK    +EI V   +  +G   +   +F++E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK---RFNIIE------GISRGLL 594
           G   + +  M++ EYM N SLDA L           RK   +F +I+      GI+ G+ 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL-----------RKHDGQFTVIQLVGMLRGIASGMK 120

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGY 651
           YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T   G++     +
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 175

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILAL 710
            +PE     +F+  SDV+S+G+++ E++S G +               W++ N++ I A+
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-------------WEMSNQDVIKAI 222

Query: 711 VDPFLSESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEI 757
                 E  ++L   + C   +H  +L C Q+   +RP    +VS+L+  I
Sbjct: 223 ------EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  103 bits (259), Expect = 1e-24
 Identities = 75/212 (35%), Positives = 111/212 (52%), Gaps = 22/212 (10%)

Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQ 535
           A      +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V+++L+
Sbjct: 2   ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 57

Query: 536 HRNLVRLLGCCVEGEEKMLIY-EYMPNRSLDALLFDPLK---KERLDWRKRFNIIEGISR 591
           H NLV+LLG  VE +  + I  EYM   SL     D L+   +  L           +  
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSL----VDYLRSRGRSVLGGDCLLKFSLDVCE 113

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            + YL  ++    +HRDL A N+L+ E+   K+SDFG+ K     Q   DTG++     +
Sbjct: 114 AMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKW 165

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GR 682
            +PE   E +FS KSDV+SFG+LL EI S GR
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  104 bits (261), Expect = 1e-24
 Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 19/216 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKL 534
           +N  L  +LG+G FG V+          +D   +AVK L  AS    ++F  E  +++ L
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD----------ALLFDPLKKERLDWRKRFN 584
           QH ++V+  G CVEG+  ++++EYM +  L+           L+ +  +   L   +  +
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           I + I+ G++YL   +    +HRDL   N L+ E L  KI DFGM++           G 
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            +    +M PE  M  +F+ +SDV+S GV+L EI +
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 97.5 bits (243), Expect = 1e-24
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 8/90 (8%)

Query: 322 KLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFD-G 380
            L C         G  DGF KL  +K+PD     +  + +ECRE CL NCSC AYA++ G
Sbjct: 2   PLNCGGD------GSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNG 55

Query: 381 GIGCMVWRSINLIDIQRLPFGGTDLYIRVA 410
             GC++W    L +++ L  GG  LY+R+A
Sbjct: 56  SGGCLLWNG-LLNNLRSLSSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (259), Expect = 2e-24
 Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 18/222 (8%)

Query: 484 QLSSKLGQGGFGPVYWG-RLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLV 540
           Q  +K+G G FG VY    L  G+ +AVK  R+     + ++E  +E+ V+  L+H NLV
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 541 RLLGCCVEGEEKMLIY-EYMPNRSLDALL-FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +  G  V   EK+ I+ EY    +L+ LL    +  E +       ++EG++    YLH 
Sbjct: 63  KYYGVEVH-REKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA----YLHS 117

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG--RVVGTFGYMSPEY 656
                I+HRD+K +NI LD     K+ DFG A     N          + GT  YM+PE 
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 657 AMEGRFSEK---SDVFSFGVLLLEIVSGRKNTSFFEDDLTIL 695
              G+       +D++S G ++LE+ +G++  S  +++  I+
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 68/214 (31%), Positives = 112/214 (52%), Gaps = 32/214 (14%)

Query: 489 LGQGGFGPVYWG-RLKDGQEIAVKR--LSKASGQG-------LEEFMNEVMVISKLQHRN 538
           +G G FG VY G     G+ +AVK+  L   S          L+    E+ ++ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLF------DPLKKERLDWRKRFNIIEGISRG 592
           +V+ LG  ++ +   +  EY+P  S+ ALL       + L +         N +  I +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---------NFVRQILKG 118

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR----VVGT 648
           L YLH  +R  IIHRD+K +NIL+D +   KISDFG++K    N     T      + G+
Sbjct: 119 LNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
             +M+PE   +  ++ K+D++S G L++E+++G+
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (256), Expect = 3e-24
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 20/210 (9%)

Query: 489 LGQGGFGPVYWG-RLKDGQEIAVKRLS-----KASGQGLEEFMNEVMVISKLQHRNLVRL 542
           LG G FG VY G  L DG   AVK +S     +   + +++   E+ ++SKLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           LG   E +   +  E +P  SL  LL  +    +  +           I  GL YLH   
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIR-----LYTRQILLGLEYLHDR- 121

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-E 659
               +HRD+K +NIL+D     K++DFGMAK      + +      G+  +M+PE    +
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQ 176

Query: 660 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFE 689
           G +   +D++S G  +LE+ +G+   S  E
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLE 206

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  103 bits (258), Expect = 3e-24
 Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 31/227 (13%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR---LKDGQE---IAVKRLSK-ASGQGLEEFMNEVMVISK 533
           NN +    +GQG FG V+  R   L   +    +AVK L + AS     +F  E  ++++
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-------------------PLKK 574
             H N+V+LLG C  G+   L++EYM    L+  L                      L  
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIF 633
             L   ++  I + ++ G+ YL   S  + +HRDL   N L+ E +  KI+DFG++  I+
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 634 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +  +A     +    +M PE     R++ +SDV+++GV+L EI S
Sbjct: 182 SADYYKASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  102 bits (254), Expect = 5e-24
 Identities = 72/205 (35%), Positives = 108/205 (52%), Gaps = 14/205 (6%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLG G FG V+        ++AVK + K     +E F+ E  V+  LQH  LV+
Sbjct: 7   SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 65

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEGISRGLLYLHR 598
           L    V  E   +I E+M   SL     D LK +   +    K  +    I+ G+ ++ +
Sbjct: 66  L-HAVVTKEPIYIITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
            +    IHRDL+A+NIL+   L  KI+DFG+A++   N+  A  G       + +PE   
Sbjct: 121 RN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAIN 176

Query: 659 EGRFSEKSDVFSFGVLLLEIVS-GR 682
            G F+ KSDV+SFG+LL+EIV+ GR
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  102 bits (256), Expect = 6e-24
 Identities = 70/223 (31%), Positives = 102/223 (45%), Gaps = 37/223 (16%)

Query: 488 KLGQGGFGPVYWGR--------LKDGQE---------IAVKRLSK-ASGQGLEEFMNEVM 529
           KLG+G FG V+            K   E         +AVK L   AS    E+F+ EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--------FDPLKKERLDWRK 581
           ++S+L   N+ RLLG C       +I EYM N  L+  L              + L +  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
              +   I+ G+ YL     L  +HRDL   N L+ +    KI+DFGM++    N   +D
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184

Query: 642 ----TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                GR      +M+ E  + G+F+ KSDV++FGV L EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  101 bits (252), Expect = 7e-24
 Identities = 69/206 (33%), Positives = 106/206 (51%), Gaps = 28/206 (13%)

Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           L   +G+G FG V  G    GQ++AVK +    + Q    F+ E  V++KL H+NLVRLL
Sbjct: 10  LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLL 65

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE------GISRGLLYLH 597
           G  +      ++ E M   +L   L       R   R   ++I+       ++ G+ YL 
Sbjct: 66  GVILH-NGLYIVMELMSKGNLVNFL-------RTRGRALVSVIQLLQFSLDVAEGMEYLE 117

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
                +++HRDL A NIL+ E+   K+SDFG+A++        D  ++     + +PE  
Sbjct: 118 SK---KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEAL 169

Query: 658 MEGRFSEKSDVFSFGVLLLEIVS-GR 682
              +FS KSDV+S+GVLL E+ S GR
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  101 bits (254), Expect = 8e-24
 Identities = 73/204 (35%), Positives = 100/204 (49%), Gaps = 22/204 (10%)

Query: 489 LGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLVRL 542
           LG+G FG V            G+ +AVK L +  GQ     +  E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 543 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
            GCC E   K   LI EY+P  SL     D L K +L+  +     + I  G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD----QADTGRVVGTFGYMSPEY 656
               IHRDL A N+LLD +   KI DFG+AK      +    + D    V  F Y + E 
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWY-AVEC 181

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVS 680
             E +FS  SDV+SFGV L E+++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 8e-24
 Identities = 80/296 (27%), Positives = 129/296 (43%), Gaps = 38/296 (12%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE---------------IAVKRL-SKASGQGLEEF 524
              +L  KLG+G FG V+    +   E               +AVK L +  +     +F
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E+ ++S+L++ N++RLLG CV  +   +I EYM N  L+  L    ++E        N
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLS---QREIESTFTHAN 121

Query: 585 IIEGISRG-LLYLHRD--------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635
            I  +S   LLY+           + L  +HRDL   N L+      KI+DFGM++    
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLT 693
                  GR V    +M+ E  + G+F+  SDV++FGV L E+ +  K    S   D+  
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241

Query: 694 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTV 749
           I        N+ + + L    L  S     +++RC           +KDRP  + +
Sbjct: 242 IENTGEFFRNQGRQIYLSQTPLCPSPV-FKLMMRCW-------SRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 60/193 (31%), Positives = 104/193 (53%), Gaps = 7/193 (3%)

Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           +LG G FG V+ G+ +   ++A+K +++ +    E+F+ E  V+ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
           + +   ++ E+M N  L  L +   ++ +L      ++ + +  G+ YL R+S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 667
           DL A N L+      K+SDFGM +    ++  + +G       +  PE     ++S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSKSD 183

Query: 668 VFSFGVLLLEIVS 680
           V+SFGVL+ E+ +
Sbjct: 184 VWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (252), Expect = 1e-23
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 10/208 (4%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKR--LSKASGQGLEEFMNEVMVISKLQHR 537
           ++++L   +G G    VY        E +A+KR  L K     ++E   EV  +S+  H 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHP 59

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+     V G+E  L+  Y+   SL  ++     +  LD      +++ + +GL YLH
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGR-VVGTFGYMSPE 655
            + +   IHRD+KA NILL E+ + KI+DFG+ A +  G        +  VGT  +M+PE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 656 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
              +   +  K+D++SFG+  +E+ +G 
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  100 bits (250), Expect = 1e-23
 Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 11/195 (5%)

Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+ KL H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
           +     ++ EYM N  L   L +  K  R    +   + + +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEGRFSEK 665
           DL A N L+D++   K+SDFG+++      D   T  V   F   +  PE  +  +FS K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 666 SDVFSFGVLLLEIVS 680
           SDV++FGVL+ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  100 bits (251), Expect = 2e-23
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 26/216 (12%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS----KASGQG--LEEFMNEVMVISKL 534
            +    +LG G F   Y  R +K G  +AVK+++     +S Q   +E    E+ ++++L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRG 592
            H +++R+LG   E     L  E+M   S+  LL  +   K+  +      N  E + RG
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRG 115

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMA-----KIFGGNQDQADTGRVV 646
           L YLH +   +IIHRD+K +N+L+D      +I+DFG A     K  G  + Q   G+++
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ---GQLL 169

Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           GT  +M+PE     ++    DV+S G +++E+ + +
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  100 bits (251), Expect = 2e-23
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 22/222 (9%)

Query: 485 LSSKLGQGGFGPVYWGR------LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
           L  +LG+G FG V+          KD   +AVK L   +    ++F  E  +++ LQH +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSL---------DALLF---DPLK-KERLDWRKRFNI 585
           +V+  G C +G+  ++++EYM +  L         DA++     P + K  L   +  +I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
              I+ G++YL   +    +HRDL   N L+   L  KI DFGM++           G  
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 687
           +    +M PE  M  +F+ +SDV+SFGV+L EI +  K   F
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.9 bits (249), Expect = 2e-23
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 17/209 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKR-----LSKASGQGLEEFMNEVMVISKL 534
            N++    LGQG FG VY     D G+E+AVK+      S  + + +     E+ ++  L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DAL-LFDPLKKERLDWRKRFNIIEGISRG 592
           QH  +V+  GC  + E   +  EYMP  S+ D L  +  L  E +  +    I+EG+   
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALT-ETVTRKYTRQILEGVE-- 118

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR-VVGTFGY 651
             YLH +    I+HRD+K +NIL D   N K+ DFG +K            + V GT  +
Sbjct: 119 --YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           MSPE      +  K+DV+S G  ++E+++
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 99.7 bits (248), Expect = 2e-23
 Identities = 68/200 (34%), Positives = 105/200 (52%), Gaps = 21/200 (10%)

Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCV 547
           LG+G FG V+ G LKD   +AVK   +   Q L+ +F++E  ++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
           + +   ++ E +P    D L F   KK+ L  ++        + G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG-------YMSPEYAMEG 660
           DL A N L+ E    KISDFGM++       Q D G +  + G       + +PE    G
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-------QEDDG-IYSSSGLKQIPIKWTAPEALNYG 169

Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           R+S +SDV+S+G+LL E  S
Sbjct: 170 RYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  100 bits (250), Expect = 3e-23
 Identities = 75/230 (32%), Positives = 116/230 (50%), Gaps = 33/230 (14%)

Query: 475 ELATATNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLS-KASGQGLEEFMNE 527
           E+  +T  F    +LG+  FG VY G L      +  Q +A+K L  KA G   EEF +E
Sbjct: 1   EINLSTVRFM--EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DPLKK 574
            M+ S+LQH N+V LLG   + +   +I+ Y  +  L   L              D   K
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
             L+     +I+  I+ G+ +L   S   ++H+DL   N+L+ ++LN KISD G+ +   
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR--- 172

Query: 635 GNQDQADTGRVVGT----FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                AD  +++G       +MSPE  M G+FS  SD++S+GV+L E+ S
Sbjct: 173 -EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 70/209 (33%), Positives = 108/209 (51%), Gaps = 19/209 (9%)

Query: 482 NFQLSSKLGQGGFGPVYW-GRLKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 538
           +F++  KLG+G +G VY   RL D Q  A+K   L   S +  E+ +NE+ +++ + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-----DWRKRFNIIEGISRGL 593
           ++      ++G +  ++ EY P   L   +    KK +L      WR    I   + RGL
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGL 116

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
             LH     +I+HRDLK++NILL      KI D G++K+   N   A T   +GT  YM+
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKT--QIGTPHYMA 169

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE      +S KSD++S G LL E+ +  
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 99.0 bits (247), Expect = 4e-23
 Identities = 67/204 (32%), Positives = 93/204 (45%), Gaps = 21/204 (10%)

Query: 488 KLGQGGFGPVYWGRLKDGQ----EIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRL 542
           KLG G FG V  G           +AVK L        +++F+ E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLYLHRD 599
            G  V     M++ E  P  SL     D L+K+ L         +    I+ G+ YL   
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD---QADTGRVVGTFGYMSPEY 656
              R IHRDL A NILL  +   KI DFG+ +    N+D     +  +V   F + +PE 
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVS 680
                FS  SDV+ FGV L E+ +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 99.5 bits (248), Expect = 5e-23
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRLSKASGQGLE-EFMNEVMVISKL 534
           N Q  + LG+G FG V+  + K  +E      + VK L K   + L+ EF  E+ +  KL
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNIIEG 588
            H+N+VRLLG C E E   +I EY     L   L       + LK   L  +++  +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           I+ G+ +L   S  R +HRDL A N L+  +   K+S   ++K    N +       +  
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY-NSEYYKLRNALIP 181

Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +++PE   E  FS KSDV+SFGVL+ E+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 98.4 bits (245), Expect = 8e-23
 Identities = 64/197 (32%), Positives = 102/197 (51%), Gaps = 13/197 (6%)

Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE---FMNEVMVISKLQHRNLVRLLGC 545
           +G+G FG V+  R K  Q++ + +         +E     NE  V+  L H N++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
            +E +  M++ EY P  +L     + ++K          I+    + LL LH      I+
Sbjct: 68  FLEDKALMIVMEYAPGGTL----AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123

Query: 606 HRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-FS 663
           HRDLK  NILLD+     KI DFG++KI   ++ +A T  VVGT  Y+SPE   EG+ ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCYISPELC-EGKPYN 179

Query: 664 EKSDVFSFGVLLLEIVS 680
           +KSD+++ G +L E+ S
Sbjct: 180 QKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 23/205 (11%)

Query: 489 LGQGGFG-PVYWGRLKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 545
           LG+G FG    + R +D   +  K   L++ S +   + +NE++++S LQH N++     
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 546 CVEGEEKMLIYEYMPNRSL-------DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
            ++    ++  EY    +L          LF+   +E + W      +  I   + Y+H+
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE---EEMVLW-----YLFQIVSAVSYIHK 119

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
                I+HRD+K  NI L +    K+ DFG++KI G     A+T  VVGT  YMSPE   
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQ 174

Query: 659 EGRFSEKSDVFSFGVLLLEIVSGRK 683
             +++ KSD+++ G +L E+++ ++
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 26/206 (12%)

Query: 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLG 544
            +LG G  G V     +  G+ +AVK +     + ++ + + E+ ++ K     +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                 +  +  EYM   SLD +L     + R+  R    I   + +GL YLH     +I
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEK--HKI 122

Query: 605 IHRDLKASNILLDEELNPKISDFG--------MAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           IHRD+K SNIL++     K+ DFG        +AK F            VGT  YM+PE 
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF------------VGTSSYMAPER 170

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGR 682
                +S KSD++S G+ L+E+ +GR
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 22/215 (10%)

Query: 483 FQLSSKLGQGGFGPVYWGRLK--DG--QEIAVK--RLSKASGQGLEEFMNEVMVISKLQH 536
            +L   LG+G FG V  G+L   DG   ++AVK  +L   +   +EEF++E   +    H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 537 RNLVRLLGCCVEGEEK------MLIYEYMPNRSLDALLFDP---LKKERLDWRKRFNIIE 587
            N+++L+G C E          M+I  +M +  L + L         E+L  +     + 
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 646
            I+ G+ YL   S    IHRDL A N +L E++   ++DFG++ KI+ G  D    GR+ 
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG--DYYRQGRIA 175

Query: 647 GT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                +++ E   +  ++ KSDV++FGV + EI +
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 13/199 (6%)

Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGFG V   ++K  G+  A K+L K      +G +  +NE  ++ K+  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 545 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
              E ++ + L+   M    L   +++  +    + R  F   + I  GL +LH+    R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQ---RR 115

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 663
           I++RDLK  N+LLD+  N +ISD G+A      +         GT GYM+PE      + 
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 664 EKSDVFSFGVLLLEIVSGR 682
              D F+ G  L E+++GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 77/281 (27%), Positives = 135/281 (48%), Gaps = 35/281 (12%)

Query: 489 LGQGGFGPVYWGRLK----DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLL 543
           +G G FG V  GRLK        +A+K L    + +   +F++E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           G   +    M+I E+M N +LD+ L       +    +   ++ GI+ G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---SEMN 126

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGN-QDQADTGRVVGTFG--YMSPEYAMEG 660
            +HRDL A NIL++  L  K+SDFG+++    +  D   T  + G     + +PE     
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 720
           +F+  SDV+S+G+++ E++      S+ E         W + N++ I A+      E  +
Sbjct: 187 KFTSASDVWSYGIVMWEVM------SYGERPY------WDMSNQDVINAI------EQDY 228

Query: 721 QLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEI 757
           +L   + C   +H  +L C Q+    RP    +VS L+  I
Sbjct: 229 RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 17/211 (8%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
            + +++  +LG G FG VY  + K+ G   A K +   S + LE+FM E+ ++S+ +H N
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 539 LVRLLGCCV-EGEEKMLIYEYMPNRSLDALLFDPLKKER-LDWRKRFNIIEGISRGLLYL 596
           +V L      E +  +LI E+    +LD+++   L+ ER L   +   +   +   L +L
Sbjct: 64  IVGLYEAYFYENKLWILI-EFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFL 119

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H     ++IHRDLKA NILL  + + K++DFG++        + DT   +GT  +M+PE 
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEV 174

Query: 657 AMEGRFSE-----KSDVFSFGVLLLEIVSGR 682
                F +     K+D++S G+ L+E+    
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 79/290 (27%), Positives = 137/290 (47%), Gaps = 41/290 (14%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDG-------QEIAVKRLS-----KASGQGLEEFMNEVM 529
            + +   LG G FG VY  R K+        +EI V   +     +   + + + ++EV 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 530 VISK-LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNII 586
           +I + L+H N+VR     +E +   ++ + +    L    F+ LK  K+R    + +NI 
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPL-GEHFNSLKEKKQRFTEERIWNIF 119

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
             +   L YLH++ R  I+HRDL  +NI+L E+    I+DFG+AK     Q ++    VV
Sbjct: 120 VQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVV 174

Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK 706
           GT  Y  PE      + EK+DV++FG +L ++ +      F+  ++  L  A K+     
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTNM--LSLATKIVE--- 227

Query: 707 ILALVDPFLSESSFQ---LDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 753
             A+ +P L E  +     D+I  C+           + RP++  V +M+
Sbjct: 228 --AVYEP-LPEGMYSEDVTDVITSCLTPD-------AEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.4 bits (237), Expect = 9e-22
 Identities = 62/200 (31%), Positives = 111/200 (55%), Gaps = 15/200 (7%)

Query: 489 LGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLL 543
           +G G FG V+ G LK  G++   +A+K L    + +  ++F++E  ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           G   + +  M+I EYM N +LD  L D          +   ++ GI+ G+ YL   S + 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGYMSPEYAMEG 660
            +HRDL A NIL++  L  K+SDFG++++   + +   T   G++     + +PE     
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIAYR 185

Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +F+  SDV+SFG+++ E++S
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 95.5 bits (237), Expect = 2e-21
 Identities = 65/198 (32%), Positives = 105/198 (53%), Gaps = 19/198 (9%)

Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           ++G G FG VY+ R +++ + +A+K++S   K S +  ++ + EV  + KL+H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           GC +      L+ EY    + D L    + K+ L   +   +  G  +GL YLH  +   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EG 660
           +IHRD+KA NILL E    K+ DFG A I       A     VGT  +M+PE  +   EG
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEG 189

Query: 661 RFSEKSDVFSFGVLLLEI 678
           ++  K DV+S G+  +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 17/216 (7%)

Query: 479 ATNNFQLSSKLGQGGFGPVYWG----RLKDGQE--IAVKRLSK-ASGQGLEEFMNEVMVI 531
           A     +S +LGQG FG VY G     +KD  E  +A+K +++ AS +   EF+NE  V+
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------WRKRFN 584
            +    ++VRLLG   +G+  ++I E M    L + L     +   +        +K   
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +           G+
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 95.1 bits (236), Expect = 2e-21
 Identities = 64/200 (32%), Positives = 118/200 (59%), Gaps = 16/200 (8%)

Query: 489 LGQGGFGPVYWG-RLKDGQEI----AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
           LG G FG VY G  + +G+ +    A+K L++ +G +   EFM+E ++++ + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           LG C+    + L+ + MP+  L  L +    K+ +  +   N    I++G++YL      
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCL--LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEG 660
           R++HRDL A N+L+    + KI+DFG+A++  G++ +  AD G++     +M+ E     
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMALECIHYR 186

Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +F+ +SDV+S+GV + E+++
Sbjct: 187 KFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 69/228 (30%), Positives = 113/228 (49%), Gaps = 39/228 (17%)

Query: 488 KLGQGGFGPVYWGRLKDGQE-----------------IAVKRL-SKASGQGLEEFMNEVM 529
           KLG+G FG V+   + + Q+                 +AVK L   A+     +F+ EV 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER------------- 576
           ++S+L+  N++RLLG CV+ +   +I EYM N  L+  L      ++             
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 577 ---LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-I 632
              + +    ++   I+ G+ YL   S L  +HRDL   N L+ E L  KI+DFGM++ +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 633 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + G+  +   GR V    +M+ E  + G+F+  SDV++FGV L EI+ 
Sbjct: 189 YAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 94.9 bits (236), Expect = 3e-21
 Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 19/203 (9%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRN 538
           F    ++G G FG VY+ R ++  + +A+K++S   K S +  ++ + EV  + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
            +   GC +      L+ EY    + D L  +  KK  L   +   I  G  +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDIL--EVHKKP-LQEVEIAAICHGALQGLAYLHS 133

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE--Y 656
             R   IHRD+KA NILL E    K++DFG A +       A++   VGT  +M+PE   
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS--FVGTPYWMAPEVIL 184

Query: 657 AM-EGRFSEKSDVFSFGVLLLEI 678
           AM EG++  K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 20/206 (9%)

Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLS------KASGQGLEEFMNEVMVISKLQHRNLVRL 542
           LG+G +G VY G    GQ IAVK++        A+ +  E+   EV ++  L+H N+V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           LG C++     +  E++P  S+ ++L  F PL  E +  +    I++G++    YLH + 
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPL-PEPVFCKYTKQILDGVA----YLHNNC 122

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAK---IFGGNQDQADTGRVV-GTFGYMSPEY 656
              ++HRD+K +N++L      K+ DFG A+     G +   ++  + + GT  +M+PE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGR 682
             E  +  KSD++S G  + E+ +G+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 94.2 bits (234), Expect = 4e-21
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 18/199 (9%)

Query: 488 KLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+GQG  G VY    +  GQE+A+K+++       E  +NE++V+ + +H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL----YLHRDSRL 602
           + G+E  ++ EY+   SL  ++ +    E          I  + R  L    +LH +   
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAVCRECLQALEFLHSN--- 134

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
           ++IHRD+K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE      +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 192

Query: 663 SEKSDVFSFGVLLLEIVSG 681
             K D++S G++ +E+V G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 93.2 bits (231), Expect = 4e-21
 Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 7/195 (3%)

Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
           ++G+G FG V+ GRL+ D   +AVK   +     L+ +F+ E  ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
           C + +   ++ E +  +  D L F   +  RL  ++   ++E  + G+ YL        I
Sbjct: 62  CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           HRDL A N L+ E+   KISDFGM++        +  G       + +PE    GR+S +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 666 SDVFSFGVLLLEIVS 680
           SDV+SFG+LL E  S
Sbjct: 177 SDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 93.3 bits (232), Expect = 6e-21
 Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 15/205 (7%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQH---R 537
           +Q    +G+G +G VY G+ +  G+ +A+K ++  +    + +   EV ++S+L+     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+ +  G  ++G    +I EY    S+  L+    K   +  +    II  +   L Y+H
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           +     +IHRD+KA+NIL+    N K+ DFG+A +   N  +  T   VGT  +M+PE  
Sbjct: 119 KVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVI 173

Query: 658 MEGR-FSEKSDVFSFGVLLLEIVSG 681
            EG+ +  K+D++S G+ + E+ +G
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 93.6 bits (232), Expect = 8e-21
 Identities = 61/196 (31%), Positives = 107/196 (54%), Gaps = 12/196 (6%)

Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V   R K  G+++AVK +     Q  E   NEV+++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + GEE  ++ E++   +L     D + + RL+  +   + E + + L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ +ILL  +   K+SDFG  A+I   ++D      +VGT  +M+PE      +  +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197

Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++++E+V G
Sbjct: 198 VDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.8 bits (230), Expect = 9e-21
 Identities = 66/203 (32%), Positives = 110/203 (54%), Gaps = 15/203 (7%)

Query: 483 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
           F    ++G+G FG VY G   R K+   I +  L +A  + +E+   E+ V+S+     +
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
            R  G  ++G +  +I EY+   S LD L   PL++  +       I+  I +GL YLH 
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHS 119

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
           +   R IHRD+KA+N+LL E+ + K++DFG+A      Q + +T   VGT  +M+PE   
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 174

Query: 659 EGRFSEKSDVFSFGVLLLEIVSG 681
           +  +  K+D++S G+  +E+  G
Sbjct: 175 QSAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 92.8 bits (230), Expect = 9e-21
 Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 25/214 (11%)

Query: 488 KLGQGGFGPVYWGRL-----KDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVR 541
           +LG+  FG +Y G L        Q +A+K L    + Q   EF  E  ++++L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLF--------------DPLKKERLDWRKRFNIIE 587
           LLG   + +   +++EY+    L   L               D   K  LD     +I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVV 646
            I+ G+ YL   S    +H+DL A NIL+ E+L+ KISD G+++ I+  +  +     ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               +M PE  M G+FS  SD++SFGV+L EI S
Sbjct: 189 -PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 16/206 (7%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN--EVMVISKLQHRNL 539
           +Q   K+G+G +G VY  R    G+ +A+K++               E+ ++ +L H N+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLH 597
           ++LL       +  L++E+M     D  L+  +K  +  L      + +  + +GL + H
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
                 I+HRDLK  N+L++ E   K++DFG+A+ FG       T  VV T  Y +PE  
Sbjct: 116 SH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVV-TRWYRAPELL 170

Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSGR 682
           +  +  S   D++S G +  E++S R
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 79/295 (26%), Positives = 134/295 (45%), Gaps = 41/295 (13%)

Query: 488 KLGQGGFGPVYWGRLKDGQE-----------------IAVKRL-SKASGQGLEEFMNEVM 529
           KLG+G FG V+    +  ++                 +AVK L   A+     +F+ E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF------DPLKKER--LDWRK 581
           ++S+L+  N++RLL  C+  +   +I EYM N  L+  L          K +   + +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQA 640
              +   I+ G+ YL   S L  +HRDL   N L+ +    KI+DFGM++ ++ G+  + 
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF--FEDDLTILGYA 698
             GR V    +MS E  + G+F+  SDV++FGV L EI++  K   +    D+  I    
Sbjct: 189 Q-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG 247

Query: 699 WKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 753
               ++ + + L  P L   S    M        L C +   K+RP+   + + L
Sbjct: 248 EFFRDQGRQVYLPKPALCPDSLYKLM--------LSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 1e-20
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 20/203 (9%)

Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF----MNEVMVISKLQHRNLVRL 542
           KLG+G +G VY  R  K G+ +A+K++        E      + E+ ++ +L+H N+V+L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR--FNIIEGISRGLLYLHRDS 600
           L       +  L++EY  +  L   L         +  K   + ++    RGL Y H   
Sbjct: 64  LDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLL----RGLAYCHSH- 117

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
             RI+HRDLK  NIL++ +   K++DFG+A+ F G   +  T  VV T  Y +PE  +  
Sbjct: 118 --RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILLGS 173

Query: 661 RFSEKS-DVFSFGVLLLEIVSGR 682
           +    + D++S G +  E+++G+
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 62/207 (29%), Positives = 113/207 (54%), Gaps = 19/207 (9%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFM-NEVMVISKLQ---H 536
           ++  +++G+G +G VY  R L  G+ +A+K++    S +G+      E+ ++ +L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 537 RNLVRLLGCC----VEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
            N+VRLL  C     + E K+ L++E++ ++ L   L     K  L      +++  + R
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
           G+ +LH     RI+HRDLK  NIL+  +   KI+DFG+A+I+    + A T  VV T  Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVV-TLWY 172

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEI 678
            +PE  ++  ++   D++S G +  E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 18/208 (8%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRL-------SKASGQGLEEFMNEVMVI 531
             NF++  K+G+G F  VY    L DG+ +A+K++       +KA     ++ + E+ ++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR----QDCLKEIDLL 56

Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGIS 590
            +L H N+++ L   +E  E  ++ E      L  ++    K++RL   R  +     + 
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
             L ++H  S+ RI+HRD+K +N+ +      K+ D G+ + F      A +  +VGT  
Sbjct: 117 SALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEI 678
           YMSPE   E  ++ KSD++S G LL E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 68/232 (29%), Positives = 114/232 (49%), Gaps = 25/232 (10%)

Query: 489 LGQGGFGPVYWG-RLKDGQEIAVKRLS---------KASGQGLEEFMN-EVMVISKLQHR 537
           +G+G +G VY    +  G+ +AVK++           +  + + + +  E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 538 NLVRLLGCCVEGEEKMLIY-EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
           N+V+ LG     EE + I+ EY+P  S+ + L    + E     + F   E +  GL YL
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-QLVRFFT--EQVLEGLAYL 124

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H      I+HRDLKA N+L+D +   KISDFG++K      D      + G+  +M+PE 
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 657 AMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK 706
                  +S K D++S G ++LE+ +GR+  S    D   +   +KL N+  
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS----DEEAIAAMFKLGNKRS 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 24/206 (11%)

Query: 489 LGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRL 542
           LG+G FG V   R        G+++AVK L   SG   + +   E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 543 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
            G C E       LI E++P+ SL   L  P  K +++ +++      I +G+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GS 127

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ------DQADTGRVVGTFGYMSP 654
           R + +HRDL A N+L++ E   KI DFG+ K    ++      D  D+      F Y +P
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS----PVFWY-AP 181

Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVS 680
           E  ++ +F   SDV+SFGV L E+++
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 92.4 bits (229), Expect = 2e-20
 Identities = 62/200 (31%), Positives = 113/200 (56%), Gaps = 16/200 (8%)

Query: 489 LGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRL 542
           LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ + + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           LG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ YL      
Sbjct: 75  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER--- 128

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYMSPEYAMEG 660
           R++HRDL A N+L+    + KI+DFG+AK+ G ++    A+ G+V     +M+ E  +  
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMALESILHR 186

Query: 661 RFSEKSDVFSFGVLLLEIVS 680
            ++ +SDV+S+GV + E+++
Sbjct: 187 IYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 92.1 bits (228), Expect = 2e-20
 Identities = 57/195 (29%), Positives = 106/195 (54%), Gaps = 10/195 (5%)

Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+GQG  G V+    +  GQE+A+K+++       E  +NE++V+ +L++ N+V  L   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 86  LVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138

Query: 607 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS 666
           RD+K+ N+LL  + + K++DFG        Q +  T  +VGT  +M+PE      +  K 
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196

Query: 667 DVFSFGVLLLEIVSG 681
           D++S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 92.2 bits (229), Expect = 3e-20
 Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 14/209 (6%)

Query: 481 NNFQLSSKLGQGGFGPVY----WGRLKDGQ--EIAVKRL-SKASGQGLEEFMNEVMVISK 533
           NN      LG G FG V     +G  K     ++AVK L   A     E  M+E+ ++S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-LDWRKRFNIIEGISR 591
           L  H N+V LLG C  G   ++I EY      D L F   K+E  L      +    +++
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
           G+ +L   +    IHRDL A N+LL      KI DFG+A+    + +    G       +
Sbjct: 153 GMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           M+PE      ++ +SDV+S+G+LL EI S
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.1 bits (228), Expect = 3e-20
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 19/198 (9%)

Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           ++G G FG VY+ R ++  + +A+K++S   K S +  ++ + EV  + +++H N +   
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           GC +      L+ EY    + D L    + K+ L   +   I  G  +GL YLH  +   
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 145

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EG 660
           +IHRD+KA NILL E    K++DFG A I       +     VGT  +M+PE  +   EG
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVILAMDEG 199

Query: 661 RFSEKSDVFSFGVLLLEI 678
           ++  K DV+S G+  +E+
Sbjct: 200 QYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 64/234 (27%), Positives = 114/234 (48%), Gaps = 43/234 (18%)

Query: 478 TATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF----MNEVMVIS 532
           +   ++++  KLG+G FG VY  R +K G+ +A+K++   + +  + F    + E+ ++ 
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILK 62

Query: 533 KLQHRNLVRLLGCCVE-----GEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRF-- 583
           KL+H N+V L+   VE       ++  +Y   P  +  L  LL +P          +   
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--------SVKLTE 114

Query: 584 ----NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF------ 633
                 +  +  G+ YLH +    I+HRD+KA+NIL+D +   KI+DFG+A+ +      
Sbjct: 115 SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Query: 634 ----GGNQDQADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 682
               GG   +  T  VV T  Y  PE  + E R++   D++  G +  E+ + R
Sbjct: 172 PKGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 14/203 (6%)

Query: 488 KLGQGGFGPVYWG--RLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           +LG G FG V  G  +++  Q ++A+K L   + + + +E M E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           G C E E  ML+ E      L+  L    KK+ +       ++  +S G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEGR 661
            +HRDL A N+LL  +   KISDFG++K  G + D     R  G +   + +PE     +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECINFRK 174

Query: 662 FSEKSDVFSFGVLLLEIVS-GRK 683
           FS +SDV+S+G+ + E  S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 90.8 bits (225), Expect = 6e-20
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 35/229 (15%)

Query: 482 NFQLSSKLGQGGFGPVYWG---RLKDG---QEIAVKRLSKASGQG-LEEFMNEVMVISKL 534
           N  L   LG+G FG V      RLK       +AVK L + +    L + ++E  ++ ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--------------------- 573
            H ++++L G C +    +LI EY    SL + L +  K                     
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 574 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
           +  L      +    ISRG+ YL   + ++++HRDL A N+L+ E    KISDFG+++  
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 634 GGNQDQADTGRVVGTF--GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
              ++ +   R  G     +M+ E   +  ++ +SDV+SFGVLL EIV+
Sbjct: 178 --YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 66/212 (31%), Positives = 111/212 (52%), Gaps = 21/212 (9%)

Query: 485 LSSKLGQGGFGPVYWGRLKDGQEI---AVKRLSKA--SGQGLEEFMNEVMVISKLQHRNL 539
           L   LG+G FG V  G+L     I   AVK +  A  +   +E+F++E + + +  H N+
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 540 VRLLGCCVEGEEK------MLIYEYMPNRSLDA-LLFDPL--KKERLDWRKRFNIIEGIS 590
           +RL+G C++  E       ++I  +M +  L + LL+  L    + L  +     +  I+
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGT- 648
            G+ YL   S    IHRDL A N +L+E +N  ++DFG++ KI+ G  D    GR+    
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG--DYYRQGRIAKMP 177

Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +++ E   +  ++ KSDV+SFGV + EI +
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 488 KLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLV 540
           +LGQG FG VY G  +D         +AVK +++ AS +   EF+NE  V+      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 541 RLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           RLLG   +G+  +++ E M +       RSL     +   +     ++   +   I+ G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            YL+     + +HRDL A N ++  +   KI DFGM +           G+ +    +M+
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE   +G F+  SD++SFGV+L EI S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 536
            +FQ+ +++GQGG+G V+  + KD  EI A+KR+ K+    L E    + E  +++  + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP--LKKERLDWRKRFNIIEGISRGLL 594
             LV+LL    + E   L  EY+P      LL +   L ++      RF + E     + 
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----ARFYMAEMFE-AVD 115

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
            LH    L  IHRDLK  N L+D   + K++DFG++K   G    A++  VVG+  YM+P
Sbjct: 116 ALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAP 167

Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           E      +    D +S G +L E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 25/212 (11%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 538
            +++  ++G+G  G V+  +  + G+ +A+K+  L +  G    + + E+  +   QH  
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD---PLKKERLDWRKRFNIIEGISRGLL- 594
           +V+LL     G   +L+ EYMP   L  +L D   PL +           ++   R LL 
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEA---------QVKSYMRMLLK 110

Query: 595 ---YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              Y+H      I+HRDLK +N+L+  +   KI+DFG+A++F   + +  + + V T  Y
Sbjct: 111 GVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWY 166

Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE     R +    D+++ G +  E+++G 
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 71/225 (31%), Positives = 112/225 (49%), Gaps = 31/225 (13%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRL-----SKASGQGLEEFMNEVMVISKLQ 535
           N++L   LGQG FG VY     D G+E+AVK++     S  + + +     E+ ++  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 536 HRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKK-----ERLDWRKRFNIIEG 588
           H  +V+  GC  +  E+ L    E+MP  S+     D LK      E +  +    I+EG
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG----R 644
           +S    YLH +    I+HRD+K +NIL D   N K+ DFG +K     Q    +G     
Sbjct: 119 VS----YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKS 168

Query: 645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE 689
           V GT  +MSPE      +  K+D++S G  ++E+++ +   + FE
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 89.3 bits (221), Expect = 3e-19
 Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 19/198 (9%)

Query: 488 KLGQGGFGPVYWGRLKDGQEI-AVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           ++G G FG VY+       E+ AVK++S   K + +  ++ + EV  + +L+H N +   
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           GC ++     L+ EY    + D L    + K+ L   +   I  G  +GL YLH  +   
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EG 660
           +IHRD+KA NILL E    K++DFG A         +     VGT  +M+PE  +   EG
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVILAMDEG 195

Query: 661 RFSEKSDVFSFGVLLLEI 678
           ++  K DV+S G+  +E+
Sbjct: 196 QYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 88.6 bits (219), Expect = 3e-19
 Identities = 58/195 (29%), Positives = 105/195 (53%), Gaps = 10/195 (5%)

Query: 488 KLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+GQG  G VY    +  GQE+A+K+++       E  +NE++V+ + ++ N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138

Query: 607 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS 666
           RD+K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE      +  K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196

Query: 667 DVFSFGVLLLEIVSG 681
           D++S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 25/212 (11%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
           +F+L   +G+G FG V   + +D +++ A+K ++K        +   +NE  ++ +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLD-WRKRFNIIEGISR 591
            LV L     + EE M    Y+    +D LL     +   +K +    + +F I E I  
Sbjct: 61  FLVNLWYS-FQDEENM----YL---VVDLLLGGDLRYHLSQKVKFSEEQVKFWICE-IVL 111

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRD+K  NILLDE+ +  I+DF +A           T    GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGY 165

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 683
           M+PE      +S   D +S GV   E + G++
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 30/210 (14%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRNLVRLLG 544
           + +G +G V+  + K  G   A+K + KA       +++ + E  ++S+ Q   +V+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 545 CCVEGEEKM-LIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
              +G++ + L+ EY+P   L +LL      D       D  +    I  I   L YLH 
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS 111

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-------ADTGRVVGTFGY 651
                IIHRDLK  NIL+D   + K++DFG++K  G  + Q        +  R+VGT  Y
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDY 167

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           ++PE  +    S+  D +S G +L E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 87.9 bits (218), Expect = 5e-19
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)

Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V     K  G+++AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ E++   +L     D +   R++  +   +   + + L +LH      +IH
Sbjct: 86  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIH 138

Query: 607 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VVGTFGYMSPEYAMEGRFS 663
           RD+K+ +ILL  +   K+SDFG    F   Q   +  R   +VGT  +M+PE      + 
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFG----FCA-QVSKEVPRRKSLVGTPYWMAPEVISRLPYG 193

Query: 664 EKSDVFSFGVLLLEIVSG 681
            + D++S G++++E+V G
Sbjct: 194 TEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 87.7 bits (217), Expect = 5e-19
 Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 16/200 (8%)

Query: 489 LGQGGFGPVYWG-RLKDGQEI----AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
           LG G FG V+ G  + +G  I    A+K +   SG Q  +E  + ++ +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDS 600
           LG C  G    L+ +  P  SL     D +++ R  LD ++  N    I++G+ YL    
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH- 128

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
             R++HR+L A NILL  +   +I+DFG+A +   +  +           +M+ E  + G
Sbjct: 129 --RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           R++ +SDV+S+GV + E++S
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (215), Expect = 6e-19
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 25/222 (11%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRL-----SKASGQGLEEFMNEVMVISKLQ 535
           N++L   LG+G FG VY     D G+E+AVK++     S+ + + +     E+ ++  L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 536 HRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-----KERLDWRKRFNIIEG 588
           H  +V+  GC  + EEK L    EYMP  S+     D LK      E +  R    I++G
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQG 118

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVG 647
           +S    YLH +    I+HRD+K +NIL D   N K+ DFG +K I            V G
Sbjct: 119 VS----YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE 689
           T  +MSPE      +  K+DV+S    ++E+++ +   + +E
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.4 bits (216), Expect = 7e-19
 Identities = 61/208 (29%), Positives = 110/208 (52%), Gaps = 15/208 (7%)

Query: 483 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
           F    ++G+G FG V+ G   R +    I +  L +A  + +E+   E+ V+S+     +
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
            +  G  ++G +  +I EY+   S LD L   P  + ++       +++ I +GL YLH 
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHS 119

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
           + +   IHRD+KA+N+LL E+ + K++DFG+A      Q + +T   VGT  +M+PE   
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174

Query: 659 EGRFSEKSDVFSFGVLLLEIVSGRKNTS 686
           +  +  K+D++S G+  +E+  G    S
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 87.1 bits (216), Expect = 7e-19
 Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 13/200 (6%)

Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DGQ+I  AVK L++ +  + +E+F+ E +++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           G C+  E   +++  YM +  L   +        +     F +   +++G+ YL   +  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYL---ASK 117

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVG-TFGYMSPEYAMEG 660
           + +HRDL A N +LDE    K++DFG+A+ I+                  +M+ E     
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +F+ KSDV+SFGVLL E+++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score = 80.8 bits (200), Expect = 7e-19
 Identities = 28/66 (42%), Positives = 37/66 (56%), Gaps = 6/66 (9%)

Query: 335 GKEDGFSKLNKMKVPDFTEWT--SPATEDECREQCLKNCSCIAYAFD---GGIGCMVWRS 389
           G  DGF +L  MK+PD T           EC ++CL NCSC AYA+    GG GC++W  
Sbjct: 2   GGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWTG 61

Query: 390 INLIDI 395
             L+D+
Sbjct: 62  -ELVDM 66

Length = 66

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 87.6 bits (218), Expect = 7e-19
 Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 33/214 (15%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA----SGQGLEEFMNEVMVISKLQ 535
           ++F+    LG G FG V   R K   +  A+K LSKA      Q +E  +NE  ++  ++
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR---- 591
           H  LV L G   +     L+ EY+P   L    F  L+K       RF   E ++R    
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSHLRKSG-----RFP--EPVARFYAA 108

Query: 592 ----GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
                L YLH    L I++RDLK  N+LLD +   KI+DFG AK   G      T  + G
Sbjct: 109 QVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCG 160

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           T  Y++PE  +   + +  D ++ G+L+ E+++G
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 87.5 bits (216), Expect = 8e-19
 Identities = 57/196 (29%), Positives = 108/196 (55%), Gaps = 12/196 (6%)

Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ NILL  + + K++DFG  A+I     +Q+    +VGT  +M+PE      +  K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++ +E++ G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 87.1 bits (216), Expect = 9e-19
 Identities = 61/218 (27%), Positives = 109/218 (50%), Gaps = 31/218 (14%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKDG-----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQH 536
             LS  L +G FG +++G L D      +E+ VK +   AS   +   + E  ++  L H
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67

Query: 537 RNLVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDP-----LKKERLDWRKRFNIIEGIS 590
           +N++ +L  C+E  E   ++Y YM   +L   L           + L  ++  ++   I+
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IF-------GGNQDQADT 642
            G+ YLH+     +IH+D+ A N ++DEEL  KI+D  +++ +F       G N+++   
Sbjct: 128 CGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP-- 182

Query: 643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                   +M+ E  +   +S  SDV+SFGVLL E+++
Sbjct: 183 ------VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 25/206 (12%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           ++L  ++G G +G VY  R +  G+ +A+K +    G   E    E+ ++ + +H N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDAL---LFDPLKKERLDWRKRFNIIEGISR----GLL 594
             G  +  ++  ++ EY    SL  +      PL + +         I  + R    GL 
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ---------IAYVCRETLKGLA 115

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH       IHRD+K +NILL E+ + K++DFG++        +  +   +GT  +M+P
Sbjct: 116 YLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAP 170

Query: 655 EYA---MEGRFSEKSDVFSFGVLLLE 677
           E A    +G +  K D+++ G+  +E
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 21/206 (10%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           +++  +LG G FG VY  + K+ G   A K +   S + LE++M E+ +++   H  +V+
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL----YLH 597
           LLG      +  ++ E+ P  ++DA++ +      LD       I+ I R +L    YLH
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLH 127

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               ++IIHRDLKA N+LL  + + K++DFG++        + D+   +GT  +M+PE  
Sbjct: 128 S---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVV 182

Query: 658 M-----EGRFSEKSDVFSFGVLLLEI 678
           M     +  +  K+D++S G+ L+E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 77/285 (27%), Positives = 133/285 (46%), Gaps = 47/285 (16%)

Query: 489 LGQGGFGPVYWGRLK--DGQE--IAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           LG G FG +  G LK    +E  +A+  L +  S +    F+ E + + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLYLHRDSRL 602
           G    G   M++ EYM N +LD+ L    K E +L   +   ++ G++ G+ YL   S +
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG------YMSPEY 656
             +H+ L A  +L++ +L  KIS F         +D+++   +  T        + +PE 
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRR-----LQEDKSEA--IYTTMSGKSPVLWAAPEA 179

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 716
                FS  SDV+SFG+++ E++      S+ E         W +  ++ I A+      
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVM------SYGERPY------WDMSGQDVIKAV------ 221

Query: 717 ESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEI 757
           E  F+L     C   +H  +L C Q+   +RP  S + S+L+  +
Sbjct: 222 EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 68/203 (33%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 485 LSSKLGQGGFGPVYW---------GRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 535
           L  +LG+G FG VY           RLK  +EI V  L+        +   E  ++SKL 
Sbjct: 4   LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLD 60

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H  +V+     +E +   +I EY   R LD  L +     +     +  + E   + LL 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ--VCEWFIQLLLG 118

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           +H   + RI+HRDLKA NI L   L  KI DFG++++  G+ D A T    GT  YMSPE
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPE 175

Query: 656 YAMEGRFSEKSDVFSFGVLLLEI 678
                 +  KSD++S G +L E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 80/265 (30%), Positives = 121/265 (45%), Gaps = 35/265 (13%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRL-----SKASGQGLEEFMNEVMVISKLQ 535
           N++    LGQG FG VY     D G+E+A K++     S  + + +     E+ ++  LQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 536 HRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-----KERLDWRKRFNIIEG 588
           H  +V+  GC  +  EK L    EYMP  S+     D LK      E +  +    I+EG
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG--RVV 646
           +S    YLH +    I+HRD+K +NIL D   N K+ DFG +K        + TG   V 
Sbjct: 119 MS----YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVT 170

Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK 706
           GT  +MSPE      +  K+DV+S G  ++E+++ +   + +E    I   A +  N   
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP-- 228

Query: 707 ILALVDPFLSESSFQLDMIIRCIHV 731
                    S  S      + CI V
Sbjct: 229 ------QLPSHISEHARDFLGCIFV 247

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 60/229 (26%), Positives = 111/229 (48%), Gaps = 20/229 (8%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHR 537
           NFQ+  K+G+G F  VY    L D + +A+K++        +  ++ + E+ ++ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-----WRKRFNIIEGISRG 592
           N+++ L   +E  E  ++ E      L  ++    K++RL      W+    +   +   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
               H  SR R++HRD+K +N+ +      K+ D G+ + F      A +  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL 701
           SPE   E  ++ KSD++S G LL E+ +    + F+ D + +     K+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDKMNLFSLCQKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 86.6 bits (214), Expect = 2e-18
 Identities = 73/225 (32%), Positives = 112/225 (49%), Gaps = 38/225 (16%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRL-KDG--QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 535
           N+ +    +G+G FG V   R+ KDG   + A+KR+ + AS     +F  E+ V+ KL  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LD 578
           H N++ LLG C       L  EY P+ +L     D L+K R                 L 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLS 122

Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
            ++  +    ++RG+ YL   S+ + IHRDL A NIL+ E    KI+DFG+++     Q+
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQE 175

Query: 639 ---QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
              +   GR+     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 176 VYVKKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 50/139 (35%), Positives = 73/139 (52%), Gaps = 17/139 (12%)

Query: 557 EYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 614
           E+M   SLD +     P+  E L       I   +  GL YL+  +  RI+HRD+K SNI
Sbjct: 83  EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--NVHRIMHRDIKPSNI 135

Query: 615 LLDEELNPKISDFGMAKIFGGN--QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFG 672
           L++     K+ DFG++    G      ADT   VGT  YMSPE    G+++ KSDV+S G
Sbjct: 136 LVNSRGQIKLCDFGVS----GELINSIADT--FVGTSTYMSPERIQGGKYTVKSDVWSLG 189

Query: 673 VLLLEIVSGRKNTSFFEDD 691
           + ++E+  G+   +F   D
Sbjct: 190 ISIIELALGKFPFAFSNID 208

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 63/202 (31%), Positives = 113/202 (55%), Gaps = 20/202 (9%)

Query: 489 LGQGGFGPVYWG-RLKDGQEI----AVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRL 542
           LG G FG VY G  + DG+ +    A+K L +  S +  +E ++E  V++ +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDS 600
           LG C+    + L+ + MP       L D ++  K+R+  +   N    I++G+ YL    
Sbjct: 75  LGICLTSTVQ-LVTQLMPY----GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAM 658
            +R++HRDL A N+L+    + KI+DFG+A++   ++ +  AD G+V     +M+ E  +
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESIL 184

Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
             RF+ +SDV+S+GV + E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 85.2 bits (211), Expect = 5e-18
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 24/206 (11%)

Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE------FMNEVMVISKLQHRNLV 540
           K+G+G +G VY GR  K GQ +A+K++   S    EE       + E+ ++ +LQH N+V
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES----EEEGVPSTAIREISLLKELQHPNIV 62

Query: 541 RLLGCCVEGEEKMLIYEYMP---NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
            L    ++     LI+E++     + LD+L         L     + I++GI    L+ H
Sbjct: 63  CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LFCH 118

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
                R++HRDLK  N+L+D +   K++DFG+A+ F G   +  T  VV T  Y +PE  
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVL 173

Query: 658 MEG-RFSEKSDVFSFGVLLLEIVSGR 682
           +   R+S   D++S G +  E+ + +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 85.1 bits (211), Expect = 6e-18
 Identities = 75/212 (35%), Positives = 105/212 (49%), Gaps = 24/212 (11%)

Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKL-QHRNLVRLL 543
           LG+G FG V    LK   E+ AVK L K        +E  M E  V++   +H  L +L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 544 GCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSR 601
             C + ++++  + EY+    L   +F   +  R D  R RF   E I  GL +LH    
Sbjct: 63  -SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE-IVLGLQFLHERG- 116

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEYAME 659
             II+RDLK  N+LLD E + KI+DFGM K  I GG      T    GT  Y++PE    
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPEILSY 170

Query: 660 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
             +    D ++ GVLL E+++G+   S FE D
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ---SPFEGD 199

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 85.3 bits (211), Expect = 7e-18
 Identities = 68/198 (34%), Positives = 96/198 (48%), Gaps = 13/198 (6%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+G FG V   RLK  G+  AVK L K        +E  M E  ++S  ++   +  L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSRLR 603
           CC +  +++       N     L+F   K  R D  R RF   E  S  L++LH      
Sbjct: 63  CCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAEITS-ALMFLHDKG--- 116

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 663
           II+RDLK  N+LLD E + K++DFGM K   G  +   T    GT  Y++PE   E  + 
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 664 EKSDVFSFGVLLLEIVSG 681
              D ++ GVLL E++ G
Sbjct: 175 PSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 17/201 (8%)

Query: 488 KLGQGGFGPV---YWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRL 542
           +LG G FG V    +   K  + +AVK L   +      +E + E  V+ +L +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C E E  ML+ E      L+  L    K + +  +    ++  +S G+ YL   +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADT-GRVVGTFGYMSPEYAME 659
             +HRDL A N+LL  +   KISDFG++K  G +++  +A T G+      + +PE    
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK--WPVKWYAPECMNY 172

Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV+SFGVL+ E  S
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.0 bits (207), Expect = 9e-18
 Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 15/203 (7%)

Query: 483 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
           F    K+G+G FG V+ G   R +    I +  L +A  + +E+   E+ V+S+     +
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
            +  G  ++  +  +I EY+   S LD L   PL + ++       I+  I +GL YLH 
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHS 119

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
           + +   IHRD+KA+N+LL E    K++DFG+A      Q + +    VGT  +M+PE   
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIK 174

Query: 659 EGRFSEKSDVFSFGVLLLEIVSG 681
           +  +  K+D++S G+  +E+  G
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 24/213 (11%)

Query: 489 LGQGGFGPVYWGRLKD------GQEIAVKRL-SKASGQGLEEFMNEVMVISKL-QHRNLV 540
           LG+G FG V                +AVK L   A+ + L + ++E+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 541 RLLGCCVEGEEKMLIYEYM-------------PNRSLDALLFDPLKKERLDWRKRFNIIE 587
            LLG C +     ++ EY              P     +       +E L  +   +   
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            ++RG+ +L   S+ + IHRDL A N+L+ E+   KI+DFG+A+          T     
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
              +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 70/228 (30%), Positives = 118/228 (51%), Gaps = 36/228 (15%)

Query: 481 NNFQLSSKLGQGGFGPVY----WGRLKDGQE----IAVKRLS-KASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V     +G  K   +    +AVK L   A+ + L + ++E+ ++
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERL 577
             + +H+N++ LLG C +     +I EY    +L   L           FD  K  +E+L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL  +SR R IHRDL A N+L+ E+   KI+DFG+A+   G  
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR---GVH 185

Query: 638 D-----QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           D     +   GR+     +M+PE   +  ++ +SDV+SFG+L+ EI +
Sbjct: 186 DIDYYKKTSNGRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 20/219 (9%)

Query: 487 SKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN-----EVMVISKLQHRNLV 540
            KLG+G +  VY  R  + G+ +A+K++     +  ++ +N     E+ ++ +L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
            LL          L++E+M    L+ ++ D  K   L      + +    RGL YLH + 
Sbjct: 66  GLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLHSNW 122

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
              I+HRDLK +N+L+  +   K++DFG+A+ F G+ ++  T +VV T  Y +PE     
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYRAPELLFGA 177

Query: 661 R-FSEKSDVFSFGVLLLEIVSGRKNTSFF--EDDLTILG 696
           R +    D++S G +  E++       F   + D+  LG
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRV---PFLPGDSDIDQLG 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 19/209 (9%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQHRNLVRLLG 544
           LG GGFG V   ++K   +  A+K + K      G +E   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 602
              + +   ++ EY     L    +  L+   L  ++  RF  I  +     YLH     
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYLHN---R 112

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            II+RDLK  N+LLD     K+ DFG AK     Q    T    GT  Y++PE  +   +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY 169

Query: 663 SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
               D +S G+LL E+++GR    F EDD
Sbjct: 170 DFSVDYWSLGILLYELLTGR--PPFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 84.2 bits (208), Expect = 2e-17
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 16/217 (7%)

Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH 536
             A+  + +   L  G  G V+    K GQ   V  + K  GQ     + E M++  + H
Sbjct: 62  VVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV--VLKI-GQKGTTLI-EAMLLQNVNH 116

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
            +++R+    V G    ++   +P+ S D   +   +   L   +   I + I  GL YL
Sbjct: 117 PSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H     RIIHRD+K  NI +++     I D G A+ F      A  G + GT    +PE 
Sbjct: 174 HA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVV-APAFLG-LAGTVETNAPEV 227

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 693
               +++ K+D++S G++L E+++     + FED  +
Sbjct: 228 LARDKYNSKADIWSAGIVLFEMLAYPS--TIFEDPPS 262

Length = 357

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 61/207 (29%), Positives = 110/207 (53%), Gaps = 17/207 (8%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGL-EEFMNEVMVISKLQHRNL 539
           +Q   K+G+G +G VY  R    G+ +A+K++  +   +G+    + E+ ++ +L H N+
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 540 VRLLGCCVEGEEKMLIYEYMP---NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
           VRLL       +  L++E++     + +D+     L    +   K +  +  + +G+ Y 
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSY--LYQLLQGIAYC 115

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H  S  R++HRDLK  N+L+D E   K++DFG+A+ FG    +  T  VV T  Y +PE 
Sbjct: 116 H--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEVV-TLWYRAPEI 170

Query: 657 AMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +  R +S   D++S G +  E+V+ R
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 81.6 bits (201), Expect = 7e-17
 Identities = 54/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)

Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V    +K  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++++E+V G
Sbjct: 197 VDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.9 bits (200), Expect = 8e-17
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 485 LSSKLGQGGFGPVYWGRLKDGQ----EIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNL 539
           L   +G+G FG VY G     +     +AVK      S    E+F+ E  ++ +  H ++
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+L+G   E     ++ E  P   L + L   + K  LD          +S  L YL   
Sbjct: 70  VKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES- 125

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ----ADTGRVVGTFGYMSPE 655
              R +HRD+ A N+L+      K+ DFG+++     +D+    A  G++     +M+PE
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKL--PIKWMAPE 178

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVS 680
                RF+  SDV+ FGV + EI+ 
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 538
            +++  K+G+G FG +Y  + K D +   +K   L+K   +  E    EV++++K++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSL-------DALLFDPLKKERLDWRKRFNIIEGISR 591
           +V       E     ++ EY     L         +LF   + + L W  +      IS 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS--EDQILSWFVQ------ISL 112

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
           GL ++H     +I+HRD+K+ NI L +  +  K+ DFG+A+    + + A T   VGT  
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           Y+SPE      ++ K+D++S G +L E+ +
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 81.2 bits (200), Expect = 9e-17
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 15/200 (7%)

Query: 489 LGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
           LG+GGFG V        G++   +++  KR+ K  G+ +   +NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
                  +   L+   M    L   ++   +    + R  F   E I  GL  LH++   
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQE--- 121

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
           RI++RDLK  NILLD+  + +ISD G+A      + Q   GR VGT GYM+PE     R+
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVKNERY 178

Query: 663 SEKSDVFSFGVLLLEIVSGR 682
           +   D ++ G LL E+++G+
Sbjct: 179 TFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 81.6 bits (201), Expect = 9e-17
 Identities = 67/243 (27%), Positives = 121/243 (49%), Gaps = 37/243 (15%)

Query: 464 KLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLS- 514
           +L + P ++F     + +   L   LG+G FG V           + K+   +AVK L  
Sbjct: 3   ELPEDPRWEF-----SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD 57

Query: 515 KASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL----- 568
            A+ + L + ++E+ ++  + +H+N++ LLG C +     +I EY    +L   L     
Sbjct: 58  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 117

Query: 569 ------FD--PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620
                 +D   +  E++ ++   +    ++RG+ YL   +  + IHRDL A N+L+ E  
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENN 174

Query: 621 NPKISDFGMAKIFGGNQD---QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLE 677
             KI+DFG+A+    N D   +   GR+     +M+PE   +  ++ +SDV+SFGVL+ E
Sbjct: 175 VMKIADFGLARDV-NNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWE 231

Query: 678 IVS 680
           I +
Sbjct: 232 IFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 65/213 (30%), Positives = 113/213 (53%), Gaps = 27/213 (12%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R    G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 539 LVRLLGCCVEGEEKM-LIYEYMPN---RSLDAL----LFDPLKKERLDWRKRFNIIEGIS 590
           +V+LL   +  E K+ L++E++     + +DA     +  PL K  L     F +++G++
Sbjct: 61  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYL-----FQLLQGLA 114

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
               + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  
Sbjct: 115 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLW 165

Query: 651 YMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
           Y +PE  +  ++ S   D++S G +  E+V+ R
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 81.2 bits (200), Expect = 9e-17
 Identities = 54/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)

Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V     K  G+++AVK++     Q  E   NEV+++    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ E++   +L     D +   R++  +   +   + R L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198

Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++++E++ G
Sbjct: 199 VDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 66/280 (23%), Positives = 126/280 (45%), Gaps = 30/280 (10%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHR 537
           NF++  K+G+G F  VY    L DG  +A+K++        +   + + E+ ++ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKK---ERLDWRKRFNIIEGISRG 592
           N+++     +E  E  ++ E      L  ++  F   K+   E+  W+    +   +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
               H  SR R++HRD+K +N+ +      K+ D G+ + F      A +  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD 712
           SPE   E  ++ KSD++S G LL E+ +    + F+ D + +     K+   +      D
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 231

Query: 713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM 752
            +  E    ++M          C+    + RP+++ V  +
Sbjct: 232 HYSEELRQLVNM----------CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 25/213 (11%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN----EVMVISKLQ 535
           N +++   +G+G +G V   R K  G+ +A+K+  K S +  E+       EV V+ +L+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLR 58

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGIS 590
           H N+V L           L++EY+    L+ L        P       W+    +++ I+
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ----LLQAIA 114

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
               Y H      IIHRD+K  NIL+ E    K+ DFG A+          T  V  T  
Sbjct: 115 ----YCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRW 166

Query: 651 YMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 682
           Y +PE  + +  + +  DV++ G ++ E++ G 
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.8 bits (202), Expect = 1e-16
 Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 21/163 (12%)

Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF--N 584
           E+ ++  + H N+V+         E  ++ E+M   SL+               ++F  +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---------THIADEQFLAD 172

Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           +   I  G+ YLHR     I+HRD+K SN+L++   N KI+DFG+++I     D  ++  
Sbjct: 173 VARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228

Query: 645 VVGTFGYMSPEYA----MEGRFSEKS-DVFSFGVLLLEIVSGR 682
            VGT  YMSPE        G +   + D++S GV +LE   GR
Sbjct: 229 -VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 70/208 (33%), Positives = 111/208 (53%), Gaps = 28/208 (13%)

Query: 488 KLGQGGFGPVYWGRLKDGQE-IAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           K+G+G +G VY  R +   E IA+K  RL +         + E+ ++ ++QH N+VRL  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 545 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEG----ISRGLLYL 596
             V  E+++ L++EY+    LD      LKK      D+ K   +I+     I RG+ Y 
Sbjct: 69  V-VHSEKRLYLVFEYL---DLD------LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 597 HRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           H  S  R++HRDLK  N+L+D   N  K++DFG+A+ F G   +  T  VV T  Y +PE
Sbjct: 119 H--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPE 173

Query: 656 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             +  R +S   D++S G +  E+V+ +
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 20/208 (9%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMN--EVMVISKLQ-HRN 538
           +++  +LG G FG VY  R K+  E+ A+K++ K      EE MN  EV  + KL  H N
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER---LDWRKRFNIIEGISRGLLY 595
           +V+L     E +E   ++EYM     +  L+  +K  +          +II  I +GL +
Sbjct: 60  IVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           +H+       HRDLK  N+L+      KI+DFG+A+     + +      V T  Y +PE
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAPE 168

Query: 656 YAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
             +     S   D+++ G ++ E+ + R
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 32/226 (14%)

Query: 476 LATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL 534
           L   T  F+L   +G+G +G VY  R  K GQ +A+K +        EE   E  ++ K 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKY 59

Query: 535 -QHRNLVRLLGC------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN--- 584
             H N+    G           ++  L+ E     S+  L+    KK +   R +     
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK---RLKEEWIA 116

Query: 585 -IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
            I+    RGL YLH +   ++IHRD+K  NILL +    K+ DFG++      Q  +  G
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA-----QLDSTLG 168

Query: 644 R---VVGTFGYMSPE-----YAMEGRFSEKSDVFSFGVLLLEIVSG 681
           R    +GT  +M+PE        +  +  +SDV+S G+  +E+  G
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 65/251 (25%), Positives = 106/251 (42%), Gaps = 51/251 (20%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA----SGQGLEEFMNE--VMVISK 533
           ++F++   +G+G FG V+  R KD  ++ A+K L K+      Q       E  ++  + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADAD 59

Query: 534 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLD--WRKRFNIIEGIS 590
                +V+L     + EE + L+ EYMP   L  LL   ++K+        RF I E + 
Sbjct: 60  --SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEET-ARFYIAELV- 111

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-----------GGNQDQ 639
              L L    +L  IHRD+K  NIL+D + + K++DFG+ K               +   
Sbjct: 112 ---LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 640 ADTGR----------------VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 683
                                 VGT  Y++PE      +  + D +S GV+L E++ G  
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF- 227

Query: 684 NTSFFEDDLTI 694
              F+ D L  
Sbjct: 228 -PPFYSDTLQE 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 34/221 (15%)

Query: 483 FQLSSKLGQGGFGPVYWGRLK---DGQEIAVKRL--SKASGQGLEE-FMNEVMVISKLQH 536
           +++   +G+G +G VY  + K   DG+E A+K+    K    G+ +    E+ ++ +L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 537 RNLVRLLGCCVEGEEKM--LIYEYMP---------NRSLDALLFDPLKKERLDWRKRFNI 585
            N+V L+   +E  +K   L+++Y           +R    +   P   + L W+     
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----- 116

Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGN-QDQA 640
              I  G+ YLH +    ++HRDLK +NIL+  E       KI D G+A++F    +  A
Sbjct: 117 ---ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVS 680
           D   VV T  Y +PE  +  R   K+ D+++ G +  E+++
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.4 bits (198), Expect = 3e-16
 Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 32/222 (14%)

Query: 485 LSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKL- 534
           L   LG+G FG V           +      +AVK L   A+ + L + ++E+ ++  + 
Sbjct: 16  LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 581
           +H+N++ LLG C +     ++ EY    +L   L           FD  K  +E+L ++ 
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--- 638
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+    N D   
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYK 191

Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           +   GR+     +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 192 KTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 80.3 bits (198), Expect = 3e-16
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)

Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+G FG V    LK   E+ A+K L K        ++  M E  +++       +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 545 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSRL 602
           CC + ++++  + EY+    L   +F   +  + D  R RF   E ++  L++LHR    
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE-VTLALMFLHRHG-- 116

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            +I+RDLK  NILLD E + K++DFGM K  I  G      T    GT  Y++PE   E 
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT----TTTFCGTPDYIAPEILQEL 171

Query: 661 RFSEKSDVFSFGVLLLEIVSGR 682
            +    D ++ GVL+ E+++G+
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 59/203 (29%), Positives = 108/203 (53%), Gaps = 15/203 (7%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAV-KRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           +++  +LG G FG VY  + K+   +A  K +   S + LE++M E+ +++   H N+V+
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII-EGISRGLLYLHRDS 600
           LL          ++ E+    ++DA++   L+ ER     +  ++ +     L YLH + 
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN- 122

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-- 658
             +IIHRDLKA NIL   + + K++DFG++        + D+   +GT  +M+PE  M  
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 178

Query: 659 ---EGRFSEKSDVFSFGVLLLEI 678
              +  +  K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 79.8 bits (197), Expect = 4e-16
 Identities = 71/201 (35%), Positives = 102/201 (50%), Gaps = 17/201 (8%)

Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVIS-KLQHRNLVRLL 543
           LG+G FG V    LK   E  A+K L K        +E  M E  V++   +H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 544 GCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLYLHRDSR 601
            C  + +E +  + EY+    L   +F      R D  R RF   E I  GL +LH+   
Sbjct: 63  -CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIIC-GLQFLHKKG- 116

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
             II+RDLK  N+LLD++ + KI+DFGM K     + +A T    GT  Y++PE     +
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQK 172

Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           ++E  D +SFGVLL E++ G+
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.3 bits (195), Expect = 4e-16
 Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 36/216 (16%)

Query: 489 LGQGGFGPVYWGRLK-DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLL 543
           +G+G FG V    +K DG ++  A+K L + AS     +F  E+ V+ KL  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LDWRKRFNII 586
           G C       +  EY P  +L     D L+K R                 L  ++     
Sbjct: 70  GACENRGYLYIAIEYAPYGNL----LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
             ++ G+ YL   S  + IHRDL A N+L+ E L  KI+DFG+++      ++    + +
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTM 177

Query: 647 GTFG--YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           G     +M+ E      ++ KSDV+SFGVLL EIVS
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.0 bits (194), Expect = 5e-16
 Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 36/216 (16%)

Query: 489 LGQGGFGPVYWGRLK-DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLL 543
           +G+G FG V   R+K DG  +  A+KR+ + AS     +F  E+ V+ KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LDWRKRFNII 586
           G C       L  EY P+ +L     D L+K R                 L  ++  +  
Sbjct: 63  GACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
             ++RG+ YL   S+ + IHRDL A NIL+ E    KI+DFG+++       +    + +
Sbjct: 119 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTM 170

Query: 647 GTFG--YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           G     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 31/215 (14%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGL-EEFMNEVMVISKLQHRNL 539
           NF+   KLG+G +  VY GR +   EI A+K +   + +G     + E+ ++ +L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 540 VRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKK------ER--LDWRKRFNIIEGIS 590
           VRL    +  E K ML++EYM            LKK       R  LD     +    + 
Sbjct: 61  VRLHDV-IHTENKLMLVFEYMDK---------DLKKYMDTHGVRGALDPNTVKSFTYQLL 110

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG--GNQDQADTGRVVGT 648
           +G+ + H +   R++HRDLK  N+L+++    K++DFG+A+ FG   N    +    V T
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE----VVT 163

Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +P+  +  R +S   D++S G ++ E+++GR
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 78.8 bits (194), Expect = 5e-16
 Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 28/218 (12%)

Query: 483 FQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ 535
           F L   LG+G FG V   +LK      Q++AVK L KA   S   +EEF+ E   + +  
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 536 HRNLVRLLGCCVEGEEK------MLIYEYMPNRSLDA-LLFDPLKKE--RLDWRKRFNII 586
           H N+++L+G  +    K      M+I  +M +  L   LL   + +E   L  +     +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGN---QDQADT 642
             I+ G+ YL   S    IHRDL A N +L+E +   ++DFG++ KI+ G+   Q  A  
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             V     +++ E   +  ++  SDV++FGV + EI++
Sbjct: 177 LPV----KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 78.6 bits (194), Expect = 8e-16
 Identities = 57/190 (30%), Positives = 97/190 (51%), Gaps = 23/190 (12%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF----MNEVMVISKLQ 535
           + ++  +K+GQG FG V+  R K  ++I A+K++        E F    + E+ ++  L+
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLK 69

Query: 536 HRNLVRLLGCC-----VEGEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRFNIIEG 588
           H N+V L+  C          K   Y         L  LL +   K  L   K+  +++ 
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMKM 127

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD---TGRV 645
           +  GL Y+HR+   +I+HRD+KA+NIL+ ++   K++DFG+A+ F  +++      T RV
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184

Query: 646 VGTFGYMSPE 655
           V T  Y  PE
Sbjct: 185 V-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 78.3 bits (193), Expect = 8e-16
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)

Query: 482 NFQLSSKLGQGGFGPVYW----GRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISK 533
           NF+L   LG G +G V+     G    G+  A+K L KA+     +  E    E  V+  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 534 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISR 591
           ++    +  L    + + K+ LI +Y+    L   L+   ++E       R  I E I  
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVYIAE-IVL 116

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFG 650
            L +LH+   L II+RD+K  NILLD E +  ++DFG++K F    +++A +    GT  
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIE 171

Query: 651 YMSPEYAM--EGRFSEKSDVFSFGVLLLEIVSG 681
           YM+PE      G   +  D +S GVL  E+++G
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 61/218 (27%), Positives = 114/218 (52%), Gaps = 29/218 (13%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEF----MNEVMVISKLQHR 537
           F +  ++G+G +G VY  R KD G+ +A+K++   + +  E F    + E+ ++ +L HR
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66

Query: 538 NLVRLLGCCVEGEEKM----------LIYEYMPNRSLDALLFDPLKKERLDWRKRFN--I 585
           N+V L     + ++ +          L++EYM     D  L   L+   + + +      
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSF 121

Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
           ++ +  GL Y H+ + L   HRD+K SNILL+ +   K++DFG+A+++   + +  T +V
Sbjct: 122 MKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 646 VGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 682
           + T  Y  PE  + E R+    DV+S G +L E+ + +
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 17/207 (8%)

Query: 483 FQLSSKLGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH 536
           F+    LG+GGFG V        G++   +++  KR+ K  G+ +   +NE  ++ K+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
           R +V L       +   L+   M    L   +++       + R  F   E I+ GL  L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-ITCGLEDL 118

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPE 655
           HR+   RI++RDLK  NILLD+  + +ISD G+A +I  G   +   GR VGT GYM+PE
Sbjct: 119 HRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ETIRGR-VGTVGYMAPE 171

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                R++   D +  G L+ E++ G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 66/221 (29%), Positives = 115/221 (52%), Gaps = 30/221 (13%)

Query: 485 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 534
           L   LG+G FG V      G  K+      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDP--LKKERLDWRK 581
           +H+N++ LLG C +     +I EY    +L   L           ++P  + +E+L ++ 
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG--GNQDQ 639
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+         +
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198

Query: 640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
              GR+     +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 199 TTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 20/202 (9%)

Query: 489 LGQGGFGPVYWGRLK----DGQEIAVKRLSKASGQGLEEF--MNEVMVISKLQHRNLVRL 542
           LGQG FG V+  R       GQ  A+K L KA+ +  +      E  +++++ H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 543 LGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRD 599
                + E K+ LI +++  R  D  LF  L KE +  +   +F + E ++  L +LH  
Sbjct: 64  -HYAFQTEGKLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS- 116

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
             L II+RDLK  NILLDEE + K++DFG++K       +       GT  YM+PE    
Sbjct: 117 --LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 660 GRFSEKSDVFSFGVLLLEIVSG 681
              ++ +D +SFGVL+ E+++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 80.3 bits (198), Expect = 2e-15
 Identities = 73/300 (24%), Positives = 140/300 (46%), Gaps = 25/300 (8%)

Query: 467 DLPLFQFEELATATNNFQLSSK-----LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG 520
           +L  F  +   + T N  LSS      + +G  G  Y G+ +K+G +  VK ++  +   
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP 730

Query: 521 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
             E  +    + KLQH N+V+L+G C   +   LI+EY+  ++L  +L        L W 
Sbjct: 731 SSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWE 780

Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
           +R  I  GI++ L +LH      ++  +L    I++D +  P +    +  +        
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-----T 834

Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF-FEDDLTILGYAW 699
           DT   + +  Y++PE       +EKSD++ FG++L+E+++G+      F    +I+ +A 
Sbjct: 835 DTKCFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR 893

Query: 700 KLWNENKILALVDPFLS-ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 758
             +++  +   +DP +  + S   + I+  +++ L C       RP  + V+  L S  R
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 60/212 (28%), Positives = 113/212 (53%), Gaps = 20/212 (9%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQE-IAVKRLS-KASGQGLE-EFMNEVMVISKLQ--- 535
           ++  +++G+G +G V+  R LK+G   +A+KR+  +   +G+    + EV V+  L+   
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 536 HRNLVRLLGCCV----EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
           H N+VRL   C     + E K+ L++E++ ++ L   L D + +  +      +++  + 
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLL 120

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
           RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+     Q     VV T  
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLW 174

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           Y +PE  ++  ++   D++S G +  E+   +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 59/203 (29%), Positives = 105/203 (51%), Gaps = 19/203 (9%)

Query: 487 SKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ-GLE-EFMNEVMVISKLQ---HRNLV 540
           +++G G +G VY  R    G  +A+K +   + + GL    + EV ++ +L+   H N+V
Sbjct: 6   AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 541 RLLGCC----VEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           RL+  C     + E K+ L++E++ ++ L   L D +    L      +++    RGL +
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           LH +    I+HRDLK  NIL+      K++DFG+A+I+     Q     VV T  Y +PE
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPE 177

Query: 656 YAMEGRFSEKSDVFSFGVLLLEI 678
             ++  ++   D++S G +  E+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 76.2 bits (187), Expect = 6e-15
 Identities = 68/202 (33%), Positives = 98/202 (48%), Gaps = 19/202 (9%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+G FG V+   LK   Q  A+K L K        +E  M E  V+S       +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 545 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSRL 602
           C  + +E +  + EY+    L   +F      + D  R  F   E I  GL +LH     
Sbjct: 63  CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAE-IICGLQFLHSKG-- 116

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            I++RDLK  NILLD + + KI+DFGM K  + G     A T    GT  Y++PE  +  
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQ 171

Query: 661 RFSEKSDVFSFGVLLLEIVSGR 682
           +++   D +SFGVLL E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 18/205 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
           ++++L  ++G G +G VY  R L  G+  AVK +    G        E+ ++ + +H N+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDAL--LFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           V   G  +  E+  +  EY    SL  +  +  PL + ++ +  R  +     +GL YLH
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEY 656
              ++   HRD+K +NILL +  + K++DFG+ AKI       A     +GT  +M+PE 
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAKI---TATIAKRKSFIGTPYWMAPEV 177

Query: 657 AM---EGRFSEKSDVFSFGVLLLEI 678
           A     G +++  D+++ G+  +E+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.9 bits (184), Expect = 8e-15
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 27/206 (13%)

Query: 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRL--SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
            K+G+G FG     + K DG++  +K +  SK S +  EE   EV V+S ++H N+V+  
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER---------LDWRKRFNIIEGISRGLL 594
               E     ++ +Y     L    +  +  +R         LDW  +      I   L 
Sbjct: 66  ESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPEDQILDWFVQ------ICLALK 115

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           ++H     +I+HRD+K+ NI L ++   K+ DFG+A++     + A T   +GT  Y+SP
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSP 170

Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVS 680
           E      ++ KSD+++ G +L E+ +
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 28/216 (12%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLV 540
           F+L   +G G +G VY GR +K GQ  A+K +   +G   EE   E+ ++ K   HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 541 RLLGCCVE------GEEKMLIYEYMPNRSLDALLFDP----LKKERLDWRKRFNIIEGIS 590
              G  ++       ++  L+ E+    S+  L+ +     LK+E + +     I   I 
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-----ICREIL 121

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
           RGL +LH+    ++IHRD+K  N+LL E    K+ DFG++        + +T   +GT  
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 176

Query: 651 YMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSG 681
           +M+PE        +  +  KSD++S G+  +E+  G
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.9 bits (187), Expect = 9e-15
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 16/206 (7%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNE---VMVISKLQ 535
           F+  + LG+G FG V     K  G+  A+K L K    +   +E  M E       +  +
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H  LV L  C    +    + EY     L   +   +  E    R  F     +  GL Y
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAVFYAAC-VVLGLQY 116

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           LH +   +I++RDLK  N+LLD E   KI+DFG+ K   G  D+  T    GT  +++PE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPE 171

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSG 681
              E  ++   D +  GVL+ E++ G
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 75.8 bits (186), Expect = 1e-14
 Identities = 73/211 (34%), Positives = 106/211 (50%), Gaps = 21/211 (9%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+G FG V    LK  G+  AVK L K        +E  M E  V++       +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 545 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLYLHRDSRL 602
           C  + +E +  + E++    L   +F    K R D +R  F   E I  GL +LH     
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAE-IVCGLQFLHSKG-- 116

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            II+RDLK  N++LD + + KI+DFGM K  +FG N  +A T    GT  Y++PE     
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAST--FCGTPDYIAPEILQGL 171

Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
           +++   D +SFGVLL E++ G+  + F  DD
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ--SPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRL-SKASGQGLEEFMNEVMVISKLQH-RNLVRLLGC 545
           +G+G FG V     K  G  +AVKR+ S    +  +  + ++ V+ +      +V+  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 546 CV-EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS----RGLLYLHRDS 600
              EG+  + + E M + SLD   F     E L       I+  I+    + L YL  + 
Sbjct: 72  LFREGDCWICM-ELM-DISLD--KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE- 126

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-YAME 659
            L+IIHRD+K SNILLD   N K+ DFG   I G   D     R  G   YM+PE     
Sbjct: 127 -LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPS 182

Query: 660 GR--FSEKSDVFSFGVLLLEIVSGR 682
            R  +  +SDV+S G+ L E+ +G+
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGFG V   +++  G+  A K+L+K      +G E  M E  +++K+  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLYLHRDSR 601
                 +  L+   M    L   +++ + +E   +   R  F   + IS GL +LH+   
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACFYTAQIIS-GLEHLHQR-- 116

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
            RII+RDLK  N+LLD + N +ISD G+A      Q +  T    GT G+M+PE      
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173

Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +    D F+ GV L E+++ R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 34/213 (15%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN--EVMVISKLQ-HRN 538
           +++  K+G+G F  V   +  K G+  A+K + K   + LE+  N  E+  + +L  H N
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPN 59

Query: 539 LVRLLGCCVEGEEK----------MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
           ++RL+    + +            M +YE +  R           K  L  ++  + +  
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMDMNLYELIKGR-----------KRPLPEKRVKSYMYQ 108

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           + + L ++HR+    I HRD+K  NIL+ +++  K++DFG  +  G       T   + T
Sbjct: 109 LLKSLDHMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCR--GIYSKPPYT-EYIST 161

Query: 649 FGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVS 680
             Y +PE  + +G +  K D+++ G +  EI+S
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 14/206 (6%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--FMNEVMVISKLQHR 537
             ++    +G+G +G V   + K+ GQ +A+K+  ++    + +   M E+ ++ +L+H 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           NLV L+      +   L++E++ +  LD L   P   +    RK    +  I RG+ + H
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK---YLFQILRGIEFCH 117

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYMSPEY 656
             +   IIHRD+K  NIL+ +    K+ DFG A+ +    +   D    V T  Y +PE 
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPEL 171

Query: 657 AM-EGRFSEKSDVFSFGVLLLEIVSG 681
            + + ++    D+++ G L+ E+++G
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 51/138 (36%), Positives = 70/138 (50%), Gaps = 33/138 (23%)

Query: 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS----RGLLYLHRDSRLRIIHRDLKAS 612
           E+M   SLD +L    KK     R   NI+  IS    RGL YL R+ + +I+HRD+K S
Sbjct: 79  EHMDGGSLDQVL----KKAG---RIPENILGKISIAVLRGLTYL-RE-KHKIMHRDVKPS 129

Query: 613 NILLDEELNPKISDFG--------MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           NIL++     K+ DFG        MA  F            VGT  YMSPE      ++ 
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLIDSMANSF------------VGTRSYMSPERLQGTHYTV 177

Query: 665 KSDVFSFGVLLLEIVSGR 682
           +SD++S G+ L+E+  GR
Sbjct: 178 QSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 71/226 (31%), Positives = 108/226 (47%), Gaps = 21/226 (9%)

Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKASGQGLEEFMNEV 528
           +   E L   T+ +++   +G+G +G VY     KDG   AVK L   S    EE   E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69

Query: 529 MVISKL-QHRNLVRLLGC------CVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWR 580
            ++  L  H N+V+  G        V G+   L+ E     S+  L+   L   +RLD  
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGGSVTELVKGLLICGQRLDEA 128

Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
               I+ G   GL +LH +   RIIHRD+K +NILL  E   K+ DFG++      + + 
Sbjct: 129 MISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185

Query: 641 DTGRVVGTFGYMSPEY-AMEGR----FSEKSDVFSFGVLLLEIVSG 681
           +T   VGT  +M+PE  A E +    +  + DV+S G+  +E+  G
Sbjct: 186 NTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 18/208 (8%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQH 536
           TN +     +G G FG V   R    GQ +A+K++ K  ++    +    E+ ++  L+H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLY 595
            N++ L    +   E +     +    L  LL   PL+K+ + +      +  I RGL Y
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-----FLYQILRGLKY 123

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           +H      ++HRDLK SNIL++E  + KI DFG+A+I    QD   TG  V T  Y +PE
Sbjct: 124 VHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTG-YVSTRYYRAPE 175

Query: 656 YAME-GRFSEKSDVFSFGVLLLEIVSGR 682
             +   ++  + D++S G +  E++ G+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 17/201 (8%)

Query: 489 LGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
           LG+GGFG V        G++   + +  KR+ K  G+ +   +NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
                  +   L+   M    L   +++       + R  F   E I  GL  LHR++  
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLHREN-- 122

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
             ++RDLK  NILLD+  + +ISD G+A KI  G   +   GR VGT GYM+PE     R
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR---GR-VGTVGYMAPEVLNNQR 177

Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           ++   D +  G L+ E++ G+
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 51/203 (25%), Positives = 103/203 (50%), Gaps = 16/203 (7%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
           +F+L  ++G G +G VY  R +  G+  A+K +    G+       E++++   +H N+V
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDAL--LFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
              G  +  ++  +  E+    SL  +  +  PL + ++ +  R  +     +GL YLH 
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHS 124

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             +   +HRD+K +NILL +  + K++DFG++         A     +GT  +M+PE A 
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAA 179

Query: 659 ---EGRFSEKSDVFSFGVLLLEI 678
              +G +++  D+++ G+  +E+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 35/210 (16%)

Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN---------EVMVISKLQHRN 538
           +G G +G V        G+++A+K+LS         F +         E+ ++  + H N
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 539 LVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYL 596
           ++ LL             + Y+    + A L + +K ++L D   +F ++  I RGL Y+
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYI 134

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD---TGRVVGTFGYMS 653
           H      IIHRDLK SNI ++E+   KI DFG+A+         D   TG V  T  Y +
Sbjct: 135 HS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-------HTDDEMTGYVA-TRWYRA 183

Query: 654 PEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           PE  +    +++  D++S G ++ E+++G+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 16/215 (7%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQHRNLVRLLGC 545
           +G+G +G V   R + DG++  +K+L+   AS +  +    E  ++S+L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHRDSRL 602
             EGE+ +L Y  M        L+  LK+++        ++E    I+  L YLH     
Sbjct: 68  W-EGEDGLL-YIVM-GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            I+HRDLK  N+ L      K+ D G+A++     D A T  ++GT  YMSPE      +
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPY 179

Query: 663 SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY 697
           + KSDV++ G  + E+ + +   +F   D+  L Y
Sbjct: 180 NYKSDVWALGCCVYEMATLKH--AFNAKDMNSLVY 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 67.2 bits (164), Expect = 6e-14
 Identities = 28/76 (36%), Positives = 45/76 (59%), Gaps = 3/76 (3%)

Query: 337 EDGFSKLNKMKVPDFTE-WTSPATEDECREQCLK-NCSCIAYAFD-GGIGCMVWRSINLI 393
           +D F +L   K+P F+    S A+ +EC  +CL  NCSC ++ ++ G  GC++W   +L 
Sbjct: 3   DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLG 62

Query: 394 DIQRLPFGGTDLYIRV 409
           D +  P GG DLY ++
Sbjct: 63  DARLFPSGGVDLYEKI 78

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 489 LGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
           LG+GGFG V   ++K+ G+  A K     RL K SG+ +     E++   K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
                      L+   M    L   +++ + +  L+  +  +    I+ G+L+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
            I++RD+K  N+LLD++ N ++SD G+A ++  G        +  GT GYM+PE   E  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----ITQRAGTNGYMAPEILKEEP 170

Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +S   D F+ G  + E+V+GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.0 bits (180), Expect = 1e-13
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 38/220 (17%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMN---------EVMVIS 532
           +++  KLG+G +G V+    +  +E+ A+K++  A       F N         E+M + 
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-------FRNATDAQRTFREIMFLQ 61

Query: 533 KL-QHRNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNII 586
           +L  H N+V+LL   V   E      L++EYM     +  L   ++   L D  KR+ I+
Sbjct: 62  ELGDHPNIVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IM 113

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF---GGNQDQADTG 643
             + + L Y+H  S   +IHRDLK SNILL+ +   K++DFG+A+       N +     
Sbjct: 114 YQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 644 RVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 682
             V T  Y +PE  +   R+++  D++S G +L E++ G+
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 20/206 (9%)

Query: 488 KLGQGGFGPVYWGRLKDGQEIA---VKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           ++G G FG V  G    G   A   VK L + A+      F+ EV    +L H N+++ L
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF--NIIEGISRGLLYLHRDSR 601
           G C+E    +L+ E+ P   L   L           +K     +   ++ GLL+LH   +
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---Q 118

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG-RVVGTFGYMSPEYAMEG 660
              IH DL   N  L  +L+ KI D+G+A +    +D   T         +++PE  +E 
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPE-LVEI 176

Query: 661 RFS--------EKSDVFSFGVLLLEI 678
           R          +KS+++S GV + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 72.6 bits (179), Expect = 1e-13
 Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 37/220 (16%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVMVIS 532
           ++L   +G G +G V      + G+++A+K++S         F +         E+ ++ 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLR 54

Query: 533 KLQHRNLVRLLGCCV-EGEEKM----LIYEYMPNRSLDALLFD--PLKKERLDWRKRFNI 585
            L+H N++ LL        E      ++ E M    L  ++    PL  + + +      
Sbjct: 55  HLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-----F 108

Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD--TG 643
           +  I RGL YLH  +   +IHRDLK SNIL++   + KI DFG+A+    ++D+    T 
Sbjct: 109 LYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 644 RVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 682
            VV T  Y +PE  +   R+++  D++S G +  E+++ +
Sbjct: 166 YVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
            F+  +++G+G +G VY  R     EI A+K  R+           + E+ ++  L+H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 539 LVRLLGCCV--EGEEKMLIYEYMPNRSLDALLFD---PLKKERLDWRKRFNIIEGISRGL 593
           +V L    V    +   L+ EY   + L +LL +   P  + ++       ++  + RGL
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFSESQVK-----CLMLQLLRGL 121

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            YLH +    IIHRDLK SN+LL ++   KI+DFG+A+ + G   +  T +VV T  Y +
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRA 176

Query: 654 PEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 682
           PE  +       + D+++ G +L E+++ +
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 19/202 (9%)

Query: 489 LGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
           LG+GGFG V        G++   +++  KR+ K  G+ +   +NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65

Query: 543 LGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
                E ++ + L+   M    L   +++ +     D ++       +  GL  L R+  
Sbjct: 66  -AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            RI++RDLK  NILLD+  + +ISD G+A +I  G   +   GR VGT GYM+PE     
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGR-VGTVGYMAPEVINNE 176

Query: 661 RFSEKSDVFSFGVLLLEIVSGR 682
           +++   D +  G L+ E++ G+
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 76/264 (28%), Positives = 108/264 (40%), Gaps = 70/264 (26%)

Query: 484 QLSSKLGQGGFGPVYW------GRLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 535
           +L   LG+G FG V         +    + +AVK L + A+    +  M E+ ++  +  
Sbjct: 10  KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH 69

Query: 536 HRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDP---------------LK 573
           H N+V LLG C + G   M+I EY    +L   L      F P                K
Sbjct: 70  HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129

Query: 574 KERLDWR--------------KRFNIIEGIS-----------------------RGLLYL 596
           K+RLD                K  + +E                          RG+ +L
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
              SR + IHRDL A NILL E    KI DFG+A+    + D    G       +M+PE 
Sbjct: 190 --ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVS 680
             +  ++ +SDV+SFGVLL EI S
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 26/213 (12%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRL---SKASGQGLEEF----MNEVMVISK 533
            ++  +++ +G +G VY  R K   EI A+K+L    +  G     F    + E+ ++ K
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-----FPITSLREINILLK 60

Query: 534 LQHRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
           LQH N+V +    V G     IY   EY+ +  L +L+     K+     +   ++  + 
Sbjct: 61  LQHPNIVTVKEVVV-GSNLDKIYMVMEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLL 116

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
            G+ +LH +    I+HRDLK SN+LL+     KI DFG+A+ +G       T  VV T  
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVV-TLW 171

Query: 651 YMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 682
           Y +PE  +    +S   D++S G +  E+++ +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 73.3 bits (180), Expect = 3e-13
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 37/229 (16%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK-ASGQGL--EEFMNEVMVISKLQHRN 538
           + +   +G+GG G VY        + +A+K++ +  S   L  + F+ E  + + L H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 539 LVRLLGCCVEGEEKMLIYEYMP---NRSLDALL-----FDPLKK---ERLDWRKRFNIIE 587
           +V +   C +G+    +Y  MP     +L +LL      + L K   E+       +I  
Sbjct: 64  IVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD-QADT---- 642
            I   + Y+H  S+  ++HRDLK  NILL       I D+G A      ++   D     
Sbjct: 121 KICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 643 -----------GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                      G++VGT  YM+PE  +    SE +D+++ GV+L ++++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.8 bits (173), Expect = 5e-13
 Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 17/200 (8%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE---FMNEVMVISK-LQHRNLVRLL 543
           +G+G FG V   + K DG   AVK L K +    +E    M E  V+ K L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSR 601
                 E+   + +Y+    L    F  L++ER  L+ R RF   E ++  + YLH    
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAE-VASAIGYLHS--- 114

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
           L II+RDLK  NILLD + +  ++DFG+ K   G + +  T    GT  Y++PE   +  
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP 172

Query: 662 FSEKSDVFSFGVLLLEIVSG 681
           +    D +  G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 5e-13
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)

Query: 482 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNL 539
            +Q  S +G+G +G V        G ++A+K++S    Q   +  + E+ ++ + +H N+
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65

Query: 540 VRLLGC-CVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRG 592
           + +L        E      ++ E M        L+  +K + L  D  + F  +  I RG
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYF--LYQILRG 118

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV---VGTF 649
           L Y+H  +   ++HRDLK SN+LL+   + KI DFG+A+I     D   TG +   V T 
Sbjct: 119 LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH--TGFLTEYVATR 173

Query: 650 GYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 682
            Y +PE  +  +   K+ D++S G +L E++S R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQHR 537
           +F     LG+G FG V     K   E+ A+K L K        +E  M E  V++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
             +  L  C +  +++  + EY+    L   ++   +  +            I+ GL +L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSP 654
           H      II+RDLK  N++LD E + KI+DFGM K  IFGG      T    GT  Y++P
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGTPDYIAP 170

Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           E      + +  D ++FGVLL E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.2 bits (172), Expect = 7e-13
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 17/200 (8%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE---FMNEVMVISK-LQHRNLVRLL 543
           +G+G FG V   + K DG+  AVK L K +    +E    M E  V+ K ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSR 601
                 ++   + +Y+    L    F  L++ER   + R RF   E I+  L YLH    
Sbjct: 63  YSFQTADKLYFVLDYVNGGEL----FFHLQRERSFPEPRARFYAAE-IASALGYLHS--- 114

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
           L II+RDLK  NILLD + +  ++DFG+ K   G +    T    GT  Y++PE   +  
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 662 FSEKSDVFSFGVLLLEIVSG 681
           +    D +  G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 70.2 bits (172), Expect = 8e-13
 Identities = 66/287 (22%), Positives = 122/287 (42%), Gaps = 60/287 (20%)

Query: 484 QLSSKLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMN------------EV 528
           Q  + LG+G +G V        G+ +A+K+  + + S    ++               E+
Sbjct: 12  QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 529 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDA--LLFDPLKKERLDWRKRF 583
            ++++++H N++ L+   VEG+   L+ + M +   + +D    L +   K         
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVK--------- 122

Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-- 641
            I+  I  GL  LH+      +HRDL  +NI ++ +   KI+DFG+A+ +G         
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 642 -----------TGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGRKNTSFF- 688
                      T +VV T  Y +PE  M   ++    D++S G +  E+++G+     F 
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK---PLFP 235

Query: 689 -EDDLTILGYAWKL--------WNENKILALVDPFLSESSFQLDMII 726
            E+++  LG  ++L        W + K L L   F       L  I 
Sbjct: 236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIF 282

Length = 335

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 8e-13
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)

Query: 489 LGQGGFGPVYWGRLKDGQE----IAVKRLSKA----SGQGLEEFMNEVMVISKLQHRNLV 540
           LG+GG+G V+  R   G +     A+K L KA    + +       E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHR 598
            L+     G +  LI EY+    L    F  L++E   ++    F + E IS  L +LH+
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSE-ISLALEHLHQ 118

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEY 656
                II+RDLK  NILLD + + K++DFG+ K  I  G      T    GT  YM+PE 
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEI 171

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSG 681
            M     +  D +S G L+ ++++G
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 68.8 bits (168), Expect = 9e-13
 Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 25/157 (15%)

Query: 488 KLGQGGFGPVYWGRLKDG---QEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           ++G G FG V  G +  G    ++ VK L   AS Q   +F+ E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 544 GCCVEGEEKMLIYEYMP----------NRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           G C E    +L+ E+ P           R  + +  DP   +R+           I+ GL
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACE--------IALGL 113

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
           L+LH+++    IH DL   N LL  +L  KI D+G++
Sbjct: 114 LHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 28/216 (12%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLV 540
           F+L   +G G +G VY GR +K GQ  A+K +     +  EE   E+ ++ K   HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76

Query: 541 RLLGCCVE------GEEKMLIYEYMPNRSLDALLF----DPLKKERLDWRKRFNIIEGIS 590
              G  ++       ++  L+ E+    S+  L+     + LK++ + +     I   I 
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-----ICREIL 131

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
           RGL +LH     ++IHRD+K  N+LL E    K+ DFG++        + +T   +GT  
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 186

Query: 651 YMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSG 681
           +M+PE        +  +  +SD++S G+  +E+  G
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVM---VISKLQH 536
           N+ +   ++G G  G VY  R  K G  +AVK++ +   +  EE    +M   V+ K  H
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SH 71

Query: 537 R--NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK-------ERLDWRKRFNIIE 587
               +V+  G  +   +  +  E M      +   D L K       E +  +    I+ 
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELM------STCLDKLLKRIQGPIPEDILGKMTVAIV- 124

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
              + L YL    +  +IHRD+K SNILLD   N K+ DFG   I G   D     R  G
Sbjct: 125 ---KALHYL--KEKHGVIHRDVKPSNILLDASGNVKLCDFG---ISGRLVDSKAKTRSAG 176

Query: 648 TFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGR 682
              YM+PE         ++  ++DV+S G+ L+E+ +G+
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 21/198 (10%)

Query: 491 QGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMN----EVMVISKLQHRNLVRLLGC 545
           +G FG VY  + +  G   A+K L K+      +  N      +++ + +   + +L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 546 CVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
               +   L+ EY+      +L+     L     DW K++  I  +  G+  LH+     
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLGGLP---EDWAKQY--IAEVVLGVEDLHQRG--- 117

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 663
           IIHRD+K  N+L+D+  + K++DFG+++    N+      + VGT  Y++PE  +     
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDD 171

Query: 664 EKSDVFSFGVLLLEIVSG 681
           + SD +S G ++ E + G
Sbjct: 172 KMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G +G VY  + KDG++     L +  G G+      E+ ++ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 547 VEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRD 599
           +   ++   L+++Y  +     + F    K     +K   +  G+ + LLY     +H  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 600 SRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGN-QDQADTGRVVGTFGYMSP 654
               ++HRDLK +NIL+     E    KI+D G A++F    +  AD   VV TF Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 655 EYAMEGR-FSEKSDVFSFGVLLLEIVS 680
           E  +  R +++  D+++ G +  E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 11/204 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V   + K    I  ++L     +     + + E+ V+ +     
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L +    +R+       +   + RGL YL  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE 121

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175

Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 38/222 (17%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
           ++ ++  +LG+G +G V   R    G  +AVKR+ +A+            V S+ Q R L
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RAT------------VNSQEQKRLL 47

Query: 540 VRL-----LGCCVE---------GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
           + L        C            E  + I   + + SLD        K           
Sbjct: 48  MDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK 107

Query: 586 IE-GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           I   I + L YLH  S+L +IHRD+K SN+L++     K+ DFG   I G   D      
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSVAKTI 162

Query: 645 VVGTFGYMSPEY---AMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             G   YM+PE     +  + +  KSDV+S G+ ++E+ +GR
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 15/206 (7%)

Query: 483 FQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNL 539
           +Q  S +G G +G V      K G  +AVK+LS+   S    +    E+ ++  ++H N+
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78

Query: 540 VRLLGCCVEGEE-KMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLH 597
           + LL         +     Y+    + A L + +K ++L D   +F +I  I RGL Y+H
Sbjct: 79  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH 137

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
                 IIHRDLK SN+ ++E+   KI DFG+A+    + D   TG  V T  Y +PE  
Sbjct: 138 SAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTG-YVATRWYRAPEIM 189

Query: 658 MEG-RFSEKSDVFSFGVLLLEIVSGR 682
           +    +++  D++S G ++ E+++GR
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 17/207 (8%)

Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G +G VY  + KDG++     L +  G G+      E+ ++ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 547 VEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRD 599
           +   ++   L+++Y  +     + F    K     +K   +   + + LLY     +H  
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 600 SRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGN-QDQADTGRVVGTFGYMSP 654
               ++HRDLK +NIL+     E    KI+D G A++F    +  AD   VV TF Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 655 EYAMEGR-FSEKSDVFSFGVLLLEIVS 680
           E  +  R +++  D+++ G +  E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 13/213 (6%)

Query: 488 KLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
           KLG+G +  V+ GR K  +  +A+K +     +G     + EV ++  L+H N+V L   
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
               +   L++EY+ ++ L   + D      +   K F  +  I RGL Y HR    +++
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRR---KVL 126

Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSE 664
           HRDLK  N+L++E    K++DFG+A+    +         V T  Y  P+  +    +S 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Query: 665 KSDVFSFGVLLLEIVSGRK--NTSFFEDDLTIL 695
           + D++  G +  E+ SGR     S  ED+L ++
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 52/198 (26%), Positives = 102/198 (51%), Gaps = 12/198 (6%)

Query: 488 KLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEF-MNEVMVISKLQHRNLVRLLG 544
           K+G+G +G V+  + ++  EI A+KR+      +G+    + E+ ++ +L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                ++  L++EY  ++ L    FD    + +D     + +  + +GL + H      +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           +HRDLK  N+L+++    K++DFG+A+ FG       +  VV T  Y  P+     +   
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWYRPPDVLFGAKLYS 178

Query: 665 KS-DVFSFGVLLLEIVSG 681
            S D++S G +  E+ + 
Sbjct: 179 TSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 33/223 (14%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
           + +    +G G FG V+  R +  +   A+K ++       +  +   NE  V+ ++ H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 538 NLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG------I 589
            ++RL     E +++ L  + EY+P   L    F  L+        RF+   G      I
Sbjct: 62  FIIRLF--WTEHDQRFLYMLMEYVPGGEL----FSYLRN-----SGRFSNSTGLFYASEI 110

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
              L YLH      I++RDLK  NILLD+E + K++DFG AK     +D+  T  + GT 
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDR--TWTLCGTP 162

Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 692
            Y++PE       ++  D ++ G+L+ E++ G     FF+D+ 
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP--PFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.9 bits (171), Expect = 4e-12
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 28/195 (14%)

Query: 505 GQEIAVKRLSKASGQGLEE---FMNEVMVISKLQHRNLVRLLGCCVEGEEKML-IYEYMP 560
           G E+A+K L   + +   +   F  E  + ++L H N+V LL         +  ++EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 561 NRSLDALL-----FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615
            R+L  +L         +  RL        +  +   L   H      I+HRDLK  NI+
Sbjct: 63  GRTLREVLAADGALPAGETGRL--------MLQVLDALACAHNQG---IVHRDLKPQNIM 111

Query: 616 L---DEELNPKISDFGMAKIFGGNQDQAD-----TGRVVGTFGYMSPEYAMEGRFSEKSD 667
           +       + K+ DFG+  +  G +D        T  V+GT  Y +PE       +  SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 668 VFSFGVLLLEIVSGR 682
           ++++G++ LE ++G+
Sbjct: 172 LYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)

Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 544
           LG+G FG V   R K   +  A+K L K      +E    + E  V+   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 602
                +    + EY     L    F  L +ER+  + R RF   E +S  L YLH     
Sbjct: 63  SFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS-ALGYLHSCD-- 115

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            +++RDLK  N++LD++ + KI+DFG+ K   G  D A      GT  Y++PE   +  +
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 663 SEKSDVFSFGVLLLEIVSGR 682
               D +  GV++ E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 54/216 (25%), Positives = 106/216 (49%), Gaps = 34/216 (15%)

Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL----- 542
           LG G  G V+     D  + +AVK++     Q ++  + E+ +I +L H N+V++     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 543 ---------LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISR 591
                    +G   E     ++ EYM     +  L + L++  L  +  + F  +  + R
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLF--MYQLLR 125

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFGGNQDQADTGRV---VG 647
           GL Y+H  +   ++HRDLK +N+ ++ E+L  KI DFG+A+I   +   +  G +   + 
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIV--DPHYSHKGYLSEGLV 180

Query: 648 TFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
           T  Y SP   +    +++  D+++ G +  E+++G+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 38/211 (18%)

Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +          
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS--------- 52

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWR-----------KRFNIIEGISR 591
               G+   ++       + D L F  D +    L +             RF   E I  
Sbjct: 53  ---TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE-IIL 108

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
           GL ++H  +R  +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GY
Sbjct: 109 GLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGY 161

Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG 681
           M+PE   +G  +   +D FS G +L +++ G
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.8 bits (165), Expect = 4e-12
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 544
           LG+G FG V   R K  G+  A+K L K      +E    + E  V+   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 602
                +    + EY+    L    F  L +ER+  + R RF   E +S  L YLH     
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL----FFHLSRERVFSEDRTRFYGAEIVS-ALDYLHSG--- 114

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
           +I++RDLK  N++LD++ + KI+DFG+ K   G  D A      GT  Y++PE   +  +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 663 SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
               D +  GV++ E++ GR    F+  D
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR--LPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 24/205 (11%)

Query: 487 SKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-------FMNEVMVISKLQHRN 538
           SK+G+G +G V+  R ++ GQ +A+K+  ++     E+        + E+ ++ +L+H N
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPN 61

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           LV L+       +  L++EY  +  L+ L  +P        +K   II    + + + H+
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK---IIWQTLQAVNFCHK 118

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEYA 657
                 IHRD+K  NIL+ ++   K+ DFG A+I  G   D  D    V T  Y +PE  
Sbjct: 119 ---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD---YVATRWYRAPELL 172

Query: 658 M-EGRFSEKSDVFSFGVLLLEIVSG 681
           + + ++    DV++ G +  E+++G
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 489 LGQGGFGPV-YWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRLLGC 545
           +G G +G V      + G ++A+K+L +     L  +    E+ ++  ++H N++ LL  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 546 CVEGE---EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
                        Y  MP    D  L   +K E+L   +   ++  + +GL Y+H     
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG-- 138

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-R 661
            IIHRDLK  N+ ++E+   KI DFG+A+      D   TG VV T  Y +PE  +    
Sbjct: 139 -IIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVV-TRWYRAPEVILNWMH 192

Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +++  D++S G ++ E+++G+
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 16/199 (8%)

Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +G+G FG V   R +D Q I A+K + KA   S   +   + E  V++++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLD-WRKRFNIIEGISRGLLYLHRDSRL 602
                E+  L+  ++    L    F  L++E R D  R RF   E +   L  LH+    
Sbjct: 61  SFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAE-LLCALENLHK---F 112

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            +I+RDLK  NILLD + +  + DFG+ K+   + D+ +T    GT  Y++PE  +   +
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGY 170

Query: 663 SEKSDVFSFGVLLLEIVSG 681
           ++  D ++ GVLL E+++G
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.6 bits (165), Expect = 6e-12
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 22/203 (10%)

Query: 489 LGQGGFGPVYWG-RLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLG- 544
           +G G +G V      + G+++A+K+LS+   S    +    E+ ++  +QH N++ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 545 --CCVEGEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               V G+E    Y  MP     L  ++  PL ++++ +     ++  +  GL Y+H   
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIHSAG 137

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
              IIHRDLK  N+ ++E+   KI DFG+A+    + D   TG VV T  Y +PE  +  
Sbjct: 138 ---IIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV-TRWYRAPEVILNW 189

Query: 661 -RFSEKSDVFSFGVLLLEIVSGR 682
             +++  D++S G ++ E+++G+
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 18/211 (8%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKAS----GQGLEEFMNEVMVISK 533
           NF+L   LG G +G V+  R   G +     A+K L KA+     +  E    E  V+  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 534 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           ++    +  L    + + K+ LI +Y+    L   L    ++ER   ++       I   
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L +LH+   L II+RD+K  NILLD   +  ++DFG++K F  ++ +       GT  YM
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYM 173

Query: 653 SPEYAM--EGRFSEKSDVFSFGVLLLEIVSG 681
           +P+     +G   +  D +S GVL+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.1 bits (161), Expect = 9e-12
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 18/201 (8%)

Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRN--LVRL 542
           +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +   +   +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 543 LGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           +       +K+  I + M    L   L         +   RF   E I  GL ++H  +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE--MRFYAAE-IILGLEHMH--NR 116

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG- 660
             +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GYM+PE   +G 
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGV 171

Query: 661 RFSEKSDVFSFGVLLLEIVSG 681
            +   +D FS G +L +++ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 67.8 bits (165), Expect = 9e-12
 Identities = 54/180 (30%), Positives = 92/180 (51%), Gaps = 25/180 (13%)

Query: 510 VKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE---YMPNRSLDA 566
           VK  S+A+ Q LE   NE++ + +L H N++++        E++L  E   YM  +  D 
Sbjct: 200 VKAGSRAAIQ-LE---NEILALGRLNHENILKI--------EEILRSEANTYMITQKYDF 247

Query: 567 LLFDPLKKERLDWRKR------FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620
            L+  +  E  DW+ R        I++ +   + Y+H     ++IHRD+K  NI L+ + 
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304

Query: 621 NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
              + DFG A  F   ++  D G V GT    SPE      + E +D++S G++LL+++S
Sbjct: 305 KIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 13/206 (6%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQHR 537
           +F     LG+G FG V     K   E+ A+K L K        +E  M E  V++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
             +  L  C +  +++  + EY+   +   L++   +  +    +       IS GL +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYV---NGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           HR     II+RDLK  N++LD E + KI+DFGM K      D   T    GT  Y++PE 
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEI 172

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGR 682
                + +  D +++GVLL E+++G+
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.1 bits (164), Expect = 1e-11
 Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 24/232 (10%)

Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 527
           +  +L     +F +   +G+G FG V   R K  +++ A+K LSK       +   F  E
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
             +++      +V+L       ++K L  + EYMP   L  L+ +    E   W  RF  
Sbjct: 94  RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KW-ARFYT 148

Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN-QDQADTGR 644
            E +   L  +H    +  IHRD+K  N+LLD+  + K++DFG       N   + DT  
Sbjct: 149 AE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA- 203

Query: 645 VVGTFGYMSPEYAM----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 692
            VGT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D L
Sbjct: 204 -VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYADSL 252

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 47/121 (38%), Positives = 63/121 (52%), Gaps = 8/121 (6%)

Query: 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE 619
           P +  D L   PL  E L     F +    +RG+ +L   SR + IHRDL A NILL E 
Sbjct: 159 PPQETDDLWKSPLTMEDLICYS-FQV----ARGMEFLA--SR-KCIHRDLAARNILLSEN 210

Query: 620 LNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 679
              KI DFG+A+    + D    G       +M+PE   +  ++ +SDV+SFGVLL EI 
Sbjct: 211 NVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270

Query: 680 S 680
           S
Sbjct: 271 S 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 11/204 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V+    K    I  ++L     +     + + E+ V+ +     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 121

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175

Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 21/209 (10%)

Query: 483 FQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKLQH 536
           +Q  + +G G +G V   Y  RL+  Q++AVK+LS+   Q L        E+ ++  ++H
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKH 73

Query: 537 RNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLL 594
            N++ LL             E Y+    + A L + +K ++L D   +F +I  + RGL 
Sbjct: 74  ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLRGLK 132

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y+H      IIHRDLK SN+ ++E+   +I DFG+A+      D   TG  V T  Y +P
Sbjct: 133 YIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTG-YVATRWYRAP 184

Query: 655 EYAMEG-RFSEKSDVFSFGVLLLEIVSGR 682
           E  +    +++  D++S G ++ E++ G+
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 19/222 (8%)

Query: 473 FEELATATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVI 531
           F+     ++ +++   +G+G +G V+     K+G + AVK L        EE   E  ++
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68

Query: 532 SKLQ-HRNLVRLLGC-----CVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRFN 584
             L  H N+V+  G         G++  L+ E     S+  L+   LK+ ER++      
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128

Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           I+     GL +LH +   + IHRD+K +NILL  E   K+ DFG++      + + +T  
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 184

Query: 645 VVGTFGYMSPEY-----AMEGRFSEKSDVFSFGVLLLEIVSG 681
            VGT  +M+PE       ++  +  + DV+S G+  +E+  G
Sbjct: 185 -VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 66.6 bits (162), Expect = 2e-11
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 20/230 (8%)

Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS--GQGLEEFMNEV 528
           +  +L     ++ +   +G+G FG V   R K  Q++ A+K LSK     +    F  E 
Sbjct: 34  KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 529 MVISKLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
             I    +   V  L C  + ++ + ++ EYMP   L  L+ +    E+  W K +    
Sbjct: 94  RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAKFYT--- 148

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 646
             +  +L L     + +IHRD+K  N+LLD+  + K++DFG   K+      + DT   V
Sbjct: 149 --AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--V 204

Query: 647 GTFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 692
           GT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D L
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFYADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 11/198 (5%)

Query: 488 KLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
           KLG+G +  VY GR K     +A+K +     +G     + EV ++  L+H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
               +   L++EY+ ++ L   L D      +   K F  +  + RGL Y HR    +++
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRR---KVL 126

Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSE 664
           HRDLK  N+L++E    K++DFG+A+    +         V T  Y  P+  +    +S 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Query: 665 KSDVFSFGVLLLEIVSGR 682
           + D++  G +  E+ +GR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 18/205 (8%)

Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +LG+G +G VY    +  G  +A+K  RL     +   + + E+ ++ K     +V   G
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66

Query: 545 C-CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
              +EG   M + EYM   SLD L    +  E +       I   + +GL +L  +    
Sbjct: 67  AFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY----AME 659
           IIHRD+K +N+L++     K+ DFG++    GN   +     +G   YM+PE        
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPN 179

Query: 660 GR--FSEKSDVFSFGVLLLEIVSGR 682
               ++ +SDV+S G+ +LE+  GR
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 38/212 (17%)

Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           +G+G FG VY  R KD + I A+K LSK      +E + +  V   +  RN+   L   +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNI---LVRTL 51

Query: 548 EGE---------------EKMLIYEYMPNRSLDALLFDPLKKE-RL-DWRKRFNIIEGIS 590
             E               +  L+ +YM    L    F  L+KE R  + R +F I E + 
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIAELV- 106

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
             L +LH+     I++RDLK  NILLD   +  + DFG++K      D   T    GT  
Sbjct: 107 LALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTE 161

Query: 651 YMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG 681
           Y++PE  ++ + +++  D +S GVL+ E+  G
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 18/209 (8%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 544
           LG+G FG V   R K  G+  A+K L K      +E    + E  V+   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 602
                +    + EY     L    F  L +ER+  + R RF   E +S  L YLH     
Sbjct: 63  AFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS-ALEYLHSRD-- 115

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++PE   +  +
Sbjct: 116 -VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 663 SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
               D +  GV++ E++ GR    F+  D
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR--LPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.3 bits (156), Expect = 7e-11
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 17/209 (8%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 544
           LG+G FG V   + K  G+  A+K L K      +E    + E  V+   +H  L  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 602
                +    + EY     L    F  L +ER+  + R RF   E +S  L YLH  S  
Sbjct: 63  SFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS-ALDYLH--SEK 115

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++PE   +  +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY 173

Query: 663 SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
               D +  GV++ E++ GR    F+  D
Sbjct: 174 GRAVDWWGLGVVMYEMMCGR--LPFYNQD 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.3 bits (156), Expect = 7e-11
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 22/216 (10%)

Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISK-LQHRNLVRLL 543
           +G+G FG V   R K  ++  AVK L K +    +E    M+E  V+ K ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSR 601
                 ++   + +Y+    L    F  L++ER  L+ R RF   E I+  L YLH    
Sbjct: 63  FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAE-IASALGYLHS--- 114

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
           L I++RDLK  NILLD + +  ++DFG+ K     +    T    GT  Y++PE   +  
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 662 FSEKSDVFSFGVLLLEIVSG-----RKNTSFFEDDL 692
           +    D +  G +L E++ G      +NT+   D++
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 7e-11
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 2/92 (2%)

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-VGTFGY 651
           LL +H      +IHRD+K++NILL      K+ DFG +K++       D GR   GT  Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA-ATVSDDVGRTFCGTPYY 211

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 683
           ++PE      +S+K+D+FS GVLL E+++ ++
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.8 bits (155), Expect = 8e-11
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 21/212 (9%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKAS----GQGLEEFMNEVMVISK 533
           NF+L   LG G +G V+  R   G +     A+K L KA+     + +E    E  V+  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 534 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGIS 590
           ++    +  L    + E K+ LI +Y+    +   L+  D   ++ +    RF   E I 
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV----RFYSGE-II 115

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
             L +LH+   L I++RD+K  NILLD E +  ++DFG++K F  ++++  T    GT  
Sbjct: 116 LALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIE 171

Query: 651 YMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 681
           YM+PE    +G   +  D +S G+L+ E+++G
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.9 bits (155), Expect = 8e-11
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +G+G +  V   RLK  + I   ++ K       + ++    E  V  +  +   +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 545 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLHRDSRL 602
            C + E ++  + EY+    L   +F   ++ +L +   RF   E IS  L YLH     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG-- 116

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++PE      +
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 663 SEKSDVFSFGVLLLEIVSGR 682
               D ++ GVL+ E+++GR
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 68/271 (25%), Positives = 126/271 (46%), Gaps = 35/271 (12%)

Query: 489 LGQGGFGPVYWGRLKDG-QEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 545
           +G+G FG     +  +  Q+ A+K  RL K+S   +E+   E ++++K++H N+V     
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 546 CVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
             E +  + ++ EY         L   +K +R        I++   +  L +      R+
Sbjct: 67  -FEADGHLYIVMEYCD----GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121

Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           +HRD+K+ NI L +    K+ DFG A++       A T   VGT  Y+ PE      ++ 
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNN 179

Query: 665 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL----VDPFLSESSF 720
           KSD++S G +L E+ + +     F+ +      +WK    N IL +      P  S  S+
Sbjct: 180 KSDIWSLGCILYELCTLKHP---FQAN------SWK----NLILKVCQGSYKPLPSHYSY 226

Query: 721 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVS 751
           +L  +I+ +       +   + RP+ +T++S
Sbjct: 227 ELRSLIKQM------FKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)

Query: 483 FQLSSKLGQGGFGPVYWGRL--KDGQEIAVKRLSKASGQGLEEFMN---------EVMVI 531
            +    +G G FG V W     +DG+ +A+K++          F N         E+ ++
Sbjct: 2   VEPDRPIGYGAFG-VVWSVTDPRDGKRVALKKMPNV-------FQNLVSCKRVFRELKML 53

Query: 532 SKLQHRNLVRLLGCCVEG-----EEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFN 584
              +H N++  L           EE  ++ E M    L  ++  P   + L  D  K F 
Sbjct: 54  CFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSP---QPLSSDHVKVF- 108

Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
            +  I RGL YLH      I+HRD+K  N+L++     KI DFG+A++   ++ +  T  
Sbjct: 109 -LYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164

Query: 645 VVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
           VV  + Y +PE  M  R ++   D++S G +  E++  R
Sbjct: 165 VVTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.5 bits (155), Expect = 1e-10
 Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 11/100 (11%)

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV--- 645
           + RGL Y+H  +   +IHRDLK SN+L++E+   +I DFGMA+  G +    +       
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHKYFMTE 170

Query: 646 -VGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRK 683
            V T  Y +PE  +    ++   D++S G +  E++ GR+
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 53/205 (25%), Positives = 101/205 (49%), Gaps = 10/205 (4%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRL--SKASGQGLEEFMNEVMVISKLQHR 537
           N F++   +G+G +G V   R K+ +EI A+K+   S+ + +  E  + E+ ++  L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V L        +  L++EY+    L+  L + +       + R  I + I + + + H
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCH 117

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           ++    I+HRD+K  N+L+      K+ DFG A+      + A+    V T  Y SPE  
Sbjct: 118 KND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELL 173

Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGR 682
           +   + +  D++S G +L E+  G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           +++G+ +L   SR + IHRDL A NILL E    KI DFG+A+    + D    G     
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 13/206 (6%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQHR 537
           +F     LG+G FG V     K   E+ A+K L K        +E  M E  V++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
             +  L  C +  +++  + EY+    L   ++   +  R            I+ GL +L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H      II+RDLK  N++LD E + KI+DFGM K      D   T    GT  Y++PE 
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEI 172

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGR 682
                + +  D ++FGVLL E+++G+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 66/254 (25%), Positives = 100/254 (39%), Gaps = 44/254 (17%)

Query: 483 FQLSSKLGQGGFGPVY----WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
           + + S L  G  G V+     G  +  +++ VK ++     G      E+ ++  + HR 
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKAVTGGKTPG-----REIDILKTISHRA 147

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLH 597
           ++ L+        K  +   MP    D  LF  + +   L   +   I   +   L YLH
Sbjct: 148 IINLIHAY---RWKSTVCMVMPKYKCD--LFTYVDRSGPLPLEQAITIQRRLLEALAYLH 202

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
                 IIHRD+K  NI LDE  N  + DFG A     + D        GT    SPE  
Sbjct: 203 GRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL 259

Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE 717
               +  K+D++S G++L E+    KN + F               + K           
Sbjct: 260 ALDPYCAKTDIWSAGLVLFEMSV--KNVTLFG-------------KQVK----------S 294

Query: 718 SSFQLDMIIRCIHV 731
           SS QL  IIRC+ V
Sbjct: 295 SSSQLRSIIRCMQV 308

Length = 392

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)

Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +G+G +  V   RLK   +I   ++ K       + ++    E  V  +      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 545 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLHRDSRL 602
            C +   ++ L+ EY+    L   +F   ++ +L +   RF   E I   L +LH     
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLHERG-- 116

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            II+RDLK  N+LLD + + K++D+GM K   G  D   T    GT  Y++PE      +
Sbjct: 117 -IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST--FCGTPNYIAPEILRGEEY 173

Query: 663 SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
               D ++ GVL+ E+++GR       D+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDN 202

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 19/201 (9%)

Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISK-LQHRNLVRLL 543
           +G+G FG V   + K DG+  AVK L K    + +  +  M E  V+ K ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSR 601
                 E+   + +++    L    F  L++ER   + R RF   E I+  L YLH    
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAAE-IASALGYLHS--- 114

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-VGTFGYMSPEYAMEG 660
           + I++RDLK  NILLD + +  ++DFG+ K       Q+DT     GT  Y++PE   + 
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 661 RFSEKSDVFSFGVLLLEIVSG 681
            +    D +  G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 16/203 (7%)

Query: 482 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNL 539
           + Q    LG G  G VY    L   + +AVK +       L+ + M+E+ ++ K     +
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           +   G         +  E+M   SLD     P   E +  R    I   + +GL YL   
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSLDVYRKIP---EHVLGR----IAVAVVKGLTYLWS- 113

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
             L+I+HRD+K SN+L++     K+ DFG++     +   A T   VGT  YM+PE    
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKT--YVGTNAYMAPERISG 167

Query: 660 GRFSEKSDVFSFGVLLLEIVSGR 682
            ++   SDV+S G+  +E+  GR
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 13/199 (6%)

Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
           KLG+G +  VY G  + +GQ +A+K +S  + +G+    + E  ++  L+H N+V L   
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK-RFNIIEGISRGLLYLHRDSRLRI 604
               E    ++EYM       ++  P      + R   F ++    RGL Y+H      I
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL----RGLAYIHGQ---HI 124

Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFS 663
           +HRDLK  N+L+      K++DFG+A+       Q  +  VV T  Y  P+  +    +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPDVLLGATDYS 182

Query: 664 EKSDVFSFGVLLLEIVSGR 682
              D++  G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 31/220 (14%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHR 537
           +F++   LG G FG V   + K  G+  A+K L K      + ++    E  ++ +L H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRF--NIIEGISRGLL 594
            +V ++ C  + E ++  + E++    +   LF  L+K       RF  ++ +     L+
Sbjct: 79  FIVNMM-CSFQDENRVYFLLEFV----VGGELFTHLRKA-----GRFPNDVAKFYHAELV 128

Query: 595 ----YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
               YLH      II+RDLK  N+LLD + + K++DFG AK     +    T  + GT  
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPE 180

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           Y++PE        +  D ++ GVLL E ++G     FF+D
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP--PFFDD 218

Length = 329

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 25/205 (12%)

Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
           KLG+G +  V+ GR K     +A+K +     +G     + EV ++  L+H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS-------RGLLYLHR 598
                   L++EY     LD+ L     K+ LD       +  +        RGL Y H+
Sbjct: 72  IHTERCLTLVFEY-----LDSDL-----KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
               +I+HRDLK  N+L++E+   K++DFG+A+    +         V T  Y  P+  +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLL 176

Query: 659 -EGRFSEKSDVFSFGVLLLEIVSGR 682
               +S   D++  G +L E+ +GR
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.1 bits (148), Expect = 7e-10
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQ--EIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 536
           +F     LG G FG V     K+     +A+KR  K+     + ++   +E  +++ + H
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI---SRGL 593
              V L G   +     L+ E++    +    F  L++      KRF    G    ++ +
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFV----IGGEFFTFLRRN-----KRFPNDVGCFYAAQIV 141

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           L       L I++RDLK  N+LLD++   K++DFG AK+         T  + GT  Y++
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIA 196

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           PE  +     + +D ++ G+ + EI+ G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.0 bits (148), Expect = 7e-10
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 544
           +G+G +  V    LK  + I A+K + K      E+      E  V     +   +  L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 545 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLHRDSRL 602
            C + E ++  + E++    L   +F   ++ +L +   RF   E IS  L +LH     
Sbjct: 63  SCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNFLHERG-- 116

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++PE      +
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 663 SEKSDVFSFGVLLLEIVSGR 682
               D ++ GVL+ E+++GR
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 52/185 (28%), Positives = 93/185 (50%), Gaps = 20/185 (10%)

Query: 505 GQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV------EGEEKMLIY 556
           G  +AVK+LS+   +    +    E++++  + H+N++ LL          E ++  L+ 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           E M + +L  ++   L  ER+ +     ++  +  G+ +LH      IIHRDLK SNI++
Sbjct: 106 ELM-DANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156

Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
             +   KI DFG+A+    N     T  VV  + Y +PE  +   + E  D++S G ++ 
Sbjct: 157 KSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213

Query: 677 EIVSG 681
           E+V G
Sbjct: 214 ELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 61.7 bits (149), Expect = 1e-09
 Identities = 69/248 (27%), Positives = 112/248 (45%), Gaps = 48/248 (19%)

Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE-----FMN 526
           ++++  +  N +++  K+G G FG V+  + K  QE    +    S +GL+E      + 
Sbjct: 4   KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVI 61

Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 586
           EV V+ +L+H+N+VR +   +    + L   Y+     DA     L +      K F  I
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKL---YILMEFCDA---GDLSRNIQKCYKMFGKI 115

Query: 587 E-----GISRGLL----YLHR----DSRLRIIHRDLKASNILLD-------------EEL 620
           E      I+R LL    Y H      +  R++HRDLK  NI L                L
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175

Query: 621 N----PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVL 674
           N     KI DFG++K  G    ++     VGT  Y SPE  +     + +KSD+++ G +
Sbjct: 176 NGRPIAKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232

Query: 675 LLEIVSGR 682
           + E+ SG+
Sbjct: 233 IYELCSGK 240

Length = 1021

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 70/250 (28%), Positives = 115/250 (46%), Gaps = 22/250 (8%)

Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 527
           +  +L     ++++   +G+G FG V   R K  +++ A+K LSK       +   F  E
Sbjct: 34  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
             +++      +V+L     +     ++ EYMP   L  L+ +    E+  W  RF   E
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--W-ARFYTAE 150

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 646
            +    L L     +  IHRD+K  N+LLD+  + K++DFG   K+      + DT   V
Sbjct: 151 VV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--V 204

Query: 647 GTFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
           GT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D L  +G   K+ 
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYADSL--VGTYSKIM 260

Query: 703 NENKILALVD 712
           N    L   D
Sbjct: 261 NHKNSLTFPD 270

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 38/238 (15%)

Query: 489 LGQGGFGPVYWG---RLKDGQ-----EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
           LGQG F  ++ G    + D       E+ +K L K+     E F     ++S+L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
              G CV G+E +++ EY+   SLD  L        + W+    + + ++  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDKG 120

Query: 601 RLRIIHRDLKASNILLDEEL-----NP---KISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
              + H ++ A N+LL  E      NP   K+SD G++      +       ++    ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIPWV 171

Query: 653 SPEYAMEGR-FSEKSDVFSFGVLLLEIVSG----------RKNTSFFEDDLTILGYAW 699
            PE     +  S  +D +SFG  L EI SG          +K   F+ED   +    W
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKW 229

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 34/193 (17%)

Query: 505 GQEIAVKRLSKASGQGLEEFMN---------EVMVISKLQHRNLVRLLGCCV------EG 549
           GQ +A+K+LS+        F N         E++++  + H+N++ LL          E 
Sbjct: 41  GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93

Query: 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDL 609
           ++  L+ E M     DA L   ++ + LD  +   ++  +  G+ +LH      IIHRDL
Sbjct: 94  QDVYLVMELM-----DANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 144

Query: 610 KASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVF 669
           K SNI++  +   KI DFG+A+  G       T  VV T  Y +PE  +   + E  D++
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 201

Query: 670 SFGVLLLEIVSGR 682
           S G ++ E++ G 
Sbjct: 202 SVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 46/224 (20%)

Query: 485 LSSKLGQG--GFGPVYWGRLKD-GQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNL 539
           L + +G+       V+  + K     +AVK+  L   S + L+    E++   +LQH N+
Sbjct: 2   LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF----------NIIEGI 589
           +  +   +   E  ++   M   S + LL           +  F           I++ +
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLL-----------KTHFPEGLPELAIAFILKDV 110

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF-GMAKIFGGNQDQADTGRVVGT 648
              L Y+H       IHR +KAS+ILL  +    +S       +    + Q    RVV  
Sbjct: 111 LNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ----RVVHD 163

Query: 649 FG--------YMSPEY---AMEGRFSEKSDVFSFGVLLLEIVSG 681
           F         ++SPE     ++G ++EKSD++S G+   E+ +G
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 24/223 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 536
            +F + S +G+G FG V   R K   +I A+K + K+     E    F  E  ++S    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNIIEGISRGL 593
             + +L     + +   L+ EY P   L +LL    D   ++      +F + E +    
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAELV---- 112

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           L +H   ++  +HRD+K  N+L+D   + K++DFG A     N+   ++   VGT  Y++
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIA 171

Query: 654 PEY--AMEG----RFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           PE    M G     +  + D +S GV+  E++ GR  + F E 
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR--SPFHEG 212

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.2 bits (140), Expect = 6e-09
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHR 537
           ++++   KLG+G +  VY G+ K +G+ +A+K  RL +  G      + E  ++  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHA 63

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V L       E   L++EY+       +   P      +  K F  +  + RGL Y+H
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHP-GGLHPENVKLF--LFQLLRGLSYIH 120

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           +     I+HRDLK  N+L+ +    K++DFG+A+    +         V T  Y  P+  
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 658 M-EGRFSEKSDVFSFGVLLLEIVSG 681
           +    +S   D++  G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 32/271 (11%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 536
           ++F++   +G+G FG V   ++K+  ++ A+K L+K       E   F  E  V+     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLL 594
           R +  L     +     L+ +Y     L  LL  F+    E +    RF + E +    L
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYLAEMV----L 113

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMS 653
            +    +L  +HRD+K  N+LLD+  + +++DFG   ++      Q++    VGT  Y+S
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VGTPDYIS 171

Query: 654 PEY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI- 707
           PE   AME   GR+  + D +S GV + E++ G   T F+ + L +  Y   + ++    
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESL-VETYGKIMNHKEHFQ 228

Query: 708 LALVDPFLSESSFQLDMIIRCIHVGLLCVQE 738
                  +SE +   D+I R     L+C  E
Sbjct: 229 FPPDVTDVSEEA--KDLIRR-----LICSPE 252

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 35/230 (15%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
           ++F++   +G+G FG V   ++K  + I A+K L+K       E +         + RN+
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW------EMLKRAETACFREERNV 54

Query: 540 --------VRLLGCCVEGEEKM-LIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEG 588
                   +  L    + E  + L+ +Y     L  LL  F+    E +    RF I E 
Sbjct: 55  LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYIAEM 111

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-VG 647
           +    L +H   +L  +HRD+K  N+LLD   + +++DFG       NQD      V VG
Sbjct: 112 V----LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVG 165

Query: 648 TFGYMSPEY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 692
           T  Y+SPE   AME   G++  + D +S GV + E++ G   T F+ + L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 57.2 bits (138), Expect = 2e-08
 Identities = 30/76 (39%), Positives = 42/76 (55%)

Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDL A NILL      KI DFG+A+    + +    G       +M+PE      ++ 
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295

Query: 665 KSDVFSFGVLLLEIVS 680
           +SDV+S+G+LL EI S
Sbjct: 296 ESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 37/125 (29%), Positives = 61/125 (48%), Gaps = 4/125 (3%)

Query: 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615
           Y+   +  +  LL D    E L      +    ++RG+ +L   +    +HRDL A N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269

Query: 616 LDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
           L +    KI DFG+A+    + +    G       +M+PE   +  ++  SDV+S+G+LL
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329

Query: 676 LEIVS 680
            EI S
Sbjct: 330 WEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 26/173 (15%)

Query: 527 EVMVISKLQHRNLVRLLG--------CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 578
           E  ++  + H ++++L G        C +    K  +Y Y+  +   A+  D L  ER  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAIC-DILAIER-- 189

Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
                     + R + YLH +   RIIHRD+KA NI ++   +  + DFG A  F  + +
Sbjct: 190 ---------SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDIN 236

Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
                   GT    +PE      +    D++S G++L E+ +     S FE D
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD--SLFEKD 287

Length = 391

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 32/158 (20%)

Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
           KLG+G +  VY GR K  GQ +A+K +     +G     + E  ++  L+H N+V  L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70

Query: 546 CVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKR-----------FNIIEGISRGL 593
            +  ++ + L++EY+ +  L         K+ +D               F ++    RGL
Sbjct: 71  IIHTKKTLTLVFEYL-DTDL---------KQYMDDCGGGLSMHNVRLFLFQLL----RGL 116

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
            Y H+    R++HRDLK  N+L+ E    K++DFG+A+
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 49/237 (20%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR-LSKASGQGL-EEFMNEVMVISKLQHR 537
           + ++   K+G+G +G VY  R    G+ +A+K+   +   +G+    + E+ ++  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 538 N-LVRLLGCCVEGEEK-------MLIYEYM--------------PNRSLDALLFDPLKKE 575
             +VRLL   VE  E+        L++EY+              P R L A         
Sbjct: 61  IYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTI------ 112

Query: 576 RLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFG 634
                K F  +  + +G+ + H+     ++HRDLK  N+L+D++    KI+D G+ + F 
Sbjct: 113 -----KSF--MYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF- 161

Query: 635 GNQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
               ++ T  +V T  Y +PE  +    +S   D++S G +  E+   RK   F  D
Sbjct: 162 SIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPLFPGD 215

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.9 bits (135), Expect = 4e-08
 Identities = 54/216 (25%), Positives = 103/216 (47%), Gaps = 24/216 (11%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQ- 535
            ++L  +LGQG +G V   R     + + +A+K+++    + +  +  + E+ ++   + 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 536 HRNLVRLLGCCV---EGEEKMLIYEYMPNRSLDALLFD--PLKKERLDWRKRFNIIEGIS 590
           H+N+  L    +       ++ +YE +    L  ++    PL        + F  I  I 
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHF---QSF--IYQIL 115

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD---TGRVVG 647
            GL Y+H  +   ++HRDLK  N+L++ +   KI DFG+A+ F  N  +     T   V 
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-YVA 171

Query: 648 TFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 682
           T  Y +PE  +  +   K+ DV+S G +L E++  +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 39/216 (18%)

Query: 489 LGQGGFGPVYWGRLKD---------GQEIAVKR-LSKASGQGLEEFMNEVMVISKLQHRN 538
           LGQG F  +Y G L+          GQE++V   +  +  +    F     ++S+L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGISRGLL 594
           LV+L G CV  E  M + EY+    LD      L +E+    L W  + ++ + ++  L 
Sbjct: 63  LVKLYGVCVRDENIM-VEEYVKFGPLDVF----LHREKNNVSLHW--KLDVAKQLASALH 115

Query: 595 YLHRDSRLRIIHRDLKASNILL-----DEELNP--KISDFGMAKIFGGNQDQADTGRVVG 647
           YL      +++H ++   NIL+     +E   P  K+SD G+       +++      V 
Sbjct: 116 YLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VE 166

Query: 648 TFGYMSPEYAMEGRFSEKS--DVFSFGVLLLEIVSG 681
              +++PE    G+ S     D +SFG  LLEI S 
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 55.9 bits (134), Expect = 4e-08
 Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 20/182 (10%)

Query: 506 QEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV------EGEEKMLIYE 557
           + +A+K+LS+   +    +    E++++  + H+N++ LL          E ++  L+ E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102

Query: 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617
            M     DA L   ++ E LD  +   ++  +  G+ +LH      IIHRDLK SNI++ 
Sbjct: 103 LM-----DANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153

Query: 618 EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLE 677
            +   KI DFG+A+  G +     T  VV  + Y +PE  +   + E  D++S G ++ E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 210

Query: 678 IV 679
           +V
Sbjct: 211 MV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.8 bits (134), Expect = 6e-08
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 14/161 (8%)

Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
           +E+  ++   H  +V+        ++ +LI EY     L+  +     K+RL     F  
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-----KQRLKEHLPFQE 168

Query: 586 IEGISRGLLY------LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
            E    GLL+      L      +++HRDLK++NI L      K+ DFG +K +  +   
Sbjct: 169 YEV---GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225

Query: 640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  GT  Y++PE     R+S+K+D++S GV+L E+++
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 55.1 bits (132), Expect = 7e-08
 Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 14/182 (7%)

Query: 506 QEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG---EEKMLIYEYMP 560
           + +A+K+LS+   +    +    E++++  + H+N++ LL         EE   +Y  M 
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM- 108

Query: 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620
              +DA L   ++ E LD  +   ++  +  G+ +LH      IIHRDLK SNI++  + 
Sbjct: 109 -ELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 163

Query: 621 NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             KI DFG+A+  G +     T  VV  + Y +PE  +   + E  D++S G ++ E++ 
Sbjct: 164 TLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIK 220

Query: 681 GR 682
           G 
Sbjct: 221 GG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 55.7 bits (134), Expect = 8e-08
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 32/165 (19%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMNEVMVISKLQHRN--- 538
           F +   + +G FG VY GR K+  ++ AVK + KA      + +N+ MV      R+   
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA------DMINKNMVHQVQAERDALA 59

Query: 539 ------LVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIE 587
                 +V L           L+ EY+    + +LL     FD    E +       I E
Sbjct: 60  LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD----EEM---AVKYISE 112

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
            ++  L YLHR     IIHRDLK  N+L+  E + K++DFG++K+
Sbjct: 113 -VALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.7 bits (132), Expect = 8e-08
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 7/94 (7%)

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
           RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+A+      D   T  VV T  
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEYVV-TRW 173

Query: 651 YMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRK 683
           Y +PE  +    ++   DV+S G +  E++ GRK
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 61/244 (25%), Positives = 108/244 (44%), Gaps = 52/244 (21%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS----GQGLEEFMNEVMVISKLQ 535
           ++F+    +G+G FG V   + KD   I A+K+L K+      Q +     E  ++++  
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59

Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGL 593
           +  +V+L     + E  + LI EY+P   +  LL   +KK+   +   RF I E I    
Sbjct: 60  NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAETI---- 111

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA------------- 640
           L +    +L  IHRD+K  N+LLD + + K+SDFG+      +                 
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171

Query: 641 --------DTGR---------------VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLE 677
                    + R                VGT  Y++PE  ++  ++++ D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Query: 678 IVSG 681
           ++ G
Sbjct: 232 MLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 23/223 (10%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQHR 537
           +F++   +G+G FG V   +LK+  ++ A+K L+K       E   F  E  V+    ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLY 595
            +  L     +     L+ +Y     L  LL  F+    E +    RF + E +    + 
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYLAEMV----IA 114

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSP 654
           +    +L  +HRD+K  NIL+D   + +++DFG   K+      Q+     VGT  Y+SP
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISP 172

Query: 655 EY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 692
           E   AME   G++  + D +S GV + E++ G   T F+ + L
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFYAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 28/76 (36%), Positives = 42/76 (55%)

Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           +HRDL A N+L+ E    KI DFG+A+    + +    G       +M+PE      ++ 
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 665 KSDVFSFGVLLLEIVS 680
            SDV+SFG+LL EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 29/80 (36%), Positives = 46/80 (57%)

Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRD+ A N+LL +    KI DFG+A+    + +    G       +M+PE   +  ++ 
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293

Query: 665 KSDVFSFGVLLLEIVSGRKN 684
           +SDV+S+G+LL EI S  K+
Sbjct: 294 QSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.2 bits (126), Expect = 3e-07
 Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 33/232 (14%)

Query: 474 EELATATNNFQLSSKLG--QGGFGPVYWGRLKDGQEIAVKRLSKASG-QGLEEFMNEVMV 530
            EL     N ++  KL    G FG V   + K  Q++ V+++ KA     +E  ++++M 
Sbjct: 7   SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMK 66

Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGI 589
                + N ++L       +  +LI +Y+     D  LFD LKKE +L   +   II  +
Sbjct: 67  ----DNPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQL 118

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFG--GNQDQADTGRVV 646
              L  LH+     IIH D+K  N+L D   +   + D+G+ KI G     D        
Sbjct: 119 VEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-------- 167

Query: 647 GTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR---KNTSFFEDDLTI 694
           GT  Y SPE  ++G   + S D ++ GVL  E+++G+   K     +++L +
Sbjct: 168 GTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE--DEDEELDL 216

Length = 267

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)

Query: 488 KLGQGGFGPVYWGRLKDGQEIA---VKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           ++G G FG V    +     +A   VK L + AS +   EF+ +      LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR-------GLLYL 596
           G CVE    +L++EY     L + L       +  W +R + +  + R       G+ ++
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT-GRVVGTFGYMSPE 655
           H   +   +H DL   N  L  +L  K+ D+G+       +D  +T         +++PE
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 656 YAME--GRF-----SEKSDVFSFGVLLLEI 678
              E  G       ++ S+V++ GV L E+
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 52.0 bits (124), Expect = 8e-07
 Identities = 61/240 (25%), Positives = 107/240 (44%), Gaps = 47/240 (19%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN---EVMVISKLQH 536
           ++F+    +G+G FG V   + KD G   A+K L KA     E+  +   E  ++ +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLY 595
             +V++     +     LI E++P   +  LL   +KK+ L +   +F I E +    L 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETV----LA 113

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGM-------------------------- 629
           +    +L  IHRD+K  N+LLD + + K+SDFG+                          
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173

Query: 630 --------AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
                   A+ +  N+ Q      VGT  Y++PE  M+  +++  D +S GV++ E++ G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.0 bits (124), Expect = 9e-07
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 51/230 (22%)

Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFMN-EVMVISKLQ 535
           +   +++L + +G G FG VY     D  E +A+K++ +       ++ N E++++  L 
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLN 117

Query: 536 HRNLVRLLGC----CVEGEEKML----IYEYMP-------------NRSLDALLFDPLKK 574
           H N++ L       C +  EK +    + E++P             N +L   L      
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177

Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAK-I 632
           +             + R L Y+H  S+  I HRDLK  N+L+D   +  K+ DFG AK +
Sbjct: 178 Q-------------LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Query: 633 FGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 681
             G   Q     +   F Y +PE  +    ++   D++S G ++ E++ G
Sbjct: 222 LAG---QRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 45/238 (18%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN---EVMVISKLQHR 537
           +F+    +G+G FG V   + KD G   A+K L KA     E+  +   E  ++ +    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYL 596
            +V++     +     LI E++P   +  LL   +KK+ L +   +F I E +    L +
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETV----LAI 114

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---------------------- 634
               +L  IHRD+K  N+LLD + + K+SDFG+                           
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 635 --GNQDQADTGR---------VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
              ++ +A+T +          VGT  Y++PE  M+  +++  D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 68/294 (23%), Positives = 123/294 (41%), Gaps = 60/294 (20%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS---GQGLEEFMNEVMVISKLQHRN 538
           F     +G G FG V   R  D   + A+K L KA             E  ++++  +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLYLH 597
           +V+L     + +    + +Y+P   + +LL    + +E L    RF I E ++  +  +H
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTCAIESVH 118

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGM---------AKIFGGN----QDQ----- 639
           +   +  IHRD+K  NIL+D + + K++DFG+         +K +       QD      
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 640 --ADTGR---------------------VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
             ++  R                     +VGT  Y++PE  +   +++  D +S GV+L 
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235

Query: 677 EIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ-LDMIIRCI 729
           E++ G+     F  D T      K+ N    L +  P  ++ S +  D+I+R  
Sbjct: 236 EMLVGQPP---FLAD-TPAETQLKVINWETTLHI--PSQAKLSREASDLILRLC 283

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 8/86 (9%)

Query: 481 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
           +N Q    LG G FG V        G+  +   +AVK L + A     E  M+E+ ++S 
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEY 558
           L QH+N+V LLG C  G   ++I EY
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEY 123

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 6/95 (6%)

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI-FGGNQDQADTGRVVGTF 649
           R L Y+H  +   + HRDLK  NIL + +   KI DFG+A++ F            V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 650 GYMSPEY--AMEGRFSEKSDVFSFGVLLLEIVSGR 682
            Y +PE   +   +++   D++S G +  E+++G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.0 bits (114), Expect = 9e-06
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 52/229 (22%)

Query: 487 SKLGQGGFGPVYWGRLK-----------------------DGQEIAV--KRLSKASGQGL 521
           + LGQG    +Y GRL+                       +G+E+ V  K L  +     
Sbjct: 1   AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIA 60

Query: 522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL---- 577
             F     ++S++ H +L  + G CV G E +++ E++ +  LD      L+KE+     
Sbjct: 61  LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC----LRKEKGRVPV 116

Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL-----LDEELNP--KISDFGMA 630
            W  +  + + ++  L YL   +   ++H ++ A NIL     L E  +P  K+SD G++
Sbjct: 117 AW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171

Query: 631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEI 678
             F     +    R+     +++PE    G   S  +D +SFG  LLEI
Sbjct: 172 --FTALSREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 35/224 (15%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLEEFMNEVMV---ISKLQH 536
            +F+    +  G +G VY  R K+  Q  A+K+++K +   L   + +V V   I     
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-LILRNQIQQVFVERDILTFAE 59

Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
              V  + C  E +  + ++ EY+       LL +    P+   R+ + +    +E    
Sbjct: 60  NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE---- 115

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI---------FGGNQDQADT 642
              YLH      I+HRDLK  N+L+    + K++DFG++KI         + G+ ++ DT
Sbjct: 116 ---YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK-DT 168

Query: 643 -----GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
                 +V GT  Y++PE  +   + +  D ++ G++L E + G
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 32/211 (15%)

Query: 489 LGQGGFGPVYWGRLKD---------GQEIAVKRLSKASGQGLEE----FMNEVMVISKLQ 535
           LG+G    +Y G L             E  +K + K       +    F     ++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H+++V L G CV   E +++ E++    LD  LF   K + L    +F + + ++  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 596 LHRDSRLRIIHRDLKASNILL-----DEELNP--KISDFGMAKIFGGNQDQADTGRVVGT 648
           L  D  L  +H ++   NILL     D E  P  K+SD G+       Q+  +       
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE------R 171

Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 678
             +++PE   + +  S  +D +SFG  L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 36/221 (16%)

Query: 484 QLSSKLGQG--GFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           +L  ++G+G      VY  R    G  + V+   L   + + L+   NEV++    +H N
Sbjct: 1   ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYL 596
           ++        G    +I  +M   S ++LL  + P   E +      NI+ G  RGL YL
Sbjct: 61  IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP---EGMSEALIGNILFGALRGLNYL 117

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ-----DQADTGRVVGTF-- 649
           H++     IHR++KAS+IL+  +        G+  + G +            +VV  F  
Sbjct: 118 HQNG---YIHRNIKASHILISGD--------GLVSLSGLSHLYSLVRNGQKAKVVYDFPQ 166

Query: 650 ------GYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGR 682
                  ++SPE   +    ++ KSD++S G+   E+ +GR
Sbjct: 167 FSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 62/242 (25%), Positives = 93/242 (38%), Gaps = 47/242 (19%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRN 538
           F+    LG+G  G V+  RLK  G+  A+K L K        ++  + E  +++ L H  
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR-----KRFNIIEGISRGL 593
           L  L           L+ +Y P   L  LL     + +          RF   E +   L
Sbjct: 63  LPTLYASFQTETYLCLVMDYCPGGELFRLL-----QRQPGKCLSEEVARFYAAE-VLLAL 116

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-------------IFGGNQDQ- 639
            YLH    L I++RDLK  NILL E  +  +SDF ++K               G  +   
Sbjct: 117 EYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 640 -------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTS 686
                          +   VGT  Y++PE           D ++ G+LL E++ G   T 
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT--TP 231

Query: 687 FF 688
           F 
Sbjct: 232 FK 233

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.1 bits (107), Expect = 7e-05
 Identities = 38/180 (21%), Positives = 83/180 (46%), Gaps = 20/180 (11%)

Query: 511 KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM----LIYEYMPNRSLDA 566
           K+  K     ++   NE+  + ++   N++++ G  ++  + +    LI EY        
Sbjct: 52  KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC----TRG 107

Query: 567 LLFDPLKKER-LDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKI 624
            L + L KE+ L ++ + ++     +GL  L++  ++    +++L + + L+ E    KI
Sbjct: 108 YLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLKI 164

Query: 625 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGR 682
              G+ KI       +   + V    Y S +   +    ++ K D++S GV+L EI +G+
Sbjct: 165 ICHGLEKIL-----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 60/252 (23%), Positives = 104/252 (41%), Gaps = 59/252 (23%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 536
            +F     +G+G FG V   + KD G+  A+K L K+       L     E  V+++   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLL 594
             +V L     + +   LI E++P   L  +L  +D   ++      RF + E +    L
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECV----L 112

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-------------KIFGG------ 635
            +    +L  IHRD+K  NIL+D   + K+SDFG++             K+  G      
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172

Query: 636 -----------------NQDQADTGR---------VVGTFGYMSPEYAMEGRFSEKSDVF 669
                            ++DQ  T +          VGT  Y++PE  ++  + ++ D +
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232

Query: 670 SFGVLLLEIVSG 681
           S G ++ E + G
Sbjct: 233 SLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 50/212 (23%)

Query: 482 NFQLSSKLGQGGFGPVYWG-----RLKDGQEIAVKRLSKASGQG-LEEFMNEVM------ 529
           +F L  KLG+G FG VY       + K   +  +K   KA+  G +E +MNE +      
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK---KATEYGAVEIWMNERVRRACPN 189

Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD---PLKKERLDWRK----- 581
             +   +  L  +     + +E  L++ Y    +L  L+     P   E     K     
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247

Query: 582 ----RFN-IIEGISRGLLY----LHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAK 631
               R N II+ I R +L+    LH      I+HRD+K  NI+  E     KI D G A 
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA- 303

Query: 632 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 663
                   AD  RV     Y+  E+ ++ R++
Sbjct: 304 --------ADL-RV--GINYIPKEFLLDPRYA 324

Length = 566

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 26/96 (27%), Positives = 47/96 (48%), Gaps = 7/96 (7%)

Query: 586 IEGISRGLL----YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
           +  ++R LL    Y+H +    IIHRD+K  N+L++   +  + DFG A    G+     
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLE 677
              + GT    +PE      ++   D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.4 bits (102), Expect = 4e-04
 Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 50/240 (20%)

Query: 474 EELATATNNFQLSSKLGQGGFGPVY--WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVI 531
           E++  +T  F++ S LG+G FG V   W R K  +  AVK +     + + ++  +  + 
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIV-----RNVPKYTRDAKI- 174

Query: 532 SKLQHRNLVRLLGCCVEGEEK---MLIYEYMPNRSLDALLFDPLKKE-RLDW-------- 579
            ++Q    VR      +  ++   M I  Y  N +    +  P      LDW        
Sbjct: 175 -EIQFMEKVRQ----ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFS 229

Query: 580 -RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNP------------- 622
            R    II      L Y H  + L ++H DLK  NIL+   D  ++P             
Sbjct: 230 HRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287

Query: 623 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           +I D G     G   ++     +V T  Y SPE  +   +   +D++S G ++ E+ +G+
Sbjct: 288 RICDLG-----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 54/244 (22%), Positives = 101/244 (41%), Gaps = 57/244 (23%)

Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG G FG V      D   + A+K L K    +   +     E  ++++  +  +V+L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
              + +    + +Y+P   + +LL    +  E L    RF I E ++  +  +H+   + 
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVHK---MG 121

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIF----------GGNQDQADTGR--------- 644
            IHRD+K  NIL+D + + K++DFG+   F           G+  + D+           
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 645 --------------------------VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 678
                                     +VGT  Y++PE  +   +++  D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241

Query: 679 VSGR 682
           + G+
Sbjct: 242 LVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.2 bits (99), Expect = 8e-04
 Identities = 31/86 (36%), Positives = 39/86 (45%), Gaps = 8/86 (9%)

Query: 481 NNFQLSSKLGQGGFGPVY----WGRLKD--GQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
           N       LG G FG V     +G  K      +AVK L   A     E  M+E+ V+S 
Sbjct: 35  NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94

Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEY 558
           L  H N+V LLG C  G   ++I EY
Sbjct: 95  LGNHINIVNLLGACTVGGPTLVITEY 120

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

 Score = 41.9 bits (99), Expect = 8e-04
 Identities = 37/157 (23%), Positives = 57/157 (36%), Gaps = 30/157 (19%)

Query: 497 VYWGRLKDGQEIAVK--RLSKASGQGLEE-------FMNEVMVISKLQH-------RNLV 540
           VY     DG+ +AVK  R S +  + +         F N      KL         RNL 
Sbjct: 64  VYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLK 123

Query: 541 RLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN-IIEGISRGL 593
           R     V           +L+ E++ +  L A     +  E  +    +  ++E + R  
Sbjct: 124 RAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRR-- 181

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
           LY        ++H DL   NIL+ +   P I D   A
Sbjct: 182 LY----KEAGLVHGDLSEYNILVHDG-EPYIIDVSQA 213

Length = 268

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.9 bits (98), Expect = 9e-04
 Identities = 58/244 (23%), Positives = 102/244 (41%), Gaps = 57/244 (23%)

Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG G FG V   R  D + + A+K L K        +     E  ++++  +  +VRL  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
              + +    + +Y+P   + +LL    +  E L    RF I E ++  +  +H+   + 
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIAE-LTCAVESVHK---MG 121

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIF----------GGN---QDQAD--------- 641
            IHRD+K  NIL+D + + K++DFG+   F           G+   QD  D         
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181

Query: 642 -----------------------TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 678
                                     +VGT  Y++PE  +   +++  D +S GV+L E+
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241

Query: 679 VSGR 682
           + G+
Sbjct: 242 LVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

 Score = 38.4 bits (89), Expect = 0.001
 Identities = 23/80 (28%), Positives = 29/80 (36%), Gaps = 7/80 (8%)

Query: 337 EDGFSKLNKMKVPDFT---EWTSPATEDECREQCLKN---CSCIAYAFDGGIGCMVWRSI 390
            D F K     +       + T   T DEC  +C KN    SC A+ F       +W   
Sbjct: 1   VDEFCKSAGTTLIKIALKIKTTKANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPF 60

Query: 391 NLIDIQRLPFG-GTDLYIRV 409
           N +   R  F  G DLY   
Sbjct: 61  NSMSGVRKEFSHGFDLYENK 80

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.2 bits (92), Expect = 0.004
 Identities = 24/113 (21%), Positives = 43/113 (38%), Gaps = 26/113 (23%)

Query: 526 NEVMVISKLQHRNLVRLLGCC------VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW 579
            E  +++K       R  G        V+ +  +++ EY+    L   L           
Sbjct: 48  REARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL----------E 91

Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
             R +++  + R +  LH+     I+H DL  SNI+L         DFG+ + 
Sbjct: 92  EARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEF 140

Length = 204

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.1 bits (93), Expect = 0.004
 Identities = 20/52 (38%), Positives = 33/52 (63%), Gaps = 1/52 (1%)

Query: 580 RKRFNIIEGISRGLLY-LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
           ++  N+I+G+ R +L  L +  R+ I+HRD+K  N+L+  +   KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	807
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.98
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.92
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.91
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.79
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
PRK10345	210	hypothetical protein; Provisional	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.72
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.71
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.69
smart00090	237	RIO RIO-like kinase.	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.53
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.53
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.52
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.44
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.41
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.34
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.28
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.26
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.22
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.19
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.11
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.1
KOG1243	690	consensus Protein kinase [General function predict	99.04
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.04
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.98
KOG3087	229	consensus Serine/threonine protein kinase [General	98.92
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.9
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.79
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.72
COG4248	637	Uncharacterized protein with protein kinase and he	98.7
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.66
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.53
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.49
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.43
PRK09902	216	hypothetical protein; Provisional	98.41
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.36
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.36
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.36
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.35
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.29
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.27
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.15
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.09
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.08
PF01636	239	APH: Phosphotransferase enzyme family This family	98.07
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.02
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	97.93
PLN02876	822	acyl-CoA dehydrogenase	97.86
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.82
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.77
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.77
PRK10593	297	hypothetical protein; Provisional	97.73
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.65
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.62
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.58
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.56
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.51
PRK05231	319	homoserine kinase; Provisional	97.42
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.38
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.06
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.94
PLN02236	344	choline kinase	96.81
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.67
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.66
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.65
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.59
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	96.53
PLN02756	418	S-methyl-5-thioribose kinase	96.35
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.3
KOG2270	520	consensus Serine/threonine protein kinase involved	96.14
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.04
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.98
PRK12396	409	5-methylribose kinase; Reviewed	95.89

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-54  Score=466.91  Aligned_cols=287  Identities=47%  Similarity=0.805  Sum_probs=254.6

Q ss_pred             CCCCcCHHHHHHHhcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEE
Q 003628          467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC  546 (807)
Q Consensus       467 ~l~~f~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  546 (807)
                      ....|+++++..||++|...+.||+|+||.||+|.+.+|+.||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56679999999999999999999999999999999999999999988765443145699999999999999999999999


Q ss_pred             EeCC-eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceee
Q 003628          547 VEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS  625 (807)
Q Consensus       547 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~  625 (807)
                      .+.+ +++||||||++|+|+++|+..... .++|.+|++||.++|+||+|||....++|+||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999875433 89999999999999999999999998899999999999999999999999


Q ss_pred             ccccccccCCCCCcccccee-eccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccC--Ccchhhhhhhhhc
Q 003628          626 DFGMAKIFGGNQDQADTGRV-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE--DDLTILGYAWKLW  702 (807)
Q Consensus       626 DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~--~~~~l~~~~~~~~  702 (807)
                      |||+|+......  ...... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...  ....+..|++..+
T Consensus       220 DFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999997543311  111112 79999999999999999999999999999999999999887543  4556889999999


Q ss_pred             cccccccccCccccCCcccH-HHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          703 NENKILALVDPFLSESSFQL-DMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       703 ~~~~~~~~~d~~l~~~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      .++++.+++|+.+....... +...++..++.+|++.+|.+||+|.||+++|+.+
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            99999999999997443554 6888999999999999999999999999999665

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-45  Score=395.85  Aligned_cols=259  Identities=31%  Similarity=0.495  Sum_probs=212.8

Q ss_pred             cccCccccCCCccEEEEEecCCcEEEEEEecccCcc--cHHHHHHHHHHHHhccCCceeEEeeEEEeCC-eEEEEEEecC
Q 003628          484 QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-EKMLIYEYMP  560 (807)
Q Consensus       484 ~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~  560 (807)
                      .+.+.||+|+||+||+|.+.....||||++......  ..+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            345669999999999999985555999999764322  2569999999999999999999999999988 7899999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC-CceeeccccccccCCCCCc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kL~DFGla~~~~~~~~~  639 (807)
                      +|+|.++++.. ....+++..+++++.+||+||.|||+.+.  ||||||||+||||+.++ ++||+|||+++......  
T Consensus       124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            99999999764 46789999999999999999999999874  99999999999999997 99999999999764332  


Q ss_pred             cccceeeccCCccChhhhc--cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          640 ADTGRVVGTFGYMSPEYAM--EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~--~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      .......||+.|||||++.  ...|+.|+|||||||+||||+||+.||....... ..   ......+     ..+.   
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-~~---~~v~~~~-----~Rp~---  266 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-VA---SAVVVGG-----LRPP---  266 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-HH---HHHHhcC-----CCCC---
Confidence            2222368999999999999  6689999999999999999999999997655421 11   1111111     1111   


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCCC
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP  761 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~  761 (807)
                        .+......+..++.+||+.||+.||++.+|+.+|+.+.....
T Consensus       267 --~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  267 --IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             --CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence              233356778899999999999999999999999987754433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=370.83  Aligned_cols=250  Identities=29%  Similarity=0.387  Sum_probs=207.2

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCC-eEEEEEEec
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-EKMLIYEYM  559 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~  559 (807)
                      .+..+.||+|..|+|||++++ +++.+|+|.+... .+...+++.+|++++++.+||+||+++|.|.... ...++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            344689999999999999987 5788999999544 3445688999999999999999999999999988 599999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhh-cCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      ++|||++++..   .+++++..+-+|+.+|++||.|||+ ++   ||||||||+||||+..|++||||||.++.+...  
T Consensus       161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999999853   3779999999999999999999996 55   999999999999999999999999999977544  


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccC-CcchhhhhhhhhccccccccccCccccC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE-DDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                        ....++||..|||||.+.+..|+.++||||||++++|+++|+.|+.... +.............      -..|.+..
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~------~ppP~lP~  304 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD------EPPPRLPE  304 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc------CCCCCCCc
Confidence              3345799999999999999999999999999999999999999987641 11222221111111      11222222


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .    ....++.+++..||++||.+||++.|++++
T Consensus       305 ~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  305 G----EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             c----cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            2    366789999999999999999999998754

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-43  Score=381.58  Aligned_cols=247  Identities=27%  Similarity=0.397  Sum_probs=212.8

Q ss_pred             cCCcccCccccCCCccEEEEEe-cCCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      .+|...+.||+|||+.+|+++. ..|+.||+|++.+.   .....+...+|+++.+.|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999998 78999999999763   3345678899999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      |+|++++|.+++.   .++.+++.++..+++||+.||.|||+++   |+|||||..|++|+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999984   5678999999999999999999999998   999999999999999999999999999988654


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      ...  ....+|||.|.|||++....++..+||||+|||||-|+.|++||+...-...+....           ..     
T Consensus       172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-----------~~-----  233 (592)
T KOG0575|consen  172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-----------LN-----  233 (592)
T ss_pred             ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-----------hc-----
Confidence            333  334899999999999999999999999999999999999999997543222111100           00     


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      +-.++.....+..+||.++|+.||.+|||+++|+.
T Consensus       234 ~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11234455677889999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=363.70  Aligned_cols=201  Identities=31%  Similarity=0.565  Sum_probs=181.3

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ..+|.+.+.||+|+||+||+|+++ ++.+||||.+.+.  ..+..+.+..|+++|+.++|||||++++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357888899999999999999986 5899999999776  5556678899999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC------CCceeeccccc
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE------LNPKISDFGMA  630 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~------~~~kL~DFGla  630 (807)
                      |||.+|+|.++|+   +.+.+++.....++.|||.||++||+++   ||||||||.||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999995   4558999999999999999999999999   9999999999999865      35899999999


Q ss_pred             cccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccC
Q 003628          631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE  689 (807)
Q Consensus       631 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~  689 (807)
                      |.+..   .......+|++.|||||+++..+|+.|+|+||+|++|||+++|+.||....
T Consensus       163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            98753   233445799999999999999999999999999999999999999997543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=378.84  Aligned_cols=253  Identities=33%  Similarity=0.513  Sum_probs=212.5

Q ss_pred             CcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      +.+.+.||+|.||.|+.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++..+||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            4557899999999999999998889999999654 445688999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcccc
Q 003628          563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT  642 (807)
Q Consensus       563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  642 (807)
                      +|.++|.. ..+..++..+.+.++.|||+||+||++++   +|||||.++||||+++..+||+||||||....+......
T Consensus       287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~  362 (468)
T KOG0197|consen  287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE  362 (468)
T ss_pred             cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence            99999976 35678999999999999999999999998   999999999999999999999999999965544433222


Q ss_pred             ceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       643 ~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                       ...-+..|.|||.+..+.|+.|||||||||+||||+| |+.|+........+.     .+..|.       ++   +.+
T Consensus       363 -~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~-----~le~Gy-------Rl---p~P  426 (468)
T KOG0197|consen  363 -GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-----LLERGY-------RL---PRP  426 (468)
T ss_pred             -CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH-----HHhccC-------cC---CCC
Confidence             2344678999999999999999999999999999999 677766544332221     111111       11   144


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      ..++.++-+|+..||+.+|++|||++.+...|+..
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            55678899999999999999999999999988776

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-43  Score=360.80  Aligned_cols=253  Identities=24%  Similarity=0.335  Sum_probs=204.4

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc-------cHHHHHHHHHHHHhccCCceeEEeeEEEeCC
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGE  550 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  550 (807)
                      ..+.|.+.+.||+|+||.|-+|..+ +|+.||||++++....       ......+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3456888999999999999999865 6999999999764211       1233579999999999999999999999999


Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC---CCceeecc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDF  627 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~---~~~kL~DF  627 (807)
                      ..|+|||||+||.|-+.+..   .+.+.+..-..++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999998853   456777777889999999999999999   9999999999999766   77999999


Q ss_pred             ccccccCCCCCccccceeeccCCccChhhhccCCC---CcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc
Q 003628          628 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF---SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE  704 (807)
Q Consensus       628 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~  704 (807)
                      |+|+..+..   ..+...+||+.|.|||++.++.+   ..+.|+||+|||||-+++|.+||.....+..+....    ..
T Consensus       324 GlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI----~~  396 (475)
T KOG0615|consen  324 GLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI----LK  396 (475)
T ss_pred             chhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH----hc
Confidence            999987632   23445899999999999987653   347899999999999999999997544333222111    11


Q ss_pred             cccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          705 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       705 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ++..       -.+....+..++.+++|.++|..||++|||+.|+++
T Consensus       397 G~y~-------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  397 GRYA-------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             Cccc-------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            1110       011233456788999999999999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-43  Score=347.64  Aligned_cols=259  Identities=24%  Similarity=0.391  Sum_probs=211.6

Q ss_pred             cCCcccCccccCCCccEEEEE-ecCCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEee-EEEeCCe-EEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLG-CCVEGEE-KMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV  555 (807)
                      .+|++.++||+|.||+|||+. +.+|..+|.|.+.-.  ..+..+....|+.+|++|+|||||++++ .+.++.. .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            458888999999999999997 458999999998632  4455678999999999999999999999 4445444 7899


Q ss_pred             EEecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCC-CcEEeCCCCCCCeeecCCCCceeecccccccc
Q 003628          556 YEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSR-LRIIHRDLKASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~  633 (807)
                      |||+.+|+|..++...+ .++.+++..+++++.|+++||+++|..-+ .-|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999997633 45679999999999999999999998421 23999999999999999999999999999998


Q ss_pred             CCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          634 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       634 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      .......  ...+|||.||+||.+.+..|+.|+||||+||++|||..-++||...    .+.+...++ ..+..      
T Consensus       179 ~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI-~qgd~------  245 (375)
T KOG0591|consen  179 SSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKI-EQGDY------  245 (375)
T ss_pred             cchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHH-HcCCC------
Confidence            7654433  3478999999999999999999999999999999999999999754    333322221 11211      


Q ss_pred             cccCCccc-HHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          714 FLSESSFQ-LDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       714 ~l~~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                          ++.+ ......+..|+..|+..||+.||+...+++.+...
T Consensus       246 ----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  246 ----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             ----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence                1122 45678889999999999999999977776666554

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8.9e-42  Score=383.95  Aligned_cols=262  Identities=30%  Similarity=0.473  Sum_probs=219.1

Q ss_pred             cCCcccCccccCCCccEEEEEec------CCcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  553 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  553 (807)
                      .+....+.||+|+||.||+|+..      +.+.||||.+++.... ..++|.+|+++|+.++|||||+|+|.|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            45566789999999999999853      3467999999877655 7889999999999999999999999999999999


Q ss_pred             EEEEecCCCCccccccCCC-------C----CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCc
Q 003628          554 LIYEYMPNRSLDALLFDPL-------K----KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  622 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~  622 (807)
                      +|+|||..|+|.+||....       .    ..+++..+.+.||.|||.||.||-++.   +|||||..+|+||.++..+
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            9999999999999995311       1    234888999999999999999999987   9999999999999999999


Q ss_pred             eeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhh
Q 003628          623 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  701 (807)
Q Consensus       623 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~  701 (807)
                      ||+|||++|...............-...|||||.++.++||++||||||||||||++| |+.|+....++..+.     .
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe-----~  717 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE-----C  717 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH-----H
Confidence            9999999997765554433323345789999999999999999999999999999998 888887655443221     2


Q ss_pred             ccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCC
Q 003628          702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  760 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~  760 (807)
                      ...+++          -+.+.+.+.++..|++.||+.+|++||+++||-..|+......
T Consensus       718 i~~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  718 IRAGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             HHcCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            223322          1256677889999999999999999999999999998864433

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=349.83  Aligned_cols=242  Identities=26%  Similarity=0.341  Sum_probs=203.3

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      .++|++.+.||+|+||.||.++.+ .++.+|+|++++.   ...+.+..++|..+|.+++||.||+++..|++.+..|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            468999999999999999999866 5889999999875   234567889999999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      +||+.||.|..+|.   +.+.+++..+.-++.+|+.||.|||+.+   ||||||||+|||||.+|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999994   4578999989999999999999999999   99999999999999999999999999996543


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ..  ..+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+......    +.....         +
T Consensus       178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~----~I~~~k---------~  242 (357)
T KOG0598|consen  178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD----KILKGK---------L  242 (357)
T ss_pred             CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH----HHhcCc---------C
Confidence            32  33444899999999999999999999999999999999999999997544222111    111111         1


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCC
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRP  744 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RP  744 (807)
                      ..  .+.-...+..+++...++.||++|-
T Consensus       243 ~~--~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 PL--PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CC--CCccCCHHHHHHHHHHhccCHHHhc
Confidence            10  1112446678899999999999995

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=370.48  Aligned_cols=269  Identities=28%  Similarity=0.459  Sum_probs=221.5

Q ss_pred             cCHHHHHHHhc---------CCcccCccccCCCccEEEEEecC----CcEEEEEEecccC-cccHHHHHHHHHHHHhccC
Q 003628          471 FQFEELATATN---------NFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQH  536 (807)
Q Consensus       471 f~~~~l~~~~~---------~~~~~~~LG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H  536 (807)
                      ++|++...|..         ...+.++||.|.||.|++|+++-    ...||||.++... +....+|+.|+.||.++.|
T Consensus       610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH  689 (996)
T KOG0196|consen  610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH  689 (996)
T ss_pred             ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence            56665544443         34677899999999999999862    3569999998653 4456789999999999999


Q ss_pred             CceeEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeee
Q 003628          537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL  616 (807)
Q Consensus       537 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll  616 (807)
                      |||++|.|........+||.|||++|+|+.||..  +.+.+++.++.-++++||.||.||.+.+   +|||||.++||||
T Consensus       690 PNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILV  764 (996)
T KOG0196|consen  690 PNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILV  764 (996)
T ss_pred             CcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheee
Confidence            9999999999999999999999999999999965  4577999999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeccccccccCCCCCccccce-eeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchh
Q 003628          617 DEELNPKISDFGMAKIFGGNQDQADTGR-VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTI  694 (807)
Q Consensus       617 ~~~~~~kL~DFGla~~~~~~~~~~~~~~-~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l  694 (807)
                      +.+..+||+|||++|.+..+.....+.. -.=...|.|||.+...++|.++|||||||||||.++ |.+|+=...+++. 
T Consensus       765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-  843 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-  843 (996)
T ss_pred             ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-
Confidence            9999999999999998765553222211 122568999999999999999999999999999887 8888743332222 


Q ss_pred             hhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCC
Q 003628          695 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  759 (807)
Q Consensus       695 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~  759 (807)
                                   ...++....- +-+++++..|.+|++.|||+|-.+||.+.+|+.+|++.++.
T Consensus       844 -------------IkaIe~gyRL-PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  844 -------------IKAIEQGYRL-PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             -------------HHHHHhccCC-CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                         1222222211 25677889999999999999999999999999999998764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=352.45  Aligned_cols=254  Identities=29%  Similarity=0.387  Sum_probs=214.1

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeE
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  552 (807)
                      ...++|...+.||+|+|++|++|+.. .+++||||++.+.   .++..+-...|-.+|.+| .||.|++|+.-|.++...
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34468999999999999999999865 5899999999764   233445677899999999 899999999999999999


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      |+|+||+++|+|.++|.   +-+.+++.....++.+|+.||+|||+.|   ||||||||+|||||+++++||+|||.|+.
T Consensus       150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999995   4578999999999999999999999999   99999999999999999999999999999


Q ss_pred             cCCCCCc---------ccc--ceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh
Q 003628          633 FGGNQDQ---------ADT--GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL  701 (807)
Q Consensus       633 ~~~~~~~---------~~~--~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~  701 (807)
                      +...+..         ...  ..++||..|.+||++..+..++.+|+|+||||||+|+.|++||....+-..+...    
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI----  299 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI----  299 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH----
Confidence            8653322         112  4489999999999999999999999999999999999999999865543222111    


Q ss_pred             ccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                            ++ ++-     .++...+..+.+|+.+.|..||.+|+|..+|.+..
T Consensus       300 ------~~-l~y-----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  300 ------QA-LDY-----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ------HH-hcc-----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                  11 111     14444557788999999999999999999998765

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=359.17  Aligned_cols=269  Identities=29%  Similarity=0.470  Sum_probs=215.9

Q ss_pred             HHHHHHhcCCcccCccccCCCccEEEEEecCCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCe
Q 003628          474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  551 (807)
Q Consensus       474 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  551 (807)
                      ++.....+.+.+.+.||+|.||+||+|++.  ..||||++...  ..+..+.|++|+..+++-+|.||+-++|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            344444566778899999999999999986  46999999754  34456889999999999999999999999998877


Q ss_pred             EEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                       .||..+|+|.+|+.+|+..  ...++..+...|++|||+||.|||.++   |||||||.+||+|.+++.+||+||||+.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence             9999999999999999763  467889999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCccccceeeccCCccChhhhcc---CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccc
Q 003628          632 IFGGNQDQADTGRVVGTFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  708 (807)
Q Consensus       632 ~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~  708 (807)
                      .-..-.-........|...|||||+++.   .+|+..+||||||+|+|||++|..|+.....++.+..       -++-.
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-------VGrG~  609 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-------VGRGY  609 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-------ecccc
Confidence            6543322222223457889999999974   3699999999999999999999999983222322211       11111


Q ss_pred             cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCCC
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP  761 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~  761 (807)
                      -..|...    ...+...++.+|...||.+++++||.+.+|+.+|+.++..+|
T Consensus       610 l~pd~s~----~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p  658 (678)
T KOG0193|consen  610 LMPDLSK----IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP  658 (678)
T ss_pred             cCccchh----hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence            1122222    223456788899999999999999999999999988865544

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.9e-40  Score=360.00  Aligned_cols=262  Identities=28%  Similarity=0.407  Sum_probs=206.0

Q ss_pred             hcCCcccCccccCCCccEEEEEe------cCCcEEEEEEecccCc-ccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCC-
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE-  550 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-  550 (807)
                      .++|++.++||+|+||.||+|..      .++..||||++..... ...+.+.+|+.++.++ +||||+++++++.... 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46789999999999999999974      2356799999975432 3346799999999999 8999999999887644 


Q ss_pred             eEEEEEEecCCCCccccccCCCC---------------------------------------------------------
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLK---------------------------------------------------------  573 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  573 (807)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999988854211                                                         


Q ss_pred             --CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccceeeccCCc
Q 003628          574 --KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY  651 (807)
Q Consensus       574 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y  651 (807)
                        ...+++.++.+++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134778888999999999999999988   999999999999999999999999999865433322222334567889


Q ss_pred             cChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHH
Q 003628          652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIH  730 (807)
Q Consensus       652 ~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~  730 (807)
                      +|||++.+..++.++||||||++||||++ |..||........+..    ....+..     ..     .+......+.+
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~----~~~~~~~-----~~-----~~~~~~~~l~~  308 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ----RLKDGTR-----MR-----APENATPEIYR  308 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH----HHhcCCC-----CC-----CCCCCCHHHHH
Confidence            99999999999999999999999999997 9999875432221111    1111110     11     11223456889


Q ss_pred             HHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          731 VGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       731 li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                      ++.+|++.||++|||+.||+++|+.++.
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.5e-40  Score=329.01  Aligned_cols=262  Identities=20%  Similarity=0.299  Sum_probs=206.5

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc--cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      +.|+...++|+|+||.|||++.+ +|+.||||++....+.  -.+-.++|+++|++++|+|+|.++..|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45777889999999999999987 4999999999765432  23557899999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |++..-|+++-.   ....++...+.+++.|+++|+.|+|+++   ++||||||+||||+.++.+||||||+||.+....
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            999876665542   3346888899999999999999999998   9999999999999999999999999999886422


Q ss_pred             CccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh----------hcccc-
Q 003628          638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK----------LWNEN-  705 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~----------~~~~~-  705 (807)
                        ...+..+.|..|.|||.+.+ .+|....||||+||++.||++|.+-|...++-+.+......          ++... 
T Consensus       156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence              22333678999999999987 67999999999999999999999988876654443322211          11111 


Q ss_pred             c-----cccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          706 K-----ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       706 ~-----~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .     +.+.-++.-.+. --.....-++++++.|++.||++|++-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~-k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLER-KYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhh-hcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1     111111111111 11233457889999999999999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-39  Score=338.40  Aligned_cols=282  Identities=22%  Similarity=0.335  Sum_probs=215.2

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  555 (807)
                      +.|+.+++||+|.||.||+|+.. +|+.||+|+++...  +....-..+|+.||++|+||||++|.+...+.  ...|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            45777889999999999999854 68999999998654  33345668999999999999999999998876  689999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      +|||++ +|.-++..  ..-.++..++..++.|++.||.|+|..+   |+|||||.+|||||.+|.+||+|||||+++..
T Consensus       197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence            999987 78777743  3457999999999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhh-------hhcccccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW-------KLWNENKI  707 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~-------~~~~~~~~  707 (807)
                      ......+. .+-|..|.|||++.+. .|+.+.|+||.||||.||+.|++.+....+-..+.....       ..|...++
T Consensus       271 ~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  271 SGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            66555454 3459999999999876 599999999999999999999998877655433332211       11221111


Q ss_pred             c--cccCccccCCc----ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCCCCCCCCCcccC
Q 003628          708 L--ALVDPFLSESS----FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTER  771 (807)
Q Consensus       708 ~--~~~d~~l~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~~p~~p~~~~~  771 (807)
                      .  ..+.+.-.-..    .-.......++|+..+|..||.+|.|+.++++.=  -+..-|.|..|...+.
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se--yF~t~p~~~~p~~Lp~  417 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE--YFTTEPLPCDPSSLPK  417 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc--ccccCCCCCCcccCCC
Confidence            1  11111111000    1112345778899999999999999999987532  1233455555555544

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=342.19  Aligned_cols=255  Identities=29%  Similarity=0.435  Sum_probs=204.6

Q ss_pred             cCCcccCccccCCCccEEEEEecC-CcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCC--eEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE--EKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E  557 (807)
                      .++...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|......  ..+++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            457778999999999999999764 8999999987653333677999999999999999999999855444  6889999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC-CCCceeeccccccccCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kL~DFGla~~~~~~  636 (807)
                      |+++|+|.+++.+.  +..+++..+.++++||++||.|||+++   |+||||||+||||+. ++.+||+|||+++.....
T Consensus        97 y~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999653  227999999999999999999999998   999999999999999 799999999999876541


Q ss_pred             -CCccccceeeccCCccChhhhccCC-CCcccceeehhHHHHHHHhCCCCCCcc-CCcchhhhhhhhhccccccccccCc
Q 003628          637 -QDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFF-EDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       637 -~~~~~~~~~~gt~~y~APE~~~~~~-~t~k~DvwSlGvvl~elltG~~p~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                       ..........||+.|||||++..+. ...++||||+||++.||+||++||... .....+.    ......     ..|
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~----~ig~~~-----~~P  242 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL----LIGRED-----SLP  242 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH----HHhccC-----CCC
Confidence             1112233478999999999999643 335999999999999999999998753 1111111    111111     111


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                           ..+.....+..+++..|++.+|++|||++++++..-
T Consensus       243 -----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  243 -----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             -----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence                 234445677889999999999999999999998763

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-39  Score=344.73  Aligned_cols=279  Identities=24%  Similarity=0.362  Sum_probs=230.1

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.  .+++.+.+.+|++|+++++||||+.+++.|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999876 5788999999765  34456789999999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+.+ +|..+|.   ..+.++++.+..|+.+++.||.|||+.+   |+|||+||.||||+.++.+|++|||+||.+..+ 
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9987 9999995   4578999999999999999999999998   999999999999999999999999999987543 


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                       ......+.||+.|||||+..+.+|+..+|+||+||++||+.+|++||....    +......+..+.        .   
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----i~~Lv~~I~~d~--------v---  217 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS----ITQLVKSILKDP--------V---  217 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----HHHHHHHHhcCC--------C---
Confidence             233445789999999999999999999999999999999999999985322    112222222111        1   


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH--HHhhccCCCCCCCCCCcccCCCCCCchhHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS--MLNSEIRDLPYPKEPAFTERQGADDSESFKQIQ  784 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~--~L~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~  784 (807)
                       ..+.+....+.+++...++.||..|-|-.+++.  ..++.+.....|..+++..-.....++..++..
T Consensus       218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn~~Ppe~kek~  285 (808)
T KOG0597|consen  218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTNNTPPEYKEKD  285 (808)
T ss_pred             -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccccCCChHHHHhh
Confidence             123356678899999999999999999999874  456666667777777776655555555555543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=347.34  Aligned_cols=249  Identities=28%  Similarity=0.431  Sum_probs=211.5

Q ss_pred             CCcccCccccCCCccEEEEEe-cCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          482 NFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      .|...++||+|+.|.||.++. .+++.||||++........+-+++|+.+|+..+|+|||+++..+...++.++|||||+
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            466678999999999999975 4688999999987766667888999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +|+|.+.+    ....+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+...+.. 
T Consensus       354 ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-  425 (550)
T KOG0578|consen  354 GGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-  425 (550)
T ss_pred             CCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc-
Confidence            99999998    4456999999999999999999999999   999999999999999999999999999987665543 


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  720 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  720 (807)
                       ...++||+.|||||+.....|++|.||||||++++||+-|++||-....-..+    +.+...+      .|.+.   .
T Consensus       426 -R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl----yLIa~ng------~P~lk---~  491 (550)
T KOG0578|consen  426 -RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLIATNG------TPKLK---N  491 (550)
T ss_pred             -cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH----HHHhhcC------CCCcC---C
Confidence             33479999999999999999999999999999999999999998642221111    1111111      22222   3


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          721 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       721 ~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      +......+.++..+||+.|+++||++.|+++.
T Consensus       492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            44566788999999999999999999999863

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=340.71  Aligned_cols=263  Identities=27%  Similarity=0.438  Sum_probs=217.9

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCccc-HHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      ....+.++||+|.||.|.++....+..||||+++...... ..+|.+|+++|.+++||||++++|.|..++..++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            3466789999999999999999888999999998765544 489999999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++|+|.++|.... .+.+......+|+.||+.||+||.+..   +|||||.++|+|++.++++||+|||++|-+......
T Consensus       618 EnGDLnqFl~ahe-apt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHE-LPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hcCcHHHHHHhcc-CcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999996542 233566677889999999999999988   999999999999999999999999999977666666


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh--CCCCCCccCCcchhhhhhhhhcccccc-ccccCcccc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS--GRKNTSFFEDDLTILGYAWKLWNENKI-LALVDPFLS  716 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt--G~~p~~~~~~~~~l~~~~~~~~~~~~~-~~~~d~~l~  716 (807)
                      ....+.+-+..|||||.+..+++|.++|||+||+++||+++  ...|+....+++...+. ......+.. .-+.     
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~-~~~~~~~~~~~~l~-----  767 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA-GEFFRDQGRQVVLS-----  767 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh-hhhcCCCCcceecc-----
Confidence            66666778899999999999999999999999999999876  56787765554433322 222222211 1111     


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                         .+.-++.++.++++.||..|.++||+++++...|...
T Consensus       768 ---~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  768 ---RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence               2233456788999999999999999999999998764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-39  Score=333.30  Aligned_cols=263  Identities=24%  Similarity=0.349  Sum_probs=210.0

Q ss_pred             hcCCcccCccccCCCccEEEEEe-cCCcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      .+.|++.+.||.|..++||+|+. +.+..||||++.-... ...+.+.+|+..|..++||||++++..|..+...++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46799999999999999999985 4679999999975432 336889999999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      ||.+||+.+++.... ...+++..+..|++++++||.|||++|   .||||||+.||||+++|.+||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999997643 334899999999999999999999999   9999999999999999999999999777654332


Q ss_pred             Ccc--ccceeeccCCccChhhhccC--CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          638 DQA--DTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       638 ~~~--~~~~~~gt~~y~APE~~~~~--~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ...  ....++||+.|||||+++..  -|+.|+|||||||+..||++|..||..+..-..+..-..     +...... .
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq-----n~pp~~~-t  254 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ-----NDPPTLL-T  254 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-----CCCCCcc-c
Confidence            211  11457899999999996543  489999999999999999999999986654333221110     1110011 1


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ..............+.+++..||+.||.+|||++++++.
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            111111333445688899999999999999999999853

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.3e-38  Score=342.00  Aligned_cols=263  Identities=28%  Similarity=0.438  Sum_probs=202.6

Q ss_pred             cCCcccCccccCCCccEEEEEecC-----------------CcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-----------------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRL  542 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  542 (807)
                      ++|.+.++||+|+||.||++.+.+                 +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997532                 3369999987643 3345679999999999999999999


Q ss_pred             eeEEEeCCeEEEEEEecCCCCccccccCCC----------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEe
Q 003628          543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPL----------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH  606 (807)
Q Consensus       543 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  606 (807)
                      ++++.+.+..++||||+++++|.+++....                ....+++..+.+++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999885321                1134678889999999999999999998   999


Q ss_pred             CCCCCCCeeecCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhC--CCC
Q 003628          607 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG--RKN  684 (807)
Q Consensus       607 ~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG--~~p  684 (807)
                      |||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999865433322223334567899999999999999999999999999999975  455


Q ss_pred             CCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          685 TSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       685 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      +........+ ............ .. .  .   ..+...+..+.+++.+|++.+|++|||+.+|++.|+
T Consensus       242 ~~~~~~~~~~-~~~~~~~~~~~~-~~-~--~---~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQVI-ENAGEFFRDQGR-QV-Y--L---FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHHHH-HHHHHHhhhccc-cc-c--c---cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            5543322211 111111111100 00 0  0   011223457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-40  Score=344.05  Aligned_cols=266  Identities=25%  Similarity=0.356  Sum_probs=211.1

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHH--HHHHHHHHHhcc-CCceeEEeeEEEeCC-eE
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE--FMNEVMVISKLQ-HRNLVRLLGCCVEGE-EK  552 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~  552 (807)
                      ...++|.+.++||.|.||+||+|+-. .|..||||++++.-.. +++  =++|+..|++|+ ||||++|...+.+.+ ..
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            34578999999999999999999865 6889999999765333 333  368999999998 999999999999988 99


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++|||||+. +|.+++.++  +..+++.++..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+||.
T Consensus        86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            999999965 999999764  678999999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCccccceeeccCCccChhhhc-cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhh-------hhccc
Q 003628          633 FGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW-------KLWNE  704 (807)
Q Consensus       633 ~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~-------~~~~~  704 (807)
                      .......   +..+.|..|.|||++. .+.|+.+.|+|++|||++|+.+-++-|...++-+.+.....       ..|.+
T Consensus       160 v~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  160 VRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            7654433   3467899999999874 66799999999999999999999998877665443322211       11111


Q ss_pred             c-ccccccC---ccccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          705 N-KILALVD---PFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       705 ~-~~~~~~d---~~l~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      + .+...+.   |.....   ..-.....++++++.+|+..||.+|||+.+.+++-
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            1 1111111   111111   01123567899999999999999999999998764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.7e-38  Score=311.31  Aligned_cols=283  Identities=22%  Similarity=0.334  Sum_probs=217.6

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc-c-HHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-G-LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      .+|...++||+|.||.||+|+.. +|+.||||+++..... + .....+|++.|+.++|+||+.+++.|-+.+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46777899999999999999864 6999999999754222 2 3567899999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      ||+- +|+..+.+  +...++..++..++.++++|++|+|.+.   |+||||||+|+|++++|.+||+|||+|+.++...
T Consensus        82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9965 89999966  4567999999999999999999999998   9999999999999999999999999999987654


Q ss_pred             CccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhc--cccc---ccccc
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW--NENK---ILALV  711 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~--~~~~---~~~~~  711 (807)
                      .....  .+-|..|.|||.+.+. .|+...|+||.|||+.||+-|.+-+....+-+.+......+-  .+.+   +.++.
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            43332  2679999999999876 499999999999999999999877665554333322221110  0000   11111


Q ss_pred             --------CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCCCCCCCCCcccCCCC
Q 003628          712 --------DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGA  774 (807)
Q Consensus       712 --------d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~~p~~p~~~~~~~~  774 (807)
                              .+..... .-.......++++..++.+||.+|.|+.|.+++=  -+..+|.|..|...+....
T Consensus       234 dY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~--yf~~~P~pt~~~~lp~p~~  301 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP--YFKSLPLPTPPSKLPIPST  301 (318)
T ss_pred             cHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcch--hhhcCCCCCChhhCcCCcc
Confidence                    1111111 1223345668999999999999999999998764  2245666666655554443

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=373.56  Aligned_cols=260  Identities=32%  Similarity=0.495  Sum_probs=215.1

Q ss_pred             CCcccCccccCCCccEEEEEecC--Cc----EEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLKD--GQ----EIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~~--g~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      +....+.||+|.||.||.|...+  |.    .||||.+.+. +.+...+|++|..+|++++|||||+++|.|.+....+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            34567889999999999998753  33    4999999875 45667899999999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCC----CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccc
Q 003628          555 IYEYMPNRSLDALLFDPL----KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla  630 (807)
                      ++|||++|+|..+|.+.+    ....++..+++.++.+||+|+.||+++.   +|||||..+|+||++...+||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence            999999999999997642    2346889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhcccccccc
Q 003628          631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILA  709 (807)
Q Consensus       631 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~  709 (807)
                      |.+..........+..-...|||||.+..+.|+.|+|||||||+|||++| |..|+...++.+.+..+    ...+    
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~----~~gg----  921 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV----LEGG----  921 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH----HhCC----
Confidence            96655544444433344578999999999999999999999999999999 66787655544332211    1122    


Q ss_pred             ccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCC
Q 003628          710 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  759 (807)
Q Consensus       710 ~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~  759 (807)
                          ++.   .+..++..+.+|+..||+.+|++||++..|++.+..++..
T Consensus       922 ----RL~---~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  922 ----RLD---PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ----ccC---CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                222   3445677888999999999999999999999998776543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.6e-38  Score=336.06  Aligned_cols=244  Identities=19%  Similarity=0.308  Sum_probs=198.7

Q ss_pred             CccccCCCccEEEEEecCCcEEEEEEecccCccc---HHHHHHHHHHHHhccCCceeEEeeEEEe----CCeEEEEEEec
Q 003628          487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEKMLIYEYM  559 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~  559 (807)
                      ..||+|++|.||+|++ +|+.||||.++......   .+.|.+|+.+|.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 58899999997654333   4778899999999999999999999877    34678999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhc-CCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      ++|+|.+++..   ...+++....+++.+++.||.|||+. +   ++||||||+||++++++.+||+|||+++.+.... 
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999954   35688999999999999999999985 5   7899999999999999999999999998654321 


Q ss_pred             ccccceeeccCCccChhhhcc--CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          639 QADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~--~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                          ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.......... .   ....+     ..+.  
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~-~---i~~~~-----~~~~--  242 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD-L---IINKN-----NSLK--  242 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH-H---HHhcC-----CCCC--
Confidence                12457899999999976  679999999999999999999999997543221111 1   10000     0011  


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                         .+...+.++.+++.+||+.||++|||+.||++.|+..
T Consensus       243 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        243 ---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             ---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence               2223456788999999999999999999999999764

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.5e-38  Score=351.59  Aligned_cols=260  Identities=27%  Similarity=0.379  Sum_probs=205.5

Q ss_pred             hcCCcccCccccCCCccEEEEEe------cCCcEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCe
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE  551 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  551 (807)
                      .++|++.+.||+|+||.||+|+.      ..+..||||+++... ....+.+.+|+.++..+ +||||++++++|.++..
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35788899999999999999963      235689999996543 33456789999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCccccccCCCC----------------------------------------------------------
Q 003628          552 KMLIYEYMPNRSLDALLFDPLK----------------------------------------------------------  573 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  573 (807)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999988854210                                                          


Q ss_pred             --------------CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          574 --------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       574 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                                    ...+++..+.+++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788889999999999999999988   999999999999999999999999999876443322


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.............    ..+..     +.    
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~----~~~~~-----~~----  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI----KEGYR-----ML----  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH----HhCcc-----CC----
Confidence            22222345678999999999999999999999999999998 888876443322222111    11100     00    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                       .+...+.++.+++.+|++.||++||++.||+++|++.
T Consensus       338 -~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 -SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             1111245788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=343.72  Aligned_cols=240  Identities=28%  Similarity=0.428  Sum_probs=201.5

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCcc
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD  565 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  565 (807)
                      ++-||+|+.|.||+|++. ++.||||+++.-.       ..+++-|++|+|+||+.+.|+|.....++||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            467999999999999998 6899999985322       25788899999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcccccee
Q 003628          566 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV  645 (807)
Q Consensus       566 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  645 (807)
                      +.|.   .+..+.......+..+||.||.|||.+.   |||||||.-||||..+..+||+|||.++.....   ...-.+
T Consensus       201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF  271 (904)
T KOG4721|consen  201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF  271 (904)
T ss_pred             HHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence            9994   4567888888999999999999999998   999999999999999999999999999876443   222347


Q ss_pred             eccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHH
Q 003628          646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMI  725 (807)
Q Consensus       646 ~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  725 (807)
                      +||..|||||++.+.+.+.|.||||||||||||+||..|+...+....+.+.       +      ...+ .-+.+..++
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV-------G------sNsL-~LpvPstcP  337 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV-------G------SNSL-HLPVPSTCP  337 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec-------c------CCcc-cccCcccCc
Confidence            8999999999999999999999999999999999999998654432221111       1      0111 112455566


Q ss_pred             HHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          726 IRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       726 ~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      .-+.-|+++||+..|.+||++++|+..|+-.
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            7788899999999999999999999999544

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=349.32  Aligned_cols=260  Identities=32%  Similarity=0.418  Sum_probs=207.7

Q ss_pred             cCCcccCccccCCCccEEEEEecC--C---cEEEEEEecc---cCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD--G---QEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~--g---~~vAvK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  552 (807)
                      ++..+.++||+|+||.||+|++..  +   ..||||..+.   .......+|++|+++|++++|||||+++|++......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            445556899999999999998763  2   2389999874   3456678999999999999999999999999999999


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++|||+|+||+|+++|...  ...++..++.+++.+.|+||+|||+++   ++||||.++|+|++.++.+||+|||+++.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence            9999999999999999652  336999999999999999999999998   99999999999999999999999999885


Q ss_pred             cCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          633 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       633 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      -.  ..........-+..|+|||.+..+.|+.++|||||||++||+++ |..|+......... ..+   ...+      
T Consensus       312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~-~kI---~~~~------  379 (474)
T KOG0194|consen  312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK-AKI---VKNG------  379 (474)
T ss_pred             Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH-HHH---HhcC------
Confidence            32  11111111234679999999999999999999999999999998 78887654322111 110   0111      


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCCC
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP  761 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~  761 (807)
                       -++.   .+...+.++..++.+|+..+|++||+|.+|.+.|+.+.....
T Consensus       380 -~r~~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  380 -YRMP---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             -ccCC---CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence             1111   222446677788889999999999999999999988754443

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=342.57  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=205.7

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc----Cc-ccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCC
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA----SG-QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGE  550 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  550 (807)
                      ...++|.+.+.||+|+||+|+.|... ++..||+|++.+.    .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34568999999999999999999765 6899999977653    12 23456778999999998 999999999999999


Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC-CCceeecccc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGM  629 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kL~DFGl  629 (807)
                      ..++||||+.+|+|.+++.+   .+++.+.+..++++|++.|++|+|+.+   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999953   567888999999999999999999999   9999999999999999 9999999999


Q ss_pred             ccccCCCCCccccceeeccCCccChhhhccCC-CC-cccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccc
Q 003628          630 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-FS-EKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI  707 (807)
Q Consensus       630 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t-~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~  707 (807)
                      +....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+..    ....... .+. 
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----~l~~ki~-~~~-  239 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----NLYRKIR-KGE-  239 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----HHHHHHh-cCC-
Confidence            99874  1222334478999999999999877 76 6899999999999999999999752221    1111111 110 


Q ss_pred             ccccCccccCCcccHHH-HHHHHHHHHhcccCCcCCCCCHHHHH
Q 003628          708 LALVDPFLSESSFQLDM-IIRCIHVGLLCVQELVKDRPNMSTVV  750 (807)
Q Consensus       708 ~~~~d~~l~~~~~~~~~-~~~l~~li~~Cl~~dP~~RPt~~ev~  750 (807)
                             .   .++... ..++..++.+|+..||.+|+|+.+|+
T Consensus       240 -------~---~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  240 -------F---KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             -------c---cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                   0   122222 56788999999999999999999998

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.3e-38  Score=350.41  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=205.6

Q ss_pred             hcCCcccCccccCCCccEEEEEec------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCe
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE  551 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  551 (807)
                      .++|.+.+.||+|+||.||+++..      ++..||||+++... ....+.+.+|+.+++.+ +|+||++++++|.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457889999999999999998742      24579999997543 23356788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCccccccCCC-----------------------------------------------------------
Q 003628          552 KMLIYEYMPNRSLDALLFDPL-----------------------------------------------------------  572 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  572 (807)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999998874321                                                           


Q ss_pred             --------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccce
Q 003628          573 --------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  644 (807)
Q Consensus       573 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  644 (807)
                              ...++++.++.+++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124778889999999999999999988   99999999999999999999999999986543322222222


Q ss_pred             eeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHH
Q 003628          645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLD  723 (807)
Q Consensus       645 ~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  723 (807)
                      ..++..|+|||++....++.++||||||+++|||++ |+.||..............    .+     ..+.     .+..
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~----~~-----~~~~-----~~~~  339 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK----RG-----YQMS-----RPDF  339 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH----cc-----cCcc-----CCCC
Confidence            345678999999999999999999999999999997 9999865433222211111    10     0000     1111


Q ss_pred             HHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          724 MIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       724 ~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                      .+.++.+++.+|++.||++|||+.+|+++|++++
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            2457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3e-37  Score=384.36  Aligned_cols=263  Identities=24%  Similarity=0.458  Sum_probs=214.4

Q ss_pred             HhcCCcccCccccCCCccEEEEEe-cCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ....+...+.||+|+||.||+|+. .++..||||++......    ...|++++++++|||||+++|+|.+....++|||
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            345677788999999999999997 47899999998654322    2356889999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++|+|.+++.      .++|.++.+|+.||++||+|||+...++|+||||||+||+++.++..++. ||........ 
T Consensus       764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            999999999984      38899999999999999999997655669999999999999999988876 6665433211 


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccC-CcchhhhhhhhhccccccccccCcccc
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE-DDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                           ....+|+.|+|||++.+..++.++|||||||++|||+||+.|+.... ....+..|+............+|+.+.
T Consensus       836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence                 12367899999999999999999999999999999999999985432 233455555554444555566676664


Q ss_pred             CC-cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          717 ES-SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       717 ~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                      .. ..+.+...++.+++.+|++.+|++||||+||+++|++..+
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            32 2455677889999999999999999999999999988744

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-37  Score=332.57  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=202.0

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      .|+..+.||+|+||.||++... +++.||||.+.+..   ......+.+|+.++.+++|+||+++++.+.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677899999999999999864 68999999986532   2234568899999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++|+|..++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999998887542 2346889999999999999999999998   9999999999999999999999999998653322


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      .   .....||..|+|||++.+..++.++|||||||++|||++|+.||............... ..        ....  
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~--------~~~~--  222 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-VK--------EDQE--  222 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-hh--------cccc--
Confidence            1   12346899999999999999999999999999999999999999754332111111100 00        0000  


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVSM  752 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~ev~~~  752 (807)
                       ..+.....++.+++.+||+.||++||+     ++++++.
T Consensus       223 -~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         223 -EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence             122334567889999999999999997     7887763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=329.88  Aligned_cols=267  Identities=27%  Similarity=0.385  Sum_probs=210.2

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHh--ccCCceeEEeeEEEeCC----eEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK--LQHRNLVRLLGCCVEGE----EKML  554 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~l  554 (807)
                      ....+.+.||+|.||.||||++. ++.||||++..   +..+.|.+|-+|...  ++|+||+++++.-..++    ++.|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            44566789999999999999998 49999999953   556788899888775  48999999999977665    8899


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhc------CCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD------SRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                      |+||.+.|+|.++|    +...++|.+..+|+..+++||+|||+.      .+++|+|||||++||||.+++++.|+|||
T Consensus       286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            99999999999999    556899999999999999999999975      35689999999999999999999999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccCC-CC-----cccceeehhHHHHHHHhCCCCCCccC--C----------
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-FS-----EKSDVFSFGVLLLEIVSGRKNTSFFE--D----------  690 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t-----~k~DvwSlGvvl~elltG~~p~~~~~--~----------  690 (807)
                      +|..+........+...+||..|||||++.+.- +.     .+.||||+|.|||||++.........  +          
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            999998766666665689999999999997542 22     26899999999999999875442110  0          


Q ss_pred             -cchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCC
Q 003628          691 -DLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  760 (807)
Q Consensus       691 -~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~  760 (807)
                       ...+..+ +    +-.+.+...|.+.........+.-+.+.+..||..||+.|-|+.=|-+.+.++....
T Consensus       442 ~hPt~e~m-q----~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  442 NHPTLEEM-Q----ELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CCCCHHHH-H----HHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence             1111111 1    112233334444333233345677889999999999999999999988887764333

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-38  Score=310.62  Aligned_cols=236  Identities=29%  Similarity=0.366  Sum_probs=201.6

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|++.+..   -...+...+|..+|+.+.||.++++++.+.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56888899999999999999977 57889999997653   233566789999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||++||.|-.+|.   +.+++++..+.-++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+.....
T Consensus       124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999994   4578999999999999999999999998   999999999999999999999999999976432


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                           +-..+|||.|+|||.+..+.+..++|.|||||++|||+.|.+||........     ++.        ++...+ 
T Consensus       198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-----Y~K--------I~~~~v-  258 (355)
T KOG0616|consen  198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-----YEK--------ILEGKV-  258 (355)
T ss_pred             -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-----HHH--------HHhCcc-
Confidence                 4458999999999999999999999999999999999999999975443111     111        111111 


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCC
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDR  743 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~R  743 (807)
                        .++.-....+.+|+...++.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              2555556678889999999999999

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.2e-37  Score=330.44  Aligned_cols=257  Identities=30%  Similarity=0.506  Sum_probs=206.9

Q ss_pred             cCCcccCccccCCCccEEEEEecC------CcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  553 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  553 (807)
                      ++|++.+.||+|+||.||+|....      ...||+|.+..... .....|.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998643      25799999865432 33467899999999999999999999999999999


Q ss_pred             EEEEecCCCCccccccCCCC-------------CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC
Q 003628          554 LIYEYMPNRSLDALLFDPLK-------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL  620 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~  620 (807)
                      ++|||+++++|.+++.....             ...+++.++..++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999854211             145788899999999999999999998   99999999999999999


Q ss_pred             CceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhh
Q 003628          621 NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAW  699 (807)
Q Consensus       621 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~  699 (807)
                      .+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+....... +..   
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-~~~---  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-VIE---  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH---
Confidence            999999999986543332222333456889999999998999999999999999999998 998986433221 111   


Q ss_pred             hhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          700 KLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       700 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                       ....+..         . ..+...+.++.+|+.+|++.+|++||++.||++.|++
T Consensus       238 -~i~~~~~---------~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 -MIRSRQL---------L-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHcCCc---------C-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             1111110         0 1233456788999999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.3e-37  Score=325.11  Aligned_cols=254  Identities=30%  Similarity=0.465  Sum_probs=207.4

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      ++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++.+.+....++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            578899999999999999999888889999998643 2346789999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++... ....+++.++..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            99999998643 3456888899999999999999999988   9999999999999999999999999998764332211


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       .....++..|+|||++....++.++||||||+++|||++ |+.|+............ .    ...    ..+      
T Consensus       161 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~----~~~----~~~------  224 (261)
T cd05072         161 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-Q----RGY----RMP------  224 (261)
T ss_pred             -cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-H----cCC----CCC------
Confidence             112345678999999998899999999999999999998 88888643322211111 0    000    001      


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                      .....+.++.+++.+|++.+|++||++++|.++|++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            111234568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.2e-37  Score=327.76  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=204.2

Q ss_pred             cCCcccCccccCCCccEEEEEec----CCcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.++.... ...+.|.+|+.++.+++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888999999999999999764    356899999976432 3346799999999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+++|+|.+++..  ....+++.+++.++.||+.||+|||+.+   ++||||||+||+++.++.+|++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999854  2357899999999999999999999998   99999999999999999999999998765322


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      ... .......++..|+|||.+.+..++.++||||||+++||+++ |+.|+........+.    .. ..+.     .. 
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~----~~-~~~~-----~~-  227 (266)
T cd05064         160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK----AV-EDGF-----RL-  227 (266)
T ss_pred             cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----HH-HCCC-----CC-
Confidence            111 11112345678999999999999999999999999999775 999986443221111    10 1110     00 


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                          +.+...+..+.+++.+|++.+|++||++++|.+.|++.
T Consensus       228 ----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 ----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                12223456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3e-37  Score=344.40  Aligned_cols=261  Identities=26%  Similarity=0.374  Sum_probs=206.8

Q ss_pred             hcCCcccCccccCCCccEEEEEec------CCcEEEEEEecccCc-ccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCe
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEE  551 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  551 (807)
                      .++|.+.++||+|+||.||+|+..      .+..||||++..... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            467889999999999999999853      134699999975433 33467999999999996 9999999999999999


Q ss_pred             EEEEEEecCCCCccccccCCCC----------------------------------------------------------
Q 003628          552 KMLIYEYMPNRSLDALLFDPLK----------------------------------------------------------  573 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  573 (807)
                      .++||||+++|+|.++|.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999988754210                                                          


Q ss_pred             -----------------------------------CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC
Q 003628          574 -----------------------------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE  618 (807)
Q Consensus       574 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~  618 (807)
                                                         ...+++.++.+++.||++||.|||+.+   |+||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               124778888999999999999999988   999999999999999


Q ss_pred             CCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhh
Q 003628          619 ELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGY  697 (807)
Q Consensus       619 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~  697 (807)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+..+.. 
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~-  351 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN-  351 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH-
Confidence            99999999999987644332222233456788999999999999999999999999999997 8888864332221111 


Q ss_pred             hhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          698 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       698 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                         ....+     ...     ..+...+.++.+++.+||+.+|++||++.+|+++|+.++
T Consensus       352 ---~~~~~-----~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         352 ---KIKSG-----YRM-----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ---HHhcC-----CCC-----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence               11111     000     012234567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=330.32  Aligned_cols=249  Identities=26%  Similarity=0.383  Sum_probs=208.2

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ..|+..+.||+|.||.||+|... .++.||+|++.-. ....++++.+|+.++..++|+||.++||.+..+....++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            34667789999999999999876 5788999999743 455678899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      |.+|++.+.|..   ...+++.++.-|++++..||.|||.++   .+|||||+.||||..+|.+||+|||++..+.....
T Consensus        93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999832   334488888889999999999999998   99999999999999999999999999987765444


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                      ..  ..++||+.|||||++....|+.|+||||||++.+||++|.+|+...+....+..          +.+-..|.+.+ 
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----------Ipk~~PP~L~~-  233 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----------IPKSAPPRLDG-  233 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe----------ccCCCCCcccc-
Confidence            33  458999999999999988999999999999999999999999865443221110          11122233332 


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                          .....+.+++..||..||+.||++.++++.
T Consensus       234 ----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  234 ----DFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence                345568899999999999999999998853

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=305.99  Aligned_cols=265  Identities=24%  Similarity=0.279  Sum_probs=213.7

Q ss_pred             HhcCCcccCccccCCCccEEEEE-ecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCC-----eE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EK  552 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~  552 (807)
                      ..++|++.+.||+|||+-||.++ ..++..+|+|++.....++.+..++|++..++++||||++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34689999999999999999998 4578899999998888788899999999999999999999999886544     48


Q ss_pred             EEEEEecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      ||+++|...|+|.+.+.... ++..+++.+.++|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999987643 3447999999999999999999999986 589999999999999999999999999988


Q ss_pred             ccCCCCCc-------cccceeeccCCccChhhhcc---CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh
Q 003628          632 IFGGNQDQ-------ADTGRVVGTFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL  701 (807)
Q Consensus       632 ~~~~~~~~-------~~~~~~~gt~~y~APE~~~~---~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~  701 (807)
                      ...-....       ........|..|.|||.+.-   ...++++|||||||+||+|+.|..||+..-.....+.     
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla-----  252 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA-----  252 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----
Confidence            65321111       11122357899999998854   4578899999999999999999999974322111111     


Q ss_pred             ccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                            .....+.+.-+ ......+.+.+++.+|++.||.+||++.+++..++.+
T Consensus       253 ------LAv~n~q~s~P-~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  253 ------LAVQNAQISIP-NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ------EeeeccccccC-CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                  11222222222 1222677899999999999999999999999999775

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-37  Score=336.68  Aligned_cols=242  Identities=23%  Similarity=0.266  Sum_probs=197.4

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      +.||+|+||.||+++.. +|+.||||++++..   ......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 68899999997532   234467889999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcccc
Q 003628          563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT  642 (807)
Q Consensus       563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  642 (807)
                      +|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence            99888853   457899999999999999999999998   9999999999999999999999999987532221  122


Q ss_pred             ceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccH
Q 003628          643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQL  722 (807)
Q Consensus       643 ~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  722 (807)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......    ... +      +.     .++.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----~~~-~------~~-----~~p~  216 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILM-E------EI-----RFPR  216 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH----HHc-C------CC-----CCCC
Confidence            336799999999999999999999999999999999999999864332211110    000 0      00     1222


Q ss_pred             HHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003628          723 DMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  752 (807)
Q Consensus       723 ~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~~  752 (807)
                      ....++.+++.+||+.||++||     ++.++++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            3456788999999999999999     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.9e-38  Score=329.08  Aligned_cols=250  Identities=34%  Similarity=0.572  Sum_probs=195.4

Q ss_pred             ccCccccCCCccEEEEEec-----CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          485 LSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       485 ~~~~LG~G~~g~Vy~~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +.+.||.|.||.||+|.+.     .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999987     25689999996543 33478999999999999999999999999988889999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++|+|.++|... ....+++.++.+|+.||++||.|||+.+   ++|++|+++||++++++.+||+|||+++.......
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999653 3467999999999999999999999988   99999999999999999999999999987633222


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      ............|+|||.+....++.++||||||+++|||++ |+.|+....... +..   .. .++..          
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-~~~---~~-~~~~~----------  223 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-IIE---KL-KQGQR----------  223 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-HHH---HH-HTTEE----------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccc---cc-ccccc----------
Confidence            222223456789999999999999999999999999999999 678875443221 111   11 11111          


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      ...+...+..+.+++..||+.+|++||++.+|++.|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            012223356688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2e-37  Score=331.16  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=205.4

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ..++|.+++.||+|+||.||+++-+ +|..+|+|++++..   ....+..+.|-.+|...++|+||+|+..|.+.+..||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999866 58999999998763   3456778899999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ||||++||++..+|.   +.+.|++..+..++.+++.|+.-||+.|   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999994   5678999999999999999999999999   9999999999999999999999999996542


Q ss_pred             CCC---------------------Ccc-----c-------------------cceeeccCCccChhhhccCCCCccccee
Q 003628          635 GNQ---------------------DQA-----D-------------------TGRVVGTFGYMSPEYAMEGRFSEKSDVF  669 (807)
Q Consensus       635 ~~~---------------------~~~-----~-------------------~~~~~gt~~y~APE~~~~~~~t~k~Dvw  669 (807)
                      ...                     ...     .                   ....+|||.|||||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            200                     000     0                   0014799999999999999999999999


Q ss_pred             ehhHHHHHHHhCCCCCCccCCcchh---hhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCC-
Q 003628          670 SFGVLLLEIVSGRKNTSFFEDDLTI---LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN-  745 (807)
Q Consensus       670 SlGvvl~elltG~~p~~~~~~~~~l---~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-  745 (807)
                      |+|||+||||.|.+||...+.....   ..|...              +..+ .......+..+||.+|+. ||++|-- 
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP-~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKFP-EEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCC-CcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            9999999999999999865543322   222111              1100 111223678899999999 9999965 


Q ss_pred             --HHHHHHH
Q 003628          746 --MSTVVSM  752 (807)
Q Consensus       746 --~~ev~~~  752 (807)
                        ++||.++
T Consensus       437 ~G~~EIK~H  445 (550)
T KOG0605|consen  437 KGAEEIKKH  445 (550)
T ss_pred             ccHHHHhcC
Confidence              6665543

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.3e-37  Score=337.73  Aligned_cols=261  Identities=30%  Similarity=0.415  Sum_probs=205.4

Q ss_pred             cCCcccCccccCCCccEEEEEec------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeC-Ce
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG-EE  551 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~  551 (807)
                      ++|++.+.||+|+||.||+|...      .++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            57899999999999999999642      24789999987543 23346788999999999 899999999988654 56


Q ss_pred             EEEEEEecCCCCccccccCCCC----------------------------------------------------------
Q 003628          552 KMLIYEYMPNRSLDALLFDPLK----------------------------------------------------------  573 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  573 (807)
                      .+++|||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999988853211                                                          


Q ss_pred             CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccceeeccCCccC
Q 003628          574 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS  653 (807)
Q Consensus       574 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~A  653 (807)
                      ...+++..+.+++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            136789999999999999999999988   99999999999999999999999999987644332222333456778999


Q ss_pred             hhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHH
Q 003628          654 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVG  732 (807)
Q Consensus       654 PE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li  732 (807)
                      ||++.+..++.++|||||||++|||++ |+.|+........+...    ...+..     +.     .+.....++.+++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~-----~~-----~~~~~~~~~~~l~  309 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR----LKEGTR-----MR-----APEYATPEIYSIM  309 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH----HhccCC-----CC-----CCccCCHHHHHHH
Confidence            999999999999999999999999998 99888643322221111    111100     00     1122345788999


Q ss_pred             HhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          733 LLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       733 ~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                      .+|++.+|++||++.||+++|+..+.
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.2e-37  Score=327.67  Aligned_cols=256  Identities=27%  Similarity=0.470  Sum_probs=206.7

Q ss_pred             cCCcccCccccCCCccEEEEEecC------CcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  553 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  553 (807)
                      ++|.+.+.||+|+||.||+|+..+      +..||||.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            467888999999999999998643      478999999765444 4578999999999999999999999999999999


Q ss_pred             EEEEecCCCCccccccCCC-----------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCc
Q 003628          554 LIYEYMPNRSLDALLFDPL-----------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  622 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~  622 (807)
                      +||||+++++|.+++....           ....+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999986421           2345788899999999999999999998   9999999999999999999


Q ss_pred             eeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhh
Q 003628          623 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  701 (807)
Q Consensus       623 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~  701 (807)
                      ||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+.......... ..   
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~-~~---  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE-CI---  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HH---
Confidence            9999999986543322222223346788999999999999999999999999999999 999986443222111 10   


Q ss_pred             ccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                       ..+...          ..+...+..+.+++.+||+.||++||++.||++.|+
T Consensus       238 -~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 -TQGRLL----------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             011110          011234567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-37  Score=337.27  Aligned_cols=245  Identities=24%  Similarity=0.283  Sum_probs=201.0

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|.+.+.||+|+||.||+++.. +++.||||.+.+..   ....+.+.+|+.++.+++||||+++++.+.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57889999999999999999976 58899999986532   234567899999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999998853   356888889999999999999999998   999999999999999999999999999865332


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      .     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.........     .....+.        +.
T Consensus       172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----~~i~~~~--------~~  233 (329)
T PTZ00263        172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-----EKILAGR--------LK  233 (329)
T ss_pred             c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-----HHHhcCC--------cC
Confidence            1     2357899999999999999999999999999999999999998643221111     0111111        00


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVSM  752 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~ev~~~  752 (807)
                         ++.....++.+++.+||+.||++||+     ++++++.
T Consensus       234 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        234 ---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               11123356789999999999999997     6777644

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.7e-37  Score=333.84  Aligned_cols=264  Identities=24%  Similarity=0.304  Sum_probs=204.3

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367899999999999999999976 57889999987542 2335679999999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  .|+||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            9999999999853   346889999999999999999999853  39999999999999999999999999998653321


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh-hccc-cc---------
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-LWNE-NK---------  706 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~-~~~~-~~---------  706 (807)
                          .....|++.|+|||++.+..++.++||||||+++|||++|+.||...+... +...... .... ..         
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCccc
Confidence                223568999999999999999999999999999999999999986433211 1100000 0000 00         


Q ss_pred             -------------------cccccCcccc---CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          707 -------------------ILALVDPFLS---ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       707 -------------------~~~~~d~~l~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                                         ..+..+....   ..........++.+++.+||+.||++|||++||++.-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                               0000000000   0000112346789999999999999999999998653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.1e-37  Score=322.20  Aligned_cols=251  Identities=27%  Similarity=0.426  Sum_probs=202.9

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      ++|++.+.||+|+||.||+++.+++..+|+|.+... ....+.|.+|+.++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457888999999999999999988889999998643 3345789999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +|+|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999988542  246889999999999999999999998   9999999999999999999999999998653322211


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.|+........+..    .. .+..  ...+      
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~----i~-~~~~--~~~~------  223 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM----IS-RGFR--LYRP------  223 (256)
T ss_pred             -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HH-CCCC--CCCC------
Confidence             112235668999999998889999999999999999999 8888864332211111    11 1100  0011      


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                        .....++.+++.+|++.+|++||++.++++.|
T Consensus       224 --~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 --KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              11235688999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=333.17  Aligned_cols=245  Identities=24%  Similarity=0.279  Sum_probs=201.3

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999976 68899999986432   233567889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999853   356889999999999999999999998   999999999999999999999999999865332


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                           .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........    .. .+.        . 
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~----i~-~~~--------~-  215 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK----IL-AGK--------L-  215 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HH-hCC--------c-
Confidence                 1235689999999999998999999999999999999999999865332211110    00 010        0 


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVSM  752 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~ev~~~  752 (807)
                        .++......+.+++.+|++.||.+||+     ++|+++.
T Consensus       216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              022223456789999999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.8e-37  Score=329.09  Aligned_cols=260  Identities=29%  Similarity=0.473  Sum_probs=208.9

Q ss_pred             cCCcccCccccCCCccEEEEEec------CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56888999999999999999752      345689999977666667789999999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCC----------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCcee
Q 003628          555 IYEYMPNRSLDALLFDPL----------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  624 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL  624 (807)
                      ||||+++++|.+++....          ....+++..+++++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999885321          2235899999999999999999999998   999999999999999999999


Q ss_pred             eccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhcc
Q 003628          625 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWN  703 (807)
Q Consensus       625 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~  703 (807)
                      +|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........+..     ..
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~-----i~  236 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC-----IT  236 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HH
Confidence            99999986543322222222345778999999998899999999999999999999 8888754432221111     11


Q ss_pred             ccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          704 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       704 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                      .+...     ..     +.....++.+++.+|++.+|.+|||+.+|++.|+++.+
T Consensus       237 ~~~~~-----~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         237 QGRVL-----QR-----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             cCCcC-----CC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            11110     01     11233568899999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=332.85  Aligned_cols=239  Identities=23%  Similarity=0.274  Sum_probs=193.9

Q ss_pred             cccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCc
Q 003628          489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  564 (807)
Q Consensus       489 LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  564 (807)
                      ||+|+||.||+++.. +++.||+|++.+.   .......+.+|+.++.+++||||+++++.+.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999876 5789999998653   233456788999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccce
Q 003628          565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  644 (807)
Q Consensus       565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  644 (807)
                      .+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            998853   356899999999999999999999998   9999999999999999999999999998643222  12233


Q ss_pred             eeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHH
Q 003628          645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  724 (807)
Q Consensus       645 ~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  724 (807)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||........    ......         ...   .++...
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~----~~~~~~---------~~~---~~~~~~  216 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM----YRKILQ---------EPL---RFPDGF  216 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH----HHHHHc---------CCC---CCCCcC
Confidence            5799999999999999999999999999999999999999864322111    111110         000   122234


Q ss_pred             HHHHHHHHHhcccCCcCCCCCH---HHHHH
Q 003628          725 IIRCIHVGLLCVQELVKDRPNM---STVVS  751 (807)
Q Consensus       725 ~~~l~~li~~Cl~~dP~~RPt~---~ev~~  751 (807)
                      ..++.+++.+||+.||++||+.   .|+++
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            4678899999999999999864   55543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.3e-37  Score=351.71  Aligned_cols=260  Identities=21%  Similarity=0.273  Sum_probs=207.4

Q ss_pred             HHHHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCC-
Q 003628          475 ELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-  550 (807)
Q Consensus       475 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-  550 (807)
                      +.....++|.+.+.||+|+||+||+++.. +++.||||++...  .......+.+|+.++..++|+||++++..+.... 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            34445679999999999999999999864 6899999998653  3344567889999999999999999988765432 


Q ss_pred             -------eEEEEEEecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCc
Q 003628          551 -------EKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  622 (807)
Q Consensus       551 -------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~  622 (807)
                             ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence                   3579999999999999986532 2356889999999999999999999988   9999999999999999999


Q ss_pred             eeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhc
Q 003628          623 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW  702 (807)
Q Consensus       623 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~  702 (807)
                      ||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||........    .....
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~----~~~~~  258 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV----MHKTL  258 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHh
Confidence            99999999876543333333346799999999999999999999999999999999999999864322111    11110


Q ss_pred             cccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       703 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                       .+.    .+      +.+.....++.+++.+||+.+|.+||++.+++++
T Consensus       259 -~~~----~~------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 -AGR----YD------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -cCC----CC------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence             010    01      1222345678899999999999999999999864

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.6e-37  Score=329.06  Aligned_cols=260  Identities=27%  Similarity=0.452  Sum_probs=209.4

Q ss_pred             cCCcccCccccCCCccEEEEEec------CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      .+|.+.+.||+|+||.||+++..      ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999743      345699999876655556789999999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCC-------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCC
Q 003628          555 IYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN  621 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~  621 (807)
                      ||||+++++|.+++....             ....+++..+++++.||+.||+|||+++   |+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985421             1245889999999999999999999998   999999999999999999


Q ss_pred             ceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhh
Q 003628          622 PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWK  700 (807)
Q Consensus       622 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~  700 (807)
                      +||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..........     
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-----  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE-----  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----
Confidence            99999999986543322222233456788999999999999999999999999999999 999875433221111     


Q ss_pred             hccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          701 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       701 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                      ....+...+          .....+..+.+++.+|++.+|++||++.+|+++|+.+.+
T Consensus       237 ~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 CITQGRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHhCCCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            111111110          111234578899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=336.25  Aligned_cols=253  Identities=24%  Similarity=0.332  Sum_probs=204.9

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.+..   ....+.+.+|++++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999976 58899999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999843   456889999999999999999999998   99999999999999999999999999986533 


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............    .....  ...+...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~--~~~~~~~  223 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK----YWKET--LQRPVYD  223 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH----hcccc--ccCCCCC
Confidence                2223578999999999999999999999999999999999999987543222111110    00000  0011110


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .  .......++.+++.+|++.+|.+||+++++++.
T Consensus       224 ~--~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 D--PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             c--cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0  011345678899999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.5e-37  Score=328.25  Aligned_cols=264  Identities=20%  Similarity=0.289  Sum_probs=203.1

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ++|++.+.||+|+||.||+++.+ +++.||||++....  ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999986 57889999987542  2345678899999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |++++++..+..   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765542   2346889999999999999999999988   9999999999999999999999999998764322


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh-----------hccccc
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-----------LWNENK  706 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~-----------~~~~~~  706 (807)
                      . .......|++.|+|||++.+..++.++|||||||++|||++|+.||........+......           ......
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            1 1222356899999999999989999999999999999999999998754432221111000           000000


Q ss_pred             cccccCccccCC-----cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          707 ILALVDPFLSES-----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 ~~~~~d~~l~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ......+.....     .........+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000001111000     011123457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-37  Score=323.72  Aligned_cols=256  Identities=29%  Similarity=0.466  Sum_probs=206.0

Q ss_pred             cCCcccCccccCCCccEEEEEecC----CcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ++|++.+.||+|+||.||+|++..    ...||||.++... ......|.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999998752    3579999987543 33456789999999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+++++|.+++..  ....+++..+.+++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999854  2347899999999999999999999988   99999999999999999999999999997752


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |..|+....... +..    ....+.    ..+ 
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-~~~----~~~~~~----~~~-  228 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-VIK----AVEDGY----RLP-  228 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-HHH----HHHcCC----CCC-
Confidence            222222222345678999999998899999999999999999998 988875432221 111    000000    000 


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                           .+...+..+.+++.+|++.+|++||+++||+++|+++
T Consensus       229 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 -----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 1123346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.8e-37  Score=327.03  Aligned_cols=259  Identities=29%  Similarity=0.436  Sum_probs=203.7

Q ss_pred             HhcCCcccCccccCCCccEEEEEec------CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCe
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  551 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  551 (807)
                      +.++|++.+.||+|+||.||+|...      .+..||||.+.... .....+|.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4577999999999999999998753      24679999986432 2344678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCccccccCCCC-------CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCcee
Q 003628          552 KMLIYEYMPNRSLDALLFDPLK-------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  624 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL  624 (807)
                      .++||||+++++|.+++.....       ...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999854211       234677888999999999999999988   999999999999999999999


Q ss_pred             eccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhcc
Q 003628          625 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWN  703 (807)
Q Consensus       625 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~  703 (807)
                      +|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+........+. .    ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~-~----~~  235 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR-F----VM  235 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-H----HH
Confidence            99999986543322222222345778999999999999999999999999999999 678875433221111 0    00


Q ss_pred             ccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          704 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       704 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                      .+...     .     .+...+..+.+++.+|++.+|++|||+.|++++|++
T Consensus       236 ~~~~~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 EGGLL-----D-----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             cCCcC-----C-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            11100     0     112234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=336.94  Aligned_cols=245  Identities=27%  Similarity=0.385  Sum_probs=209.5

Q ss_pred             HHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCe
Q 003628          477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEE  551 (807)
Q Consensus       477 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  551 (807)
                      .-..++|.+.++||+|.||+|+++.++ +++.+|||.+++.   ..++.+..+.|.+|+.... ||.|++++.++...++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            344578999999999999999999987 5788999999875   4567788999999998885 9999999999999999


Q ss_pred             EEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      .++||||+.||++..+.    +...+++..+.-++..|+.||+|||+++   |||||||.+|||||.+|.+||+|||+++
T Consensus       444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999965554    4568999999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          632 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       632 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      .--.  ....+..++||+.|||||++.+..|+...|.|||||+||||+.|+.||...+++.......    .+       
T Consensus       517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~----~d-------  583 (694)
T KOG0694|consen  517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV----ND-------  583 (694)
T ss_pred             ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----cC-------
Confidence            5322  3345667999999999999999999999999999999999999999998655443222111    11       


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNM  746 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~  746 (807)
                           +..++.....+.+.|+.+.+..+|++|.-+
T Consensus       584 -----~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 -----EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                 112555667889999999999999999877

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.5e-38  Score=320.91  Aligned_cols=248  Identities=23%  Similarity=0.371  Sum_probs=210.0

Q ss_pred             hcCCcccCccccCCCccEEEEEe-cCCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ..+|++.+.||+|.||.|-++.. ..|+.||||.+++..   +++.-.+.+|++||..|+||||+.++..|...+...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45788899999999999999986 679999999998753   44556678999999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||..+|.|.+++.   ..+.+++.+...+++||..|+.|.|.++   ++|||||.+|||||.|+++||+|||++-++..
T Consensus       132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999994   5678999999999999999999999998   99999999999999999999999999987743


Q ss_pred             CCCccccceeeccCCccChhhhccCCC-CcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~-t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      .   .....++|++.|.+||+..+.+| .+..|-|||||+||-|+.|..||+..+......+..     .|..       
T Consensus       206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs-----~GaY-------  270 (668)
T KOG0611|consen  206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS-----RGAY-------  270 (668)
T ss_pred             c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh-----cccc-------
Confidence            3   22345899999999999999988 468999999999999999999998765433222111     1211       


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                           ...+.+....-||++||..||++|.|+++|....
T Consensus       271 -----rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  271 -----REPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -----cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                 1112233455789999999999999999999876

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.1e-37  Score=333.47  Aligned_cols=256  Identities=25%  Similarity=0.433  Sum_probs=202.8

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCc----EEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      .+|++.+.||+|+||.||+|++. ++.    .||||.++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46889999999999999999864 333    48999986543 33457899999999999999999999999764 5679


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      |+||+++|+|.+++..  ....+++..+++++.||++||+|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            9999999999999864  2346888999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... +..    ....+.       
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~-------  228 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISS----ILEKGE-------  228 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HHhCCC-------
Confidence            4333222222334678999999999999999999999999999998 999886432211 111    111110       


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                      ...   .+.....++.+++..|++.+|++||++.+++..|....
T Consensus       229 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         229 RLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             CCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            000   11123356789999999999999999999999997764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.3e-37  Score=323.43  Aligned_cols=256  Identities=29%  Similarity=0.450  Sum_probs=211.4

Q ss_pred             HhcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ...+|++.++||+|+||.||+|...++..+|+|.+..........+.+|+.+++.++|+||+++++++.+....++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34568889999999999999999988999999999876665677899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++.+. ....+++.++.+++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999653 3456899999999999999999999998   99999999999999999999999999986643221


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      ..  ....++..|+|||.+....++.++||||||+++|+|++ |+.|+........+... .    .+     ...    
T Consensus       160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~-~----~~-----~~~----  223 (261)
T cd05148         160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI-T----AG-----YRM----  223 (261)
T ss_pred             cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-H----hC-----CcC----
Confidence            11  12345678999999998899999999999999999998 88888654322211111 0    00     000    


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                       +.+...+..+.+++.+|++.+|++|||+.++++.|++
T Consensus       224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 -PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence             1122344678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=320.85  Aligned_cols=255  Identities=29%  Similarity=0.430  Sum_probs=206.8

Q ss_pred             hcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35688899999999999999998888899999986543 34678999999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++... ....+++..+.+++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            999999998653 2346899999999999999999999998   999999999999999999999999999876532211


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                      . ......+..|+|||++.+..++.++||||||+++|||++ |+.|+........+...     ....     ..     
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-----~~~~-----~~-----  223 (261)
T cd05068         160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-----DQGY-----RM-----  223 (261)
T ss_pred             c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-----HcCC-----CC-----
Confidence            1 111223457999999998899999999999999999999 88888643322111110     0000     00     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                      +.+......+.+++.+|++.+|++||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            0122334678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.6e-37  Score=350.06  Aligned_cols=252  Identities=19%  Similarity=0.231  Sum_probs=204.3

Q ss_pred             CCcccCccccCCCccEEEEEec-C-CcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-D-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .|.+.+.||+|++|.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999764 3 5788999876555455567888999999999999999999999999999999999


Q ss_pred             CCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          560 PNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       560 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      ++|+|.+++.... ....+++.++..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            9999998885422 3446888999999999999999999988   99999999999999999999999999987654332


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+........+.    ... .+..    +      
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~----~~~-~~~~----~------  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ----QVL-YGKY----D------  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHH-hCCC----C------
Confidence            222334679999999999999999999999999999999999999986433211111    100 0000    0      


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      +.+.....++.+++..||+.+|++||++++++.
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            012223457889999999999999999999874

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-37  Score=334.44  Aligned_cols=248  Identities=25%  Similarity=0.340  Sum_probs=208.8

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      .-|++.+.||+|+-|.|-.|++. +|+.+|||++.+..   ......+.+|+.+|+.|.||||+++++.+.+..+.|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45888999999999999999875 69999999997652   223466789999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|-|-+++.   .++++.+.+..++++||+.|+.|.|..+   |+|||+||+|+|||.++++||+|||+|.+-..+
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999984   5678999999999999999999999998   999999999999999999999999999864332


Q ss_pred             CCccccceeeccCCccChhhhccCCCC-cccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFS-EKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t-~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                         ......+|.+.|.|||++++.+|. .++||||.|||||.|+||+.||+    ++++..... +...|..        
T Consensus       166 ---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd----DdNir~LLl-KV~~G~f--------  229 (786)
T KOG0588|consen  166 ---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD----DDNIRVLLL-KVQRGVF--------  229 (786)
T ss_pred             ---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC----CccHHHHHH-HHHcCcc--------
Confidence               233346899999999999999984 58999999999999999999997    222222221 1112211        


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                         ..+.....++.+|+.+|+..||++|-|++||++.-
T Consensus       230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence               13345667889999999999999999999999864

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.9e-37  Score=325.63  Aligned_cols=257  Identities=30%  Similarity=0.467  Sum_probs=203.6

Q ss_pred             cCCcccCccccCCCccEEEEEe-----cCCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ++|++.+.||+|+||.||+|..     ..+..+|+|.+.... .+....+.+|++++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4678889999999999999984     246789999997533 3344678999999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCC--------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC
Q 003628          555 IYEYMPNRSLDALLFDPL--------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL  620 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~  620 (807)
                      ||||+++++|.+++....              ....+++.++..++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999884321              1234788889999999999999999998   99999999999999999


Q ss_pred             CceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhh
Q 003628          621 NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAW  699 (807)
Q Consensus       621 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~  699 (807)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...... .+.... 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-~~~~~~-  239 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-EVIEMV-  239 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH-
Confidence            999999999987644332222233445778999999998889999999999999999999 88887543221 111111 


Q ss_pred             hhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          700 KLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       700 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                         ......     .     .+.....++.+++.+|++.+|++||++.+|.++|..
T Consensus       240 ---~~~~~~-----~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 ---RKRQLL-----P-----CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HcCCcC-----C-----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence               111100     0     112234578899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-37  Score=300.08  Aligned_cols=250  Identities=27%  Similarity=0.374  Sum_probs=209.9

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      +.++|.+.+.||+|.||.||.|+.+ ++..||+|++.+.   ..+...++.+|+++-..|+||||+++++++.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            3468999999999999999999976 5778999999764   23345788999999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ++||..+|+|...|.+. ...++++.....++.|+|.||.|+|..+   ++||||||+|+|++..+.+||+|||-+....
T Consensus       100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            99999999999999653 4567899999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                          .......+||..|.+||...+..++.+.|+|++|++.||++.|.+||+............           .+|- 
T Consensus       176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~-----------k~~~-  239 (281)
T KOG0580|consen  176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR-----------KVDL-  239 (281)
T ss_pred             ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH-----------Hccc-
Confidence                222334799999999999999999999999999999999999999997544222111110           0111 


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                          .++........+++..|+..+|.+|.+..|++..
T Consensus       240 ----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  240 ----KFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                1334456678899999999999999999998764

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1e-36  Score=332.67  Aligned_cols=242  Identities=23%  Similarity=0.276  Sum_probs=197.3

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      +.||+|+||.||+++.. +++.||||++.+.   .......+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999875 5899999999754   2334567889999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcccc
Q 003628          563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT  642 (807)
Q Consensus       563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  642 (807)
                      +|..++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            99888743   356899999999999999999999998   9999999999999999999999999987542221  122


Q ss_pred             ceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccH
Q 003628          643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQL  722 (807)
Q Consensus       643 ~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  722 (807)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+......    .... .      +.     .++.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~----~~~~-~------~~-----~~p~  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILM-E------DI-----KFPR  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH----Hhcc-C------Cc-----cCCC
Confidence            23579999999999999999999999999999999999999986433221111    0000 0      00     1222


Q ss_pred             HHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003628          723 DMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  752 (807)
Q Consensus       723 ~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~~  752 (807)
                      ....++.+++.+||+.||++||     ++.|+++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            3456788999999999999997     88998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.2e-37  Score=335.21  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=201.3

Q ss_pred             hcCCcccCccccCCCccEEEEEecC--CcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKD--GQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~--g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      .++|.+.+.||+|+||.||+|+...  +..||+|++.+.   .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3578899999999999999998653  368999998653   23345678899999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999853   346889999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+......    ... .+.        
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~i~-~~~--------  244 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ----KIL-EGI--------  244 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH----HHh-cCC--------
Confidence            22     123578999999999999889999999999999999999999996433221111    111 110        


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  752 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~~  752 (807)
                      .   .++......+.+++.+|++.+|++|+     +++++++.
T Consensus       245 ~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 I---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             C---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            0   01122335678999999999999995     88888765

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-37  Score=320.46  Aligned_cols=256  Identities=25%  Similarity=0.338  Sum_probs=202.4

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--------------cccHHHHHHHHHHHHhccCCceeEE
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--------------GQGLEEFMNEVMVISKLQHRNLVRL  542 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~l  542 (807)
                      ...++|++.+.||+|.||.|-+|+.. +++.||||++.+..              ....+...+|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            44578999999999999999999865 68999999997531              1124688999999999999999999


Q ss_pred             eeEEEe--CCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC
Q 003628          543 LGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL  620 (807)
Q Consensus       543 ~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~  620 (807)
                      +.+..+  .+..|||+|||..|.+...--   ....++..++.++++++..||+|||.++   ||||||||.|+||+++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            999875  467899999999988865431   2223999999999999999999999999   99999999999999999


Q ss_pred             CceeeccccccccCCCC---CccccceeeccCCccChhhhccCC----CCcccceeehhHHHHHHHhCCCCCCccCCcch
Q 003628          621 NPKISDFGMAKIFGGNQ---DQADTGRVVGTFGYMSPEYAMEGR----FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT  693 (807)
Q Consensus       621 ~~kL~DFGla~~~~~~~---~~~~~~~~~gt~~y~APE~~~~~~----~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~  693 (807)
                      ++||+|||.+..+....   ........+||+.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||.....   
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---  324 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---  324 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence            99999999998763221   112233368999999999987743    34578999999999999999999853211   


Q ss_pred             hhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          694 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       694 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                       ....         ..++...+.-+ ...++.+++.+|++++|++||+.|.+..+|....
T Consensus       325 -~~l~---------~KIvn~pL~fP-~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  325 -LELF---------DKIVNDPLEFP-ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             -HHHH---------HHHhcCcccCC-CcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence             1111         11222222222 2234567889999999999999999999998776

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.6e-37  Score=333.05  Aligned_cols=241  Identities=23%  Similarity=0.266  Sum_probs=196.1

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      +.||+|+||.||+++.. +|+.||+|++++.   .......+.+|++++++++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999875 6899999999754   2334567789999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcccc
Q 003628          563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT  642 (807)
Q Consensus       563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  642 (807)
                      +|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence            99888743   346899999999999999999999998   99999999999999999999999999875322211  12


Q ss_pred             ceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccH
Q 003628          643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQL  722 (807)
Q Consensus       643 ~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  722 (807)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+........    ...       +..     ++.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~----~~~-------~~~-----~p~  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----LME-------EIR-----FPR  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----hcC-------CCC-----CCC
Confidence            2356899999999999999999999999999999999999998644322111111    000       000     222


Q ss_pred             HHHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003628          723 DMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  751 (807)
Q Consensus       723 ~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~  751 (807)
                      ....++.+++.+|++.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            3345778999999999999998     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-36  Score=321.17  Aligned_cols=255  Identities=28%  Similarity=0.408  Sum_probs=205.6

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .+|.+.++||+|+||.||+|... .++.||+|.+... ....+++.+|++++++++|+||+++++++..+...++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45778899999999999999876 4788999998643 344678999999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++... ....+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999998542 3346889999999999999999999988   999999999999999999999999999876432211


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |..|+...+.... .   . ....+     ..+.    
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~---~-~~~~~-----~~~~----  225 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-Y---E-LLEKG-----YRME----  225 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-H---H-HHHCC-----CCCC----
Confidence             1111234568999999999999999999999999999998 8888764322111 1   0 00000     0111    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                       .+...+.++.+++.+|++.+|++||++.+++++|+.+
T Consensus       226 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 -RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             2223456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-36  Score=318.20  Aligned_cols=248  Identities=28%  Similarity=0.405  Sum_probs=197.3

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCc
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  564 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  564 (807)
                      +.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999875 68899999886543 33456799999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccce
Q 003628          565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  644 (807)
Q Consensus       565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  644 (807)
                      .+++..  ....+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999853  2346889999999999999999999998   99999999999999999999999999886432211111111


Q ss_pred             eeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHH
Q 003628          645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLD  723 (807)
Q Consensus       645 ~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  723 (807)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..|+.......... ..             ...... ..+..
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-~~-------------~~~~~~-~~~~~  220 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-AI-------------EQGVRL-PCPEL  220 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-HH-------------HcCCCC-CCccc
Confidence            123457999999999999999999999999999998 888875433211111 00             000000 12223


Q ss_pred             HHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          724 MIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       724 ~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      .+.++.+++.+|++.+|++|||+.+|.++|+
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.9e-36  Score=318.67  Aligned_cols=252  Identities=27%  Similarity=0.469  Sum_probs=203.4

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      ++|.+.+.||+|+||.||+++..++..+|||.+... ....+.|.+|+.++.+++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            457788999999999999999887778999998643 3345789999999999999999999999999888999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++...  ...+++..+++++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999998542  236899999999999999999999998   999999999999999999999999998865432211 


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..........    ... .+.     .+.     
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~-~~~-----~~~-----  221 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE----KVS-QGL-----RLY-----  221 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----HHh-cCC-----CCC-----
Confidence            1111235678999999998889999999999999999999 988886544321111    010 110     000     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      .+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11112467889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-36  Score=319.09  Aligned_cols=256  Identities=26%  Similarity=0.432  Sum_probs=202.4

Q ss_pred             CcccCccccCCCccEEEEEecC----CcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCe-----
Q 003628          483 FQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE-----  551 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  551 (807)
                      |.+.+.||+|+||.||+|....    +..||||+++...  ....+.+.+|++.++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998652    3679999987532  3345689999999999999999999999876554     


Q ss_pred             -EEEEEEecCCCCccccccCCC---CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecc
Q 003628          552 -KMLIYEYMPNRSLDALLFDPL---KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  627 (807)
Q Consensus       552 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DF  627 (807)
                       .++||||+++++|..++....   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999999885432   2346889999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccc
Q 003628          628 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENK  706 (807)
Q Consensus       628 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~  706 (807)
                      |+++...............++..|+|||.+....++.++||||||+++|||++ |..|+....... +....    ..+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-~~~~~----~~~~  232 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-IYDYL----RHGN  232 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH----HcCC
Confidence            99987644332222222345678999999988899999999999999999999 888875433221 11111    0110


Q ss_pred             cccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          707 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       707 ~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      .     ..     .+.....++.+++.+|++.||++||++.||++.|+++
T Consensus       233 ~-----~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 R-----LK-----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             C-----CC-----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0     00     1223456789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-36  Score=322.54  Aligned_cols=257  Identities=26%  Similarity=0.424  Sum_probs=201.4

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCc----EEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ++|++.+.||+|+||.||+|+.. +++    .+++|.+..... ....++..|+.++++++||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46788899999999999999864 344    478888754322 23467888899999999999999999875 455788


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      |+||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999864  3456899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .....    ...+...  ..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-~~~~~----~~~~~~~--~~~  233 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-EVPDL----LEKGERL--AQP  233 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH----HHCCCcC--CCC
Confidence            4332222333557789999999999999999999999999999998 98888643221 11111    1111110  011


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                      .        .....+.+++.+|+..+|++|||+.|+++.|....+
T Consensus       234 ~--------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         234 Q--------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             C--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            1        123456789999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-36  Score=324.71  Aligned_cols=256  Identities=29%  Similarity=0.449  Sum_probs=203.3

Q ss_pred             CCcccCccccCCCccEEEEEecC------CcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      +|++.+.||+|+||.||+|...+      ++.||||+++..... ..+.+.+|+.++.+++||||+++++++.+....++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            46778899999999999998642      478999999754333 24678899999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCC-------------CCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCC
Q 003628          555 IYEYMPNRSLDALLFDP-------------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN  621 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~  621 (807)
                      ++||+++++|.+++...             .....+++..+.+++.|++.||.|||+.+   |+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            99999999999998421             11235788889999999999999999998   999999999999999999


Q ss_pred             ceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhh
Q 003628          622 PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWK  700 (807)
Q Consensus       622 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~  700 (807)
                      +||+|||+++...............+++.|+|||.+....++.++||||||+++|||++ |..|+....... ...    
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~~----  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VIE----  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----
Confidence            99999999986644332222233456789999999998899999999999999999998 777775433221 111    


Q ss_pred             hccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          701 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       701 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                      ....+..          ...+...+..+.+++..|++.+|++||++.+|++.|+.
T Consensus       238 ~i~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 MIRNRQV----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHcCCc----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111110          01223345668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.6e-36  Score=323.39  Aligned_cols=263  Identities=22%  Similarity=0.299  Sum_probs=200.2

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|.+.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888999999999999999876 68899999986543 23346788999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++ +|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 88888743  2345788899999999999999999998   99999999999999999999999999986533221


Q ss_pred             ccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh-------hcc----ccc
Q 003628          639 QADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-------LWN----ENK  706 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~-------~~~----~~~  706 (807)
                        ......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||........+......       .+.    ...
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence              1222467999999999875 56899999999999999999999998754432222111110       000    000


Q ss_pred             cccccCccccCCc---ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          707 ILALVDPFLSESS---FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 ~~~~~d~~l~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ......+.....+   .......++.+++.+|++.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111111110000   00112356789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-36  Score=324.24  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=204.5

Q ss_pred             CCcccCccccCCCccEEEEEec------CCcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      +|++.+.||+|+||.||+|+..      ....+|+|.+..... ...+++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4678899999999999999853      235689998865432 345679999999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCC---------------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCC
Q 003628          555 IYEYMPNRSLDALLFDPL---------------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN  613 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~N  613 (807)
                      |+||+++++|.+++....                     ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1235788899999999999999999988   9999999999


Q ss_pred             eeecCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcc
Q 003628          614 ILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDL  692 (807)
Q Consensus       614 Ill~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~  692 (807)
                      |++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986543332222222345778999999988889999999999999999998 98888543221 


Q ss_pred             hhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          693 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       693 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                      .+...    ....     ....     .+.....++.+++.+|++.+|++||++.|+++.|++.+
T Consensus       237 ~~~~~----~~~~-----~~~~-----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         237 RLFNL----LKTG-----YRME-----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHHH----HhCC-----CCCC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            11111    1111     0000     12223457889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-36  Score=327.27  Aligned_cols=264  Identities=22%  Similarity=0.337  Sum_probs=198.5

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999976 688999999875432 234567899999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |++ ++|.+++..  ....++...+..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 577776643  3356888999999999999999999998   9999999999999999999999999997543222


Q ss_pred             CccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc---ccc---c--
Q 003628          638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE---NKI---L--  708 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~---~~~---~--  708 (807)
                      .  ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||....+..............   ...   .  
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence            1  1222467899999999865 457889999999999999999999997544322111111100000   000   0  


Q ss_pred             cccCcc-cc--CC-cc-----cHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          709 ALVDPF-LS--ES-SF-----QLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       709 ~~~d~~-l~--~~-~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ...++. ..  .. ..     .......+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000000 00  00 00     0011246778999999999999999999885

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-36  Score=322.17  Aligned_cols=266  Identities=27%  Similarity=0.405  Sum_probs=203.6

Q ss_pred             CcccCccccCCCccEEEEEe-----cCCcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeEEE
Q 003628          483 FQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKML  554 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  554 (807)
                      |++.+.||+|+||.||++..     .++..||+|.++.... ...+.|.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988653     3577899999875432 3457789999999999999999999998754  45789


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ||||+++++|.+++..    ..+++.++..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999843    35899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCCccc-cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCc-chhhhhhhhhccccccccccC
Q 003628          635 GNQDQAD-TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD-LTILGYAWKLWNENKILALVD  712 (807)
Q Consensus       635 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~~~d  712 (807)
                      ....... .....++..|+|||.+....++.++||||||+++|||++|+.|+...... ...............+.+.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            3322111 11124566799999999889999999999999999999999987543221 111111110111111112222


Q ss_pred             ccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       713 ~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      ..... +.+...+.++.+++.+|++.+|++|||+++|+++|+..
T Consensus       239 ~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         239 RGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             cCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            22211 12334457889999999999999999999999999775

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.4e-36  Score=333.37  Aligned_cols=248  Identities=25%  Similarity=0.333  Sum_probs=193.8

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|+..++||+|+||.||+++.. +++.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34566789999999999999875 689999999865432 3346789999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|....       ..++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986543       3456778899999999999999998   99999999999999999999999999987643221


Q ss_pred             ccccceeeccCCccChhhhcc-----CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          639 QADTGRVVGTFGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~-----~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                        ......||..|+|||.+..     ...+.++|||||||++|||++|+.||....... ...........      ..+
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~------~~~  294 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAICMS------QPP  294 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhcc------CCC
Confidence              1223578999999998743     234568999999999999999999987322211 11100000000      000


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                           ........++.+++.+||+.||++|||+.||++.
T Consensus       295 -----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 -----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0122345678899999999999999999999875

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2e-36  Score=324.89  Aligned_cols=261  Identities=26%  Similarity=0.416  Sum_probs=207.2

Q ss_pred             HhcCCcccCccccCCCccEEEEEecC------CcEEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCC
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE  550 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  550 (807)
                      ..++|++.+.||+|+||.||++...+      ...+|+|.+... ..+...++.+|+.++.++ +|+||+++++++..+.
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34578889999999999999998642      367999998754 233456788999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCCccccccCC-------------CCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeec
Q 003628          551 EKMLIYEYMPNRSLDALLFDP-------------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD  617 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~  617 (807)
                      ..++||||+++++|.+++...             .....+++..+++++.|++.||.|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998532             22456889999999999999999999988   99999999999999


Q ss_pred             CCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhh
Q 003628          618 EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILG  696 (807)
Q Consensus       618 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~  696 (807)
                      +++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.........  
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--  244 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--  244 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH--
Confidence            999999999999987654322222222345678999999998899999999999999999998 88887543321111  


Q ss_pred             hhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          697 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       697 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                         .....+..       .   ..+.....++.+++.+|++.+|++|||+.||++.|++++
T Consensus       245 ---~~~~~~~~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 ---KLLKEGYR-------M---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ---HHHHcCCc-------C---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence               11111100       0   012233457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-36  Score=323.86  Aligned_cols=263  Identities=27%  Similarity=0.428  Sum_probs=201.6

Q ss_pred             cCCcccCccccCCCccEEEEEecC---------------CcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEee
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD---------------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLG  544 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~---------------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g  544 (807)
                      ++|++.+.||+|+||.||+++..+               ...||+|.++... ....+.|.+|++++.+++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578899999999999999987542               2348999987542 334567999999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCCccccccCCC---------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCee
Q 003628          545 CCVEGEEKMLIYEYMPNRSLDALLFDPL---------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL  615 (807)
Q Consensus       545 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIl  615 (807)
                      ++......++||||+++++|.+++....         ....+++..+++++.|+++||+|||+.+   ++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999885421         1124678889999999999999999998   999999999999


Q ss_pred             ecCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh--CCCCCCccCCcch
Q 003628          616 LDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS--GRKNTSFFEDDLT  693 (807)
Q Consensus       616 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt--G~~p~~~~~~~~~  693 (807)
                      +++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++  |..|+........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999986543322222222345778999999999999999999999999999998  4456554332222


Q ss_pred             hhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          694 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       694 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      +... .............    .   .+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus       242 ~~~~-~~~~~~~~~~~~~----~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 IENT-GEFFRNQGRQIYL----S---QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHH-HHhhhhccccccC----C---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1111 1111110000000    0   11123457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.1e-36  Score=322.92  Aligned_cols=263  Identities=23%  Similarity=0.323  Sum_probs=196.6

Q ss_pred             cCCcccCccccCCCccEEEEEec--CCcEEEEEEecccC--cccHHHHHHHHHHHHhc---cCCceeEEeeEEEe-----
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKL---QHRNLVRLLGCCVE-----  548 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----  548 (807)
                      ++|++.+.||+|+||.||+++..  +++.||||.++...  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  46789999986532  22335667788877766   69999999999862     


Q ss_pred             CCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       549 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                      ....++||||++ ++|.+++... ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456789999996 5888888543 2345889999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhc--cccc
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW--NENK  706 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~--~~~~  706 (807)
                      +++.....   .......||+.|+|||.+.+..++.++||||||+++|||++|++||....+...+........  ....
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            99865432   122335689999999999988999999999999999999999999876543322221111000  0000


Q ss_pred             cc-------cccCccccC--CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          707 IL-------ALVDPFLSE--SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 ~~-------~~~d~~l~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ..       ....+....  .....+....+.+++.+|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00       000000000  0011123456789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.7e-36  Score=321.78  Aligned_cols=264  Identities=27%  Similarity=0.432  Sum_probs=206.0

Q ss_pred             hcCCcccCccccCCCccEEEEEecC-----------------CcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKD-----------------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVR  541 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~  541 (807)
                      ..+|++.+.||+|+||.||+++..+                 +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578899999999999999987642                 2458999987543 334678999999999999999999


Q ss_pred             EeeEEEeCCeEEEEEEecCCCCccccccCCC--------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCC
Q 003628          542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN  613 (807)
Q Consensus       542 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~N  613 (807)
                      +++++..+...++||||+++++|.+++....        ....+++..++.++.|++.||.|||+.+   |+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986432        1236889999999999999999999988   9999999999


Q ss_pred             eeecCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh--CCCCCCccCCc
Q 003628          614 ILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS--GRKNTSFFEDD  691 (807)
Q Consensus       614 Ill~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt--G~~p~~~~~~~  691 (807)
                      |+++.++.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++  |..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986543332222333456788999999998899999999999999999998  56666543322


Q ss_pred             chhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          692 LTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       692 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      ..+ .................       .+...+.++.+++.+|++.+|++|||+.||++.|+
T Consensus       241 ~~~-~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 QVI-ENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHH-HHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            221 11111111111100000       11223467899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.4e-36  Score=328.43  Aligned_cols=264  Identities=19%  Similarity=0.269  Sum_probs=196.3

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCC-----eEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EKM  553 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  553 (807)
                      +|++.++||+|+||.||+|+.. +++.||||++...  .......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999865 6899999998643  2233467889999999999999999999886432     479


Q ss_pred             EEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccccc
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~  633 (807)
                      +||||+. ++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 688888743   346899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCCc-cccceeeccCCccChhhhcc--CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhh----------h
Q 003628          634 GGNQDQ-ADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW----------K  700 (807)
Q Consensus       634 ~~~~~~-~~~~~~~gt~~y~APE~~~~--~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~----------~  700 (807)
                      ...... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........+.....          .
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            322211 11223578999999999876  6789999999999999999999999865432111100000          0


Q ss_pred             hcccccc---ccccCccccCC--cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          701 LWNENKI---LALVDPFLSES--SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       701 ~~~~~~~---~~~~d~~l~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .......   ...+.+.....  .........+.+++.+|++.||++|||++|+++.
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000   00000000000  0001123567899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.4e-37  Score=328.48  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=212.4

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCe-EEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE-KMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~  556 (807)
                      ++|..++.+|+|+||.++..+.+ ++..+++|.+.-.  .....+....|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999998876 5778999998643  34445578899999999999999999999999888 89999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      +|++||+|.+.|... ++..++++.+.+++.|++.|+.|||+..   |+|||||+.||+++.+..+||+|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            999999999999764 3567899999999999999999999877   999999999999999999999999999988655


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      ..  ....++||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+-..    ...+..          ... 
T Consensus       160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----Li~ki~----------~~~-  222 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----LILKIN----------RGL-  222 (426)
T ss_pred             hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----HHHHHh----------hcc-
Confidence            42  3344789999999999999999999999999999999999999987544221    111111          111 


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      -.+.+.....++..++..|++.+|+.||++.+++.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            122555677889999999999999999999999876

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.6e-36  Score=330.24  Aligned_cols=252  Identities=26%  Similarity=0.328  Sum_probs=199.1

Q ss_pred             CCcccCccccCCCccEEEEEec----CCcEEEEEEecccC----cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS----GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  552 (807)
                      +|++.+.||+|+||.||+++..    +++.||+|++.+..    ....+.+..|+.++.++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788899999999999998753    57899999986532    22346688999999999 599999999999999999


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++||||+++|+|.+++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999998853   356889999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          633 FGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       633 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      +...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..................       .
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~  226 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-------C  226 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-------C
Confidence            5432222 22235799999999999865 4788999999999999999999998643322211111111110       1


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  752 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~~  752 (807)
                      ++.     .+......+.+++.+|++.||++||     +++++++.
T Consensus       227 ~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         227 DPP-----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCC-----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            111     2223345678999999999999999     66677653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.1e-36  Score=329.79  Aligned_cols=244  Identities=25%  Similarity=0.357  Sum_probs=194.7

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHH---HhccCCceeEEeeEEEeCCeEEEE
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVI---SKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      |++.+.||+|+||.||++... +++.||||++++..   ....+.+.+|++++   .+++||||+++++++.+....++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999875 58899999997532   23345677777665   456799999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+++++|..++.    ...+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999988873    356899999999999999999999998   99999999999999999999999999875322


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ..  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+....+...    .. +.      .. 
T Consensus       154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i----~~-~~------~~-  219 (324)
T cd05589         154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI----VN-DE------VR-  219 (324)
T ss_pred             CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh-CC------CC-
Confidence            21  1223357899999999999999999999999999999999999998654322211111    00 00      00 


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  751 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~  751 (807)
                          .+......+.+++.+||+.||.+||     ++.++++
T Consensus       220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                1222345678999999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-36  Score=317.33  Aligned_cols=251  Identities=29%  Similarity=0.445  Sum_probs=202.5

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      .+|++.+.||+|+||.||+++.+++..+|+|.+.+.. ...+.|.+|+.++++++|+||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3577889999999999999998877889999986432 345678999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            99999998542  346899999999999999999999998   9999999999999999999999999998654322111


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....+......    .. .     .....     
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~-~-----~~~~~-----  221 (256)
T cd05059         158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES----VS-A-----GYRLY-----  221 (256)
T ss_pred             -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH----HH-c-----CCcCC-----
Confidence             111223457999999999999999999999999999999 7888865433221111    00 0     00111     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      .+...+.++.+++.+|++.+|++|||+.||+++|
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            1122456788999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4e-36  Score=328.79  Aligned_cols=200  Identities=29%  Similarity=0.387  Sum_probs=174.1

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      .++|++.++||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999999876 57889999886542 2334679999999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++++|.+++..   ...+++..+..++.++++||.|||+..  .|+||||||+|||+++++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            9999999999853   346888899999999999999999742  39999999999999999999999999997653221


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCcc
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF  688 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~  688 (807)
                          .....|+..|+|||++.+..++.++|||||||++|||++|+.|+...
T Consensus       159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                12246899999999999889999999999999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.6e-36  Score=320.16  Aligned_cols=246  Identities=25%  Similarity=0.333  Sum_probs=196.6

Q ss_pred             cccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCc
Q 003628          489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  564 (807)
Q Consensus       489 LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  564 (807)
                      ||+|+||+||++... +++.||+|.+.+..   ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999875 68899999986532   22346678899999999999999999999999999999999999999


Q ss_pred             cccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccc
Q 003628          565 DALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG  643 (807)
Q Consensus       565 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  643 (807)
                      ..++.... ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+......  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            88875422 3456899999999999999999999998   999999999999999999999999999865433221  22


Q ss_pred             eeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHH
Q 003628          644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLD  723 (807)
Q Consensus       644 ~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  723 (807)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||...............         ......   ..+..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---------~~~~~~---~~~~~  223 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---------ILNDSV---TYPDK  223 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh---------hcccCC---CCccc
Confidence            356899999999999999999999999999999999999998654322111111100         011111   12233


Q ss_pred             HHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003628          724 MIIRCIHVGLLCVQELVKDRP-----NMSTVVS  751 (807)
Q Consensus       724 ~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~  751 (807)
                      ....+.+++.+|++.||++||     +++++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            456788999999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.9e-36  Score=328.53  Aligned_cols=242  Identities=27%  Similarity=0.317  Sum_probs=194.9

Q ss_pred             CccccCCCccEEEEEec----CCcEEEEEEecccC----cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          487 SKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +.||+|+||.||+++..    .++.||||.+++..    ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999853    57899999987532    23345678999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++..   ...+.+..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            999999988843   346788888899999999999999998   99999999999999999999999999875432221


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+......    ...         ....   
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~----~~~---------~~~~---  217 (323)
T cd05584         156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID----KIL---------KGKL---  217 (323)
T ss_pred             --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH----HHH---------cCCC---
Confidence              1223578999999999998889999999999999999999999986533221111    111         1111   


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  752 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~~  752 (807)
                      ..+.....++.+++.+|++.+|++||     +++++++.
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            01222345678999999999999999     78887663

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.4e-36  Score=315.20  Aligned_cols=253  Identities=31%  Similarity=0.486  Sum_probs=203.3

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      ++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46888999999999999999988888999999865432 4577999999999999999999999875 456789999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++... ....+++.++.+++.+++.||.|||+.+   ++||||||+||++++++.++|+|||++..+.......
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            99999998642 2345889999999999999999999998   9999999999999999999999999998764322111


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.|+...........    ... +     ...     +
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~~-~-----~~~-----~  223 (260)
T cd05070         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ----VER-G-----YRM-----P  223 (260)
T ss_pred             -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-C-----CCC-----C
Confidence             111235668999999998899999999999999999999 8888864332211111    100 0     000     1


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                      .+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            222345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-36  Score=334.47  Aligned_cols=270  Identities=18%  Similarity=0.222  Sum_probs=201.0

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .+|++.+.||+|+||.||++... .++.||+|...      .+.+.+|++++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999875 58899999753      245789999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      . ++|..++..   ...+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence            5 678777743   346889999999999999999999998   99999999999999999999999999975432211 


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCC-------cchhhhhhhhhc------c---
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED-------DLTILGYAWKLW------N---  703 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~-------~~~l~~~~~~~~------~---  703 (807)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.....       ...+........      .   
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            122235799999999999999999999999999999999999987643211       011110000000      0   


Q ss_pred             cccccccc---------CccccC-CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCCCCCCCC
Q 003628          704 ENKILALV---------DPFLSE-SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP  766 (807)
Q Consensus       704 ~~~~~~~~---------d~~l~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~~p~~p  766 (807)
                      ...+.+..         .+.... .......+.++.+++.+||+.||++|||++|+++.=  .++.++.|..+
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp--~f~~~~~~~~~  388 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA--AFQDIPDPYPN  388 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh--hhccCCCCCCC
Confidence            00000000         000000 001113456789999999999999999999998532  23444544433

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.2e-36  Score=320.73  Aligned_cols=257  Identities=29%  Similarity=0.462  Sum_probs=202.7

Q ss_pred             hcCCcccCccccCCCccEEEEEecC------CcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  552 (807)
                      .++|.+.+.||+|++|.||+|...+      +..||+|.+.... ......|.+|+.++++++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678899999999999999998753      5678999886443 33446799999999999999999999999999999


Q ss_pred             EEEEEecCCCCccccccCCCC----CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC---Cceee
Q 003628          553 MLIYEYMPNRSLDALLFDPLK----KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL---NPKIS  625 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~---~~kL~  625 (807)
                      ++||||+++++|.+++.....    ...+++..+.+++.||+.||+|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999864321    235889999999999999999999998   99999999999998765   59999


Q ss_pred             ccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccc
Q 003628          626 DFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNE  704 (807)
Q Consensus       626 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~  704 (807)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||....... +...   ....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-~~~~---~~~~  237 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-VMEF---VTGG  237 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH---HHcC
Confidence            9999987633222111222234568999999999999999999999999999997 888886433221 1111   0000


Q ss_pred             cccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          705 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       705 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      ..           ...+...+.++.+++.+|++.+|++||++.+|++.|+
T Consensus       238 ~~-----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 GR-----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             Cc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            00           0012233467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5e-36  Score=317.99  Aligned_cols=256  Identities=27%  Similarity=0.440  Sum_probs=198.9

Q ss_pred             CcccCccccCCCccEEEEEecCC-c--EEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeC------Ce
Q 003628          483 FQLSSKLGQGGFGPVYWGRLKDG-Q--EIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------EE  551 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~~g-~--~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~  551 (807)
                      |.+.+.||+|+||.||+|+..+. .  .+|+|.++..  .....+.+.+|++++++++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            34678999999999999997643 2  5899988653  234467889999999999999999999987542      24


Q ss_pred             EEEEEEecCCCCccccccCCC---CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          552 KMLIYEYMPNRSLDALLFDPL---KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                      .++||||+++|+|.+++....   ....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998874321   2345889999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhcccccc
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKI  707 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~  707 (807)
                      +++.+.............+++.|+|||.+....++.++||||||+++|||++ |+.|+...... .+..    ....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~----~~~~~~~  232 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-EIYD----YLRQGNR  232 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH----HHHcCCC
Confidence            9987643322111222345778999999999999999999999999999999 78887643321 1111    1111111


Q ss_pred             ccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          708 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       708 ~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      ..          .+......+.+++.+|++.+|++|||+.+|++.|+++
T Consensus       233 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 LK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00          1122345688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.4e-36  Score=329.55  Aligned_cols=242  Identities=22%  Similarity=0.264  Sum_probs=195.7

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      +.||+|+||.||+++.. +++.||+|.+.+.   .......+..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 6889999999753   2234567788999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhh-cCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      +|..++..   ...+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  152 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T  152 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence            99888743   3468999999999999999999997 56   99999999999999999999999999875432221  1


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .   .. ..      ...     ++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~-~---i~-~~------~~~-----~p  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-L---IL-ME------EIR-----FP  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH-H---Hh-cC------CCC-----CC
Confidence            223569999999999999999999999999999999999999986433221111 0   00 00      000     12


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  752 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~~  752 (807)
                      .....++.+++.+|++.||++|+     ++.++++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            22345678999999999999996     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.9e-36  Score=317.18  Aligned_cols=259  Identities=22%  Similarity=0.361  Sum_probs=207.5

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+...   .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999875 6899999987542   2233467899999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          557 EYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      ||+++++|.+++.... +...++...+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885422 2345788899999999999999999988   99999999999999999999999999987643


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ...  ......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+......  ...+.... .     ....+..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~-~-----~~~~~~~  228 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKI-E-----QCDYPPL  228 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHH-h-----cCCCCCC
Confidence            321  112246788999999999888999999999999999999999997532211  11111110 0     0001111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                          ........+.+++.+|++.+|++||++++|++.|++.
T Consensus       229 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         229 ----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                1223456788999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.5e-36  Score=333.92  Aligned_cols=253  Identities=22%  Similarity=0.295  Sum_probs=197.2

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      .|.+.+.||+|+||+||+|+.. +++.||||++.+..   ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999865 57899999996532   2345678999999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999853   346888888999999999999999998   9999999999999999999999999986432110


Q ss_pred             Cc---------------------------------------------cccceeeccCCccChhhhccCCCCcccceeehh
Q 003628          638 DQ---------------------------------------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFG  672 (807)
Q Consensus       638 ~~---------------------------------------------~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlG  672 (807)
                      ..                                             .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            00                                             001224799999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHh--cccCCcCCCCCHHHHH
Q 003628          673 VLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLL--CVQELVKDRPNMSTVV  750 (807)
Q Consensus       673 vvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~--Cl~~dP~~RPt~~ev~  750 (807)
                      |++|||++|+.||............    ......     ....   .......++.+++.+  |+..+|..||+++|++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i----~~~~~~-----~~~~---~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKV----INWENT-----LHIP---PQVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHH----Hccccc-----cCCC---CCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            9999999999999754432211110    000000     0000   111123456677766  5666777799999998


Q ss_pred             HH
Q 003628          751 SM  752 (807)
Q Consensus       751 ~~  752 (807)
                      +.
T Consensus       304 ~h  305 (381)
T cd05626         304 AH  305 (381)
T ss_pred             cC
Confidence            75

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-36  Score=332.80  Aligned_cols=253  Identities=25%  Similarity=0.314  Sum_probs=204.5

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|.+.+.||+|+||.||+++.. +++.||||++.+..   ......+.+|++++..++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999976 68999999997532   234567899999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||+|+.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999999854   257899999999999999999999988   999999999999999999999999999876433


Q ss_pred             C---------------------------CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccC
Q 003628          637 Q---------------------------DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE  689 (807)
Q Consensus       637 ~---------------------------~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~  689 (807)
                      .                           .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0011223568999999999999999999999999999999999999987544


Q ss_pred             CcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCC-HHHHHHH
Q 003628          690 DDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN-MSTVVSM  752 (807)
Q Consensus       690 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~ev~~~  752 (807)
                      .......    .....       ..+... .......++.+++..|++ +|.+||+ ++++++.
T Consensus       235 ~~~~~~~----i~~~~-------~~~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQETYNK----IINWK-------ESLRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHH----HhccC-------CcccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            2211110    10000       000000 111135678889999997 9999999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.5e-36  Score=321.04  Aligned_cols=256  Identities=28%  Similarity=0.443  Sum_probs=204.7

Q ss_pred             cCCcccCccccCCCccEEEEEec------CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      .++...++||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45777899999999999999642      356799999887666667889999999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCCC------------CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCc
Q 003628          555 IYEYMPNRSLDALLFDPLK------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  622 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~  622 (807)
                      ||||+++++|.+++.....            ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999854211            135888999999999999999999988   9999999999999999999


Q ss_pred             eeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhh
Q 003628          623 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  701 (807)
Q Consensus       623 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~  701 (807)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..........    ..
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~  237 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE----CI  237 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH----HH
Confidence            9999999986543322222222345788999999999999999999999999999998 888875432221110    00


Q ss_pred             ccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                       ..+.     ...     .+...+..+.+++.+|++.||++||++.||++.|+
T Consensus       238 -~~~~-----~~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 -TQGR-----ELE-----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -HcCc-----cCC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             0000     000     11223456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.6e-36  Score=326.67  Aligned_cols=242  Identities=24%  Similarity=0.352  Sum_probs=195.4

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+|+.. +++.||||++.+.   .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 4789999999754   233456678899999876 799999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      ++|...+..   ...+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence            999888843   356889999999999999999999998   99999999999999999999999999875432221  1


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........    .....    ..        .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~----i~~~~----~~--------~p  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES----ILHDD----VL--------YP  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH----HHcCC----CC--------CC
Confidence            2235789999999999999999999999999999999999999975443222111    11100    00        11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCC-------CHHHHHHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRP-------NMSTVVSM  752 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RP-------t~~ev~~~  752 (807)
                      .....++.+++..|++.||++||       +++++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            12345678999999999999999       77777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.5e-37  Score=314.10  Aligned_cols=260  Identities=23%  Similarity=0.321  Sum_probs=201.3

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCe-----EEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE-----KMLI  555 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lV  555 (807)
                      .|...+++|.|+||.||+|.+. +++.||||+......    ---+|+++|+++.|||||+|+.+|.....     ..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4666789999999999999976 468999999864322    22379999999999999999999875432     3489


Q ss_pred             EEecCCCCccccccCC-CCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC-CCceeecccccccc
Q 003628          556 YEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIF  633 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kL~DFGla~~~  633 (807)
                      ||||+. +|.+.+... ..+.+++...+.-+..||.+||.|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 888887542 23467888888899999999999999988   9999999999999976 99999999999988


Q ss_pred             CCCCCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc--c------
Q 003628          634 GGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN--E------  704 (807)
Q Consensus       634 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~--~------  704 (807)
                      ......   .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|...+..+.+.....-+-.  .      
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            655443   224568999999999876 5999999999999999999999998876655555444332110  0      


Q ss_pred             -cccccccCccccCCc----ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          705 -NKILALVDPFLSESS----FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       705 -~~~~~~~d~~l~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                       ....+.-.|.+....    +......+.++++.++++++|.+|.++.|++.+
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence             011122222232221    334456788999999999999999999998754

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=314.32  Aligned_cols=274  Identities=22%  Similarity=0.307  Sum_probs=215.1

Q ss_pred             CHHHHHHHhcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhc--cCCceeEEeeEEEeC
Q 003628          472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL--QHRNLVRLLGCCVEG  549 (807)
Q Consensus       472 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~  549 (807)
                      ++-..+.......+.+.||+|.||.||+|++. |+.||||++..   .+.+.+.+|.+|.+..  +|+||+.+++.-..+
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            34445666778899999999999999999998 89999999964   3457788999988864  999999999886543


Q ss_pred             ----CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhh-----cCCCcEEeCCCCCCCeeecCCC
Q 003628          550 ----EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-----DSRLRIIHRDLKASNILLDEEL  620 (807)
Q Consensus       550 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~DIkp~NIll~~~~  620 (807)
                          ...+||.+|.+.|||.++|    +...++....++++..+|.||+|||.     +++|.|.|||||++||||..++
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence                3578999999999999999    45689999999999999999999995     5888999999999999999999


Q ss_pred             CceeeccccccccCCCCC--ccccceeeccCCccChhhhccCC----C--CcccceeehhHHHHHHHhC----------C
Q 003628          621 NPKISDFGMAKIFGGNQD--QADTGRVVGTFGYMSPEYAMEGR----F--SEKSDVFSFGVLLLEIVSG----------R  682 (807)
Q Consensus       621 ~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~----~--t~k~DvwSlGvvl~elltG----------~  682 (807)
                      ...|+|+|||........  .......+||..|||||++...-    |  -..+||||||.|+||++..          +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            999999999998765432  22344468999999999985432    2  1258999999999999864          2


Q ss_pred             CCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          683 KNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       683 ~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                      .||....+.+....-..+..    ..+.+.|.+.....+.+.+..+.+|++.||..||.-|-|+-.|.+.|.++.
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCcccCCCCCCCHHHHhcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            34443222222211112222    233344444444466688999999999999999999999999999998764

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=318.05  Aligned_cols=252  Identities=25%  Similarity=0.327  Sum_probs=202.3

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      +|++.++||+|+||.||++... +++.||||++....   ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999875 68899999986532   2223567889999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999887542 3346899999999999999999999998   9999999999999999999999999998654322


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      .   .....|+..|+|||++.+..++.++||||+|+++|||++|+.||..............          .+....  
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~----------~~~~~~--  221 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER----------RVKEDQ--  221 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH----------Hhhhcc--
Confidence            1   1224689999999999998999999999999999999999999975433221111100          000000  


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  752 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~~  752 (807)
                      ...+......+.+++..|++.||++||     +++++++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            012233556788999999999999999     78888654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.5e-36  Score=314.45  Aligned_cols=254  Identities=29%  Similarity=0.449  Sum_probs=204.0

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      ++|++.++||+|+||.||+|+..++..||+|+++... ...+.|.+|+.++++++|+||+++++++. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            5688999999999999999998877789999997532 34568999999999999999999999874 456789999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||.++.+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            99999999642 2346789999999999999999999988   999999999999999999999999999866433211 


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                      ......++..|+|||+..+..++.++||||||+++|||++ |+.|+..........    .... +     ..     ..
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~----~~~~-~-----~~-----~~  223 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVER-G-----YR-----MP  223 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH----HHhc-C-----CC-----CC
Confidence            1112346678999999998999999999999999999999 777875433221111    0000 0     00     01


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      ...+.+..+.+++.+|++.+|++||++.+++++|+..
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            2234556788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.8e-36  Score=334.57  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=205.1

Q ss_pred             hcCCcccCccccCCCccEEEEEec------CCcEEEEEEecccCcc-cHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCe
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEE  551 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  551 (807)
                      .++|.+.++||+|+||.||+|++.      .+..||||+++..... ..+.+++|+++|.++. ||||+++++++.....
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            356778899999999999999853      3468999999764322 3457899999999997 9999999999999999


Q ss_pred             EEEEEEecCCCCccccccCCCC----------------------------------------------------------
Q 003628          552 KMLIYEYMPNRSLDALLFDPLK----------------------------------------------------------  573 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  573 (807)
                      .++||||+++|+|.++++....                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999998854211                                                          


Q ss_pred             -------------------------------------CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeee
Q 003628          574 -------------------------------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL  616 (807)
Q Consensus       574 -------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll  616 (807)
                                                           ...+++..+.+++.||+.||.|||+.+   ++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence                                                 123667778899999999999999987   9999999999999


Q ss_pred             cCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhh
Q 003628          617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTIL  695 (807)
Q Consensus       617 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~  695 (807)
                      ++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.|+........+.
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~  352 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY  352 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence            9999999999999986543322222222456789999999998889999999999999999998 888876433222111


Q ss_pred             hhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          696 GYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       696 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                      ...    ..+.     .+.     .+.....++.+++..|++.+|.+||+++||++.|++++
T Consensus       353 ~~~----~~~~-----~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         353 NAI----KRGY-----RMA-----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHH----HcCC-----CCC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111    0110     000     11223467889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.1e-36  Score=330.69  Aligned_cols=253  Identities=23%  Similarity=0.299  Sum_probs=201.4

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|.+.+.||+|+||.||+++.. +++.||+|+++...   ....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999876 68899999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++++|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999854  2356899999999999999999999998   999999999999999999999999999876433


Q ss_pred             CCccccceeeccCCccChhhhc------cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAM------EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  710 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~------~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~  710 (807)
                      ... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||..........    .......... 
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~----~i~~~~~~~~-  229 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN----NIMNFQRFLK-  229 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH----HHHcCCCccC-
Confidence            222 222346899999999986      4567899999999999999999999986433222111    1111110000 


Q ss_pred             cCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       711 ~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                          ..   .......++.+++..|++ +|++||+++++++.
T Consensus       230 ----~~---~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         230 ----FP---EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ----CC---CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                00   111234567788999998 99999999998853

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-35  Score=319.43  Aligned_cols=263  Identities=27%  Similarity=0.422  Sum_probs=202.5

Q ss_pred             cCCcccCccccCCCccEEEEEec-----------------CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-----------------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRL  542 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-----------------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  542 (807)
                      ++|++.+.||+|+||.||++...                 +...+|+|.+.... ....++|.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56889999999999999998532                 23468999987543 3345789999999999999999999


Q ss_pred             eeEEEeCCeEEEEEEecCCCCccccccCCCC--------CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCe
Q 003628          543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI  614 (807)
Q Consensus       543 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NI  614 (807)
                      ++++...+..++||||+++++|.+++.....        ...+++.++.+++.|++.||+|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999864221        134777889999999999999999998   99999999999


Q ss_pred             eecCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh--CCCCCCccCCcc
Q 003628          615 LLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS--GRKNTSFFEDDL  692 (807)
Q Consensus       615 ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt--G~~p~~~~~~~~  692 (807)
                      ++++++.++|+|||+++.+.............++..|+|||....+.++.++||||||+++|||++  |..|+.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543322222222345678999999988899999999999999999998  667775443322


Q ss_pred             hhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          693 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       693 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      ...... ........ ....+      .+...+..+.+++.+|++.||++||++.||++.|+
T Consensus       242 ~~~~~~-~~~~~~~~-~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VIENTG-EFFRDQGR-QVYLP------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHH-HHHhhccc-cccCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            211110 11111000 00000      11123467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5e-36  Score=327.42  Aligned_cols=246  Identities=25%  Similarity=0.349  Sum_probs=194.3

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+++.. +++.||+|++++.   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999976 5789999999754   223446678899988877 899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence            999888743   356899999999999999999999998   99999999999999999999999999975322211  2


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCc----chhhhhhhhhccccccccccCccccC
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD----LTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~----~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......    .....+.........        .  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~--  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------I--  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--------C--
Confidence            23357899999999999999999999999999999999999998642211    111111111111110        0  


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCC------HHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPN------MSTVVS  751 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~ev~~  751 (807)
                       ..+.....++.+++.+||+.||++||+      +.++++
T Consensus       223 -~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         223 -RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence             122234566789999999999999998      456644

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.6e-36  Score=303.24  Aligned_cols=279  Identities=23%  Similarity=0.311  Sum_probs=210.0

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCccc--HHHHHHHHHHHHhccCCceeEEeeEEEe--CCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQG--LEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV  555 (807)
                      ++|+.++.|++|.||.||+|+.+ +++.||+|+++...+..  .-.-++|+.+|.+++|||||.+-.....  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            46888899999999999999976 57899999997543221  1345799999999999999999888763  4578999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      ||||+. +|..++..-  .+++...++.-++.|+++|++|||...   |+||||||+|+|+...|.+||+|||+||.++.
T Consensus       156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999977 888888652  367899999999999999999999998   99999999999999999999999999998876


Q ss_pred             CCCccccceeeccCCccChhhhccCC-CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh-------hcccccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-------LWNENKI  707 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~-~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~-------~~~~~~~  707 (807)
                      ....  .+..+-|..|.|||.+.+.+ |++..|+||+|||+.||+++++-|....+-..+......       .|..-..
T Consensus       230 p~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  230 PLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             Cccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            5322  23356699999999998764 899999999999999999999988765543322211111       1111000


Q ss_pred             cccc---------CccccCCcccHH-HHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCCCCCCCCCccc
Q 003628          708 LALV---------DPFLSESSFQLD-MIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTE  770 (807)
Q Consensus       708 ~~~~---------d~~l~~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~~p~~p~~~~  770 (807)
                      ...+         ...+.. .+... ....-.++....+.+||.+|-|++|-++.  +-+.+.|.|..|...+
T Consensus       308 lp~~k~~~f~~~pyn~lr~-kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~P  377 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRK-KFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFP  377 (419)
T ss_pred             cchhhccccCCCCchhhhh-hccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcC
Confidence            0000         000110 11111 33566788889999999999999997753  3346666666665543

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=342.20  Aligned_cols=257  Identities=25%  Similarity=0.301  Sum_probs=210.1

Q ss_pred             hcCCcccCccccCCCccEEEEEecCC-cEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeEEee-EEEe------CC
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLG-CCVE------GE  550 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g-~~~~------~~  550 (807)
                      ..++++.+.|.+|||+.||.+++..+ ..+|+|++-...+...+...+|+++|++|. |+|||.+++ ....      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45678889999999999999998766 999999998888888899999999999996 999999999 3321      23


Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla  630 (807)
                      +.+|.||||++|+|-+++...... +|++.++++|+.++++|+++||... +||||||||-+||||..+++.||||||.+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            678999999999999999765444 4999999999999999999999985 88999999999999999999999999988


Q ss_pred             cccCCCCCccc-------cceeeccCCccChhhh---ccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh
Q 003628          631 KIFGGNQDQAD-------TGRVVGTFGYMSPEYA---MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK  700 (807)
Q Consensus       631 ~~~~~~~~~~~-------~~~~~gt~~y~APE~~---~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~  700 (807)
                      .--........       .-...-|+-|+|||.+   .+..+++|+|||+|||+||-|+....||+....          
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence            75332221100       0012469999999987   577899999999999999999999999974321          


Q ss_pred             hccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          701 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       701 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                             ..+++..-.-+ ....+..++.+||..||+.||.+||++-+|+..+-.+
T Consensus       264 -------laIlng~Y~~P-~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  264 -------LAILNGNYSFP-PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             -------eeEEeccccCC-CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                   11222222222 2246788999999999999999999999999888665

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.1e-36  Score=322.86  Aligned_cols=259  Identities=27%  Similarity=0.389  Sum_probs=206.2

Q ss_pred             hcCCcccCccccCCCccEEEEEec------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCe
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE  551 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  551 (807)
                      .++|.+.+.||+|+||.||++...      .+..||||.++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            457899999999999999999742      34579999987543 33356789999999999 79999999999999999


Q ss_pred             EEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      .++||||+++++|.+++... ....+++.++..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999998542 2234899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccc
Q 003628          632 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILAL  710 (807)
Q Consensus       632 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~  710 (807)
                      ...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.............    ..+.    
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~----~~~~----  261 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI----KEGY----  261 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH----HcCC----
Confidence            6644322222222345778999999999999999999999999999998 898876433222111111    1110    


Q ss_pred             cCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       711 ~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                       .+.     .+.....++.+++.+|++.+|++||++.||++.|++.
T Consensus       262 -~~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 -RMA-----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -cCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence             000     1112345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.4e-36  Score=320.02  Aligned_cols=260  Identities=25%  Similarity=0.396  Sum_probs=207.2

Q ss_pred             hcCCcccCccccCCCccEEEEEecC-----CcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEe-CCeE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEK  552 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  552 (807)
                      .++|.+.+.||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999999765     6889999986542 3345778999999999999999999999876 4678


Q ss_pred             EEEEEecCCCCccccccCCCCC-----CCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKK-----ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  627 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DF  627 (807)
                      ++++||+++++|.+++......     ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            8999999999999998653222     46889999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccc
Q 003628          628 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENK  706 (807)
Q Consensus       628 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~  706 (807)
                      |+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+..... ..+.....    .+.
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~----~~~  236 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAYLK----DGY  236 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHHHHH----cCC
Confidence            99986643322222222345778999999998889999999999999999999 9999864322 11111111    110


Q ss_pred             cccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          707 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       707 ~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                           ...     .....+.++.+++.+|++.+|++|||+.+|++.|+...
T Consensus       237 -----~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         237 -----RLA-----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             -----CCC-----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                 000     11123456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1e-35  Score=313.58  Aligned_cols=254  Identities=33%  Similarity=0.483  Sum_probs=204.8

Q ss_pred             hcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .++|++.++||+|+||.||+|..++++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            35688899999999999999999889999999986543 34578999999999999999999999864 56689999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++... ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            999999988543 3456889999999999999999999988   999999999999999999999999999876432211


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                       ......++..|+|||.+....++.++||||||+++|||++ |+.|+...........    . ..+     ....    
T Consensus       159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~-~~~-----~~~~----  223 (260)
T cd05067         159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN----L-ERG-----YRMP----  223 (260)
T ss_pred             -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH----H-HcC-----CCCC----
Confidence             1112345678999999998899999999999999999999 9999864332211111    0 000     0000    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                       .+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 -RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence             112234578999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-36  Score=329.14  Aligned_cols=238  Identities=26%  Similarity=0.285  Sum_probs=193.1

Q ss_pred             CccccCCCccEEEEEe----cCCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          487 SKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      +.||+|+||.||+++.    .+|+.||+|++.+..  ......+..|++++++++||||+++++++.+....++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999875    357899999997542  2234567889999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            9999998843   356899999999999999999999998   9999999999999999999999999998653321  1


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  720 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  720 (807)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.......    ... .        ..   ..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----i~~-~--------~~---~~  217 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM----ILK-A--------KL---GM  217 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH----HHc-C--------CC---CC
Confidence            22235789999999999988899999999999999999999999865432211111    100 0        00   01


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCCHHH
Q 003628          721 QLDMIIRCIHVGLLCVQELVKDRPNMST  748 (807)
Q Consensus       721 ~~~~~~~l~~li~~Cl~~dP~~RPt~~e  748 (807)
                      +......+.+++.+||+.||++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            2223456789999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-36  Score=318.56  Aligned_cols=257  Identities=28%  Similarity=0.428  Sum_probs=205.5

Q ss_pred             hcCCcccCccccCCCccEEEEEecC------CcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  552 (807)
                      .++|.+.+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.++..++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578889999999999999998652      3689999986543 23356789999999999999999999999999999


Q ss_pred             EEEEEecCCCCccccccCCC-------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceee
Q 003628          553 MLIYEYMPNRSLDALLFDPL-------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS  625 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~  625 (807)
                      ++||||+++++|.+++....       ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999986422       1234788899999999999999999988   9999999999999999999999


Q ss_pred             ccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccc
Q 003628          626 DFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNE  704 (807)
Q Consensus       626 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~  704 (807)
                      |||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ ....    ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~----~~  236 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-LKFV----ID  236 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-HHHH----hc
Confidence            9999986644332222233456789999999998899999999999999999998 8888764332211 1111    11


Q ss_pred             cccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          705 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       705 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      +..     +.     .+...+.++.+++.+|++.+|++|||+.++++.|+
T Consensus       237 ~~~-----~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 GGH-----LD-----LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCC-----CC-----CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111     01     11223567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=332.02  Aligned_cols=264  Identities=27%  Similarity=0.417  Sum_probs=216.6

Q ss_pred             HHHHHHhcCCcccCccccCCCccEEEEEecC-CcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeE
Q 003628          474 EELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       474 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  552 (807)
                      ++.+-...+.....+||-|.||.||.|.++. .-.||||.++. ..-..++|+.|+.+|+.++|||+|+|+|.|..+..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3444444556677899999999999999885 55799999965 445689999999999999999999999999999999


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      |||.|||.+|+|.++|.+- ++..++...++.++.||+.||+||..+.   +|||||..+|+||.++..+||+||||+|+
T Consensus       339 YIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence            9999999999999999764 4556778888999999999999999988   99999999999999999999999999999


Q ss_pred             cCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          633 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       633 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      +..+....... ..-...|.|||-+....++.|+|||+|||+||||.| |..|+...+-     ..++.++..+-     
T Consensus       415 MtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----SqVY~LLEkgy-----  483 (1157)
T KOG4278|consen  415 MTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYGLLEKGY-----  483 (1157)
T ss_pred             hcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----HHHHHHHhccc-----
Confidence            87665433222 234678999999999999999999999999999998 6667654331     11222222221     


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                        ++  . .+..++..+.+|+++||+.+|.+||++.||.+.++..+.
T Consensus       484 --RM--~-~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  484 --RM--D-GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             --cc--c-CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence              11  1 344567788999999999999999999999999977643

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.6e-36  Score=326.48  Aligned_cols=236  Identities=28%  Similarity=0.364  Sum_probs=191.9

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+++.+ +++.||||++.+.   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 5789999998753   233456788899998877 699999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      |+|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            999988843   356889999999999999999999998   9999999999999999999999999987543221  12


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........    .. .+.        .   ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~----i~-~~~--------~---~~~  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----IL-NDE--------V---VYP  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH----Hh-cCC--------C---CCC
Confidence            2335789999999999999999999999999999999999999975432221111    11 000        0   011


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNM  746 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~  746 (807)
                      .....++.+++.+|++.||++||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            2234567899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.9e-36  Score=326.15  Aligned_cols=241  Identities=26%  Similarity=0.342  Sum_probs=195.0

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      +|.+.+.||+|+||.||+++.. +++.||||.+.+..   ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999876 47899999987542   23345677888888877 6899999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999988843   356889999999999999999999998   999999999999999999999999999754321


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+........    . ..        .. 
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i----~-~~--------~~-  218 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI----M-EH--------NV-  218 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH----H-hC--------CC-
Confidence            1  1223357899999999999999999999999999999999999999754332211111    0 00        00 


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNM  746 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~  746 (807)
                        .++.....++.+++.+|++.+|.+|++.
T Consensus       219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 --AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              1222345678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.4e-36  Score=319.00  Aligned_cols=268  Identities=27%  Similarity=0.425  Sum_probs=202.9

Q ss_pred             cCCcccCccccCCCccEEEEEec-----CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEe--CCeEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKM  553 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  553 (807)
                      ++|++.+.||+|+||.||++..+     ++..||+|.+........+.|.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888999999999999999743     578999999977666667789999999999999999999998754  34678


Q ss_pred             EEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccccc
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~  633 (807)
                      +||||+++++|.+++..  ....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999999854  2346899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCccc-cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc----ccccc
Q 003628          634 GGNQDQAD-TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN----ENKIL  708 (807)
Q Consensus       634 ~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~----~~~~~  708 (807)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||++|..+.......  ..........    ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hhhhcccccccccchHHHH
Confidence            43322111 11122345699999999889999999999999999999987764322110  0000000000    00000


Q ss_pred             cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      +.+..... .+.....+.++.+++.+|++.+|++|||+.||++.|+.+
T Consensus       237 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11111100 011223456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.7e-36  Score=324.58  Aligned_cols=240  Identities=28%  Similarity=0.367  Sum_probs=192.0

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+|+.. +++.||||.++...   ....+.+..|..++..+ +||||+++++.+..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 57889999997532   23445667777777654 899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999988843   346889999999999999999999988   9999999999999999999999999998643222  22


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......    ....       .+.     .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~----i~~~-------~~~-----~~  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS----ILND-------RPH-----FP  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHcC-------CCC-----CC
Confidence            2335799999999999999999999999999999999999999875433221111    1000       011     12


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHH-HHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMS-TVV  750 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~-ev~  750 (807)
                      .....++.+++.+||+.+|++||++. ++.
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            22345678899999999999999876 453

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.4e-36  Score=326.56  Aligned_cols=241  Identities=26%  Similarity=0.342  Sum_probs=194.6

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccC-CceeEEeeEEEeCCeEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~  556 (807)
                      +|++.+.||+|+||.||+|+.. +++.||||++.+.   .....+.+..|.+++..++| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999876 4778999999753   23445678899999999976 56888999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999988843   346889999999999999999999998   999999999999999999999999998753221


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...........    .. ..      ..   
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~----i~-~~------~~---  218 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS----IM-EH------NV---  218 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HH-cC------CC---
Confidence            1  122335799999999999999999999999999999999999999865432221111    10 00      00   


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNM  746 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~  746 (807)
                        ..+.....++.+++.+|++.||++||+.
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 --SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              1122234567899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.5e-36  Score=314.17  Aligned_cols=248  Identities=28%  Similarity=0.413  Sum_probs=196.8

Q ss_pred             CccccCCCccEEEEEec---CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      ++||+|+||.||+|.++   ++..+|+|+++...  ....+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            36899999999999753   57889999986443  223567999999999999999999999875 4567899999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      ++|.+++..   ...+++..+.+++.|++.||+|||+.+   |+||||||.||++++++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          80 GPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999999843   346889999999999999999999998   99999999999999999999999999987654332111


Q ss_pred             -cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          642 -TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       642 -~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.|+...... .+....    ..+..     +.     
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~i----~~~~~-----~~-----  218 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQMI----ESGER-----ME-----  218 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH----HCCCC-----CC-----
Confidence             111234578999999988889999999999999999998 99998654322 111111    11110     00     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      .+...+.++.+++.+|++.||++||++.+|+++|++.
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            1223456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-35  Score=311.82  Aligned_cols=250  Identities=28%  Similarity=0.432  Sum_probs=205.1

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|.+.+.||+|++|.||+++.. +++.|++|.+...  .....+.+.+|++++++++||||+++++++.+....++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677899999999999999876 5889999998643  334567899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++... ....+++..+.+++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998653 2457889999999999999999999988   99999999999999999999999999987654322


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                      .  .....|++.|+|||++.+..++.++|+||||+++|||++|+.|+..........    ... .+.    . +     
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~-~~~----~-~-----  219 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL----KII-RGV----F-P-----  219 (256)
T ss_pred             h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHH-cCC----C-C-----
Confidence            1  223468899999999999999999999999999999999999986543221111    000 000    0 0     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ..+......+.+++.+|++.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1222345678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-36  Score=332.87  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=199.5

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||.||+++.. +++.||||++.+..   ......+.+|+.++..++||||+++++.+.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999976 58899999997532   233466889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999853   346899999999999999999999998   999999999999999999999999998765322


Q ss_pred             CCcc------------------------------------ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh
Q 003628          637 QDQA------------------------------------DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS  680 (807)
Q Consensus       637 ~~~~------------------------------------~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt  680 (807)
                      ....                                    .....+||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1100                                    0012469999999999999999999999999999999999


Q ss_pred             CCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCC---HHHHHHH
Q 003628          681 GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN---MSTVVSM  752 (807)
Q Consensus       681 G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~ev~~~  752 (807)
                      |+.||..........    .......       .+... .......++.+++.+|+. +|.+|++   ++|+++.
T Consensus       235 G~~Pf~~~~~~~~~~----~i~~~~~-------~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQETYR----KIINWKE-------TLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHHHHHH----HHHcCCC-------ccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999986443221111    1100000       00000 011123466788888886 8999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.3e-36  Score=333.15  Aligned_cols=254  Identities=23%  Similarity=0.271  Sum_probs=201.2

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ..++|++.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3467999999999999999999876 5889999999643   22334567899999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ||||+++|+|.+++..    ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999998843    35788888899999999999999998   9999999999999999999999999998654


Q ss_pred             CCCCccccceeeccCCccChhhhccC----CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEG----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  710 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~  710 (807)
                      ..... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||..........    .......    
T Consensus       194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~----~i~~~~~----  264 (370)
T cd05596         194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS----KIMDHKN----  264 (370)
T ss_pred             CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHH----HHHcCCC----
Confidence            32211 12235799999999998653    47889999999999999999999986533221111    1111000    


Q ss_pred             cCccccCCcccHHHHHHHHHHHHhcccCCcCC--CCCHHHHHHH
Q 003628          711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKD--RPNMSTVVSM  752 (807)
Q Consensus       711 ~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~ev~~~  752 (807)
                       .....   .......++.+++..||+.+|.+  ||+++|+++.
T Consensus       265 -~~~~~---~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 -SLTFP---DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -cCCCC---CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence             00010   11123567889999999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-35  Score=306.29  Aligned_cols=266  Identities=23%  Similarity=0.307  Sum_probs=203.2

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc--cHHHHHHHHHHHHhccCCc-eeEEeeEEEeCC------
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRN-LVRLLGCCVEGE------  550 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------  550 (807)
                      ..|...++||+|+||+||+|+.+ +|+.||+|+++-...+  ......+|+.++++++|+| |+++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            44666788999999999999865 6899999999765432  3456689999999999999 999999999877      


Q ss_pred             eEEEEEEecCCCCccccccCCCCC-CCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  629 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGl  629 (807)
                      ..++|+||++. +|..++...... ..++...+..++.||++||+|||+++   |+||||||+||||++.|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            78899999955 898888654322 35666789999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh-------h
Q 003628          630 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-------L  701 (807)
Q Consensus       630 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~-------~  701 (807)
                      |+.+.-....  ....++|..|.|||++.+. .|+...||||+|||+.||++++.-|....+...+......       .
T Consensus       167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9976533222  3335789999999999887 6999999999999999999998888766553333222111       1


Q ss_pred             ccccccccccCccccCC----cccHHH---HHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          702 WNENKILALVDPFLSES----SFQLDM---IIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~----~~~~~~---~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      |..-......++.....    ......   .....+++.+|++.+|++|.|++..+++
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111111111111110    011111   1477899999999999999999999876

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6e-36  Score=328.84  Aligned_cols=261  Identities=28%  Similarity=0.374  Sum_probs=202.6

Q ss_pred             cCCcccCccccCCCccEEEEEe------cCCcEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeC-Ce
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG-EE  551 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~  551 (807)
                      ++|++.+.||+|+||.||+|+.      .+++.||||+++... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5789999999999999999973      346789999997543 23456788999999999 789999999988654 45


Q ss_pred             EEEEEEecCCCCccccccCCCC----------------------------------------------------------
Q 003628          552 KMLIYEYMPNRSLDALLFDPLK----------------------------------------------------------  573 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  573 (807)
                      .++||||+++|+|.+++.....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999988853210                                                          


Q ss_pred             ------CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccceeec
Q 003628          574 ------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG  647 (807)
Q Consensus       574 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  647 (807)
                            ...+++..+.+++.||++||+|||+.+   |+||||||+||++++++.+||+|||+++...............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                  124678888999999999999999998   99999999999999999999999999987543322222222345


Q ss_pred             cCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHH
Q 003628          648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMII  726 (807)
Q Consensus       648 t~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  726 (807)
                      +..|+|||.+.+..++.++||||||+++|||++ |..|+........+..    ....+..     ..     .+.....
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~~-----~~-----~~~~~~~  309 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR----RLKEGTR-----MR-----APDYTTP  309 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH----HHhccCC-----CC-----CCCCCCH
Confidence            678999999999999999999999999999997 8888764332211111    1111110     00     0111234


Q ss_pred             HHHHHHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          727 RCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       727 ~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                      ++.+++..|++.+|++||++.||++.|+.+++
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            67899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-35  Score=312.18  Aligned_cols=253  Identities=30%  Similarity=0.451  Sum_probs=202.7

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      ++|.+.+.||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4588889999999999999998877789999886432 34577899999999999999999999875 456789999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++........ 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            99999998643 3345889999999999999999999988   999999999999999999999999999866432211 


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.|+....+..... ..   . .+     ..+     .
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~---~-~~-----~~~-----~  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE-QV---E-RG-----YRM-----P  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HH---H-cC-----CCC-----C
Confidence            1112345678999999998899999999999999999999 888876433221111 10   0 00     000     1


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                      .+...+..+.+++.+|++.+|++||++++|++.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            222345678899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.1e-35  Score=312.05  Aligned_cols=259  Identities=23%  Similarity=0.367  Sum_probs=209.0

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999987 7899999988642   2233578999999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          557 EYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      ||+++++|.+++.+.. ....+++.++..++.++++||.|||+.+   |+||||+|+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886432 2456889999999999999999999998   99999999999999999999999999886543


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ....  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.....  ........ ...+..     +..
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~-~~~~~~-----~~~  228 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKK-IEKCDY-----PPL  228 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhh-hhcCCC-----CCC
Confidence            2211  1224688999999999988899999999999999999999999853321  11111111 001100     001


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                          ........+.+++.+|++.+|++|||+.+|+++|+..
T Consensus       229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                1113456788999999999999999999999999765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.9e-36  Score=315.46  Aligned_cols=256  Identities=27%  Similarity=0.471  Sum_probs=204.3

Q ss_pred             cCCcccCccccCCCccEEEEEecC-C---cEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-G---QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ++|+..+.||+|+||.||+|+... +   ..+|+|.+.... ....+.+..|++++++++|+||+++++++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            467788999999999999998753 3   379999986542 33457799999999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+++++|.+++..  +...+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999854  2356899999999999999999999998   99999999999999999999999999986643


Q ss_pred             CCCcccc-ceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          636 NQDQADT-GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       636 ~~~~~~~-~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ....... .....+..|+|||++....++.++||||||+++|||++ |+.|+.........    .... .+        
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~----~~i~-~~--------  226 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM----KAIN-DG--------  226 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH----HHHh-cC--------
Confidence            3221111 11223457999999998889999999999999999998 99998643322111    1110 10        


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                       .. .+...+.+.++.+++.+|++.+|++||++.+|++.|+++
T Consensus       227 -~~-~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 -FR-LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -CC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             00 001223346788999999999999999999999999775

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.5e-36  Score=315.42  Aligned_cols=254  Identities=22%  Similarity=0.369  Sum_probs=202.6

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++||||+++++.+..+...++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            57899999999999999999964 68899999997655555677889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..... 
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            99999998843   346889999999999999999999988   99999999999999999999999999986643221 


Q ss_pred             cccceeeccCCccChhhhc---cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          640 ADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~---~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                       ......|+..|+|||.+.   ...++.++||||||+++|||++|+.|+............     ....   ...+...
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----~~~~---~~~~~~~  232 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----SKSN---FQPPKLK  232 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----ecCC---CCCCCCc
Confidence             112246889999999884   345788999999999999999999997533221111100     0000   0011111


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                         ........+.+++.+|++.+|++|||+++|++.|
T Consensus       233 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 ---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence               1122346788999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.5e-36  Score=319.81  Aligned_cols=260  Identities=27%  Similarity=0.441  Sum_probs=203.6

Q ss_pred             HhcCCcccCccccCCCccEEEEEec------CCcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCe
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  551 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  551 (807)
                      ..++|++.++||+|+||.||+|..+      .+..||+|.+..... .....+.+|+.++++++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4568999999999999999999754      245799998864432 234568899999999999999999999999999


Q ss_pred             EEEEEEecCCCCccccccCCCC-------CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCcee
Q 003628          552 KMLIYEYMPNRSLDALLFDPLK-------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  624 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL  624 (807)
                      .++||||+++|+|.+++.....       ...+++..+.+++.|++.||.|||+.+   |+||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999954211       234566778899999999999999998   999999999999999999999


Q ss_pred             eccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhcc
Q 003628          625 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWN  703 (807)
Q Consensus       625 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~  703 (807)
                      +|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ....   .. 
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-~~~~---~~-  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-VLKF---VM-  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH---HH-
Confidence            99999986543322222222345678999999999999999999999999999999 677875432221 1110   00 


Q ss_pred             ccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          704 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       704 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      .+..     ..     .+......+.+++.+|++.+|++|||+.++++.|++.
T Consensus       236 ~~~~-----~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         236 DGGY-----LD-----QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             cCCC-----CC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            0100     00     1122346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-35  Score=313.90  Aligned_cols=259  Identities=22%  Similarity=0.357  Sum_probs=208.2

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|++|.||+++.. ++..+|||.+....   ....+++.+|+.+++.++|+||+++++++.+++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999964 78999999886532   233467899999999999999999999999999999999


Q ss_pred             EecCCCCccccccCC-CCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          557 EYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       557 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      ||+++++|.+++... .....+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988532 23456899999999999999999999998   99999999999999999999999999886643


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ....  .....|+..|+|||.+.+..++.++|+||||+++|||++|..|+.....+  .......      +.....+..
T Consensus       159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~------~~~~~~~~~  228 (267)
T cd08229         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKK------IEQCDYPPL  228 (267)
T ss_pred             CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhh------hhcCCCCCC
Confidence            3221  12246889999999999889999999999999999999999998533211  1111110      111111111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                          .......++.+++.+|++.+|++||||.+|++++++.
T Consensus       229 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         229 ----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                1123456788999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.7e-36  Score=323.33  Aligned_cols=261  Identities=25%  Similarity=0.404  Sum_probs=206.6

Q ss_pred             HhcCCcccCccccCCCccEEEEEec--------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeEEeeEEEe
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE  548 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  548 (807)
                      ..++|.+.+.||+|+||.||+++..        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3467888999999999999999741        24579999986542 34457899999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCccccccCCC-------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCee
Q 003628          549 GEEKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL  615 (807)
Q Consensus       549 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIl  615 (807)
                      ....++||||+++++|.+++....             ....+++.++..++.||++||.|||+.+   ++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            999999999999999999986531             1235788889999999999999999998   999999999999


Q ss_pred             ecCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchh
Q 003628          616 LDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTI  694 (807)
Q Consensus       616 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l  694 (807)
                      +++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.......  
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--  247 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  247 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence            99999999999999987644332222222345678999999998889999999999999999998 777765332111  


Q ss_pred             hhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          695 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       695 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                        ..... ..+..       .   ..+......+.+++.+|++.+|++||++.||++.|++++
T Consensus       248 --~~~~~-~~~~~-------~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         248 --LFKLL-KEGHR-------M---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             --HHHHH-HcCCc-------C---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence              11111 11110       0   011234567889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6e-36  Score=322.08  Aligned_cols=259  Identities=26%  Similarity=0.366  Sum_probs=202.3

Q ss_pred             cCCcccCccccCCCccEEEEEecC-C--cEEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-G--QEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g--~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999998764 3  34788888643 333456799999999999 799999999999999999999


Q ss_pred             EEecCCCCccccccCCC-------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCc
Q 003628          556 YEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  622 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~  622 (807)
                      +||+++++|.+++....             ....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985421             1135888899999999999999999988   9999999999999999999


Q ss_pred             eeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhh
Q 003628          623 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  701 (807)
Q Consensus       623 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~  701 (807)
                      ||+|||++......   ........+..|+|||++....++.++||||||+++|||++ |..||..........    . 
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~----~-  230 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE----K-  230 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----H-
Confidence            99999998643211   11111223557999999998899999999999999999998 999986433211110    0 


Q ss_pred             ccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCC
Q 003628          702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  760 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~  760 (807)
                      ...+     ..+.     .+......+.+++.+|++.+|.+||++++|++.|+...+..
T Consensus       231 ~~~~-----~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         231 LPQG-----YRME-----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HhcC-----CCCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            0000     0000     11223456889999999999999999999999998875433

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8e-36  Score=325.87  Aligned_cols=246  Identities=24%  Similarity=0.312  Sum_probs=195.1

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+++.. +++.||||++++..   ....+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999876 58899999997532   23346688999999998 799999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence            999888743   357999999999999999999999998   9999999999999999999999999987432211  12


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCc----chhhhhhhhhccccccccccCccccC
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD----LTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~----~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .....+........        ... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~-  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------QIR-  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------CCC-
Confidence            23357899999999999999999999999999999999999999643211    11111111111111        110 


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCC------HHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPN------MSTVVS  751 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~ev~~  751 (807)
                        .+.....++.+++.+|++.||.+||+      ++++++
T Consensus       224 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 --IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             --CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence              12223456889999999999999997      567764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.7e-36  Score=329.99  Aligned_cols=254  Identities=21%  Similarity=0.261  Sum_probs=199.2

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ..++|++.+.||+|+||.||+++.. +++.+|+|.+.+.   .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3468999999999999999999976 5788999998642   22334568899999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus       121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999999843    35788899999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCCccccceeeccCCccChhhhccCC----CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGR----FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  710 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~----~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~  710 (807)
                      .... .......||+.|+|||++....    ++.++||||+||++|||++|+.||..........    ........   
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~----~i~~~~~~---  265 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS----KIMDHKNS---  265 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCcc---
Confidence            3221 1223357999999999987543    7889999999999999999999996543221111    11110000   


Q ss_pred             cCccccCCcccHHHHHHHHHHHHhcccCCcCC--CCCHHHHHHH
Q 003628          711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKD--RPNMSTVVSM  752 (807)
Q Consensus       711 ~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~ev~~~  752 (807)
                        ....   ........+.+++..|++.++.+  ||++.|+++.
T Consensus       266 --~~~p---~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 --LNFP---EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --cCCC---CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              0010   11223456778888899865544  8999999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.6e-36  Score=323.89  Aligned_cols=261  Identities=26%  Similarity=0.397  Sum_probs=205.3

Q ss_pred             hcCCcccCccccCCCccEEEEEec--------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeC
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG  549 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  549 (807)
                      .++|.+.+.||+|+||.||+++..        ....+|+|.+.... .....++.+|+.++.++ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357899999999999999999753        23569999997542 33456788999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCCccccccCCCC-------------CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeee
Q 003628          550 EEKMLIYEYMPNRSLDALLFDPLK-------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL  616 (807)
Q Consensus       550 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll  616 (807)
                      ...++||||+++++|.+++.....             ...+++.++++++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999965321             235888999999999999999999988   9999999999999


Q ss_pred             cCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhh
Q 003628          617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTIL  695 (807)
Q Consensus       617 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~  695 (807)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... +.
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-~~  252 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LF  252 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-HH
Confidence            9999999999999986543221111211234568999999998889999999999999999998 788875432111 11


Q ss_pred             hhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          696 GYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       696 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                         .. ...+..       .   ..+.....++.+++.+|++.+|++||+|.+|++.|+.++.
T Consensus       253 ---~~-~~~~~~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         253 ---KL-LKEGHR-------M---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             ---HH-HHcCCC-------C---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence               11 111100       0   1222345678899999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.5e-36  Score=315.51  Aligned_cols=256  Identities=27%  Similarity=0.464  Sum_probs=202.8

Q ss_pred             cCCcccCccccCCCccEEEEEecC-C---cEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-G---QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g---~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ..|++.+.||+|+||.||+|+... +   ..||||.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357788999999999999998753 3   36999998754 333457899999999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+++++|.+++..  ....+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999854  2356899999999999999999999988   99999999999999999999999999886643


Q ss_pred             CCCccc-cceee--ccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          636 NQDQAD-TGRVV--GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       636 ~~~~~~-~~~~~--gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ...... .....  .+..|+|||.+....++.++||||||+++|||++ |..|+....... ......   ..      .
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-~~~~i~---~~------~  228 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VINAIE---QD------Y  228 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-HHHHHH---cC------C
Confidence            222111 11111  2357999999999999999999999999999886 998885433221 111110   00      0


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                        .+   +.+.+.+..+.+++.+|++.+|++||++++|+++|++.
T Consensus       229 --~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 --RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              00   01223345678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-36  Score=331.97  Aligned_cols=253  Identities=23%  Similarity=0.307  Sum_probs=197.3

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|.+.++||+|+||.||+++.. +++.||||++.+..   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999865 68899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999853   356888899999999999999999998   999999999999999999999999999743211


Q ss_pred             CCc-----------c----------------------------------ccceeeccCCccChhhhccCCCCcccceeeh
Q 003628          637 QDQ-----------A----------------------------------DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSF  671 (807)
Q Consensus       637 ~~~-----------~----------------------------------~~~~~~gt~~y~APE~~~~~~~t~k~DvwSl  671 (807)
                      ...           .                                  ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000           0                                  0012469999999999999999999999999


Q ss_pred             hHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCC---CCHHH
Q 003628          672 GVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDR---PNMST  748 (807)
Q Consensus       672 Gvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~e  748 (807)
                      ||++|||++|+.||..........    ..........     +.   .......++.+++.+|++ +|.+|   |++.|
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~~-----~p---~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYR----KIINWRETLY-----FP---DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHH----HHHccCCccC-----CC---CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            999999999999986533221111    1110000000     00   011234567788999997 66665   59999


Q ss_pred             HHHH
Q 003628          749 VVSM  752 (807)
Q Consensus       749 v~~~  752 (807)
                      +++.
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            8875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=9.8e-36  Score=332.16  Aligned_cols=251  Identities=22%  Similarity=0.286  Sum_probs=193.9

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      +|.+.++||+|+||.||+|+.. +++.||||++.+..   ....+.+.+|+.++++++|+||+++++.+.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788999999999999999875 57899999997542   2335678899999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999998853   346888888999999999999999998   9999999999999999999999999986432100


Q ss_pred             C---------------------------------------------ccccceeeccCCccChhhhccCCCCcccceeehh
Q 003628          638 D---------------------------------------------QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFG  672 (807)
Q Consensus       638 ~---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlG  672 (807)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001124699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCC---HHHH
Q 003628          673 VLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN---MSTV  749 (807)
Q Consensus       673 vvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~ev  749 (807)
                      |++|||++|+.||............    ...       ...+... .......++.+++.+++ .+|++|++   +.++
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i----~~~-------~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKV----INW-------QTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHH----Hcc-------CCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            9999999999999754322211110    000       0000000 11122344556666655 49999997   7777


Q ss_pred             HH
Q 003628          750 VS  751 (807)
Q Consensus       750 ~~  751 (807)
                      ++
T Consensus       303 ~~  304 (382)
T cd05625         303 KA  304 (382)
T ss_pred             hc
Confidence            65

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-35  Score=316.83  Aligned_cols=255  Identities=25%  Similarity=0.400  Sum_probs=201.5

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCc----EEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ++|++.++||+|+||.||+|+.. ++.    .||+|.++... ....+.+.+|+.++..++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            56888899999999999999854 444    48999987543 3345678999999999999999999999875 45679


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ++||+++|+|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        86 ~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            9999999999999854  2356899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .+.....    .+..     +
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~----~~~~-----~  230 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-EIPDLLE----KGER-----L  230 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH----CCCc-----C
Confidence            3322211212234678999999999999999999999999999998 88887543221 1111111    1100     0


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                           +.+.....++.+++.+|++.||++||++.++++.|+..
T Consensus       231 -----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                 01122345678999999999999999999999999776

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1e-35  Score=323.53  Aligned_cols=242  Identities=27%  Similarity=0.331  Sum_probs=196.0

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+++.. +++.||||++++.   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 4789999999754   233456778899999888 799999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      ++|..++..   ...+++.++..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            999888743   347899999999999999999999998   9999999999999999999999999987532221  12


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||...+......    ... ...      ..     .+
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~----~i~-~~~------~~-----~~  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ----SIL-EDE------VR-----YP  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH----HHH-cCC------CC-----CC
Confidence            233578999999999999999999999999999999999999986443221111    110 000      00     12


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCH-----HHHHHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNM-----STVVSM  752 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~-----~ev~~~  752 (807)
                      .....++.+++.+||+.||++||++     .++++.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            2234578899999999999999999     777653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2e-35  Score=317.92  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=205.0

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999864 68899999997665556678999999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++.    ...+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++........
T Consensus       100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            9999999984    345788999999999999999999998   999999999999999999999999998865432211


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                        .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........+...    ...+      .+.+.   
T Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~----~~~~------~~~~~---  237 (296)
T cd06654         173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----ATNG------TPELQ---  237 (296)
T ss_pred             --cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH----hcCC------CCCCC---
Confidence              12246889999999999888999999999999999999999998643322111110    0000      01111   


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .+......+.+++.+|+..+|++||++.||++.
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            122345678899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=307.49  Aligned_cols=268  Identities=22%  Similarity=0.326  Sum_probs=204.9

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEe-----CC
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-----GE  550 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~  550 (807)
                      +...|...+.||+|+||.|..+..+ +|..||||++...  .....++..+|+++|+.++|+||+.+++.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            4456666799999999999999876 6899999999743  44456889999999999999999999999875     34


Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla  630 (807)
                      ..|+|+|+| ..+|...+.   ..+.++..+..-++.||++||.|+|+.+   |+||||||.|++++.+..+||+|||+|
T Consensus       100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence            679999999 668999884   2344999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhh----------
Q 003628          631 KIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW----------  699 (807)
Q Consensus       631 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~----------  699 (807)
                      |...........+..+.|..|.|||++.. ..|+.+.||||.||||.||++|++-|...+.-..+.....          
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            98765433333455788999999998854 5699999999999999999999998876553211111000          


Q ss_pred             hhccccccccccCc--cccCCccc---HHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          700 KLWNENKILALVDP--FLSESSFQ---LDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       700 ~~~~~~~~~~~~d~--~l~~~~~~---~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      ...........+..  .....++.   .+.....++|..+||..||.+|+|++|.++.-
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence            00010111111110  11111111   12346788999999999999999999987653

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-35  Score=309.41  Aligned_cols=247  Identities=28%  Similarity=0.400  Sum_probs=198.6

Q ss_pred             CccccCCCccEEEEEecCCcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCcc
Q 003628          487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD  565 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  565 (807)
                      ++||+|+||.||+|...+++.+|+|.+...... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            479999999999999888899999998765432 3457899999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcccccee
Q 003628          566 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV  645 (807)
Q Consensus       566 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  645 (807)
                      +++..  ....+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........ .....
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            98854  2346889999999999999999999988   999999999999999999999999998754322211 11112


Q ss_pred             eccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHH
Q 003628          646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  724 (807)
Q Consensus       646 ~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  724 (807)
                      .++..|+|||++....++.++||||||+++|||++ |..|+..........    . ...+     ....     .+...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----~-~~~~-----~~~~-----~~~~~  219 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE----Q-VEKG-----YRMS-----CPQKC  219 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----H-HHcC-----CCCC-----CCCCC
Confidence            34678999999998899999999999999999998 888886432221110    0 0000     0000     12224


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          725 IIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       725 ~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      +..+.+++.+|++.+|++||++.|+++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            567889999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-35  Score=310.91  Aligned_cols=255  Identities=31%  Similarity=0.470  Sum_probs=207.2

Q ss_pred             hcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .++|.+.++||+|+||.||++..++++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46788999999999999999998888899999986533 34578999999999999999999999999889999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++... ....+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+......
T Consensus        84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            999999998653 2346899999999999999999999998   999999999999999999999999999876432111


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                       ......++..|+|||.+.+..++.++|+||||+++|||++ |+.|+........+.....          ....     
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~----------~~~~-----  223 (261)
T cd05034         160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER----------GYRM-----  223 (261)
T ss_pred             -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----------CCCC-----
Confidence             1112234578999999998899999999999999999999 8988864332221111100          0000     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                      ..+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            0112235678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.2e-35  Score=311.53  Aligned_cols=254  Identities=27%  Similarity=0.398  Sum_probs=193.8

Q ss_pred             CccccCCCccEEEEEecC---CcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          487 SKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~---g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      +.||+|+||.||+|...+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            469999999999998653   45799999875432 33457899999999999999999999999999999999999999


Q ss_pred             CccccccCCCC--CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          563 SLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       563 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +|.+++.....  ....++..+.+++.|+++||.|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999864321  234567778899999999999999998   9999999999999999999999999997544332222


Q ss_pred             ccceeeccCCccChhhhccC-------CCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccC
Q 003628          641 DTGRVVGTFGYMSPEYAMEG-------RFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVD  712 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~-------~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d  712 (807)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||.......... ..   . .+......+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-~~---~-~~~~~~~~~  232 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-YT---V-REQQLKLPK  232 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-HH---h-hcccCCCCC
Confidence            22234577889999988642       35789999999999999996 999986544332211 10   0 111112222


Q ss_pred             ccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       713 ~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      +.+..     .....+.+++..|+ .+|++|||++||++.|+
T Consensus       233 ~~~~~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRLKL-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CccCC-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22221     12345677888998 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1e-35  Score=323.18  Aligned_cols=240  Identities=27%  Similarity=0.329  Sum_probs=192.3

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+++.. +|+.||+|.+++..   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999976 58899999997542   23456677888888765 899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      |+|..++..   ...+++.++..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            999988843   356889999999999999999999998   9999999999999999999999999987432111  12


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+...... ..    ..      ..+.     .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~-~~----~~------~~~~-----~~  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE-SI----RV------DTPH-----YP  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-HH----Hh------CCCC-----CC
Confidence            233578999999999999999999999999999999999999986433221111 00    00      0111     11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHH-HHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMS-TVV  750 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~-ev~  750 (807)
                      .....++.+++.+|++.||++||++. ++.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            12345678999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.7e-35  Score=317.04  Aligned_cols=258  Identities=27%  Similarity=0.480  Sum_probs=203.6

Q ss_pred             hcCCcccCccccCCCccEEEEEec------CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  552 (807)
                      .++|++.+.||+|+||.||++...      ++..||+|.+.... ....++|.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            357889999999999999999864      46789999987543 23456799999999999999999999999999999


Q ss_pred             EEEEEecCCCCccccccCCC-------------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCC
Q 003628          553 MLIYEYMPNRSLDALLFDPL-------------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN  613 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~N  613 (807)
                      ++||||+++++|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999985321                   1134778889999999999999999988   9999999999


Q ss_pred             eeecCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcc
Q 003628          614 ILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDL  692 (807)
Q Consensus       614 Ill~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~  692 (807)
                      |++++++.+||+|||+++................+..|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999886543322111222334678999999998999999999999999999998 777775322211


Q ss_pred             hhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          693 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       693 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                       ..   . ....+...          ..+...+.++.+++.+|++.+|++|||+.|+++.|++
T Consensus       241 -~~---~-~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 -VI---Y-YVRDGNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -HH---H-HHhcCCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence             11   1 11111110          0112234678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.6e-35  Score=321.67  Aligned_cols=241  Identities=27%  Similarity=0.358  Sum_probs=192.9

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+|+.. +++.||||.++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 47899999997542   23446677788888764 899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      |+|.+++..   ...+++.++..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            999998843   346888999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......     ...      ..+.     .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~-----i~~------~~~~-----~~  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS-----IRM------DNPC-----YP  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHh------CCCC-----CC
Confidence            2335789999999999999999999999999999999999999865432211110     000      0111     11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHH-HHHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMS-TVVS  751 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~-ev~~  751 (807)
                      .....++.+++.+|++.+|++||++. ++.+
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            12345678999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-35  Score=328.66  Aligned_cols=202  Identities=26%  Similarity=0.370  Sum_probs=175.0

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||+||+++.. +++.||||++++..   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999875 58899999997532   233467889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999853   457899999999999999999999998   999999999999999999999999999865321


Q ss_pred             CCc---------------------------------cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCC
Q 003628          637 QDQ---------------------------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK  683 (807)
Q Consensus       637 ~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~  683 (807)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCCcc
Q 003628          684 NTSFF  688 (807)
Q Consensus       684 p~~~~  688 (807)
                      ||...
T Consensus       235 Pf~~~  239 (363)
T cd05628         235 PFCSE  239 (363)
T ss_pred             CCCCC
Confidence            99643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9e-36  Score=331.78  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=196.6

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      .+|++.+.||+|+||.||+++.. +++.||||++.+..   ....+.+.+|++++++++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999875 58899999986532   233567889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999999853   346788888899999999999999998   999999999999999999999999998533210


Q ss_pred             CC-----------------------------------------ccccceeeccCCccChhhhccCCCCcccceeehhHHH
Q 003628          637 QD-----------------------------------------QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLL  675 (807)
Q Consensus       637 ~~-----------------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl  675 (807)
                      ..                                         ........||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            00                                         0001124699999999999999999999999999999


Q ss_pred             HHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCC---CHHHHHHH
Q 003628          676 LEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP---NMSTVVSM  752 (807)
Q Consensus       676 ~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RP---t~~ev~~~  752 (807)
                      |||++|+.||............    .....  ....+      .......++.+++.+|+ .+|.+|+   ++.|+++.
T Consensus       235 yell~G~~Pf~~~~~~~~~~~i----~~~~~--~~~~~------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLKV----INWET--TLHIP------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHHH----hccCc--cccCC------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999999754432211110    00000  00000      01122345566777765 4999999   88888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-35  Score=308.41  Aligned_cols=248  Identities=30%  Similarity=0.432  Sum_probs=199.6

Q ss_pred             CccccCCCccEEEEEecCCcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCcc
Q 003628          487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD  565 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  565 (807)
                      ++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999998765433 4578999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcccccee
Q 003628          566 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV  645 (807)
Q Consensus       566 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  645 (807)
                      +++...  ...+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||+++..............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998542  346788899999999999999999998   999999999999999999999999999865422211111122


Q ss_pred             eccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHH
Q 003628          646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  724 (807)
Q Consensus       646 ~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  724 (807)
                      ..+..|+|||.+.+..++.++|+||||+++|||++ |..|+.......... .             +..... ...+...
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~-~-------------~~~~~~-~~~~~~~  220 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-R-------------IESGYR-MPAPQLC  220 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH-H-------------HhcCCC-CCCCccC
Confidence            34567999999998899999999999999999999 777775433211111 0             000000 0122234


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          725 IIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       725 ~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      +.++.+++.+|++.+|.+|||+.||++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.9e-36  Score=324.72  Aligned_cols=237  Identities=24%  Similarity=0.295  Sum_probs=188.8

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHH-HHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+++.. +|+.||||++.+..   ....+.+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999976 68999999996532   223345555555 46778999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      |+|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence            999988843   456888999999999999999999998   9999999999999999999999999987532221  12


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....    .....         ....   ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~i~~---------~~~~---~~  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY----DNILN---------KPLR---LK  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH----HHHHc---------CCCC---CC
Confidence            23357899999999999999999999999999999999999998643321111    11110         0000   11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMS  747 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~  747 (807)
                      ......+.+++.+|++.||++||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            12356688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.8e-35  Score=310.91  Aligned_cols=249  Identities=29%  Similarity=0.407  Sum_probs=200.3

Q ss_pred             CccccCCCccEEEEEecC--C--cEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLKD--G--QEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~--g--~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999998753  2  3699999987655 556789999999999999999999999988 888999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc-c
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-A  640 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~-~  640 (807)
                      ++|.+++.+... ..+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865322 56899999999999999999999998   999999999999999999999999999877543221 1


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...........    .....       ....   
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~~~~-------~~~~---  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK----IDKEG-------ERLE---  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhcC-------CcCC---
Confidence            1122456789999999999999999999999999999999 9999864332221111    00000       0000   


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      .+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11223467889999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-35  Score=308.61  Aligned_cols=250  Identities=35%  Similarity=0.512  Sum_probs=204.6

Q ss_pred             CccccCCCccEEEEEecC----CcEEEEEEecccCccc-HHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||++....    +..||+|.+....... .+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998764    7889999997654333 68899999999999999999999999999999999999999


Q ss_pred             CCccccccCCCC------CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          562 RSLDALLFDPLK------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       562 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      ++|.+++.....      ...+++.++.+++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965321      367999999999999999999999988   99999999999999999999999999997755


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      ...........++..|+|||.+....++.++||||+|+++|||++ |+.|+....... +...    ...+.       .
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~----~~~~~-------~  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEY----LRKGY-------R  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-HHHH----HHcCC-------C
Confidence            432222333567889999999998899999999999999999999 588886543221 1111    10100       0


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      .   ..+.....++.+++.+|++.+|++|||+.|++++|+
T Consensus       226 ~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 L---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0   122233567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-35  Score=319.89  Aligned_cols=260  Identities=25%  Similarity=0.414  Sum_probs=204.6

Q ss_pred             cCCcccCccccCCCccEEEEEec--------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCC
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE  550 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  550 (807)
                      ++|.+.++||+|+||.||+++..        ....+|+|.++... ......+.+|+.+++++ +||||+++++++.+..
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57888999999999999999742        24569999987542 33456789999999999 6999999999999999


Q ss_pred             eEEEEEEecCCCCccccccCCC-------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeec
Q 003628          551 EKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD  617 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~  617 (807)
                      ..++||||+++|+|.+++....             ....+++.++.+++.||+.||.|||+.+   ++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999986421             1245888999999999999999999988   99999999999999


Q ss_pred             CCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhh
Q 003628          618 EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILG  696 (807)
Q Consensus       618 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~  696 (807)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... +..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-~~~  247 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-LFK  247 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-HHH
Confidence            999999999999986643222211222234567999999999999999999999999999999 888875433211 111


Q ss_pred             hhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          697 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       697 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                      .    ...+...          ..+.....++.+++.+|++.+|++|||+.|+++.|++...
T Consensus       248 ~----~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         248 L----LREGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             H----HHcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            1    1111100          0122234577899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=311.12  Aligned_cols=252  Identities=28%  Similarity=0.405  Sum_probs=202.4

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-----cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ++|.+.+.||+|++|.||++... +++.+|+|.+....     ....+.+.+|++++++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999865 58999999986432     1234578899999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      |+||+++++|.+++..   ...+++..+.+++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998853   346888899999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCCccc-cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          635 GNQDQAD-TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       635 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...+.........    ...     ..+
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~-----~~~  226 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA----TQP-----TNP  226 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh----ccC-----CCC
Confidence            3221111 122457889999999999899999999999999999999999986432221111100    000     001


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .     .+......+.+++.+|+..+|.+|||+.++++.
T Consensus       227 ~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         227 Q-----LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             C-----CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            1     222345578899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-35  Score=319.97  Aligned_cols=257  Identities=29%  Similarity=0.432  Sum_probs=201.2

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCc--EEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ--EIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~--~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ++|++.+.||+|+||.||+|... ++.  .+|+|.+.... ....+.+.+|++++.++ +|+||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57888899999999999999875 344  46888776432 33456789999999999 899999999999999999999


Q ss_pred             EEecCCCCccccccCCC-------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCc
Q 003628          556 YEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  622 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~  622 (807)
                      |||+++++|.+++....             ....+++.+++.++.||++||+|||+.+   ++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999986421             1235788999999999999999999988   9999999999999999999


Q ss_pred             eeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhh
Q 003628          623 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  701 (807)
Q Consensus       623 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~  701 (807)
                      ||+|||+++.....   .......++..|+|||++....++.++||||||+++|||+| |..|+........ ..   ..
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~---~~  236 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YE---KL  236 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-HH---HH
Confidence            99999998632111   11111234667999999988889999999999999999998 9998864332211 10   00


Q ss_pred             ccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                       ..+     .  ...   .+......+.+++.+|++.+|++||++++++++|+..+.
T Consensus       237 -~~~-----~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         237 -PQG-----Y--RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             -hcC-----C--cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             000     0  000   111234567899999999999999999999999977643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=310.46  Aligned_cols=250  Identities=31%  Similarity=0.448  Sum_probs=205.0

Q ss_pred             hcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .++|++.+.||+|+||.||++... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888899999999999999876 78999999976544 5678999999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            999999998543 2236899999999999999999999998   99999999999999999999999999986632221 


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                          ....+..|+|||.+....++.++||||||+++|||++ |+.|+....... +.....    .+     ....    
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~----~~-----~~~~----  219 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPHVE----KG-----YRME----  219 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHh----cC-----CCCC----
Confidence                1234668999999998899999999999999999997 888876433221 111110    00     0000    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                       .+...+.++.+++.+|+..+|++||+++|++++|++
T Consensus       220 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         220 -APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             -CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence             112234678899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.6e-35  Score=311.86  Aligned_cols=256  Identities=28%  Similarity=0.464  Sum_probs=203.9

Q ss_pred             cCCcccCccccCCCccEEEEEec----CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      .+|++.+.||+|+||.||+|+..    .+..+|+|.++... ....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46888999999999999999864    23479999986543 23456889999999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+++++|.+++..  ....+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999854  2346899999999999999999999998   99999999999999999999999999987644


Q ss_pred             CCCccc-cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          636 NQDQAD-TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       636 ~~~~~~-~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ...... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.|+.......... ..    .++     ...
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~-~~----~~~-----~~~  228 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK-AI----EEG-----YRL  228 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH-HH----hCC-----CcC
Confidence            322111 111223568999999998899999999999999999887 999986433221111 11    000     000


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                           +.+...+..+.+++.+|++.+|.+||+|.+|++.|++.
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 -----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                 01122345678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.5e-35  Score=309.28  Aligned_cols=248  Identities=27%  Similarity=0.428  Sum_probs=195.3

Q ss_pred             ccccCCCccEEEEEec---CCcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCC
Q 003628          488 KLGQGGFGPVYWGRLK---DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRS  563 (807)
Q Consensus       488 ~LG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  563 (807)
                      .||+|+||.||+|.+.   .+..||+|.+..... ...+.|.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999764   355799999875533 33467999999999999999999999875 457889999999999


Q ss_pred             ccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc-c
Q 003628          564 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-T  642 (807)
Q Consensus       564 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~-~  642 (807)
                      |.+++..  ....+++..+.+++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.......... .
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999854  2456899999999999999999999998   99999999999999999999999999986543322111 1


Q ss_pred             ceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       643 ~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.|+......... .    ....+..          ...+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~----~~~~~~~----------~~~~  220 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-S----FIEQGKR----------LDCP  220 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-H----HHHCCCC----------CCCC
Confidence            11223578999999988889999999999999999996 99998643322111 1    1111100          0122


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      .....++.+++.+|++.+|++||++.+|.+.|+..
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            23456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4e-35  Score=312.36  Aligned_cols=247  Identities=24%  Similarity=0.326  Sum_probs=194.9

Q ss_pred             cccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCc
Q 003628          489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  564 (807)
Q Consensus       489 LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  564 (807)
                      ||+|+||.||+++.+ +|+.||+|.+....   ......+..|++++++++||||+++++.+.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999875 58999999986432   12234567799999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccce
Q 003628          565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  644 (807)
Q Consensus       565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  644 (807)
                      .+++... ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++........   ...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence            9887543 3345888999999999999999999988   99999999999999999999999999986643221   122


Q ss_pred             eeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHH
Q 003628          645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  724 (807)
Q Consensus       645 ~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  724 (807)
                      ..|+..|+|||++.+..++.++||||+||++|||++|+.|+.................         ......  .....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~--~~~~~  222 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL---------EDEVKF--EHQNF  222 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh---------cccccc--ccccC
Confidence            4689999999999998999999999999999999999999865433221111111111         001100  01123


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          725 IIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       725 ~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      ..++.+++..||+.||++||+++|+++.+
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            45678999999999999999998776544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.5e-35  Score=310.21  Aligned_cols=240  Identities=22%  Similarity=0.336  Sum_probs=189.4

Q ss_pred             CccccCCCccEEEEEecC-------------CcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEE
Q 003628          487 SKLGQGGFGPVYWGRLKD-------------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  553 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  553 (807)
                      +.||+|+||.||+|+...             ...||+|.+..........|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358999887655555678899999999999999999999999999999


Q ss_pred             EEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCC-------ceeec
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN-------PKISD  626 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~-------~kL~D  626 (807)
                      +||||+++++|+.++..  ....+++..+.+++.||++||+|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988753  3356899999999999999999999988   999999999999987664       89999


Q ss_pred             cccccccCCCCCccccceeeccCCccChhhhc-cCCCCcccceeehhHHHHHHH-hCCCCCCccCCcchhhhhhhhhccc
Q 003628          627 FGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIV-SGRKNTSFFEDDLTILGYAWKLWNE  704 (807)
Q Consensus       627 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~k~DvwSlGvvl~ell-tG~~p~~~~~~~~~l~~~~~~~~~~  704 (807)
                      ||++......      ....++..|+|||.+. ...++.++||||||+++|||+ +|+.|+....... ..    ... .
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~----~~~-~  223 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KE----RFY-E  223 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-HH----HHH-h
Confidence            9998754322      1245788999999886 466899999999999999998 5777765322111 00    000 0


Q ss_pred             cccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          705 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       705 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      +..      ..     ......++.+++.+|++.||.+||++.+|++.|+
T Consensus       224 ~~~------~~-----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 GQC------ML-----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             cCc------cC-----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            000      00     1112356789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.6e-35  Score=312.60  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=201.6

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      |++.+.||+|+||.||++... .+..+++|.+........+.+.+|+++++.++||||+++++++..+...++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567789999999999999976 4778899998766656678899999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      ++|..++..  ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.......  .
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~  159 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R  159 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence            999888753  2356899999999999999999999998   99999999999999999999999999876533221  1


Q ss_pred             cceeeccCCccChhhhc-----cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          642 TGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~-----~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      .....++..|+|||++.     ...++.++|||||||++|||++|+.|+..............    .      ..+.+.
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~------~~~~~~  229 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK----S------EPPTLA  229 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh----c------CCCCCC
Confidence            22356899999999984     44578899999999999999999999865432222111110    0      001111


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                         .+.....++.+++.+|++.+|.+||++.++++.-
T Consensus       230 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         230 ---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence               1222346788999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.8e-35  Score=328.08  Aligned_cols=258  Identities=23%  Similarity=0.265  Sum_probs=201.1

Q ss_pred             HHHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCe
Q 003628          476 LATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  551 (807)
Q Consensus       476 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  551 (807)
                      +....++|++.+.||+|+||.||+++.. +++.+|+|.+.+.   .....+.+.+|+.+++.++||||+++++.+.++..
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3445588999999999999999999976 5788999998642   22334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      .++||||+++|+|.+++..    ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999998843    35788888999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCccccceeeccCCccChhhhccC----CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccc
Q 003628          632 IFGGNQDQADTGRVVGTFGYMSPEYAMEG----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI  707 (807)
Q Consensus       632 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~  707 (807)
                      ....... .......||+.|+|||++...    .++.++|||||||++|||++|+.||...+.....    .........
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~  265 (371)
T cd05622         191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----SKIMNHKNS  265 (371)
T ss_pred             EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCc
Confidence            7643221 112235799999999998754    3788999999999999999999999743321111    111111000


Q ss_pred             ccccCccccCCcccHHHHHHHHHHHHhcccCCcCC--CCCHHHHHHHH
Q 003628          708 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKD--RPNMSTVVSML  753 (807)
Q Consensus       708 ~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~ev~~~L  753 (807)
                      ..     ..   .......++.+++..|++.++.+  ||+++||++..
T Consensus       266 ~~-----~~---~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         266 LT-----FP---DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             cc-----CC---CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            00     00   11234556788999999854443  78999988754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.2e-35  Score=314.25  Aligned_cols=269  Identities=24%  Similarity=0.401  Sum_probs=201.8

Q ss_pred             CCcccCccccCCCccEEEEEe-----cCCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKM  553 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  553 (807)
                      .|++.+.||+|+||.||+++.     .++..||+|.++... ....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467889999999999999974     247889999987543 33456799999999999999999999998875  5678


Q ss_pred             EEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccccc
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~  633 (807)
                      +||||+++++|.+++..  ....+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.+
T Consensus        85 lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          85 LIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence            99999999999999853  2346899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCc-cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCc-chhhhhhhhhcccccccccc
Q 003628          634 GGNQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD-LTILGYAWKLWNENKILALV  711 (807)
Q Consensus       634 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++++.|....... .................+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            433221 1122345677899999999888999999999999999999987654221100 00000000000000000000


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      ..... .+.......++.+++.+|++.+|++||++.+|++.|+.+
T Consensus       240 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGKR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCcc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00000 001223456789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-35  Score=323.79  Aligned_cols=242  Identities=22%  Similarity=0.259  Sum_probs=190.8

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHH-HHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+++.. +|+.+|||++.+..   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999865 68999999986532   233455666655 46778999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      |+|..++.   +...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence            99988874   3457899999999999999999999998   9999999999999999999999999987532221  12


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....    ..... .        .+.   ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~----~~~~~-~--------~~~---~~  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY----DNILH-K--------PLV---LR  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH----HHHHc-C--------Ccc---CC
Confidence            23357999999999999999999999999999999999999998643322111    11110 0        000   11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ......+.+++..|++.+|.+||++.+.++.
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            1234567789999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.2e-35  Score=311.53  Aligned_cols=254  Identities=24%  Similarity=0.352  Sum_probs=190.6

Q ss_pred             CccccCCCccEEEEEecC---CcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          487 SKLGQGGFGPVYWGRLKD---GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~---g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      +.||+|+||.||+|...+   ...+|+|.+.... ......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   3568899876443 233467899999999999999999999999999999999999999


Q ss_pred             CccccccCCCC--CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          563 SLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       563 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +|.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865322  233567778899999999999999998   9999999999999999999999999987543322211


Q ss_pred             ccceeeccCCccChhhhcc-------CCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccC
Q 003628          641 DTGRVVGTFGYMSPEYAME-------GRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVD  712 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~-------~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d  712 (807)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..|+....+...+...    ... ......+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~----~~~-~~~~~~~  232 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV----VRE-QDIKLPK  232 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH----hhc-cCccCCC
Confidence            1222345678999998743       356889999999999999999 67777544332221111    111 1111222


Q ss_pred             ccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       713 ~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      +.+     +......+.+++..|+ .||++|||+++|+++|.
T Consensus       233 ~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 PQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             Ccc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            222     2233455667888888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.1e-35  Score=312.58  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=198.0

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|++++.+++||||+++++++......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            35778899999999999999864 6889999998654 233446799999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            9999996542       4677888899999999999999998   9999999999999999999999999998653321 


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                         .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+.............. ..  ..+.....+.+.. 
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~-  222 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ-LL--QCIVDEDPPVLPV-  222 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHH-HH--HHHhccCCCCCCC-
Confidence               2235689999999999998999999999999999999999999864332111100000 00  0000001111111 


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                         .....++.+++.+|++.+|++||+++|+++.
T Consensus       223 ---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         223 ---GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence               1234567899999999999999999998864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.2e-35  Score=345.64  Aligned_cols=263  Identities=21%  Similarity=0.325  Sum_probs=205.8

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.++||+|+||.||+|+.. .++.||||+++....   ...++|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999876 588999999975422   23467999999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCC--------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          557 EYMPNRSLDALLFDPL--------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                      ||+++++|.+++....        ....+++..+++++.||++||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1234566778899999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCC----------------ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcc
Q 003628          629 MAKIFGGNQD----------------QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL  692 (807)
Q Consensus       629 la~~~~~~~~----------------~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~  692 (807)
                      +++.......                ........||+.|+|||.+.+..++.++|||||||++|||++|+.|+.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987622110                011123469999999999999999999999999999999999999986422211


Q ss_pred             hhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCC-CHHHHHHHHhhccCC
Q 003628          693 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP-NMSTVVSMLNSEIRD  759 (807)
Q Consensus       693 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~ev~~~L~~~~~~  759 (807)
                      ...        ...   ..++....  ...+.+..+.+++.+|++.||++|| +++++.+.|+..+..
T Consensus       239 i~~--------~~~---i~~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 ISY--------RDV---ILSPIEVA--PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhh--------hhh---ccChhhcc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            000        000   00110000  0123445678999999999999995 677788888776543

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.4e-35  Score=321.20  Aligned_cols=241  Identities=26%  Similarity=0.359  Sum_probs=193.8

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~  556 (807)
                      +|...+.||+|+||.||+++.. +++.||||++.+.   .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667889999999999999875 5889999999753   2234567888999998885 578888999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999988843   356899999999999999999999998   999999999999999999999999998854322


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      .  .......||+.|+|||++.+..++.++||||||+++|||++|+.|+...........    .. ..        .. 
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~----i~-~~--------~~-  218 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS----IM-EH--------NV-  218 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HH-hC--------CC-
Confidence            1  112235689999999999999999999999999999999999999875432211111    00 00        00 


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNM  746 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~  746 (807)
                        ..+.....++.+++.+|++.+|.+|++.
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              0122234567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.8e-35  Score=312.27  Aligned_cols=253  Identities=26%  Similarity=0.396  Sum_probs=199.9

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeC------
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG------  549 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------  549 (807)
                      .+++.|++.+.||+|+||.||+|... +++.||+|.+... ......+..|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677888999999999999999875 5788999998644 34457789999999998 799999999998753      


Q ss_pred             CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccc
Q 003628          550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  629 (807)
Q Consensus       550 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGl  629 (807)
                      ...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4678999999999999998642 3346889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCccccceeeccCCccChhhhc-----cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc
Q 003628          630 AKIFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE  704 (807)
Q Consensus       630 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~  704 (807)
                      ++.......  ......|+..|+|||++.     ...++.++||||||+++|||++|+.|+...........    ... 
T Consensus       158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~-  230 (272)
T cd06637         158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPR-  230 (272)
T ss_pred             ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----Hhc-
Confidence            986533221  223356899999999986     34578899999999999999999999864332111110    000 


Q ss_pred             cccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          705 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       705 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                           ...+...    ......++.+++.+|++.+|.+|||+.||++
T Consensus       231 -----~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 -----NPAPRLK----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -----CCCCCCC----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                 0011111    1123456889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-35  Score=312.77  Aligned_cols=239  Identities=24%  Similarity=0.336  Sum_probs=188.4

Q ss_pred             ccccCCCccEEEEEecC-------------------------CcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEE
Q 003628          488 KLGQGGFGPVYWGRLKD-------------------------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL  542 (807)
Q Consensus       488 ~LG~G~~g~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l  542 (807)
                      +||+|+||.||+|.+..                         ...||+|.+..........|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13589999876555555788999999999999999999


Q ss_pred             eeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC--
Q 003628          543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL--  620 (807)
Q Consensus       543 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~--  620 (807)
                      ++++.+....++||||+++++|..++..  ....+++..+.+++.||++||+|||+.+   |+||||||+||+++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999998854  3456889999999999999999999988   99999999999997654  


Q ss_pred             -----CceeeccccccccCCCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHH-hCCCCCCccCCcch
Q 003628          621 -----NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIV-SGRKNTSFFEDDLT  693 (807)
Q Consensus       621 -----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~ell-tG~~p~~~~~~~~~  693 (807)
                           .+|++|||++.......      ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 37999999886442211      1346788999998865 56899999999999999995 68888764332211


Q ss_pred             hhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          694 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       694 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                       ....    ..       ....     +.....++.+++.+|++.+|++||++.+|++.|.
T Consensus       231 -~~~~----~~-------~~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 -ERFY----EK-------KHRL-----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -HHHH----Hh-------ccCC-----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             1110    00       0011     1112246789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.3e-35  Score=321.83  Aligned_cols=243  Identities=23%  Similarity=0.261  Sum_probs=190.4

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHH-HHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999876 57789999986532   222344455544 56778999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      ++|.+++..   ...++...+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            999998853   345778888889999999999999998   9999999999999999999999999997543221  12


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........    ....         ....   ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----~i~~---------~~~~---~~  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILN---------KPLQ---LK  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH----HHHh---------CCcC---CC
Confidence            233579999999999999999999999999999999999999986433221111    1100         0000   11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      ......+.+++.+|++.+|.+||++.+.+..+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence            23345678999999999999999987544433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5e-35  Score=307.36  Aligned_cols=250  Identities=20%  Similarity=0.296  Sum_probs=202.7

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      +|++.+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999876 5889999998643 2344577889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++... ....++...+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||+++........
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999999887542 3446788999999999999999999998   999999999999999999999999999866432221


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                        .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+.....    .... .+...          .
T Consensus       157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~----~~~~-~~~~~----------~  219 (255)
T cd08219         157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI----LKVC-QGSYK----------P  219 (255)
T ss_pred             --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH----HHHh-cCCCC----------C
Confidence              22356889999999999889999999999999999999999998643211111    1110 11110          0


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .+......+.+++.+||+.+|++||++.+|++.
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            122234567899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-34  Score=320.84  Aligned_cols=263  Identities=22%  Similarity=0.248  Sum_probs=197.4

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCC----
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----  550 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  550 (807)
                      ...++|++.+.||+|+||.||+++.. .|..||||++...  .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            34578999999999999999999875 5889999999653  2334567889999999999999999999986543    


Q ss_pred             --eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          551 --EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       551 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                        ..++||||+++ +|.+.+.     ..++...+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence              46899999976 5555542     24788889999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh-------
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------  701 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~-------  701 (807)
                      +++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+............       
T Consensus       169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            998543221   1223568999999999999999999999999999999999999997544221111110000       


Q ss_pred             -----------cccc------ccccccCccccC--CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          702 -----------WNEN------KILALVDPFLSE--SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       702 -----------~~~~------~~~~~~d~~l~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                                 ....      ...+........  .........++.+++.+|++.||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                       0000      000000000000  00111123567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.7e-35  Score=309.36  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=201.6

Q ss_pred             HHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       477 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      +.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345566666789999999999999865 5778999998776666678899999999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC-CCCceeeccccccccC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFG  634 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kL~DFGla~~~~  634 (807)
                      +||+++++|.+++.........++..+..++.||++||.|||+.+   |+||||||+||+++. ++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999999864321112277888899999999999999988   999999999999976 6789999999988654


Q ss_pred             CCCCccccceeeccCCccChhhhccCC--CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccC
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD  712 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d  712 (807)
                      ....  ......|+..|+|||++....  ++.++||||||+++|||++|+.|+.......... +.....       ...
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-~~~~~~-------~~~  230 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-FKVGMF-------KIH  230 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-hhhhhh-------ccC
Confidence            3221  122245789999999986654  7889999999999999999999986432211100 000000       001


Q ss_pred             ccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       713 ~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      +     ..+.....++.+++.+|++.+|++|||+.||++
T Consensus       231 ~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 P-----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             C-----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            1     122334567889999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.8e-35  Score=314.09  Aligned_cols=270  Identities=27%  Similarity=0.440  Sum_probs=205.5

Q ss_pred             cCCcccCccccCCCccEEEEEec-----CCcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEe--CCeE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEK  552 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-----~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  552 (807)
                      +.|++.+.||+|+||.||+++..     .+..+|||.+...... ..+.|.+|++++++++|+||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35777899999999999999854     3678999999765443 46789999999999999999999999887  5678


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999542  336899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCc-cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcc-hhhhhhhhhccccccccc
Q 003628          633 FGGNQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKLWNENKILAL  710 (807)
Q Consensus       633 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~-~l~~~~~~~~~~~~~~~~  710 (807)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..............+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            7533221 11111244567999999998899999999999999999999998875422111 000000000000001111


Q ss_pred             cCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       711 ~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      +...... +.+...+.++.+++.+|++.+|++||||.||+++|+++
T Consensus       239 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111110 11223346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.2e-35  Score=306.92  Aligned_cols=248  Identities=29%  Similarity=0.398  Sum_probs=199.1

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEE-eCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV-EGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~  559 (807)
                      ++|.+.+.||+|+||.||++... +..+|+|.++..  ...+.+.+|+.++++++|+|++++++++. .+...++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999876 788999998643  33568999999999999999999999765 456789999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++... ....+++..+.+++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  157 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-  157 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence            999999998643 2345889999999999999999999998   99999999999999999999999999885433221 


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                          ...++..|+|||++....++.++||||||+++|||++ |+.|+.......    ...... .+     ..+.    
T Consensus       158 ----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~----~~~~~~-~~-----~~~~----  219 (256)
T cd05082         158 ----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVE-KG-----YKMD----  219 (256)
T ss_pred             ----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHh-cC-----CCCC----
Confidence                1234568999999998899999999999999999998 888875332111    111110 00     0011    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                       .....+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus       220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence             112335678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.3e-35  Score=308.27  Aligned_cols=254  Identities=28%  Similarity=0.452  Sum_probs=204.2

Q ss_pred             hcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .++|++.++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+||+++++++.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            3578889999999999999999888888999988643 3345789999999999999999999999887 7789999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++... ....+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999998653 3456888899999999999999999988   999999999999999999999999999866432211


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                       ......++..|+|||++....++.++|+||||+++|||++ |+.|+...+... +....    ..+..       .  .
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~----~~~~~-------~--~  223 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRAL----ERGYR-------M--P  223 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH----hCCCC-------C--C
Confidence             1112345678999999998889999999999999999999 888886433221 11110    01100       0  0


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                       .....+.++.+++.+|++.+|++||++.++.++|+.
T Consensus       224 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             112334678899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.4e-35  Score=312.72  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=199.0

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      |+..+.||+|+||+||++... +++.+|+|.+....   ......+.+|++++++++|+||+++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566789999999999999875 68899999986532   22345678899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            9999999888643 2346999999999999999999999998   99999999999999999999999999976532211


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                         .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||....+........... ...      ..     
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~-~~~------~~-----  222 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV-LET------EE-----  222 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh-hcc------cc-----
Confidence               122468999999999998999999999999999999999999987543322111111100 000      00     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVS  751 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~ev~~  751 (807)
                      ........++.+++..|++.||++||+     +.+++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            012233456789999999999999999     556655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.2e-35  Score=312.80  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=202.5

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      +.|++.++||+|+||.||+|+.. +++.+|+|.+........+.+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999976 48899999998766666788999999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|..++..  ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.......  
T Consensus        92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--  164 (292)
T cd06644          92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--  164 (292)
T ss_pred             CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence            99999888743  2346899999999999999999999988   9999999999999999999999999987543221  


Q ss_pred             cccceeeccCCccChhhhc-----cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          640 ADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~-----~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      .......++..|+|||++.     ...++.++||||||+++|||++|+.|+.............          ....+.
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~----------~~~~~~  234 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----------KSEPPT  234 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh----------cCCCcc
Confidence            1122356889999999884     3457889999999999999999999986433221111110          000111


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ..   .+.....++.+++.+|++.+|++||++++|++
T Consensus       235 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 LS---QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11   12234456889999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.5e-35  Score=308.20  Aligned_cols=251  Identities=27%  Similarity=0.418  Sum_probs=193.1

Q ss_pred             CccccCCCccEEEEEec----CCcEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEE-eCCeEEEEEEecC
Q 003628          487 SKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCV-EGEEKMLIYEYMP  560 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~  560 (807)
                      +.||+|+||.||+|...    .+..+|+|.+... .....+.+.+|+.+++.++||||+++++++. .+...++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            47899999999999864    2457999998543 2334578899999999999999999999876 4556789999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc-
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-  639 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~-  639 (807)
                      +++|.+++...  ...+++..+..++.|+++||.|||+.+   ++||||||+||++++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998542  334677888899999999999999988   999999999999999999999999999865332111 


Q ss_pred             -cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCC-CCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          640 -ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK-NTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       640 -~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~-p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                       .......++..|+|||.+....++.++||||||+++|||++|+. |+... +...+...   ... +.     .+.   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~---~~~-~~-----~~~---  222 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVY---LLQ-GR-----RLL---  222 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHH---Hhc-CC-----CCC---
Confidence             11112345778999999988899999999999999999999654 44322 11111111   110 00     000   


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                        .+...+..+.+++.+|++.+|++||++.||++.|++.+
T Consensus       223 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         223 --QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             --CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence              11122456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-35  Score=309.69  Aligned_cols=250  Identities=29%  Similarity=0.423  Sum_probs=195.2

Q ss_pred             CccccCCCccEEEEEecC-Cc--EEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLKD-GQ--EIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~-g~--~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+|+..+ +.  .+|+|.++... ....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999764 33  47889886532 34456889999999999 899999999999999999999999999


Q ss_pred             CCccccccCCC-------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          562 RSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       562 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                      ++|.+++....             ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986421             1235788999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhcccccc
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKI  707 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~  707 (807)
                      +++.....   ........+..|+|||++....++.++||||||+++|||++ |..||....... ..   ... ..+. 
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~---~~~-~~~~-  228 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LY---EKL-PQGY-  228 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-HH---HHH-hCCC-
Confidence            98632211   11111233567999999988899999999999999999997 999885432211 11   000 0000 


Q ss_pred             ccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          708 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       708 ~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                            ...   .+.....++.+++.+|++.+|.+|||+.+++..|++++
T Consensus       229 ------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 ------RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ------CCC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                  000   11123456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.5e-35  Score=314.85  Aligned_cols=258  Identities=25%  Similarity=0.313  Sum_probs=201.2

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|++.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|++++.+++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999875 57889999886542 23346788999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhc-CCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+. +   ++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            999999999853   35688999999999999999999974 5   9999999999999999999999999987543221


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccc-----------
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK-----------  706 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~-----------  706 (807)
                          .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...+... .............           
T Consensus       155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCC
Confidence                223568899999999988889999999999999999999999986433211 1110000000000           


Q ss_pred             ---------ccccc-------CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          707 ---------ILALV-------DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       707 ---------~~~~~-------d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                               ..+..       .+.+..    .....++.+++.+|++.+|++||++++|++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPS----GAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcC----cccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                     00000       011100    01345688999999999999999999998763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-35  Score=330.60  Aligned_cols=261  Identities=18%  Similarity=0.230  Sum_probs=196.4

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ..+|.+.+.||+|+||.||+++.. .++.||||...      ...+.+|+++|++++|+||+++++++..+...++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999976 47889999642      23467899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +. ++|.+++..  ....+++.++..|+.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 688887743  2346999999999999999999999998   99999999999999999999999999987644322


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCC-------cchhhhhhhhh-ccccccccc
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED-------DLTILGYAWKL-WNENKILAL  710 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~-------~~~l~~~~~~~-~~~~~~~~~  710 (807)
                      ........||..|+|||++.+..++.++|||||||+||||++|..++.....       ...+....... .........
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            2222235799999999999999999999999999999999998865432111       01111111100 000000000


Q ss_pred             ----------------cCccccCCccc--HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          711 ----------------VDPFLSESSFQ--LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       711 ----------------~d~~l~~~~~~--~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                                      ..+........  ......+.+|+.+||+.||++|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                            00000000000  0122467889999999999999999999874

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.8e-35  Score=309.68  Aligned_cols=252  Identities=22%  Similarity=0.388  Sum_probs=201.3

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      ++|.+.+.||+|+||.||+++.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            47888899999999999999865 58899999987655555667889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++..   .+.+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......  
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            99999998843   456899999999999999999999998   9999999999999999999999999987654322  


Q ss_pred             cccceeeccCCccChhhhc---cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          640 ADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~---~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      .......|+..|+|||++.   ...++.++|||||||++|||++|+.|+........+.....     ..   ...+...
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-----~~---~~~~~~~  232 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-----SN---FQPPKLK  232 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-----cC---CCCCccc
Confidence            1122356899999999874   45688899999999999999999998754332211111100     00   0011111


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .   .......+.+++.+|++.+|++||++++|++
T Consensus       233 ~---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 D---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             c---cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0   1122346789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.7e-35  Score=319.93  Aligned_cols=260  Identities=26%  Similarity=0.406  Sum_probs=204.5

Q ss_pred             cCCcccCccccCCCccEEEEEec--------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCC
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE  550 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  550 (807)
                      .+|.+.+.||+|+||.||+++..        .+..||+|.+.... ....+++.+|+.+++++ +||||+++++++..+.
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999742        12368999887542 33457899999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCCccccccCCC-------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeec
Q 003628          551 EKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD  617 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~  617 (807)
                      ..++||||+++|+|.+++....             ....+++.++..++.|+++||.|||+.+   ++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986421             2235788899999999999999999988   99999999999999


Q ss_pred             CCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhh
Q 003628          618 EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILG  696 (807)
Q Consensus       618 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~  696 (807)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....+...  
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--  246 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--  246 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH--
Confidence            999999999999986643322222222334567999999999999999999999999999998 77887543221111  


Q ss_pred             hhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          697 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       697 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                        ... ..+...          ..+.....++.+++.+|++.+|++||++.|+++.|+.+..
T Consensus       247 --~~~-~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         247 --KLL-KEGHRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             --HHH-HcCCCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence              111 011000          0112234578899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.9e-35  Score=318.20  Aligned_cols=241  Identities=25%  Similarity=0.341  Sum_probs=192.0

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+++.. +++.||+|++++..   ....+.+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999876 57899999997542   23456688999999888 699999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      ++|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            999888743   356899999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcc--hhhhhhhhhccccccccccCccccCCc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL--TILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....+..  ............        ...   .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~---~  221 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--------KPI---R  221 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--------CCC---C
Confidence            223579999999999999999999999999999999999999996433211  111111111111        000   0


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNM  746 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~  746 (807)
                      .+.....++.+++.+||+.||++||++
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            222234567899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.8e-35  Score=305.70  Aligned_cols=249  Identities=26%  Similarity=0.407  Sum_probs=205.0

Q ss_pred             cCCcccCccccCCCccEEEEEecC-CcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      ++|++.+.||+|+||.||+++..+ ++.+|+|.+.....  .+++.+|++++++++|+||+++++.+.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578899999999999999999875 78999999865432  688999999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++..  ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999999853  3457899999999999999999999998   99999999999999999999999999987643321 


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+............          .....+.+.   
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~----------~~~~~~~~~---  220 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI----------PNKPPPTLS---  220 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh----------ccCCCCCCC---
Confidence             122345788999999999989999999999999999999999998653322111100          000011111   


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .+.....++.+++.+|++.+|++|||++||++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            22234467889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-35  Score=310.52  Aligned_cols=252  Identities=29%  Similarity=0.433  Sum_probs=199.9

Q ss_pred             CcccCccccCCCccEEEEEecC-CcEEEEEEecccCcccH--HHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      |++.+.||+|+||+||+++... ++.+|+|.+........  ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678999999999999999874 66899999976543332  23456999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++.   +...+++..+..++.||++||.+||+.+   |+|+||||+||++++++.++|+|||.+.....  ..
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence            9999999995   3567899999999999999999999998   99999999999999999999999999986521  12


Q ss_pred             cccceeeccCCccChhhhc-cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          640 ADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~-~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                      .......++..|+|||++. +..++.++||||+|+++|+|++|+.|+.................      ........  
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~--  224 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK------RPLPSSSQ--  224 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH------THHHHHTT--
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc------cccccccc--
Confidence            2233456899999999998 88899999999999999999999999875421111111100000      00000000  


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                       .......++.+++..|++.||++||++.++++
T Consensus       225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00011278899999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.5e-35  Score=326.47  Aligned_cols=262  Identities=21%  Similarity=0.292  Sum_probs=198.1

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCC-----eEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EKM  553 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  553 (807)
                      +|++.+.||+|+||.||++... +++.||||++....  ....+++.+|+++++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999875 68999999986532  234567899999999999999999999998776     789


Q ss_pred             EEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccccc
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~  633 (807)
                      +||||+. ++|.+.+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 57777663   3457899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccc------
Q 003628          634 GGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK------  706 (807)
Q Consensus       634 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~------  706 (807)
                      ...... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+....+... ........      
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i-~~~~g~~~~~~~~~  231 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI-TDLLGTPSLEAMRS  231 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH-HHHcCCCCHHHHHH
Confidence            432221 12224678999999998874 4789999999999999999999999754432211111 00000000      


Q ss_pred             ----ccccc-----Cc-cccC-CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          707 ----ILALV-----DP-FLSE-SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       707 ----~~~~~-----d~-~l~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                          ....+     .+ .... .........++.+++.+|++.||++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                00000     00 0000 00111234678899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3e-35  Score=320.32  Aligned_cols=237  Identities=23%  Similarity=0.272  Sum_probs=187.9

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHH-HHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999976 58899999986532   223345555654 57889999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      ++|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+||+|+.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            999888743   356888889999999999999999988   9999999999999999999999999987532221  12


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.....    ....         ...+   ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~---------~~~~---~~~  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY----DNIL---------HKPL---QLP  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH----HHHh---------cCCC---CCC
Confidence            23357899999999999989999999999999999999999998643321111    1111         0001   022


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMS  747 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~  747 (807)
                      .....++.+++.+|++.+|.+||+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            23345688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-35  Score=306.06  Aligned_cols=248  Identities=31%  Similarity=0.468  Sum_probs=197.5

Q ss_pred             CccccCCCccEEEEEecC----CcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      ++||+|+||.||+|+...    +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997542    26899999876543 24578999999999999999999999875 5568999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      ++|.+++..   ...+++..+..++.|++.||+|||..+   ++|+||||+||+++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999954   236899999999999999999999988   99999999999999999999999999987644332211


Q ss_pred             -cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          642 -TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       642 -~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.|+...+.. .+.....    ....       .   .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~~----~~~~-------~---~  218 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLE----SGER-------L---P  218 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHH----cCCc-------C---C
Confidence             111224567999999998999999999999999999998 99998654322 1211111    1100       0   0


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      .+...+..+.+++.+|++.+|++||++.+|++.|++.
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1222345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.7e-35  Score=307.00  Aligned_cols=251  Identities=29%  Similarity=0.489  Sum_probs=202.0

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      .+|++.+.||+|+||.||++...++..+|+|.+... ......|.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            467788999999999999999877889999998643 2345689999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++..  ....+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999998854  2346789999999999999999999988   9999999999999999999999999998654322111


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+........+    ... ..+  .....+..    
T Consensus       158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~----~~~-~~~--~~~~~~~~----  225 (256)
T cd05112         158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV----ETI-NAG--FRLYKPRL----  225 (256)
T ss_pred             -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH----HHH-hCC--CCCCCCCC----
Confidence             111234678999999998899999999999999999998 88888643322111    111 000  01111111    


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                          ...++.+++.+|++.+|++||++.|++++|
T Consensus       226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                235788999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-35  Score=310.96  Aligned_cols=257  Identities=26%  Similarity=0.422  Sum_probs=203.9

Q ss_pred             cCCcccCccccCCCccEEEEEecC-Cc----EEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-GQ----EIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~----~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      .+|++.+.||+|+||.||+|..++ |.    .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            467888999999999999998653 32    589998875543 345778999999999999999999999987 78899


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ||||+++|+|.+++..  ....+++..+.+++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999864  2345899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ............++..|+|||.+....++.++|+||||+++||+++ |+.|+....... +...    ...+..      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~----~~~~~~------  229 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDL----LEKGER------  229 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-HHHH----HhCCCC------
Confidence            3332222111234568999999988899999999999999999999 999986543211 1111    001100      


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccC
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~  758 (807)
                       .   +.+.....++.+++.+|+..+|++||++.++++.|+...+
T Consensus       230 -~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 -L---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             0   0111233567889999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.6e-35  Score=333.72  Aligned_cols=262  Identities=20%  Similarity=0.263  Sum_probs=193.1

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeC--------C
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--------E  550 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~  550 (807)
                      ..+|++.+.||+|+||.||+|... .++.||||++....    ....+|+.++++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999875 58899999885432    2345799999999999999999886532        2


Q ss_pred             eEEEEEEecCCCCccccccC-CCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC-Cceeeccc
Q 003628          551 EKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFG  628 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kL~DFG  628 (807)
                      ..++||||+++ +|.+++.. ......+++..+..++.||++||+|||+.+   |+||||||+||||+.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            35689999985 66665532 123457899999999999999999999998   99999999999998664 79999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc--cc
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN--EN  705 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~--~~  705 (807)
                      +++.+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|++||........+.......-.  ..
T Consensus       217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            9986643221   1224689999999998764 6899999999999999999999998754433222221111000  00


Q ss_pred             -------ccccccCccccC----CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          706 -------KILALVDPFLSE----SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       706 -------~~~~~~d~~l~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                             ...+.--+....    ..++...+.++.+++.+||+.||.+|||+.|+++.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                   000000000000    00122234678999999999999999999998843

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=305.89  Aligned_cols=253  Identities=23%  Similarity=0.369  Sum_probs=206.6

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      ++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|++++++++||||+++++++.++...+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999875 57889999998766566788999999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++..  ....++..++..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........ 
T Consensus        83 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          83 GGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            99999998854  2356889999999999999999999988   99999999999999999999999999986543221 


Q ss_pred             cccceeeccCCccChhhhccC---CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEG---RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~---~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                       ......++..|+|||.+...   .++.++||||||+++|||++|+.|+..............     .   ....+.+.
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-----~---~~~~~~~~  227 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-----S---NFPPPKLK  227 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----c---cCCCcccc
Confidence             11224678899999999777   789999999999999999999999865442222111100     0   00111111


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                         .......++.+++.+|++.+|.+|||+.+|+.
T Consensus       228 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         228 ---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               22345677899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1e-34  Score=310.78  Aligned_cols=262  Identities=22%  Similarity=0.310  Sum_probs=195.1

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhc---cCCceeEEeeEEEe-----CC
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKL---QHRNLVRLLGCCVE-----GE  550 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~  550 (807)
                      +|++.+.||+|+||.||+|+.. +++.||+|.++....  .....+.+|+.+++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999876 588999999875322  2234566777777766   69999999998864     34


Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla  630 (807)
                      ..++||||+++ +|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999975 888877542 2345899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhc--cccccc
Q 003628          631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW--NENKIL  708 (807)
Q Consensus       631 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~--~~~~~~  708 (807)
                      +.......   .....||..|+|||++.+..++.++||||+||++|||++|++||........+........  ......
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            87643221   1234678999999999999999999999999999999999999865443222211111000  000000


Q ss_pred             -------cccCccccC--CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          709 -------ALVDPFLSE--SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       709 -------~~~d~~l~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                             ....+....  .....+...++.+++.+|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   000000000  0011234467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.4e-35  Score=313.92  Aligned_cols=249  Identities=25%  Similarity=0.391  Sum_probs=204.3

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .+|++.+.||.|++|.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46888999999999999999864 68999999997655555678899999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++.    ...+++.++..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            9999999884    346899999999999999999999998   999999999999999999999999998865433221


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                        .....++..|+|||.+.+..++.++||||||+++|||++|+.||...+.........    . ..     .+.+.   
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~----~-~~-----~~~~~---  236 (296)
T cd06655         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----T-NG-----TPELQ---  236 (296)
T ss_pred             --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----h-cC-----CcccC---
Confidence              122468899999999998889999999999999999999999986544322111110    0 00     00110   


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .+......+.+++.+|++.+|++||++.+|++
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            12223456788999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.1e-35  Score=311.39  Aligned_cols=250  Identities=26%  Similarity=0.349  Sum_probs=199.1

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      |+..+.||+|+||.||++... +++.||||.+.....   ...+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999876 588999999865422   2235678899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            9999999988542 2345889999999999999999999988   99999999999999999999999999876533221


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                         .....|+..|+|||.+.+..++.++||||||+++|||++|+.||............ ......      ....    
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~-~~~~~~------~~~~----  223 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKE------VQEE----  223 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH-Hhhhhh------hhhh----
Confidence               11246899999999999999999999999999999999999999753322111100 000000      0000    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVS  751 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~ev~~  751 (807)
                       .......++.+++..|++.||++|||     ++|+++
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 -YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             12223456789999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.9e-35  Score=313.40  Aligned_cols=249  Identities=24%  Similarity=0.372  Sum_probs=204.4

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .+|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            67889999999999999999864 68999999997655555678899999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++.    ...+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            9999999984    345788899999999999999999988   999999999999999999999999998865433221


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                        .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+....+..    ....+      .+...   
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~~~~------~~~~~---  236 (297)
T cd06656         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNG------TPELQ---  236 (297)
T ss_pred             --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----eccCC------CCCCC---
Confidence              1224688999999999998899999999999999999999999864332211110    00000      00110   


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .+......+.+++.+|++.+|++||++++|++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12234456788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-34  Score=317.03  Aligned_cols=255  Identities=21%  Similarity=0.249  Sum_probs=197.4

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|.+.+.||+|+||.||+++.. +++.||+|.+.+.   .....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999876 5788999998653   2223456888999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++..  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999954  2346888899999999999999999998   999999999999999999999999999866433


Q ss_pred             CCccccceeeccCCccChhhhcc-----CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~-----~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ... ......||+.|+|||++..     +.++.++||||||+++|||++|+.||...+......    .......... +
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~~-~  229 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG----KIMNHEERFQ-F  229 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH----HHHcCCCccc-C
Confidence            221 1223569999999999875     467889999999999999999999986433221111    1111000000 0


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCC--CCCHHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKD--RPNMSTVVSM  752 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~ev~~~  752 (807)
                      .+      ...+...++.+++.+|+..++++  |++++++++.
T Consensus       230 p~------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         230 PS------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CC------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            11      11123456778888888865544  4688888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-35  Score=304.02  Aligned_cols=272  Identities=23%  Similarity=0.266  Sum_probs=219.9

Q ss_pred             cCCcccCccccCCCccEEEEEecC-CcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||.|.-|+||++++.+ +..+|+|++.+..   .+...+...|.+||+.++||.++.||+.+..+...+|||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456778999999999999999875 5889999997653   344567788999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      |||+||+|..+++. +..+.+++..+.-++.+++-||+|||..|   ||+|||||+||||.++|++.|+||.|+......
T Consensus       157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999998865 35678999999999999999999999999   999999999999999999999999988653110


Q ss_pred             --------------------------------C-C---------------------ccccceeeccCCccChhhhccCCC
Q 003628          637 --------------------------------Q-D---------------------QADTGRVVGTFGYMSPEYAMEGRF  662 (807)
Q Consensus       637 --------------------------------~-~---------------------~~~~~~~~gt~~y~APE~~~~~~~  662 (807)
                                                      . .                     ......++||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     011223579999999999999999


Q ss_pred             CcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCC
Q 003628          663 SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKD  742 (807)
Q Consensus       663 t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~  742 (807)
                      +.+.|.|+|||+||||+.|..||...+...++.+.+.+-.           ...   ...+....+.+||+..|.+||.+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-----------~Fp---~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-----------KFP---EEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-----------cCC---CCCcchhHHHHHHHHHhccChhh
Confidence            9999999999999999999999998877776655433211           111   12245678899999999999999


Q ss_pred             CCC----HHHHHHH--Hhh----ccCCCCCCCCCCccc
Q 003628          743 RPN----MSTVVSM--LNS----EIRDLPYPKEPAFTE  770 (807)
Q Consensus       743 RPt----~~ev~~~--L~~----~~~~~~~p~~p~~~~  770 (807)
                      |-.    +.||.+.  .++    +++...+|..|....
T Consensus       379 Rlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d  416 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVD  416 (459)
T ss_pred             hhccccchHHhhcCccccCCChhheeccCCCcCCCccc
Confidence            998    8887654  233    234445555454433

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-35  Score=310.86  Aligned_cols=253  Identities=25%  Similarity=0.380  Sum_probs=204.4

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      .++|.+.+.||+|+||.||++... ++..+|+|.+........+.|.+|++++++++|+||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356889999999999999999875 5889999999766666667899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999999854  2346899999999999999999999998   99999999999999999999999999876533221


Q ss_pred             ccccceeeccCCccChhhhc-----cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          639 QADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~-----~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                        ......+++.|+|||.+.     ...++.++|+||||+++|||++|+.|+...+....+....     .     ...+
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~-----~~~~  226 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-----K-----SEPP  226 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh-----c-----CCCC
Confidence              122356899999999975     3457789999999999999999999986543222111110     0     0011


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .+.   .+.....++.+++..|++.+|.+||++.+|++.
T Consensus       227 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 TLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CcC---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            111   112234567899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=327.69  Aligned_cols=264  Identities=27%  Similarity=0.402  Sum_probs=215.1

Q ss_pred             CcccCccccCCCccEEEEEe-cCC----cEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          483 FQLSSKLGQGGFGPVYWGRL-KDG----QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~-~~g----~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      .+..++||+|+||+||+|.+ ++|    -+||+|++... ..+..+++++|+-+|.+++||||+||+|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            44568999999999999975 333    46899998754 4445689999999999999999999999998776 88999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      +||+.|+|.++++.  ++..+..+..+.|..|||+||.|||.+.   +|||||..+||||.+...+||+|||+++.+..+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999976  5677899999999999999999999887   999999999999999999999999999998776


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ..+.......-.+.|||-|.+....|+.++|||||||++||++| |..|+.....+. +    ...++.+      +. +
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I----~dlle~g------eR-L  919 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-I----PDLLEKG------ER-L  919 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-h----hHHHhcc------cc-C
Confidence            66555544555788999999999999999999999999999998 788876533211 0    1111111      11 2


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCCCCCCCCC
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA  767 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~~p~~p~  767 (807)
                         +.+......+..++.+||..|++.||+++++...+.+..++...-..++
T Consensus       920 ---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~  968 (1177)
T KOG1025|consen  920 ---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQ  968 (1177)
T ss_pred             ---CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEeeeh
Confidence               1445567788899999999999999999999998877655544333333

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-34  Score=306.49  Aligned_cols=249  Identities=28%  Similarity=0.457  Sum_probs=200.9

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc---------cHHHHHHHHHHHHhccCCceeEEeeEEEeCCe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ---------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  551 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  551 (807)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+......         ..+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677889999999999999865 5789999988654221         23568899999999999999999999999999


Q ss_pred             EEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999843   356888899999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCc----cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccc
Q 003628          632 IFGGNQDQ----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI  707 (807)
Q Consensus       632 ~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~  707 (807)
                      ........    .......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+...........          .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----------~  224 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK----------I  224 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH----------H
Confidence            76532111    111224578999999999988899999999999999999999999865332211110          0


Q ss_pred             ccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          708 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       708 ~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .....+.     .+......+.+++.+||+.+|.+||++.||++
T Consensus       225 ~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GENASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hccCCCc-----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            0111111     22334567889999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.4e-35  Score=309.51  Aligned_cols=251  Identities=30%  Similarity=0.485  Sum_probs=198.7

Q ss_pred             CccccCCCccEEEEEecC-------CcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          487 SKLGQGGFGPVYWGRLKD-------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~-------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +.||+|+||.||+|+..+       +..+|||.+.+.. ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998653       2579999886543 23467899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCC----CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC-----Cceeecccc
Q 003628          559 MPNRSLDALLFDPL----KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-----NPKISDFGM  629 (807)
Q Consensus       559 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~-----~~kL~DFGl  629 (807)
                      +++++|.+++....    ....+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986422    2234788999999999999999999988   99999999999999887     899999999


Q ss_pred             ccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccc
Q 003628          630 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKIL  708 (807)
Q Consensus       630 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~  708 (807)
                      ++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+....... ....   . ..+.  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-~~~~---~-~~~~--  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQH---V-TAGG--  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-HHHH---H-hcCC--
Confidence            986543322222222345788999999999999999999999999999998 998886433211 1111   0 0000  


Q ss_pred             cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                           ..   ..+...+..+.+++.+|++.+|.+||++.+|+++|++
T Consensus       231 -----~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 -----RL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -----cc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 00   0122345678899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.9e-35  Score=310.99  Aligned_cols=263  Identities=24%  Similarity=0.323  Sum_probs=199.7

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|++.+.||+|++|.||+|+.. +++.||||+++...  ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999875 68899999986532  22346788999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      ++ ++|.+++........+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 588888765444467899999999999999999999998   99999999999999999999999999986543221


Q ss_pred             ccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh-------cccc----c
Q 003628          639 QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------WNEN----K  706 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~-------~~~~----~  706 (807)
                        ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+....+...........       +...    .
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence              11223568899999988654 47889999999999999999999987543222111111000       0000    0


Q ss_pred             cccccCccccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          707 ILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 ~~~~~d~~l~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .....+. ....   ........++.+++.+|++.||++|||+.+|++
T Consensus       235 ~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPK-WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccc-cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000 0000   001123467789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.5e-35  Score=315.88  Aligned_cols=263  Identities=23%  Similarity=0.326  Sum_probs=199.1

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|.+.++||+|+||.||+|+.+ +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999876 57889999987543 22345688999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 78777744  2345788899999999999999999998   99999999999999999999999999986533221


Q ss_pred             ccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh-------c---cc-cc
Q 003628          639 QADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------W---NE-NK  706 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~-------~---~~-~~  706 (807)
                      .  .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+....+.......       +   .. ..
T Consensus       160 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 T--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             c--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            1  122467899999998865 458899999999999999999999987544322221111100       0   00 00


Q ss_pred             cccccCccccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          707 ILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 ~~~~~d~~l~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ....-.+.....   ........++.+++.+|++.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000000000   001123456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.3e-34  Score=320.88  Aligned_cols=262  Identities=21%  Similarity=0.230  Sum_probs=197.4

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeC------
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------  549 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  549 (807)
                      ..++|++.+.||+|+||.||++... .++.||||++....  ....+.+.+|+.+++.++||||+++++.+...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999865 57899999997532  33456788999999999999999999987643      


Q ss_pred             CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccc
Q 003628          550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  629 (807)
Q Consensus       550 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGl  629 (807)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            356999999975 6666652     24788889999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh--------
Q 003628          630 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL--------  701 (807)
Q Consensus       630 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~--------  701 (807)
                      ++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...+............        
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            98653321   1223468999999999999999999999999999999999999997544221111111000        


Q ss_pred             ----------cccc-ccc----cccCccccC---CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          702 ----------WNEN-KIL----ALVDPFLSE---SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       702 ----------~~~~-~~~----~~~d~~l~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                                .... ...    +.+.+....   .........++.+++.+|++.||.+|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                      0000 000    000000000   00111123567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=307.58  Aligned_cols=248  Identities=28%  Similarity=0.424  Sum_probs=203.5

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|++.+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999876 58899999986543 34456789999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999999843    37899999999999999999999988   99999999999999999999999999987654321


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...+......     .     +.....+.+...
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-----~-----~~~~~~~~~~~~  221 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-----L-----IPKNNPPSLEGN  221 (274)
T ss_pred             --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-----H-----hhhcCCCCCccc
Confidence              1223467889999999999889999999999999999999999986433211110     0     000111111111


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                          .....+.+++.+|++.+|++|||++++++
T Consensus       222 ----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 ----KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                14456889999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.4e-35  Score=309.41  Aligned_cols=240  Identities=25%  Similarity=0.392  Sum_probs=190.5

Q ss_pred             CccccCCCccEEEEEecC--------CcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          487 SKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +.||+|+||.||+|....        ..++|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999998642        234888888665555567899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCC--------ceeeccccc
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN--------PKISDFGMA  630 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~--------~kL~DFGla  630 (807)
                      +++|+|.+++...  ...+++..+.+++.||+.||.|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998642  346889999999999999999999998   999999999999987765        599999988


Q ss_pred             cccCCCCCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCC-CCCCccCCcchhhhhhhhhccccccc
Q 003628          631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR-KNTSFFEDDLTILGYAWKLWNENKIL  708 (807)
Q Consensus       631 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~-~p~~~~~~~~~l~~~~~~~~~~~~~~  708 (807)
                      ......      ....++..|+|||++.+. .++.++||||||+++|||++|. .|+...+.... ....    ..    
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~----~~----  220 (258)
T cd05078         156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFY----ED----  220 (258)
T ss_pred             cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHH----Hc----
Confidence            754321      224578899999999864 5789999999999999999995 44433222111 1000    00    


Q ss_pred             cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                         ...     .+.....++.+++.+||+.+|++|||+++|++.|+
T Consensus       221 ---~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ---RHQ-----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---ccc-----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               001     11122356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=316.42  Aligned_cols=255  Identities=23%  Similarity=0.277  Sum_probs=195.8

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999976 5889999998652   2234466889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999853  2456889999999999999999999998   999999999999999999999999998765432


Q ss_pred             CCccccceeeccCCccChhhhcc-----CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~-----~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ... ......||+.|+|||++..     ..++.++|||||||++|||++|+.||.........    ............ 
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~----~~i~~~~~~~~~-  229 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----GKIMNHKEHFQF-  229 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCcccC-
Confidence            221 1222468999999999863     45788999999999999999999998643221111    111111100000 


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccC--CcCCCCCHHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQE--LVKDRPNMSTVVSM  752 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~--dP~~RPt~~ev~~~  752 (807)
                      .+      ........+.+++.+|+..  ++..||+++++++.
T Consensus       230 ~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 PP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            00      1111344566777776654  44448899998876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.7e-35  Score=315.46  Aligned_cols=256  Identities=27%  Similarity=0.470  Sum_probs=200.4

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCc----EEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ++|+..+.||+|+||.||+|... ++.    .+|+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46778899999999999999864 343    578998865432 2345789999999999999999999998754 4679


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ++||+++|+|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            9999999999999854  2346888999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .....+.    ..+..      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~----~~~~~------  229 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLL----EKGER------  229 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HCCCC------
Confidence            4332222222345778999999998899999999999999999998 8888754321 1111111    11100      


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                       ..   .+......+.+++..|+..+|++||+++++++.|+.+.
T Consensus       230 -~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         230 -LP---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             -CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             00   11122356789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-35  Score=326.45  Aligned_cols=260  Identities=20%  Similarity=0.254  Sum_probs=198.9

Q ss_pred             cCCcccCccccCCCccEEEEEec---CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      .+|.+.+.||+|+||.||++...   .+..||+|.+...     +.+.+|++++++++||||+++++++......++|||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            57999999999999999999754   3578999988543     345689999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      ++. ++|.+++.   ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       167 ~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        167 KYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            996 57877772   3467999999999999999999999998   9999999999999999999999999998765443


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcc---hhhhhhhhhc------ccc---
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL---TILGYAWKLW------NEN---  705 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~---~l~~~~~~~~------~~~---  705 (807)
                      .........||+.|+|||++....++.++|||||||++|||++|+.|+.......   .+.......-      ...   
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            3333334679999999999999999999999999999999999999986543211   1111110000      000   


Q ss_pred             -------ccccccCccccCCc--ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          706 -------KILALVDPFLSESS--FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       706 -------~~~~~~d~~l~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                             .......+......  .......++.+++.+|++.||++|||+.|+++.
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   00000000000000  001123567889999999999999999999875

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3e-34  Score=303.11  Aligned_cols=258  Identities=26%  Similarity=0.401  Sum_probs=207.3

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..+...++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999865 57889999986542 33567899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++........+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999865333356899999999999999999999988   99999999999999999999999999987654332


Q ss_pred             cc--ccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          639 QA--DTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       639 ~~--~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ..  ......|+..|+|||.+... .++.++|+||||+++|||++|+.|+..............    .      ..+..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~------~~~~~  227 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ----N------DPPSL  227 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc----C------CCCCc
Confidence            21  22335689999999998877 789999999999999999999999864433221111110    0      11111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ............+.+++..|++.||++||++++|++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111011234567889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-34  Score=307.75  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=202.4

Q ss_pred             cCCcccCccccCCCccEEEEEecC----CcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ++|.+.+.||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999998653    2468999886554 3455789999999999999999999998875 457899


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+++++|.+++...  ...+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999998542  345899999999999999999999988   99999999999999999999999999987644


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      ..... .....++..|+|||.+....++.++||||||+++|||++ |+.||...........    .. .+.     ...
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~-~~~-----~~~  228 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IE-NGE-----RLP  228 (270)
T ss_pred             cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HH-cCC-----cCC
Confidence            32211 112234568999999988889999999999999999986 9999864432221111    00 110     000


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                           .+...+.++.+++.+|+..+|++|||+.++++.|++..
T Consensus       229 -----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         229 -----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 11223457889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.8e-35  Score=310.96  Aligned_cols=247  Identities=26%  Similarity=0.394  Sum_probs=200.7

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566788999999999999865 57889999986443 334567899999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++.    ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+..... 
T Consensus        85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            9999998883    346889999999999999999999988   99999999999999999999999999986543221 


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..........     ..     .....+.     
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~-----~~~~~~~-----  220 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----LI-----PKNSPPT-----  220 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----hh-----hcCCCCC-----
Confidence             1222467889999999999899999999999999999999999976332211110     00     0001111     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ........+.+++.+|++.+|++||++.+|+++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            122345678899999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-34  Score=307.93  Aligned_cols=256  Identities=30%  Similarity=0.415  Sum_probs=203.3

Q ss_pred             cCCcccCccccCCCccEEEEEec------CCcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  553 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  553 (807)
                      ++|++.+.||+|+||.||+|+.+      +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999864      2467999988654433 4578999999999999999999999999999999


Q ss_pred             EEEEecCCCCccccccCCCCC------CCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecc
Q 003628          554 LIYEYMPNRSLDALLFDPLKK------ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  627 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DF  627 (807)
                      +||||+++++|.+++......      ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998653321      26899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccc
Q 003628          628 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENK  706 (807)
Q Consensus       628 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~  706 (807)
                      |+++...... ........++..|+|||.+.+...+.++||||||+++|||++ |..|+....+......     ...+.
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~-----~~~~~  235 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-----LQAGK  235 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH-----HHcCC
Confidence            9987543222 112222456778999999988889999999999999999999 7778754332221111     11111


Q ss_pred             cccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          707 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       707 ~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      .. .   .     .....+..+.+++.+|++.+|++||++.|++++|.
T Consensus       236 ~~-~---~-----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         236 LE-L---P-----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cC-C---C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            10 0   0     11123457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-34  Score=309.70  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=200.9

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|++.+.||+|+||.||+++.. .+..||+|.++.. .....+.+.+|+.++.+++|+||+++++.+......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999976 6899999988653 233457899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhc-CCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      +++++|..++........+++..+..++.+++.||.|||+. +   |+|+||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999886533345789999999999999999999974 5   9999999999999999999999999987653221


Q ss_pred             CccccceeeccCCccChhhhccCC------CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGR------FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~------~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                          .....++..|+|||.+.+..      ++.++|+||||+++|||++|+.||........... ..         ...
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~---------~~~  223 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-LS---------AIV  223 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-HH---------HHh
Confidence                12245788999999985543      58899999999999999999999864322111110 00         000


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      +...  ...+.....++.+++.+|++.+|++||++++++.
T Consensus       224 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         224 DGDP--PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hcCC--CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1000  1122335677889999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.9e-35  Score=322.65  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=196.1

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||.||+++.. +++.||||+++...   ......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999876 58899999996532   334567889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999853   456889999999999999999999998   999999999999999999999999998754321


Q ss_pred             CCc---------------------------------cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCC
Q 003628          637 QDQ---------------------------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK  683 (807)
Q Consensus       637 ~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~  683 (807)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00112469999999999999999999999999999999999999


Q ss_pred             CCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCC---HHHHHHH
Q 003628          684 NTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN---MSTVVSM  752 (807)
Q Consensus       684 p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~ev~~~  752 (807)
                      ||...........    ........ .+.+.       .....++.+++.+++. +|.+|++   ++|+++.
T Consensus       235 Pf~~~~~~~~~~~----i~~~~~~~-~~p~~-------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQETYRK----VMNWKETL-VFPPE-------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHHHHHHH----HHcCCCce-ecCCC-------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            9865432221110    10000000 00111       0123456677777664 9999985   5666544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.6e-34  Score=314.41  Aligned_cols=255  Identities=21%  Similarity=0.248  Sum_probs=196.0

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.++||+|+||.||+++.+ .++.+|+|.+.+.   .......+.+|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999976 4778999998642   2223455888999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999954  2346888899999999999999999998   999999999999999999999999998765332


Q ss_pred             CCccccceeeccCCccChhhhc-----cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~-----~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+......    .........   
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~---  227 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG----KIMNHKERF---  227 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH----HHhCCCccc---
Confidence            21 1222357999999999986     3468899999999999999999999986433211111    111110000   


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcC--CCCCHHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVK--DRPNMSTVVSM  752 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~--~RPt~~ev~~~  752 (807)
                        ..  .........++.+++.+|+..++.  .||+++|+++.
T Consensus       228 --~~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 --QF--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --cC--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              00  001112345677788887755444  47899998876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.3e-34  Score=302.41  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=204.3

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|+..+.||+|+||.||.++.. +++.+++|.+...  .....+++.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788899999999999998865 5889999987643  334457789999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++... ....+++.++..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||+++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999998643 2456899999999999999999999988   99999999999999999999999999987644332


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                        ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+..........    ... .+..    .+     
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~----~~~-~~~~----~~-----  220 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV----KIV-QGNY----TP-----  220 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHH-cCCC----CC-----
Confidence              1223568999999999988889999999999999999999999986433211111    111 1111    00     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                       .......++.+++.+|++.+|++||+++++++.+
T Consensus       221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence             1123456788999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-34  Score=305.70  Aligned_cols=251  Identities=25%  Similarity=0.404  Sum_probs=201.1

Q ss_pred             CCcccCccccCCCccEEEEEecCCcEEEEEEecccC------cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      +|.+.+.||+|+||.||+|...+++.+|||.+....      ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999886432      12235688999999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||+++....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999853   346788999999999999999999988   99999999999999999999999999886532


Q ss_pred             CCC----ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          636 NQD----QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       636 ~~~----~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ...    ........|+..|+|||++.+..++.++||||||+++|||++|+.|+...+.........    ..    ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----~~----~~~  226 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG----AH----RGL  226 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh----hc----cCC
Confidence            111    111222468899999999998889999999999999999999999986433221111000    00    000


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .+.     .+.....++.+++.+|++.+|++||++.++++
T Consensus       227 ~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 MPR-----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC-----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111     22234567889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.8e-34  Score=308.29  Aligned_cols=263  Identities=24%  Similarity=0.333  Sum_probs=201.4

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ++|++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999976 58899999986542  2234668899999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++++|..++..   ...+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999998887632   346899999999999999999999988   9999999999999999999999999998764432


Q ss_pred             CccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh----------ccccc
Q 003628          638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL----------WNENK  706 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~----------~~~~~  706 (807)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....+...+.......          +....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            2  1122457889999999876 457899999999999999999999987544322221111000          00000


Q ss_pred             c-ccccCccccCC----cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          707 I-LALVDPFLSES----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 ~-~~~~d~~l~~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      . .....+.....    .........+.+++.+|++.+|++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0 00000000000    001123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.1e-34  Score=302.69  Aligned_cols=250  Identities=22%  Similarity=0.351  Sum_probs=201.0

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEe-CCeEEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEKMLIYE  557 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E  557 (807)
                      +|++.+.||+|++|.||+++.. +++.+|+|++....  ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999876 47889999986432  3345678999999999999999999998764 446789999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++++|.+++... ....+++.++.+++.+++.|+.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999998642 3346899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      .  ......+++.|+|||++.+..++.++||||||++++||++|+.|+...+....    ..... .+..     +    
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~----~~~~~-~~~~-----~----  220 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL----VYRII-EGKL-----P----  220 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHH-hcCC-----C----
Confidence            2  22235688999999999999999999999999999999999999864332111    11111 1111     0    


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                       ..+.....++.+++.+|++.+|++||++.++++.
T Consensus       221 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 -PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             1222345678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-34  Score=310.32  Aligned_cols=262  Identities=25%  Similarity=0.356  Sum_probs=203.3

Q ss_pred             HHHHHHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEEE---
Q 003628          473 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCV---  547 (807)
Q Consensus       473 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~---  547 (807)
                      ++.+..+.++|++.+.||+|+||.||+++.. .++.+|+|.+... ......+.+|+.+++++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3455667889999999999999999999875 5789999988643 22346788999999999 6999999999884   


Q ss_pred             --eCCeEEEEEEecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCcee
Q 003628          548 --EGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  624 (807)
Q Consensus       548 --~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL  624 (807)
                        .+...++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              3456899999999999998875322 3356888899999999999999999988   999999999999999999999


Q ss_pred             eccccccccCCCCCccccceeeccCCccChhhhcc-----CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhh
Q 003628          625 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW  699 (807)
Q Consensus       625 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~  699 (807)
                      +|||+++.......  ......|+..|+|||++..     ..++.++||||+|+++|||++|+.|+........+.... 
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~-  242 (286)
T cd06638         166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP-  242 (286)
T ss_pred             ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc-
Confidence            99999986543221  1223468999999998853     447889999999999999999999986443222111100 


Q ss_pred             hhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          700 KLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       700 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                          ..     ..+.+.   .+.....++.+++.+|++.+|++|||+.||++.+
T Consensus       243 ----~~-----~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         243 ----RN-----PPPTLH---QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ----cc-----CCCccc---CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                00     011111   1111234688999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-34  Score=305.38  Aligned_cols=253  Identities=27%  Similarity=0.423  Sum_probs=201.0

Q ss_pred             CCcccCccccCCCccEEEEEecC--CcEEEEEEeccc----------CcccHHHHHHHHHHHHh-ccCCceeEEeeEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLKD--GQEIAVKRLSKA----------SGQGLEEFMNEVMVISK-LQHRNLVRLLGCCVE  548 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~~--g~~vAvK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~  548 (807)
                      +|++.+.||+|+||.||++....  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999765  678999987532          22234567889988875 799999999999999


Q ss_pred             CCeEEEEEEecCCCCccccccCC-CCCCCCChhhhHHHHHHHHhhhHhhhh-cCCCcEEeCCCCCCCeeecCCCCceeec
Q 003628          549 GEEKMLIYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISD  626 (807)
Q Consensus       549 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kL~D  626 (807)
                      .+..++||||+++++|.+++... .....+++..+++++.|++.||.|||+ .+   ++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999887432 234568899999999999999999996 55   99999999999999999999999


Q ss_pred             cccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccc
Q 003628          627 FGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK  706 (807)
Q Consensus       627 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~  706 (807)
                      ||++.......   ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.........    ... ..+.
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~----~~~-~~~~  229 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA----TKI-VEAV  229 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH----HHH-hhcc
Confidence            99998754332   223356889999999999988999999999999999999999998543221111    110 0111


Q ss_pred             cccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          707 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       707 ~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      .    .+ ..    .......+.+++.+|++.||++||++.||..+++
T Consensus       230 ~----~~-~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 Y----EP-LP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             C----Cc-CC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            0    01 00    1123456889999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.7e-34  Score=318.99  Aligned_cols=263  Identities=22%  Similarity=0.239  Sum_probs=198.0

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeC-----
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----  549 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  549 (807)
                      ...++|++.+.||+|+||.||++... .++.||||++....  ....+.+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45578999999999999999999865 58899999997542  23346788999999999999999999988643     


Q ss_pred             -CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          550 -EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       550 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                       ...++||||+++ +|.+.+.     ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence             346899999975 5655552     24788889999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh-------
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------  701 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~-------  701 (807)
                      +++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...+............       
T Consensus       165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            998653321   1223568999999999999999999999999999999999999986543211111110000       


Q ss_pred             -----------ccc-cccccccCcc------cc-CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          702 -----------WNE-NKILALVDPF------LS-ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       702 -----------~~~-~~~~~~~d~~------l~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                                 ... ........+.      .. ..........++.+++.+|++.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                       000 0000000000      00 000111234577899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.2e-34  Score=314.36  Aligned_cols=263  Identities=20%  Similarity=0.269  Sum_probs=194.6

Q ss_pred             ccCccccC--CCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          485 LSSKLGQG--GFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       485 ~~~~LG~G--~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      +.++||+|  +|++||+++.+ +|+.||||++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  67899999875 68999999996542  233456778999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++... ....+++..+.+++.|++.||.|||+.+   |+||||||+||+++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            999999998542 2345889999999999999999999998   999999999999999999999999865543211110


Q ss_pred             -----cccceeeccCCccChhhhcc--CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc----cc---
Q 003628          640 -----ADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN----EN---  705 (807)
Q Consensus       640 -----~~~~~~~gt~~y~APE~~~~--~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~----~~---  705 (807)
                           .......++..|+|||++.+  ..++.++|||||||++|||++|+.||..................    ..   
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                 01112356778999999976  45899999999999999999999998653322211111000000    00   


Q ss_pred             --cc-----ccccCccc----------------cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          706 --KI-----LALVDPFL----------------SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       706 --~~-----~~~~d~~l----------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                        ..     ....+...                ............+.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence              00     00000000                000112234567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.3e-34  Score=305.28  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=203.4

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ..|+..+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+.++++++|+||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34677889999999999999875 58899999986542 34567899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++.    ...+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999999884    346888899999999999999999988   99999999999999999999999999986643221


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                        ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+..........              .+.... ..
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------------~~~~~~-~~  219 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--------------LIPKNN-PP  219 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--------------hhhcCC-CC
Confidence              1222457889999999998889999999999999999999999986433211110              000000 01


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ......+..+.+++.+|++.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1334466788999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.3e-34  Score=304.93  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=190.1

Q ss_pred             CccccCCCccEEEEEecCC---cEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          487 SKLGQGGFGPVYWGRLKDG---QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~g---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      +.||+|+||.||+++..++   ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975443   346677765433 334578999999999999999999999999999999999999999


Q ss_pred             CccccccCCCC-CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          563 SLDALLFDPLK-KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       563 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      +|.+++..... ....+...+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999865321 234566777899999999999999988   99999999999999999999999999864322211112


Q ss_pred             cceeeccCCccChhhhcc-------CCCCcccceeehhHHHHHHHhC-CCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          642 TGRVVGTFGYMSPEYAME-------GRFSEKSDVFSFGVLLLEIVSG-RKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~-------~~~t~k~DvwSlGvvl~elltG-~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+....+...+..    ... +......++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----~~~-~~~~~~~~~  232 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH----VIK-DQQVKLFKP  232 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHh-hcccccCCC
Confidence            223467889999998743       2457899999999999999975 556654332221111    111 112223334


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      .+...     ...++.+++..|+ .+|++||++++|++.|.
T Consensus       233 ~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         233 QLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            43322     3356677888899 57999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-34  Score=302.63  Aligned_cols=238  Identities=24%  Similarity=0.400  Sum_probs=189.4

Q ss_pred             CccccCCCccEEEEEecCCc-----------EEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          487 SKLGQGGFGPVYWGRLKDGQ-----------EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~g~-----------~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      +.||+|+||.||+|...+..           .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999986433           5788887654333 6889999999999999999999999988 778999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC-------Cceeeccc
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-------NPKISDFG  628 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~-------~~kL~DFG  628 (807)
                      |||+++++|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999998642  226889999999999999999999988   99999999999999888       79999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccC--CCCcccceeehhHHHHHHHhC-CCCCCccCCcchhhhhhhhhcccc
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSG-RKNTSFFEDDLTILGYAWKLWNEN  705 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~k~DvwSlGvvl~elltG-~~p~~~~~~~~~l~~~~~~~~~~~  705 (807)
                      +++....      .....++..|+|||++...  .++.++||||||+++|||++| ..|+.......... .    +...
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~----~~~~  222 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-F----YQDQ  222 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-H----HhcC
Confidence            9986543      1123567789999999876  789999999999999999995 66664432111110 0    0000


Q ss_pred             ccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          706 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       706 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                             .....     .....+.+++.+|++.+|.+|||+.+|++.|+
T Consensus       223 -------~~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 -------HRLPM-----PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -------CCCCC-----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   00100     11167889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.3e-34  Score=305.46  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=199.4

Q ss_pred             CcccCccccCCCccEEEEEec----CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCC------
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------  550 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~----~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  550 (807)
                      |.+.+.||+|+||.||+|.+.    .++.||||++...  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999864    3688999998654  2334677899999999999999999999887543      


Q ss_pred             eEEEEEEecCCCCccccccCCC---CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPL---KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  627 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DF  627 (807)
                      ..++++||+++|+|..++....   +...+++..+.+++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999988874321   2235788889999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccc
Q 003628          628 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENK  706 (807)
Q Consensus       628 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~  706 (807)
                      |+++...............++..|++||.+....++.++||||||+++|||++ |+.|+...+. ..+.....    ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~~~----~~~  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLI----KGN  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHHHH----cCC
Confidence            99987643332222222345678999999998899999999999999999999 7888754322 11111111    000


Q ss_pred             cccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          707 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       707 ~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      .       +.   .+.....++.+++.+|++.+|++||++.++++.|+++
T Consensus       233 ~-------~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 R-------LK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             c-------CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0       00   1112345788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-34  Score=309.14  Aligned_cols=253  Identities=25%  Similarity=0.343  Sum_probs=203.3

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56888899999999999999865 58899999886543 33457899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhh-cCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      +++++|.+++..   .+.+++..+..++.+++.||.|||+ .+   ++||||||+||++++++.++|+|||++.......
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            999999988743   3468999999999999999999997 45   9999999999999999999999999987542221


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcc-------hhhhhhhhhccccccccc
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-------TILGYAWKLWNENKILAL  710 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~-------~l~~~~~~~~~~~~~~~~  710 (807)
                          .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......       .+.........      .
T Consensus       159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~  228 (284)
T cd06620         159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ------E  228 (284)
T ss_pred             ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh------c
Confidence                223568999999999988899999999999999999999999987533211       01111111100      0


Q ss_pred             cCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       711 ~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      ..+.+.    ....+.++.+++.+|++.||++|||+.||+++.
T Consensus       229 ~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         229 PPPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             cCCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            011111    112456788999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.2e-34  Score=311.56  Aligned_cols=197  Identities=26%  Similarity=0.445  Sum_probs=160.6

Q ss_pred             cCccccCCCccEEEEEec---CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEe--CCeEEEEEEecC
Q 003628          486 SSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLIYEYMP  560 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~  560 (807)
                      .++||+|+||.||+|+..   +++.||+|.+....  ....+.+|+.++++++||||+++++.+..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999865   46789999986432  23567899999999999999999998864  456789999996


Q ss_pred             CCCccccccCC------CCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeee----cCCCCceeeccccc
Q 003628          561 NRSLDALLFDP------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMA  630 (807)
Q Consensus       561 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll----~~~~~~kL~DFGla  630 (807)
                      + +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 776665321      12235888899999999999999999998   9999999999999    45678999999999


Q ss_pred             cccCCCCC-ccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCcc
Q 003628          631 KIFGGNQD-QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFF  688 (807)
Q Consensus       631 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~  688 (807)
                      +.+..... ........||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            87654322 1222345789999999998774 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.6e-34  Score=301.99  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=202.7

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|++.+.||+|+||.||+++.. +++.||+|.+...  .....+++.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999865 6889999998643  233456889999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++... ....+++.++.+++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999988542 2345788999999999999999999988   99999999999999999999999999986643221


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                      .  .....|+..|+|||++.+..++.++|+||||++++||++|+.|+...+.....    .... .+..     +     
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~----~~~~-~~~~-----~-----  219 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV----LKII-RGSY-----P-----  219 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH----HHHh-cCCC-----C-----
Confidence            1  12245788999999999989999999999999999999999998643221111    1111 0000     0     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ..+.....++.+++.+|++.+|++||++.+|++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1222345678899999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=316.03  Aligned_cols=244  Identities=29%  Similarity=0.455  Sum_probs=201.7

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      |...+.||.|+||.||.++.. +.+.||||++.-..   ...+.+++.|+..|.+++|||++.+-|++..+...+|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            666789999999999999875 57789999997443   34467899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      |- ||-.+++.-  .++++.+.++..|..+.+.||+|||+++   .||||||+.||||.+.|.+||+|||.|.+....  
T Consensus       108 Cl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--  179 (948)
T KOG0577|consen  108 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--  179 (948)
T ss_pred             Hh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence            94 577777643  3567888999999999999999999998   999999999999999999999999999876432  


Q ss_pred             ccccceeeccCCccChhhhc---cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          639 QADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~---~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                          ..++|||.|||||++.   .+.|+-|+|||||||+-.||.-.++|....+.-..+...+          .--.|.+
T Consensus       180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA----------QNesPtL  245 (948)
T KOG0577|consen  180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----------QNESPTL  245 (948)
T ss_pred             ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH----------hcCCCCC
Confidence                3478999999999984   5679999999999999999999999875333211111111          1112333


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .    ..+....+.+++..||+.-|.+|||.+++++.
T Consensus       246 q----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  246 Q----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             C----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            2    34677889999999999999999999998764

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=315.24  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=209.6

Q ss_pred             CCcccCccccCCCccEEEEEecC---C--cEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLKD---G--QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~~---g--~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      .....++||.|.||.||+|...+   |  -.||||..+.. .....+.|+.|..+|++++||||++++|.|.+ ...++|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            34556789999999999998542   3  35899998763 45567889999999999999999999999976 456899


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      ||.++-|.|..+|..  +...++......++.||+.||.|||+..   +|||||..+||||.+.--+||+|||++|.+..
T Consensus       469 mEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  469 MELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            999999999999965  4567888899999999999999999998   99999999999999999999999999998866


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      +...... +..-+..|||||.+.-.+++.++|||.|||.+|||++ |..||....+.+.+.              .++..
T Consensus       544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------------~iEnG  608 (974)
T KOG4257|consen  544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------------HIENG  608 (974)
T ss_pred             cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------------EecCC
Confidence            5544332 4456789999999999999999999999999999976 889987654332211              11111


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                      - ..+.+..++..+..|+.+||.++|.+||+..||...|+.+.
T Consensus       609 e-RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  609 E-RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             C-CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence            1 12356677888999999999999999999999998886553

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.6e-34  Score=302.17  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=195.3

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-----cccHHHHHHHHHHHHhccCCceeEEeeEEEe--CCeE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEK  552 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  552 (807)
                      .+|+..+.||+|+||.||++... .+..||+|++....     .+..+.+.+|+.++++++||||+++++++.+  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999875 58899999886432     1234568899999999999999999998875  3567


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++++||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999853   345888999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCC-ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          633 FGGNQD-QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       633 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+...+.......    ....     ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~-----~~  226 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQ-----PT  226 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcC-----CC
Confidence            533211 1112224578999999999988899999999999999999999999864332211110    0000     00


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .+.     .+......+..++ +|+..+|++||+++||++
T Consensus       227 ~~~-----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 NPQ-----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCC-----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            111     2222334455565 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-34  Score=301.72  Aligned_cols=247  Identities=28%  Similarity=0.392  Sum_probs=200.9

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-----cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      +|+..+.||+|++|.||+|... ++..|++|.+....     .+..+.+.+|+.++++++|+||+++++++..+...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 78999999986533     23457799999999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999853   345889999999999999999999998   99999999999999999999999999886543


Q ss_pred             CCCccccceeeccCCccChhhhccCC-CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~-~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      ..   ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.|+............    ......       
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~~-------  220 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI----GRSKEL-------  220 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH----HhcccC-------
Confidence            32   122356889999999987776 899999999999999999999998654321111110    000000       


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                         ...+......+.+++.+|++.+|++||+++++++
T Consensus       221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               0122233466788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.7e-34  Score=308.15  Aligned_cols=263  Identities=28%  Similarity=0.374  Sum_probs=205.4

Q ss_pred             cCHHHHHHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEEEe
Q 003628          471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE  548 (807)
Q Consensus       471 f~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  548 (807)
                      ++..++..+.++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            444556667889999999999999999999875 68899999986432 2346778899999999 89999999999875


Q ss_pred             C-----CeEEEEEEecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCc
Q 003628          549 G-----EEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  622 (807)
Q Consensus       549 ~-----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~  622 (807)
                      .     ...++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            4     35799999999999999875322 3456899999999999999999999988   9999999999999999999


Q ss_pred             eeeccccccccCCCCCccccceeeccCCccChhhhccCC-----CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhh
Q 003628          623 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-----FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY  697 (807)
Q Consensus       623 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~  697 (807)
                      ||+|||+++........  .....|+..|+|||.+....     ++.++||||||+++|||++|+.|+........+...
T Consensus       168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~  245 (291)
T cd06639         168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI  245 (291)
T ss_pred             EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence            99999999865432211  12246789999999886443     688999999999999999999998654332222111


Q ss_pred             hhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          698 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       698 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .     ..     ..+.+.   .+.+....+.+++.+|++.+|++||++.|+++.
T Consensus       246 ~-----~~-----~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         246 P-----RN-----PPPTLL---HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             h-----cC-----CCCCCC---cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0     00     001111   112334568899999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-34  Score=312.42  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=212.0

Q ss_pred             HHhcCCcccCccccCCCccEEEEEecC-CcEEEEEEecccCcc---cHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeE
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ---GLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~  552 (807)
                      .....|.+.+.||+|.||.||+++.+. |+.+|+|.+.+....   ..+.+.+|+.+|+++. |||||.+++.+.+....
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            345678889999999999999999875 999999999775433   4568999999999998 99999999999999999


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC----CCceeeccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE----LNPKISDFG  628 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~----~~~kL~DFG  628 (807)
                      ++|||++.||.|.+.+...    .+++..+..++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999998654    3999999999999999999999998   9999999999999643    479999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccc
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  708 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~  708 (807)
                      ++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||....+.........     +.. 
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~-----~~~-  255 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR-----GDF-  255 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-----CCC-
Confidence            9998765   2334458999999999999999999999999999999999999999986554443331111     111 


Q ss_pred             cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                           ....+ .-......+.+++..++..||.+|+|+.++++.
T Consensus       256 -----~f~~~-~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 -----DFTSE-PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -----CCCCC-CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                 11111 222346778899999999999999999999984

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=298.02  Aligned_cols=248  Identities=24%  Similarity=0.395  Sum_probs=208.9

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      |.++++||+|+||.||++.++ .|+.+|||.+.-  ..+.+++..|+.+|++.+.|++|++||.+......++|||||-.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            667889999999999999876 589999999853  45678999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      |+..+++.-  +++.+++.++..+++..++||+|||...   -+|||||+.||||+.+|.+||+|||.|-.+.....  .
T Consensus       113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--K  185 (502)
T KOG0574|consen  113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--K  185 (502)
T ss_pred             CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH--h
Confidence            999999854  5678999999999999999999999987   79999999999999999999999999986643322  2


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      ...+.||+-|||||++..-.|..++||||+|++..||..|++|+.....-..+.          -+.....|...   .+
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------MIPT~PPPTF~---KP  252 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------MIPTKPPPTFK---KP  252 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------eccCCCCCCCC---Ch
Confidence            334789999999999999999999999999999999999999986433211110          01111222222   34


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .....++-++++.||-.+|++|-|+.++++.
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            5667889999999999999999999888764

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=320.02  Aligned_cols=251  Identities=29%  Similarity=0.407  Sum_probs=206.9

Q ss_pred             CcccCccccCCCccEEEEEec--CCc--EEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK--DGQ--EIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~--~g~--~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ..+.++||+|.||.|++|.+.  +|+  .||||.++..... ...+|++|+.+|.+|+|+|+++|||...+ ...++|+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            445689999999999999876  343  5899999865444 67899999999999999999999999887 77889999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      .++.|||.+.|.+ .....+-...+..++.|||.||.||..+.   +|||||..+|+||-....+||+||||.|.++.+.
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999977 35567778888999999999999999998   9999999999999999999999999999987654


Q ss_pred             Ccc-ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          638 DQA-DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       638 ~~~-~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ... ......-...|+|||.+....|+.++|||+|||+||||+| |+.||......              .+.+.+|..-
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------------qIL~~iD~~e  332 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------------QILKNIDAGE  332 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------------HHHHhccccc
Confidence            332 2222334678999999999999999999999999999999 55676543322              2333344222


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      . -+-+..+.+++.++++.||..+|++|||+..|.+.+
T Consensus       333 r-LpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  333 R-LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             c-CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            1 124556788999999999999999999999997444

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-34  Score=310.26  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=200.7

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      |.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            333467999999999999875 5889999998765555667899999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      ++|.+++.    ...+++.++..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++........  .
T Consensus       104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~  174 (292)
T cd06658         104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K  174 (292)
T ss_pred             CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence            99999873    345889999999999999999999998   99999999999999999999999999976543222  1


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+........+..          +...+.+....   .
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----------~~~~~~~~~~~---~  241 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR----------IRDNLPPRVKD---S  241 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----------HHhcCCCcccc---c
Confidence            2235689999999999888899999999999999999999999864332111110          00111111111   1


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ......+.+++..|++.+|++|||++++++.
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1234467789999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=317.97  Aligned_cols=244  Identities=29%  Similarity=0.454  Sum_probs=203.9

Q ss_pred             ccccCCCccEEEEEecC-CcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCccc
Q 003628          488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDA  566 (807)
Q Consensus       488 ~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  566 (807)
                      +||+|.||+||.|++.+ ...+|||.+.....+..+-+.+|+.+-++++|.|||+++|.+.+++..-+.||.++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999875 45699999988777778889999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCC--ChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeec-CCCCceeeccccccccCCCCCccccc
Q 003628          567 LLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFGGNQDQADTG  643 (807)
Q Consensus       567 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~-~~~~~kL~DFGla~~~~~~~~~~~~~  643 (807)
                      +|..  +-+++  ++...--+.+||++||.|||+..   |||||||-.||||+ -.|.+||+|||.++.+.+-  ...+.
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence            9965  33455  67777788999999999999998   99999999999996 5688999999999876432  23445


Q ss_pred             eeeccCCccChhhhccCC--CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          644 RVVGTFGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       644 ~~~gt~~y~APE~~~~~~--~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .+.||.-|||||++..++  |..++|||||||++.||.||++||......+..      .++-|-  -.+.     ++.+
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA------MFkVGm--yKvH-----P~iP  801 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA------MFKVGM--YKVH-----PPIP  801 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh------hhhhcc--eecC-----CCCc
Confidence            588999999999998775  888999999999999999999999754433211      111110  1111     2366


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .+...++..++++|..++|.+||++.++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            778899999999999999999999999875

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.9e-34  Score=310.47  Aligned_cols=246  Identities=24%  Similarity=0.372  Sum_probs=200.0

Q ss_pred             ccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCC
Q 003628          485 LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRS  563 (807)
Q Consensus       485 ~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  563 (807)
                      ....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..+...++||||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3458999999999999875 689999999876555556788999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccc
Q 003628          564 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG  643 (807)
Q Consensus       564 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  643 (807)
                      |.+++.    ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+.....  ...
T Consensus       105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  175 (297)
T cd06659         105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK  175 (297)
T ss_pred             HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence            998873    346889999999999999999999998   99999999999999999999999999876543221  122


Q ss_pred             eeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHH
Q 003628          644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLD  723 (807)
Q Consensus       644 ~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  723 (807)
                      ...|+..|+|||++.+..++.++||||||+++|||++|+.|+........+...     ...     ..+...   ....
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-----~~~-----~~~~~~---~~~~  242 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-----RDS-----PPPKLK---NAHK  242 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----hcc-----CCCCcc---ccCC
Confidence            356899999999999889999999999999999999999998643322211110     000     000010   1112


Q ss_pred             HHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          724 MIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       724 ~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ....+.+++.+|++.+|++||++++|++.
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            34567889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.4e-34  Score=302.06  Aligned_cols=247  Identities=28%  Similarity=0.424  Sum_probs=197.8

Q ss_pred             cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      ++|++.+.||+|+||.||++.. .++.||+|.++...  ..+.+.+|+.++++++||||+++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688899999999999999975 57889999986532  346789999999999999999999998654 5789999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++... ....+++..+.+++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......   
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999998643 2345888999999999999999999988   9999999999999999999999999987543221   


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                        .....+..|+|||.+.+..++.++|+||||+++|||++ |+.|+....... .   .... ..+..   .+       
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~---~~~~-~~~~~---~~-------  217 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-V---KECV-EKGYR---ME-------  217 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-H---HHHH-hCCCC---CC-------
Confidence              11234568999999998899999999999999999998 888876433211 1   1111 01100   00       


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                      .....+..+.+++.+|++.+|++||++.+|+..|++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            112234677899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.8e-34  Score=309.70  Aligned_cols=263  Identities=22%  Similarity=0.308  Sum_probs=198.6

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888999999999999999876 57899999986443 23345678999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      ++ ++|.+++..  ....+++..+..++.||++||.|||+.+   |+|+||||+||++++++.+||+|||+++.......
T Consensus        86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 588888754  2346888999999999999999999998   99999999999999999999999999986433221


Q ss_pred             ccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh-------hc----cccc
Q 003628          639 QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-------LW----NENK  706 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~-------~~----~~~~  706 (807)
                      .  .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+....+......       .+    ....
T Consensus       160 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 T--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             c--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence            1  1223568899999988654 4788999999999999999999998754422111100000       00    0000


Q ss_pred             cccccCccccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          707 ILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 ~~~~~d~~l~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ....-.+.....   .........+.+++.+|++.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000100000   011123456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.8e-34  Score=302.86  Aligned_cols=255  Identities=27%  Similarity=0.403  Sum_probs=199.8

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc----------ccHHHHHHHHHHHHhccCCceeEEeeEEEeCC
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG----------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE  550 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  550 (807)
                      +|.+.+.||+|+||.||+|... +++.+|+|.++....          ...+.+.+|+.++++++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677899999999999999865 688999998853211          11356888999999999999999999999999


Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla  630 (807)
                      ..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            99999999999999999854   256888999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCccccceeeccCCccChhhhccCC--CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccc
Q 003628          631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  708 (807)
Q Consensus       631 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~  708 (807)
                      +...............|+..|+|||.+....  ++.++|+||||+++||+++|+.|+...+....+.    .... ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~-~~~~  230 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF----KLGN-KRSA  230 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH----Hhhc-cccC
Confidence            8654322222223346889999999987655  7899999999999999999999985322211111    1100 1111


Q ss_pred             cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ..+...     ........+.+++.+|++.+|.+||++++|++.
T Consensus       231 ~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         231 PPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            111111     112345678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=315.97  Aligned_cols=240  Identities=23%  Similarity=0.279  Sum_probs=186.7

Q ss_pred             cccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc---cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL---QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       489 LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      ||+|+||.||+|+.. +++.||||++.+..   ......+..|..++.+.   +||||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999876 58999999986432   22334556677777665   699999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      |+|..++.   +...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~  152 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T  152 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence            99998884   3456899999999999999999999998   99999999999999999999999999875432221  1


Q ss_pred             cceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcc
Q 003628          642 TGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  720 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  720 (807)
                      .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..........    .. ..+.      ..+...  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~----~i-~~~~------~~~~~~--  219 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR----NI-AFGK------VRFPKN--  219 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH----HH-HcCC------CCCCCc--
Confidence            2235799999999998765 48999999999999999999999986433221111    11 0010      011111  


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCC----HHHHHH
Q 003628          721 QLDMIIRCIHVGLLCVQELVKDRPN----MSTVVS  751 (807)
Q Consensus       721 ~~~~~~~l~~li~~Cl~~dP~~RPt----~~ev~~  751 (807)
                        ....++.+++.+||+.||.+||+    +.++++
T Consensus       220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              12456778999999999999984    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=308.26  Aligned_cols=264  Identities=22%  Similarity=0.319  Sum_probs=203.2

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ++|++.+.||+|+||.||+|... +++.||||+++...  ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999876 57899999986532  3345789999999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |++++.+..++.   +...+++.++..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999877776553   2345899999999999999999999998   9999999999999999999999999998765443


Q ss_pred             CccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh----------c-ccc
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL----------W-NEN  705 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~----------~-~~~  705 (807)
                      .. ......++..|+|||++... .++.++||||||+++|||++|+.|+........+.......          + ...
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            21 12235678999999999888 78999999999999999999999886543221111100000          0 000


Q ss_pred             c-----cccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          706 K-----ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       706 ~-----~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .     ..+..++.......+.....++.+++++|++.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0     000000000000122223678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.4e-34  Score=306.84  Aligned_cols=263  Identities=22%  Similarity=0.281  Sum_probs=199.3

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc-----cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-----GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      +|.+.+.||+|++|.||+|... +++.||||.++.....     ....+..|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999875 6899999999754322     235677899999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+ +++|.+++...  ...+++..+.+++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 89999998542  236899999999999999999999998   99999999999999999999999999987644


Q ss_pred             CCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh-------cc-ccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------WN-ENK  706 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~-------~~-~~~  706 (807)
                      ....  .....++..|+|||.+.+ ..++.++||||||+++|||++|.+++....+...+.......       +. ...
T Consensus       155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            3221  122346788999998865 457889999999999999999977765433221111110000       00 000


Q ss_pred             cccccCccccC----CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          707 ILALVDPFLSE----SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       707 ~~~~~d~~l~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ...........    .........++.+++.+|++.+|++|||+.||+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000000    00112235678899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-34  Score=315.77  Aligned_cols=193  Identities=23%  Similarity=0.356  Sum_probs=165.4

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ....+|++.+.||+|+||.||+|+.. .++.||+|.....      ....|+.++++++|+||+++++++.+....++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34467999999999999999999976 4678999975432      2357999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+. ++|.+++..  ....+++..+.+|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 578887753  3457899999999999999999999998   999999999999999999999999999753222


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCC
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT  685 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~  685 (807)
                      .   ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            1   122356899999999999999999999999999999999976554

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-34  Score=312.50  Aligned_cols=262  Identities=21%  Similarity=0.291  Sum_probs=196.3

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeC-----
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----  549 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  549 (807)
                      ...++|.+.+.||+|+||.||++... +++.||||++....  ....+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            44578999999999999999999865 67899999986532  22346688999999999999999999987543     


Q ss_pred             -CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          550 -EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       550 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                       ...++++|++ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468999988 778888773    356899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh------
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL------  701 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~------  701 (807)
                      +++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+....+.......      
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99865332     123468999999999877 568999999999999999999999986533221111111000      


Q ss_pred             ----ccccccccccC--ccccCCc---ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          702 ----WNENKILALVD--PFLSESS---FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       702 ----~~~~~~~~~~d--~~l~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                          .........+.  +......   ........+.+++.+|++.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                00000000000  0000000   000112357799999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.6e-34  Score=298.67  Aligned_cols=251  Identities=36%  Similarity=0.542  Sum_probs=200.7

Q ss_pred             CcccCccccCCCccEEEEEecC-----CcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          483 FQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~~-----g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      +.+.+.||+|+||.||+++..+     +..||+|.+...... ..+.+..|+.++.+++|+||+++++++.+.+..++||
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998764     378999999765433 5678999999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999985421 122899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ...... ...++..|+|||.+....++.++||||+|++++||++ |+.|+....... +...   .. .+..     .. 
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-~~~~---~~-~~~~-----~~-  224 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-VLEY---LK-KGYR-----LP-  224 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH---Hh-cCCC-----CC-
Confidence            222111 2236789999999988889999999999999999998 777765422211 1111   00 0100     00 


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                          .....+.++.+++.+|+..+|++|||+.|++++|
T Consensus       225 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 ----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                1122456788999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=301.50  Aligned_cols=286  Identities=22%  Similarity=0.318  Sum_probs=227.6

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc--cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      .-|.+.+.||+|.|..|-++++- .|..||||++.+..-.  ....+++|++.|+.++|||||+||.....+...|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            34677899999999999999864 7999999999875433  34678999999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeee-cCCCCceeeccccccccCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL-DEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll-~~~~~~kL~DFGla~~~~~~  636 (807)
                      .-++|+|.++|..  ....+++.-..+++.||+.|+.|.|+..   +|||||||+||.+ ..-|-+||+|||++-.+...
T Consensus        98 LGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999965  3457899999999999999999999988   9999999999977 55688999999999876543


Q ss_pred             CCccccceeeccCCccChhhhccCCCCc-ccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSE-KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~-k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      +   .....+|...|-|||++.+..|+. +.||||||||||-|+.|+.||...++...+..             ++|-. 
T Consensus       173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm-------------ImDCK-  235 (864)
T KOG4717|consen  173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM-------------IMDCK-  235 (864)
T ss_pred             c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh-------------hhccc-
Confidence            3   334478999999999999999864 68999999999999999999987665544432             12211 


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH--HHhhccCCCCCCCCCCcccCCCCCCchhHHHHHHHHHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS--MLNSEIRDLPYPKEPAFTERQGADDSESFKQIQQRILLMILL  793 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~--~L~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  793 (807)
                        -..+.....+|.+||..||..||.+|.+.+||+.  .|+.. +.-+....|-+..++.  .++.+..|.|.|.+=...
T Consensus       236 --YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~-D~~~sT~iPLvsr~~L--~ee~Ha~IIq~Mv~G~IA  310 (864)
T KOG4717|consen  236 --YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG-DRGLSTAIPLVSRHHL--PEEAHATIIQQMVAGAIA  310 (864)
T ss_pred             --ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC-CCCccccCceeehhhC--ChHHHHHHHHHHhccccc
Confidence              1266678899999999999999999999999985  44443 3333333443333333  234455566666655543

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7e-34  Score=300.53  Aligned_cols=251  Identities=26%  Similarity=0.378  Sum_probs=197.5

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-----cccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEK  552 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  552 (807)
                      ++|++.+.||+|+||.||++... ++..||||.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999875 58899999885321     12346788999999999999999999988764  467


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++||||+++++|.+++..   ...+++....+++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999998853   245788889999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCCc-cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          633 FGGNQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       633 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...........    ....     ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~-----~~  226 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQ-----PT  226 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH----HhcC-----CC
Confidence            5422111 112234588999999999888899999999999999999999999864322211110    0000     00


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .     ...+......+.+++.+|+. +|++||+++||++.
T Consensus       227 ~-----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         227 N-----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             C-----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            1     11333455677888888885 89999999998863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-34  Score=308.65  Aligned_cols=263  Identities=24%  Similarity=0.344  Sum_probs=200.1

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc--cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ++|++.++||+|+||.||++... +++.||+|++......  ..+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999986 5889999998654322  34678899999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++++|..+...   ...+++.++..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||+++......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887642   345899999999999999999999988   9999999999999999999999999998764332


Q ss_pred             CccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhh---hhc-------cccc
Q 003628          638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW---KLW-------NENK  706 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~---~~~-------~~~~  706 (807)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|++|+..............   ...       ....
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            2  1222457889999999875 4478899999999999999999988864332111111000   000       0000


Q ss_pred             -cccccCccccCC----cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          707 -ILALVDPFLSES----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 -~~~~~d~~l~~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                       ......+.....    .........+.+++.+|++.+|++||++.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             000000110000    011133567899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.7e-34  Score=328.77  Aligned_cols=264  Identities=19%  Similarity=0.226  Sum_probs=192.9

Q ss_pred             HHHHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccC------CceeEEeeEEE
Q 003628          475 ELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH------RNLVRLLGCCV  547 (807)
Q Consensus       475 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~  547 (807)
                      ++....++|++.++||+|+||.||++... .++.||||+++... .....+..|+.++..++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445688999999999999999999875 57889999996432 233456678888777754      45899999887


Q ss_pred             eC-CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhc-CCCcEEeCCCCCCCeeecCCC-----
Q 003628          548 EG-EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEEL-----  620 (807)
Q Consensus       548 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DIkp~NIll~~~~-----  620 (807)
                      .. ...++|||++ +++|.+++..   ...+++..+..|+.||+.||.|||++ +   |+||||||+|||++.++     
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence            64 4678999988 6788887743   35789999999999999999999974 6   99999999999998765     


Q ss_pred             -----------CceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccC
Q 003628          621 -----------NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE  689 (807)
Q Consensus       621 -----------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~  689 (807)
                                 .+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                       499999998764221     1223679999999999999999999999999999999999999997544


Q ss_pred             Ccchhhhhhhhh------cc----c----------cccccccCccc----cC-Cc-ccHHHHHHHHHHHHhcccCCcCCC
Q 003628          690 DDLTILGYAWKL------WN----E----------NKILALVDPFL----SE-SS-FQLDMIIRCIHVGLLCVQELVKDR  743 (807)
Q Consensus       690 ~~~~l~~~~~~~------~~----~----------~~~~~~~d~~l----~~-~~-~~~~~~~~l~~li~~Cl~~dP~~R  743 (807)
                      ....+.......      +.    .          +.+....++.-    .. .. ........+++|+.+||+.||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            322111110000      00    0          00000000000    00 00 000113467899999999999999


Q ss_pred             CCHHHHHH
Q 003628          744 PNMSTVVS  751 (807)
Q Consensus       744 Pt~~ev~~  751 (807)
                      ||++|+++
T Consensus       430 ~ta~e~L~  437 (467)
T PTZ00284        430 LNARQMTT  437 (467)
T ss_pred             CCHHHHhc
Confidence            99999987

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.2e-34  Score=304.43  Aligned_cols=259  Identities=25%  Similarity=0.390  Sum_probs=202.9

Q ss_pred             CHHHHHHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEEEe-
Q 003628          472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE-  548 (807)
Q Consensus       472 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-  548 (807)
                      ++.++....+.|++.+.||+|+||.||+|+.. +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44555566788999999999999999999975 57899999985432 3446788999999998 79999999999863 


Q ss_pred             -----CCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCce
Q 003628          549 -----GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK  623 (807)
Q Consensus       549 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~k  623 (807)
                           ....++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 45779999999999999988543 2345788888999999999999999998   99999999999999999999


Q ss_pred             eeccccccccCCCCCccccceeeccCCccChhhhc-----cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhh
Q 003628          624 ISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA  698 (807)
Q Consensus       624 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~  698 (807)
                      |+|||+++.......  ......|+..|+|||.+.     ...++.++||||||+++|||++|+.|+...........  
T Consensus       162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--  237 (282)
T cd06636         162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--  237 (282)
T ss_pred             EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence            999999886532211  122356899999999875     34678899999999999999999999864332111110  


Q ss_pred             hhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          699 WKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       699 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                              ......+.+.    ......++.+++.+||+.||.+||++.||++
T Consensus       238 --------~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 --------IPRNPPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --------HhhCCCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                    0011111111    1124567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.9e-34  Score=306.64  Aligned_cols=262  Identities=20%  Similarity=0.302  Sum_probs=196.1

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|++.+.||+|+||.||+++.. +|+.+|+|+++...  ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999976 68899999986432  22335678899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++ +|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            974 77777643  2356899999999999999999999998   99999999999999999999999999986543221


Q ss_pred             ccccceeeccCCccChhhhccCC-CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc---c---cccccc
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE---N---KILALV  711 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~-~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~---~---~~~~~~  711 (807)
                      .  .....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+....+..............   .   .+....
T Consensus       155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence            1  12245788999999987654 7899999999999999999998864322211111000000000   0   000000


Q ss_pred             Cc----cccC----CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          712 DP----FLSE----SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 d~----~l~~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      +.    ....    .........++.+++.+|++.||.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00    0000    0011123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-34  Score=302.56  Aligned_cols=255  Identities=26%  Similarity=0.398  Sum_probs=202.4

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCC-----
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE-----  550 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-----  550 (807)
                      ..+++|++.+.||+|++|.||+|... +++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35688999999999999999999975 57889999986543 3457899999999999 7999999999997644     


Q ss_pred             -eEEEEEEecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          551 -EKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       551 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                       ..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999885422 2457899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhcc-----CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN  703 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~  703 (807)
                      ++.........  .....|+..|+|||.+..     ..++.++||||||+++|||++|+.|+........+....     
T Consensus       159 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----  231 (275)
T cd06608         159 VSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP-----  231 (275)
T ss_pred             cceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh-----
Confidence            98865432211  222468899999998753     346789999999999999999999986433222211110     


Q ss_pred             ccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          704 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       704 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                           ....+.+.   .+.....++.+++.+|+..||++|||+.+|++
T Consensus       232 -----~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 -----RNPPPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -----ccCCCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 01111111   12234567889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-34  Score=339.63  Aligned_cols=256  Identities=23%  Similarity=0.343  Sum_probs=199.3

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeE
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEK  552 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  552 (807)
                      ...++|.+.++||+|+||.||+++.. .+..+|+|.+...  .......|..|+.++.+++||||+++++++.+.  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            44578999999999999999999976 4678999988643  233457799999999999999999999988653  568


Q ss_pred             EEEEEecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCC----CcEEeCCCCCCCeeecCC--------
Q 003628          553 MLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSR----LRIIHRDLKASNILLDEE--------  619 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~DIkp~NIll~~~--------  619 (807)
                      +|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.+        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            89999999999999986422 23569999999999999999999998542    249999999999999642        


Q ss_pred             ---------CCceeeccccccccCCCCCccccceeeccCCccChhhhcc--CCCCcccceeehhHHHHHHHhCCCCCCcc
Q 003628          620 ---------LNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFF  688 (807)
Q Consensus       620 ---------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~k~DvwSlGvvl~elltG~~p~~~~  688 (807)
                               ..+||+|||+++.+.....   .....||+.|+|||++..  ..++.++||||||||||||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     3489999999986643221   223578999999999864  45889999999999999999999998654


Q ss_pred             CCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          689 EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       689 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .....+....    ...       +.+..    .....++.+|+..||+.+|.+||++.+++.
T Consensus       247 ~~~~qli~~l----k~~-------p~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFSQLISEL----KRG-------PDLPI----KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHHHHHHHH----hcC-------CCCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            3322221111    000       11111    112456889999999999999999999984

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-34  Score=308.64  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=204.3

Q ss_pred             hcCCcccCccccCCCccEEEEEecCCcEEEEEEecc--cCcccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ...|++.++||+||.+.||++...+.+.+|+|++..  ...+....|.+|+..|.+|+ |.+|++|++|-..++..|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            356899999999999999999999889999998753  45566788999999999995 999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||= ..+|..+|...  ...+....+..+..||+.++.++|+++   |||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus       440 E~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            987 45899999653  222332377889999999999999999   999999999999965 68999999999988777


Q ss_pred             CCccccceeeccCCccChhhhccCC-----------CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGR-----------FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN  705 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~-----------~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~  705 (807)
                      .........+||+.||+||.+....           .+.++||||+|||||+|+.|++||..+...     +       .
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-----~-------a  580 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-----I-------A  580 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----H-------H
Confidence            7666666689999999999985432           567899999999999999999999643211     1       1


Q ss_pred             ccccccCccccCCcccH-HHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          706 KILALVDPFLSESSFQL-DMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       706 ~~~~~~d~~l~~~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ++..+.+|.-.-+ ++. ....+++++++.||+.||.+|||..|+++.
T Consensus       581 Kl~aI~~P~~~Ie-fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 KLHAITDPNHEIE-FPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHHhhcCCCcccc-ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            2334455533211 111 111238999999999999999999999864

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.2e-34  Score=305.35  Aligned_cols=265  Identities=23%  Similarity=0.318  Sum_probs=197.3

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++..+...++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999865 688999999865432 23356789999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+. ++|.+++..  ....+.+..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 677666543  2345778888999999999999999998   999999999999999999999999999864332


Q ss_pred             CCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc-----------
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE-----------  704 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~-----------  704 (807)
                      ...  .....++..|+|||.+.+. .++.++||||||+++|||++|+.||....+........+.....           
T Consensus       157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            211  1224578999999998764 47889999999999999999999987544321111111110000           


Q ss_pred             -ccc-ccccCc----cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          705 -NKI-LALVDP----FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       705 -~~~-~~~~d~----~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                       ... .+....    .+............+.+++.+|++.||++|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             000 000000    00000000012356778999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.9e-34  Score=305.01  Aligned_cols=250  Identities=25%  Similarity=0.377  Sum_probs=204.3

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      ++|.+.+.||+|+||.||++... ++..||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67889999999999999999864 67899999987555555678899999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++++|.+++..    ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999999843    35788899999999999999999998   999999999999999999999999998765433221


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                        .....+++.|+|||.+....++.++|+||||+++||+++|+.||........+...    ...+      .+...   
T Consensus       172 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~----~~~~------~~~~~---  236 (293)
T cd06647         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----ATNG------TPELQ---  236 (293)
T ss_pred             --cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh----hcCC------CCCCC---
Confidence              12246888999999998888999999999999999999999998643322111100    0000      00110   


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ........+.+++.+|++.+|++||++.+++.+
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122344578899999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.9e-34  Score=304.28  Aligned_cols=263  Identities=21%  Similarity=0.323  Sum_probs=201.5

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|++.+.||+|++|.||+|+.. +|+.||||++....  ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999875 68999999987543  33457899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      + +++|.+++...  ...+++.++..++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 99999988542  356899999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccc------------
Q 003628          639 QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN------------  705 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~------------  705 (807)
                       .......++..|+|||.+.+. .++.++||||+|+++|||++|++++....+...+... .......            
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV-FRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH-HHHcCCCChHHHhhccCcc
Confidence             112234688999999988654 4688999999999999999997776543322111111 0000000            


Q ss_pred             ccccccCccccC---CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          706 KILALVDPFLSE---SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       706 ~~~~~~d~~l~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .......+....   .....+....+.+++.+|++.+|++|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000000   00111234788999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.3e-33  Score=297.70  Aligned_cols=252  Identities=27%  Similarity=0.389  Sum_probs=206.8

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|++.+.||+|++|.||+++.. +++.||||++..... ...+.+.+|+..+.+++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999987 489999999876543 4467899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhh-cCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      +++++|.+++..   ...+++..+.+++.|+++||.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999854   2678999999999999999999999 88   9999999999999999999999999998764433


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      ...  ....++..|+|||.+.+..++.++|+||||+++|||++|+.|+...... ...........      ...+.   
T Consensus       155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~------~~~~~---  222 (264)
T cd06623         155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICD------GPPPS---  222 (264)
T ss_pred             Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhc------CCCCC---
Confidence            221  2356889999999999999999999999999999999999998654320 11111111110      00111   


Q ss_pred             CcccHH-HHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          718 SSFQLD-MIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       718 ~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                        .+.. .+..+.+++.+|++.+|++||++.++++.
T Consensus       223 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 --LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              1222 45678899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-33  Score=306.65  Aligned_cols=197  Identities=27%  Similarity=0.448  Sum_probs=159.9

Q ss_pred             cCccccCCCccEEEEEec---CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEe--CCeEEEEEEecC
Q 003628          486 SSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLIYEYMP  560 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~  560 (807)
                      ..+||+|+||.||+|+..   ++..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            368999999999999865   35789999986532  23567899999999999999999999854  456789999997


Q ss_pred             CCCccccccCC------CCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeee----cCCCCceeeccccc
Q 003628          561 NRSLDALLFDP------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMA  630 (807)
Q Consensus       561 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll----~~~~~~kL~DFGla  630 (807)
                      + +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 666655321      12235788889999999999999999998   9999999999999    56678999999999


Q ss_pred             cccCCCCCc-cccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCcc
Q 003628          631 KIFGGNQDQ-ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFF  688 (807)
Q Consensus       631 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~  688 (807)
                      +........ .......||+.|+|||.+.+. .++.++||||||+++|||+||+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876543221 122335789999999998764 5789999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-33  Score=301.92  Aligned_cols=259  Identities=25%  Similarity=0.301  Sum_probs=200.9

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~  556 (807)
                      ++|...+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999985 578899999875433 3457799999999999999999999998654  4689999


Q ss_pred             EecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          557 EYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      ||+++++|.+++.... ....++...+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999998875322 3456888899999999999999999998   99999999999999999999999999875532


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCc-chhhhhhhhhccccccccccCcc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD-LTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      ...    ....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ........... ..... .+...
T Consensus       158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~  231 (287)
T cd06621         158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNP-ELKDE  231 (287)
T ss_pred             ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCch-hhccC
Confidence            211    1245788999999999999999999999999999999999998754221 01111111000 00000 01101


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ..   ........+.+++.+|++.+|++|||+.||++
T Consensus       232 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 PG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            10   11224567899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.1e-34  Score=297.58  Aligned_cols=249  Identities=26%  Similarity=0.383  Sum_probs=201.0

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|+..+.||+|+||.||++... +++.+|||.+...  .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999875 6889999998654  233467899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC-CCceeeccccccccCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kL~DFGla~~~~~~~  637 (807)
                      +++++|.+++... ....+++..+.+++.++++||.|||+.+   ++|+||+|+||+++++ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999998542 2345889999999999999999999998   9999999999999865 458999999998764332


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      .   .....++..|+|||.+....++.++||||||+++|+|++|+.|+...+......    .... ...     .    
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~----~~~~-~~~-----~----  219 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL----KIMS-GTF-----A----  219 (256)
T ss_pred             c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH----HHHh-cCC-----C----
Confidence            2   122467899999999998889999999999999999999999986543221111    1100 000     0    


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                       ..+.....++.+++.+|++.+|++|||++|+++.
T Consensus       220 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         220 -PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence             0112245578899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.6e-34  Score=307.41  Aligned_cols=256  Identities=19%  Similarity=0.253  Sum_probs=201.4

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||.||++... .++.||+|.+....   ....+.+.+|+++++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999876 47899999987543   233567889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999843   346889999999999999999999988   999999999999999999999999998742111


Q ss_pred             CC-------------ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc
Q 003628          637 QD-------------QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN  703 (807)
Q Consensus       637 ~~-------------~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~  703 (807)
                      ..             ........++..|+|||.+....++.++|+||||+++|||++|+.|+....... +.   .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~---~~~~~  230 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LF---GQVIS  230 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH---HHHHh
Confidence            00             001112457889999999998889999999999999999999999986332211 11   11000


Q ss_pred             ccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          704 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       704 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                       +   ....+..     ....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus       231 -~---~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 -D---DIEWPEG-----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -c---ccCCCCc-----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence             0   0011111     11234567899999999999999998777777755

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.5e-33  Score=297.31  Aligned_cols=252  Identities=29%  Similarity=0.459  Sum_probs=202.6

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc--cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|.+.+.||+|+||.||+|... +++.||+|.++.....  ..+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999865 6889999998765443  567899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++..   ...+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999853   345788999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccc--cceeeccCCccChhhhccCC---CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          639 QAD--TGRVVGTFGYMSPEYAMEGR---FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       639 ~~~--~~~~~gt~~y~APE~~~~~~---~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ...  .....++..|+|||++....   ++.++||||||+++|||++|+.||...+......   ....      ....+
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~---~~~~------~~~~~  225 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM---FHVG------AGHKP  225 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH---HHHh------cCCCC
Confidence            211  11246788999999998766   8899999999999999999999986543221111   0000      00111


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .+..   .......+.+++.+|++.+|.+||++.|+++
T Consensus       226 ~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 PIPD---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCc---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111   1122456779999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=302.91  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=197.0

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|++.+.||+|++|.||+|+.+ +++.||||.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999976 6889999998654322 235677899999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++ +|.+++...  ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 898887542  346888999999999999999999998   99999999999999999999999999875432111


Q ss_pred             ccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccc---cc-------
Q 003628          639 QADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN---KI-------  707 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~---~~-------  707 (807)
                      .  .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.|+....+...............   ..       
T Consensus       159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence            1  112346789999999875 4588999999999999999999999864432211111111111000   00       


Q ss_pred             --ccc----cC-ccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          708 --LAL----VD-PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       708 --~~~----~d-~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                        ...    .. ..+...........++.+++.+|++.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              000    00 000000000011257789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-33  Score=297.71  Aligned_cols=253  Identities=26%  Similarity=0.449  Sum_probs=201.5

Q ss_pred             CCcccCccccCCCccEEEEEe-cCCcEEEEEEecccCc------ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASG------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      +|+..+.||+|++|.||+++. .+++.||+|.+.....      ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999986 4688999999864321      134678999999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC-Cceeecccccccc
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIF  633 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kL~DFGla~~~  633 (807)
                      ||||+++++|.+++.+   ...+++..+.+++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   346889999999999999999999998   99999999999998776 5999999999876


Q ss_pred             CCCCCc--cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          634 GGNQDQ--ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       634 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ......  .......++..|+|||.+.+..++.++||||+|+++++|++|+.|+.......... .....         .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~---------~  224 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFKI---------A  224 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHHH---------h
Confidence            543211  11223468899999999988889999999999999999999999986432211111 00000         0


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .. ......+.....++.+++.+|++.+|++||++.++++
T Consensus       225 ~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 SA-TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             cc-CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            00 0011133445677889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.8e-34  Score=300.28  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=202.8

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++|+..+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++.+......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777899999999999999986 58899999987653 34457789999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhh-cCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      +++++|.+++...  ...++...+.+++.|+++||.|||+ .+   ++|+||||+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999999998542  2578889999999999999999999 77   9999999999999999999999999987653221


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCC-cchhhhhhhhhccccccccccCcccc
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED-DLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      ..    ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... .............      ...+.+.
T Consensus       156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~  225 (265)
T cd06605         156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------EPPPRLP  225 (265)
T ss_pred             hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc------CCCCCCC
Confidence            11    15678899999999999999999999999999999999999864421 1111111111110      0011111


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                          ......++.+++.+|+..+|++|||+.++++
T Consensus       226 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         226 ----SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                1114567889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.2e-35  Score=316.53  Aligned_cols=245  Identities=26%  Similarity=0.402  Sum_probs=196.5

Q ss_pred             cccCccccCCCccEEEEEec-CCcEEEEEEec--c--cCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCe--EEEEE
Q 003628          484 QLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLS--K--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE--KMLIY  556 (807)
Q Consensus       484 ~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~  556 (807)
                      +...+||+|+|-+||+|.+. +|-+||--.++  +  ..+...++|..|+.+|+.|+||||++++.++.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44579999999999999875 47777643332  1  234456899999999999999999999999987765  67899


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC-CCCceeeccccccccCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGG  635 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kL~DFGla~~~~~  635 (807)
                      |.|..|+|..|+.   +.++++...+.+|++||++||.|||++. +||+|||||..||+|+. .|.+||+|+|||.....
T Consensus       123 EL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            9999999999985   4567888999999999999999999986 79999999999999975 48999999999998754


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ...    ..+.|||.|||||... ..|....||||||+.++||+|+..|+........+    ++....|.-     |.-
T Consensus       199 s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI----YKKV~SGiK-----P~s  264 (632)
T KOG0584|consen  199 SHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI----YKKVTSGIK-----PAA  264 (632)
T ss_pred             ccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH----HHHHHcCCC-----HHH
Confidence            432    2378999999999766 78999999999999999999999998765543322    222222211     111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                          +..-...++.++|..||.. .++|||+.|++.
T Consensus       265 ----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  265 ----LSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----hhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                1111135678899999999 999999999985

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.9e-33  Score=299.45  Aligned_cols=246  Identities=26%  Similarity=0.396  Sum_probs=200.0

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      |+..+.||+|+||.||+|... ++..+|||.+.... ....+.+.+|+.++.+++||||+++++++..+...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            667789999999999999865 67899999986432 2345678899999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++.    ...+++..+..++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........  
T Consensus        86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06641          86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence            999999884    346889999999999999999999988   99999999999999999999999999876543221  


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  720 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  720 (807)
                      ......++..|+|||.+.+..++.++|+||||+++|||++|..|+...........     .....     .+.     .
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~-----~~~-----~  221 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-----IPKNN-----PPT-----L  221 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-----HhcCC-----CCC-----C
Confidence            11224678899999999888899999999999999999999999864332111100     00000     111     2


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          721 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       721 ~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ......++.+++.+|++.+|.+||++.++++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            22345678899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=286.91  Aligned_cols=251  Identities=24%  Similarity=0.297  Sum_probs=200.1

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecc--cCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++.|++-+.||+|.|+.||+.... .|+.+|+|++.-  -...+.+++.+|++|.+.|+||||++|.....+....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467888899999999999998654 688999888753  23446788999999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC---CCceeecccccccc
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIF  633 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~---~~~kL~DFGla~~~  633 (807)
                      |+|+|++|-.-|.   .+..+++..+-..++||+++|.|.|.++   |||||+||+|++|.+.   --+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999865543   2356777888889999999999999998   9999999999999543   34999999999987


Q ss_pred             CCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          634 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       634 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ..   .......+|||+|||||++...+|+..+|||+.|||||-|+.|..||...+.......     ...+..  .+++
T Consensus       164 ~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~-----I~~g~y--d~~~  233 (355)
T KOG0033|consen  164 ND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQ-----IKAGAY--DYPS  233 (355)
T ss_pred             CC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHH-----Hhcccc--CCCC
Confidence            62   2233346899999999999999999999999999999999999999864332221111     111111  1111


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                           +.-....++..+|+.+||..||++|-|+.|.++
T Consensus       234 -----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 -----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -----cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                 011234567789999999999999999998664

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1e-33  Score=298.28  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=201.6

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEe--CCeEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLIY  556 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~  556 (807)
                      +|++.+.||.|+||.||++... +++.+|+|.+...  .....+.+..|+.++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999865 6789999998643  23345678899999999999999999998764  45678999


Q ss_pred             EecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcC--CCcEEeCCCCCCCeeecCCCCceeecccccccc
Q 003628          557 EYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDS--RLRIIHRDLKASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~  633 (807)
                      ||+++++|.+++.... ....+++..+..++.||+.||.|||..+  ...++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999999985432 2457899999999999999999999332  233999999999999999999999999999876


Q ss_pred             CCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          634 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       634 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ......  .....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+...+.. .+...    ...+.     .+
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~----~~~~~-----~~  228 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-QLASK----IKEGK-----FR  228 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-HHHHH----HhcCC-----CC
Confidence            543321  12246899999999999988999999999999999999999998754321 11111    11111     01


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                           ..+.....++.+++.+|++.+|++||++.+|+++
T Consensus       229 -----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 -----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                 1233445678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=298.93  Aligned_cols=247  Identities=27%  Similarity=0.445  Sum_probs=199.7

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhcc---CCceeEEeeEEEeCCeEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~  556 (807)
                      .|+..+.||+|+||.||+|... +++.||+|.+... .....+++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777899999999999999964 6889999998654 3345577889999999996   999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++++|.+++..    ..+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998843    36889999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ...  .....|+..|+|||.+.++ .++.++|+||||+++|+|++|+.|+..........     .     +.....+.+
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-----~-----~~~~~~~~~  222 (277)
T cd06917         155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-----L-----IPKSKPPRL  222 (277)
T ss_pred             ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-----c-----cccCCCCCC
Confidence            321  2234688999999998754 46889999999999999999999986433211110     0     000111112


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ...    ....++.+++.+|++.+|++||++.|+++
T Consensus       223 ~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 EDN----GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             Ccc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111    13457889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.6e-33  Score=299.71  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=205.6

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      .++.|+..+.||+|++|.||++... +++.+|+|.+..... ..+.+.+|++++++++|+||+++++.+......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999987 688999999975543 56788999999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++++|.+++....  ..+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999996421  37999999999999999999999988   9999999999999999999999999987654322


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      .  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.............     ....     +... 
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~-----~~~~-----~~~~-  237 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT-----TKGI-----PPLK-  237 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hcCC-----CCCc-
Confidence            1  1122457889999999998889999999999999999999999986433221111100     0000     0010 


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                        ........+.+++.+|++.+|.+||++.+|++.
T Consensus       238 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         238 --NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             --chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              111245678899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.2e-33  Score=302.98  Aligned_cols=244  Identities=28%  Similarity=0.363  Sum_probs=200.0

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999876 58899999986532   234567899999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++++|.+++..   ...++...+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999853   357889999999999999999999988   999999999999999999999999999876433


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                           .....+++.|+|||.+.+...+.++||||||+++|||++|+.|+...+......    ... .+.      ..  
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~-~~~------~~--  216 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE----KIL-EGK------VR--  216 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHh-cCC------cc--
Confidence                 223468899999999988889999999999999999999999986433111110    000 000      01  


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  751 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~  751 (807)
                         .+......+.+++.+|++.+|.+||     +++|+++
T Consensus       217 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         217 ---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               1222346788999999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.1e-33  Score=310.91  Aligned_cols=197  Identities=26%  Similarity=0.354  Sum_probs=170.1

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhcc-C-----CceeEEeeEEEeCCeEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H-----RNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l  554 (807)
                      +|.+.+.||+|+||.|.++... +++.||||+++.. ..-..+-..|+.+|..|+ |     -|+|+++++|...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7899999999999999999865 5899999999643 344566778999999996 5     389999999999999999


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC--Cceeeccccccc
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL--NPKISDFGMAKI  632 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~--~~kL~DFGla~~  632 (807)
                      |+|.++ -+|.++|... +-..++...+..|+.||+.||.+||+.+   |||+||||+||||.+..  .+||+|||.+..
T Consensus       266 VfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            999995 5999999765 3445999999999999999999999998   99999999999997544  599999999986


Q ss_pred             cCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccC
Q 003628          633 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE  689 (807)
Q Consensus       633 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~  689 (807)
                      ......     ...-+..|.|||++.+.+|+.+.||||||||+.||.+|.+-|...+
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            543322     3556789999999999999999999999999999999987665544

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.3e-33  Score=299.41  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=194.1

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHH-HHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMV-ISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ++|++.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.+ ++.++||||+++++++..+...++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999976 58999999987543 2334556667765 556689999999999999999999999


Q ss_pred             ecCCCCccccccCC-CCCCCCChhhhHHHHHHHHhhhHhhhhc-CCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          558 YMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       558 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |++ ++|.+++... .....+++..+.+++.||+.||+|||++ +   ++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6887777542 2335789999999999999999999986 6   99999999999999999999999999986532


Q ss_pred             CCCccccceeeccCCccChhhhcc----CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAME----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~----~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ..   ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+..........   ....      ...
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~------~~~  224 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL---KQVV------EEP  224 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH---HHHH------hcC
Confidence            21   1122457889999998864    456889999999999999999999986432211100   0000      011


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .+.+..    ...+.++.+++.+|++.+|++||++.+|++
T Consensus       225 ~~~~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 SPQLPA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111    123467889999999999999999999976

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=305.01  Aligned_cols=253  Identities=23%  Similarity=0.246  Sum_probs=203.1

Q ss_pred             cCCcccCccccCCCccEEEEEecC-CcEEEEEEecccCcc---cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ---GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|++|.||++...+ ++.+|+|.+......   ..+.+.+|++++.+++|+||+++++.+.++...++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368888999999999999998764 899999999764322   4567899999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+.+++|.+++... ....+++..+..++.|+++||+|||..+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999998542 3457899999999999999999999988   999999999999999999999999998765322


Q ss_pred             CCc---------------------------cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccC
Q 003628          637 QDQ---------------------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE  689 (807)
Q Consensus       637 ~~~---------------------------~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~  689 (807)
                      ...                           .......|+..|+|||++.+..++.++||||||+++|+|++|+.|+...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01112468899999999999889999999999999999999999986544


Q ss_pred             CcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCC----HHHHHH
Q 003628          690 DDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN----MSTVVS  751 (807)
Q Consensus       690 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt----~~ev~~  751 (807)
                      ....+....             .....-. ........+.+++.+|++.+|++||+    ++|++.
T Consensus       237 ~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDETFSNIL-------------KKEVTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHHHHHHh-------------cCCccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            332221111             1111000 11114577899999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.1e-33  Score=300.50  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=199.8

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      |...+.||+|++|.||++... +++.+|+|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            444579999999999999864 6889999998655555567789999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      ++|.+++..    ..+++.++..++.|++.||+|||+.+   |+||||+|+||+++.++.++|+|||++.........  
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--  171 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--  171 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--
Confidence            999999843    46889999999999999999999998   999999999999999999999999988765432221  


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+.........    ....      ....+.+..   .
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~----~~~~------~~~~~~~~~---~  238 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM----KRIR------DNLPPKLKN---L  238 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH----HHHH------hcCCCCCcc---c
Confidence            12246889999999999888999999999999999999999998542211111    1000      011111111   1


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ......+.+++.+|++.+|++||++.++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            123467889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4e-33  Score=291.06  Aligned_cols=250  Identities=28%  Similarity=0.450  Sum_probs=205.3

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      +|...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677899999999999999986 688999999977655567889999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++...  ...+++..+..++.|+++||.|||..+   ++||||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            99999998542  257899999999999999999999988   99999999999999999999999999987654322  


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  720 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  720 (807)
                       .....++..|+|||.+....++.++||||||+++|+|++|+.|+...+..........          ...+.+.   .
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------~~~~~~~---~  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----------NGPPGLR---N  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------cCCCCcC---c
Confidence             2335688999999999988899999999999999999999999865432221111100          0000111   1


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          721 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       721 ~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ......++.+++.+|++.+|++|||+.|+++.
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11124678899999999999999999998763

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.4e-34  Score=302.64  Aligned_cols=263  Identities=21%  Similarity=0.317  Sum_probs=198.0

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999875 68899999986432  22346789999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +. ++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||+++.......
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 5888887543 3456899999999999999999999988   99999999999999999999999999986543221


Q ss_pred             ccccceeeccCCccChhhhccCC-CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc-cc-------c--
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE-NK-------I--  707 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~-~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~-~~-------~--  707 (807)
                      .  .....++..|+|||.+.+.. ++.++||||||+++|||+||+.|+...++...+.......-.. ..       +  
T Consensus       156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            1  12235688999999887654 5889999999999999999999986544322222111100000 00       0  


Q ss_pred             -ccccCccccCC--cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          708 -LALVDPFLSES--SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       708 -~~~~d~~l~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                       ...........  ........++.+++.+|++.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence             00000000000  001122356789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=308.41  Aligned_cols=270  Identities=21%  Similarity=0.305  Sum_probs=200.5

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEEeCC-----eE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EK  552 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~  552 (807)
                      .++|++.++||+|+||.||+|+.. +|+.||||.+.... ......+.+|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999865 68999999986432 234567889999999999999999999876543     57


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++|+||+++ +|.+++    ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            899999975 777766    3456899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCcc-ccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc---ccc
Q 003628          633 FGGNQDQA-DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE---NKI  707 (807)
Q Consensus       633 ~~~~~~~~-~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~---~~~  707 (807)
                      ........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+...+.......+ ......   ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~-~~~~~~~~~~~~  234 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI-LGVLGTPSQEDL  234 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHcCCCCHHHH
Confidence            64322211 1223468899999998755 46889999999999999999999998643321111110 000000   000


Q ss_pred             ccccCc-------------cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH--HhhccC
Q 003628          708 LALVDP-------------FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSEIR  758 (807)
Q Consensus       708 ~~~~d~-------------~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~--L~~~~~  758 (807)
                      ....+.             .............++.+++.+|++.+|++|||+.|+++.  ++....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            000000             000000011234678899999999999999999999986  655433

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.3e-33  Score=296.61  Aligned_cols=250  Identities=22%  Similarity=0.385  Sum_probs=200.8

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|++.+.||+|+||.||++... +|..+|+|.+....  ....+.+.+|+.++++++|+||+++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999976 57899999986532  23456788999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCC-ceeeccccccccCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN-PKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~-~kL~DFGla~~~~~~~  637 (807)
                      +++++|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988542 2345789999999999999999999988   999999999999998854 6999999998764332


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      ..  .....|++.|+|||++.+..++.++|+||||++++||++|+.|+.........    ..... +.    ..+    
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~-~~----~~~----  221 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV----LKICQ-GY----FAP----  221 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHHhc-cc----CCC----
Confidence            21  12245889999999998888999999999999999999999998643321111    11110 10    110    


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                        ........+.+++.+|++.+|++|||+.||++.
T Consensus       222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         222 --ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              111234568899999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.8e-33  Score=301.73  Aligned_cols=246  Identities=29%  Similarity=0.448  Sum_probs=196.2

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      +.|.+.+.||+|+||.||+|+.. +++.||+|.+.....   ...+++.+|+++++.++||||+++++++.+....++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999875 588999999864322   23467889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||++ |+|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 566666532  2346899999999999999999999988   999999999999999999999999998764322


Q ss_pred             CCccccceeeccCCccChhhhc---cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~---~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                            ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+...+.......    ... .     ..+
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----~~~-~-----~~~  232 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQ-N-----DSP  232 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH----Hhc-C-----CCC
Confidence                  1245788999999874   45688999999999999999999999854332211110    000 0     001


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .+    ........+.+++.+||+.+|++||++.+|+++
T Consensus       233 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         233 TL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            11    112345678999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.1e-33  Score=298.59  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=200.6

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      +|++.++||+|++|.||+|+.. +|..||||+++..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999986 5889999998765332 3567889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++ +|.+++........+++..+.+++.|+++||.|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            85 88888765433456899999999999999999999988   999999999999999999999999999865432211


Q ss_pred             cccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhc--ccccc-----cccc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW--NENKI-----LALV  711 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~--~~~~~-----~~~~  711 (807)
                        .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+...+.............  .+...     ....
T Consensus       157 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         157 --FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             --cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence              1123568899999988664 468899999999999999999999875443222111110000  00000     0000


Q ss_pred             CccccC------CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          712 DPFLSE------SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 d~~l~~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ......      ..........+.+++..|++.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000      0011123467889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.8e-33  Score=300.53  Aligned_cols=262  Identities=22%  Similarity=0.296  Sum_probs=198.9

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  555 (807)
                      ++|++.+.||+|+||.||+|... +++.+|+|.++....  .....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            47888899999999999999986 588999999864432  2234678899999999999999999999877  889999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+++ +|.+++...  ...+++.++..++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999975 888887542  236899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCccccceeeccCCccChhhhccCC-CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh----------c--
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL----------W--  702 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~-~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~----------~--  702 (807)
                      ....  .....+++.|+|||.+.+.. ++.++|+||||+++|||++|+.|+........+.......          +  
T Consensus       159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            3211  12245788999999987654 6889999999999999999999987544322111110000          0  


Q ss_pred             ----cccccccccCccccCCcccHH-HHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          703 ----NENKILALVDPFLSESSFQLD-MIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       703 ----~~~~~~~~~d~~l~~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                          ............+. ..++.. ....+.+++.+|++.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                00000000000111 112211 3566789999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.2e-34  Score=280.29  Aligned_cols=254  Identities=25%  Similarity=0.331  Sum_probs=201.8

Q ss_pred             HHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-----cc---cHHHHHHHHHHHHhc-cCCceeEEeeEE
Q 003628          477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQ---GLEEFMNEVMVISKL-QHRNLVRLLGCC  546 (807)
Q Consensus       477 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-----~~---~~~~~~~E~~~l~~l-~H~niv~l~g~~  546 (807)
                      +..-+.|.-.+.||+|..++|-++..+ .|.+.|+|++....     ++   -.+...+|+.||+++ -||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344466777899999999999988765 58889999885321     11   135567899999998 699999999999


Q ss_pred             EeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeec
Q 003628          547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISD  626 (807)
Q Consensus       547 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~D  626 (807)
                      ......++|+|.|+.|.|-++|.   ..-.+++++..+|++|+.+|+.|||..+   ||||||||+|||++++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            99999999999999999999994   3457999999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCCccccceeeccCCccChhhhccC------CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh
Q 003628          627 FGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG------RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK  700 (807)
Q Consensus       627 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~  700 (807)
                      ||++..+....   .....+|||+|+|||.+...      .|+...|+|+.||++|.|+.|.+||-....-..+    . 
T Consensus       167 FGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML----R-  238 (411)
T KOG0599|consen  167 FGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML----R-  238 (411)
T ss_pred             cceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH----H-
Confidence            99999775443   23447999999999988532      4778899999999999999999998432211111    1 


Q ss_pred             hccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          701 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       701 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ..-+|+. +.-.|      .-.+......+|+.+||+.||.+|-|++|.++
T Consensus       239 ~ImeGky-qF~sp------eWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  239 MIMEGKY-QFRSP------EWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHhccc-ccCCc------chhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1111111 11111      22345677889999999999999999999875

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.3e-33  Score=290.81  Aligned_cols=251  Identities=28%  Similarity=0.443  Sum_probs=205.9

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLIY  556 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~  556 (807)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++|+||+++++.+.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999987 688999999875542  4568899999999999999999999999988  8899999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+++++|.+++...   ..+++.++..++.++++||.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998542   37899999999999999999999988   999999999999999999999999999877554


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      ..........++..|+|||.+.....+.++||||||+++++|++|+.|+...++....   ..........         
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~---------  222 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA---LYKIGSSGEP---------  222 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---HHhccccCCC---------
Confidence            3211122356889999999999888999999999999999999999998755421111   1111100000         


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                       ...+......+.+++.+|++.+|++||++.++++
T Consensus       223 -~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 -PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             0122233577889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=305.11  Aligned_cols=266  Identities=21%  Similarity=0.303  Sum_probs=197.1

Q ss_pred             CCcccCccccCCCccEEEEEecC---CcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKM  553 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~~---g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  553 (807)
                      +|.+.++||+|+||.||+|+...   ++.||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788999999999999999754   7899999997633   33456788999999999999999999999988  8899


Q ss_pred             EEEEecCCCCccccccCCC--CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC----CCCceeecc
Q 003628          554 LIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE----ELNPKISDF  627 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~----~~~~kL~DF  627 (807)
                      +||||+++ +|.+++....  ....++...+..++.||+.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 5656553321  2236888999999999999999999998   999999999999999    899999999


Q ss_pred             ccccccCCCCC-ccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcch---------hhh
Q 003628          628 GMAKIFGGNQD-QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT---------ILG  696 (807)
Q Consensus       628 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~---------l~~  696 (807)
                      |+++....... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+........         +..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987644322 1222335678999999988764 578999999999999999999999875443220         000


Q ss_pred             hhhhhcc-----------ccccccccCc----cccCCc----ccH--HHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          697 YAWKLWN-----------ENKILALVDP----FLSESS----FQL--DMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       697 ~~~~~~~-----------~~~~~~~~d~----~l~~~~----~~~--~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .......           ........+.    ......    ...  ....++.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000           0000000000    000000    000  23357889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-35  Score=312.35  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=208.5

Q ss_pred             cCCcccCccccCCCccEEEEEecCC-cEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      +.|.++..||.|+||.||++..++. -..|-|.+...+....++|+-|++||....||+||+|++.|...+..+++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            3467778999999999999998753 345778887777788899999999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      .||-.+.++..  -...+.+.++.-++.|++.||.|||++.   |||||||+.|||++-+|.++|+|||.+.....  ..
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR  184 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence            99999998865  3457999999999999999999999998   99999999999999999999999998864322  12


Q ss_pred             cccceeeccCCccChhhhc-----cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          640 ADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~-----~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      .....+.|||+|||||+.+     ..+|+.++|||||||+|.||..+.+|......-..++..+          .--.|.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia----------KSePPT  254 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----------KSEPPT  254 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh----------hcCCCc
Confidence            2234478999999999874     5579999999999999999999999976544332222211          112233


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      +.   .+......+.++...||..||..||++.++++.
T Consensus       255 Ll---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  255 LL---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             cc---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            33   344567788999999999999999999998763

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=299.35  Aligned_cols=260  Identities=23%  Similarity=0.321  Sum_probs=197.6

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      |++.+.||+|++|.||+|... +|..||+|++....  ....+.+.+|++++++++|||++++++++.++...++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999875 68999999986543  223467889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      + ++|.+++... ....+++..+.+++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|||+++........
T Consensus        81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 6898888542 2246899999999999999999999988   999999999999999999999999999865432211


Q ss_pred             cccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccc-----------cc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN-----------KI  707 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~-----------~~  707 (807)
                        .....++..|+|||++.+. .++.++||||||+++|||++|+.||...++...+...........           ..
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence              1123568899999988664 578899999999999999999999865443222221111100000           00


Q ss_pred             c----cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          708 L----ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       708 ~----~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .    ........  .........+.+++.+|++.+|++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLS--KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchh--hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0    00000000  011223467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4e-33  Score=305.73  Aligned_cols=267  Identities=20%  Similarity=0.312  Sum_probs=200.1

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeC-----Ce
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----EE  551 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  551 (807)
                      .++|.+.+.||+|+||.||+++.. +++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467999999999999999999865 5899999998653  233456778999999999999999999988654     34


Q ss_pred             EEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      .++||||+. ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 688877743   356899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhc--------
Q 003628          632 IFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW--------  702 (807)
Q Consensus       632 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~--------  702 (807)
                      .......  ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+...... ......        
T Consensus       157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~  233 (337)
T cd07858         157 TTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK-LITELLGSPSEEDL  233 (337)
T ss_pred             ccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHHHhCCCChHHh
Confidence            6643221  1223467889999998865 468899999999999999999999986433111110 000000        


Q ss_pred             ---cccccccccC--ccccC---CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH--Hhhc
Q 003628          703 ---NENKILALVD--PFLSE---SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSE  756 (807)
Q Consensus       703 ---~~~~~~~~~d--~~l~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~--L~~~  756 (807)
                         ......+.+.  +....   .........++.+++.+|++.+|++|||++++++.  ++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence               0000000000  00000   00112345678899999999999999999999876  5554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.4e-33  Score=299.22  Aligned_cols=265  Identities=20%  Similarity=0.267  Sum_probs=196.7

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCe-----
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE-----  551 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~-----  551 (807)
                      ++|++.+.||+|+||.||+|... +++.||||.+.....  .....+.+|+.+++++ +|+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999975 688999999865422  2346788999999999 56999999999887665     


Q ss_pred             EEEEEEecCCCCccccccCCCC--CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC-CCCceeeccc
Q 003628          552 KMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFG  628 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kL~DFG  628 (807)
                      .++||||+++ +|.+++.....  ...+++..+..++.||++||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 78888754322  346899999999999999999999998   999999999999998 8899999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc-cc
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE-NK  706 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~-~~  706 (807)
                      +++.+......  .....+++.|+|||++.+ ..++.++||||||+++|||++|+.|+....+...+.......... ..
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99865332111  112356889999998865 457899999999999999999999986544322221111100000 00


Q ss_pred             c----cccc----CccccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          707 I----LALV----DPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 ~----~~~~----d~~l~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .    .+..    -+.....   ........++.+++.+|++.||++||+++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0    0000    0000000   011124567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.1e-33  Score=299.34  Aligned_cols=254  Identities=25%  Similarity=0.346  Sum_probs=195.4

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|...+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556689999999999999875 58899999987543 234567899999999996 99999999999999999999999


Q ss_pred             cCCCCccccccC--CCCCCCCChhhhHHHHHHHHhhhHhhhhc-CCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          559 MPNRSLDALLFD--PLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       559 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      +.. +|.++...  ......+++..+.+++.+++.||+|||+. +   ++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 55443311  11235789999999999999999999975 6   99999999999999999999999999986543


Q ss_pred             CCCccccceeeccCCccChhhhccC---CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccC
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEG---RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD  712 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~---~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d  712 (807)
                      ...   .....|+..|+|||.+.+.   .++.++||||||+++|||++|+.|+.....   .........      ....
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~------~~~~  228 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVV------KGDP  228 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhc------CCCC
Confidence            221   1223578999999999776   689999999999999999999999864431   111111110      0111


Q ss_pred             ccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       713 ~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      +.+... .......++.+++.+|++.+|++|||+++|++.
T Consensus       229 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 PILSNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122111 223356678999999999999999999998864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.8e-33  Score=294.64  Aligned_cols=247  Identities=25%  Similarity=0.301  Sum_probs=201.7

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      +|++.+.||.|+||.||+++.. +++.||+|.+.+..   ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999976 58899999997542   2346789999999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999843   257889999999999999999999988   9999999999999999999999999988764332


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ...... ...         ..  ..
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~-~~~---------~~--~~  218 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIR-AKQ---------ET--AD  218 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHH-HHh---------cc--cc
Confidence               122346788999999999888999999999999999999999998754421 011111 000         00  00


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCH--HHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNM--STVV  750 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~ev~  750 (807)
                      ...+...+..+.+++.+|++.+|.+||++  +|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11233345788899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.6e-34  Score=327.58  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=191.1

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEEe-------
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-------  548 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------  548 (807)
                      .-.++|+..+.||+||||.||+++.+ ||+.||||++.-. +......+.+|+..+++|+|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567888999999999999999987 8999999999754 34445678999999999999999998654321       


Q ss_pred             --------------------------------------------------------------------------------
Q 003628          549 --------------------------------------------------------------------------------  548 (807)
Q Consensus       549 --------------------------------------------------------------------------------  548 (807)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhh
Q 003628          549 ------------------------G--------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL  596 (807)
Q Consensus       549 ------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL  596 (807)
                                              .        ...||-||||+..+|++++.+.....  .....++++++|++||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                    0        12356789998888888875422111  4567889999999999999


Q ss_pred             hhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC---C-------------CCCccccceeeccCCccChhhhccC
Q 003628          597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---G-------------NQDQADTGRVVGTFGYMSPEYAMEG  660 (807)
Q Consensus       597 H~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~---~-------------~~~~~~~~~~~gt~~y~APE~~~~~  660 (807)
                      |+.+   ||||||||.||+|+++..+||+|||+|....   .             .......+..+||..|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9999   9999999999999999999999999999721   0             0111123446899999999999665


Q ss_pred             C---CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhccc
Q 003628          661 R---FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQ  737 (807)
Q Consensus       661 ~---~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~  737 (807)
                      .   |+.|+|+||+||||+||+   .||...-+.....    ..++.+.+...       ..+..+....=.++++++++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL----~~LR~g~iP~~-------~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASIL----TNLRKGSIPEP-------ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHH----HhcccCCCCCC-------cccccccchHHHHHHHHHhc
Confidence            4   999999999999999999   4554322222111    11222222111       11333444555789999999


Q ss_pred             CCcCCCCCHHHHHH
Q 003628          738 ELVKDRPNMSTVVS  751 (807)
Q Consensus       738 ~dP~~RPt~~ev~~  751 (807)
                      .||++|||+.|++.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999875

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.1e-33  Score=305.32  Aligned_cols=262  Identities=22%  Similarity=0.252  Sum_probs=197.9

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeC------
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------  549 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  549 (807)
                      ..++|++.+.||+|+||.||+++.. +++.||||.+.+.  .....+.+.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999875 6899999998643  223346788999999999999999999988643      


Q ss_pred             CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccc
Q 003628          550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  629 (807)
Q Consensus       550 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGl  629 (807)
                      ...++||||+.+ +|.+.+..     .++...+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            356899999964 77777632     2888899999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh---------
Q 003628          630 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK---------  700 (807)
Q Consensus       630 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~---------  700 (807)
                      ++.......   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+...........         
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            986543221   22245789999999999999999999999999999999999998654321111100000         


Q ss_pred             ---------hcccc------ccccccCccccC---CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          701 ---------LWNEN------KILALVDPFLSE---SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       701 ---------~~~~~------~~~~~~d~~l~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                               .....      ...+.....+..   .........++.+++.+|++.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                     00000      000011100000   00012345678899999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=297.60  Aligned_cols=261  Identities=23%  Similarity=0.347  Sum_probs=198.4

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeEEEEEE
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLIYE  557 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E  557 (807)
                      |++.+.||+|++|.||+|+.. +++.+|+|++....  ....+.+.+|++++++++|+|++++++++.+.  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999876 48899999997653  33446788999999999999999999999988  88999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++ +|.+++...  ...+++..+..++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 888887542  247899999999999999999999988   9999999999999999999999999998765443


Q ss_pred             CccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc---cc---ccc-
Q 003628          638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE---NK---ILA-  709 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~---~~---~~~-  709 (807)
                      ... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........+..... ....   ..   ... 
T Consensus       155 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  232 (287)
T cd07840         155 SAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE-LCGSPTDENWPGVSKL  232 (287)
T ss_pred             ccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCchhhccccccc
Confidence            211 122356788999998765 4578999999999999999999999865443222111110 0000   00   000 


Q ss_pred             ----ccCcccc-----CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          710 ----LVDPFLS-----ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       710 ----~~d~~l~-----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                          ...+...     .......+...+.+++.+|++.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                0000000     00011112567899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.4e-33  Score=294.37  Aligned_cols=259  Identities=20%  Similarity=0.276  Sum_probs=193.7

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcc-CCceeEEeeEEEeC--CeEEEEEE
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG--EEKMLIYE  557 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E  557 (807)
                      |++.++||+|+||.||+++.. +++.||+|+++... ........+|+.++.++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999865 68899999987542 222344567999999985 99999999999987  88999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |++ ++|.+.+..  ....+++.++..++.|++.||+|||+.+   ++||||||+||+++. +.+||+|||+++......
T Consensus        81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 477777743  2356899999999999999999999998   999999999999999 999999999998764332


Q ss_pred             CccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhh----------hhccccc
Q 003628          638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW----------KLWNENK  706 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~----------~~~~~~~  706 (807)
                      ..   ....++..|+|||.+.. ..++.++|||||||++|||++|+.|+...+..........          .......
T Consensus       154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            21   12457889999997654 5578899999999999999999999865432211111000          0000000


Q ss_pred             cccccCccccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          707 ILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 ~~~~~d~~l~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ......+.....   ......+..+.+++.+|++.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000001100000   011234678999999999999999999999876

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.2e-33  Score=291.75  Aligned_cols=242  Identities=25%  Similarity=0.329  Sum_probs=194.7

Q ss_pred             cccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCc
Q 003628          489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  564 (807)
Q Consensus       489 LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  564 (807)
                      ||.|++|.||+++.. .++.+|+|.+.+..   ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999986 48899999986542   23446799999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccce
Q 003628          565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  644 (807)
Q Consensus       565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  644 (807)
                      .+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999854   345889999999999999999999988   9999999999999999999999999998764332   1222


Q ss_pred             eeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHH
Q 003628          645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  724 (807)
Q Consensus       645 ~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  724 (807)
                      ..++..|+|||.+....++.++|+||+|+++|||++|+.|+....++.  .......         .+.. .....+...
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~---------~~~~-~~~~~~~~~  219 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDI---------LKGN-GKLEFPNYI  219 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHH---------hccC-CCCCCCccc
Confidence            467899999999988889999999999999999999999987544211  1111110         0000 001122223


Q ss_pred             HHHHHHHHHhcccCCcCCCCC-----HHHHHH
Q 003628          725 IIRCIHVGLLCVQELVKDRPN-----MSTVVS  751 (807)
Q Consensus       725 ~~~l~~li~~Cl~~dP~~RPt-----~~ev~~  751 (807)
                      ..++.+++.+|++.+|++||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            567899999999999999999     555544

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=310.14  Aligned_cols=269  Identities=25%  Similarity=0.363  Sum_probs=206.8

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCC------eEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------EKM  553 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~  553 (807)
                      .+...+.||+|+||.||+|+.+ .|+.||||.+++. .....+...+|+++|++++|+|||++++.-.+..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3556789999999999999965 6999999999864 3445688899999999999999999999865433      568


Q ss_pred             EEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC--CC--Cceeecccc
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE--EL--NPKISDFGM  629 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~--~~--~~kL~DFGl  629 (807)
                      +|||||.+|||...|.+..+...+++.+.+.++.+++.||.|||+++   |+||||||.||++-.  +|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999999888889999999999999999999999998   999999999999943  23  379999999


Q ss_pred             ccccCCCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccc--
Q 003628          630 AKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK--  706 (807)
Q Consensus       630 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~--  706 (807)
                      ||-+..+.   ....++||..|++||.+.. +.|+..+|.|||||++||.+||..||.............+.......  
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            99775544   3445899999999999984 88999999999999999999999999876655433333332221110  


Q ss_pred             cccccCcccc-----------CCcccHHHHHHHHHHHHhcccCCcCCCC--CHHHHHHHHhhc
Q 003628          707 ILALVDPFLS-----------ESSFQLDMIIRCIHVGLLCVQELVKDRP--NMSTVVSMLNSE  756 (807)
Q Consensus       707 ~~~~~d~~l~-----------~~~~~~~~~~~l~~li~~Cl~~dP~~RP--t~~ev~~~L~~~  756 (807)
                      +.-...+...           ..........++-.....++.-+|++|-  ...+....+..+
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            0000000000           0113334455666677777788888887  555555555444

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.7e-33  Score=297.33  Aligned_cols=264  Identities=22%  Similarity=0.302  Sum_probs=195.5

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ++|++.+.||+|++|.||+|+.. +++.||+|.+.....  ...+.+.+|++++++++|+||+++++++.++...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57888999999999999999876 688999999865422  334678899999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC-CCCceeeccccccccCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kL~DFGla~~~~~~  636 (807)
                      |++ ++|.+++... ....+++..+..++.||+.||+|||+.+   ++|+||+|+||+++. ++.+||+|||+++.....
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 4777776432 2234577788899999999999999988   999999999999985 567999999999865432


Q ss_pred             CCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc--ccc------c
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN--ENK------I  707 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~--~~~------~  707 (807)
                      ...  .....+++.|+|||.+.+. .++.++||||+|+++|+|+||+.|+........+.........  +..      +
T Consensus       157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 VRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             ccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            211  1223568899999988664 5789999999999999999999998654332222111100000  000      0


Q ss_pred             cc--ccCccccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          708 LA--LVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       708 ~~--~~d~~l~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ..  ...+.....   ........++.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00  000000000   011123456889999999999999999999986

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.4e-32  Score=298.80  Aligned_cols=247  Identities=29%  Similarity=0.456  Sum_probs=196.5

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      |...+.||+|+||.||+++.. ++..+|+|++....   ....+.+.+|++++++++|+|++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667789999999999999865 58899999986432   22345788999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++ +|.+++..  ....+++.++..++.+++.||.|||+.+   |+||||+|+||+++.++.+||+|||++......  
T Consensus       107 ~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         107 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             CCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            975 77776643  2446899999999999999999999998   999999999999999999999999998754321  


Q ss_pred             ccccceeeccCCccChhhhc---cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          639 QADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~---~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                          ....|+..|+|||++.   .+.++.++||||||+++|||++|+.|+........+.....    ..      .+..
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~------~~~~  244 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NE------SPTL  244 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh----cc------CCCC
Confidence                1246788999999974   45688999999999999999999999764322211111110    00      0111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                          ........+.+++.+|++.+|.+||++.+|++.+--
T Consensus       245 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         245 ----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             ----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence                112234568899999999999999999999987644

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.2e-33  Score=297.37  Aligned_cols=243  Identities=23%  Similarity=0.334  Sum_probs=197.2

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCcc
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD  565 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  565 (807)
                      .+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            58999999999999875 68899999986555555677999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcccccee
Q 003628          566 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV  645 (807)
Q Consensus       566 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  645 (807)
                      +++.    ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........  .....
T Consensus       106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~  176 (292)
T cd06657         106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL  176 (292)
T ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence            8873    345889999999999999999999998   99999999999999999999999999876543221  12235


Q ss_pred             eccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHH
Q 003628          646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMI  725 (807)
Q Consensus       646 ~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  725 (807)
                      .|+..|+|||.+....++.++|+||+|+++|||++|+.|+.......... ...         ....+.+.   ......
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~---------~~~~~~~~---~~~~~~  243 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIR---------DNLPPKLK---NLHKVS  243 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHH---------hhCCcccC---CcccCC
Confidence            68899999999988889999999999999999999999986433221111 110         01111111   111234


Q ss_pred             HHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          726 IRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       726 ~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ..+.+++.+|++.+|.+||++.++++
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            56778999999999999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=293.90  Aligned_cols=246  Identities=26%  Similarity=0.336  Sum_probs=204.3

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      +.|+.-++||+||||.||-++.. +|+-+|.|++.+.   ..++..--++|-.+|.+++.+.||.+-..+...+..++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45777789999999999999865 5888999988643   2345566789999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ..|.||+|.-+|++. ..+.+++..+.-++.+|+.||++||...   ||.||+||+|||||+.|+++|+|+|||..+...
T Consensus       265 tlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            999999999999875 3467999999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      +...   ..+||.+|||||++.++.|+...|.||+||+||||+.|+.||....+...-.              -+|.+..
T Consensus       341 ~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e--------------Evdrr~~  403 (591)
T KOG0986|consen  341 KPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE--------------EVDRRTL  403 (591)
T ss_pred             Cccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH--------------HHHHHHh
Confidence            4332   2389999999999999999999999999999999999999997544321110              1111111


Q ss_pred             --CCcccHHHHHHHHHHHHhcccCCcCCCCCHH
Q 003628          717 --ESSFQLDMIIRCIHVGLLCVQELVKDRPNMS  747 (807)
Q Consensus       717 --~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~  747 (807)
                        ...++....+++.+|....|+.||++|.--.
T Consensus       404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence              1125556677888999999999999996544

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-32  Score=293.38  Aligned_cols=244  Identities=25%  Similarity=0.343  Sum_probs=192.6

Q ss_pred             cccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCc
Q 003628          489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  564 (807)
Q Consensus       489 LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  564 (807)
                      ||+|+||+||++... +|+.+|+|.+....   ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 58899999986532   22345678899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccce
Q 003628          565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  644 (807)
Q Consensus       565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  644 (807)
                      .+++... ....+++.++..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++......   ....
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            9998653 2246899999999999999999999998   9999999999999999999999999988654321   1122


Q ss_pred             eeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHH
Q 003628          645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  724 (807)
Q Consensus       645 ~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  724 (807)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.|+...............      ...  .    ....+...
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~--~----~~~~~~~~  221 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR------TLE--M----AVEYPDKF  221 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc------ccc--c----cccCCccC
Confidence            45788999999998888999999999999999999999998654321111110000      000  0    00122233


Q ss_pred             HHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003628          725 IIRCIHVGLLCVQELVKDRP-----NMSTVVS  751 (807)
Q Consensus       725 ~~~l~~li~~Cl~~dP~~RP-----t~~ev~~  751 (807)
                      ...+.+++.+||+.+|++||     ++.++++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            56788999999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=288.56  Aligned_cols=247  Identities=27%  Similarity=0.409  Sum_probs=203.1

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|++.+.||+|++|.||+++.. +++.||+|.+.....  ...+.+.+|++++.+++|+|++++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999876 578999999976543  4567899999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999999853   257899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                      .  .....++..|+|||......++.++||||+|+++|+|++|+.|+............    .. .     ..+.    
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~----~~-~-----~~~~----  218 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI----VQ-D-----DHPP----  218 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----hc-c-----CCCC----
Confidence            1  22346789999999998888899999999999999999999998643321111110    00 0     0011    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                       .+......+.+++.+|++.+|++||++.++++
T Consensus       219 -~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 -LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             22233567889999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=295.96  Aligned_cols=260  Identities=16%  Similarity=0.205  Sum_probs=185.8

Q ss_pred             hcCCcccCccccCCCccEEEEEecCC----cEEEEEEecccCcccH-----------HHHHHHHHHHHhccCCceeEEee
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSKASGQGL-----------EEFMNEVMVISKLQHRNLVRLLG  544 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~g----~~vAvK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g  544 (807)
                      .++|++.++||+|+||.||+|...++    ..+|+|..........           .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36799999999999999999987643    4566665432221110           11223344556678999999999


Q ss_pred             EEEeCC----eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC
Q 003628          545 CCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL  620 (807)
Q Consensus       545 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~  620 (807)
                      ++....    ..++++|++.. ++.+.+..   ....++..+..|+.|+++||.|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            876543    34677777643 55555422   223567788899999999999999988   99999999999999999


Q ss_pred             CceeeccccccccCCCCCc-----cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhh
Q 003628          621 NPKISDFGMAKIFGGNQDQ-----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTIL  695 (807)
Q Consensus       621 ~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~  695 (807)
                      .++|+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........+.
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999876432211     11223469999999999999999999999999999999999999997654333222


Q ss_pred             hhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003628          696 GYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  754 (807)
Q Consensus       696 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~  754 (807)
                      .......    +..+..+...    ....+.++.+++..|++.+|++||++.+|++.|+
T Consensus       244 ~~~~~~~----~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDF----IKRLHEGKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHH----HHHhhhhhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1111100    0111111111    1122467889999999999999999999998763

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.2e-33  Score=299.08  Aligned_cols=266  Identities=23%  Similarity=0.341  Sum_probs=194.6

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCC-----
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----  550 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  550 (807)
                      ..++|++.++||+|+||.||+++.. +++.||||.+....  ......+.+|+.++++++||||+++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999875 58899999986432  222345678999999999999999999987654     


Q ss_pred             ---eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecc
Q 003628          551 ---EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  627 (807)
Q Consensus       551 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DF  627 (807)
                         ..++||||+.+ +|.+.+..  ....+++.++..++.||+.||.|||+++   ++|+||||+||+++.++.+||+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence               34999999965 77777643  2346899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCCc--cccceeeccCCccChhhhccCC-CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc-
Q 003628          628 GMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN-  703 (807)
Q Consensus       628 Gla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~-~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~-  703 (807)
                      |++..+......  .......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+........+ ........ 
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~-~~~~~~~~~  242 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL-TLISQLCGS  242 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCC
Confidence            999876433221  1112245788999999887654 788999999999999999999988654322111 11111100 


Q ss_pred             -------ccccccccCc-cccCC---cc-----cHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          704 -------ENKILALVDP-FLSES---SF-----QLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       704 -------~~~~~~~~d~-~l~~~---~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                             ........+. .....   ..     .......+.+++.+|++.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                   0000000000 00000   00     0001245678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.4e-32  Score=291.35  Aligned_cols=242  Identities=26%  Similarity=0.280  Sum_probs=187.6

Q ss_pred             ccccCCCccEEEEEec-CCcEEEEEEecccCc---ccHHHHHHHHHHHHh---ccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISK---LQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       488 ~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~---l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      .||+|+||.||++... +++.+|+|.+.+...   .....+.+|..++..   .+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 588999999865321   222334555544444   379999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999988853   356899999999999999999999998   9999999999999999999999999987553221   


Q ss_pred             ccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       .....|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||..........  .....      ......     
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~------~~~~~~-----  217 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMT------LTVNVE-----  217 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHHHh------hcCCcC-----
Confidence             122468999999999864 558999999999999999999999986433211110  00000      001111     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  752 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~~  752 (807)
                      .+.....++.+++.+|++.||++||     +++|++++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2233456788999999999999999     59998875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-32  Score=301.17  Aligned_cols=266  Identities=22%  Similarity=0.334  Sum_probs=199.0

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeC--CeE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG--EEK  552 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~  552 (807)
                      ..++|++.+.||+|+||.||+|... +++.+|||++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578899999999999999999976 5789999988643  233446678899999999 999999999998653  467


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++||||++ ++|.+++..    ..+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 588888743    37888899999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCc---cccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh-------
Q 003628          633 FGGNQDQ---ADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------  701 (807)
Q Consensus       633 ~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~-------  701 (807)
                      .......   .......|+..|+|||.+.. ..++.++||||||+++|||++|+.|+................       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6443221   12233568999999998765 457889999999999999999999986543221111100000       


Q ss_pred             ---ccccccccccCccccC-----CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          702 ---WNENKILALVDPFLSE-----SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       702 ---~~~~~~~~~~d~~l~~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                         ........+++.....     .........++.+++.+|++.+|++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence               0000000011000000     00111135678999999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.6e-33  Score=290.02  Aligned_cols=249  Identities=27%  Similarity=0.379  Sum_probs=203.6

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|++.++||+|+||.||+++.. +++.+|+|.+....  ......+.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999765 67899999987532  33456788999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          559 MPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      +++++|.+++.+.. ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            99999999885422 2356889999999999999999999998   9999999999999999999999999998765431


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                          .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+...+... +.   .. ...+..          
T Consensus       158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~---~~-~~~~~~----------  218 (256)
T cd08530         158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-LR---YK-VQRGKY----------  218 (256)
T ss_pred             ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH---HH-HhcCCC----------
Confidence                112457889999999999999999999999999999999999986543221 11   00 001110          


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ...+.....++.+++.+|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            11223456778999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=332.97  Aligned_cols=255  Identities=27%  Similarity=0.362  Sum_probs=204.5

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEE
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ..+-++.-...||.|.||.||.+... +|...|||.++..  .....+...+|+.++..|+|||+|+++|.-.+++..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            34556777889999999999999854 6888999988643  34455778899999999999999999999999999999


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      .||||++|+|.+.+..   ++..++.....+..|++.|+.|||+++   ||||||||.||+|+.+|.+|++|||.|+.+.
T Consensus      1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999999843   334555555667889999999999999   9999999999999999999999999999876


Q ss_pred             CCCCc--cccceeeccCCccChhhhccCC---CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccc
Q 003628          635 GNQDQ--ADTGRVVGTFGYMSPEYAMEGR---FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA  709 (807)
Q Consensus       635 ~~~~~--~~~~~~~gt~~y~APE~~~~~~---~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~  709 (807)
                      .....  .......||+.|||||++.+..   ...++||||+|||+.||+||++||...+.+-.+.=.+    ..+.   
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V----~~gh--- 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV----AAGH--- 1458 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH----hccC---
Confidence            54211  1223468999999999997654   5668999999999999999999998776543221111    1111   


Q ss_pred             ccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          710 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       710 ~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                             .+.++.....+-.+++.+|++.||++|.++.|+++.
T Consensus      1459 -------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                   122444566777899999999999999888876654

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.9e-33  Score=291.99  Aligned_cols=247  Identities=26%  Similarity=0.358  Sum_probs=197.8

Q ss_pred             cccCCCccEEEEEecC-CcEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCc
Q 003628          489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  564 (807)
Q Consensus       489 LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  564 (807)
                      ||+|+||.||+++... |+.+|+|.+.....   ...+.+.+|++++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999874 89999999865433   3457789999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC------
Q 003628          565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD------  638 (807)
Q Consensus       565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~------  638 (807)
                      .+++..   ...+++..+.+++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            999854   236899999999999999999999988   99999999999999999999999999886533211      


Q ss_pred             ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCC
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                      ........++..|+|||.+.....+.++||||||+++|||++|+.|+............    . .+..      ...  
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~-~~~~------~~~--  221 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI----L-NGKI------EWP--  221 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----h-cCCc------CCC--
Confidence            11223356788999999998888999999999999999999999998644322111110    0 0000      000  


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       719 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                       ........+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         222 -EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             -ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence             001125678899999999999999999777776643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=289.75  Aligned_cols=243  Identities=20%  Similarity=0.248  Sum_probs=189.9

Q ss_pred             CccccCCCccEEEEEec-CCcEEEEEEecccCc---ccHHHHHHHHHHHH-hccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVIS-KLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|+||.||+|... +++.||||.+.+...   .....+..|..++. ..+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999875 588999999865422   22234455555544 45899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      ++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||+|+||++++++.+||+|||+++....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999853   346889999999999999999999988   99999999999999999999999999885432      


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCccc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  721 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  721 (807)
                      .....++..|+|||.+.+..++.++||||||+++|||++|..|+............     ..+..    .  .. ....
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~----~--~~-~~~~  217 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-----LSRRI----N--WP-EEVK  217 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----Hhccc----C--CC-Cccc
Confidence            12245788999999998888999999999999999999999998643322111110     00100    0  00 0011


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          722 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       722 ~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      .....++.+++.+|++.+|++||++.++.+.|
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            12456788999999999999999887666655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.6e-32  Score=297.20  Aligned_cols=278  Identities=23%  Similarity=0.311  Sum_probs=202.1

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKML  554 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  554 (807)
                      .++|++.+.||+|+||.||+|... +|+.||+|.++....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467899999999999999999975 589999999864322  2234567899999999999999999998765  56899


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ||||+++ +|.+++...  ...+++.++..++.||++||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 787777542  356899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc-cccc-----
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN-ENKI-----  707 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~-~~~~-----  707 (807)
                      .....  .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.|+...++...+.......-. ....     
T Consensus       160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            43211  112345788999999865 45789999999999999999999998754432222111110000 0000     


Q ss_pred             ----ccccC---ccccC-CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCCCCCCCCC
Q 003628          708 ----LALVD---PFLSE-SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA  767 (807)
Q Consensus       708 ----~~~~d---~~l~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~~p~~p~  767 (807)
                          .....   ..... .........++.+++.+|++.||++|||++|+++.-  -++..+.|..|.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~--~f~~~~~~~~~~  303 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS--YFKEKPLPCEPE  303 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh--hhccCCCCCCCC
Confidence                00000   00000 000011245678899999999999999999998643  223344444443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-32  Score=295.30  Aligned_cols=255  Identities=27%  Similarity=0.342  Sum_probs=200.6

Q ss_pred             CCcccCccccCCCccEEEEEec----CCcEEEEEEecccC----cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS----GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  552 (807)
                      +|++.+.||+|++|.||+++..    ++..||||.+++..    ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4677899999999999998743    56889999986532    22346788999999999 699999999999999999


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999988843   346888999999999999999999988   99999999999999999999999999886


Q ss_pred             cCCCCCccccceeeccCCccChhhhccCC--CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccc
Q 003628          633 FGGNQDQADTGRVVGTFGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  710 (807)
Q Consensus       633 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~  710 (807)
                      +...... ......|+..|+|||.+.+..  .+.++||||||+++|||++|+.|+...................      
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------  227 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS------  227 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc------
Confidence            5433221 122246889999999987665  7889999999999999999999986432221111111111100      


Q ss_pred             cCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       711 ~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                       .+     ..+......+.+++.+|++.+|++|||+.++...|+-
T Consensus       228 -~~-----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -KP-----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -CC-----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence             01     1122234567889999999999999999998887754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-32  Score=299.99  Aligned_cols=263  Identities=21%  Similarity=0.322  Sum_probs=195.3

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeC------C
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------E  550 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~  550 (807)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++.+..  ......+.+|+.++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378999999999999999999865 68999999986532  22346688999999999999999999998754      3


Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla  630 (807)
                      ..++|+||+.. +|..++     ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999964 666554     235888999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh---------
Q 003628          631 KIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK---------  700 (807)
Q Consensus       631 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~---------  700 (807)
                      +.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+....+......         
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            854321     122467889999999876 46889999999999999999999998754321111111100         


Q ss_pred             -hccccccccccC--ccccCCcc---cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH--Hhhc
Q 003628          701 -LWNENKILALVD--PFLSESSF---QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSE  756 (807)
Q Consensus       701 -~~~~~~~~~~~d--~~l~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~--L~~~  756 (807)
                       ............  +.......   ......++.+++.+|++.||++||++++++..  ++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence             000000000000  00000000   01134568899999999999999999999854  6554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2e-32  Score=287.09  Aligned_cols=250  Identities=24%  Similarity=0.385  Sum_probs=204.9

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|++.+.||+|+||.||++... ++..+|+|++.....  ...+.+.+|++++++++|+|++++++.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999976 588999999875432  4567789999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          559 MPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      +++++|.+++.... ....+++.++..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986532 2467999999999999999999999998   9999999999999999999999999998764433


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      .  ......|++.|+|||.+....++.++|+||+|+++++|++|+.|+...+.....    .... ....     +.   
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~-~~~~-----~~---  222 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA----LKIL-KGQY-----PP---  222 (258)
T ss_pred             c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH----HHHh-cCCC-----CC---
Confidence            1  222346889999999999888999999999999999999999998644321111    1111 0000     01   


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                        .+......+.+++.+|+..+|++|||+.|+++
T Consensus       223 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 --IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              11233467889999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-32  Score=289.94  Aligned_cols=261  Identities=22%  Similarity=0.322  Sum_probs=196.5

Q ss_pred             CcccCccccCCCccEEEEEecC-CcEEEEEEecccCcc--cHHHHHHHHHHHHhc---cCCceeEEeeEEEeCCe-----
Q 003628          483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ--GLEEFMNEVMVISKL---QHRNLVRLLGCCVEGEE-----  551 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----  551 (807)
                      |++.+.||+|+||.||+|+.+. ++.||+|+++.....  ....+.+|+.++.++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5677899999999999999874 899999999743222  234567788877766   59999999999988776     


Q ss_pred             EEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      .+++|||+.+ +|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 788877542 2236899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccc----
Q 003628          632 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI----  707 (807)
Q Consensus       632 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~----  707 (807)
                      ........   ....++..|+|||.+.+..++.++|+||||+++|||++|+.|+....+...+.............    
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            76433221   22357889999999999999999999999999999999998886544332222111111000000    


Q ss_pred             -----ccccCccccC--CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          708 -----LALVDPFLSE--SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       708 -----~~~~d~~l~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                           ..........  .....+....+.+++.+|++.||++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 0000000000  0112234577889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-33  Score=320.17  Aligned_cols=270  Identities=21%  Similarity=0.304  Sum_probs=187.2

Q ss_pred             HHhcCCcccCccccCCCccEEEEEecC--CcEEEEEE--------------ec---ccCcccHHHHHHHHHHHHhccCCc
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLKD--GQEIAVKR--------------LS---KASGQGLEEFMNEVMVISKLQHRN  538 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~--g~~vAvK~--------------l~---~~~~~~~~~~~~E~~~l~~l~H~n  538 (807)
                      ...++|++.++||+|+||+||++..+.  +...++|.              +.   .........+.+|+.+|++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999987542  22222221              11   112223466889999999999999


Q ss_pred             eeEEeeEEEeCCeEEEEEEecCCCCccccccCCCC--CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeee
Q 003628          539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL  616 (807)
Q Consensus       539 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll  616 (807)
                      |+++++++.+.+..++|+|++. ++|.+++.....  .......++..|+.||+.||.|||+.+   |+||||||+||||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999995 466666543211  122345667789999999999999998   9999999999999


Q ss_pred             cCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCC-CCccCC--cch
Q 003628          617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFED--DLT  693 (807)
Q Consensus       617 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p-~~~~~~--~~~  693 (807)
                      +.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.+ +.....  ...
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            99999999999999876433221 12235799999999999999999999999999999999999854 322111  111


Q ss_pred             hhhhhhhhc-ccc-------ccccccCcc-ccC--Ccc-----cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          694 ILGYAWKLW-NEN-------KILALVDPF-LSE--SSF-----QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       694 l~~~~~~~~-~~~-------~~~~~~d~~-l~~--~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      +........ ...       .+.+.++.. ...  ...     .......+.+++.+||+.||.+|||+.|++++
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111110000 000       000000000 000  000     00122356778999999999999999999864

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.4e-32  Score=296.37  Aligned_cols=263  Identities=19%  Similarity=0.234  Sum_probs=194.1

Q ss_pred             ccCccccCCCccEEEEEecCCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       485 ~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      +.+.+|.|+++.||+++. +++.||||++...  .....+.+.+|++++++++|+||+++++++.+.+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455555555565554 5899999998754  3445678999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC----
Q 003628          563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD----  638 (807)
Q Consensus       563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~----  638 (807)
                      +|.+++... ....+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||.+........    
T Consensus        85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999998643 2345888899999999999999999998   99999999999999999999999998876532211    


Q ss_pred             -ccccceeeccCCccChhhhccC--CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh----cccc------
Q 003628          639 -QADTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL----WNEN------  705 (807)
Q Consensus       639 -~~~~~~~~gt~~y~APE~~~~~--~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~----~~~~------  705 (807)
                       ........++..|+|||++...  .++.++||||||+++|||++|+.||........+.......    ....      
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence             1111224577899999998763  58899999999999999999999987543322221111000    0000      


Q ss_pred             -cccc----ccCccc---cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          706 -KILA----LVDPFL---SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       706 -~~~~----~~d~~l---~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                       ....    ..++..   ...........++.+++.+||+.||++|||++++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             0000    000000   0011223345678899999999999999999998864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.5e-32  Score=294.30  Aligned_cols=265  Identities=22%  Similarity=0.322  Sum_probs=198.5

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCC----
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----  550 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  550 (807)
                      ...++|++.+.||+|+||.||+|..+ +++.||+|.++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999986 58899999986542  223457789999999999999999999987654    


Q ss_pred             ------eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCcee
Q 003628          551 ------EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  624 (807)
Q Consensus       551 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL  624 (807)
                            ..++|+||+++ +|...+..  ....+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 66666643  2346899999999999999999999998   999999999999999999999


Q ss_pred             eccccccccCCCCCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc
Q 003628          625 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN  703 (807)
Q Consensus       625 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~  703 (807)
                      +|||++......... ......++..|+|||.+.+. .++.++||||||+++|||++|++|+...++...+.........
T Consensus       158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999999876443221 11223467889999988654 5788999999999999999999998754332222111110000


Q ss_pred             --ccccccc--------cCc------cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          704 --ENKILAL--------VDP------FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       704 --~~~~~~~--------~d~------~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                        .......        .++      .+..  .....+..+.+++..|++.+|++||++++|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLRE--EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchhh--hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              0000000        000      0000  00113467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-32  Score=288.05  Aligned_cols=250  Identities=26%  Similarity=0.374  Sum_probs=197.6

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc-----CcccHHHHHHHHHHHHhccCCceeEEeeEEEeC--CeE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-----SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEK  552 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  552 (807)
                      .+|++.+.||+|+||.||+|+.. ++..||+|.+...     ..+....+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47889999999999999999875 5889999987432     223456789999999999999999999998764  457


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++|+||+++++|.+++..   ...+++..+.+++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998853   345788899999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCC-ccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccccccccc
Q 003628          633 FGGNQD-QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       633 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ...... ........++..|+|||.+.+..++.++|+||||+++|||++|+.|+............    ...     ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~-----~~  226 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI----ATQ-----PT  226 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH----HcC-----CC
Confidence            532111 11112346889999999999888999999999999999999999998643222111110    000     00


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .     ...+.....++.+++.+|++ +|.+||+..++++
T Consensus       227 ~-----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 K-----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             C-----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            0     11333455678899999999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.7e-32  Score=298.03  Aligned_cols=261  Identities=23%  Similarity=0.299  Sum_probs=193.6

Q ss_pred             CccccC--CCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQG--GFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G--~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.||+|  +||+||+++.. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  88999999875 68999999986432  23357789999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc-
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA-  640 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~-  640 (807)
                      ++|.+++... ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+|++||+.+.......... 
T Consensus        84 ~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9999988653 2335888899999999999999999988   9999999999999999999999998654332211110 


Q ss_pred             ----ccceeeccCCccChhhhccC--CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh-hcc----------
Q 003628          641 ----DTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-LWN----------  703 (807)
Q Consensus       641 ----~~~~~~gt~~y~APE~~~~~--~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~-~~~----------  703 (807)
                          ......++..|+|||++.+.  .++.++||||||+++|||++|+.|+............... ...          
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                01112346679999999764  4789999999999999999999998654322211111000 000          


Q ss_pred             ----------------ccc-----cccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          704 ----------------ENK-----ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       704 ----------------~~~-----~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                                      +..     .....+..+. .+........+.+++.+||+.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                            000     0001111111 11233456788999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-32  Score=296.65  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=194.3

Q ss_pred             cCCcccCccccCCCccEEEEEecC-CcEEEEEEecccC-cccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ++|.+.+.||+|+||.||+|+..+ ++.||||.++... ......+..|+.++.+.+ |+||+++++++.++...++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            568889999999999999999875 8899999997543 233456777888777775 9999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhc-CCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      |+.+ +|.+++..  ....+++..+..++.|+++||+|||+. +   |+||||+|+||++++++.+||+|||++..+...
T Consensus        95 ~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            9854 67666643  234788999999999999999999974 6   999999999999999999999999999865432


Q ss_pred             CCccccceeeccCCccChhhhccCC----CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccC
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGR----FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD  712 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~----~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d  712 (807)
                      ...   ....++..|+|||.+....    ++.++||||||+++|||++|+.|+..........   .......      .
T Consensus       169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~------~  236 (296)
T cd06618         169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL---TKILQEE------P  236 (296)
T ss_pred             Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH---HHHhcCC------C
Confidence            221   1235788999999987554    7889999999999999999999986432221111   1111000      0


Q ss_pred             ccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       713 ~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      +.+.   .......++.+++.+|++.+|.+||++.+++++
T Consensus       237 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 PSLP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111   111234578899999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.1e-33  Score=300.47  Aligned_cols=248  Identities=24%  Similarity=0.349  Sum_probs=204.8

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc--cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ...|.+.+.||+|.|+.|..++.. .+..||||.+.+..-.  ....+.+|+++|..++|||||+++.+.......|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            457889999999999999999875 6899999999876433  3356899999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      ||+.+|.+.+++..   .++........++.|+.+|++|+|+++   |||||||++||||+.+.++||+|||++..+...
T Consensus       135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999954   456666888899999999999999999   999999999999999999999999999987533


Q ss_pred             CCccccceeeccCCccChhhhccCCC-CcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~-t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                         ......+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+...    +..     +++..+.    ...
T Consensus       209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~----lk~-----Lr~rvl~----gk~  272 (596)
T KOG0586|consen  209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN----LKE-----LRPRVLR----GKY  272 (596)
T ss_pred             ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----ccc-----ccchhee----eee
Confidence               23344789999999999998876 578999999999999999999996321    111     0111110    001


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .   .+.-...++-+++++.|-.+|.+|+++++|.+.
T Consensus       273 r---Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  273 R---IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             c---ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            0   222234678899999999999999999998753

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.5e-32  Score=292.69  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=196.3

Q ss_pred             CCcccCccccCCCccEEEEEe----cCCcEEEEEEecccC----cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  552 (807)
                      +|++.+.||+|+||.||+++.    .+|..||+|++....    ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999986    368899999987532    22346788999999999 699999999999999999


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||+|+||+++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999853   346888899999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCccccceeeccCCccChhhhccC--CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccc
Q 003628          633 FGGNQDQADTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  710 (807)
Q Consensus       633 ~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~  710 (807)
                      ....... ......|+..|+|||.+...  .++.++||||||+++|+|++|+.|+...................      
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------  227 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------  227 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc------
Confidence            5432211 12235688999999998753  46789999999999999999999986433222222111111110      


Q ss_pred             cCccccCCcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003628          711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  751 (807)
Q Consensus       711 ~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~  751 (807)
                       .     .+.+......+.+++.+|++.+|++||     ++++++.
T Consensus       228 -~-----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 -E-----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -C-----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence             0     112223456778999999999999997     5566544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.4e-32  Score=301.00  Aligned_cols=267  Identities=18%  Similarity=0.271  Sum_probs=200.2

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEe----CCeE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEK  552 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~  552 (807)
                      .++|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999865 58999999987542  2345678899999999999999999998763    3567


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++||||+. ++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 588888743   345899999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCc--cccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh---------
Q 003628          633 FGGNQDQ--ADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK---------  700 (807)
Q Consensus       633 ~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~---------  700 (807)
                      .......  .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||...+....+......         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            6433221  11123468899999999865 45889999999999999999999998643321111100000         


Q ss_pred             -hccccccccccCccccCCc-----ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          701 -LWNENKILALVDPFLSESS-----FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       701 -~~~~~~~~~~~d~~l~~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                       ......+.+..+..-....     .......++.+++.+|++.+|++||++++++..-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence             0000111111110000000     1122457889999999999999999999988743

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=292.27  Aligned_cols=261  Identities=22%  Similarity=0.321  Sum_probs=200.4

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc--cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      |++.+.||+|++|.||++... +++.+|+|++......  ....+.+|+.++++++|+||+++++++.++...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999875 6889999998754322  4567889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      ++ +|.+++..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.+||+|||.+........ 
T Consensus        81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            75 88777754  2357899999999999999999999998   99999999999999999999999999987654431 


Q ss_pred             cccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc--cccccccc-----
Q 003628          640 ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN--ENKILALV-----  711 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~--~~~~~~~~-----  711 (807)
                       ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+....+.........  ........     
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence             11224578899999998876 7899999999999999999999988654432111111000000  00000000     


Q ss_pred             ------Ccc-ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          712 ------DPF-LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 ------d~~-l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                            +.. ............++.+++.+|++.||.+||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                  000 0001122345678999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=9.8e-33  Score=293.65  Aligned_cols=249  Identities=27%  Similarity=0.374  Sum_probs=203.6

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV  555 (807)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.++.+++ |+||+++++.+...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999876 6899999998653   2233567889999999998 99999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999853   347999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCc------------------cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhh
Q 003628          636 NQDQ------------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY  697 (807)
Q Consensus       636 ~~~~------------------~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~  697 (807)
                      ....                  .......++..|+|||.+....++.++||||||++++++++|+.|+........+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  234 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI  234 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            3221                  1222346789999999999888999999999999999999999998754422211110


Q ss_pred             hhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCH----HHHHH
Q 003628          698 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNM----STVVS  751 (807)
Q Consensus       698 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~----~ev~~  751 (807)
                      .             +..   ...+......+.+++.+|++.+|.+||++    +++++
T Consensus       235 ~-------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         235 L-------------KLE---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             H-------------hcC---CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            0             000   01222335678899999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=273.96  Aligned_cols=293  Identities=20%  Similarity=0.231  Sum_probs=226.5

Q ss_pred             HhcCCccc-CccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEEEe----CCe
Q 003628          479 ATNNFQLS-SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE----GEE  551 (807)
Q Consensus       479 ~~~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~  551 (807)
                      ++++|++. ++||-|-.|.|..+..+ .++.+|+|++...     ....+|+++--.. .|||||.+++.+..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45667664 57999999999999876 5889999999643     4456788876665 69999999998763    456


Q ss_pred             EEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC---CCCceeeccc
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFG  628 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~---~~~~kL~DFG  628 (807)
                      .++|||.|+||.|-.-+.+. ....+++.++-.|++||+.|+.|||+.+   |.||||||+|+|...   |-.+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            78999999999999888663 4567999999999999999999999998   999999999999964   4569999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccc
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  708 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~  708 (807)
                      +|+....   .......+-|+.|.|||++-..+|+..+|+||+||++|-|+.|.+||.-........++...+ ..+. .
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI-~~gq-y  284 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI-RTGQ-Y  284 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh-hccC-c
Confidence            9996433   222334577999999999999999999999999999999999999996544322222221111 1111 1


Q ss_pred             cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCCCCCCCCCcccCCCCCCchhHHHHHHHHH
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQQRIL  788 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~  788 (807)
                      ++.++.+      ....+...++|+..|..+|++|.|++++...== +...-..|..|....+...++.+.|..+|++|.
T Consensus       285 ~FP~pEW------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw-i~~~~~vp~tpl~t~~~l~~a~e~w~dvqeem~  357 (400)
T KOG0604|consen  285 EFPEPEW------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW-INQYEAVPQTPLSTSRMLKEAVEAWDDVQEEMT  357 (400)
T ss_pred             cCCChhH------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCch-hcccccCCCCCchhhhhcchhhhhhHHHHHHHH
Confidence            1222221      245677889999999999999999999875320 112345688888888999999999999999987


Q ss_pred             HHHH
Q 003628          789 LMIL  792 (807)
Q Consensus       789 ~~~~  792 (807)
                      ..-.
T Consensus       358 ~~lA  361 (400)
T KOG0604|consen  358 ETLA  361 (400)
T ss_pred             HHHH
Confidence            6544

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=4.1e-33  Score=273.69  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=198.1

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +.+.+..||.|..|.|++.+.. .|..+|||.+.+.. .++.++++..++++.+-+ .|.||+.+|+|.......+.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3445678999999999999876 58899999998764 445578888888887775 89999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      |. ..++.++..  -.+++++.-+-++...+++||.||.++.  .|+|||+||+|||+|+.|++|+||||++-.+.... 
T Consensus       173 Ms-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-  246 (391)
T KOG0983|consen  173 MS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-  246 (391)
T ss_pred             HH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence            94 355566543  2345888888899999999999998754  69999999999999999999999999998764433 


Q ss_pred             ccccceeeccCCccChhhhcc---CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          639 QADTGRVVGTFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~---~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                        ...+..|-+.|||||.+.-   ..|+.++||||||++|+||.||+.|+...+.+-....-+         ..-..|.+
T Consensus       247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv---------ln~ePP~L  315 (391)
T KOG0983|consen  247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV---------LNEEPPLL  315 (391)
T ss_pred             --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH---------HhcCCCCC
Confidence              2344679999999999854   468999999999999999999999998755433222111         11122444


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .+.   ......+++++..||+.|+.+||...++++.
T Consensus       316 ~~~---~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  316 PGH---MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             Ccc---cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            433   2255678899999999999999999987753

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.98  E-value=7.3e-32  Score=285.70  Aligned_cols=247  Identities=23%  Similarity=0.308  Sum_probs=191.3

Q ss_pred             HHHHHhcCCcccCcc--ccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCC
Q 003628          475 ELATATNNFQLSSKL--GQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE  550 (807)
Q Consensus       475 ~l~~~~~~~~~~~~L--G~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  550 (807)
                      +.....++|.+.+.+  |+|+||.||+++.+ ++..+|+|.+........     |+.....+ +||||+++++.+...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334445677777776  99999999999865 578899999865322211     22222222 7999999999999999


Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC-Cceeecccc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGM  629 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kL~DFGl  629 (807)
                      ..++||||+++++|.+++..   ...+++.++..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            99999999999999999853   237899999999999999999999998   99999999999999998 999999999


Q ss_pred             ccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcc-hhhhhhhhhccccccc
Q 003628          630 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKLWNENKIL  708 (807)
Q Consensus       630 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~-~l~~~~~~~~~~~~~~  708 (807)
                      ++......      ...++..|+|||++.+..++.++||||||+++|||++|+.|+....+.. ....+....       
T Consensus       157 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  223 (267)
T PHA03390        157 CKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-------  223 (267)
T ss_pred             ceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-------
Confidence            88654321      2357899999999999899999999999999999999999987433221 111111100       


Q ss_pred             cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCC-HHHHHH
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN-MSTVVS  751 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~ev~~  751 (807)
                         ....   .........+.+++.+|++.+|.+||+ ++++++
T Consensus       224 ---~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 ---QKKL---PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---cccC---CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence               0000   112234567889999999999999996 588774

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=1.9e-32  Score=300.91  Aligned_cols=264  Identities=21%  Similarity=0.298  Sum_probs=195.6

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeC---------
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG---------  549 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------  549 (807)
                      ..+|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367899999999999999999875 5889999998766656678899999999999999999999776543         


Q ss_pred             -----CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeec-CCCCce
Q 003628          550 -----EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPK  623 (807)
Q Consensus       550 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~-~~~~~k  623 (807)
                           ...++||||++ ++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+||+++ +++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 35789999997 58887773    346889999999999999999999998   99999999999997 456789


Q ss_pred             eeccccccccCCCCCcc-ccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh
Q 003628          624 ISDFGMAKIFGGNQDQA-DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL  701 (807)
Q Consensus       624 L~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~  701 (807)
                      |+|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+...........
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998653321111 1122357889999998754 457889999999999999999999996543222111111100


Q ss_pred             c--cc---ccccccc---------CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          702 W--NE---NKILALV---------DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       702 ~--~~---~~~~~~~---------d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .  ..   ......+         .+.............++.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0  00   0000000         0000000011123467889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=5e-32  Score=293.19  Aligned_cols=246  Identities=30%  Similarity=0.461  Sum_probs=195.0

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      .|...+.||+|+||.||+|+.. ++..+|+|.+...   .....+++.+|+++++.++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4666789999999999999975 5788999998642   22334678899999999999999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+. |+|.+.+..  ....+++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++...... 
T Consensus        96 ~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          96 YCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             ccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            996 577776643  2345889999999999999999999988   999999999999999999999999998765322 


Q ss_pred             CccccceeeccCCccChhhhc---cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          638 DQADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~---~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                           ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+........+....     .+     ..+.
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~-----~~~~  233 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QN-----ESPA  233 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-----hc-----CCCC
Confidence                 1245788999999974   3567889999999999999999999975433221111111     00     0011


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      .    ........+.+++.+|++.+|++||++.+|++.-
T Consensus       234 ~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         234 L----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             c----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            1    1123446688999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=5.5e-32  Score=297.36  Aligned_cols=261  Identities=20%  Similarity=0.319  Sum_probs=196.2

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCC----
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----  550 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  550 (807)
                      ...++|++.+.||+|+||.||++... ++..||||++....  ....+.+.+|+.++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            35678999999999999999999865 68999999986432  223456889999999999999999999987553    


Q ss_pred             --eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          551 --EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       551 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                        ..++||||+ +++|.+++.    ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence              458999999 778888873    346899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhh--------
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW--------  699 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~--------  699 (807)
                      +++.....     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.|+...+..........        
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            99865322     122457889999999876 4588899999999999999999999864432111111000        


Q ss_pred             --hhccccccccccC--ccccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          700 --KLWNENKILALVD--PFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       700 --~~~~~~~~~~~~d--~~l~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                        ...........+.  +.....   .........+.+++.+|++.||++|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0000000000000  000000   011123456889999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=3.7e-32  Score=294.10  Aligned_cols=263  Identities=25%  Similarity=0.330  Sum_probs=195.3

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc--cHHHHHHHHHHHHhccCCceeEEeeEEEeCC------
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------  550 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  550 (807)
                      .++|++.++||+|+||.||+|+.. +++.+|||++......  ....+.+|++++++++|+||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999976 5889999998654322  2356789999999999999999999876543      


Q ss_pred             --eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          551 --EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       551 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                        ..++||||+.+ +|...+..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              45899999975 66666543  2446999999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCcc---------ccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhh
Q 003628          629 MAKIFGGNQDQA---------DTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA  698 (807)
Q Consensus       629 la~~~~~~~~~~---------~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~  698 (807)
                      +++.........         ......+++.|+|||.+.+. .++.++||||||+++|||++|++|+....+........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            998764332211         11224678899999988654 58899999999999999999999986443322111110


Q ss_pred             hhhccc---------ccccc--------ccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          699 WKLWNE---------NKILA--------LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       699 ~~~~~~---------~~~~~--------~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                       .....         ..+..        ...+.+..  ........+.+++.+|++.+|++|||+.|+++
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 -KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             -HHhCCCChhhchhhhhcccccccccCCCCCccHHH--HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence             00000         00000        00011100  00112357889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=1e-31  Score=293.93  Aligned_cols=263  Identities=22%  Similarity=0.267  Sum_probs=192.2

Q ss_pred             CCcccCccccCCCccEEEEEec-C--CcEEEEEEecccC--cccHHHHHHHHHHHHhc-cCCceeEEeeEEEeC----Ce
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-D--GQEIAVKRLSKAS--GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG----EE  551 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~--g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~  551 (807)
                      +|++.+.||+|+||.||+++.. .  +..||+|++....  ....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999975 3  6789999986532  22356788999999999 599999999976533    45


Q ss_pred             EEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      .++++||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678899886 58888874   3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCc--cccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh-------
Q 003628          632 IFGGNQDQ--ADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------  701 (807)
Q Consensus       632 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~-------  701 (807)
                      ........  .......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.|+...+....+.......       
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            66432211  11223568999999998765 468999999999999999999999986543211111100000       


Q ss_pred             ---ccccccccccC-----ccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          702 ---WNENKILALVD-----PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       702 ---~~~~~~~~~~d-----~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                         ...........     +...-..........+.+++.+|++.+|++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               00000000000     000000001112457889999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=1.1e-31  Score=286.03  Aligned_cols=241  Identities=26%  Similarity=0.288  Sum_probs=186.9

Q ss_pred             ccccCCCccEEEEEec-CCcEEEEEEecccCc---ccHHHHHHHHHHH---HhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVI---SKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       488 ~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      .||+|+||.||+++.. +++.||+|.+.+...   .....+..|..++   ...+||||+++++.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 588999999865421   2223344554444   34579999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++..   ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+....   
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            9999988843   457999999999999999999999988   9999999999999999999999999987653322   


Q ss_pred             ccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          641 DTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.|+.......... ... .      .....+.     
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~-~------~~~~~~~-----  217 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDR-M------TLTMAVE-----  217 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHH-H------hhccCCC-----
Confidence             1224689999999998754 68999999999999999999999986542211100 000 0      0001111     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  751 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~  751 (807)
                      .+.....++.+++.+|+..+|++||     ++.++++
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1222356788999999999999999     8999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.4e-33  Score=276.93  Aligned_cols=267  Identities=23%  Similarity=0.272  Sum_probs=212.5

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      .++|...++||+|.||.|.+++.+ .++.+|+|++++..   ..+...-+.|-++|+..+||.+..|...+...+..++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467889999999999999999876 58899999998753   34456677899999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      |||..||.|.-+|.   +...+++....-+-.+|+.||.|||+++   ||.||||.+|.|||.+|++||+|||+++.-..
T Consensus       247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999988884   3556888888888899999999999988   99999999999999999999999999984322


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                        ....+..++|||.|+|||++....|..+.|.|.+|||+|||+.|+.||...+.+... ..+             -.  
T Consensus       321 --~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF-eLI-------------l~--  382 (516)
T KOG0690|consen  321 --YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF-ELI-------------LM--  382 (516)
T ss_pred             --ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH-HHH-------------Hh--
Confidence              234455689999999999999999999999999999999999999999765443221 111             00  


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHHH--hh------ccCCCCCCCCCCccc
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSML--NS------EIRDLPYPKEPAFTE  770 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~ev~~~L--~~------~~~~~~~p~~p~~~~  770 (807)
                      .+-.++.....+...|....|..||.+|.     .+.||.+.=  ..      ..+.+++|-.|.+..
T Consensus       383 ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtS  450 (516)
T KOG0690|consen  383 EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTS  450 (516)
T ss_pred             hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCccc
Confidence            01125555566777888889999999995     344444321  11      124556666666543

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.98  E-value=5.2e-32  Score=295.61  Aligned_cols=263  Identities=23%  Similarity=0.302  Sum_probs=197.9

Q ss_pred             HHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEe-CCeE
Q 003628          477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEK  552 (807)
Q Consensus       477 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  552 (807)
                      ..++++|++.+.||+|+||.||++... ++..||||++.+..  ....+.+.+|++++.+++||||+++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346788999999999999999999865 68999999886432  2345678899999999999999999998875 5678


Q ss_pred             EEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++|+||+ +++|.+++.    ...+++..+..++.|+++||.|||+.+   |+||||+|+||++++++.+||+|||+++.
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            8999998 568888773    345788888899999999999999998   99999999999999999999999999875


Q ss_pred             cCCCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhh----------hh
Q 003628          633 FGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW----------KL  701 (807)
Q Consensus       633 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~----------~~  701 (807)
                      ....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..............          ..
T Consensus       158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            4321     112456889999998766 5689999999999999999999999865432111110000          00


Q ss_pred             ccccccccccCccccCCccc-----HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          702 WNENKILALVDPFLSESSFQ-----LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ...+...+.+.........+     .....++.+++.+|++.+|++|||+++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000100000000011     1234678899999999999999999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=4.7e-32  Score=289.27  Aligned_cols=262  Identities=26%  Similarity=0.343  Sum_probs=196.5

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEEEEec
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      |++.+.||+|++|+||+|+.. +++.||||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999986 478899999865432 22334567999999999 999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                       +++|.+++... ....+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||+++........
T Consensus        81 -~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          81 -EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             -CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence             88998887543 2347899999999999999999999998   999999999999999999999999999865432221


Q ss_pred             cccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhh-------hhcccc-ccccc
Q 003628          640 ADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW-------KLWNEN-KILAL  710 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~-------~~~~~~-~~~~~  710 (807)
                         ....++..|+|||.+.. ..++.++|+||||++++||++|+.|+..............       ..+.++ .....
T Consensus       156 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         156 ---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             ---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence               22457889999998754 4578999999999999999999998865432221110000       000000 00000


Q ss_pred             cCccccCC------cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          711 VDPFLSES------SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       711 ~d~~l~~~------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .+..+...      ........++.+++.+|++.+|++|||++|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000      0001124678899999999999999999998753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=1.2e-31  Score=290.77  Aligned_cols=244  Identities=28%  Similarity=0.449  Sum_probs=192.1

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      |...+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|++++++++|||++++++++.++...++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999875 588999999864322   2345788999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +. ++|.+++..  ....+++.++..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 567666643  2346889999999999999999999998   99999999999999999999999999864321   


Q ss_pred             ccccceeeccCCccChhhhc---cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          639 QADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~---~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                         .....|+..|+|||++.   ...++.++||||||+++|||++|+.|+...+....+...    ... .     .+..
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~-~-----~~~~  240 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQN-D-----SPTL  240 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----Hhc-C-----CCCC
Confidence               12346889999999984   456888999999999999999999997543322111111    000 0     0111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .    .......+.+++.+|++.+|.+||++.++++.
T Consensus       241 ~----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 Q----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1    11223457889999999999999999998854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-32  Score=317.28  Aligned_cols=263  Identities=27%  Similarity=0.397  Sum_probs=208.3

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec----C----CcEEEEEEecccCc-ccHHHHHHHHHHHHhc-cCCceeEEeeEEE
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK----D----GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCV  547 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~----g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  547 (807)
                      ...++..+.+.||+|.||.|++|...    .    ...||||.++.... .+.+.++.|+++|..+ +|+||+.++|+|.
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            33445566779999999999999754    1    35699999986533 4568899999999999 6999999999999


Q ss_pred             eCCeEEEEEEecCCCCccccccCCC-----------CC--CCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCe
Q 003628          548 EGEEKMLIYEYMPNRSLDALLFDPL-----------KK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI  614 (807)
Q Consensus       548 ~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NI  614 (807)
                      .....++|+||++.|+|.++|...+           ..  ..++..+++.++.|||.||+||++..   +|||||..+||
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV  449 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV  449 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence            9999999999999999999997643           00  23888999999999999999999987   99999999999


Q ss_pred             eecCCCCceeeccccccccCCCCCcccc-ceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcc
Q 003628          615 LLDEELNPKISDFGMAKIFGGNQDQADT-GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDL  692 (807)
Q Consensus       615 ll~~~~~~kL~DFGla~~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~  692 (807)
                      |+.++..+||+|||++|........... ....-...|||||.+....|+.|+|||||||+||||+| |..|+.......
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            9999999999999999965444333211 11012456999999999999999999999999999999 667775422122


Q ss_pred             hhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          693 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       693 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                      .+.    +..++|...+          .+.....++.++++.||+.+|++||+..++++.++..+
T Consensus       530 ~l~----~~l~~G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  530 ELL----EFLKEGNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             HHH----HHHhcCCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            222    2333333221          23344667889999999999999999999999998854

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=7.1e-32  Score=296.76  Aligned_cols=267  Identities=22%  Similarity=0.294  Sum_probs=199.3

Q ss_pred             HHHHHHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeC
Q 003628          473 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG  549 (807)
Q Consensus       473 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  549 (807)
                      ..++..++++|.+.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++.+++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3456677899999999999999999999864 68899999987532  22346788999999999999999999988643


Q ss_pred             ------CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCce
Q 003628          550 ------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK  623 (807)
Q Consensus       550 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~k  623 (807)
                            ...+++++++ +++|.+++.    ...+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  3467888876 788988773    346899999999999999999999998   99999999999999999999


Q ss_pred             eeccccccccCCCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhc
Q 003628          624 ISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW  702 (807)
Q Consensus       624 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~  702 (807)
                      |+|||+++.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...+....+........
T Consensus       161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999998854321     122467889999999866 4688899999999999999999999864432221111110000


Q ss_pred             -cccccccccC-----------ccccCCcc---cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          703 -NENKILALVD-----------PFLSESSF---QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       703 -~~~~~~~~~d-----------~~l~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                       ....+...+.           +......+   ......++.+++.+|++.+|.+||++.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence             0000000000           00000000   00124567899999999999999999998864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=1.3e-31  Score=293.49  Aligned_cols=264  Identities=21%  Similarity=0.276  Sum_probs=196.2

Q ss_pred             cCCc-ccCccccCCCccEEEEEec-CCcEEEEEEecccCccc--------------HHHHHHHHHHHHhccCCceeEEee
Q 003628          481 NNFQ-LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQG--------------LEEFMNEVMVISKLQHRNLVRLLG  544 (807)
Q Consensus       481 ~~~~-~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g  544 (807)
                      ++|. +.+.||+|+||.||+|+.. +++.||||.++......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 4577999999999999865 68999999986542221              125789999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCcee
Q 003628          545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  624 (807)
Q Consensus       545 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL  624 (807)
                      ++..++..++||||++ ++|.+++..   ...+++.....++.|++.||+|||+.+   |+|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 588888743   346889999999999999999999988   999999999999999999999


Q ss_pred             eccccccccCCCCC------------ccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCc
Q 003628          625 SDFGMAKIFGGNQD------------QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD  691 (807)
Q Consensus       625 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~  691 (807)
                      +|||+++.......            ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+...++.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999987651110            0111123468899999998764 4688999999999999999999998755432


Q ss_pred             chhhhhhhhhccccc---ccc--------ccCccccCC--cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          692 LTILGYAWKLWNENK---ILA--------LVDPFLSES--SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       692 ~~l~~~~~~~~~~~~---~~~--------~~d~~l~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      ..+... ........   ...        ...+.....  ........++.+++..|++.+|++|||++|++..
T Consensus       241 ~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        241 DQLGRI-FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHH-HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            222111 11100000   000        000000000  0011224678899999999999999999999864

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9.3e-32  Score=293.93  Aligned_cols=268  Identities=22%  Similarity=0.298  Sum_probs=203.3

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCC-----eEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EKM  553 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  553 (807)
                      +|.+.+.||+|++|.||+++.. .++.+|||++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999976 48899999987643  344578999999999999999999999988775     789


Q ss_pred             EEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccccc
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~  633 (807)
                      +||||++ ++|.+++..   ...+++..+..++.+|++||.|||+.+   |+||||||+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 478888743   347999999999999999999999998   999999999999999999999999999976


Q ss_pred             CCCCCc-cccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh----------
Q 003628          634 GGNQDQ-ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL----------  701 (807)
Q Consensus       634 ~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~----------  701 (807)
                      ...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........+.......          
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            543210 112234678899999999888 78999999999999999999999986544221111000000          


Q ss_pred             ccccccccccCccccCC-----cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH--Hhhc
Q 003628          702 WNENKILALVDPFLSES-----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSE  756 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~--L~~~  756 (807)
                      .......+.+...-...     .........+.+++.+||+.+|++||+++++++.  +++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            00000000000000000     0111235678899999999999999999999974  5443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=6.7e-32  Score=284.46  Aligned_cols=249  Identities=26%  Similarity=0.337  Sum_probs=195.2

Q ss_pred             CCcccCccccCCCccEEEEEecC-CcEEEEEEeccc-----CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA-----SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      +|.+.++||+|+||.||+++... +..+++|.++..     ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998753 445666665432     122345677899999999999999999999999999999


Q ss_pred             EEecCCCCccccccCC-CCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          556 YEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      |||+++++|.+++... .....+++.++..++.|+++||.|||+.+   ++|+||+|+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888542 23457899999999999999999999988   999999999999975 569999999998764


Q ss_pred             CCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      .....  .....|+..|+|||.+....++.++|+||||+++|+|++|..|+........    .....      ....+.
T Consensus       157 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~----~~~~~------~~~~~~  224 (260)
T cd08222         157 GSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV----VLRIV------EGPTPS  224 (260)
T ss_pred             CCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHH------cCCCCC
Confidence            33221  2224578899999999888899999999999999999999999853221111    11100      001111


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                           .+.....++.+++.+|++.+|++||++.|+++
T Consensus       225 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         225 -----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                 22345567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-31  Score=285.65  Aligned_cols=260  Identities=25%  Similarity=0.349  Sum_probs=198.5

Q ss_pred             CcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      |+..+.||+|++|.||+|+.. +++.+|+|.+....  ....+.+..|+.++++++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456789999999999999976 48999999997653  333467889999999999999999999999999999999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      + ++|.+++...  ...+++..+.+++.++++||+|||+.+   |+||||+|+||++++++.+||+|||+++........
T Consensus        81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            8 5899998542  246899999999999999999999998   999999999999999999999999999876433221


Q ss_pred             cccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh-------ccc-ccc---
Q 003628          640 ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------WNE-NKI---  707 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~-------~~~-~~~---  707 (807)
                        .....++..|+|||.+... .++.++||||||+++|||++|+.|+........+.......       +.. ...   
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence              1223457789999998776 78999999999999999999998886533221111110000       000 000   


Q ss_pred             ccccC---ccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          708 LALVD---PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       708 ~~~~d---~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .....   ...... ........+.+++.+|++.+|++||++++++.
T Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000   000000 01112567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-32  Score=271.02  Aligned_cols=285  Identities=23%  Similarity=0.324  Sum_probs=210.6

Q ss_pred             HHHHHHHhcCCcccCccccCCCccEEEEE-ecCCcEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCC
Q 003628          473 FEELATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGE  550 (807)
Q Consensus       473 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  550 (807)
                      ++++-+.+     .+.||+|+|+.|--++ +.+|.++|||++.+.......+..+|++++...+ |+||++|+.+|++++
T Consensus        75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            45555554     3689999999999886 5689999999998887777889999999999995 999999999999999


Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCC---ceeecc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDF  627 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~---~kL~DF  627 (807)
                      ..|||||-|.||+|..+|.   ++..+++.++.++.++|+.||.+||.++   |.|||+||+|||-.+...   +||+||
T Consensus       150 ~FYLVfEKm~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             eEEEEEecccCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence            9999999999999999985   4567999999999999999999999999   999999999999976554   899999


Q ss_pred             ccccccCCCCC-----ccccceeeccCCccChhhhc-----cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhh
Q 003628          628 GMAKIFGGNQD-----QADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY  697 (807)
Q Consensus       628 Gla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~-----~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~  697 (807)
                      .+..-...+..     .......+|+..|||||+..     ...|+.++|.||||||||-|++|.+||...=..+.  +|
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--GW  301 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--GW  301 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--Cc
Confidence            98765432211     11222357899999999863     33588899999999999999999999964321110  11


Q ss_pred             hhhhccccc----cccccCccccCC--cccH----HHHHHHHHHHHhcccCCcCCCCCHHHHHH--HHhhccCCCCCCCC
Q 003628          698 AWKLWNENK----ILALVDPFLSES--SFQL----DMIIRCIHVGLLCVQELVKDRPNMSTVVS--MLNSEIRDLPYPKE  765 (807)
Q Consensus       698 ~~~~~~~~~----~~~~~d~~l~~~--~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~ev~~--~L~~~~~~~~~p~~  765 (807)
                           ..|.    ..+.+-.+++++  .++.    ....+..+++...+..++.+|-++.+++.  ..+++ ..-+.-+.
T Consensus       302 -----drGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~-~~ekalpt  375 (463)
T KOG0607|consen  302 -----DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC-APEKALPT  375 (463)
T ss_pred             -----cCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc-chhccCCC
Confidence                 1110    001111111111  1222    34567778888889999999999999887  23333 11233344


Q ss_pred             CCcccCCCCCC
Q 003628          766 PAFTERQGADD  776 (807)
Q Consensus       766 p~~~~~~~~~~  776 (807)
                      |....+.+...
T Consensus       376 p~v~~r~~s~~  386 (463)
T KOG0607|consen  376 PQVLQRNSSTM  386 (463)
T ss_pred             CcccccCccch
Confidence            44454444433

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9.9e-32  Score=295.42  Aligned_cols=262  Identities=22%  Similarity=0.305  Sum_probs=197.6

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCe---
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE---  551 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---  551 (807)
                      ...++|.+.+.||+|++|.||+|+.. +++.||||++...  .....+.+.+|+.++++++|+||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999976 5789999998653  22234667889999999999999999998776554   


Q ss_pred             ---EEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          552 ---KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       552 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                         .++|+||+ +++|.+++.    ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               89999999 668988874    356899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhcc-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh-------
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-------  700 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~-------  700 (807)
                      ++......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........+......       
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence            99865332     122457889999999865 36788999999999999999999998644322111110000       


Q ss_pred             ---hccccccccccCc--cccCCcc---cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          701 ---LWNENKILALVDP--FLSESSF---QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       701 ---~~~~~~~~~~~d~--~l~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                         .+........+..  ......+   ......++.+++.+|++.+|++|||+.||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence               0000000000000  0000000   01125678999999999999999999998763

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-32  Score=285.23  Aligned_cols=244  Identities=28%  Similarity=0.385  Sum_probs=197.1

Q ss_pred             cCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          486 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      .+.||+|.||+||-|+.. +|+.||||++.+.  ..+...++.+|+.||++++||.||.+.-.|+..+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            578999999999999865 7999999999764  3445588999999999999999999999999999999999999665


Q ss_pred             CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC---CCceeeccccccccCCCCCc
Q 003628          563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~---~~~kL~DFGla~~~~~~~~~  639 (807)
                      -|+-+|..  +.+++++....-++.||+.||.|||.++   |+|+||||+||||.+.   -.+||||||+||+++..+..
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            55544432  5678999888889999999999999999   9999999999999754   35999999999998754322


Q ss_pred             cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                         ..++||+.|+|||++.++.|...-|+||.|||+|--++|..||...++-.+..+-+.-.+...              
T Consensus       724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~--------------  786 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPN--------------  786 (888)
T ss_pred             ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCC--------------
Confidence               237899999999999999999999999999999999999999976554322222111111110              


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      --.+...+.+++|...||..-.+|-|..+-+.
T Consensus       787 PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            11234567788888889998889988776543

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=1.1e-31  Score=267.91  Aligned_cols=205  Identities=25%  Similarity=0.401  Sum_probs=170.7

Q ss_pred             hcCCcccCccccCCCccEEEEEecC-----CcEEEEEEecccCcc--cHHHHHHHHHHHHhccCCceeEEeeEEEe-CCe
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEE  551 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~  551 (807)
                      ...|+....||+|.||.||+|.-++     ...+|+|+++.....  -.....+|+.+++.++||||+.|...+.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3568888999999999999996432     237999999754222  23567899999999999999999999887 788


Q ss_pred             EEEEEEecCCCCccccccC--CCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC----CCceee
Q 003628          552 KMLIYEYMPNRSLDALLFD--PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE----LNPKIS  625 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~----~~~kL~  625 (807)
                      .++++||.+. +|..+|+.  ..+...++...+..|+.||+.|+.|||++=   |+||||||.||||..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            8999999987 77777753  223457888999999999999999999987   9999999999999877    899999


Q ss_pred             ccccccccCCCCCc-cccceeeccCCccChhhhccCC-CCcccceeehhHHHHHHHhCCCCCCcc
Q 003628          626 DFGMAKIFGGNQDQ-ADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFF  688 (807)
Q Consensus       626 DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~-~t~k~DvwSlGvvl~elltG~~p~~~~  688 (807)
                      |||++|++...-.. .....++-|..|.|||.+.+.. ||.+.|||+.|||+.||+|-++-|...
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            99999998654332 2445577899999999998875 899999999999999999988877543

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-31  Score=277.02  Aligned_cols=236  Identities=29%  Similarity=0.354  Sum_probs=192.9

Q ss_pred             cccCCCccEEEEEec-CCcEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCc
Q 003628          489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  564 (807)
Q Consensus       489 LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  564 (807)
                      ||+|+||.||++... +++.+|+|.+.....   ...+.+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999876 488999999875432   2456889999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccce
Q 003628          565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  644 (807)
Q Consensus       565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  644 (807)
                      .+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT  152 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence            999853   336899999999999999999999988   99999999999999999999999999987643321  1233


Q ss_pred             eeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHH
Q 003628          645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  724 (807)
Q Consensus       645 ~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  724 (807)
                      ..++..|+|||...+...+.++|+||||+++|||++|+.|+...+......    ...         ....   ..+...
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~----~~~---------~~~~---~~~~~~  216 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE----KIL---------KDPL---RFPEFL  216 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHh---------cCCC---CCCCCC
Confidence            567889999999988889999999999999999999999986443211111    000         0011   122223


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHH
Q 003628          725 IIRCIHVGLLCVQELVKDRPNMST  748 (807)
Q Consensus       725 ~~~l~~li~~Cl~~dP~~RPt~~e  748 (807)
                      ...+.+++.+|+..||++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            567889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=5.5e-31  Score=312.21  Aligned_cols=146  Identities=30%  Similarity=0.454  Sum_probs=131.2

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      .++|.+.++||+|+||.||+|+.. +++.||||+++...   ......+..|+.++..++|+||+++++.+......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367899999999999999999976 68899999997532   22346788999999999999999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      |||+++++|.+++..   ...+++..+++|+.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999853   346788899999999999999999988   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-33  Score=273.46  Aligned_cols=253  Identities=25%  Similarity=0.322  Sum_probs=194.8

Q ss_pred             ccCccccCCCccEEEEEec-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecCC
Q 003628          485 LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       485 ~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      ....||.|+||+|+|-.++ .|+.+|||+++.... .+.++++.|.+...+- +.||||+++|.+..++..++.||.|+ 
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence            3468999999999999876 689999999986544 5668889998876655 79999999999999999999999994 


Q ss_pred             CCccccccC--CCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCc
Q 003628          562 RSLDALLFD--PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       562 gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  639 (807)
                      .||+.+...  ..+...+++.-+-.|....++||.||...-  .|+||||||+||||+..|.+||||||++-.+...   
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---  221 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---  221 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH---
Confidence            466554321  123457888888888899999999998764  5999999999999999999999999998765332   


Q ss_pred             cccceeeccCCccChhhhccC--CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccC
Q 003628          640 ADTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~--~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                      ...+.-+|-..|||||.+...  .|+.++||||||++|||+.||+.|+...+.....   ..... .+     -.|.+..
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq---l~~Vv-~g-----dpp~l~~  292 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ---LCQVV-IG-----DPPILLF  292 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH---HHHHH-cC-----CCCeecC
Confidence            222335788999999998643  4899999999999999999999998765431111   11111 01     1122222


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       718 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      .....+....+.+++-.|+..|..+||...++.++
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            22334467789999999999999999999987654

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=304.42  Aligned_cols=277  Identities=24%  Similarity=0.281  Sum_probs=215.8

Q ss_pred             HHHHHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecc---cCcccHHHHHHHHHHHHhccCCceeEEeeEEEeC
Q 003628          474 EELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG  549 (807)
Q Consensus       474 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  549 (807)
                      .+++-..++|.++++||+|+||.|..++.+ .++.||+|++.+   .......-|..|-.+|..-+.+-|+.+...|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344555678999999999999999999986 578899999987   2344557789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccc
Q 003628          550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  629 (807)
Q Consensus       550 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGl  629 (807)
                      .+.|+|||||+||+|-.++.+   ..++++..+.-++..|+-||.-||+.|   +|||||||.|||||..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence            999999999999999999954   237899989999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCccccceeeccCCccChhhhc----c-CCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc
Q 003628          630 AKIFGGNQDQADTGRVVGTFGYMSPEYAM----E-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE  704 (807)
Q Consensus       630 a~~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~  704 (807)
                      +-.+..+.. ......+|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||....    ++.-..++...
T Consensus       222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----lveTY~KIm~h  296 (1317)
T KOG0612|consen  222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----LVETYGKIMNH  296 (1317)
T ss_pred             HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----HHHHHHHHhch
Confidence            987764433 2233468999999999985    2 569999999999999999999999996422    22222222211


Q ss_pred             cccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCC---HHHHHHHH--hhc----cCCCCCCCCCCccc
Q 003628          705 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN---MSTVVSML--NSE----IRDLPYPKEPAFTE  770 (807)
Q Consensus       705 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~ev~~~L--~~~----~~~~~~p~~p~~~~  770 (807)
                      .....+.        ...+.+.+..+||.+.+. +|+.|..   ++++-.+-  +++    +++..+|..|.+..
T Consensus       297 k~~l~FP--------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevss  362 (1317)
T KOG0612|consen  297 KESLSFP--------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSS  362 (1317)
T ss_pred             hhhcCCC--------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCC
Confidence            1111111        113356677788877665 6778887   88887654  221    36666676666544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=289.34  Aligned_cols=239  Identities=23%  Similarity=0.313  Sum_probs=195.8

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ++.|.+...+|.|+|+.|-.+... +++..+||++.+..    .+-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567888888999999999998865 57889999997652    2334677666666 79999999999999999999999


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeee-cCCCCceeeccccccccCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL-DEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll-~~~~~~kL~DFGla~~~~~~  636 (807)
                      .+.++-|.+.+..   .+... .++..|+.+|+.|+.|||.++   +|||||||+|||+ ++.++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            9999888776632   22233 777789999999999999998   9999999999999 68999999999999876544


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                           ....+-|..|.|||++....|++++|+||||++||+|++|+.|+.....+..+..                 ++.
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~-----------------~i~  527 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT-----------------RIQ  527 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH-----------------hhc
Confidence                 2224568899999999999999999999999999999999999986555422221                 122


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .++++........+|+.+||+.||.+||+|.++..
T Consensus       528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            22344566778899999999999999999999864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=292.45  Aligned_cols=259  Identities=25%  Similarity=0.385  Sum_probs=212.3

Q ss_pred             HHHHHHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEEEe--
Q 003628          473 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE--  548 (807)
Q Consensus       473 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~--  548 (807)
                      ++.+...++-|++.+.||.|.+|.||+++.. +++.+|+|++... ....+++..|.++++.. +|||++.++|++..  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            4444455678999999999999999999864 6888999998543 44557788899999988 79999999999873  


Q ss_pred             ---CCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceee
Q 003628          549 ---GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS  625 (807)
Q Consensus       549 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~  625 (807)
                         ++..+||||||.+||.-+++.... ..++.|..+..|++.+++|+++||...   ++|||||-.||||+.++.+||.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence               578999999999999999998765 788999999999999999999999987   9999999999999999999999


Q ss_pred             ccccccccCCCCCccccceeeccCCccChhhhccC-----CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh
Q 003628          626 DFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK  700 (807)
Q Consensus       626 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~  700 (807)
                      |||++..+...  ........||+.|||||++...     .|+.++|+||||++..||.-|.+|+.....-..+..    
T Consensus       166 DFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~----  239 (953)
T KOG0587|consen  166 DFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----  239 (953)
T ss_pred             eeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc----
Confidence            99999866432  2233347899999999998643     478899999999999999999999764443322221    


Q ss_pred             hccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          701 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       701 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                            +..-..|.+.   -+....+++.++|..||..|-++||++.++++
T Consensus       240 ------IpRNPPPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 ------IPRNPPPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ------CCCCCCcccc---chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                  1122233343   34567889999999999999999999998765

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=274.26  Aligned_cols=241  Identities=26%  Similarity=0.349  Sum_probs=200.1

Q ss_pred             hcCCcccCccccCCCccEEEEEecC-CcEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  554 (807)
                      ..+|..+.+||+|+||.|.++..+. .+.+|||++++.   ...+.+--+.|-++|+.. +-|.++++..++..-+..|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            3568888999999999999998663 567999999875   233456667888888877 56889999999999999999


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ||||+.||+|.-++.   +-+++.+..+.-+|.+||-||-+||+++   |+.||||..||||+.+|++||+|||+++.-.
T Consensus       428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            999999999988874   4567888889999999999999999999   9999999999999999999999999998422


Q ss_pred             CCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                        .....+..++||+.|+|||++...+|+...|.|||||+||||+.|++||+..+++......             .+..
T Consensus       502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI-------------~ehn  566 (683)
T KOG0696|consen  502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI-------------MEHN  566 (683)
T ss_pred             --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------------HHcc
Confidence              2234455689999999999999999999999999999999999999999875544322211             1111


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCC
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRP  744 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RP  744 (807)
                      .   .++.....+...++...+...|.+|.
T Consensus       567 v---syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 V---SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             C---cCcccccHHHHHHHHHHhhcCCcccc
Confidence            1   25566677888999999999999994

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.5e-30  Score=270.62  Aligned_cols=221  Identities=19%  Similarity=0.138  Sum_probs=177.0

Q ss_pred             CCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCccccccC
Q 003628          492 GGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD  570 (807)
Q Consensus       492 G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  570 (807)
                      |.+|.||+++.. +++.+|+|+++...     .+..|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999875 68899999996542     234556666667899999999999999999999999999999998853


Q ss_pred             CCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccceeeccCC
Q 003628          571 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG  650 (807)
Q Consensus       571 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  650 (807)
                         ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++++|||.+.......     ....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence               345899999999999999999999988   9999999999999999999999999887654321     12345678


Q ss_pred             ccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHH
Q 003628          651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIH  730 (807)
Q Consensus       651 y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~  730 (807)
                      |+|||.+....++.++||||+|+++|||++|+.|+.......               .......     .+.....++.+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~~~-----~~~~~~~~~~~  207 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTTLN-----IPEWVSEEARS  207 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccccC-----CcccCCHHHHH
Confidence            999999988889999999999999999999998764221110               0000000     12223456889


Q ss_pred             HHHhcccCCcCCCCCHHH
Q 003628          731 VGLLCVQELVKDRPNMST  748 (807)
Q Consensus       731 li~~Cl~~dP~~RPt~~e  748 (807)
                      ++.+|++.||++||++.+
T Consensus       208 li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         208 LLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHHHccCCHHHhcCCCc
Confidence            999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-31  Score=274.47  Aligned_cols=258  Identities=27%  Similarity=0.339  Sum_probs=201.3

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecc--cCc-----ccHHHHHHHHHHHHhccCCceeEEeeEEE-eC
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK--ASG-----QGLEEFMNEVMVISKLQHRNLVRLLGCCV-EG  549 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~--~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~  549 (807)
                      ..++|-++.+||+|||+.||++.+- ..+.||||+-.-  .-.     .-.+...+|.+|-+.|.||.||++|+++. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            3456888899999999999999754 577899997532  111     12355678999999999999999999986 56


Q ss_pred             CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC---CCCceeec
Q 003628          550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISD  626 (807)
Q Consensus       550 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~---~~~~kL~D  626 (807)
                      +.++-|+||++|.+|+-+|.   ....+++.++..|+.||+.||.||.+.. +||||-||||.||||.+   -|.+||+|
T Consensus       541 dsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence            67899999999999999984   4567999999999999999999999875 78999999999999954   47799999


Q ss_pred             cccccccCCCCCcc-----ccceeeccCCccChhhhccC----CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhh
Q 003628          627 FGMAKIFGGNQDQA-----DTGRVVGTFGYMSPEYAMEG----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY  697 (807)
Q Consensus       627 FGla~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~----~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~  697 (807)
                      ||+++++..+....     .+....||..|++||.+.-+    +++.|.||||.|||+|..+.|++||......++++..
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe  696 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE  696 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence            99999997765442     24446899999999998644    4788999999999999999999999865544444322


Q ss_pred             hhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHH
Q 003628          698 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVV  750 (807)
Q Consensus       698 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~  750 (807)
                             ..+...-+-.+.   ..+....+...+|++||++.-++|-...++.
T Consensus       697 -------NTIlkAtEVqFP---~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  697 -------NTILKATEVQFP---PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -------hchhcceeccCC---CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                   222111111111   1122345677899999999999998766654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.6e-29  Score=292.54  Aligned_cols=261  Identities=20%  Similarity=0.234  Sum_probs=168.0

Q ss_pred             HhcCCcccCccccCCCccEEEEEecC-----CcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeE------EE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC------CV  547 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~  547 (807)
                      ..++|.+.++||+|+||.||+|++.+     +..||||++.....  .+.+..|  .+....+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            46789999999999999999999764     68999999864322  1222222  1122222222222211      24


Q ss_pred             eCCeEEEEEEecCCCCccccccCCCCC-----------------CCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCC
Q 003628          548 EGEEKMLIYEYMPNRSLDALLFDPLKK-----------------ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK  610 (807)
Q Consensus       548 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIk  610 (807)
                      .+...++||||+.+++|.+++......                 .......+..++.||+.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            567789999999999999888542110                 01112335578999999999999988   9999999


Q ss_pred             CCCeeecC-CCCceeeccccccccCCCCCccccceeeccCCccChhhhccC----------------------CCCcccc
Q 003628          611 ASNILLDE-ELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG----------------------RFSEKSD  667 (807)
Q Consensus       611 p~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~t~k~D  667 (807)
                      |+|||++. ++.+||+|||+++.+...... ......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 578999999999865433222 22336789999999976422                      2345679


Q ss_pred             eeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc----cccccccCccccCC-----cccHHHHHHHHHHHHhcccC
Q 003628          668 VFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE----NKILALVDPFLSES-----SFQLDMIIRCIHVGLLCVQE  738 (807)
Q Consensus       668 vwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~----~~~~~~~d~~l~~~-----~~~~~~~~~l~~li~~Cl~~  738 (807)
                      ||||||+||||+++..+.+.     .+..+.......    ......+.+.....     ...........+|+.+||+.
T Consensus       362 VwSlGviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            99999999999997655321     111111100000    00011111110000     00000122345899999999


Q ss_pred             CcCCCCCHHHHHHH
Q 003628          739 LVKDRPNMSTVVSM  752 (807)
Q Consensus       739 dP~~RPt~~ev~~~  752 (807)
                      ||++|||++|+++.
T Consensus       437 dP~kR~ta~e~L~H  450 (566)
T PLN03225        437 KGRQRISAKAALAH  450 (566)
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=8.3e-30  Score=263.99  Aligned_cols=238  Identities=28%  Similarity=0.377  Sum_probs=193.7

Q ss_pred             CCccEEEEEecC-CcEEEEEEecccCccc-HHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCccccccC
Q 003628          493 GFGPVYWGRLKD-GQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD  570 (807)
Q Consensus       493 ~~g~Vy~~~~~~-g~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  570 (807)
                      +||.||+|+..+ ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999874 8999999997665544 78999999999999999999999999999999999999999999999854


Q ss_pred             CCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccceeeccCC
Q 003628          571 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG  650 (807)
Q Consensus       571 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  650 (807)
                      .   ..+++..+..++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            2   23889999999999999999999998   9999999999999999999999999998765432   2223567889


Q ss_pred             ccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHH
Q 003628          651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIH  730 (807)
Q Consensus       651 y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~  730 (807)
                      |++||.+....++.++||||||+++++|++|..|+....+.........    ..        .............++.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~----~~--------~~~~~~~~~~~~~~~~~  219 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG----KP--------KPPFPPPEWKISPEAKD  219 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----cc--------CCCCccccccCCHHHHH
Confidence            9999999988899999999999999999999999865332222211111    00        00000000014467889


Q ss_pred             HHHhcccCCcCCCCCHHHHHH
Q 003628          731 VGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       731 li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-30  Score=262.29  Aligned_cols=264  Identities=24%  Similarity=0.352  Sum_probs=212.5

Q ss_pred             HHHHHhcCCcccCccccCCCccEEEEEec------CCcEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeEEeeEEE
Q 003628          475 ELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCV  547 (807)
Q Consensus       475 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  547 (807)
                      ++.....+++..-.+-+|.||.||+|.+.      +.+.|-||.++... +-....++.|...+..+.|||+..+.+.++
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            33344466888888999999999999654      34567888876543 334578899999999999999999999988


Q ss_pred             eC-CeEEEEEEecCCCCcccccc-----CCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCC
Q 003628          548 EG-EEKMLIYEYMPNRSLDALLF-----DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN  621 (807)
Q Consensus       548 ~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~  621 (807)
                      +. ...+++|.++.-|+|..+|.     +....+.++..+...++.|++.|++|||.++   +||.||..+|.+||+..+
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence            65 56788999999999999997     5555667888889999999999999999998   999999999999999999


Q ss_pred             ceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhh
Q 003628          622 PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWK  700 (807)
Q Consensus       622 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~  700 (807)
                      +||+|=.++|.+-......-......+..||+||.+.+..|+.++||||||++||||+| |+.|+...+..    ++. .
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf----Em~-~  509 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF----EME-H  509 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH----HHH-H
Confidence            99999999998766555544444456789999999999999999999999999999988 77887543321    111 1


Q ss_pred             hccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          701 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       701 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      +..+|.       ++.   .+.+++.++..++.-||...|++||+.++++.-|.+.
T Consensus       510 ylkdGy-------Rla---QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  510 YLKDGY-------RLA---QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHhccc-------eec---CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            122221       111   3445778899999999999999999999999988653

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2e-29  Score=284.47  Aligned_cols=261  Identities=20%  Similarity=0.287  Sum_probs=180.6

Q ss_pred             HhcCCcccCccccCCCccEEEEEe-----------------cCCcEEEEEEecccCcccHHH--------------HHHH
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRL-----------------KDGQEIAVKRLSKASGQGLEE--------------FMNE  527 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~~~~--------------~~~E  527 (807)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 235679999986543322233              3457


Q ss_pred             HHHHHhccCCce-----eEEeeEEEe--------CCeEEEEEEecCCCCccccccCCCC---------------------
Q 003628          528 VMVISKLQHRNL-----VRLLGCCVE--------GEEKMLIYEYMPNRSLDALLFDPLK---------------------  573 (807)
Q Consensus       528 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~---------------------  573 (807)
                      +.++.+++|.++     ++++++|..        ....+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777888876654     677887753        3567999999999999998864211                     


Q ss_pred             CCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccceeeccCCccC
Q 003628          574 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS  653 (807)
Q Consensus       574 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~A  653 (807)
                      ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++........ ......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence            123466778899999999999999988   999999999999999999999999999765432211 1112335789999


Q ss_pred             hhhhccCCC----------------------CcccceeehhHHHHHHHhCCC-CCCccCC-cchhhh--h---hhhhccc
Q 003628          654 PEYAMEGRF----------------------SEKSDVFSFGVLLLEIVSGRK-NTSFFED-DLTILG--Y---AWKLWNE  704 (807)
Q Consensus       654 PE~~~~~~~----------------------t~k~DvwSlGvvl~elltG~~-p~~~~~~-~~~l~~--~---~~~~~~~  704 (807)
                      ||.+.....                      ..+.||||+||++|||++|.. |+..... ...+..  .   .|.....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            998754321                      124699999999999999875 5532110 000000  0   0111111


Q ss_pred             cccccccCccccCCcccHHHHHHHHHHHHhcccCCc---CCCCCHHHHHHH
Q 003628          705 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELV---KDRPNMSTVVSM  752 (807)
Q Consensus       705 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP---~~RPt~~ev~~~  752 (807)
                      ..    .+-.     ..........+++..++..+|   .+|+|++|++++
T Consensus       459 ~~----~~~~-----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        459 QK----YDFS-----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             cC----CCcc-----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            11    0100     111234567788889998765   689999998863

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=6.2e-30  Score=236.54  Aligned_cols=262  Identities=21%  Similarity=0.299  Sum_probs=191.6

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +|...++||+|.||+||+|+.. .++.||+|+++-..  +.-....++|+-+++.++|+|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4555689999999999999976 47889999987432  22346788999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +.. +|..+...  -.+.++.+....++.|+++||.+.|++.   +.|||+||.|.|++.+|++|++|||++|.++-...
T Consensus        83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            954 77776533  3567888899999999999999999998   99999999999999999999999999998764322


Q ss_pred             ccccceeeccCCccChhhhccCC-CCcccceeehhHHHHHHHhCCCC-CCccCCcchhhhhhhhhc--cccc---ccccc
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKN-TSFFEDDLTILGYAWKLW--NENK---ILALV  711 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~-~t~k~DvwSlGvvl~elltG~~p-~~~~~~~~~l~~~~~~~~--~~~~---~~~~~  711 (807)
                      -  ....+-|..|.+|.++.+.+ |++..|+||.||++.|+..-.+| |...+.++.+....+.+-  .+..   +..+.
T Consensus       157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            1  11234589999999998876 88899999999999999885555 444443333333222111  1111   11111


Q ss_pred             Cccc----cCC----cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          712 DPFL----SES----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 d~~l----~~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      |...    ...    ..-+.....=.++....+.-+|..|-++++.++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1111    000    011111223345666667779999999887665

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-30  Score=263.24  Aligned_cols=262  Identities=19%  Similarity=0.219  Sum_probs=200.6

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhcc-C-Cc----eeEEeeEEEeCCe
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H-RN----LVRLLGCCVEGEE  551 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H-~n----iv~l~g~~~~~~~  551 (807)
                      .+++|.+...+|+|.||.|...... .+..||||+++. ...-.+.-+-|+++|++|. + |+    ++.+.+++...++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            3688999999999999999999865 368899999854 3344566788999999993 3 32    7888889999999


Q ss_pred             EEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC-------------
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-------------  618 (807)
Q Consensus       552 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~-------------  618 (807)
                      .++|+|.+ |-|+.++|.+. +-.+++..++..|+.|+++++++||+..   ++|-||||+|||+.+             
T Consensus       166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            99999999 66899999653 4457888999999999999999999998   999999999999932             


Q ss_pred             -------CCCceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCc
Q 003628          619 -------ELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD  691 (807)
Q Consensus       619 -------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~  691 (807)
                             +..+||+|||.|+......     ..++.|..|.|||++.+..++.++||||+||||.|+.||..-|...++.
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                   2358999999998653332     4478899999999999999999999999999999999999887655532


Q ss_pred             chhhhh----------------hhhhcccccc-----------ccccCcccc---CCcccHHHHHHHHHHHHhcccCCcC
Q 003628          692 LTILGY----------------AWKLWNENKI-----------LALVDPFLS---ESSFQLDMIIRCIHVGLLCVQELVK  741 (807)
Q Consensus       692 ~~l~~~----------------~~~~~~~~~~-----------~~~~d~~l~---~~~~~~~~~~~l~~li~~Cl~~dP~  741 (807)
                      ..+..+                +.++...+++           ....++...   --.....+..+|.+|+..+|.+||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            222110                0111111110           001111100   0012334567899999999999999


Q ss_pred             CCCCHHHHHH
Q 003628          742 DRPNMSTVVS  751 (807)
Q Consensus       742 ~RPt~~ev~~  751 (807)
                      +|+|+.|+++
T Consensus       396 ~RiTl~EAL~  405 (415)
T KOG0671|consen  396 RRITLREALS  405 (415)
T ss_pred             ccccHHHHhc
Confidence            9999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.1e-30  Score=253.62  Aligned_cols=264  Identities=22%  Similarity=0.405  Sum_probs=195.0

Q ss_pred             CCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcc--cHHHHHHHHHHHHhccCCceeEEeeEEEe--------CC
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVE--------GE  550 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~  550 (807)
                      .|.-..+||+|.||.||+|+.+ .|+.||+|+.....+.  -...-++|+++|..++|+|++.++..|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3455678999999999999876 4778899876543222  23456799999999999999999988753        33


Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla  630 (807)
                      ..++|+.+++. +|..+|.+  ...+++..++.+++.++..||.|+|...   |+|||+||.|+||+.++.+||+|||++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence            57999999976 78777754  3467899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCcc--ccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhh-------
Q 003628          631 KIFGGNQDQA--DTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-------  700 (807)
Q Consensus       631 ~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~-------  700 (807)
                      |.+.......  ..+..+-|..|.+||.+.+. .|+++.|||..|||+.||.||.+-+....+.+.+. ....       
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~-~Is~LcGs~tk  250 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLH-LISQLCGSITK  250 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHH-HHHHHhccCCc
Confidence            8775433221  12223458999999998875 58999999999999999999998877655443332 1111       


Q ss_pred             -hcccc---cccccc--CccccCCcc--cHHHH------HHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          701 -LWNEN---KILALV--DPFLSESSF--QLDMI------IRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       701 -~~~~~---~~~~~~--d~~l~~~~~--~~~~~------~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                       .|.+-   .+.+.+  +| +.+..+  -.+..      .+.++|+..++..||.+|+.+.+++...
T Consensus       251 evWP~~d~lpL~~sie~eP-l~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEP-LPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             ccCCCcccchHHHhccCCC-CCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence             11111   111111  11 111100  01111      2677899999999999999999987643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=280.98  Aligned_cols=245  Identities=27%  Similarity=0.397  Sum_probs=187.3

Q ss_pred             CcccCccccCCCcc-EEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          483 FQLSSKLGQGGFGP-VYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       483 ~~~~~~LG~G~~g~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      |...+.+|.|+-|+ ||+|... |+.||||++-..   ..+...+|+..|+.- +|||||++++.-.++...||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            44456789999985 7999986 789999998532   234557899999988 69999999999999999999999995


Q ss_pred             CCCccccccCC-CCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC---C--CCceeeccccccccC
Q 003628          561 NRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---E--LNPKISDFGMAKIFG  634 (807)
Q Consensus       561 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~---~--~~~kL~DFGla~~~~  634 (807)
                       .+|++++... .......-.....++.|++.||++||+.+   ||||||||.||||+.   +  .+++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             5999999653 11112222455778999999999999987   999999999999976   2  569999999999987


Q ss_pred             CCCCc-cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhC-CCCCCccCC-cchhhhhhhhhcccccccccc
Q 003628          635 GNQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG-RKNTSFFED-DLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       635 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG-~~p~~~~~~-~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ..... .......||.+|+|||.+....-+.+.||||+|||+|..++| .+||...-+ +.+++       ....-...+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~~L~~L  735 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNYTLVHL  735 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCccceeee
Confidence            65433 234456899999999999999888999999999999999997 789863221 11111       110000000


Q ss_pred             CccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .     . .. +.  +..+||.+|++++|..||++.+|+.
T Consensus       736 ~-----~-~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  736 E-----P-LP-DC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             c-----c-Cc-hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0     0 11 11  6789999999999999999999874

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=272.45  Aligned_cols=249  Identities=23%  Similarity=0.307  Sum_probs=206.3

Q ss_pred             cCCcccCccccCCCccEEEEEecCCc-EEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~g~-~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      .+++.+..||-||||.|=+.+.+... .+|+|++++.   .....+....|-.+|...+.|.||++|.-|.+....|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34556678999999999998876433 3889888764   3344577889999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      |-|-||.|...|.   .++.++.....-++..+.+|++|||+++   ||.|||||+|.+|+.+|-+||.|||+|+.++..
T Consensus       500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999995   4577888888889999999999999999   999999999999999999999999999988654


Q ss_pred             CCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcccc
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      .   .+-.++||+.|.|||++.++..+.++|.||||+++|||++|.+||...+.-.......          .-+|    
T Consensus       574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL----------kGid----  636 (732)
T KOG0614|consen  574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL----------KGID----  636 (732)
T ss_pred             C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH----------hhhh----
Confidence            3   3455899999999999999999999999999999999999999998765433221111          1111    


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHHH
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVSM  752 (807)
Q Consensus       717 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~ev~~~  752 (807)
                      .-.++........+++++.+..+|.+|.-     +.||.++
T Consensus       637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  637 KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            11255666778889999999999999976     6666544

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1e-28  Score=248.28  Aligned_cols=245  Identities=25%  Similarity=0.371  Sum_probs=197.7

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ++|.+.++||+|+|..|..++++ ..+.+|+|++++.   ..++++=...|..+..+- +||.+|.+..++..+...++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57888999999999999999976 4678999999864   333445566777777766 799999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      .||+++|+|.-++.   +...++++.+.-+..+|+.||.|||+.+   |+.||||..|+|||..|.+||+|+|+++.-..
T Consensus       330 ieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence            99999999977763   4567899999999999999999999999   99999999999999999999999999985332


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccC---CcchhhhhhhhhccccccccccC
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE---DDLTILGYAWKLWNENKILALVD  712 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~---~~~~l~~~~~~~~~~~~~~~~~d  712 (807)
                        ....+..++||+.|.|||.+.+..|....|.|++||+++||+.|+.||+...   .+.+-..+.....        ++
T Consensus       404 --~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--------le  473 (593)
T KOG0695|consen  404 --PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--------LE  473 (593)
T ss_pred             --CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------hh
Confidence              2334556899999999999999999999999999999999999999997533   2222222222222        12


Q ss_pred             ccccCCcccHHHHHHHHHHHHhcccCCcCCCC
Q 003628          713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRP  744 (807)
Q Consensus       713 ~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RP  744 (807)
                      ..+.   .+.....+...+.+.-+..||.+|.
T Consensus       474 kqir---iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  474 KQIR---IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hccc---ccceeehhhHHHHHHhhcCCcHHhc
Confidence            2221   3333455667888889999999985

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-29  Score=238.09  Aligned_cols=205  Identities=26%  Similarity=0.344  Sum_probs=169.4

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCCeEEEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ..+...-...||+|++|.|-+-++. +|+..|+|+++.. ..+..++.+.|+.+..+. ..|.+|.++|........++.
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            3344555678999999999888764 7999999999765 445667888999987665 799999999999999999999


Q ss_pred             EEecCCCCccccccCC-CCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          556 YEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      ||.|. .||+.+-.+. .++..+++..+-+|+..+.+||.|||++-  .++|||+||+|||++.+|++|+||||++-.+.
T Consensus       124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            99994 5887765432 24567889999999999999999999874  69999999999999999999999999998764


Q ss_pred             CCCCccccceeeccCCccChhhhcc----CCCCcccceeehhHHHHHHHhCCCCCCccC
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAME----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFE  689 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~----~~~t~k~DvwSlGvvl~elltG~~p~~~~~  689 (807)
                      ..-..   +.-.|-..|||||.+..    ..|+.|+||||||+++.||.+++.|++...
T Consensus       201 dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  201 DSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             hhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            33221   22357889999998853    368999999999999999999999987544

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.95  E-value=2.4e-29  Score=227.55  Aligned_cols=111  Identities=46%  Similarity=0.768  Sum_probs=82.2

Q ss_pred             CceEEEEecCCCCCCCC--cceEEEecCCcEEEEcCCCcEEEee-ccccccccceEEEEecCCCEEEEeccccceEeccc
Q 003628           69 EKAVIWVANRDNPLKDS--SGIITISEDGNLVLVNGQKEVLWSS-NVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF  145 (807)
Q Consensus        69 ~~~~vW~anr~~p~~~~--~~~l~~~~~g~l~l~~~~~~~~ws~-~~~~~~~~~~~~~l~~~GNlvl~~~~~~~~~WqSF  145 (807)
                      ++|+||+|||+.|+..+  ..+|.|+.||+|+|++.+++++|++ ++.+....+..|+|+|+|||||++. .++++||||
T Consensus         1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-~~~~lW~Sf   79 (114)
T PF01453_consen    1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-SGNVLWQSF   79 (114)
T ss_dssp             ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-TSEEEEEST
T ss_pred             CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-cceEEEeec
Confidence            36999999999999653  3789999999999999999999999 5554322578999999999999996 788999999


Q ss_pred             cCCccccCCCCcccccccCCCeeEEEEcccCCCCC
Q 003628          146 QEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPS  180 (807)
Q Consensus       146 d~PTDtllpg~~lg~~~~~~~~~~l~S~~s~~dps  180 (807)
                      ||||||+||||+|+.+..++.+..++||++.+|||
T Consensus        80 ~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   80 DYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             TSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             CCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            99999999999999988887777899999999997

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=6e-28  Score=260.18  Aligned_cols=203  Identities=25%  Similarity=0.379  Sum_probs=172.4

Q ss_pred             cCCcccCccccCCCccEEEEEecC-CcEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      .-|..++.||-|+||.|.++.-.| ...+|+|.+++..   .+.....+.|-.||+.-..+-||+|+..|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            447778899999999999997544 5678999998753   334566788999999999999999999999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~  636 (807)
                      +|++||++-.+|.   +.+.+.+..+.-++.++..|+++.|..|   +|||||||.|||||.+|++||+||||+.-+.-.
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999984   4567777777788899999999999998   999999999999999999999999999865210


Q ss_pred             CC--------c--------------------------------cccceeeccCCccChhhhccCCCCcccceeehhHHHH
Q 003628          637 QD--------Q--------------------------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL  676 (807)
Q Consensus       637 ~~--------~--------------------------------~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~  676 (807)
                      .+        .                                ......+||+.|+|||++....++..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence            00        0                                0011247999999999999999999999999999999


Q ss_pred             HHHhCCCCCCccC
Q 003628          677 EIVSGRKNTSFFE  689 (807)
Q Consensus       677 elltG~~p~~~~~  689 (807)
                      ||+.|+.||....
T Consensus       863 em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  863 EMLVGQPPFLADT  875 (1034)
T ss_pred             HHhhCCCCccCCC
Confidence            9999999997543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=7.9e-27  Score=235.51  Aligned_cols=211  Identities=37%  Similarity=0.605  Sum_probs=183.6

Q ss_pred             cccCCCccEEEEEecC-CcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCccc
Q 003628          489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDA  566 (807)
Q Consensus       489 LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  566 (807)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999865 899999999755332 35789999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC-CCCceeeccccccccCCCCCcccccee
Q 003628          567 LLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGGNQDQADTGRV  645 (807)
Q Consensus       567 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~~  645 (807)
                      ++...  ...+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKEN--EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            98542  146889999999999999999999998   999999999999999 89999999999987644321  12224


Q ss_pred             eccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHH
Q 003628          646 VGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  724 (807)
Q Consensus       646 ~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  724 (807)
                      .+...|++||.+... ..+.+.|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999887 788999999999999998                                              


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          725 IIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       725 ~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                       ..+.+++..|++.+|++||++.++++.+
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence             4577899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8e-29  Score=243.02  Aligned_cols=261  Identities=22%  Similarity=0.290  Sum_probs=192.5

Q ss_pred             cccCccccCCCccEEEEEec-CCcEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeEEeeEEEeC-----CeEEEE
Q 003628          484 QLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----EEKMLI  555 (807)
Q Consensus       484 ~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV  555 (807)
                      +-.+.||.|+||.||...++ +|+.||+|++...-  -...+.+.+|+++|..++|.|++..++.....     .+.|+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34689999999999999875 79999999985432  22357899999999999999999998876543     245788


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      .|.|. .+|..+|..   .+.++...+.-++.||++||.|||+.+   |.||||||.|.|+++|..+||+|||++|....
T Consensus       136 TELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            89885 478888753   457888899999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCccccceeeccCCccChhhhccCC-CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc-----------
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN-----------  703 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~-~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~-----------  703 (807)
                      ++....+. .+-|..|.|||.+++.+ |+.+.||||.||++.||+..+--|.....-+.+ .+...++.           
T Consensus       209 d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  209 RDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-QMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-HHHHHHhCCCcHHHHHHHh
Confidence            54444333 35588999999999875 899999999999999999887766543322111 11111111           


Q ss_pred             ccccccccCccccCC--------cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          704 ENKILALVDPFLSES--------SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       704 ~~~~~~~~d~~l~~~--------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      +|....++.......        ..+...-.+...+...++..+|.+|-+.++.+..+
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            110001111111100        01112234556777888999999999999988766

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=1.8e-27  Score=228.53  Aligned_cols=256  Identities=19%  Similarity=0.320  Sum_probs=195.6

Q ss_pred             hcCCcccCccccCCCccEEEEEe-cCCcEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCC--eEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGE--EKMLI  555 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lV  555 (807)
                      .++|++.+++|+|.|+.||.|.. .+.+.++||+++..   ..+.+.+|+.+|..|. ||||+++++...+..  ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46899999999999999999984 56789999999643   3477889999999997 999999999988754  45799


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC-CCceeeccccccccC
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFG  634 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kL~DFGla~~~~  634 (807)
                      +||+.+.+...+.      +.++..++...+.++++||.|.|+.|   |.|||+||.|+++|.. ..++|+|+|+|.+..
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998876554      35777788889999999999999999   9999999999999865 559999999999886


Q ss_pred             CCCCccccceeeccCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCc-chhhhhhhhhccccc------
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD-LTILGYAWKLWNENK------  706 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~-~~l~~~~~~~~~~~~------  706 (807)
                      ......   ..+.+..|--||.+..- .|+..-|+|||||+|..|+..+.||-...++ +.++..+. .+.-..      
T Consensus       185 p~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak-VLGt~el~~Yl~  260 (338)
T KOG0668|consen  185 PGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK-VLGTDELYAYLN  260 (338)
T ss_pred             CCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH-HhChHHHHHHHH
Confidence            554432   24567889999998765 4788999999999999999999998765543 33333332 111110      


Q ss_pred             -cccccCccccC--------C------cccHH-HHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          707 -ILALVDPFLSE--------S------SFQLD-MIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 -~~~~~d~~l~~--------~------~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                       ..-.+||....        .      +.... ...+.++++...|..|-.+|||+.|...
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             00012222211        0      00011 1367889999999999999999998653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=260.85  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=206.4

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      .++|.....+|+|.||.|||++.. .+...|||.++-.......-..+|+-+++..+|+|||.++|.+...+...+.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            367888999999999999999976 5888999999877777788889999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~  638 (807)
                      +.+|+|++.-+   -.+.+++.++....++..+||+|||+.+   -+|||||-.||++++.+.+|++|||.+..+...- 
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-  166 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-  166 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence            99999999874   3568899999999999999999999998   7999999999999999999999999987654322 


Q ss_pred             ccccceeeccCCccChhhhc---cCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          639 QADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~---~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                       .....+.||+.|||||+..   .+.|..++|||+.|+...|+-.-++|.......+.+.-+-.....        .|.+
T Consensus       167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~q--------pp~l  237 (829)
T KOG0576|consen  167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQ--------PPTL  237 (829)
T ss_pred             -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCC--------CCcc
Confidence             2233478999999999874   556899999999999999998888775433333332222111111        1222


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .   ........+.++++.|+..+|++||+++.+++
T Consensus       238 k---Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 K---DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             c---CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            2   22344567889999999999999999987654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-27  Score=253.97  Aligned_cols=196  Identities=26%  Similarity=0.390  Sum_probs=166.6

Q ss_pred             cCCcccCccccCCCccEEEEEecC-CcEEEEEEecccC--------cccHHHHHHHHHHHHhcc---CCceeEEeeEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS--------GQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVE  548 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~  548 (807)
                      .+|...+.||+|+||.|+.+.++. ...|+||.+.+..        ....-..-.|+.||..++   |+||+|++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            458889999999999999999874 5679999887642        111122446999999997   9999999999999


Q ss_pred             CCeEEEEEEecC-CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecc
Q 003628          549 GEEKMLIYEYMP-NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  627 (807)
Q Consensus       549 ~~~~~lV~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DF  627 (807)
                      ++.+||+||-.. +-+|-++|.   .++++++.+..-|++||+.|+++||+++   |||||||-+|++|+.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            999999999764 556777773   4578999999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCCccccceeeccCCccChhhhccCCCCc-ccceeehhHHHHHHHhCCCCCC
Q 003628          628 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE-KSDVFSFGVLLLEIVSGRKNTS  686 (807)
Q Consensus       628 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~-k~DvwSlGvvl~elltG~~p~~  686 (807)
                      |.+......    ....++||..|.|||++.+.+|-- .-|||++|++||.++....|+.
T Consensus       715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999865433    234589999999999999988754 5899999999999998888864

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.94  E-value=6.5e-26  Score=207.08  Aligned_cols=115  Identities=43%  Similarity=0.734  Sum_probs=103.4

Q ss_pred             cccCCCCeEEeCCCeeEEEEecCCCCCceEEEEEeecCCCceEEEEecCCCCCCCCcceEEEecCCcEEEEcCCCcEEEe
Q 003628           30 QLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWS  109 (807)
Q Consensus        30 ~~l~~~~~l~s~~g~f~~gF~~~~~~~~~ylgiw~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws  109 (807)
                      ++|.+|++|+|++|.|++|||.+......+.+|||.+.+ +++||.||++.|. ...+.|.|+.||+|+|+|.++.++|+
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~   79 (116)
T cd00028           2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWS   79 (116)
T ss_pred             cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEE
Confidence            578899999999999999999997665479999999887 8999999999984 55688999999999999999999999


Q ss_pred             eccccccccceEEEEecCCCEEEEeccccceEeccccCC
Q 003628          110 SNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEP  148 (807)
Q Consensus       110 ~~~~~~~~~~~~~~l~~~GNlvl~~~~~~~~~WqSFd~P  148 (807)
                      +++.+ .....+|+|+|+|||||++. ++++||||||||
T Consensus        80 S~~~~-~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~P  116 (116)
T cd00028          80 SNTTR-VNGNYVLVLLDDGNLVLYDS-DGNFLWQSFDYP  116 (116)
T ss_pred             ecccC-CCCceEEEEeCCCCEEEECC-CCCEEEcCCCCC
Confidence            99876 35677899999999999997 578999999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.2e-25  Score=230.57  Aligned_cols=199  Identities=35%  Similarity=0.505  Sum_probs=172.6

Q ss_pred             CcccCccccCCCccEEEEEecC-CcEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecC
Q 003628          483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      |.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999875 889999999766544 67889999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +++|.+++....  ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++.++.++|+|||.+......... 
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            999999985421  11788999999999999999999997   999999999999999999999999999877543211 


Q ss_pred             ccceeeccCCccChhhh-ccCCCCcccceeehhHHHHHHHhCCCCCCc
Q 003628          641 DTGRVVGTFGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIVSGRKNTSF  687 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~-~~~~~t~k~DvwSlGvvl~elltG~~p~~~  687 (807)
                      ......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22235678899999998 666788899999999999999999999854

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-26  Score=232.95  Aligned_cols=262  Identities=21%  Similarity=0.222  Sum_probs=191.7

Q ss_pred             HhcCCcccCccccCCCccEEEEEec-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCC-----
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----  550 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  550 (807)
                      ...+|...+.+|.|.- .|..+.+. .+++||+|++...  .....++-.+|+..+..++|+||++++.++.-..     
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3456777888998888 55555443 5899999998653  3345677889999999999999999999987543     


Q ss_pred             -eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccc
Q 003628          551 -EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  629 (807)
Q Consensus       551 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGl  629 (807)
                       +.|+|||+|. .+|.+.+.     -.++-..+..|..|++.|++|||+.+   |+||||||+||++..+..+||.|||+
T Consensus        94 ~e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   94 QEVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HhHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence             5689999995 48888774     34666778899999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcc-----------------
Q 003628          630 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-----------------  692 (807)
Q Consensus       630 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~-----------------  692 (807)
                      |+.-...   ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|...+.-+                 
T Consensus       165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            9854322   23344678999999999999889999999999999999999987665332100                 


Q ss_pred             -hhhhhhhhhcccc------ccccc-cCccccCC-cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          693 -TILGYAWKLWNEN------KILAL-VDPFLSES-SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       693 -~l~~~~~~~~~~~------~~~~~-~d~~l~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                       .+...++.+....      ...+. .|...... ..+.-....+.+++.+||..+|++|-+++++++.=
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence             0111111111100      00010 11111100 01111234566889999999999999999998764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6e-26  Score=223.24  Aligned_cols=252  Identities=19%  Similarity=0.369  Sum_probs=187.3

Q ss_pred             hcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeE-EEeCCeEEEEE
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGC-CVEGEEKMLIY  556 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~  556 (807)
                      .+.|.+.+.||+|.||.+.+++++ ..+.+++|.+.+. ....++|.+|...--.| .|.||+.-++. |...+.+.+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            356888899999999999999987 4678999988654 34568899998876666 69999988765 55667778999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeee-c-CCCCceeeccccccccC
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL-D-EELNPKISDFGMAKIFG  634 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll-~-~~~~~kL~DFGla~~~~  634 (807)
                      ||++.|+|.+-+    ....+.+.-..+++.|++.||.|||+++   +||||||.+|||| + +..++||||||+.+..+
T Consensus       102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999998887    3456778888999999999999999998   9999999999999 3 34579999999998654


Q ss_pred             CCCCccccceeeccCCccChhhhccC-----CCCcccceeehhHHHHHHHhCCCCCCccC-Ccchhhhhhhhhccccccc
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEG-----RFSEKSDVFSFGVLLLEIVSGRKNTSFFE-DDLTILGYAWKLWNENKIL  708 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~k~DvwSlGvvl~elltG~~p~~~~~-~~~~l~~~~~~~~~~~~~~  708 (807)
                      ..-..     ..-+..|.+||.....     ...+.+|+|.||++++.++||+.|+.... .+...  |-+..|..+...
T Consensus       175 ~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~~~~w~~rk~~  247 (378)
T KOG1345|consen  175 TTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WEWEQWLKRKNP  247 (378)
T ss_pred             ceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HHHHHHhcccCc
Confidence            32221     2346689999987533     25678999999999999999999997322 22222  223334333332


Q ss_pred             cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      .+.+..      . ....++.++.++-+..+|++|--..++.++-
T Consensus       248 ~~P~~F------~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  248 ALPKKF------N-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             cCchhh------c-ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            221111      1 1345677888899999999995555554443

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=3.4e-26  Score=242.30  Aligned_cols=266  Identities=19%  Similarity=0.224  Sum_probs=204.2

Q ss_pred             HHHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhcc------CCceeEEeeEEEeC
Q 003628          477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ------HRNLVRLLGCCVEG  549 (807)
Q Consensus       477 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~  549 (807)
                      +..-.+|.+....|+|-|++|.+|... .|+.||||+++.. +.-.+.=+.|+++|.+|+      --|.++++..|.+.
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            344567888889999999999999875 4889999999653 233455578999999995      35899999999999


Q ss_pred             CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC-Cceeeccc
Q 003628          550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFG  628 (807)
Q Consensus       550 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kL~DFG  628 (807)
                      .+++||+|-+ .-+|.++|......-.|....+..++.|+.-||..|...+   |+|.||||.||||++.. .+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence            9999999988 4589999987766777888999999999999999999888   99999999999998765 58999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhh-------hh
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW-------KL  701 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~-------~~  701 (807)
                      .|.....+....    ..-+.-|.|||++.+.+|+...|+||.||+||||.||+..|....+++.+.-+..       ++
T Consensus       583 SA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  583 SASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             cccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence            998765443222    1224579999999999999999999999999999999988776554433221110       01


Q ss_pred             cccc---------------------------ccccccCc------cccC----CcccHHHHHHHHHHHHhcccCCcCCCC
Q 003628          702 WNEN---------------------------KILALVDP------FLSE----SSFQLDMIIRCIHVGLLCVQELVKDRP  744 (807)
Q Consensus       702 ~~~~---------------------------~~~~~~d~------~l~~----~~~~~~~~~~l~~li~~Cl~~dP~~RP  744 (807)
                      ++.+                           .++..+.|      .+.+    +.........+.+|...|+..||++|-
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence            1111                           11111222      1111    113344567889999999999999999


Q ss_pred             CHHHHHH
Q 003628          745 NMSTVVS  751 (807)
Q Consensus       745 t~~ev~~  751 (807)
                      |..+.+.
T Consensus       739 t~nqAL~  745 (752)
T KOG0670|consen  739 TVNQALK  745 (752)
T ss_pred             CHHHHhc
Confidence            9988764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=4.1e-25  Score=231.08  Aligned_cols=266  Identities=21%  Similarity=0.352  Sum_probs=198.4

Q ss_pred             HHHHhcCCcccCccccCCCccEEEEEec----CCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEEEeCC
Q 003628          476 LATATNNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE  550 (807)
Q Consensus       476 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  550 (807)
                      +....+.|..+++||+|.|++||++.+.    ..+.||+|.+...+.  ..++.+|+++|..+ -|.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4455677899999999999999999754    357899999876533  46789999999999 5999999999999999


Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC-CCCceeecccc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGM  629 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kL~DFGl  629 (807)
                      ...+|+||++.....+++..      ++..++...++.+..||.++|..|   ||||||||.|+|.+. .+.-.|.|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999998888743      667888899999999999999999   999999999999974 46789999999


Q ss_pred             ccccCCCC-------------Cc-----------------------------cccceeeccCCccChhhhcc-CCCCccc
Q 003628          630 AKIFGGNQ-------------DQ-----------------------------ADTGRVVGTFGYMSPEYAME-GRFSEKS  666 (807)
Q Consensus       630 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~APE~~~~-~~~t~k~  666 (807)
                      |......+             ..                             .......||++|.|||++.. ...+++.
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            98321100             00                             00111369999999999865 4579999


Q ss_pred             ceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcc----------ccc--ccc---------------ccC-cc----
Q 003628          667 DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN----------ENK--ILA---------------LVD-PF----  714 (807)
Q Consensus       667 DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~----------~~~--~~~---------------~~d-~~----  714 (807)
                      ||||.|||++-+++++.||-...++............          .++  +.+               .++ ..    
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            9999999999999999998665433222111111100          011  000               010 00    


Q ss_pred             ----ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          715 ----LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       715 ----l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                          ..........+..+.++..+|+..||.+|-|++|.++.
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                01111122234578899999999999999999997754

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=7.2e-25  Score=231.55  Aligned_cols=132  Identities=26%  Similarity=0.415  Sum_probs=111.6

Q ss_pred             cCCcccCccccCCCccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhcc-----C---CceeEEeeEEEe---
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-----H---RNLVRLLGCCVE---  548 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~---  548 (807)
                      .+|.+.++||-|.|++||++.+. ..+.||+|+.+. ...-.+.-+.|+++|++++     |   .+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            57899999999999999999865 578899999854 3344567789999999983     3   369999999974   


Q ss_pred             -CCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeec
Q 003628          549 -GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD  617 (807)
Q Consensus       549 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~  617 (807)
                       +.+.++|+|++ |.+|..+|... .-+.++...+.+|++||+.||.|||.++  .|||-||||+|||+.
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence             56889999999 66887777543 4456889999999999999999999987  699999999999983

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.91  E-value=3.3e-24  Score=195.29  Aligned_cols=113  Identities=42%  Similarity=0.726  Sum_probs=100.7

Q ss_pred             cccCCCCeEEeCCCeeEEEEecCCCCCceEEEEEeecCCCceEEEEecCCCCCCCCcceEEEecCCcEEEEcCCCcEEEe
Q 003628           30 QLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWS  109 (807)
Q Consensus        30 ~~l~~~~~l~s~~g~f~~gF~~~~~~~~~ylgiw~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws  109 (807)
                      +.|..|+.|+|++|.|++|||.+... ..+.+|||++.+ +++||.|||+.|+.. ++.|.++.||+|+|++.++.++|+
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~   78 (114)
T smart00108        2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWS   78 (114)
T ss_pred             cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEE
Confidence            56889999999999999999998754 579999999987 899999999999865 478999999999999999999999


Q ss_pred             eccccccccceEEEEecCCCEEEEeccccceEeccccC
Q 003628          110 SNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE  147 (807)
Q Consensus       110 ~~~~~~~~~~~~~~l~~~GNlvl~~~~~~~~~WqSFd~  147 (807)
                      |++.. ..+..+|+|+|+|||||++. .++++||||||
T Consensus        79 S~t~~-~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~  114 (114)
T smart00108       79 SNTTG-ANGNYVLVLLDDGNLVIYDS-DGNFLWQSFDY  114 (114)
T ss_pred             ecccC-CCCceEEEEeCCCCEEEECC-CCCEEeCCCCC
Confidence            99872 34677899999999999997 56799999997

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.91  E-value=2.1e-24  Score=194.93  Aligned_cols=99  Identities=47%  Similarity=0.957  Sum_probs=90.3

Q ss_pred             EecCCCCCcccccccccceeeeeeeeeeeCC-----------CCceEEEEEcccceEEEEEeecCCCccEEEEEecccCc
Q 003628          206 WRSGPWNGQIFIGIPELKSVYLFRHNFTFGF-----------ANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTEC  274 (807)
Q Consensus       206 w~s~~~~g~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~~G~l~~~~w~~~~~~W~~~~~~~~~~C  274 (807)
                      ||+|+|||..|.++|+|.....+.+.|+.+.           ...++|++||.+|+++++.|++..+.|.+.|.+|.++|
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C   80 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC   80 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence            8999999999999999997777777777554           22389999999999999999999999999999999999


Q ss_pred             CCCcccCCCccccCCCCCcccccCCCCCCC
Q 003628          275 DVYGKCGAFGICNSQEKPICSCLEGFEPKN  304 (807)
Q Consensus       275 d~~g~CG~~g~C~~~~~~~C~C~~Gf~~~~  304 (807)
                      |+|+.||+||+|+.+..|.|+||+||+|++
T Consensus        81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN  110 (110)
T ss_pred             CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence            999999999999988889999999999974

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=6.2e-25  Score=266.86  Aligned_cols=197  Identities=19%  Similarity=0.205  Sum_probs=140.4

Q ss_pred             hccC-CceeEEeeEE-------EeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcE
Q 003628          533 KLQH-RNLVRLLGCC-------VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI  604 (807)
Q Consensus       533 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  604 (807)
                      .++| +||+++++.|       .+....++++||+ +++|.++|..  ....+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4455 5888888877       2334567788988 5699999954  2356999999999999999999999998   9


Q ss_pred             EeCCCCCCCeeecC-------------------CCCceeeccccccccCCCCC--------------ccccceeeccCCc
Q 003628          605 IHRDLKASNILLDE-------------------ELNPKISDFGMAKIFGGNQD--------------QADTGRVVGTFGY  651 (807)
Q Consensus       605 vH~DIkp~NIll~~-------------------~~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y  651 (807)
                      +||||||+||||+.                   ++.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   45567777777764321000              0001123578899


Q ss_pred             cChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHH
Q 003628          652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHV  731 (807)
Q Consensus       652 ~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l  731 (807)
                      ||||++.+..++.++|||||||+||||++|..|+.....  .......         ..+.+..      .....+...+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~---------~~~~~~~------~~~~~~~~~~  244 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRH---------RVLPPQI------LLNWPKEASF  244 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHH---------hhcChhh------hhcCHHHHHH
Confidence            999999999999999999999999999998887542111  1100000         0111111      1112345678


Q ss_pred             HHhcccCCcCCCCCHHHHHHH
Q 003628          732 GLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       732 i~~Cl~~dP~~RPt~~ev~~~  752 (807)
                      +.+||+.+|.+||+|.||++.
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            899999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=1.7e-23  Score=206.85  Aligned_cols=166  Identities=20%  Similarity=0.145  Sum_probs=125.6

Q ss_pred             CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccc
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  641 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  641 (807)
                      |+|.+++..  ....+++.++..|+.||++||.|||+.+         ||+||+++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            688888853  2456999999999999999999999875         999999999999999  99998654321    


Q ss_pred             cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcch-hhhhhhhhccccccccccCccccCCcc
Q 003628          642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT-ILGYAWKLWNENKILALVDPFLSESSF  720 (807)
Q Consensus       642 ~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~~  720 (807)
                         ..||+.|||||++.+..++.++|||||||++|||++|+.|+........ +........      . .++..  ...
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------~-~~~~~--~~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP------A-DDPRD--RSN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc------c-CCccc--ccc
Confidence               2578999999999999999999999999999999999999864332111 111110000      0 00000  001


Q ss_pred             cHHHHH--HHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          721 QLDMII--RCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       721 ~~~~~~--~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      ......  ++.+++.+|++.+|++||++.|+++.+...
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            222233  689999999999999999999999988654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.1e-22  Score=220.67  Aligned_cols=168  Identities=19%  Similarity=0.223  Sum_probs=131.9

Q ss_pred             HHHHhcCCcccCccccCCCccEEEEEec--CCcEEEEEEeccc-----CcccHHHHHHHHHHHHhccCCceeE-EeeEEE
Q 003628          476 LATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKA-----SGQGLEEFMNEVMVISKLQHRNLVR-LLGCCV  547 (807)
Q Consensus       476 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~  547 (807)
                      .....++|.+.+.||+|+||+||+|+..  +++.+|||++...     .....+.|.+|+++|++++|+|+++ ++.   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            3456688999999999999999999875  4777899987533     1223467999999999999999985 443   


Q ss_pred             eCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCC-CCCCeeecCCCCceeec
Q 003628          548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDL-KASNILLDEELNPKISD  626 (807)
Q Consensus       548 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DI-kp~NIll~~~~~~kL~D  626 (807)
                       ....++||||+++++|....    ...      ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+|
T Consensus        90 -~~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             -cCCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence             24579999999999996321    111      1467899999999999998   999999 99999999999999999


Q ss_pred             cccccccCCCCCccc------cceeeccCCccChhhhccC
Q 003628          627 FGMAKIFGGNQDQAD------TGRVVGTFGYMSPEYAMEG  660 (807)
Q Consensus       627 FGla~~~~~~~~~~~------~~~~~gt~~y~APE~~~~~  660 (807)
                      ||+++.+........      .....+++.|+|||.+...
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999998755432111      1245788999999988644

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=6.7e-22  Score=214.91  Aligned_cols=263  Identities=22%  Similarity=0.263  Sum_probs=198.3

Q ss_pred             CCcccCccccCCCccEEEEEecCC--cEEEEEEecccCcccHHHHHHHHHHHHhccC----CceeEEeeEE-EeCCeEEE
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLKDG--QEIAVKRLSKASGQGLEEFMNEVMVISKLQH----RNLVRLLGCC-VEGEEKML  554 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~~g--~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l  554 (807)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|..++..+.+    +++.++++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  4789998766543333378899999999873    6899999998 47778899


Q ss_pred             EEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC-----CCceeecccc
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-----LNPKISDFGM  629 (807)
Q Consensus       555 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~-----~~~kL~DFGl  629 (807)
                      ||+.+ |.+|.++..... .+.++..+.++|+.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 889999875433 578999999999999999999999999   9999999999999765     4599999999


Q ss_pred             cc--ccCCCCC----cc-c-cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhh
Q 003628          630 AK--IFGGNQD----QA-D-TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL  701 (807)
Q Consensus       630 a~--~~~~~~~----~~-~-~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~  701 (807)
                      ++  .+.....    .. . .....||..|++++.+.+...+.+.|+||++.++.|++.|..|+................
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            99  3322211    11 1 223569999999999999999999999999999999999999986544322211111100


Q ss_pred             ccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCC
Q 003628          702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  760 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~  760 (807)
                           ....... .     ....+.++.++...+-..+..++|....+...|.......
T Consensus       254 -----~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  254 -----RKLLTDR-F-----GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -----hhhcccc-c-----cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence                 0001110 1     1112344555555555689999999999999987765444

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.6e-22  Score=197.43  Aligned_cols=248  Identities=23%  Similarity=0.324  Sum_probs=187.0

Q ss_pred             ccCccccCCCccEEEEEecCCcEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       485 ~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      +..+|.+...|..|+|+++ |..+++|++.-.  .....++|..|.-.|+-+.||||+.++|.|....+..+|..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3457888999999999998 445666776432  3334578999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcccc
Q 003628          563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT  642 (807)
Q Consensus       563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  642 (807)
                      ||...|++. ..-..+..++.+++.+||+|++|||+.. +-|.---|.++.+++|++.+++|.= +-+++.     ....
T Consensus       273 slynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfs-----fqe~  344 (448)
T KOG0195|consen  273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFS-----FQEV  344 (448)
T ss_pred             HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceee-----eecc
Confidence            999999764 4456788899999999999999999986 2344446899999999999988742 111110     0001


Q ss_pred             ceeeccCCccChhhhccCCCC---cccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCc
Q 003628          643 GRVVGTFGYMSPEYAMEGRFS---EKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       643 ~~~~gt~~y~APE~~~~~~~t---~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       ...-.+.||+||.+..++-+   .++|+|||+++||||.|...||.....-..-...+         .+-+...     
T Consensus       345 -gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia---------leglrv~-----  409 (448)
T KOG0195|consen  345 -GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA---------LEGLRVH-----  409 (448)
T ss_pred             -ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---------hcccccc-----
Confidence             12336889999999877643   36899999999999999999997543211111000         1111222     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       720 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~  756 (807)
                      .++.....+.+++.-|+..||.+||.+..|+-.|++.
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            3444566788999999999999999999999999875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=3.8e-20  Score=199.59  Aligned_cols=259  Identities=30%  Similarity=0.404  Sum_probs=197.8

Q ss_pred             CcccCccccCCCccEEEEEecCCcEEEEEEecccCcc---cHHHHHHHHHHHHhccCC-ceeEEeeEEEeCCeEEEEEEe
Q 003628          483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ---GLEEFMNEVMVISKLQHR-NLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~  558 (807)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567789999999999999987  78999999765433   367899999999999988 799999999777778999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC-CceeeccccccccCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kL~DFGla~~~~~~~  637 (807)
                      +.++++.+++........+.......++.|++.++.|+|..+   ++||||||+||+++... .++++|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643211136888899999999999999999998   99999999999999998 79999999998665443


Q ss_pred             Ccc----ccceeeccCCccChhhhcc---CCCCcccceeehhHHHHHHHhCCCCCCccCC---cchhhhhhhhhcccccc
Q 003628          638 DQA----DTGRVVGTFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFED---DLTILGYAWKLWNENKI  707 (807)
Q Consensus       638 ~~~----~~~~~~gt~~y~APE~~~~---~~~t~k~DvwSlGvvl~elltG~~p~~~~~~---~~~l~~~~~~~~~~~~~  707 (807)
                      ...    ......|+..|+|||.+..   ..++...|+||+|++++++++|..|+.....   ..............   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            221    2345789999999999987   5788899999999999999999999654432   11111111111100   


Q ss_pred             ccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003628          708 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       708 ~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~  752 (807)
                        ......... ........+.+++..++..+|..|.++.+....
T Consensus       234 --~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 --SLASPLSPS-NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --ccccccCcc-ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              000000000 001223567788999999999999999887653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=3.1e-20  Score=188.10  Aligned_cols=264  Identities=19%  Similarity=0.283  Sum_probs=195.6

Q ss_pred             cCCcccCccccCCCccEEEEE-ecCCcEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEEEEe
Q 003628          481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      -+|++.++||+|.||.++.|+ +-++++||||.-...  ....++..|.+..+.|. .++|...+.|-.++.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            478999999999999999998 447899999975433  33467788999988884 69999999999999999999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCC-----Cceeecccccccc
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-----NPKISDFGMAKIF  633 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~-----~~kL~DFGla~~~  633 (807)
                      + |-||+++..  .-..+++.+++.-||.|++.-++|+|++.   +|.|||||+|+||...+     .+.|+|||+|+.+
T Consensus       106 L-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 889988763  24668999999999999999999999998   99999999999996543     4899999999988


Q ss_pred             CCCCCc-----cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccc
Q 003628          634 GGNQDQ-----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  708 (807)
Q Consensus       634 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~  708 (807)
                      ......     .......||..||+-....+...+.+.|+=|+|-|++..+.|..||.....+-.-..  ++...+.+..
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k--YeKIGe~Kr~  257 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK--YEKIGETKRS  257 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH--HHHhcccccc
Confidence            654322     233446799999999999999999999999999999999999999976543221111  1111111111


Q ss_pred             cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCC
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  760 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~  760 (807)
                      --++ .     .....+.++..-+.-.-..+-.+-|..+-+.+.+..+++.+
T Consensus       258 T~i~-~-----Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  258 TPIE-V-----LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             CCHH-H-----HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            1111 1     11122334444443333456667788776666665554433

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=1.1e-20  Score=183.32  Aligned_cols=272  Identities=19%  Similarity=0.280  Sum_probs=203.1

Q ss_pred             HhcCCcccCccccCCCccEEEEE-ecCCcEEEEEEecccCcccHHHHHHHHHHHHhccC-CceeEEeeEEEeCCeEEEEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~  556 (807)
                      ...+|.++++||.|+||.+|.|. ..+|.+||||.-+...  ...++..|..+.+.|+| ..|+.+..+..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            34689999999999999999997 4679999999865433  33567889999999975 78888899999999999999


Q ss_pred             EecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC---CCceeecccccccc
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIF  633 (807)
Q Consensus       557 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~---~~~kL~DFGla~~~  633 (807)
                      +.+ |-||++++.-  -...++..+++-++.|++.-++|+|.++   ++||||||+|+|..-+   ..+.++|||+++.+
T Consensus        91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            998 8899888743  3457888999999999999999999999   9999999999999654   45899999999987


Q ss_pred             CCCCCc-----cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccc
Q 003628          634 GGNQDQ-----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  708 (807)
Q Consensus       634 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~  708 (807)
                      ......     .......||..|.+-....+...+.+.|+=|+|.+|..+..|..||..........  .++...+.+..
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q--KyEkI~EkK~s  242 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ--KYEKISEKKMS  242 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH--HHHHHHHhhcC
Confidence            543321     22334679999999998888889999999999999999999999997544221111  11111111111


Q ss_pred             cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccCCCCCCCCC
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP  766 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~~p~~p  766 (807)
                      -.+ ..     .....+.++.-.+.-|-..--++-|...-+-++..-+.+.+.....=
T Consensus       243 ~~i-e~-----LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~  294 (341)
T KOG1163|consen  243 TPI-EV-----LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDY  294 (341)
T ss_pred             CCH-HH-----HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCe
Confidence            111 11     12223456666777777777788888777666665555555444333

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=2.4e-21  Score=223.76  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=188.4

Q ss_pred             ccCccccCCCccEEEEEec-CCcEEEEEEecc---cCcc---cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          485 LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQ---GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       485 ~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~---~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ..+.+|.|++|.|+..... .....+.|..+.   ....   ....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4578999999988877643 233344443321   1111   11225667778888899999888888777777777799


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      |+++ +|..++..   ...+...++..++.|+..|+.|||..+   |.|||+|++|+++..++.+||+|||.+..+....
T Consensus       402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 99888843   247888899999999999999999999   9999999999999999999999999999876554


Q ss_pred             Cc--cccceeeccCCccChhhhccCCCCcc-cceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCcc
Q 003628          638 DQ--ADTGRVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       638 ~~--~~~~~~~gt~~y~APE~~~~~~~t~k-~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      +.  ......+|...|+|||++....|.+. .||||.|+++..|++|+.||......++..... ...  .+.    ...
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-~~~--~~~----~~~  547 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-NYS--DQR----NIF  547 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-ccc--ccc----ccc
Confidence            44  44555789999999999999999875 799999999999999999987644322211000 000  000    000


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      ..........+.+...++.++|+.+|.+|-|+++|++
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0011133455678889999999999999999999975

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=4.2e-20  Score=186.54  Aligned_cols=171  Identities=13%  Similarity=0.172  Sum_probs=134.3

Q ss_pred             HhcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHH---H------HHHHHHHHHhccCCceeEEeeEEEeC
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE---E------FMNEVMVISKLQHRNLVRLLGCCVEG  549 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~---~------~~~E~~~l~~l~H~niv~l~g~~~~~  549 (807)
                      ..++|+..+.||.|+||.||.... ++..+|||.++........   .      +.+|+..+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            457899999999999999999765 5778999999754333222   2      67999999999999999999886643


Q ss_pred             --------CeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCC
Q 003628          550 --------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN  621 (807)
Q Consensus       550 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~  621 (807)
                              ...+|||||++|.+|.++..       ++.    ....+++.+|..+|+.+   ++||||||+||+++.++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999977631       222    35669999999999998   99999999999999988 


Q ss_pred             ceeeccccccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHH
Q 003628          622 PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV  679 (807)
Q Consensus       622 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ell  679 (807)
                      ++|+|||..+........              ..+.....+..++|+||||+++.-+.
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988754211110              11344455677999999999987665

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=7.4e-20  Score=182.61  Aligned_cols=139  Identities=17%  Similarity=0.176  Sum_probs=108.8

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccCcc--c-------HHHH-----------------HHHHHHHHhccCCce
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--G-------LEEF-----------------MNEVMVISKLQHRNL  539 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~--~-------~~~~-----------------~~E~~~l~~l~H~ni  539 (807)
                      ...||+|++|.||+|...+|+.||||+++.....  .       ...|                 ..|++++.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999999754211  1       1122                 349999999988776


Q ss_pred             eEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhh-hhcCCCcEEeCCCCCCCeeecC
Q 003628          540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL-HRDSRLRIIHRDLKASNILLDE  618 (807)
Q Consensus       540 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~DIkp~NIll~~  618 (807)
                      .....+..  ...+|||||++++++...+.   +...++..+..+++.|++.+|.|| |+.+   |+||||||+||+++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            44333222  23489999999987765432   235688899999999999999999 6777   99999999999998 


Q ss_pred             CCCceeecccccccc
Q 003628          619 ELNPKISDFGMAKIF  633 (807)
Q Consensus       619 ~~~~kL~DFGla~~~  633 (807)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=2.4e-19  Score=197.76  Aligned_cols=215  Identities=25%  Similarity=0.377  Sum_probs=165.6

Q ss_pred             HHhccCCceeEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCC
Q 003628          531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK  610 (807)
Q Consensus       531 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIk  610 (807)
                      |+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+..  ....+++.....++++|++||+|||...  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3568999999999999999999999999999999999975  4567899999999999999999999875  23999999


Q ss_pred             CCCeeecCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCC-------CCcccceeehhHHHHHHHhCCC
Q 003628          611 ASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-------FSEKSDVFSFGVLLLEIVSGRK  683 (807)
Q Consensus       611 p~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-------~t~k~DvwSlGvvl~elltG~~  683 (807)
                      +.|.+++..+.+||+|||+.................-...|.|||.+....       .+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999998764311111111123456899999987641       4667999999999999999999


Q ss_pred             CCCccCCcc---hhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003628          684 NTSFFEDDL---TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       684 p~~~~~~~~---~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~~~  757 (807)
                      ||.......   .+...+..     .....+.|.+...   .+...++..++..||..+|++||++++|-..++...
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            997643221   22222111     1122233333221   134447899999999999999999999999997763

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.79  E-value=5.4e-19  Score=176.97  Aligned_cols=141  Identities=21%  Similarity=0.247  Sum_probs=111.8

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccCcc---------------------c-----HHHHHHHHHHHHhccCCce
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ---------------------G-----LEEFMNEVMVISKLQHRNL  539 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~ni  539 (807)
                      ...||+|++|.||+|+..+|+.||||+++.....                     .     ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999888999999998754211                     0     1224678999999999987


Q ss_pred             eEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhh-cCCCcEEeCCCCCCCeeecC
Q 003628          540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDE  618 (807)
Q Consensus       540 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DIkp~NIll~~  618 (807)
                      .....+...  ..+|||||++++++.....   ....++..+..+++.+++.++.+||+ .+   |+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  2489999999886543321   23457788899999999999999999 88   99999999999999 


Q ss_pred             CCCceeeccccccccCC
Q 003628          619 ELNPKISDFGMAKIFGG  635 (807)
Q Consensus       619 ~~~~kL~DFGla~~~~~  635 (807)
                      ++.++|+|||+++....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.78  E-value=4.8e-20  Score=211.38  Aligned_cols=251  Identities=19%  Similarity=0.187  Sum_probs=182.3

Q ss_pred             CCcccCccccCCCccEEEEEecCCcEEEEEEecccC-cccHHHHHHHHHHHH--hccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS-GQGLEEFMNEVMVIS--KLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       482 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ++...+.||++.|=.|.+++..+|. |+||++-+.. .-..+.|.++++-++  .++|||.+++...-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5777899999999999999999887 9999987654 334566655554444  45899999998887777888899999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC-
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ-  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~-  637 (807)
                      ..+ +|.+.|   ..++-+...+.+-|+.|++.||...|..+   |+|||||.+||||+.-.-+.|+||...+...-.. 
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            966 777776   35667888888899999999999999999   9999999999999999999999998776542211 


Q ss_pred             Cccccce----eeccCCccChhhhccC----------C-CCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhh
Q 003628          638 DQADTGR----VVGTFGYMSPEYAMEG----------R-FSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  701 (807)
Q Consensus       638 ~~~~~~~----~~gt~~y~APE~~~~~----------~-~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~  701 (807)
                      .......    ...-..|.|||.+...          . .+++.||||+||++.||++ |+++|...    .+..+-.. 
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~-  250 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSG-  250 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhcc-
Confidence            1111111    1233579999988542          2 6788999999999999987 56666421    11111110 


Q ss_pred             ccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                        +....+.+-..+.        ...+.++++.|++.||++|-++++.++.-.+
T Consensus       251 --~~~~~e~~Le~Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  251 --NADDPEQLLEKIE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             --CccCHHHHHHhCc--------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence              0000011111111        1256789999999999999999999987433

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=2.4e-18  Score=169.95  Aligned_cols=184  Identities=21%  Similarity=0.186  Sum_probs=139.7

Q ss_pred             cccCccccCCCccEEEEEecCCcEEEEEEecccCcc----cHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEEEEe
Q 003628          484 QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ----GLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       484 ~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      .+...|++|+||+||.+.. .+.+++.+.+.....-    ....|.+|+++|++++ |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997765 5788888877543221    1235889999999995 5889999886    446899999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCC-CCCCeeecCCCCceeeccccccccCCCC
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDL-KASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DI-kp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      ++|.+|...+.    .      ....++.|++++|.++|+.+   |+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99999865431    1      12357889999999999999   999999 7999999999999999999998654433


Q ss_pred             Cc----cc-------cceeeccCCccChhhhccC-CCC-cccceeehhHHHHHHHhCCCCC
Q 003628          638 DQ----AD-------TGRVVGTFGYMSPEYAMEG-RFS-EKSDVFSFGVLLLEIVSGRKNT  685 (807)
Q Consensus       638 ~~----~~-------~~~~~gt~~y~APE~~~~~-~~t-~k~DvwSlGvvl~elltG~~p~  685 (807)
                      ..    ..       ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            11    00       1112468889999866433 233 4678889999999999998765

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=2e-17  Score=166.65  Aligned_cols=136  Identities=21%  Similarity=0.253  Sum_probs=106.3

Q ss_pred             ccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhc-----cCCceeEEeeEEEeCC---e-EEEE
Q 003628          485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-----QHRNLVRLLGCCVEGE---E-KMLI  555 (807)
Q Consensus       485 ~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV  555 (807)
                      -.+.||+|+||.||.  .++....+||++........+.+.+|+.+++.+     .||||++++|++.++.   . ..+|
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            357899999999996  443333479988765445567899999999999     5799999999998764   3 3378


Q ss_pred             EEe--cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhh-HhhhhcCCCcEEeCCCCCCCeeecC----CCCceeeccc
Q 003628          556 YEY--MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL-LYLHRDSRLRIIHRDLKASNILLDE----ELNPKISDFG  628 (807)
Q Consensus       556 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~DIkp~NIll~~----~~~~kL~DFG  628 (807)
                      +||  +++++|.+++.+    ..+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  668999999943    235444  35677888777 9999998   999999999999974    3479999955


Q ss_pred             ccc
Q 003628          629 MAK  631 (807)
Q Consensus       629 la~  631 (807)
                      .++
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.7e-18  Score=190.57  Aligned_cols=225  Identities=24%  Similarity=0.265  Sum_probs=178.3

Q ss_pred             ccccCCCccEEEEE----ecCCcEEEEEEecccCcc--cHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEEEEecC
Q 003628          488 KLGQGGFGPVYWGR----LKDGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       488 ~LG~G~~g~Vy~~~----~~~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      .+|+|.||.|+..+    ...|..+|+|.+++....  .......|..++..++ ||.++++...+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999764    334777999988764321  1225667888899997 9999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  640 (807)
                      +|.|-..+.   +...+...........++-++.++|+.+   |+|||+|++||+++.+|.+++.|||+++..-....  
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999977774   3455666777778888999999999998   99999999999999999999999999986543222  


Q ss_pred             ccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcc
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  720 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  720 (807)
                          .+||..|||||++.  .....+|.||||++++||+||-.||..    ....             .++...   ...
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~-------------~Il~~~---~~~  206 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMK-------------RILKAE---LEM  206 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHH-------------HHhhhc---cCC
Confidence                28999999999998  567789999999999999999999864    0000             011111   125


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCCH
Q 003628          721 QLDMIIRCIHVGLLCVQELVKDRPNM  746 (807)
Q Consensus       721 ~~~~~~~l~~li~~Cl~~dP~~RPt~  746 (807)
                      +.+......+++..+...+|.+|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            56667778888888889999999755

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.71  E-value=5.2e-18  Score=176.41  Aligned_cols=232  Identities=21%  Similarity=0.256  Sum_probs=150.4

Q ss_pred             CcccCccccCCCccEEEEEecC-CcEEEEEEeccc---CcccHHHHHHHHHHHHhcc----------CCceeEEeeEEE-
Q 003628          483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ----------HRNLVRLLGCCV-  547 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~----------H~niv~l~g~~~-  547 (807)
                      +...+.||.|+++.||.+++.+ ++++|||++...   .....+++++|.-.+..+.          |-.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            4456789999999999999874 899999988533   3345677888876666642          222333333222 


Q ss_pred             --------eC---C-----eEEEEEEecCCCCccccccC----CCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeC
Q 003628          548 --------EG---E-----EKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR  607 (807)
Q Consensus       548 --------~~---~-----~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~  607 (807)
                              ..   .     +.+++|+-+ .++|.+++.-    ......+....++.+..|+++.+++||+.+   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                    11   1     236788888 5588777531    111223445556677799999999999999   9999


Q ss_pred             CCCCCCeeecCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccC--------CCCcccceeehhHHHHHHH
Q 003628          608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG--------RFSEKSDVFSFGVLLLEIV  679 (807)
Q Consensus       608 DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~t~k~DvwSlGvvl~ell  679 (807)
                      ||+|+|++++.+|.++|+||+.....+.....     ...+..|.+||.....        .++.+.|.|++|+++|.|.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999987754332111     2345789999977442        4788999999999999999


Q ss_pred             hCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCC
Q 003628          680 SGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDR  743 (807)
Q Consensus       680 tG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~R  743 (807)
                      +|..|+..........                 ..+..  .. +.++.+..|+..+|+.||++|
T Consensus       245 C~~lPf~~~~~~~~~~-----------------~~f~~--C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPE-----------------WDFSR--CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSG-----------------GGGTT--SS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCcccccc-----------------ccchh--cC-CcCHHHHHHHHHHccCCcccC
Confidence            9999987543221110                 01111  33 678889999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=6.1e-17  Score=190.47  Aligned_cols=196  Identities=21%  Similarity=0.259  Sum_probs=159.1

Q ss_pred             HhcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhcc---CCceeEEeeEEEeCCeEEEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV  555 (807)
                      -...|.+.+.||+|+||+||+|...+|+.||+|+-+....=+   |.--.+++.+|+   -+-|..+...+...+.-+||
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            346788999999999999999999889999999976543221   222223333333   24455556666677888999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeec-------CCCCceeeccc
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-------EELNPKISDFG  628 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~-------~~~~~kL~DFG  628 (807)
                      +||.+.|+|.+++.   ..+.++|.-++.++.|+++-+++||..+   |||+||||+|.||.       ++..++|+|||
T Consensus       773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence            99999999999995   5678999999999999999999999998   99999999999994       23459999999


Q ss_pred             cccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCC
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK  683 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~  683 (807)
                      -+..+.--.........++|-.+--+|...+.+.+...|.|.++-+++-|+.|++
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9887654444444455788999999999999999999999999999999999985

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.9e-16  Score=163.49  Aligned_cols=143  Identities=18%  Similarity=0.199  Sum_probs=112.6

Q ss_pred             cCCcccCccccCCCccEEEEE--ecCCcEEEEEEecccCcc------------------------cHHHHHHHHHHHHhc
Q 003628          481 NNFQLSSKLGQGGFGPVYWGR--LKDGQEIAVKRLSKASGQ------------------------GLEEFMNEVMVISKL  534 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~--~~~g~~vAvK~l~~~~~~------------------------~~~~~~~E~~~l~~l  534 (807)
                      ..|.+.+.||+|++|.||+|.  ..+|+.||||+++.....                        ....+..|+.++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347888999999999999998  568999999998743210                        012356899999999


Q ss_pred             cC--CceeEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCC
Q 003628          535 QH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKAS  612 (807)
Q Consensus       535 ~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~  612 (807)
                      .+  ..+++++++    ...++||||+++.+|.....   ....+...+...++.||+.++++||+.+  .|+||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            75  335555543    23589999999988876642   2234555667899999999999999886  4999999999


Q ss_pred             CeeecCCCCceeecccccccc
Q 003628          613 NILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       613 NIll~~~~~~kL~DFGla~~~  633 (807)
                      ||+++ ++.++|+|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998854

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=1.9e-16  Score=161.36  Aligned_cols=134  Identities=22%  Similarity=0.317  Sum_probs=113.6

Q ss_pred             CccccCCCccEEEEEecCCcEEEEEEecccCcc--------cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +.||+|++|.||+|.. .|..++||+.......        ....+.+|+.++..++|++|+....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6799999999999987 5778999986543211        124578899999999999988877777778888999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      +++++|.+++...      .. ++..++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++|+|||.++.
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988431      11 78899999999999999998   99999999999999 78899999999874

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=2.8e-16  Score=158.47  Aligned_cols=144  Identities=19%  Similarity=0.222  Sum_probs=113.4

Q ss_pred             HHHHHhcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcc----------------------cHHHHHHHHHHHH
Q 003628          475 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ----------------------GLEEFMNEVMVIS  532 (807)
Q Consensus       475 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~----------------------~~~~~~~E~~~l~  532 (807)
                      ++......|.+.+.||+|+||.||++...+|+.||||++......                      ....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            333444447788999999999999999888999999987543200                      1123678899999


Q ss_pred             hccCC--ceeEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCC
Q 003628          533 KLQHR--NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK  610 (807)
Q Consensus       533 ~l~H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIk  610 (807)
                      ++.|+  .+++.++.    ...++||||+++++|.....         ......++.++++++.++|+.+   |+|||||
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence            99887  45555543    44589999999999876542         1345678999999999999988   9999999


Q ss_pred             CCCeeecCCCCceeeccccccccC
Q 003628          611 ASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       611 p~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      |+||++++++.++|+|||++....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCC
Confidence            999999999999999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=5.4e-16  Score=156.51  Aligned_cols=130  Identities=23%  Similarity=0.365  Sum_probs=106.7

Q ss_pred             ccccCCCccEEEEEecCCcEEEEEEecccCcc--------cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEec
Q 003628          488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       488 ~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  559 (807)
                      .||+|++|.||+|.. ++..+++|........        ..+++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 4788999986542211        1356788999999999887665555566677789999999


Q ss_pred             CCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++++|.+.+...   . .      .++.+++.+|.+||+.+   ++|+|++|+||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~---~-~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG---N-D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc---H-H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998887431   1 0      78999999999999998   99999999999999 88999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=4e-16  Score=181.18  Aligned_cols=140  Identities=20%  Similarity=0.292  Sum_probs=114.2

Q ss_pred             HHHhcCCcccCccccCCCccEEEEEecCCcEEEEEE-ecccCc-------ccHHHHHHHHHHHHhccCCceeEEeeEEEe
Q 003628          477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR-LSKASG-------QGLEEFMNEVMVISKLQHRNLVRLLGCCVE  548 (807)
Q Consensus       477 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~-l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  548 (807)
                      ......|...+.||+|+||.||+|.+.+.. +++|+ ..+...       ...+++.+|++++.+++|++++....++.+
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            344455677899999999999999876443 44443 222111       123568899999999999999988888888


Q ss_pred             CCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccc
Q 003628          549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       549 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFG  628 (807)
                      ....++||||+++++|.+++.           ...+++.+++++|.|||+.+   ++||||||+||++ +++.++|+|||
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence            778899999999999998873           35679999999999999998   9999999999999 67899999999


Q ss_pred             cccc
Q 003628          629 MAKI  632 (807)
Q Consensus       629 la~~  632 (807)
                      +++.
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9985

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=4.5e-17  Score=176.18  Aligned_cols=174  Identities=24%  Similarity=0.324  Sum_probs=131.7

Q ss_pred             eEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccc
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       551 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla  630 (807)
                      ..++.|+++.-.+|.++|.........++...+.++.|++.|+.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            467999999999999999876677788899999999999999999   55   999999999999999999999999999


Q ss_pred             cccCCCC----CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHh-CCCCCCccCCcchhhhhhhhhcccc
Q 003628          631 KIFGGNQ----DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNEN  705 (807)
Q Consensus       631 ~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~  705 (807)
                      .......    .........||..||+||.+.+..|+.|+||||||++|+|++. -...++....        ....+.+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t--------~~d~r~g  475 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT--------LTDIRDG  475 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh--------hhhhhcC
Confidence            8765444    2334455789999999999999999999999999999999997 2222221100        0001111


Q ss_pred             ccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHH
Q 003628          706 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMST  748 (807)
Q Consensus       706 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e  748 (807)
                      .    ++|.     +..+.+. =..+..++++.+|.+||++.+
T Consensus       476 ~----ip~~-----~~~d~p~-e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  476 I----IPPE-----FLQDYPE-EYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             C----CChH-----HhhcCcH-HHHHHHHhcCCCcccCchHHH
Confidence            1    1111     1111122 236788999999999994444

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=1.1e-15  Score=158.40  Aligned_cols=197  Identities=20%  Similarity=0.263  Sum_probs=137.4

Q ss_pred             cCCceeEEeeEEEe---------------------------CCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHH
Q 003628          535 QHRNLVRLLGCCVE---------------------------GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE  587 (807)
Q Consensus       535 ~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  587 (807)
                      +|||||++.++|.+                           ....|+||...+. +|.+++.    ....+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~----~~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW----TRHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh----cCCCchHHHHHHHH
Confidence            59999999998764                           2356888887754 8888884    33456667777899


Q ss_pred             HHHhhhHhhhhcCCCcEEeCCCCCCCeeec--CCC--CceeeccccccccCC--CC--CccccceeeccCCccChhhhcc
Q 003628          588 GISRGLLYLHRDSRLRIIHRDLKASNILLD--EEL--NPKISDFGMAKIFGG--NQ--DQADTGRVVGTFGYMSPEYAME  659 (807)
Q Consensus       588 ~ia~gL~yLH~~~~~~ivH~DIkp~NIll~--~~~--~~kL~DFGla~~~~~--~~--~~~~~~~~~gt~~y~APE~~~~  659 (807)
                      |+++|+.|||+++   |.|||+|++||||.  ++.  .+.|+|||.+---..  -+  .........|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   99999999999993  343  378899997653221  11  1111112347778999998864


Q ss_pred             CC------CCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHH
Q 003628          660 GR------FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGL  733 (807)
Q Consensus       660 ~~------~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~  733 (807)
                      .+      --.|+|.|+.|.+.||++....||....+ ..+        ......+.--|.     .+..++..+.+++.
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L--------~~r~Yqe~qLPa-----lp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLL--------DTRTYQESQLPA-----LPSRVPPVARQLVF  491 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-hee--------chhhhhhhhCCC-----CcccCChHHHHHHH
Confidence            33      13489999999999999999999864221 111        111122222222     33345566789999


Q ss_pred             hcccCCcCCCCCHHHHHHHH
Q 003628          734 LCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       734 ~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      ..++.||++||+..-....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999876655554

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=1.5e-14  Score=138.13  Aligned_cols=135  Identities=23%  Similarity=0.238  Sum_probs=115.6

Q ss_pred             ccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccC--CceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       485 ~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.++..++|  .++++++++...++..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999865 7899999865433  5679999999999976  59999999988888899999999988


Q ss_pred             CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      .+..+          +......++.++++++.+||......++|+|++|+||++++.+.++++|||.++.
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          4456678899999999999987545699999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=9.8e-15  Score=145.75  Aligned_cols=137  Identities=21%  Similarity=0.255  Sum_probs=100.5

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccCcc--cHHH----------------------HHHHHHHHHhccCC--ce
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--GLEE----------------------FMNEVMVISKLQHR--NL  539 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~--ni  539 (807)
                      .+.||+|+||.||+|...+++.||||+++.....  ....                      ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4789999999999999888999999998653211  1111                      13566667776544  35


Q ss_pred             eEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhh-cCCCcEEeCCCCCCCeeecC
Q 003628          540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDE  618 (807)
Q Consensus       540 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DIkp~NIll~~  618 (807)
                      .+.+++    ...++||||++++.+......   ..... .+..+++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~---~~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLK---DVRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhh---hhhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            555543    245899999999654322111   00011 5678899999999999999 77   99999999999999 


Q ss_pred             CCCceeeccccccccC
Q 003628          619 ELNPKISDFGMAKIFG  634 (807)
Q Consensus       619 ~~~~kL~DFGla~~~~  634 (807)
                      ++.++|+|||.++...
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.53  E-value=3.4e-15  Score=172.17  Aligned_cols=226  Identities=20%  Similarity=0.208  Sum_probs=147.9

Q ss_pred             HhcCCcccCccccCCCccEEEEEecC-CcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  557 (807)
                      ...+|..++.|..|+||.||..+++. .+++|+|+= +..     .+.+-  ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~-----lilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN-----LILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhccc-ccc-----hhhhc--cccccCCccee-----------------
Confidence            34678889999999999999998874 567888432 211     11110  22222333333                 


Q ss_pred             ecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                          |+-...+.   ..+.++.        +++.+++|||+.+   |+|||+||.|.+|+.-|.+|++|||+.+.-....
T Consensus       136 ----gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                23223332   1122222        2377999999998   9999999999999999999999999998642111


Q ss_pred             -------------CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccc
Q 003628          638 -------------DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE  704 (807)
Q Consensus       638 -------------~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~  704 (807)
                                   .+.....++||+.|.|||++...-|....|.|++|+|+||.+-|+.||.....+..+-..+....  
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i--  275 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI--  275 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc--
Confidence                         11123346899999999999999999999999999999999999999876543322222211110  


Q ss_pred             cccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCC-CHHHHHHHHhhccCCC
Q 003628          705 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP-NMSTVVSMLNSEIRDL  760 (807)
Q Consensus       705 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~ev~~~L~~~~~~~  760 (807)
                          +..     +  .......+..+++.+.|+.+|..|- |..+..-+-++.+..+
T Consensus       276 ----~wp-----E--~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  276 ----EWP-----E--EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             ----ccc-----c--cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence                011     1  1223445678889999999999994 3333333333444443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=4.5e-14  Score=146.19  Aligned_cols=134  Identities=22%  Similarity=0.321  Sum_probs=105.4

Q ss_pred             Cccc-cCCCccEEEEEecCCcEEEEEEecccC-------------cccHHHHHHHHHHHHhccCCce--eEEeeEEEeCC
Q 003628          487 SKLG-QGGFGPVYWGRLKDGQEIAVKRLSKAS-------------GQGLEEFMNEVMVISKLQHRNL--VRLLGCCVEGE  550 (807)
Q Consensus       487 ~~LG-~G~~g~Vy~~~~~~g~~vAvK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~  550 (807)
                      ..|| .||.|+||+.... +..++||++....             ......+.+|++++.+++|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 8999999999876 6789999885321             1223568899999999998874  77787754432


Q ss_pred             e----EEEEEEecCC-CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceee
Q 003628          551 E----KMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS  625 (807)
Q Consensus       551 ~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~  625 (807)
                      .    .++|||++++ .+|.+++..    ..++.    ..+.+|+.+|.+||+.+   |+||||||+|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    2599999997 688888743    23433    34678999999999999   9999999999999999999999


Q ss_pred             ccccccc
Q 003628          626 DFGMAKI  632 (807)
Q Consensus       626 DFGla~~  632 (807)
                      |||.++.
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9999875

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.53  E-value=9.5e-15  Score=118.28  Aligned_cols=59  Identities=49%  Similarity=1.082  Sum_probs=52.3

Q ss_pred             CCCCeeEeccccCCCccccc--CcccHHHHHHHHhccCCeeeEeec---CCeeEEEeeeeeeccc
Q 003628          336 KEDGFSKLNKMKVPDFTEWT--SPATEDECREQCLKNCSCIAYAFD---GGIGCMVWRSINLIDI  395 (807)
Q Consensus       336 ~~~~f~~~~~~~~pd~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~---~g~gC~~w~~~~l~~~  395 (807)
                      ++|+|+++++|++|++....  ...++++|++.|++||||+||+|.   ++++|++|++ +|+|+
T Consensus         3 ~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~-~L~d~   66 (66)
T PF08276_consen    3 SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYG-DLVDL   66 (66)
T ss_pred             CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcC-EeecC
Confidence            57899999999999986655  346999999999999999999998   5789999999 99874

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=3.5e-15  Score=172.79  Aligned_cols=255  Identities=22%  Similarity=0.277  Sum_probs=189.7

Q ss_pred             cCCcccCccccCCCccEEEEEecC--CcEEEEEEecccC--cccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEE
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD--GQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~--g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV  555 (807)
                      ..|.+.+.||+|+|+.|-......  ...+|+|.+....  ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            457778889999999998877643  3456777665443  223344555777777776 99999999999999999999


Q ss_pred             EEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhh-hcCCCcEEeCCCCCCCeeecCCC-Cceeecccccccc
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH-RDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIF  633 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~DIkp~NIll~~~~-~~kL~DFGla~~~  633 (807)
                      .||..++++-+.+... .....+.......+.|+..++.|+| ..+   +.|+||||+|.+++..+ .++++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999998887321 2224555667788999999999999 777   99999999999999999 9999999999988


Q ss_pred             CC-CCCccccceeec-cCCccChhhhccC-CCCcccceeehhHHHHHHHhCCCCCCccCCcch-hhhhhhhhcccccccc
Q 003628          634 GG-NQDQADTGRVVG-TFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT-ILGYAWKLWNENKILA  709 (807)
Q Consensus       634 ~~-~~~~~~~~~~~g-t~~y~APE~~~~~-~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~-l~~~~~~~~~~~~~~~  709 (807)
                      .. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ...|....   +....
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~  252 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRFTQ  252 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---ccccc
Confidence            76 444444555678 9999999998874 456789999999999999999999876543221 11111110   00000


Q ss_pred             ccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003628          710 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       710 ~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~  751 (807)
                      .         ..........++...++..+|..|.+.+++..
T Consensus       253 ~---------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  253 L---------PWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             C---------ccccCChhhhhcccccccCCchhccccccccc
Confidence            0         11122344567778888899999999888653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.44  E-value=5.2e-13  Score=150.12  Aligned_cols=141  Identities=24%  Similarity=0.291  Sum_probs=102.3

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccCcccH----------------------------------------HHHH
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL----------------------------------------EEFM  525 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~----------------------------------------~~~~  525 (807)
                      .+.||+|++|.||+|++++|+.||||+.+.......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999865321110                                        1255


Q ss_pred             HHHHHHHhcc----CCceeEEeeEE-EeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHh-hhHhhhhc
Q 003628          526 NEVMVISKLQ----HRNLVRLLGCC-VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR-GLLYLHRD  599 (807)
Q Consensus       526 ~E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~  599 (807)
                      +|++.+.+++    |.+-+.+-..+ ...+..+|||||++|++|.++....  ....   .+.+++..+++ .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCC---CHHHHHHHHHHHHHHHHHhC
Confidence            6777666663    32223322222 2345679999999999998876321  1111   34567777776 47888988


Q ss_pred             CCCcEEeCCCCCCCeeecCCCCceeeccccccccC
Q 003628          600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       600 ~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~  634 (807)
                      +   ++|+|+||.||++++++.++++|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   9999999999999999999999999998653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.41  E-value=2.7e-13  Score=113.30  Aligned_cols=68  Identities=25%  Similarity=0.377  Sum_probs=60.9

Q ss_pred             CCCCeeEeccccCCCcccccCcccHHHHHHHHhc---cCCeeeEeec-CCeeEEEeeeeee-ccccccCCCccceEEE
Q 003628          336 KEDGFSKLNKMKVPDFTEWTSPATEDECREQCLK---NCSCIAYAFD-GGIGCMVWRSINL-IDIQRLPFGGTDLYIR  408 (807)
Q Consensus       336 ~~~~f~~~~~~~~pd~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~-~g~gC~~w~~~~l-~~~~~~~~~~~~lylr  408 (807)
                      ..++|+++.+|++|++..    .+++||++.|++   ||||+||+|. .+.||.+|++ +| +|++++..++.++|+|
T Consensus         7 ~~g~fl~~~~~klpd~~~----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~-~l~~d~~~~~~~g~~Ly~r   79 (80)
T cd00129           7 SAGTTLIKIALKIKTTKA----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPF-NSMSGVRKEFSHGFDLYEN   79 (80)
T ss_pred             cCCeEEEeecccCCcccc----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecC-cchhhHHhccCCCceeEeE
Confidence            457799999999999875    589999999999   9999999997 3568999999 99 9999888889999998

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=6.1e-13  Score=135.50  Aligned_cols=204  Identities=21%  Similarity=0.224  Sum_probs=142.6

Q ss_pred             HHHHHhccCCceeEEeeEEEeCC-----eEEEEEEecCCCCccccccCCC-CCCCCChhhhHHHHHHHHhhhHhhhhcCC
Q 003628          528 VMVISKLQHRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSR  601 (807)
Q Consensus       528 ~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  601 (807)
                      ...|-.+.|.|||+++.|..+..     ...++.|||+-|+|..+|.+.. ....+......+++.||..||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            44566678999999999876543     4578999999999999997633 3346778888899999999999999875 


Q ss_pred             CcEEeCCCCCCCeeecCCCCceeecccc--ccccCCCCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHH
Q 003628          602 LRIIHRDLKASNILLDEELNPKISDFGM--AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV  679 (807)
Q Consensus       602 ~~ivH~DIkp~NIll~~~~~~kL~DFGl--a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~ell  679 (807)
                      ++|+|+++..+-|++..++-+||.--.-  ....-............+-++|.|||.=.....+..+|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            8899999999999999999888753111  11100111122233346789999999887777888999999999999998


Q ss_pred             hCCCCCCccCCcchhhhhhhhhccccccc---cccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003628          680 SGRKNTSFFEDDLTILGYAWKLWNENKIL---ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  753 (807)
Q Consensus       680 tG~~p~~~~~~~~~l~~~~~~~~~~~~~~---~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L  753 (807)
                      -+..-.......         ...+..+.   -.+...+.            ...+..|++.+|..||+|++++...
T Consensus       277 ilEiq~tnseS~---------~~~ee~ia~~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  277 ILEIQSTNSESK---------VEVEENIANVIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HheeccCCCcce---------eehhhhhhhheeeccCccc------------cCcCcccccCCCCCCcchhhhhcCc
Confidence            876432111100         00000010   11111111            2467899999999999999987654

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.28  E-value=7.2e-12  Score=107.48  Aligned_cols=73  Identities=44%  Similarity=0.914  Sum_probs=61.1

Q ss_pred             CCCeeEeccccCCCcccccCcccHHHHHHHHhccCCeeeEeecC-CeeEEEeeeeeeccccccCCCccceEEEEc
Q 003628          337 EDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDG-GIGCMVWRSINLIDIQRLPFGGTDLYIRVA  410 (807)
Q Consensus       337 ~~~f~~~~~~~~pd~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~-g~gC~~w~~~~l~~~~~~~~~~~~lylrl~  410 (807)
                      .++|..+.++++|+........++++|++.|++||+|+||+|.+ +++|.+|.+ ++.+.+.....+.++|+|++
T Consensus        11 ~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~-~~~~~~~~~~~~~~~yiKv~   84 (84)
T cd01098          11 TDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNG-LLNNLRSLSSGGGTLYLRLA   84 (84)
T ss_pred             CCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEec-eecceEeecCCCcEEEEEeC
Confidence            36899999999998765444459999999999999999999974 668999998 88887766656688999974

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.26  E-value=2.2e-11  Score=119.38  Aligned_cols=131  Identities=22%  Similarity=0.153  Sum_probs=98.9

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCce-eEEeeEEEeCCeEEEEEEecCCCCc
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEYMPNRSL  564 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL  564 (807)
                      .+.|+.|.++.||+++.. +..+++|....... ....+..|+.++..+.+.++ ++++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            367899999999999876 77899999755432 23456789999999865554 4555543  3345899999999887


Q ss_pred             cccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcC--CCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS--RLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ....           .....++.+++++|+.||..+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430           112346789999999999886  23369999999999999 66899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.22  E-value=1.4e-11  Score=136.63  Aligned_cols=247  Identities=23%  Similarity=0.262  Sum_probs=177.7

Q ss_pred             CCcccCcccc--CCCccEEEEEe--c-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEE
Q 003628          482 NFQLSSKLGQ--GGFGPVYWGRL--K-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKM  553 (807)
Q Consensus       482 ~~~~~~~LG~--G~~g~Vy~~~~--~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  553 (807)
                      .|.+.+.+|+  |.+|.||.+..  . ++..+|+|+-+...  ......=++|+....+++ |+|.++.+..+..++..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556788999  99999999987  3 57889999854332  233344457777777774 999999888888888888


Q ss_pred             EEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHh----hhHhhhhcCCCcEEeCCCCCCCeeecCC-CCceeeccc
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFG  628 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kL~DFG  628 (807)
                      +-.|++. .+|.++.+..  ...++...++.+..+..+    ||.++|...   ++|-|+||.||++..+ ...+++|||
T Consensus       195 iqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            8888885 6887777542  334666677778888888    999999998   9999999999999999 889999999


Q ss_pred             cccccCCCCCccc---cceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhcccc
Q 003628          629 MAKIFGGNQDQAD---TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN  705 (807)
Q Consensus       629 la~~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~  705 (807)
                      +...++.......   ..+..|...|++||.. .+.++.++|+|++|.++.+...+..........      .|...+..
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~~r~~  341 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQLRQG  341 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccccccc
Confidence            9998865542211   1223578899999965 456788999999999999999987654322100      11111111


Q ss_pred             ccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHH
Q 003628          706 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVV  750 (807)
Q Consensus       706 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~  750 (807)
                      .   +.+.      +......++...+.++++.+|..|++.+.+.
T Consensus       342 ~---ip~e------~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  342 Y---IPLE------FCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             c---Cchh------hhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            1   1111      1212233444588899999999999877654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.19  E-value=4.3e-11  Score=136.18  Aligned_cols=146  Identities=21%  Similarity=0.276  Sum_probs=96.1

Q ss_pred             cCCcccCccccCCCccEEEEEecC-CcEEEEEEecccCccc----------------------------------H----
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQG----------------------------------L----  521 (807)
Q Consensus       481 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~~----------------------------------~----  521 (807)
                      ..|.. +.||+|++|.||+|++++ |+.||||+.++...+.                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34665 789999999999999987 9999999997532110                                  0    


Q ss_pred             --HHHHHHHHHHHhcc----CCceeEEeeEEEe-CCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhh-h
Q 003628          522 --EEFMNEVMVISKLQ----HRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG-L  593 (807)
Q Consensus       522 --~~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L  593 (807)
                        -+|.+|+..+.+++    +.+.+.+-..+.+ ....+|||||++|+.+.++-.-  .....+   +..++...++. +
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d---~~~la~~~v~~~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTD---MKLLAERGVEVFF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCC---HHHHHHHHHHHHH
Confidence              12455666666653    3333333333322 4567899999999999764211  111111   22233322222 2


Q ss_pred             HhhhhcCCCcEEeCCCCCCCeeecCCC----CceeeccccccccCC
Q 003628          594 LYLHRDSRLRIIHRDLKASNILLDEEL----NPKISDFGMAKIFGG  635 (807)
Q Consensus       594 ~yLH~~~~~~ivH~DIkp~NIll~~~~----~~kL~DFGla~~~~~  635 (807)
                      ..++..+   ++|+|+||.||+++.++    .++++|||++..+..
T Consensus       274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3344456   99999999999999888    999999999987744

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.11  E-value=8.4e-10  Score=109.44  Aligned_cols=137  Identities=15%  Similarity=0.120  Sum_probs=100.3

Q ss_pred             cCccccCCCccEEEEEecC-------CcEEEEEEecccC----------------------cccHHHHH----HHHHHHH
Q 003628          486 SSKLGQGGFGPVYWGRLKD-------GQEIAVKRLSKAS----------------------GQGLEEFM----NEVMVIS  532 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~-------g~~vAvK~l~~~~----------------------~~~~~~~~----~E~~~l~  532 (807)
                      ...||.|--+.||.|...+       +..+|||+.+...                      ....+.+.    +|.+.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998553       4789999875311                      01122333    7999999


Q ss_pred             hccC--CceeEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhh-hhcCCCcEEeCCC
Q 003628          533 KLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL-HRDSRLRIIHRDL  609 (807)
Q Consensus       533 ~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~DI  609 (807)
                      ++..  -++++++++    ...+|||||+.+..+....   .+...++..+...+..+++.+|..| |..+   ++|+||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            9953  577777765    5678999999875442211   1122344456677889999999999 7777   999999


Q ss_pred             CCCCeeecCCCCceeecccccccc
Q 003628          610 KASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       610 kp~NIll~~~~~~kL~DFGla~~~  633 (807)
                      ++.||+++ ++.+.|+|||-+...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeC
Confidence            99999997 467999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.10  E-value=5.9e-10  Score=114.16  Aligned_cols=142  Identities=18%  Similarity=0.287  Sum_probs=111.8

Q ss_pred             CccccCCCccEEEEEecCCcEEEEEEecccCc-ccHHHHHHHHHHHHhccC--CceeEEeeEEEeCC---eEEEEEEecC
Q 003628          487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQH--RNLVRLLGCCVEGE---EKMLIYEYMP  560 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~E~~~  560 (807)
                      +.|+.|..+.||+++..+|..+++|....... .....+..|+++++.+++  .++++++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999987778999999765432 245678999999999975  45677888766542   5689999999


Q ss_pred             CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcC----------------------------------------
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS----------------------------------------  600 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  600 (807)
                      +.++.+.+..    ..++..++..++.+++++|.+||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988776521    34677777888889999998888531                                        


Q ss_pred             -------------CCcEEeCCCCCCCeeecC--CCCceeeccccccc
Q 003628          601 -------------RLRIIHRDLKASNILLDE--ELNPKISDFGMAKI  632 (807)
Q Consensus       601 -------------~~~ivH~DIkp~NIll~~--~~~~kL~DFGla~~  632 (807)
                                   ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245899999999999998  56689999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.04  E-value=2.1e-09  Score=120.45  Aligned_cols=166  Identities=19%  Similarity=0.247  Sum_probs=125.6

Q ss_pred             ecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhh
Q 003628          502 LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK  581 (807)
Q Consensus       502 ~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~  581 (807)
                      ..++.+|.|+..+.......+...+-++.|+.++||||++++......+..|||+|-+.  -|..++..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            34688899988876655444567788999999999999999999999999999999874  34445532      33555


Q ss_pred             hHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCccccceeeccCCccChhhhccCC
Q 003628          582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR  661 (807)
Q Consensus       582 ~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~  661 (807)
                      ..-.+.||+.||.+||+.+  .++|++|....|+|++.|+.||++|.++........  ......--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            6667899999999999776  499999999999999999999999998865432221  011112223566676543322


Q ss_pred             CCcccceeehhHHHHHHHhC
Q 003628          662 FSEKSDVFSFGVLLLEIVSG  681 (807)
Q Consensus       662 ~t~k~DvwSlGvvl~elltG  681 (807)
                        -..|.|.||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.04  E-value=1.3e-09  Score=104.28  Aligned_cols=131  Identities=23%  Similarity=0.335  Sum_probs=101.9

Q ss_pred             CccccCCCccEEEEEecCCcEEEEEEe-cccCcc-------cHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEEEe
Q 003628          487 SKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQ-------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~g~~vAvK~l-~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  558 (807)
                      ..+++|+-+.+|.+.+. |.++++|.= .+....       ..++..+|++++.+++--.|.-.+=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999775 445666643 222111       135577899999999766665555566788888999999


Q ss_pred             cCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      ++|..|.+.+...          ...++..+-+-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888442          3567788888888999999   99999999999998765 99999999984

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.98  E-value=4.7e-10  Score=124.55  Aligned_cols=247  Identities=19%  Similarity=0.187  Sum_probs=176.7

Q ss_pred             HhcCCcccCccccCCCccEEEEEec--CCcEEEEEEecccCcccHHHH--HHHHHHHHhc-cCCceeEEeeEEEeCCeEE
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASGQGLEEF--MNEVMVISKL-QHRNLVRLLGCCVEGEEKM  553 (807)
Q Consensus       479 ~~~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vAvK~l~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  553 (807)
                      ...+|..+..||.|.|+.|++....  ++..|++|.+.+.......+.  +.|+.+...+ .|.++++.+..+..-+..+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            4467888999999999999987643  577899998876543333322  4566666666 5899999888887778888


Q ss_pred             EEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCC-CCceeeccccccc
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKI  632 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kL~DFGla~~  632 (807)
                      +=-||++++++...+   .....++...++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||....
T Consensus       343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            889999999987665   23456778888999999999999999887   9999999999999886 8899999999874


Q ss_pred             cCCCCCccccceeeccCCcc--ChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccc
Q 003628          633 FGGNQDQADTGRVVGTFGYM--SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  710 (807)
Q Consensus       633 ~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~  710 (807)
                      +.-...     .....-.++  +|+......+-.+.|++|||..+.|.+++..-......-             ..+..-
T Consensus       417 ~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-------------~~i~~~  478 (524)
T KOG0601|consen  417 LAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-------------LTIRSG  478 (524)
T ss_pred             cceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcccccc-------------eeeecc
Confidence            321111     112233344  566666777889999999999999999987532211100             001111


Q ss_pred             cCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       711 ~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                      .-+...      ....++..+.+-++..++..||.+.++..+.+-
T Consensus       479 ~~p~~~------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  479 DTPNLP------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             cccCCC------chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            111111      112556677778889999999998887766543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.92  E-value=5.2e-09  Score=99.47  Aligned_cols=143  Identities=21%  Similarity=0.295  Sum_probs=105.9

Q ss_pred             ccCccccCCCccEEEEEecCCcEEEEEE-ecccC-------cccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEEEEE
Q 003628          485 LSSKLGQGGFGPVYWGRLKDGQEIAVKR-LSKAS-------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       485 ~~~~LG~G~~g~Vy~~~~~~g~~vAvK~-l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ....|-+|+-+.|+++.++ |+...||. +.+..       .-...+.++|++.|.+++--.|.-..=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4678899999999999987 67766664 33321       112466789999999997555555555666777778999


Q ss_pred             EecCC-CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCC---ceeeccccccc
Q 003628          557 EYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKI  632 (807)
Q Consensus       557 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~---~kL~DFGla~~  632 (807)
                      ||+++ .++.+++......+. .......+++.|-+.+.-||..+   |+|+||..+||+|..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 477777755332222 22233678889999999999998   999999999999976654   58999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.90  E-value=2e-08  Score=109.13  Aligned_cols=218  Identities=18%  Similarity=0.269  Sum_probs=155.6

Q ss_pred             CccEEEEEec-CCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeEEeeEEE----eCCeEEEEEEecCC-CCcccc
Q 003628          494 FGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV----EGEEKMLIYEYMPN-RSLDAL  567 (807)
Q Consensus       494 ~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~  567 (807)
                      -.+.||+... ||..|++|+++....+.......-++.++++.|.|||++...+.    .+...++||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578898755 79999999995444343434456688999999999999998876    34577899999985 566665


Q ss_pred             ccCCC------------CCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          568 LFDPL------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       568 l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      -+...            +....++..++.++.|+..||.++|+.|   +.-+-|.|++|+++.+.+++|...|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            54321            2234677889999999999999999999   88899999999999999999998888766543


Q ss_pred             CCCccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccc
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      +..                |-+..   -.+-|.=.||.+++.|.||.......+..+..                     
T Consensus       446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s---------------------  485 (655)
T KOG3741|consen  446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS---------------------  485 (655)
T ss_pred             CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH---------------------
Confidence            320                11111   12567788999999999997543221111110                     


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~~~L~~  755 (807)
                      ...........++.+++.-....++++ -++.+++.++-+
T Consensus       486 ~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~  524 (655)
T KOG3741|consen  486 HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS  524 (655)
T ss_pred             HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence            000122345566777888888888887 688998888744

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.85  E-value=1.9e-08  Score=99.50  Aligned_cols=125  Identities=26%  Similarity=0.307  Sum_probs=84.9

Q ss_pred             cEEEEEecCCcEEEEEEecccC--------------c-------c-----cHHHHHHHHHHHHhccCC--ceeEEeeEEE
Q 003628          496 PVYWGRLKDGQEIAVKRLSKAS--------------G-------Q-----GLEEFMNEVMVISKLQHR--NLVRLLGCCV  547 (807)
Q Consensus       496 ~Vy~~~~~~g~~vAvK~l~~~~--------------~-------~-----~~~~~~~E~~~l~~l~H~--niv~l~g~~~  547 (807)
                      .||.|...+|..+|||..+...              .       .     ......+|.+.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899999999999999875311              0       0     023467899999999755  577777652 


Q ss_pred             eCCeEEEEEEecC--CCCccccccCCCCCCCCChhhhHHHHHHHHhhhHh-hhhcCCCcEEeCCCCCCCeeecCCCCcee
Q 003628          548 EGEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-LHRDSRLRIIHRDLKASNILLDEELNPKI  624 (807)
Q Consensus       548 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~DIkp~NIll~~~~~~kL  624 (807)
                         ...|||||++  +..+..+..     ..++......++.++++.+.. +|..+   |+|+|+.+.||+++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               4579999998  555544331     122245667788888886666 46777   9999999999999988 9999


Q ss_pred             ecccccccc
Q 003628          625 SDFGMAKIF  633 (807)
Q Consensus       625 ~DFGla~~~  633 (807)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.79  E-value=1.7e-09  Score=125.90  Aligned_cols=251  Identities=18%  Similarity=0.148  Sum_probs=169.3

Q ss_pred             HHhcCCcccCccccCCCccEEEEEec-CCcEEEEEEecc---cCcccHHHHHHHHHHHHhccCCceeEEeeEEEeCCeEE
Q 003628          478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  553 (807)
Q Consensus       478 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vAvK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  553 (807)
                      ...+.+.+.+-+-+|.++.++.++-. .|...+.|....   ...+..+....+-.++-..+||-+++...-+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            45567888888999999999977643 232233333221   12222333333333333345677776666556677889


Q ss_pred             EEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccccc
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       554 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~  633 (807)
                      ||++|..+++|...|+..   +..+..-....+..+..+++|||...   +.|+|++|.|++...++..+++|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            999999999998888642   34454444556667888999999876   899999999999999999999999844432


Q ss_pred             CCC-------------------------CCc----cccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCC
Q 003628          634 GGN-------------------------QDQ----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN  684 (807)
Q Consensus       634 ~~~-------------------------~~~----~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p  684 (807)
                      +..                         +..    .......||+.|.|||...+......+|.|++|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            110                         000    112235799999999999999999999999999999999999999


Q ss_pred             CCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHH
Q 003628          685 TSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMS  747 (807)
Q Consensus       685 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~  747 (807)
                      +......+...+.+.             ..+.-...+.....+..+++...+..+|.+|-.|.
T Consensus      1035 ~na~tpq~~f~ni~~-------------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILN-------------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhhhhhcccc-------------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            976554433321111             11111112233445566777788888999997665

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.72  E-value=9.3e-08  Score=100.26  Aligned_cols=133  Identities=19%  Similarity=0.137  Sum_probs=97.6

Q ss_pred             ccEEEEEecCCcEEEEEEecccCc-----------ccHHHHHHHHHHHHhccCC--ceeEEeeEEEe-----CCeEEEEE
Q 003628          495 GPVYWGRLKDGQEIAVKRLSKASG-----------QGLEEFMNEVMVISKLQHR--NLVRLLGCCVE-----GEEKMLIY  556 (807)
Q Consensus       495 g~Vy~~~~~~g~~vAvK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~-----~~~~~lV~  556 (807)
                      ..|++..+ +|+.+.||+......           .....+.+|...+.++...  ..++++++...     ....+||+
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            34667665 477899997743221           1122478999999998543  34455666543     23468999


Q ss_pred             EecCCC-CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC-------CCCceeeccc
Q 003628          557 EYMPNR-SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-------ELNPKISDFG  628 (807)
Q Consensus       557 E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~-------~~~~kL~DFG  628 (807)
                      |++++. +|.+++.+.. ....+...+..++.+++..+.-||..+   |+|+|++++|||++.       +..+.|+||+
T Consensus       115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            999986 8888874321 234455677789999999999999999   999999999999975       4679999999


Q ss_pred             cccc
Q 003628          629 MAKI  632 (807)
Q Consensus       629 la~~  632 (807)
                      .++.
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.70  E-value=2.5e-07  Score=98.19  Aligned_cols=259  Identities=14%  Similarity=0.152  Sum_probs=154.5

Q ss_pred             cccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeEEeeEE-------EeCCeEEEE
Q 003628          484 QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCC-------VEGEEKMLI  555 (807)
Q Consensus       484 ~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~-------~~~~~~~lV  555 (807)
                      ...+.||+|+-+.+|-.-  +-...+-|+..+.......+   .+..|.+. .||-+-.-+.+=       ..+...-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            346789999999999432  11223457766544332222   22233333 455433211110       111224467


Q ss_pred             EEecCCCCccccccCC----CCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          556 YEYMPNRSLDALLFDP----LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       556 ~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      |+.+++.---..+++.    ..-...+|...++.++.+|.+.+-||.+|   .+-+|+.++|+|+.+++.+.|.|=....
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            7777664322223222    12245789999999999999999999999   8899999999999999999999866554


Q ss_pred             ccCCCCCccccceeeccCCccChhhhc-----cCCCCcccceeehhHHHHHHHhC-CCCCCccCC----cc----hhhhh
Q 003628          632 IFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSG-RKNTSFFED----DL----TILGY  697 (807)
Q Consensus       632 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~k~DvwSlGvvl~elltG-~~p~~~~~~----~~----~l~~~  697 (807)
                      +....   ....-.+|...|.+||.-.     +..-+...|.|.+|+++++++.| ++||.....    ..    .+...
T Consensus       166 i~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 INANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            43221   1122246889999999764     23456789999999999999887 889865321    10    11000


Q ss_pred             hhhhccccccccccCccccCCcccHH-HHHHHHHHHHhcccC--CcCCCCCHHHHHHHHhhcc
Q 003628          698 AWKLWNENKILALVDPFLSESSFQLD-MIIRCIHVGLLCVQE--LVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       698 ~~~~~~~~~~~~~~d~~l~~~~~~~~-~~~~l~~li~~Cl~~--dP~~RPt~~ev~~~L~~~~  757 (807)
                      ...+..+.+......|.  .  .+.. .+..+..+..+|...  ++.-|||++..+..|..+-
T Consensus       243 ~f~ya~~~~~g~~p~P~--~--~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         243 RFAYASDQRRGLKPPPR--S--IPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             eeeechhccCCCCCCCC--C--CChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            00011111110111111  1  1111 234566677777765  3668999999998886653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.66  E-value=1.3e-07  Score=95.95  Aligned_cols=134  Identities=22%  Similarity=0.249  Sum_probs=98.8

Q ss_pred             CcccCccccCCCccEEEEEecCCcEEEEEEecccC----------------------cccHHHHHHHHHHHHhccCC--c
Q 003628          483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----------------------GQGLEEFMNEVMVISKLQHR--N  538 (807)
Q Consensus       483 ~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~----------------------~~~~~~~~~E~~~l~~l~H~--n  538 (807)
                      ..+..+||-|--+.||.|..++|.++|||.-+...                      .-......+|.++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34568999999999999999999999999643210                      00123456899999999755  7


Q ss_pred             eeEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC
Q 003628          539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE  618 (807)
Q Consensus       539 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~  618 (807)
                      |++.+++    +...+||||+++--|...-        ++....-.|+..|++-+.-+-..|   |||+|+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            8887765    5568999999997664432        233344445555555555555556   999999999999999


Q ss_pred             CCCceeecccccc
Q 003628          619 ELNPKISDFGMAK  631 (807)
Q Consensus       619 ~~~~kL~DFGla~  631 (807)
                      +|.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999995443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.53  E-value=3.4e-07  Score=103.79  Aligned_cols=160  Identities=21%  Similarity=0.296  Sum_probs=106.2

Q ss_pred             CCCCcCHHHHHHHh------------cCCcccCccccCCCccEEEEEecCCcEEEEEEecccCccc--------------
Q 003628          467 DLPLFQFEELATAT------------NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG--------------  520 (807)
Q Consensus       467 ~l~~f~~~~l~~~~------------~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~--------------  520 (807)
                      ..|.|++++.....            ..|. .+.|+.++-|.||+|++++|+.||||+.+..-...              
T Consensus       100 ~vpp~~~~~~~~iie~eLG~~iee~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~  178 (517)
T COG0661         100 RVPPFPFEEAERIIEEELGRPIEELFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARL  178 (517)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCHHHHHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHH
Confidence            35667766655443            2343 36789999999999999999999999986532110              


Q ss_pred             --------------------------HHHHHHHHHHHHhcc-----CCceeEEeeEEEeCCeEEEEEEecCCCCcccccc
Q 003628          521 --------------------------LEEFMNEVMVISKLQ-----HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF  569 (807)
Q Consensus       521 --------------------------~~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  569 (807)
                                                .-++.+|...+.+++     .++|.-..=+........|+|||++|-.+.+...
T Consensus       179 ~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~  258 (517)
T COG0661         179 IKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAA  258 (517)
T ss_pred             HHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHH
Confidence                                      112445666666652     3333222222233567889999999999988852


Q ss_pred             CCCCCCCCChhhhHHHHHHHHhh-hHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCC
Q 003628          570 DPLKKERLDWRKRFNIIEGISRG-LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       570 ~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~  635 (807)
                      -  +....+   +..++..++++ +..+-..+   ++|.|.+|.||+++.++++.+.|||+...+..
T Consensus       259 l--~~~g~d---~k~ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         259 L--KSAGID---RKELAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             H--HhcCCC---HHHHHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2  123343   34455555544 33333345   99999999999999999999999999887643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=6.5e-08  Score=109.07  Aligned_cols=155  Identities=19%  Similarity=0.320  Sum_probs=105.0

Q ss_pred             HHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCCCcc-------ccceeeccCCccChhhh
Q 003628          585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA-------DTGRVVGTFGYMSPEYA  657 (807)
Q Consensus       585 i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~-------~~~~~~gt~~y~APE~~  657 (807)
                      =+.+++.||.|+|..-  .+||++|.|++|.++.++..||+.|+.+..........       ...-..-...|.|||++
T Consensus       104 nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  104 NLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            3455669999999875  59999999999999999999999999887654421110       01112345689999999


Q ss_pred             ccCCCCcccceeehhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhccc
Q 003628          658 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQ  737 (807)
Q Consensus       658 ~~~~~t~k~DvwSlGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~  737 (807)
                      .....+.++|+||+|+++|-+..|..+.-........-.....         ..+....  ..+.+.+.++.+=+.+.+.
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~---------~~~~~~~--~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN---------LLNAGAF--GYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc---------ccccccc--cccccCcHHHHHHHHHHhc
Confidence            9988899999999999999999555443221111110000000         0011110  1334556777788888999


Q ss_pred             CCcCCCCCHHHHHHH
Q 003628          738 ELVKDRPNMSTVVSM  752 (807)
Q Consensus       738 ~dP~~RPt~~ev~~~  752 (807)
                      .++.-||++.++.+.
T Consensus       251 ~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLSI  265 (700)
T ss_pred             CCcccCcchhhhhcc
Confidence            999999987776553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.43  E-value=8.2e-07  Score=90.00  Aligned_cols=107  Identities=24%  Similarity=0.266  Sum_probs=85.8

Q ss_pred             HHHHHHHHHHHHhcc--CCceeEEeeEEEeCC----eEEEEEEecCCC-CccccccCCCCCCCCChhhhHHHHHHHHhhh
Q 003628          521 LEEFMNEVMVISKLQ--HRNLVRLLGCCVEGE----EKMLIYEYMPNR-SLDALLFDPLKKERLDWRKRFNIIEGISRGL  593 (807)
Q Consensus       521 ~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL  593 (807)
                      .....+|...+.++.  .-..++.+++.....    ..+||+|++++. +|.+++...   ...+......++.++++.+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence            456788999988885  344667777766532    358999999984 788888542   1256667788999999999


Q ss_pred             HhhhhcCCCcEEeCCCCCCCeeecCCC---Cceeecccccccc
Q 003628          594 LYLHRDSRLRIIHRDLKASNILLDEEL---NPKISDFGMAKIF  633 (807)
Q Consensus       594 ~yLH~~~~~~ivH~DIkp~NIll~~~~---~~kL~DFGla~~~  633 (807)
                      .-||..+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999   99999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.41  E-value=2.4e-06  Score=85.05  Aligned_cols=139  Identities=16%  Similarity=0.149  Sum_probs=104.2

Q ss_pred             cccCCCccEEEEEecCCcEEEEEEeccc------CcccHHHHHHHHHHHHhccC--CceeEEeeEEEeC----CeEEEEE
Q 003628          489 LGQGGFGPVYWGRLKDGQEIAVKRLSKA------SGQGLEEFMNEVMVISKLQH--RNLVRLLGCCVEG----EEKMLIY  556 (807)
Q Consensus       489 LG~G~~g~Vy~~~~~~g~~vAvK~l~~~------~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~----~~~~lV~  556 (807)
                      -|+||.+.|++-.+. |..+-+|+-...      .+.+...|.+|...|.++..  -.+++++.+....    -..+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            466999999998776 447888876411      14467889999999999953  3366666332221    2357999


Q ss_pred             EecCC-CCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCC--ceeeccccccc
Q 003628          557 EYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN--PKISDFGMAKI  632 (807)
Q Consensus       557 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~--~kL~DFGla~~  632 (807)
                      |-+++ .+|.+++.+. ...+.+...+..++.++++.+.-||+.+   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97763 5788887442 2235677778899999999999999999   999999999999986666  99999987764

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.36  E-value=1.6e-06  Score=78.85  Aligned_cols=55  Identities=36%  Similarity=0.657  Sum_probs=45.0

Q ss_pred             EEEecCCcEEEEcCC-CcEEEeeccccccccceEEEEecCCCEEEEeccccceEecc
Q 003628           89 ITISEDGNLVLVNGQ-KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES  144 (807)
Q Consensus        89 l~~~~~g~l~l~~~~-~~~~ws~~~~~~~~~~~~~~l~~~GNlvl~~~~~~~~~WqS  144 (807)
                      +.++.||+||+++.. +.++|++++.........+.|.++|||||++. ++.++|+|
T Consensus        24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S   79 (114)
T smart00108       24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG-DGRVVWSS   79 (114)
T ss_pred             cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC-CCCEEEEe
Confidence            456689999999865 58999999875444457899999999999987 56789998

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.36  E-value=1.5e-06  Score=98.20  Aligned_cols=156  Identities=19%  Similarity=0.296  Sum_probs=103.2

Q ss_pred             CCCcCHHHHHHHhc------------CCcccCccccCCCccEEEEEecCCcEEEEEEecccCccc---------------
Q 003628          468 LPLFQFEELATATN------------NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG---------------  520 (807)
Q Consensus       468 l~~f~~~~l~~~~~------------~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~---------------  520 (807)
                      .|.++++++....+            .|. .+.|+.-+.|.|++|++++|+.||||+-+..-...               
T Consensus       137 ~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l  215 (538)
T KOG1235|consen  137 APPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVL  215 (538)
T ss_pred             CCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHH
Confidence            45666666554432            233 36799999999999999999999999876432111               


Q ss_pred             ----------------------HHHHHHHHHHHHhc----cCCc------eeEEeeEEEeCCeEEEEEEecCCCCccccc
Q 003628          521 ----------------------LEEFMNEVMVISKL----QHRN------LVRLLGCCVEGEEKMLIYEYMPNRSLDALL  568 (807)
Q Consensus       521 ----------------------~~~~~~E~~~l~~l----~H~n------iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  568 (807)
                                            .-+|.+|++...+.    .|-+      |++++-.  ....+.|+||||+|..+.+.-
T Consensus       216 ~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~  293 (538)
T KOG1235|consen  216 QKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLD  293 (538)
T ss_pred             HHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHH
Confidence                                  11255666666655    3555      4444332  245789999999999888774


Q ss_pred             cCCCCCCCCChhhhHHHHHHHHhhhH-hhhhcCCCcEEeCCCCCCCeeecC----CCCceeeccccccccC
Q 003628          569 FDPLKKERLDWRKRFNIIEGISRGLL-YLHRDSRLRIIHRDLKASNILLDE----ELNPKISDFGMAKIFG  634 (807)
Q Consensus       569 ~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivH~DIkp~NIll~~----~~~~kL~DFGla~~~~  634 (807)
                      .-  ....++..   .|+..+.++.. .+=..|   ++|+|-+|.||++..    ++++.+.|||+.....
T Consensus       294 ~i--~~~gi~~~---~i~~~l~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  294 AI--DKRGISPH---DILNKLVEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HH--HHcCCCHH---HHHHHHHHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            32  23345544   34444444322 222234   999999999999984    6789999999988654

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.36  E-value=9.8e-07  Score=74.07  Aligned_cols=71  Identities=39%  Similarity=0.895  Sum_probs=54.6

Q ss_pred             CCCeeEeccccCCCccccc-CcccHHHHHHHHhc-cCCeeeEeecC-CeeEEEee-eeeeccccccCCCccceEEE
Q 003628          337 EDGFSKLNKMKVPDFTEWT-SPATEDECREQCLK-NCSCIAYAFDG-GIGCMVWR-SINLIDIQRLPFGGTDLYIR  408 (807)
Q Consensus       337 ~~~f~~~~~~~~pd~~~~~-~~~s~~~C~~~Cl~-nCsC~a~~~~~-g~gC~~w~-~~~l~~~~~~~~~~~~lylr  408 (807)
                      ...|.+++++.+++..... ...++++|++.|++ +|+|.||.|.. +.+|.+|. + .+.+....+..+.++|.+
T Consensus         3 ~~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~-~~~~~~~~~~~~~~~y~~   77 (78)
T smart00473        3 DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSES-SLGDARLFPSGGVDLYEK   77 (78)
T ss_pred             CceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCC-ccccceecccCCceeEEe
Confidence            3568899999998665432 33499999999999 99999999984 67899999 6 777766445555666654

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.35  E-value=4.4e-06  Score=85.77  Aligned_cols=132  Identities=17%  Similarity=0.183  Sum_probs=86.8

Q ss_pred             CccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCc--eeEEeeEEEeCCeEEEEEEecCCCC-
Q 003628          487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN--LVRLLGCCVEGEEKMLIYEYMPNRS-  563 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs-  563 (807)
                      ..||+|..+.||+.   .+..+++|......  ......+|.+++..+..-.  +++.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999983   25567888876533  3456789999999986433  5778888877777889999999963 


Q ss_pred             ccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhh----------------------------------------cCCCc
Q 003628          564 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR----------------------------------------DSRLR  603 (807)
Q Consensus       564 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~----------------------------------------~~~~~  603 (807)
                      +...+..       +......++..+++.+.-||+                                        .....
T Consensus        82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            2212110       001111111111211111111                                        12234


Q ss_pred             EEeCCCCCCCeeecCCCCceeecccccc
Q 003628          604 IIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       604 ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      ++|+|+.|.||++++++ +.|+||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            79999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.29  E-value=4.7e-06  Score=83.28  Aligned_cols=137  Identities=16%  Similarity=0.203  Sum_probs=91.8

Q ss_pred             hcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHH---------HHHHHHHhccCCc---eeEEeeEE-
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFM---------NEVMVISKLQHRN---LVRLLGCC-  546 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~---------~E~~~l~~l~H~n---iv~l~g~~-  546 (807)
                      .++|...+.+-......|.+-... |..+++|..+.......+.|.         +++..+.+++...   ...++... 
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            456777777777777777766654 788999988765433333322         3444444443222   22222222 


Q ss_pred             ----EeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCc
Q 003628          547 ----VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  622 (807)
Q Consensus       547 ----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~  622 (807)
                          ......++||||++|..|.++..       ++.    .++..+++++.-||..|   ++|+|.+|.|+++++++ +
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence                12345568999999988866541       221    35567888899999999   99999999999998654 9


Q ss_pred             eeeccccccc
Q 003628          623 KISDFGMAKI  632 (807)
Q Consensus       623 kL~DFGla~~  632 (807)
                      +++||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987663

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.27  E-value=2.7e-06  Score=77.66  Aligned_cols=55  Identities=35%  Similarity=0.645  Sum_probs=44.6

Q ss_pred             EEEec-CCcEEEEcCC-CcEEEeeccccccccceEEEEecCCCEEEEeccccceEecc
Q 003628           89 ITISE-DGNLVLVNGQ-KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES  144 (807)
Q Consensus        89 l~~~~-~g~l~l~~~~-~~~~ws~~~~~~~~~~~~~~l~~~GNlvl~~~~~~~~~WqS  144 (807)
                      +.++. ||+||+++.. ++++|++|+.........+.|.++|||||++. ++.++|+|
T Consensus        24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S   80 (116)
T cd00028          24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG-SGTVVWSS   80 (116)
T ss_pred             CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC-CCcEEEEe
Confidence            44555 8999999765 58999999876444667899999999999987 56789997

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.15  E-value=2.3e-05  Score=79.18  Aligned_cols=153  Identities=20%  Similarity=0.266  Sum_probs=105.2

Q ss_pred             CcCHHHHHHHhcCCcccCccc---cCCCccEEEEEecCCcEEEEEEecccCcc-------------------cHHH----
Q 003628          470 LFQFEELATATNNFQLSSKLG---QGGFGPVYWGRLKDGQEIAVKRLSKASGQ-------------------GLEE----  523 (807)
Q Consensus       470 ~f~~~~l~~~~~~~~~~~~LG---~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~-------------------~~~~----  523 (807)
                      ..+++.+....++..+....|   .|--+.||+|...++..+|||+.+.....                   ..++    
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            356677777777777766655   56667899999888999999998643211                   1111    


Q ss_pred             -HHHHHHHHHhcc--CCceeEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhh-c
Q 003628          524 -FMNEVMVISKLQ--HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-D  599 (807)
Q Consensus       524 -~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~  599 (807)
                       ..+|...|.++.  +-.+++.+++.    .-.|||||+....+..   -..+.-.+...+...+..++++.+.-|-. .
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pA---P~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPA---PRLKDVPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCC---CCcccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence             235777788773  55666666653    3479999997542111   01122223333567778888888888876 4


Q ss_pred             CCCcEEeCCCCCCCeeecCCCCceeecccccccc
Q 003628          600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       600 ~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~  633 (807)
                      +   +||+||+.=|||+. ++.+.|+|||-|...
T Consensus       187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             C---cccccchhhheEEE-CCeEEEEECcccccc
Confidence            4   99999999999999 889999999987754

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.09  E-value=3.1e-05  Score=80.74  Aligned_cols=76  Identities=16%  Similarity=0.149  Sum_probs=56.2

Q ss_pred             ccccCCC-ccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeEEeeEEEeCCeEEEEEEecCCCCcc
Q 003628          488 KLGQGGF-GPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSLD  565 (807)
Q Consensus       488 ~LG~G~~-g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  565 (807)
                      .|..|.. ..||+.... +..+.||+.....   ...+.+|++++..+. +--+++++++....+..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            4555665 688988765 4788888875432   345678999998884 455778888877767789999999998876


Q ss_pred             cc
Q 003628          566 AL  567 (807)
Q Consensus       566 ~~  567 (807)
                      ..
T Consensus        81 ~~   82 (244)
T cd05150          81 AL   82 (244)
T ss_pred             Hh
Confidence            44

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.08  E-value=8.7e-07  Score=98.85  Aligned_cols=189  Identities=19%  Similarity=0.149  Sum_probs=137.1

Q ss_pred             hcCCcccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCc-eeEEeeEEEeCCeEEEEEEe
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       480 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~  558 (807)
                      +.-+.....++++++++++|.+....+....+.+...     ....-++++|.+++||| .++.++-+..++...+++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            3334445668899999999988654444555555332     44557899999999999 77777777777788899999


Q ss_pred             cCCC-CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccccccCCCC
Q 003628          559 MPNR-SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       559 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~~~~~~  637 (807)
                      +..+ +-..-.  ......+...+...+.+.-++++++||+..   =+|+|    ||+..+ +..|..||+....+.+..
T Consensus       316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence            9877 221111  011223444455567777888999999864   58998    777665 689999999888665433


Q ss_pred             CccccceeeccCCccChhhhccCCCCcccceeehhHHHHHHHhCCCCCC
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTS  686 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~t~k~DvwSlGvvl~elltG~~p~~  686 (807)
                         ......+|+.++|||+.....+..+-|+|+.|+-..++.-|-+|-.
T Consensus       386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence               2334678999999999999999999999999998778877776643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.07  E-value=2.2e-05  Score=80.81  Aligned_cols=143  Identities=24%  Similarity=0.238  Sum_probs=85.3

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCC--ceeEEeeEEEe---CCeEEEEEEecC
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR--NLVRLLGCCVE---GEEKMLIYEYMP  560 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lV~E~~~  560 (807)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+..|..+++.+...  .+++++.+...   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3578899999999999887 69999997554  4457788999999888533  46777775533   335689999999


Q ss_pred             CCCccc----------------cc---cCC-CCCCCCChhh---------hHHH------------HHHHHh-hhHhhhh
Q 003628          561 NRSLDA----------------LL---FDP-LKKERLDWRK---------RFNI------------IEGISR-GLLYLHR  598 (807)
Q Consensus       561 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~  598 (807)
                      +..+..                .+   +.. ..........         ....            ...+.+ .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   000 0001111100         0000            111222 2333332


Q ss_pred             ----cCCCcEEeCCCCCCCeeec-CCCCceeecccccc
Q 003628          599 ----DSRLRIIHRDLKASNILLD-EELNPKISDFGMAK  631 (807)
Q Consensus       599 ----~~~~~ivH~DIkp~NIll~-~~~~~kL~DFGla~  631 (807)
                          .....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                1334599999999999999 66666899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.02  E-value=1.5e-05  Score=79.17  Aligned_cols=105  Identities=20%  Similarity=0.229  Sum_probs=84.1

Q ss_pred             HHHHHHHHhccC-CceeEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCc
Q 003628          525 MNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR  603 (807)
Q Consensus       525 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  603 (807)
                      ..|..+++.+++ +++++++|+|    ..++|.||...+++...-..-.+--..+|..|.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            368888999976 6999999998    35789999998766432100012235789999999999999999999865556


Q ss_pred             EEeCCCCCCCeeecCCCCceeecccccccc
Q 003628          604 IIHRDLKASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       604 ivH~DIkp~NIll~~~~~~kL~DFGla~~~  633 (807)
                      +...|++++|+-+++++++|++|.+.+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999877644

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=97.93  E-value=0.00013  Score=66.05  Aligned_cols=100  Identities=27%  Similarity=0.466  Sum_probs=66.8

Q ss_pred             CeEEeCCCeeEEEEecCCCCCceEEEEEeecCCCceEEEEe-cCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeecccc
Q 003628           36 DAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVA-NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSN  114 (807)
Q Consensus        36 ~~l~s~~g~f~~gF~~~~~~~~~ylgiw~~~~~~~~~vW~a-nr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~  114 (807)
                      +.+.+.+|.+.|-|-..|+     |-| |+.  ..+++|.+ +...... ..+.+.|..||||||+|..+.++|++... 
T Consensus        12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~-   81 (114)
T PF01453_consen   12 SPLTSSSGNYTLILQSDGN-----LVL-YDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY-   81 (114)
T ss_dssp             EEEEECETTEEEEEETTSE-----EEE-EET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS-
T ss_pred             cccccccccccceECCCCe-----EEE-EcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC-
Confidence            4565655889999977664     233 432  25779999 4344332 45789999999999999999999998432 


Q ss_pred             ccccceEEEEec--CCCEEEEeccccceEeccccCCc
Q 003628          115 LVNNSTSAQLLD--SGNLVLRDNINRAIVWESFQEPT  149 (807)
Q Consensus       115 ~~~~~~~~~l~~--~GNlvl~~~~~~~~~WqSFd~PT  149 (807)
                        ...+.+..++  .||++ +.. ...+.|.|=+.|+
T Consensus        82 --ptdt~L~~q~l~~~~~~-~~~-~~~~sw~s~~dps  114 (114)
T PF01453_consen   82 --PTDTLLPGQKLGDGNVT-GKN-DSLTSWSSNTDPS  114 (114)
T ss_dssp             --SS-EEEEEET--TSEEE-EES-TSSEEEESS----
T ss_pred             --CccEEEeccCcccCCCc-ccc-ceEEeECCCCCCC
Confidence              3456778888  89999 654 3567899877663

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=97.86  E-value=0.00014  Score=89.22  Aligned_cols=80  Identities=19%  Similarity=0.377  Sum_probs=59.3

Q ss_pred             cCccccCCCccEEEEEecCC---cEEEEEEecccC-cccHHHHHHHHHHHHhcc-CCce--eEEeeEEEeC---CeEEEE
Q 003628          486 SSKLGQGGFGPVYWGRLKDG---QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNL--VRLLGCCVEG---EEKMLI  555 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV  555 (807)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  ++++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46788999999999877654   467888764322 123457889999999995 6664  8888888764   457899


Q ss_pred             EEecCCCCcc
Q 003628          556 YEYMPNRSLD  565 (807)
Q Consensus       556 ~E~~~~gsL~  565 (807)
                      |||+++..+.
T Consensus       123 ME~v~G~~~~  132 (822)
T PLN02876        123 MEYLEGRIFV  132 (822)
T ss_pred             EEecCCcccC
Confidence            9999987643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.82  E-value=0.00012  Score=75.75  Aligned_cols=75  Identities=19%  Similarity=0.248  Sum_probs=49.1

Q ss_pred             CccccCCCc-cEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCC---ceeEEeeEEEeCC---eEEEEEEec
Q 003628          487 SKLGQGGFG-PVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR---NLVRLLGCCVEGE---EKMLIYEYM  559 (807)
Q Consensus       487 ~~LG~G~~g-~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lV~E~~  559 (807)
                      +.|+.|+.. .||+.    +..+++|..+..  .....+.+|.+++..+...   -+.++++.....+   ..++|||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            567777776 48865    245777875432  2345788999999988532   3555555443322   347899999


Q ss_pred             CCCCcccc
Q 003628          560 PNRSLDAL  567 (807)
Q Consensus       560 ~~gsL~~~  567 (807)
                      +|.++.+.
T Consensus        77 ~G~~l~~~   84 (235)
T cd05155          77 EGETATAA   84 (235)
T ss_pred             cCCCCCcc
Confidence            99887543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.77  E-value=0.00017  Score=71.98  Aligned_cols=132  Identities=20%  Similarity=0.285  Sum_probs=92.8

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccC----------------cccHHHHHHHHHHHHhcc------CCceeEEe
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----------------GQGLEEFMNEVMVISKLQ------HRNLVRLL  543 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~  543 (807)
                      ...||+|+.=.||  .+++.....||+.....                ....+++.+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            4689999999999  55666778889887654                223566777777776665      88999999


Q ss_pred             eEEEeCCeEEEEEEecCCC------CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeec
Q 003628          544 GCCVEGEEKMLIYEYMPNR------SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD  617 (807)
Q Consensus       544 g~~~~~~~~~lV~E~~~~g------sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~  617 (807)
                      |+.......-+|+|.+.+.      +|.+++    ..+.++. ...+.+.++   ..||-++.   |+.+|++|+||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEEE
Confidence            9999999999999988642      355555    3334554 334444443   45555555   99999999999996


Q ss_pred             CCC----Cceeec-cccc
Q 003628          618 EEL----NPKISD-FGMA  630 (807)
Q Consensus       618 ~~~----~~kL~D-FGla  630 (807)
                      ...    .+.|+| ||-.
T Consensus       153 ~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ecCCCceEEEEEeCCCCc
Confidence            432    467776 4433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.77  E-value=0.00011  Score=70.29  Aligned_cols=129  Identities=22%  Similarity=0.284  Sum_probs=90.7

Q ss_pred             cccCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCceeE-EeeEEEeCCeEEEEEEecCCC
Q 003628          484 QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR-LLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       484 ~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      ...+.|++|.+|.||+|.+. |..+|+|+-+..  .....+..|+++|..++-.++-+ ++.+-    ...+.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            34578999999999999987 568999986543  34578999999999998766543 44442    234459999998


Q ss_pred             CccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCC-CCCeeecCCCCceeeccccccc
Q 003628          563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK-ASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIk-p~NIll~~~~~~kL~DFGla~~  632 (807)
                      .|.+.-..      .+.    +-+..+++.-.-|-..+   |-|+.|+ |..++|..++.+.|+||..|+.
T Consensus        98 ~L~~~~~~------~~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIG------GDR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhc------ccH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            88665421      122    23344555545555556   9999886 5555555666999999999884

>PRK10593 hypothetical protein; Provisional

Probab=97.73  E-value=0.00037  Score=74.83  Aligned_cols=76  Identities=11%  Similarity=0.047  Sum_probs=58.1

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccC---CceeEEeeEEEeC---CeEEEEEEec
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH---RNLVRLLGCCVEG---EEKMLIYEYM  559 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~E~~  559 (807)
                      .+.||.|..+.||+....++ .+.+|..+.  ......|..|.+.|+.+.-   -.++++++.+..+   +..+||||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            46899999999999877655 466676432  1133688999999999853   4788999888653   5689999999


Q ss_pred             CCCCc
Q 003628          560 PNRSL  564 (807)
Q Consensus       560 ~~gsL  564 (807)
                      ++.++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98766

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.65  E-value=0.00063  Score=67.46  Aligned_cols=135  Identities=24%  Similarity=0.387  Sum_probs=95.4

Q ss_pred             CCCCCcCHHHHHHHhcCCcccCccccCCC-ccEEEEEecCCcEEEEEEecc---cC---------c---------ccHHH
Q 003628          466 QDLPLFQFEELATATNNFQLSSKLGQGGF-GPVYWGRLKDGQEIAVKRLSK---AS---------G---------QGLEE  523 (807)
Q Consensus       466 ~~l~~f~~~~l~~~~~~~~~~~~LG~G~~-g~Vy~~~~~~g~~vAvK~l~~---~~---------~---------~~~~~  523 (807)
                      +.+..|+.     -+.+++..+.||.|.- |.||++++. |+.+|+|.++.   ..         .         .-.+.
T Consensus        27 PKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P  100 (207)
T PF13095_consen   27 PKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP  100 (207)
T ss_pred             CCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence            34445555     2378889999999999 999999987 67999999431   00         0         11235


Q ss_pred             HHHHHHHHHhcc---CCce--eEEeeEEEeC------------------CeEEEEEEecCCCCccccccCCCCCCCCChh
Q 003628          524 FMNEVMVISKLQ---HRNL--VRLLGCCVEG------------------EEKMLIYEYMPNRSLDALLFDPLKKERLDWR  580 (807)
Q Consensus       524 ~~~E~~~l~~l~---H~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~  580 (807)
                      |..|.+...+|+   +.++  |+.+|+..-.                  ..+.||.||++...            .+   
T Consensus       101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~---  165 (207)
T PF13095_consen  101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL---  165 (207)
T ss_pred             HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc---
Confidence            888999988884   4566  9999997422                  12346777665422            11   


Q ss_pred             hhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecCCCCceeeccccc
Q 003628          581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       581 ~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla  630 (807)
                       ..+-+.+|.+-|..+|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       166 -~~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  166 -QIRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             -chhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence             2234567778888899988   999999999976     4689999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.62  E-value=0.00042  Score=72.74  Aligned_cols=138  Identities=15%  Similarity=0.087  Sum_probs=79.4

Q ss_pred             ccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCCc-eeEEeeEEEeCCeEEEEEEecCCCCccc
Q 003628          488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGEEKMLIYEYMPNRSLDA  566 (807)
Q Consensus       488 ~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~gsL~~  566 (807)
                      .+..|-...+|+.. .++..+++|..........-...+|.++++.+.... .+++++...    ..+||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            45567778999887 446788898765432221123578999999886433 345554432    368999999877653


Q ss_pred             c-----------------ccCCC-CCCCCChhhh-HHHHHHH---------HhhhHhhhhc-----CCCcEEeCCCCCCC
Q 003628          567 L-----------------LFDPL-KKERLDWRKR-FNIIEGI---------SRGLLYLHRD-----SRLRIIHRDLKASN  613 (807)
Q Consensus       567 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~i---------a~gL~yLH~~-----~~~~ivH~DIkp~N  613 (807)
                      .                 |+... ...+++.... .....++         .+.+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            2                 11110 0111111111 1111111         1111112111     12348999999999


Q ss_pred             eeecCCCCceeecccccc
Q 003628          614 ILLDEELNPKISDFGMAK  631 (807)
Q Consensus       614 Ill~~~~~~kL~DFGla~  631 (807)
                      |++++++ +.|+||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999877 7899998876

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.58  E-value=0.00064  Score=75.23  Aligned_cols=76  Identities=13%  Similarity=0.186  Sum_probs=57.1

Q ss_pred             cCccccCCCccEEEEEecCC-cEEEEEEeccc-----C--cccHHHHHHHHHHHHhcc---CCceeEEeeEEEeCCeEEE
Q 003628          486 SSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKA-----S--GQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g-~~vAvK~l~~~-----~--~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l  554 (807)
                      .+.||.|.+..||+....+| +.++||.-...     .  .-..+++..|.+.|..+.   -.++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36799999999999999877 48999985421     1  234577888999888873   2467888877  4466789


Q ss_pred             EEEecCCCC
Q 003628          555 IYEYMPNRS  563 (807)
Q Consensus       555 V~E~~~~gs  563 (807)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.56  E-value=0.00061  Score=70.45  Aligned_cols=74  Identities=18%  Similarity=0.239  Sum_probs=49.2

Q ss_pred             CccccCCCccEEEEEecC--CcEEEEEEecccCcccHHHHHHHHHHHHhccC-CceeEEeeEEEeCCeEEEEEEecCCCC
Q 003628          487 SKLGQGGFGPVYWGRLKD--GQEIAVKRLSKASGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIYEYMPNRS  563 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~--g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gs  563 (807)
                      +.|..|-...+|+....+  +..|++|+....... .-...+|+.++..+.. .-.+++++...    ..+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            467777788999988764  678999977543221 1233478888888853 33455554432    237999999987


Q ss_pred             cc
Q 003628          564 LD  565 (807)
Q Consensus       564 L~  565 (807)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            64

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.51  E-value=0.00064  Score=72.99  Aligned_cols=142  Identities=17%  Similarity=0.177  Sum_probs=86.4

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCC--ceeEEeeE------EEeCCeEEEEEE
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR--NLVRLLGC------CVEGEEKMLIYE  557 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E  557 (807)
                      .+.|..|....+|+....+ ..+++|+...   ...+....|++++..+++.  .+++++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567778778999987654 4788898754   3345677888888888533  35555442      123445689999


Q ss_pred             ecCCCCcccc----c----------cCCC---CC-----CCCChhhhH----------HHHHHHHhhhHhhhh----cCC
Q 003628          558 YMPNRSLDAL----L----------FDPL---KK-----ERLDWRKRF----------NIIEGISRGLLYLHR----DSR  601 (807)
Q Consensus       558 ~~~~gsL~~~----l----------~~~~---~~-----~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~  601 (807)
                      |++|..+...    .          +...   ..     ....|....          .....+..++.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9999876431    0          1000   00     011111110          011123334444443    112


Q ss_pred             CcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          602 LRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       602 ~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      ..++|+|+.|.||+++++..+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            349999999999999998778899998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.42  E-value=0.0021  Score=69.82  Aligned_cols=155  Identities=17%  Similarity=0.207  Sum_probs=83.5

Q ss_pred             HHHHHHHhcCCcc-----cCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCC--ceeEEee-
Q 003628          473 FEELATATNNFQL-----SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR--NLVRLLG-  544 (807)
Q Consensus       473 ~~~l~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g-  544 (807)
                      .+++......|.+     .+.|+.|....+|+....+| .+++|+...   ...+....|+.++..|...  .+++.+. 
T Consensus         9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~   84 (319)
T PRK05231          9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVAR   84 (319)
T ss_pred             HHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence            3444444444543     34566777789999887655 688898752   1234444566666665321  2344442 


Q ss_pred             -----EEEeCCeEEEEEEecCCCCcccc----c----------cCCCC--------CCCCCh-hhhHH------------
Q 003628          545 -----CCVEGEEKMLIYEYMPNRSLDAL----L----------FDPLK--------KERLDW-RKRFN------------  584 (807)
Q Consensus       545 -----~~~~~~~~~lV~E~~~~gsL~~~----l----------~~~~~--------~~~l~~-~~~~~------------  584 (807)
                           +....+..++++||++|..+...    .          +....        ...+.| .+...            
T Consensus        85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (319)
T PRK05231         85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA  164 (319)
T ss_pred             CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence                 12234567899999999865321    0          11000        001111 11111            


Q ss_pred             HHHH-HHhhhHhhhhc----CCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          585 IIEG-ISRGLLYLHRD----SRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       585 i~~~-ia~gL~yLH~~----~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      .+.+ +...+..+...    -+..++|+|++|.||+++.+...-|+||+.+.
T Consensus       165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            1111 11122222211    12359999999999999976656899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.38  E-value=0.0022  Score=69.33  Aligned_cols=143  Identities=17%  Similarity=0.185  Sum_probs=83.1

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhccCC--ceeEEeeEE------EeCCeEEEEEE
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR--NLVRLLGCC------VEGEEKMLIYE  557 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~------~~~~~~~lV~E  557 (807)
                      .+.++.|....+|+....+| .+++|+.....  ..+....|++++..|...  .+++++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            35567777789999876544 67788775421  234556677777777422  244554421      22455689999


Q ss_pred             ecCCCCcccc--------------ccCCCCC---------CCCChhhhH------------HHHHHHHhhhHhhhh----
Q 003628          558 YMPNRSLDAL--------------LFDPLKK---------ERLDWRKRF------------NIIEGISRGLLYLHR----  598 (807)
Q Consensus       558 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~gL~yLH~----  598 (807)
                      |++|..+...              ++.....         ..-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998765321              1110000         001111100            011123334555532    


Q ss_pred             cCCCcEEeCCCCCCCeeecCCCCceeecccccc
Q 003628          599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       599 ~~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~  631 (807)
                      .....++|+|+++.||++++++...|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            123459999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.06  E-value=0.0026  Score=68.58  Aligned_cols=140  Identities=24%  Similarity=0.297  Sum_probs=83.3

Q ss_pred             CccccCCCccEEEEEecC-------CcEEEEEEecccCcccHHHHHHHHHHHHhccCC-ceeEEeeEEEeCCeEEEEEEe
Q 003628          487 SKLGQGGFGPVYWGRLKD-------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR-NLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~-------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~  558 (807)
                      +.|..|-...+|+....+       ++.+++|+..... .......+|.+++..+... -.+++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            345556666899888665       5789999975543 2234567888888888532 24455665532    358999


Q ss_pred             cCCCCccccc-----------------cCCCCCC------CCC--hhhhHH--------------------------HHH
Q 003628          559 MPNRSLDALL-----------------FDPLKKE------RLD--WRKRFN--------------------------IIE  587 (807)
Q Consensus       559 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~  587 (807)
                      ++|..+....                 +......      ..+  +..+.+                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9988775321                 1110000      000  101100                          111


Q ss_pred             HHHhhhHhhhh------cCCCcEEeCCCCCCCeeecCC----CCceeecccccc
Q 003628          588 GISRGLLYLHR------DSRLRIIHRDLKASNILLDEE----LNPKISDFGMAK  631 (807)
Q Consensus       588 ~ia~gL~yLH~------~~~~~ivH~DIkp~NIll~~~----~~~kL~DFGla~  631 (807)
                      .+.+-+..|..      .....++|+|+.|.||+++++    +.++++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22222333432      133469999999999999985    889999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.94  E-value=0.0081  Score=64.26  Aligned_cols=127  Identities=18%  Similarity=0.264  Sum_probs=81.5

Q ss_pred             cEEEEEecCCcEEEEEEecc--cCcccHHHHHHHHHHHHhccC--CceeEEeeEEEeCC--eEEEEEEecCCCCcccccc
Q 003628          496 PVYWGRLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQH--RNLVRLLGCCVEGE--EKMLIYEYMPNRSLDALLF  569 (807)
Q Consensus       496 ~Vy~~~~~~g~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~  569 (807)
                      .+|..... ++++++. ...  ..........+|..+|+.+.-  --+.+.++.|.++.  ..+.||+|++|..+.+.+.
T Consensus        40 ~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          40 DTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             ceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            44444443 7788888 321  122334566788888888743  44566777777766  6689999999865544432


Q ss_pred             CCCCCCCCChhhhHHHH-HHHHhhhHhhhh--------------------------------------------------
Q 003628          570 DPLKKERLDWRKRFNII-EGISRGLLYLHR--------------------------------------------------  598 (807)
Q Consensus       570 ~~~~~~~l~~~~~~~i~-~~ia~gL~yLH~--------------------------------------------------  598 (807)
                      ...    ..    .+++ ..+++.|.-||+                                                  
T Consensus       118 ~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~  189 (321)
T COG3173         118 PES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA  189 (321)
T ss_pred             ccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence            110    00    1111 244444444443                                                  


Q ss_pred             c-----CCCcEEeCCCCCCCeeecCCCCceeeccccccc
Q 003628          599 D-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       599 ~-----~~~~ivH~DIkp~NIll~~~~~~kL~DFGla~~  632 (807)
                      +     +++.++|+|+++.||+++.+..+-|.||+++..
T Consensus       190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            1     235699999999999999999999999999874

>PLN02236 choline kinase

Probab=96.81  E-value=0.009  Score=65.56  Aligned_cols=141  Identities=21%  Similarity=0.274  Sum_probs=81.2

Q ss_pred             CccccCCCccEEEEEecC-----CcEEEEEEecccCcccHHHHHHHHHHHHhccCCc-eeEEeeEEEeCCeEEEEEEecC
Q 003628          487 SKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~  560 (807)
                      +.|..|-.-.+|+....+     ++.|++|+.........++ .+|..++..+..-+ -+++++.+..+    .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345456667889887542     3678999886654333333 67999998885433 34556665332    5899998


Q ss_pred             CCCcccc-----------------ccCCC-CC-C-CCChhhhHHHHHHH-----------------HhhhHhh----hh-
Q 003628          561 NRSLDAL-----------------LFDPL-KK-E-RLDWRKRFNIIEGI-----------------SRGLLYL----HR-  598 (807)
Q Consensus       561 ~gsL~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~~i-----------------a~gL~yL----H~-  598 (807)
                      +.+|...                 +|... .. . ..-+.++.++..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8777422                 11110 00 0 11122222222111                 1111112    11 


Q ss_pred             cCCCcEEeCCCCCCCeeecC-CCCceeeccccccc
Q 003628          599 DSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKI  632 (807)
Q Consensus       599 ~~~~~ivH~DIkp~NIll~~-~~~~kL~DFGla~~  632 (807)
                      .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            12235899999999999986 47899999988763

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.67  E-value=0.013  Score=62.14  Aligned_cols=72  Identities=15%  Similarity=0.191  Sum_probs=42.3

Q ss_pred             ccccCCCc---cEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhcc-C-C-ceeEEeeEEEeCCeEEEEEEecCC
Q 003628          488 KLGQGGFG---PVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H-R-NLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       488 ~LG~G~~g---~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H-~-niv~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      .+..|+.|   .|+.....+|..+++|.-+.  ......+.+|.++|+.+. | + -+++++..    ....++|++++|
T Consensus        15 ~~~~~~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~----~~~~~~y~~i~G   88 (276)
T cd05152          15 TLSLNESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWRVH----TPELIAYPKLPG   88 (276)
T ss_pred             cceecCCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCceeee----cCceEEEeccCC
Confidence            34444444   45555445688999998743  223456789999999985 3 2 12332221    123567888877


Q ss_pred             CCcc
Q 003628          562 RSLD  565 (807)
Q Consensus       562 gsL~  565 (807)
                      ..+.
T Consensus        89 ~p~~   92 (276)
T cd05152          89 VPAA   92 (276)
T ss_pred             Cccc
Confidence            6553

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.66  E-value=0.0023  Score=77.00  Aligned_cols=198  Identities=21%  Similarity=0.188  Sum_probs=134.4

Q ss_pred             HHHHHHHHHHHhccCCceeEEeeEEEeCCeEE----EEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhh
Q 003628          522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH  597 (807)
Q Consensus       522 ~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH  597 (807)
                      ....-|+..+.++.|+|+++++.+-.+....-    +..|++..-++...+.   ....++......+..++.+||.|+|
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHH
Confidence            33456777888899999999999977654443    3457777777777774   3456778888888999999999999


Q ss_pred             hcCCCcEEeCCCCCC---CeeecCCCCceee--ccccccccCCCCCccccceeeccCCccChhhhccCCCCc--ccceee
Q 003628          598 RDSRLRIIHRDLKAS---NILLDEELNPKIS--DFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE--KSDVFS  670 (807)
Q Consensus       598 ~~~~~~ivH~DIkp~---NIll~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~--k~DvwS  670 (807)
                      ...   ..|.-+..+   +--.+..+...+.  ||+..+.+.......   ...-+..+.|||......++.  ..|+|.
T Consensus       304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHH
Confidence            885   555444444   4445566666666  888877654332211   123456788888777665554  479999


Q ss_pred             hhHHHHHHHhCCCCCCccCCcchhhhhhhhhccccccccccCccccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHH
Q 003628          671 FGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVV  750 (807)
Q Consensus       671 lGvvl~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev~  750 (807)
                      +|..+..+..|..+.......                ..+++..     .    ...+.+....|+..++++|++..+++
T Consensus       378 lgll~~~~~~~~~i~~~~~~~----------------~~~l~~~-----~----~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSAVP----------------VSLLDVL-----S----TSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHHHHhhhhhcCcccccccch----------------hhhhccc-----c----chhhhhhhhhhcchhhhhccchhhhh
Confidence            999999999987654321100                0011100     1    11455677899999999999999998


Q ss_pred             HHH
Q 003628          751 SML  753 (807)
Q Consensus       751 ~~L  753 (807)
                      .+.
T Consensus       433 ~~~  435 (1351)
T KOG1035|consen  433 THP  435 (1351)
T ss_pred             hch
Confidence            765

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.65  E-value=0.01  Score=63.09  Aligned_cols=73  Identities=18%  Similarity=0.242  Sum_probs=49.0

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEecccCcccHHHHHHHHHHHHhcc---CCceeEEeeEEEeCCeEEEEEEecCCC
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLIYEYMPNR  562 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~g  562 (807)
                      .+.++.|.-..+|+.. .+++.+.||.-.   ......|..|.+-|+.|.   --.+++++++....+..+||+||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4568888889999887 567889999875   233467888998888883   456889999988777889999999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.59  E-value=0.004  Score=65.27  Aligned_cols=144  Identities=15%  Similarity=0.213  Sum_probs=100.7

Q ss_pred             cCHHHHHHHhcC---CcccCccccCCCccEEEEEecCCcEEEEEEeccc-----------------Cccc-----HHHHH
Q 003628          471 FQFEELATATNN---FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA-----------------SGQG-----LEEFM  525 (807)
Q Consensus       471 f~~~~l~~~~~~---~~~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~-----------------~~~~-----~~~~~  525 (807)
                      +.|--+++..++   +.+.+.||-|--+.||.+...+|++.++|.-+-.                 ....     .-...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            555555555544   6778999999999999999999999999853210                 0000     12345


Q ss_pred             HHHHHHHhccC--CceeEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCc
Q 003628          526 NEVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR  603 (807)
Q Consensus       526 ~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  603 (807)
                      +|...|+.|..  --+++.+++    ...++|||++.+-.|...-+      ..+..+   +...+..-+.-|-.+|   
T Consensus       159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---  222 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---  222 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---
Confidence            78888988853  345666655    45689999999988765532      122222   3344444455666677   


Q ss_pred             EEeCCCCCCCeeecCCCCceeeccccc
Q 003628          604 IIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       604 ivH~DIkp~NIll~~~~~~kL~DFGla  630 (807)
                      +||+|..-=||+++++..++++||--.
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHh
Confidence            999999999999999999999999643

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=96.53  E-value=0.0024  Score=52.83  Aligned_cols=32  Identities=19%  Similarity=0.712  Sum_probs=27.5

Q ss_pred             ccHHHHHHHHhccCCeeeEeecC-CeeEEEeee
Q 003628          358 ATEDECREQCLKNCSCIAYAFDG-GIGCMVWRS  389 (807)
Q Consensus       358 ~s~~~C~~~Cl~nCsC~a~~~~~-g~gC~~w~~  389 (807)
                      .+.++|+..|+.+|+|.||.|.. ...|+++.+
T Consensus        25 ~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~   57 (73)
T cd01100          25 SSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS   57 (73)
T ss_pred             CCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence            38999999999999999999984 456888776

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.35  E-value=0.03  Score=61.89  Aligned_cols=80  Identities=13%  Similarity=0.078  Sum_probs=54.4

Q ss_pred             cCccccCCCccEEEEEecCCcEEEEEEeccc----Cc---ccHHHHHHHHHHHHhcc---CCceeEEeeEEEeCCeEEEE
Q 003628          486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA----SG---QGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~----~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV  555 (807)
                      .+.||.|....||+.... +..++||+-...    ..   -..++-..|++.|+.+.   ..++++++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            467899999999998865 557999986521    11   13445555677776663   357888998876  456789


Q ss_pred             EEecCC--CCccccc
Q 003628          556 YEYMPN--RSLDALL  568 (807)
Q Consensus       556 ~E~~~~--gsL~~~l  568 (807)
                      ||++++  ..+.+-+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999977  3444433

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.30  E-value=0.021  Score=62.08  Aligned_cols=72  Identities=15%  Similarity=0.171  Sum_probs=50.5

Q ss_pred             ccccCCCccEEEEEecCC-cEEEEEEeccc-------CcccHHHHHHHHHHHHhcc--CC-ceeEEeeEEEeCCeEEEEE
Q 003628          488 KLGQGGFGPVYWGRLKDG-QEIAVKRLSKA-------SGQGLEEFMNEVMVISKLQ--HR-NLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       488 ~LG~G~~g~Vy~~~~~~g-~~vAvK~l~~~-------~~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV~  556 (807)
                      .||.|-...||++..++| +.|+||.-...       -+-..++..-|.+.|....  -| .+++++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            578899999999998754 58999975421       1334566677888887663  24 45566654  566677999


Q ss_pred             EecCC
Q 003628          557 EYMPN  561 (807)
Q Consensus       557 E~~~~  561 (807)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99964

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.14  E-value=0.023  Score=60.76  Aligned_cols=139  Identities=19%  Similarity=0.226  Sum_probs=95.1

Q ss_pred             ccCccccCCCccEEEEEecCCcEEEEEEecccC----------------------cccHHH----HHHHHHHHHhccCCc
Q 003628          485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----------------------GQGLEE----FMNEVMVISKLQHRN  538 (807)
Q Consensus       485 ~~~~LG~G~~g~Vy~~~~~~g~~vAvK~l~~~~----------------------~~~~~~----~~~E~~~l~~l~H~n  538 (807)
                      +...|..|--+.||.+.-.+|..+|||+.+...                      ....+.    ...|++.|.+|+.-.
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            345688899999999999999999999875320                      000111    135788888886544


Q ss_pred             eeEEeeEEEeCCeEEEEEEecCCCCccccccCCCCCCCCChhhhHHHHHHHHhhhHhhhhcCCCcEEeCCCCCCCeeecC
Q 003628          539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE  618 (807)
Q Consensus       539 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DIkp~NIll~~  618 (807)
                      |+-.--...  ....|||+|+....   +-....+...++...+..+-.++++-|.-|.+.+  .+||.||.-=|+|+.+
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd  300 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD  300 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence            322111111  23468999996422   2222234556777788888889999999998887  5999999999999864


Q ss_pred             CCCceeecccccc
Q 003628          619 ELNPKISDFGMAK  631 (807)
Q Consensus       619 ~~~~kL~DFGla~  631 (807)
                       |.+.|+|-+-+.
T Consensus       301 -G~lyiIDVSQSV  312 (520)
T KOG2270|consen  301 -GKLYIIDVSQSV  312 (520)
T ss_pred             -CEEEEEEccccc
Confidence             578889987554

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.04  E-value=0.04  Score=60.15  Aligned_cols=141  Identities=18%  Similarity=0.274  Sum_probs=78.7

Q ss_pred             CccccCCCccEEEEEecC----CcEEEEEEecccCcccHHHHHHHHHHHHhccCCce-eEEeeEEEeCCeEEEEEEecCC
Q 003628          487 SKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~LG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~  561 (807)
                      +.|..|=.-.+|+....+    +..|++|+....... .-.-.+|..+++.+..-++ +++++++..+    +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence            344446666788876543    237899988654332 2233578889888865444 4566665322    48999988


Q ss_pred             CCcccc-------c----------cCCC-C-CCCC-ChhhhHHHHHHH----------------------HhhhH----h
Q 003628          562 RSLDAL-------L----------FDPL-K-KERL-DWRKRFNIIEGI----------------------SRGLL----Y  595 (807)
Q Consensus       562 gsL~~~-------l----------~~~~-~-~~~l-~~~~~~~i~~~i----------------------a~gL~----y  595 (807)
                      ..|..-       +          +... . .... -|..+.++..++                      .+-+.    .
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            766321       1          1100 0 0001 122222221111                      11111    1


Q ss_pred             hhh-cCCCcEEeCCCCCCCeeecC-CCCceeeccccccc
Q 003628          596 LHR-DSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKI  632 (807)
Q Consensus       596 LH~-~~~~~ivH~DIkp~NIll~~-~~~~kL~DFGla~~  632 (807)
                      +.. ....-++|+|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            111 11234899999999999975 57899999998763

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.98  E-value=0.02  Score=58.08  Aligned_cols=30  Identities=33%  Similarity=0.504  Sum_probs=21.5

Q ss_pred             cEEeCCCCCCCeee-cCCCCceeeccccccc
Q 003628          603 RIIHRDLKASNILL-DEELNPKISDFGMAKI  632 (807)
Q Consensus       603 ~ivH~DIkp~NIll-~~~~~~kL~DFGla~~  632 (807)
                      -+.|+|+.|.|||+ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8899999999998763

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.89  E-value=0.015  Score=63.97  Aligned_cols=74  Identities=11%  Similarity=0.106  Sum_probs=52.8

Q ss_pred             cCccccCCCccEEEEEecC-CcEEEEEEeccc------CcccHHHHHHHHHHHHhcc--CC-ceeEEeeEEEeCCeEEEE
Q 003628          486 SSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA------SGQGLEEFMNEVMVISKLQ--HR-NLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       486 ~~~LG~G~~g~Vy~~~~~~-g~~vAvK~l~~~------~~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV  555 (807)
                      .+.||.|--.-||++...+ ++.|+||.-...      -+-..++..-|.+.|+...  -| .+++++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4678999999999999853 568999975421      1334577778888888763  34 46666655  56667789


Q ss_pred             EEecCC
Q 003628          556 YEYMPN  561 (807)
Q Consensus       556 ~E~~~~  561 (807)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	807
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-57
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-56
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-44
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-43
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-38
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-37
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-36
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-25
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-24
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-24
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-24
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-24
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-24
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-24
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-24
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-24
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-24
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-24
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-24
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-24
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-24
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-23
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-23
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-23
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-23
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-23
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-23
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-23
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-23
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-23
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-23
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-23
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-23
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-22
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-22
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-22
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-22
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-22
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-22
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-22
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-22
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-22
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-22
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-22
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-22
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-21
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-21
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-21
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-21
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-21
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-20
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-19
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-19
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-19
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-19
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-19
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-19
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-19
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-19
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-19
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-19
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-19
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-19
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-19
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-19
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-19
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-18
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-18
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-18
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-18
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-18
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-17
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-17
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-17
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-16
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-16
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-16
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-16
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-16
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
3soa_A	444	Full-Length Human Camkii Length = 444		2e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  220 bits (561), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 130/300 (43%), Positives = 181/300 (60%), Gaps = 8/300 (2%)
Query: 463 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
           V L  L  F   EL  A++NF   + LG+GGFG VY GRL DG  +AVKRL +   QG E
Sbjct: 20  VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGE 79
Query: 523 -EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWR 580
            +F  EV +IS   HRNL+RL G C+   E++L+Y YM N S+ + L + P  +  LDW 
Sbjct: 80  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 139
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
           KR  I  G +RGL YLH     +IIHRD+KA+NILLDEE    + DFG+AK+    +D  
Sbjct: 140 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXH 198
Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF----EDDLTILG 696
               V GT G+++PEY   G+ SEK+DVF +GV+LLE+++G++         +DD+ +L 
Sbjct: 199 VXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 258
Query: 697 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 756
           +   L  E K+ ALVD  L + +++ + + + I V LLC Q    +RP MS VV ML  +
Sbjct: 259 WVKGLLKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  218 bits (554), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 129/300 (43%), Positives = 180/300 (60%), Gaps = 8/300 (2%)
Query: 463 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
           V L  L  F   EL  A++NF   + LG+GGFG VY GRL DG  +AVKRL +   QG E
Sbjct: 12  VHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGE 71
Query: 523 -EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWR 580
            +F  EV +IS   HRNL+RL G C+   E++L+Y YM N S+ + L + P  +  LDW 
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
           KR  I  G +RGL YLH     +IIHRD+KA+NILLDEE    + DFG+AK+    +D  
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXH 190
Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF----EDDLTILG 696
               V G  G+++PEY   G+ SEK+DVF +GV+LLE+++G++         +DD+ +L 
Sbjct: 191 VXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 697 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 756
           +   L  E K+ ALVD  L + +++ + + + I V LLC Q    +RP MS VV ML  +
Sbjct: 251 WVKGLLKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  176 bits (447), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 117/295 (39%), Positives = 171/295 (57%), Gaps = 12/295 (4%)
Query: 468 LPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE 527
           +PL   EE   ATNNF     +G G FG VY G L+DG ++A+KR +  S QG+EEF  E
Sbjct: 29  VPLVDLEE---ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-DPLKKERLDWRKRFNII 586
           +  +S  +H +LV L+G C E  E +LIY+YM N +L   L+   L    + W +R  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
            G +RGL YLH  +   IIHRD+K+ NILLDE   PKI+DFG++K  G   DQ     VV
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLXXVV 201
Query: 647 -GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLTILGYAWKLWN 703
            GT GY+ PEY ++GR +EKSDV+SFGV+L E++  R     S   + + +  +A +  N
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 704 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 758
             ++  +VDP L++   + + + +     + C+    +DRP+M  V+  L   +R
Sbjct: 262 NGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  174 bits (440), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 116/295 (39%), Positives = 170/295 (57%), Gaps = 12/295 (4%)
Query: 468 LPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE 527
           +PL   EE   ATNNF     +G G FG VY G L+DG ++A+KR +  S QG+EEF  E
Sbjct: 29  VPLVDLEE---ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-DPLKKERLDWRKRFNII 586
           +  +S  +H +LV L+G C E  E +LIY+YM N +L   L+   L    + W +R  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
            G +RGL YLH  +   IIHRD+K+ NILLDE   PKI+DFG++K  G    Q     VV
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVV 201
Query: 647 -GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLTILGYAWKLWN 703
            GT GY+ PEY ++GR +EKSDV+SFGV+L E++  R     S   + + +  +A +  N
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 704 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 758
             ++  +VDP L++   + + + +     + C+    +DRP+M  V+  L   +R
Sbjct: 262 NGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  155 bits (392), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 93/221 (42%), Positives = 127/221 (57%), Gaps = 15/221 (6%)
Query: 471 FQFEELATATNNFQL------SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE- 523
           F F EL   TNNF         +K+G+GGFG VY G + +   +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 524 ---FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
              F  E+ V++K QH NLV LLG   +G++  L+Y YMPN SL   L        L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
            R  I +G + G+ +LH +     IHRD+K++NILLDE    KISDFG+A+         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
              R+VGT  YM+PE A+ G  + KSD++SFGV+LLEI++G
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  155 bits (391), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 93/221 (42%), Positives = 127/221 (57%), Gaps = 15/221 (6%)
Query: 471 FQFEELATATNNFQL------SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE- 523
           F F EL   TNNF         +K+G+GGFG VY G + +   +AVK+L+       EE 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 524 ---FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
              F  E+ V++K QH NLV LLG   +G++  L+Y YMPN SL   L        L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
            R  I +G + G+ +LH +     IHRD+K++NILLDE    KISDFG+A+         
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
              R+VGT  YM+PE A+ G  + KSD++SFGV+LLEI++G
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  154 bits (390), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 93/221 (42%), Positives = 127/221 (57%), Gaps = 15/221 (6%)
Query: 471 FQFEELATATNNFQL------SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE- 523
           F F EL   TNNF         +K+G+GGFG VY G + +   +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 524 ---FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
              F  E+ V++K QH NLV LLG   +G++  L+Y YMPN SL   L        L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
            R  I +G + G+ +LH +     IHRD+K++NILLDE    KISDFG+A+         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
              R+VGT  YM+PE A+ G  + KSD++SFGV+LLEI++G
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  149 bits (376), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 91/221 (41%), Positives = 123/221 (55%), Gaps = 15/221 (6%)
Query: 471 FQFEELATATNNFQL------SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE- 523
           F F EL   TNNF         +K G+GGFG VY G + +   +AVK+L+       EE 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 524 ---FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
              F  E+ V +K QH NLV LLG   +G++  L+Y Y PN SL   L        L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
            R  I +G + G+ +LH +     IHRD+K++NILLDE    KISDFG+A+         
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
              R+VGT  Y +PE A+ G  + KSD++SFGV+LLEI++G
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 114/201 (56%), Gaps = 6/201 (2%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNL 539
           +  +  K+G G FG V+      G ++AVK L +     + + EF+ EV ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V  +G   +     ++ EY+   SL  LL     +E+LD R+R ++   +++G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
               I+HRDLK+ N+L+D++   K+ DFG++++         +    GT  +M+PE   +
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASX--FLXSKXAAGTPEWMAPEVLRD 213
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
              +EKSDV+SFGV+L E+ +
Sbjct: 214 EPSNEKSDVYSFGVILWELAT 234

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 115/201 (57%), Gaps = 6/201 (2%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNL 539
           +  +  K+G G FG V+      G ++AVK L +     + + EF+ EV ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V  +G   +     ++ EY+   SL  LL     +E+LD R+R ++   +++G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
               I+HR+LK+ N+L+D++   K+ DFG++++       + +    GT  +M+PE   +
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRD 213
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
              +EKSDV+SFGV+L E+ +
Sbjct: 214 EPSNEKSDVYSFGVILWELAT 234

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHR 598
           L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ R
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
              +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+
Sbjct: 299 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 354
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
            GRF+ KSDV+SFG+LL E+ +
Sbjct: 355 YGRFTIKSDVWSFGILLTELTT 376

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 66
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 597
           +L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 67  QLYAVVSE-EPIXIVTEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 122 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAA 177
Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 178 LYGRFTIKSDVWSFGILLTELTT 200

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHR 598
           L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ R
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
              +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+
Sbjct: 299 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 354
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
            GRF+ KSDV+SFG+LL E+ +
Sbjct: 355 YGRFTIKSDVWSFGILLTELTT 376

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYG 190
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHR 598
           L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ R
Sbjct: 327 LYAVVSE-EPIYIVTEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
              +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+
Sbjct: 382 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 437
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
            GRF+ KSDV+SFG+LL E+ +
Sbjct: 438 YGRFTIKSDVWSFGILLTELTT 459

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 65
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 66  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 121
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 122 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 179
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           RF+ KSDV+SFG+LL E+ +
Sbjct: 180 RFTIKSDVWSFGILLTELTT 199

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 69
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 597
           +L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 70  QLYAVVSE-EPIYIVTEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 124
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 125 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 180
Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 181 LYGRFTIKSDVWSFGILLTELTT 203

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 67
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 68  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 123
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 124 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 181
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           RF+ KSDV+SFG+LL E+ +
Sbjct: 182 RFTIKSDVWSFGILLTELTT 201

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHR 598
           L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ R
Sbjct: 244 LYAVVSE-EPIYIVGEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
              +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+
Sbjct: 299 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 354
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
            GRF+ KSDV+SFG+LL E+ +
Sbjct: 355 YGRFTIKSDVWSFGILLTELTT 376

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  109 bits (272), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 137/282 (48%), Gaps = 36/282 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  +LG G FG V+ G   +  ++AVK L K     ++ F+ E  ++  LQH  LV
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 71
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           RL       E   +I EYM   SL D L  D   K  L   K  +    I+ G+ Y+ R 
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERK 129
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL+A+N+L+ E L  KI+DFG+A++   N+  A  G       + +PE    
Sbjct: 130 N---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINF 185
Query: 660 GRFSEKSDVFSFGVLLLEIVS-------GRKNTSFFEDDLTILGYAWKLWNENKILALVD 712
           G F+ KSDV+SFG+LL EIV+       GR N     D +T L   +++           
Sbjct: 186 GCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNA----DVMTALSQGYRM----------- 230
Query: 713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 754
           P +     +L  I++      +C +E  ++RP    + S+L+
Sbjct: 231 PRVENCPDELYDIMK------MCWKEKAEERPTFDYLQSVLD 266

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 597
           +L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 74  QLYAVVSE-EPIYIVTEYMNKGSL----LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 129 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 184
Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTT 207

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 93/326 (28%), Positives = 156/326 (47%), Gaps = 48/326 (14%)
Query: 471 FQFEELATATNNF---------QLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA- 516
           F FE+   A   F         ++   +G G FG V  GRLK  G+    +A+K L    
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 517 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER 576
           + +   +F++E  ++ +  H N++ L G   + +  M+I EYM N SLDA L       R
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGR 127
Query: 577 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
               +   ++ GI  G+ YL   S +  +HRDL A NIL++  L  K+SDFGM+++   +
Sbjct: 128 FTVIQLVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 637 QDQADTGRVVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTIL 695
            + A T R       + +PE     +F+  SDV+S+G+++ E++S  +            
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP---------- 234
Query: 696 GYAWKLWNENKILALVDPFLSESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVS 751
              W + N++ I A+      E  ++L   + C   +H  +L C Q+   DRP    +V+
Sbjct: 235 --YWDMSNQDVIKAI------EEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVN 286
Query: 752 MLNSEIRDLPYPKEPAFTERQGADDS 777
           ML+  IR+      P   +R G++ S
Sbjct: 287 MLDKLIRN------PNSLKRTGSESS 306

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/199 (35%), Positives = 108/199 (54%), Gaps = 7/199 (3%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 186 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQ 244
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R   
Sbjct: 245 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER--- 299
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
           +  +HRDL+A+NIL+ E L  K++DFG+ ++   N+  A  G       + +PE A+ GR
Sbjct: 300 MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGR 358
Query: 662 FSEKSDVFSFGVLLLEIVS 680
           F+ KSDV+SFG+LL E+ +
Sbjct: 359 FTIKSDVWSFGILLTELTT 377

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ K++H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLV 76
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 108/200 (54%), Gaps = 7/200 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            +  +HRDL A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 597
           +L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 74  QLYAVVSE-EPIYIVTEYMNKGSL----LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 129 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAA 184
Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTT 207

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 597
           +L     E E   ++ EYM        L D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 77  QLYAVVSE-EPIYIVMEYMSK----GCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 187
Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTT 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 597
           +L     E E   ++ EYM        L D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSK----GCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 187
Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTT 210

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 66
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 67  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 124
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 125 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 180
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 181 PEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 65
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 66  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 123
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 124 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 179
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 180 PEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 64
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 122
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 178
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 73
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 74  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 131
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 132 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 187
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 188 PEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 64
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 122
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 178
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 72
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 73  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 130
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 131 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 186
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 187 PEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 70
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 71  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 128
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 129 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 184
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 150/305 (49%), Gaps = 39/305 (12%)
Query: 483 FQLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHR 537
            ++   +G G FG V  GRLK  G+    +A+K L    + +   +F++E  ++ +  H 
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N++ L G   + +  M+I EYM N SLDA L       R    +   ++ GI  G+ YL 
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGSGMKYL- 126
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT-FGYMSPEY 656
             S +  +HRDL A NIL++  L  K+SDFGM+++   + + A T R       + +PE 
Sbjct: 127 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 716
               +F+  SDV+S+G+++ E++S  +               W + N++ I A+      
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERP------------YWDMSNQDVIKAI------ 226
Query: 717 ESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQ 772
           E  ++L   + C   +H  +L C Q+   DRP    +V+ML+  IR+      P   +R 
Sbjct: 227 EEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRN------PNSLKRT 280
Query: 773 GADDS 777
           G++ S
Sbjct: 281 GSESS 285

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 64
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 122
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTA 178
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 70
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 71  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 128
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 129 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTA 184
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 69
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 70  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 127
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 128 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTA 183
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 184 PEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 150/305 (49%), Gaps = 39/305 (12%)
Query: 483 FQLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHR 537
            ++   +G G FG V  GRLK  G+    +A+K L    + +   +F++E  ++ +  H 
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N++ L G   + +  M+I EYM N SLDA L       R    +   ++ GI  G+ YL 
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGSGMKYL- 132
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT-FGYMSPEY 656
             S +  +HRDL A NIL++  L  K+SDFGM+++   + + A T R       + +PE 
Sbjct: 133 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 716
               +F+  SDV+S+G+++ E++S  +               W + N++ I A+      
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERP------------YWDMSNQDVIKAI------ 232
Query: 717 ESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQ 772
           E  ++L   + C   +H  +L C Q+   DRP    +V+ML+  IR+      P   +R 
Sbjct: 233 EEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRN------PNSLKRT 286
Query: 773 GADDS 777
           G++ S
Sbjct: 287 GSESS 291

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 74
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 75  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 132
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 133 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTA 188
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 189 PEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 59
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 60  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 117
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 118 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTA 173
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG+A++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR 208
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 138/281 (49%), Gaps = 36/281 (12%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLG G FG V+ G   +  ++AVK L K     ++ F+ E  ++  LQH  LVR
Sbjct: 13  SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVR 71
Query: 542 LLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           L     + E   +I E+M   SL D L  D   K  L   K  +    I+ G+ Y+ R +
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN 129
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
               IHRDL+A+N+L+ E L  KI+DFG+A++   N+  A  G       + +PE    G
Sbjct: 130 ---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 185
Query: 661 RFSEKSDVFSFGVLLLEIVS-------GRKNTSFFEDDLTILGYAWKLWNENKILALVDP 713
            F+ KS+V+SFG+LL EIV+       GR N     D ++ L   +++           P
Sbjct: 186 CFTIKSNVWSFGILLYEIVTYGKIPYPGRTNA----DVMSALSQGYRM-----------P 230
Query: 714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 754
            +     +L  I++      +C +E  ++RP    + S+L+
Sbjct: 231 RMENCPDELYDIMK------MCWKEKAEERPTFDYLQSVLD 265

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 140/291 (48%), Gaps = 37/291 (12%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKL 534
            +   +   +G G  G V +GRL+  GQ    +A+K L    + +   +F++E  ++ + 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            H N++RL G    G   M++ EYM N SLD  L       +    +   ++ G+  G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMR 165
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGY 651
           YL   S L  +HRDL A N+L+D  L  K+SDFG++++   + D A T   G++     +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRW 220
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV 711
            +PE      FS  SDV+SFGV++ E+++  +               W + N + I ++ 
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY------------WNMTNRDVISSV- 267
Query: 712 DPFLSESSFQLDMIIRCIH----VGLLCVQELVKDRPNMSTVVSMLNSEIR 758
                E  ++L   + C H    + L C  +    RP  S +VS+L++ IR
Sbjct: 268 -----EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/199 (35%), Positives = 108/199 (54%), Gaps = 7/199 (3%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + QL  +LG G FG V+ G      ++A+K L K      E F+ E  ++ KL+H  LV+
Sbjct: 10  SLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQ 68
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           L     E E   ++ EYM   SL   L D  +   L      ++   ++ G+ Y+ R   
Sbjct: 69  LYAVVSE-EPIYIVTEYMNKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER--- 123
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
           +  IHRDL+++NIL+   L  KI+DFG+A++   N+  A  G       + +PE A+ GR
Sbjct: 124 MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGR 182
Query: 662 FSEKSDVFSFGVLLLEIVS 680
           F+ KSDV+SFG+LL E+V+
Sbjct: 183 FTIKSDVWSFGILLTELVT 201

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 140/291 (48%), Gaps = 37/291 (12%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKL 534
            +   +   +G G  G V +GRL+  GQ    +A+K L    + +   +F++E  ++ + 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            H N++RL G    G   M++ EYM N SLD  L       +    +   ++ G+  G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMR 165
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGY 651
           YL   S L  +HRDL A N+L+D  L  K+SDFG++++   + D A T   G++     +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRW 220
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV 711
            +PE      FS  SDV+SFGV++ E+++  +               W + N + I ++ 
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY------------WNMTNRDVISSV- 267
Query: 712 DPFLSESSFQLDMIIRCIH----VGLLCVQELVKDRPNMSTVVSMLNSEIR 758
                E  ++L   + C H    + L C  +    RP  S +VS+L++ IR
Sbjct: 268 -----EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/199 (35%), Positives = 109/199 (54%), Gaps = 7/199 (3%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
             +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +LQH+ LVR
Sbjct: 10  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 68
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           L     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+ ++   + 
Sbjct: 69  LYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN- 125
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
              IHR+L+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +PE    G 
Sbjct: 126 --YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGT 182
Query: 662 FSEKSDVFSFGVLLLEIVS 680
           F+ KSDV+SFG+LL EIV+
Sbjct: 183 FTIKSDVWSFGILLTEIVT 201

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 5   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 59
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 117
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 118 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 174
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 175 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 37  QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 91
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 149
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 150 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 206
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 10  QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 64
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 122
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 123 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 179
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 180 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 33  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 91
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 149
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 150 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 207 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 254
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 255 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 308

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 4   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 58
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 116
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 117 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 173
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 174 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 12  QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 66
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 124
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 125 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 181
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 182 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKL 534
           +N  L  +LG+G FG V+          +D   +AVK L  AS    ++F  E  +++ L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD----------ALLFDPLKKERLDWRKRFN 584
           QH ++V+  G CVEG+  ++++EYM +  L+           L+ +      L   +  +
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           I + I+ G++YL   +    +HRDL   N L+ E L  KI DFGM++           G 
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            +    +M PE  M  +F+ +SDV+S GV+L EI +
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 6   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 118
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 119 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 175
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 23  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 81
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 139
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 140 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 197 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 244
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 245 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 298

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 13  QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 67
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 68  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 125
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 126 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 182
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 183 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 6   VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 122
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 123 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 227
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 228 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 11  QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 65
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 123
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 124 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 180
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 181 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 6   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 118
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 119 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 175
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 9   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 121
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 122 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/219 (34%), Positives = 112/219 (51%), Gaps = 18/219 (8%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEF 524
           + QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F
Sbjct: 22  MTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 76
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKR 582
             E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K 
Sbjct: 77  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 134
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
                 I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++    
Sbjct: 135 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 643 GRV-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                    + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/219 (34%), Positives = 112/219 (51%), Gaps = 18/219 (8%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEF 524
           + QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F
Sbjct: 22  MTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 76
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKR 582
             E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K 
Sbjct: 77  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 134
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
                 I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++    
Sbjct: 135 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 643 GRV-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                    + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 147/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG+ ++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/218 (35%), Positives = 113/218 (51%), Gaps = 20/218 (9%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 6   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 118
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADT 642
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++  +   
Sbjct: 119 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                 F Y +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 176 PGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 110/217 (50%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 9   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L      ER+D  K   
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQ 121
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 122 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 9   QFEE-----RHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI E++P  SL   L     KER+D  K   
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQ 121
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 122 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
             +L  +LG G  G V+ G      ++AVK L + S    + F+ E  ++ +LQH+ LVR
Sbjct: 14  TLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 72
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           L     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+ ++   + 
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAME 659
              IHRDL+A+NIL+ + L+ KI+DFG+A++    +D   T R    F   + +PE    
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLI---EDAEXTAREGAKFPIKWTAPEAINY 184
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
           G F+ KSDV+SFG+LL EIV+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 526
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 7   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 119
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
               I +G+ YL      R IHR+L   NIL++ E   KI DFG+ K+   +++      
Sbjct: 120 YTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 176
Query: 645 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 177 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 147/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ E M N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 147/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ E M N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 147/300 (49%), Gaps = 34/300 (11%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 524
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 6   VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           + E  ++ +  H N++RL G   + +  M++ E M N SLD+ L       +    +   
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK--HDAQFTVIQLVG 122
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 123 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 645 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 227
Query: 704 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 228 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 135/279 (48%), Gaps = 30/279 (10%)
Query: 489 LGQGGFGPVYWGRLKDGQ-----EIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRL 542
           +G G FG VY G LK         +A+K L     +    +F+ E  ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
            G   + +  M+I EYM N +LD  L +  K       +   ++ GI+ G+ YL   + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGYMSPEYAME 659
             +HRDL A NIL++  L  K+SDFG++++   + +   T   G++     + +PE    
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTAPEAISY 224
Query: 660 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS 719
            +F+  SDV+SFG+++ E+++  +               W+L N   + A+ D F   + 
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPY------------WELSNHEVMKAINDGFRLPTP 272
Query: 720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 758
             +D       + + C Q+    RP  + +VS+L+  IR
Sbjct: 273 --MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLG G FG V+        ++AVK + K     +E F+ E  V+  LQH  LV+
Sbjct: 16  SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 74
Query: 542 LLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           L    V  E   +I E+M   SL D L  D   K+ L   K  +    I+ G+ ++ + +
Sbjct: 75  L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN 131
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
               IHRDL+A+NIL+   L  KI+DFG+A++   N+  A  G       + +PE    G
Sbjct: 132 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 187
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
            F+ KSDV+SFG+LL+EIV+
Sbjct: 188 SFTIKSDVWSFGILLMEIVT 207

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 139/279 (49%), Gaps = 29/279 (10%)
Query: 489 LGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLL 543
           +G G FG V  GRLK  G+    +A+K L    + +   +F+ E  ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE--RLDWRKRFNIIEGISRGLLYLHRDSR 601
           G   + +  M++ EYM N SLD  L    KK   +    +   ++ GIS G+ YL   S 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFL----KKNDGQFTVIQLVGMLRGISAGMKYL---SD 142
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT-FGYMSPEYAMEG 660
           +  +HRDL A NIL++  L  K+SDFG++++   + + A T R       + +PE     
Sbjct: 143 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 720
           +F+  SDV+S+G+++ E+VS  +               W++ N++ I A+ + +   S  
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERPY------------WEMTNQDVIKAVEEGYRLPSP- 249
Query: 721 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
            +D       + L C Q+    RP    +V+ML+  IR+
Sbjct: 250 -MDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRN 287

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 485 LSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
           L  +LG+G FG V+          +D   +AVK L +AS    ++F  E  +++ LQH++
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLF------------DPLKKERLDWRKRFNII 586
           +VR  G C EG   ++++EYM +  L+  L             + +    L   +   + 
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
             ++ G++YL   + L  +HRDL   N L+ + L  KI DFGM++           GR +
Sbjct: 142 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               +M PE  +  +F+ +SDV+SFGV+L EI +
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 485 LSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
           L  +LG+G FG V+          +D   +AVK L +AS    ++F  E  +++ LQH++
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSL---------DALLF---DPLKKERLDWRKRFNII 586
           +VR  G C EG   ++++EYM +  L         DA L    + +    L   +   + 
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
             ++ G++YL   + L  +HRDL   N L+ + L  KI DFGM++           GR +
Sbjct: 136 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               +M PE  +  +F+ +SDV+SFGV+L EI +
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 488 KLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           +LG+G FG V+          +D   +AVK L +AS    ++F  E  +++ LQH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 542 LLGCCVEGEEKMLIYEYMPNRSL---------DALLF---DPLKKERLDWRKRFNIIEGI 589
             G C EG   ++++EYM +  L         DA L    + +    L   +   +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
           + G++YL   + L  +HRDL   N L+ + L  KI DFGM++           GR +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            +M PE  +  +F+ +SDV+SFGV+L EI +
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLG G FG V+        ++AVK + K     +E F+ E  V+  LQH  LV+
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 542 LLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           L    V  E   +I E+M   SL D L  D   K+ L   K  +    I+ G+ ++ + +
Sbjct: 248 L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN 304
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
               IHRDL+A+NIL+   L  KI+DFG+A++   N+  A  G       + +PE    G
Sbjct: 305 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 360
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
            F+ KSDV+SFG+LL+EIV+
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 115/218 (52%), Gaps = 25/218 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQG-------LEEFMNEVMV 530
           A N  +   ++G+GGFG V+ GRL KD   +A+K L     +G        +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
           +S L H N+V+L G         ++ E++P   L   L D  K   + W  +  ++  I+
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD--EELNP---KISDFGMAKIFGGNQDQADTGRV 645
            G+ Y+ ++    I+HRDL++ NI L   +E  P   K++DFG+++     Q       +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGL 186
Query: 646 VGTFGYMSPEY--AMEGRFSEKSDVFSFGVLLLEIVSG 681
           +G F +M+PE   A E  ++EK+D +SF ++L  I++G
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 90
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       ++ EYMP  +L   L +   +E +       +   IS  + YL + 
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNLLDYLRE-CNREEVTAVVLLYMATQISSAMEYLEKK 149
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 150 N---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 205
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
             FS KSDV++FGVLL EI +
Sbjct: 206 NTFSIKSDVWAFGVLLWEIAT 226

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV+L G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 605
           E     L++E+M +  L     D L+ +R          +   +  G+ YL   S   +I
Sbjct: 73  EQAPICLVFEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VI 125
Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 184
Query: 666 SDVFSFGVLLLEIVS-------GRKNTSFFED 690
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 216

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 114/218 (52%), Gaps = 25/218 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQG-------LEEFMNEVMV 530
           A N  +   ++G+GGFG V+ GRL KD   +A+K L     +G        +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
           +S L H N+V+L G         ++ E++P   L   L D  K   + W  +  ++  I+
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD--EELNP---KISDFGMAKIFGGNQDQADTGRV 645
            G+ Y+ ++    I+HRDL++ NI L   +E  P   K++DFG ++     Q       +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGL 186
Query: 646 VGTFGYMSPEY--AMEGRFSEKSDVFSFGVLLLEIVSG 681
           +G F +M+PE   A E  ++EK+D +SF ++L  I++G
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV+L G C+
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 605
           E     L++E+M +  L     D L+ +R          +   +  G+ YL       +I
Sbjct: 71  EQAPICLVFEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 182
Query: 666 SDVFSFGVLLLEIVS-------GRKNTSFFED 690
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 114/229 (49%), Gaps = 25/229 (10%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLS-KASGQGLEEF 524
           + +E++ +   F    +LG+  FG VY G L      +  Q +A+K L  KA G   EEF
Sbjct: 19  KLKEISLSAVRFM--EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 76
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DP 571
            +E M+ ++LQH N+V LLG   + +   +I+ Y  +  L   L              D 
Sbjct: 77  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 136
Query: 572 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
             K  L+     +++  I+ G+ YL   S   ++H+DL   N+L+ ++LN KISD G+ +
Sbjct: 137 TVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193
Query: 632 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                      G  +    +M+PE  M G+FS  SD++S+GV+L E+ S
Sbjct: 194 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV+L G C+
Sbjct: 17  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 605
           E     L++E+M +  L     D L+ +R          +   +  G+ YL       +I
Sbjct: 76  EQAPICLVFEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 187
Query: 666 SDVFSFGVLLLEIVS-------GRKNTSFFED 690
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 219

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 114/229 (49%), Gaps = 25/229 (10%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLS-KASGQGLEEF 524
           + +E++ +   F    +LG+  FG VY G L      +  Q +A+K L  KA G   EEF
Sbjct: 2   KLKEISLSAVRFM--EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 59
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DP 571
            +E M+ ++LQH N+V LLG   + +   +I+ Y  +  L   L              D 
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 572 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
             K  L+     +++  I+ G+ YL   S   ++H+DL   N+L+ ++LN KISD G+ +
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 632 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                      G  +    +M+PE  M G+FS  SD++S+GV+L E+ S
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 143/288 (49%), Gaps = 35/288 (12%)
Query: 484 QLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHRN 538
           ++   +G G FG V  GRLK  G++   +A+K L    + +   EF++E  ++ + +H N
Sbjct: 19  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 78
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           ++RL G        M++ E+M N +LD+ L   L   +    +   ++ GI+ G+ YL  
Sbjct: 79  IIRLEGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYL-- 134
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN-QDQADTGRVVGTFG--YMSPE 655
            + +  +HRDL A NIL++  L  K+SDFG+++    N  D  +T  + G     + +PE
Sbjct: 135 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 715
                +F+  SD +S+G+++ E++      SF E         W + N++ I A+     
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVM------SFGERPY------WDMSNQDVINAI----- 236
Query: 716 SESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRD 759
            E  ++L     C   +H  +L C Q+    RP    VVS L+  IR+
Sbjct: 237 -EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRN 283

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV+L G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 605
           E     L++E+M +  L     D L+ +R          +   +  G+ YL       +I
Sbjct: 73  EQAPICLVFEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 184
Query: 666 SDVFSFGVLLLEIVS-------GRKNTSFFED 690
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 216

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 485 LSSKLGQGGFGPVYWGR------LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
           L  +LG+G FG V+          KD   +AVK L   +    ++F  E  +++ LQH +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSL---------DALLF---DPLK-KERLDWRKRFNI 585
           +V+  G C +G+  ++++EYM +  L         DA++     P + K  L   +  +I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
              I+ G++YL   +    +HRDL   N L+   L  KI DFGM++           G  
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 687
           +    +M PE  M  +F+ +SDV+SFGV+L EI +  K   F
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 25/218 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQG-------LEEFMNEVMV 530
           A N  +   ++G+GGFG V+ GRL KD   +A+K L     +G        +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
           +S L H N+V+L G         ++ E++P   L   L D  K   + W  +  ++  I+
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD--EELNP---KISDFGMAKIFGGNQDQADTGRV 645
            G+ Y+ ++    I+HRDL++ NI L   +E  P   K++DF +++     Q       +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGL 186
Query: 646 VGTFGYMSPEY--AMEGRFSEKSDVFSFGVLLLEIVSG 681
           +G F +M+PE   A E  ++EK+D +SF ++L  I++G
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAY 191
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 117/200 (58%), Gaps = 16/200 (8%)
Query: 489 LGQGGFGPVYWGR-LKDGQ----EIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRL 542
           LG G FG VY G  + +G+     +A+K L++ +G     EFM+E ++++ + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           LG C+    + L+ + MP+  L   + +   K+ +  +   N    I++G++YL      
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 159
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEG 660
           R++HRDL A N+L+    + KI+DFG+A++  G++ +  AD G++     +M+ E     
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMALECIHYR 217
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +F+ +SDV+S+GV + E+++
Sbjct: 218 KFTHQSDVWSYGVTIWELMT 237

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           ++G G FG V+ G   +  ++A+K + + S    ++F+ E  V+ KL H  LV+L G C+
Sbjct: 34  EIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 605
           E     L++E+M +  L     D L+ +R          +   +  G+ YL       +I
Sbjct: 93  EQAPICLVFEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 204
Query: 666 SDVFSFGVLLLEIVS-------GRKNTSFFED 690
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 205 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 236

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 130/297 (43%), Gaps = 41/297 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 534
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISKL
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 590
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 706
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 268
Query: 707 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 269 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 130/297 (43%), Gaps = 41/297 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 534
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISKL
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 590
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 706
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 254
Query: 707 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 255 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G FG VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAY 184
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 191
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 108/213 (50%), Gaps = 7/213 (3%)
Query: 469 PLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNE 527
           P   +++      +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKE 60
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
             V+ +++H NLV+LLG C       +I E+M   +L   L +   ++ ++      +  
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMAT 119
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            IS  + YL + +    IHRDL A N L+ E    K++DFG++++  G+   A  G    
Sbjct: 120 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF- 175
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
              + +PE     +FS KSDV++FGVLL EI +
Sbjct: 176 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 191
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 144/314 (45%), Gaps = 44/314 (14%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 526
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 578
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLAPPS 121
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 122 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 178
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA 698
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI              T+    
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA-------------TLAEQP 225
Query: 699 WKLWNENKILALV--DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 756
           ++  +  ++L  V     L +     DM++  +    +C Q   K RP+   ++S +  E
Sbjct: 226 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMR---MCWQYNPKMRPSFLEIISSIKEE 282
Query: 757 IRDLPYPKEPAFTE 770
           +       EP F E
Sbjct: 283 M-------EPGFRE 289

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 117/200 (58%), Gaps = 16/200 (8%)
Query: 489 LGQGGFGPVYWGR-LKDGQ----EIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRL 542
           LG G FG VY G  + +G+     +A+K L++ +G     EFM+E ++++ + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           LG C+    + L+ + MP+  L   + +   K+ +  +   N    I++G++YL      
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEG 660
           R++HRDL A N+L+    + KI+DFG+A++  G++ +  AD G++     +M+ E     
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMALECIHYR 194
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +F+ +SDV+S+GV + E+++
Sbjct: 195 KFTHQSDVWSYGVTIWELMT 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRN 538
             L   +G GGFG VY      G E+AVK           Q +E    E  + + L+H N
Sbjct: 9   LTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           ++ L G C++     L+ E+     L+ +L      +R+      N    I+RG+ YLH 
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 599 DSRLRIIHRDLKASNILLDEELNP--------KISDFGMAKIFGGNQDQADTGRVVGTFG 650
           ++ + IIHRDLK+SNIL+ +++          KI+DFG+A+ +      +      G + 
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS----AAGAYA 179
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +M+PE      FS+ SDV+S+GVLL E+++G
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 140/288 (48%), Gaps = 35/288 (12%)
Query: 484 QLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHRN 538
           ++   +G G FG V  GRLK  G++   +A+K L    + +   EF++E  ++ + +H N
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 76
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           ++RL G        M++ E+M N +LD+ L   L   +    +   ++ GI+ G+ YL  
Sbjct: 77  IIRLEGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYL-- 132
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG---TFGYMSPE 655
            + +  +HRDL A NIL++  L  K+SDFG+++    N         +G      + +PE
Sbjct: 133 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 715
                +F+  SD +S+G+++ E++      SF E         W + N++ I A+     
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVM------SFGERPY------WDMSNQDVINAI----- 234
Query: 716 SESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRD 759
            E  ++L     C   +H  +L C Q+    RP    VVS L+  IR+
Sbjct: 235 -EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRN 281

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 20/215 (9%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           ++G G FG VY+ R +++ + +A+K++S   K S +  ++ + EV  + KL+H N ++  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           GC +      L+ EY    + D L    + K+ L   +   +  G  +GL YLH  +   
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 174
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EG 660
           +IHRD+KA NILL E    K+ DFG A I       A     VGT  +M+PE  +   EG
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEG 228
Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTIL 695
           ++  K DV+S G+  +E+   RK   F  + ++ L
Sbjct: 229 QYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSAL 262

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 143/289 (49%), Gaps = 37/289 (12%)
Query: 483 FQLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHR 537
            ++   +G G FG V  GRLK  G+    +A+K L    + +   +F+ E  ++ +  H 
Sbjct: 45  IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHP 104
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V L G    G+  M++ E+M N +LDA L       +    +   ++ GI+ G+ YL 
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRK--HDGQFTVIQLVGMLRGIAAGMRYL- 161
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGYMSP 654
             + +  +HRDL A NIL++  L  K+SDFG++++   + +   T   G++     + +P
Sbjct: 162 --ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI--PVRWTAP 217
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF 714
           E     +F+  SDV+S+G+++ E++S  +               W + N++ I A+    
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPY------------WDMSNQDVIKAI---- 261
Query: 715 LSESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRD 759
             E  ++L   + C   +H  +L C Q+   +RP    +V +L+  IR+
Sbjct: 262 --EEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRN 308

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 134
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 135 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 190
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIAT 211

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV+L G C+
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 605
           E     L+ E+M +  L     D L+ +R          +   +  G+ YL       +I
Sbjct: 74  EQAPICLVTEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 185
Query: 666 SDVFSFGVLLLEIVS-------GRKNTSFFED 690
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 20/215 (9%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           ++G G FG VY+ R +++ + +A+K++S   K S +  ++ + EV  + KL+H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           GC +      L+ EY    + D L    + K+ L   +   +  G  +GL YLH  +   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EG 660
           +IHRD+KA NILL E    K+ DFG A I       A     VGT  +M+PE  +   EG
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEG 189
Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTIL 695
           ++  K DV+S G+  +E+   RK   F  + ++ L
Sbjct: 190 QYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSAL 223

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAY 184
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 102/193 (52%), Gaps = 7/193 (3%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 667
           DL A N L++++   K+SDFG+++    +++ +  G       +  PE  M  +FS KSD
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF-PVRWSPPEVLMYSKFSSKSD 203
Query: 668 VFSFGVLLLEIVS 680
           +++FGVL+ EI S
Sbjct: 204 IWAFGVLMWEIYS 216

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 526
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 578
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPS 130
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 131 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 187
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 188 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 191
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 534
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 590
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 706
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 268
Query: 707 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 269 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 129/298 (43%), Gaps = 41/298 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISK 533
            N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGI 589
             H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVV 646
           + G  YL  +     IHRD+ A N LL         KI DFGMA+           G  +
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNEN 705
               +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQ 244
Query: 706 KILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 245 EVLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 297

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 534
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 590
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 706
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 254
Query: 707 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 255 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 73
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 188
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/333 (27%), Positives = 141/333 (42%), Gaps = 49/333 (14%)
Query: 454 KLSATNVNTVKLQDLPLFQFEELATATN--------NFQLSSKLGQGGFGPVYWGRLK-- 503
           KLS    +T+     P + F    ++ +        N  L   LG G FG VY G++   
Sbjct: 2   KLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 61
Query: 504 ----DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
                  ++AVK L +   +  E +F+ E ++ISK  H+N+VR +G  ++   + ++ E 
Sbjct: 62  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 121
Query: 559 MPNRSLDALLFD----PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 614
           M    L + L +    P +   L      ++   I+ G  YL  +     IHRD+ A N 
Sbjct: 122 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 178
Query: 615 LLD---EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSF 671
           LL         KI DFGMA+           G  +    +M PE  MEG F+ K+D +SF
Sbjct: 179 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 238
Query: 672 GVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENKILALVDPFLSESSFQLDMIIRC-- 728
           GVLL EI S              LGY  +   +  ++L  V      S  ++D    C  
Sbjct: 239 GVLLWEIFS--------------LGYMPYPSKSNQEVLEFVT-----SGGRMDPPKNCPG 279
Query: 729 --IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
               +   C Q   +DRPN + ++  +    +D
Sbjct: 280 PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 312

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 534
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 590
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 706
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 253
Query: 707 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 254 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 73
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 188
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 84
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 85  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 143
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 144 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 199
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 200 NKFSIKSDVWAFGVLLWEIAT 220

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 72
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 73  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 132 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF-PIKWTAPESLAY 187
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 188 NKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 73
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF-PIKWTAPESLAY 188
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 534
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 590
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 706
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 253
Query: 707 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 254 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 534
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 590
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML 208
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 706
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 254
Query: 707 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 255 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE- 522
           +F  +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 523 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD---- 578
           EF+NE  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +    
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVL 123
Query: 579 ----WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
                 K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +   
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 180
Query: 635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                   G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 181 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 135
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 191
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKL 534
           N  L   LG G FG VY G++          ++AVK L +  S Q   +F+ E ++ISK 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 590
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 706
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 268
Query: 707 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 269 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 129/298 (43%), Gaps = 41/298 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISK 533
            N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGI 589
             H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVV 646
           + G  YL  +     IHRD+ A N LL         KI DFGMA+           G  +
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNEN 705
               +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQ 269
Query: 706 KILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 270 EVLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 322

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 661
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +S +SDV++FG++L E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 90/333 (27%), Positives = 141/333 (42%), Gaps = 49/333 (14%)
Query: 454 KLSATNVNTVKLQDLPLFQFEELATATN--------NFQLSSKLGQGGFGPVYWGRLK-- 503
           KLS    +T+     P + F    ++ +        N  L   LG G FG VY G++   
Sbjct: 22  KLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 81
Query: 504 ----DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
                  ++AVK L +   +  E +F+ E ++ISK  H+N+VR +G  ++   + ++ E 
Sbjct: 82  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 141
Query: 559 MPNRSLDALLFD----PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 614
           M    L + L +    P +   L      ++   I+ G  YL  +     IHRD+ A N 
Sbjct: 142 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 198
Query: 615 LLD---EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSF 671
           LL         KI DFGMA+           G  +    +M PE  MEG F+ K+D +SF
Sbjct: 199 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 258
Query: 672 GVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENKILALVDPFLSESSFQLDMIIRC-- 728
           GVLL EI S              LGY  +   +  ++L  V      S  ++D    C  
Sbjct: 259 GVLLWEIFS--------------LGYMPYPSKSNQEVLEFVT-----SGGRMDPPKNCPG 299
Query: 729 --IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
               +   C Q   +DRPN + ++  +    +D
Sbjct: 300 PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 332

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 17  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 661
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +S +SDV++FG++L E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 106/202 (52%), Gaps = 16/202 (7%)
Query: 489 LGQGGFGPVYWGRL-----KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
           LG+G FG V   R        G+++AVK L   SG   + +   E+ ++  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 543 LGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
            G C E  G    LI E++P+ SL   L  P  K +++ +++      I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 132
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT--GRVVGTFGYMSPEYAM 658
           R + +HRDL A N+L++ E   KI DFG+ K    +++       R    F Y +PE  M
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
           + +F   SDV+SFGV L E+++
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 115/237 (48%), Gaps = 17/237 (7%)
Query: 458 TNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVK 511
            +VN        ++  +E   A     +S +LGQG FG VY G     +KD  E  +A+K
Sbjct: 2   ASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 61
Query: 512 RLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RS 563
            +++A+      EF+NE  V+ +    ++VRLLG   +G+  ++I E M         RS
Sbjct: 62  TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
Query: 564 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK 623
           L   + +          K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   K
Sbjct: 122 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 178
Query: 624 ISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           I DFGM +           G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 106/202 (52%), Gaps = 16/202 (7%)
Query: 489 LGQGGFGPVYWGRL-----KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
           LG+G FG V   R        G+++AVK L   SG   + +   E+ ++  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 543 LGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
            G C E  G    LI E++P+ SL   L  P  K +++ +++      I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 144
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT--GRVVGTFGYMSPEYAM 658
           R + +HRDL A N+L++ E   KI DFG+ K    +++       R    F Y +PE  M
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 202
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
           + +F   SDV+SFGV L E+++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF-PIKWTAPESLAY 184
Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 526
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 578
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPS 129
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 130 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 110/201 (54%), Gaps = 9/201 (4%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                 +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 72  YST-APQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 661
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +S +SDV++FG++L E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 17/221 (7%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 526
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDW 579
           E  V+ +    ++VRLLG   +G+  ++I E M         RSL   + +         
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
            K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +        
Sbjct: 128 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
              G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 14  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 74  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 661
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +S +SDV++FG++L E+++G+
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQ 208

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 485 LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRL 542
           L  ++G+G FG V+ GRL+ D   +AVK   +     L+ +F+ E  ++ +  H N+VRL
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C + +   ++ E +  +  D L F   +  RL  +    ++   + G+ YL      
Sbjct: 178 IGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC-- 233
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
             IHRDL A N L+ E+   KISDFGM++        A  G       + +PE    GR+
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRY 292
Query: 663 SEKSDVFSFGVLLLEIVS 680
           S +SDV+SFG+LL E  S
Sbjct: 293 SSESDVWSFGILLWETFS 310

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 534
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 590
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 192 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 248
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 706
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 294
Query: 707 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 295 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 117/238 (49%), Gaps = 19/238 (7%)
Query: 458 TNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVK 511
            +VN        ++  +E   A     +S +LGQG FG VY G     +KD  E  +A+K
Sbjct: 2   ASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 61
Query: 512 RLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 570
            +++A+      EF+NE  V+ +    ++VRLLG   +G+  ++I E M    L + L  
Sbjct: 62  TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
Query: 571 PLKKERLD--------WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622
            L+ E  +          K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   
Sbjct: 122 -LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 177
Query: 623 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           KI DFGM +           G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 526
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 578
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLAPPS 129
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 130 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 74  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 128
Query: 608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 667
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSD 187
Query: 668 VFSFGVLLLEIVS 680
           +++FGVL+ EI S
Sbjct: 188 IWAFGVLMWEIYS 200

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 129/298 (43%), Gaps = 41/298 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISK 533
            N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGI 589
             H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVV 646
           + G  YL  +     IHRD+ A N LL         KI DFGMA+           G  +
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNEN 705
               +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQ 270
Query: 706 KILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
           ++L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 271 EVLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 323

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 526
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 578
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPS 130
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 131 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 187
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 188 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 17  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 661
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +S +SDV++FG++L E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 526
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 578
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPS 123
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 124 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 180
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 667
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYSKFSSKSD 203
Query: 668 VFSFGVLLLEIVS 680
           +++FGVL+ EI S
Sbjct: 204 IWAFGVLMWEIYS 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 667
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSD 188
Query: 668 VFSFGVLLLEIVS 680
           +++FGVL+ EI S
Sbjct: 189 IWAFGVLMWEIYS 201

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 117/238 (49%), Gaps = 19/238 (7%)
Query: 458 TNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVK 511
            +VN        ++  +E   A     +S +LGQG FG VY G     +KD  E  +A+K
Sbjct: 24  ASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 83
Query: 512 RLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 570
            +++A+      EF+NE  V+ +    ++VRLLG   +G+  ++I E M    L + L  
Sbjct: 84  TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-R 142
Query: 571 PLKKERLD--------WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622
            L+ E  +          K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   
Sbjct: 143 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 199
Query: 623 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           KI DFGM +           G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 200 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 144/310 (46%), Gaps = 44/310 (14%)
Query: 471 FQFEELATATNNF---------QLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRL-SKA 516
           F FE+   A   F         ++   +G G FG V  G LK  G+    +A+K L S  
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 517 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER 576
           + +   +F++E  ++ +  H N++ L G   +    M+I E+M N SLD+ L       +
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 131
Query: 577 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
               +   ++ GI+ G+ YL   + +  +HRDL A NIL++  L  K+SDFG+++    +
Sbjct: 132 FTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188
Query: 637 QDQADTGRVVG---TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 693
                    +G      + +PE     +F+  SDV+S+G+++ E++S  +          
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------- 240
Query: 694 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTV 749
                W + N++ I A+      E  ++L   + C   +H  +L C Q+    RP    +
Sbjct: 241 ----YWDMTNQDVINAI------EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 290
Query: 750 VSMLNSEIRD 759
           V+ L+  IR+
Sbjct: 291 VNTLDKMIRN 300

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 70  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 667
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSD 183
Query: 668 VFSFGVLLLEIVS 680
           +++FGVL+ EI S
Sbjct: 184 IWAFGVLMWEIYS 196

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 81  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 135
Query: 608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 667
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSD 194
Query: 668 VFSFGVLLLEIVS 680
           +++FGVL+ EI S
Sbjct: 195 IWAFGVLMWEIYS 207

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 485 LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRL 542
           L  ++G+G FG V+ GRL+ D   +AVK   +     L+ +F+ E  ++ +  H N+VRL
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C + +   ++ E +  +  D L F   +  RL  +    ++   + G+ YL      
Sbjct: 178 IGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC-- 233
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
             IHRDL A N L+ E+   KISDFGM++        A  G       + +PE    GR+
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 663 SEKSDVFSFGVLLLEIVS 680
           S +SDV+SFG+LL E  S
Sbjct: 293 SSESDVWSFGILLWETFS 310

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 16  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              +  +  ++ ++    SL   L     + + + +K  +I    +RG+ YLH  S   I
Sbjct: 76  YSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EGR 661
           IHRDLK++NI L E+   KI DFG+A +           ++ G+  +M+PE         
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +S +SDV++FG++L E+++G+
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQ 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 39  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 99  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 661
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +S +SDV++FG++L E+++G+
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQ 233

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 667
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYSKFSSKSD 188
Query: 668 VFSFGVLLLEIVS 680
           +++FGVL+ EI S
Sbjct: 189 IWAFGVLMWEIYS 201

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 110/204 (53%), Gaps = 17/204 (8%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LS+++G G FG VY G+      + + ++   + +  + F NEV V+ K +H N++  +G
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              + +   ++ ++    SL   L   +++ +    +  +I    ++G+ YLH  +   I
Sbjct: 100 YMTK-DNLAIVTQWCEGSSLYKHLH--VQETKFQMFQLIDIARQTAQGMDYLHAKN---I 153
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKI----FGGNQDQADTGRVVGTFGYMSPEYAM-- 658
           IHRD+K++NI L E L  KI DFG+A +     G  Q +  TG V+    +M+PE     
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL----WMAPEVIRMQ 209
Query: 659 -EGRFSEKSDVFSFGVLLLEIVSG 681
               FS +SDV+S+G++L E+++G
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 40  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 661
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +S +SDV++FG++L E+++G+
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 143/314 (45%), Gaps = 44/314 (14%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 526
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 578
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLAPPS 123
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
             K   +   I+ G+ YL+ +   + +HRDL A N  + E+   KI DFGM +       
Sbjct: 124 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY 180
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA 698
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI              T+    
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA-------------TLAEQP 227
Query: 699 WKLWNENKILALV--DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 756
           ++  +  ++L  V     L +     DM++  +    +C Q   K RP+   ++S +  E
Sbjct: 228 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMR---MCWQYNPKMRPSFLEIISSIKEE 284
Query: 757 IRDLPYPKEPAFTE 770
           +       EP F E
Sbjct: 285 M-------EPGFRE 291

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 19/210 (9%)
Query: 489 LGQGGFG-PVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           LG+G FG  +     + G+ + +K L +   +    F+ EV V+  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
           + +    I EY+   +L  ++       +  W +R +  + I+ G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 608 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR------------VVGTFGYMSPE 655
           DL + N L+ E  N  ++DFG+A++    + Q +  R            VVG   +M+PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNT 685
                 + EK DVFSFG++L EI+ GR N 
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII-GRVNA 221

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 23/202 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + +L  KLG G FG V+        ++AVK + K     +E F+ E  V+  LQH  LV+
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 241
Query: 542 LLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           L    V  E   +I E+M   SL D L  D   K+ L   K  +    I+ G+ ++ + +
Sbjct: 242 L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN 298
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAM 658
               IHRDL+A+NIL+   L  KI+DFG+A             RV   F   + +PE   
Sbjct: 299 ---YIHRDLRAANILVSASLVCKIADFGLA-------------RVGAKFPIKWTAPEAIN 342
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
            G F+ KSDV+SFG+LL+EIV+
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVT 364

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 7/200 (3%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
           +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
               IHR+L A N L+ E    K++DFG++++  G+   A  G       + +PE     
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 394
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +FS KSDV++FGVLL EI +
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
           +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NLV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 318
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + +
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN 377
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
               IHR+L A N L+ E    K++DFG++++  G+   A  G       + +PE     
Sbjct: 378 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 433
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +FS KSDV++FGVLL EI +
Sbjct: 434 KFSIKSDVWAFGVLLWEIAT 453

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 33/215 (15%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQ 535
           A      +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V+++L+
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 244
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSL---------DALLFDPLKKERLDWRKRFNI 585
           H NLV+LLG  VE +  + ++ EYM   SL           L  D L K  LD  +    
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
           +EG +              +HRDL A N+L+ E+   K+SDFG+ K     Q   DTG++
Sbjct: 305 LEGNN-------------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL 348
Query: 646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                + +PE   E +FS KSDV+SFG+LL EI S
Sbjct: 349 --PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 33/215 (15%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQ 535
           A      +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V+++L+
Sbjct: 2   ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 57
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSL---------DALLFDPLKKERLDWRKRFNI 585
           H NLV+LLG  VE +  + ++ EYM   SL           L  D L K  LD  +    
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
           +EG +              +HRDL A N+L+ E+   K+SDFG+ K     Q   DTG++
Sbjct: 118 LEGNN-------------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL 161
Query: 646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                + +PE   E +FS KSDV+SFG+LL EI S
Sbjct: 162 --PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 33/215 (15%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQ 535
           A      +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V+++L+
Sbjct: 17  ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 72
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSL---------DALLFDPLKKERLDWRKRFNI 585
           H NLV+LLG  VE +  + ++ EYM   SL           L  D L K  LD  +    
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
           +EG +              +HRDL A N+L+ E+   K+SDFG+ K     Q   DTG++
Sbjct: 133 LEGNN-------------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL 176
Query: 646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                + +PE   E +FS KSDV+SFG+LL EI S
Sbjct: 177 --PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 115/205 (56%), Gaps = 17/205 (8%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 605 IHRDLKASNILLDEELNPKISDFGMA----KIFGGNQDQADTGRVVGTFGYMSPEYA-ME 659
           IHRDLK++NI L E+L  KI DFG+A    +  G +Q +  +G ++    +M+PE   M+
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 181
Query: 660 GR--FSEKSDVFSFGVLLLEIVSGR 682
            +  +S +SDV++FG++L E+++G+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 175
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 176
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 175
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 180
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 181 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V   R K  G+++AVK +     Q  E   NEV+++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + GEE  ++ E++   +L     D + + RL+  +   + E + + L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ +ILL  +   K+SDFG  A+I   ++D      +VGT  +M+PE      ++ +
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKXLVGTPYWMAPEVISRSLYATE 221
Query: 666 SDVFSFGVLLLEIVSGRKNTSFFED 690
            D++S G++++E+V G     +F D
Sbjct: 222 VDIWSLGIMVIEMVDG--EPPYFSD 244

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 33/215 (15%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQ 535
           A      +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V+++L+
Sbjct: 8   ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 63
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSL---------DALLFDPLKKERLDWRKRFNI 585
           H NLV+LLG  VE +  + ++ EYM   SL           L  D L K  LD  +    
Sbjct: 64  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 123
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
           +EG +              +HRDL A N+L+ E+   K+SDFG+ K     Q   DTG++
Sbjct: 124 LEGNN-------------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL 167
Query: 646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                + +PE   E  FS KSDV+SFG+LL EI S
Sbjct: 168 --PVKWTAPEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG +        + DT  + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT--LCGTLDYLPP 176
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 122/231 (52%), Gaps = 16/231 (6%)
Query: 459 NVNTVKLQDLPLFQFEEL------ATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVK 511
           ++ TV+L++ P  Q ++L            F +  KLG+G +G VY    K+ GQ +A+K
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 512 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 571
           ++   S   L+E + E+ ++ +    ++V+  G   +  +  ++ EY    S+  ++   
Sbjct: 61  QVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR-- 116
Query: 572 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
           L+ + L   +   I++   +GL YLH    +R IHRD+KA NILL+ E + K++DFG+A 
Sbjct: 117 LRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAG 173
Query: 632 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                   A    V+GT  +M+PE   E  ++  +D++S G+  +E+  G+
Sbjct: 174 QL--TDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQGLEE--FMNEVMVI 531
            T    + +   LG+G FG V   + KD    QE AVK ++KAS +  +    + EV ++
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGIS 590
            KL H N+++L     +     ++ E          LFD + K++R        II+ + 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTG----GELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G+ Y+H+ +   I+HRDLK  NILL+   ++ + KI DFG++  F  N    D    +G
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IG 185
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           T  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQGLEE--FMNEVMVI 531
            T    + +   LG+G FG V   + KD    QE AVK ++KAS +  +    + EV ++
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGIS 590
            KL H N+++L     +     ++ E          LFD + K++R        II+ + 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTG----GELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G+ Y+H+ +   I+HRDLK  NILL+   ++ + KI DFG++  F  N    D    +G
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IG 185
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           T  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 481 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEY--------MPNRSLDALLFDP---LKKERLDWRK 581
           L QH N+V LLG C  G   ++I EY           R    L  DP   +    L  R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +    +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+    + +   
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            G       +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 115/205 (56%), Gaps = 17/205 (8%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 32  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 92  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 605 IHRDLKASNILLDEELNPKISDFGMA----KIFGGNQDQADTGRVVGTFGYMSPEYA-ME 659
           IHRDLK++NI L E+L  KI DFG+A    +  G +Q +  +G ++    +M+PE   M+
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 201
Query: 660 GR--FSEKSDVFSFGVLLLEIVSGR 682
            +  +S +SDV++FG++L E+++G+
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 110/205 (53%), Gaps = 17/205 (8%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                 +  ++ ++    SL   L     + + + +K  +I    +RG+ YLH  S   I
Sbjct: 88  YST-APQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 605 IHRDLKASNILLDEELNPKISDFGMA----KIFGGNQDQADTGRVVGTFGYMSPEYAM-- 658
           IHRDLK++NI L E+   KI DFG+A    +  G +Q +  +G ++    +M+PE     
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 197
Query: 659 -EGRFSEKSDVFSFGVLLLEIVSGR 682
               +S +SDV++FG++L E+++G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 135/303 (44%), Gaps = 47/303 (15%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR------LKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
           NN +    +G+G FG V+  R       +    +AVK L  +AS     +F  E  ++++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDWRKRFN-- 584
             + N+V+LLG C  G+   L++EYM         RS+       L    L  R R +  
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 585 ------------IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK- 631
                       I   ++ G+ YL   S  + +HRDL   N L+ E +  KI+DFG+++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 632 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
           I+  +  +AD    +    +M PE     R++ +SDV+++GV+L EI S      +    
Sbjct: 224 IYSADYYKADGNDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 692 LTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS 751
             ++ Y      +  ILA  +        +L  ++R      LC  +L  DRP+  ++  
Sbjct: 283 EEVIYYV----RDGNILACPE----NCPLELYNLMR------LCWSKLPADRPSFCSIHR 328
Query: 752 MLN 754
           +L 
Sbjct: 329 ILQ 331

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              +  +  ++ ++    SL   L     + + + +K  +I    +RG+ YLH  S   I
Sbjct: 88  YSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 605 IHRDLKASNILLDEELNPKISDFGMA----KIFGGNQDQADTGRVVGTFGYMSPEYAM-- 658
           IHRDLK++NI L E+   KI DFG+A    +  G +Q +  +G ++    +M+PE     
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 197
Query: 659 -EGRFSEKSDVFSFGVLLLEIVSGR 682
               +S +SDV++FG++L E+++G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 481 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------FDPLKKERLDWRKRFNI 585
           L QH N+V LLG C  G   ++I EY     L   L        D      L+ R   + 
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
              +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+    + +    G  
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 115/205 (56%), Gaps = 17/205 (8%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 40  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 605 IHRDLKASNILLDEELNPKISDFGMA----KIFGGNQDQADTGRVVGTFGYMSPEYA-ME 659
           IHRDLK++NI L E+L  KI DFG+A    +  G +Q +  +G ++    +M+PE   M+
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 209
Query: 660 GR--FSEKSDVFSFGVLLLEIVSGR 682
            +  +S +SDV++FG++L E+++G+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDD---LCGTLDYLPP 201
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 202 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 181 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 178 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 19/226 (8%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLE 522
           +F  +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 523 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD---- 578
           EF+NE  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 124
Query: 579 ----WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
                ++   +   I+ G+ YL+     + +HRDL A N ++  +   KI DFGM +   
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 181
Query: 635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                   G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 182 ETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 19/226 (8%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLE 522
           +F  +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 523 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD---- 578
           EF+NE  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +    
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 121
Query: 579 ----WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
                ++   +   I+ G+ YL+     + +HRDL A N ++  +   KI DFGM +   
Sbjct: 122 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 178
Query: 635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                   G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 179 ETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 180 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDD---LCGTLDYLPP 178
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 175 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 481 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------FDPLKKERLDWRKRFNI 585
           L QH N+V LLG C  G   ++I EY     L   L        D      L+ R   + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
              +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+    + +    G  
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 201
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 202 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 655 EYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 181 E-XIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 192
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 193 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K+ + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 481 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDW 579
           L QH N+V LLG C  G   ++I EY     L   L           ++P    +E+L  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
           R   +    +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+    + + 
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
              G       +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 173 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQGLEE--FMNEVMVI 531
            T    + +   LG+G FG V   + KD    QE AVK ++KAS +  +    + EV ++
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGIS 590
            KL H N+++L     +     ++ E          LFD + K++R        II+ + 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTG----GELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G+ Y+H+ +   I+HRDLK  NILL+   ++ + KI DFG++  F  N    D    +G
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IG 185
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           T  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMN 526
           +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   EF+N
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 578
           E  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +        
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPT 128
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
            ++   +   I+ G+ YL+     + +HRDL A N ++  +   KI DFGM +       
Sbjct: 129 LQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 185
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRFNIIEGISRGL 593
           +H N++RL G   +     LI EY P       ++  L+K  + D ++    I  ++  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPR----GEVYKELQKLSKFDEQRTATYITELANAL 126
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ 
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 179
Query: 654 PEYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           PE  +EGR   EK D++S GVL  E + G+
Sbjct: 180 PE-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 7/196 (3%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           L  +LG G FG V  G+ K   ++AVK + + S    +EF  E   + KL H  LV+  G
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
            C +     ++ EY+ N  L   L    K   L+  +   +   +  G+ +L      + 
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDL A N L+D +L  K+SDFGM +    +Q  +  G       + +PE     ++S 
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF-PVKWSAPEVFHYFKYSS 184
Query: 665 KSDVFSFGVLLLEIVS 680
           KSDV++FG+L+ E+ S
Sbjct: 185 KSDVWAFGILMWEVFS 200

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 137/288 (47%), Gaps = 35/288 (12%)
Query: 484 QLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRL-SKASGQGLEEFMNEVMVISKLQHRN 538
           ++   +G G FG V  G LK  G+    +A+K L S  + +   +F++E  ++ +  H N
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           ++ L G   +    M+I E+M N SLD+ L       +    +   ++ GI+ G+ YL  
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYL-- 125
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG---TFGYMSPE 655
            + +  +HR L A NIL++  L  K+SDFG+++    +         +G      + +PE
Sbjct: 126 -ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 715
                +F+  SDV+S+G+++ E++S  +               W + N++ I A+     
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERP------------YWDMTNQDVINAI----- 227
Query: 716 SESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRD 759
            E  ++L   + C   +H  +L C Q+    RP    +V+ L+  IR+
Sbjct: 228 -EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 274

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 481 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEY--------MPNRSLDALLFDP---LKKERLDWRK 581
           L QH N+V LLG C  G   ++I EY           R    L  DP   +       R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +    +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+    + +   
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            G       +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRFNIIEGISRGL 593
           +H N++RL G   +     LI EY P       ++  L+K  + D ++    I  ++  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPR----GEVYKELQKLSKFDEQRTATYITELANAL 126
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ 
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLP 179
Query: 654 PEYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           PE  +EGR   EK D++S GVL  E + G+
Sbjct: 180 PE-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 488 KLGQGGFGPVYWG--RLKDGQ-EIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +LG G FG V  G  R++  Q ++A+K L + + +   EE M E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           G C + E  ML+ E      L   L    K+E +       ++  +S G+ YL   +   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT--FGYMSPEYAMEGR 661
            +HRDL A N+LL      KISDFG++K  G + D   T R  G     + +PE     +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRK 189
Query: 662 FSEKSDVFSFGVLLLEIVS 680
           FS +SDV+S+GV + E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 108/228 (47%), Gaps = 31/228 (13%)
Query: 481 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEY--------MPNRSLDALLF-------DP--LKKE 575
           L QH N+V LLG C  G   ++I EY           R  +A+L        DP  L KE
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 576 R---LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
               L+ R   +    +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+ 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 633 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
              + +    G       +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI++FG    +  +   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 178 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 19/226 (8%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLE 522
           +F  +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 523 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD---- 578
           EF+NE  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 124
Query: 579 ----WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
                ++   +   I+ G+ YL+     + +HRDL A N ++  +   KI DFGM +   
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                   G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 182 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 19/226 (8%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLE 522
           +F  +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 523 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD---- 578
           EF+NE  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 124
Query: 579 ----WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
                ++   +   I+ G+ YL+     + +HRDL A N ++  +   KI DFGM +   
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                   G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 182 ETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 607 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS 666
           RD+K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE      +  K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 197
Query: 667 DVFSFGVLLLEIVSG 681
           D++S G++ +E++ G
Sbjct: 198 DIWSLGIMAIEMIEG 212

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 534
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           Y H     R+IHRD+K  N+LL      KI++FG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 655 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           G C+  E   +++  YM +  L   + +      +     F +   +++G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
           + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E     
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +F+ KSDV+SFGVLL E+++
Sbjct: 212 KFTTKSDVWSFGVLLWELMT 231

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 108/196 (55%), Gaps = 12/196 (6%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ NILL  + + K++DFG  A+I     +Q+    +VGT  +M+PE      +  K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++ +E++ G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 108/196 (55%), Gaps = 12/196 (6%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ NILL  + + K++DFG  A+I     +Q+    +VGT  +M+PE      +  K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++ +E++ G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 108/196 (55%), Gaps = 12/196 (6%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 88  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ NILL  + + K++DFG  A+I     +Q+    +VGT  +M+PE      +  K
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++ +E++ G
Sbjct: 198 VDIWSLGIMAIEMIEG 213

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 488 KLGQGGFGPVYWG--RLKDGQ-EIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +LG G FG V  G  R++  Q ++A+K L + + +   EE M E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           G C + E  ML+ E      L   L    K+E +       ++  +S G+ YL   +   
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG--TFGYMSPEYAMEGR 661
            +HR+L A N+LL      KISDFG++K  G + D   T R  G     + +PE     +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRK 515
Query: 662 FSEKSDVFSFGVLLLEIVS 680
           FS +SDV+S+GV + E +S
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L  C  + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 148
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 149 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
           +NF+    LG+G FG V   R+K+ G   AVK L K        +E  M E  ++S  ++
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLY 595
              +  L CC +  +++       N     L+F   K  R D  R RF   E IS  L++
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAEIIS-ALMF 139
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           LH      II+RDLK  N+LLD E + K++DFGM K   G  +   T    GT  Y++PE
Sbjct: 140 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPE 194
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
              E  +    D ++ GVLL E++ G 
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           G C+  E   +++  YM +  L   + +      +     F +   +++G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
           + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E     
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +F+ KSDV+SFGVLL E+++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 148
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEY 656
            +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVS 680
               +F+ KSDV+SFGVLL E+++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 168
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEY 656
            +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVS 680
               +F+ KSDV+SFGVLL E+++
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           G C+  E   +++  YM +  L   + +      +     F +   +++G+ YL   +  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 144
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
           + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E     
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +F+ KSDV+SFGVLL E+++
Sbjct: 205 KFTTKSDVWSFGVLLWELMT 224

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKLQH 536
            +F +   LG+G FG VY  R +  + I A+K L K   +  G+E +   EV + S L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
            N++RL G   +     LI EY P   L  +  +  K  R D ++    I  ++  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H     R+IHRD+K  N+LL      KI+DFG +        + DT  + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDT--LCGTLDYLPPE- 180
Query: 657 AMEGRFS-EKSDVFSFGVLLLEIVSG 681
            +EGR   EK D++S GVL  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 149
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEY 656
            +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVS 680
               +F+ KSDV+SFGVLL E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 167
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEY 656
            +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVS 680
               +F+ KSDV+SFGVLL E+++
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           G C+  E   +++  YM +  L   + +      +     F +   +++G+ YL   +  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 147
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
           + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E     
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +F+ KSDV+SFGVLL E+++
Sbjct: 208 KFTTKSDVWSFGVLLWELMT 227

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 147
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEY 656
            +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVS 680
               +F+ KSDV+SFGVLL E+++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ YL  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 146
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEY 656
            +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVS 680
               +F+ KSDV+SFGVLL E+++
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 19/211 (9%)
Query: 485 LSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHR 537
           L  +LGQG FG VY G  +D         +AVK +++ AS +   EF+NE  V+      
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD--------WRKRFNIIEGI 589
           ++VRLLG   +G+  +++ E M +  L + L   L+ E  +         ++   +   I
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
           + G+ YL+     + +HRDL A N ++  +   KI DFGM +           G+ +   
Sbjct: 139 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHR 537
           +F++ + LG+G F  VY    +  G E+A+K + K +      ++   NEV +  +L+H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           +++ L     +     L+ E   N  ++  L + +K    +  + F  +  I  G+LYLH
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYLH 129
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
                 I+HRDL  SN+LL   +N KI+DFG+A       ++  T  + GT  Y+SPE A
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIA 184
Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGR 682
                  +SDV+S G +   ++ GR
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 88  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 607 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS 666
           R++K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE      +  K 
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 198
Query: 667 DVFSFGVLLLEIVSG 681
           D++S G++ +E++ G
Sbjct: 199 DIWSLGIMAIEMIEG 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 489 LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           LG+G +G VY GR L +   IA+K + +   +  +    E+ +   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 548 EGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNI-IEGISRGLLYLHRDSRLR 603
           E     +  E +P  SL ALL   + PLK    D  +      + I  GL YLH +   +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLK----DNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 604 IIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR- 661
           I+HRD+K  N+L++      KISDFG +K   G     +T    GT  YM+PE   +G  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPR 200
Query: 662 -FSEKSDVFSFGVLLLEIVSGRKNTSFFE 689
            + + +D++S G  ++E+ +G+    F+E
Sbjct: 201 GYGKAADIWSLGCTIIEMATGK--PPFYE 227

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ + + L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMN 526
           +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   EF+N
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 578
           E  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +        
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPT 128
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
            ++   +   I+ G+ YL+     + +HR+L A N ++  +   KI DFGM +       
Sbjct: 129 LQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 9/208 (4%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKL 534
           A    ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L
Sbjct: 1   APFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            H N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVV 117
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++P
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 655 EYAMEGRF-SEKSDVFSFGVLLLEIVSG 681
           E      F +E  DV+S G++L  +++G
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFM 525
           +F     A  ++ ++    LG+G FG V   + K  GQE AVK +SK         E  +
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 80
Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
            EV ++ +L H N+++L       E+K   Y      +   L  + + ++R        I
Sbjct: 81  REVQLLKQLDHPNIMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 137
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADT 642
           I  +  G+ Y+H++   +I+HRDLK  N+LL+   ++ N +I DFG++  F  ++   D 
Sbjct: 138 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 194
Query: 643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
              +GT  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 195 ---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 147
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 655
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 205
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVS 680
                +F+ KSDV+SFGVLL E+++
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 489 LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           LG+G +G VY GR L +   IA+K + +   +  +    E+ +   L+H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 548 EGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNI-IEGISRGLLYLHRDSRLR 603
           E     +  E +P  SL ALL   + PLK    D  +      + I  GL YLH +   +
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLK----DNEQTIGFYTKQILEGLKYLHDN---Q 128
Query: 604 IIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR- 661
           I+HRD+K  N+L++      KISDFG +K   G     +T    GT  YM+PE   +G  
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPR 186
Query: 662 -FSEKSDVFSFGVLLLEIVSGRKNTSFFE 689
            + + +D++S G  ++E+ +G+    F+E
Sbjct: 187 GYGKAADIWSLGCTIIEMATGK--PPFYE 213

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKLQH 536
            +F +   LG+G FG VY  R +  + I A+K L K   +  G+E +   EV + S L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
            N++RL G   +     LI EY P   L  +  +  K  R D ++    I  ++  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPE- 180
Query: 657 AMEGRFS-EKSDVFSFGVLLLEIVSG 681
            +EGR   EK D++S GVL  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMN 526
           +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   EF+N
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 70
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 578
           E  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +        
Sbjct: 71  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPT 129
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
            ++   +   I+ G+ YL+     + +HR+L A N ++  +   KI DFGM +       
Sbjct: 130 LQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 186
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 187 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 154
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 655
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 212
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVS 680
                +F+ KSDV+SFGVLL E+++
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 149
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 655
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 207
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVS 680
                +F+ KSDV+SFGVLL E+++
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 150
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 655
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 208
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVS 680
                +F+ KSDV+SFGVLL E+++
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 117/225 (52%), Gaps = 21/225 (9%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQ--EIAVK--RLSKASGQGLEEFM 525
           + E++    N   L   LG+G FG V  G LK  DG   ++AVK  +L  +S + +EEF+
Sbjct: 25  KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL 84
Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEK-----MLIYEYMPNRSLDA-LLFDPLKK--ERL 577
           +E   +    H N++RLLG C+E   +     M+I  +M    L   LL+  L+   + +
Sbjct: 85  SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGN 636
             +     +  I+ G+ YL   S    +HRDL A N +L +++   ++DFG++ KI+ G 
Sbjct: 145 PLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG- 200
Query: 637 QDQADTGRVVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            D    GR+      +++ E   +  ++ KSDV++FGV + EI +
Sbjct: 201 -DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 208
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 655
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL-PVKWMALE 266
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVS 680
                +F+ KSDV+SFGVLL E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 149
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 655
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 207
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVS 680
                +F+ KSDV+SFGVLL E+++
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 126 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 180
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 133 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 187
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHRNL 539
           ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+  G   EG  + L  EY     L   +   +     D ++ F+ +     G++YLH  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG- 123
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
             + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE    
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 660 GRF-SEKSDVFSFGVLLLEIVSG 681
             F +E  DV+S G++L  +++G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRL---SKASGQGLEEFMNEVMVISKLQHRN 538
           +++  KLG GG   VY         ++A+K +    +   + L+ F  EV   S+L H+N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYL 596
           +V ++    E +   L+ EY+   +L   +    PL  +        N    I  G+ + 
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVD-----TAINFTNQILDGIKHA 127
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H    +RI+HRD+K  NIL+D     KI DFG+AK          T  V+GT  Y SPE 
Sbjct: 128 HD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQ 183
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGR 682
           A      E +D++S G++L E++ G 
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 27/207 (13%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 150
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMA-----KIFGGNQDQADTGRVVGTFGYMS 653
            +  + +HRDL A N +LDE+   K++DFG+A     K F    ++      V    +M+
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV---KWMA 206
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            E     +F+ KSDV+SFGVLL E+++
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHRNL 539
           ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+  G   EG  + L  EY     L   +   +     D ++ F+ +     G++YLH  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG- 122
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
             + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE    
Sbjct: 123 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 660 GRF-SEKSDVFSFGVLLLEIVSG 681
             F +E  DV+S G++L  +++G
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 136 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 190
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 116/234 (49%), Gaps = 47/234 (20%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFM 525
           +F     A  ++ ++    LG+G FG V   + K  GQE AVK +SK         E  +
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDAL---------LFDPLKKER 576
            EV ++ +L H N+++L             YE+  ++    L         LFD +    
Sbjct: 75  REVQLLKQLDHPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIIS-- 119
Query: 577 LDWRKRFN------IIEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDF 627
              RKRF+      II  +  G+ Y+H++   +I+HRDLK  N+LL+   ++ N +I DF
Sbjct: 120 ---RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 628 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           G++  F  ++   D    +GT  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 174 GLSTHFEASKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 132 YLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 137
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 138 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 192
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 193 ALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E   S+ SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 133 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 187
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
           N++L   +G+G F  V   R +  G+E+A+K + K   +   L++   EV ++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           +V+L       +   LI EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-EARSKFR---QIVSAVQYCH 131
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPE 655
           +    RI+HRDLKA N+LLD ++N KI+DFG +  F  GG  D        G   Y +PE
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-----FCGAPPYAAPE 183
Query: 656 YAMEGRFS-EKSDVFSFGVLLLEIVSG 681
                ++   + DV+S GV+L  +VSG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
           N++L   +G+G F  V   R +  G+E+A+K + K   +   L++   EV ++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           +V+L       +   LI EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-EARSKFR---QIVSAVQYCH 128
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPE 655
           +    RI+HRDLKA N+LLD ++N KI+DFG +  F  GG  D        G+  Y +PE
Sbjct: 129 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-----FCGSPPYAAPE 180
Query: 656 YAMEGRFS-EKSDVFSFGVLLLEIVSG 681
                ++   + DV+S GV+L  +VSG
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 139 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 26/220 (11%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNE 527
           FEE      + +  S+LG+G FG V   R        G  +AVK+L  +      +F  E
Sbjct: 20  FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 74
Query: 528 VMVISKLQHRNLVRLLGCCV-EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
           + ++  L    +V+  G     G + + L+ EY+P+  L   L     + RLD  +    
Sbjct: 75  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLY 132
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
              I +G+ YL   SR R +HRDL A NIL++ E + KI+DFG+AK+   ++D      V
Sbjct: 133 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----V 185
Query: 646 VGTFG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           V   G     + +PE   +  FS +SDV+SFGV+L E+ +
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNE 527
           FEE      + +  S+LG+G FG V   R        G  +AVK+L  +      +F  E
Sbjct: 4   FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 58
Query: 528 VMVISKLQHRNLVRLLGCCVEG--EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
           + ++  L    +V+  G        E  L+ EY+P+  L   L     + RLD  +    
Sbjct: 59  IQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLY 116
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
              I +G+ YL   SR R +HRDL A NIL++ E + KI+DFG+AK+   ++D      V
Sbjct: 117 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXX----V 169
Query: 646 VGTFG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           V   G     + +PE   +  FS +SDV+SFGV+L E+ +
Sbjct: 170 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 141
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 142 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 196
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 26/220 (11%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNE 527
           FEE      + +  S+LG+G FG V   R        G  +AVK+L  +      +F  E
Sbjct: 7   FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 61
Query: 528 VMVISKLQHRNLVRLLGCCV-EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
           + ++  L    +V+  G     G + + L+ EY+P+  L   L     + RLD  +    
Sbjct: 62  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLY 119
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
              I +G+ YL   SR R +HRDL A NIL++ E + KI+DFG+AK+   ++D      V
Sbjct: 120 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----V 172
Query: 646 VGTFG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           V   G     + +PE   +  FS +SDV+SFGV+L E+ +
Sbjct: 173 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 110/224 (49%), Gaps = 36/224 (16%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DG--QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 535
           N+ +    +G+G FG V   R+K DG   + A+KR+ + AS     +F  E+ V+ KL  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LD 578
           H N++ LLG C       L  EY P+ +L     D L+K R                 L 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
            ++  +    ++RG+ YL   S+ + IHRDL A NIL+ E    KI+DFG+++       
Sbjct: 131 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQ 182
Query: 639 QADTGRVVGTFG--YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           +    + +G     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 183 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 156
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 157 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 211
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 110/224 (49%), Gaps = 36/224 (16%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DG--QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 535
           N+ +    +G+G FG V   R+K DG   + A+KR+ + AS     +F  E+ V+ KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LD 578
           H N++ LLG C       L  EY P+ +L     D L+K R                 L 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
            ++  +    ++RG+ YL   S+ + IHRDL A NIL+ E    KI+DFG+++       
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQ 192
Query: 639 QADTGRVVGTFG--YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           +    + +G     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 26/220 (11%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNE 527
           FEE      + +  S+LG+G FG V   R        G  +AVK+L  +      +F  E
Sbjct: 8   FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 62
Query: 528 VMVISKLQHRNLVRLLGCCV-EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
           + ++  L    +V+  G     G + + L+ EY+P+  L   L     + RLD  +    
Sbjct: 63  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLY 120
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
              I +G+ YL   SR R +HRDL A NIL++ E + KI+DFG+AK+   ++D      V
Sbjct: 121 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----V 173
Query: 646 VGTFG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           V   G     + +PE   +  FS +SDV+SFGV+L E+ +
Sbjct: 174 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 24/287 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
              ++   +G+G FG V   + +  +++A+K++   S +  + F+ E+  +S++ H N+V
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 65
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L G C+      L+ EY    SL  +L               +     S+G+ YLH   
Sbjct: 66  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              +IHRDLK  N+LL       KI DFG A        Q       G+  +M+PE    
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEG 178
Query: 660 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS 719
             +SEK DVFS+G++L E+++ RK   F E         W + N  +      P +    
Sbjct: 179 SNYSEKCDVFSWGIILWEVITRRK--PFDEIGGPAFRIMWAVHNGTR-----PPLIKNLP 231
Query: 720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 766
             ++ ++        C  +    RP+M  +V ++   +R  P   EP
Sbjct: 232 KPIESLM------TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 272

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFM 525
           +F     A  ++ ++    LG+G FG V   + K  GQE AVK +SK         E  +
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 97
Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
            EV ++ +L H N+++L       E+K   Y      +   L  + + ++R        I
Sbjct: 98  REVQLLKQLDHPNIMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 154
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADT 642
           I  +  G+ Y+H++   +I+HRDLK  N+LL+   ++ N +I DFG++  F  ++   D 
Sbjct: 155 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 211
Query: 643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
              +GT  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 212 ---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFM 525
           +F     A  ++ ++    LG+G FG V   + K  GQE AVK +SK         E  +
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 98
Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
            EV ++ +L H N+++L       E+K   Y      +   L  + + ++R        I
Sbjct: 99  REVQLLKQLDHPNIMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 155
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADT 642
           I  +  G+ Y+H++   +I+HRDLK  N+LL+   ++ N +I DFG++  F  ++   D 
Sbjct: 156 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 212
Query: 643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
              +GT  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 213 ---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 24/287 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
              ++   +G+G FG V   + +  +++A+K++   S +  + F+ E+  +S++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L G C+      L+ EY    SL  +L               +     S+G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              +IHRDLK  N+LL       KI DFG A        Q       G+  +M+PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEG 177
Query: 660 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS 719
             +SEK DVFS+G++L E+++ RK   F E         W + N  +      P +    
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK--PFDEIGGPAFRIMWAVHNGTR-----PPLIKNLP 230
Query: 720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 766
             ++ ++        C  +    RP+M  +V ++   +R  P   EP
Sbjct: 231 KPIESLM------TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 121
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 10/213 (4%)
Query: 476 LATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFM--NEVMVIS 532
           + +   ++++   +G G +G     R K DG+ +  K L   S    E+ M  +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 533 KLQHRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGI 589
           +L+H N+VR     ++     L  + EY     L +++    K ++ LD      ++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 590 SRGLLYLHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
           +  L   HR  D    ++HRDLK +N+ LD + N K+ DFG+A+I   N D +     VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVG 178
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T  YMSPE      ++EKSD++S G LL E+ +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 21/207 (10%)
Query: 484 QLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
           ++  +LG G FG VY  + K+ G   A K +   S + LE+++ E+ +++   H  +V+L
Sbjct: 14  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 73
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL----YLHR 598
           LG      +  ++ E+ P  ++DA++ +      LD       I+ + R +L    +LH 
Sbjct: 74  LGAYYHDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
               RIIHRDLKA N+L+  E + +++DFG++        + D+   +GT  +M+PE  M
Sbjct: 128 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 182
Query: 659 -----EGRFSEKSDVFSFGVLLLEIVS 680
                +  +  K+D++S G+ L+E+  
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMAQ 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 10/213 (4%)
Query: 476 LATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFM--NEVMVIS 532
           + +   ++++   +G G +G     R K DG+ +  K L   S    E+ M  +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 533 KLQHRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGI 589
           +L+H N+VR     ++     L  + EY     L +++    K ++ LD      ++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 590 SRGLLYLHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
           +  L   HR  D    ++HRDLK +N+ LD + N K+ DFG+A+I   N D +     VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVG 178
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T  YMSPE      ++EKSD++S G LL E+ +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 25/222 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K+   D  K F  
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLT 148
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 149 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 205
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 206 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 120
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 10/213 (4%)
Query: 476 LATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFM--NEVMVIS 532
           + +   ++++   +G G +G     R K DG+ +  K L   S    E+ M  +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 533 KLQHRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGI 589
           +L+H N+VR     ++     L  + EY     L +++    K ++ LD      ++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 590 SRGLLYLHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
           +  L   HR  D    ++HRDLK +N+ LD + N K+ DFG+A+I   N D+      VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFVG 178
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T  YMSPE      ++EKSD++S G LL E+ +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 118
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 119
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 125
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 126 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I+ G+ 
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAEGMN 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 129 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 183
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 21/207 (10%)
Query: 484 QLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
           ++  +LG G FG VY  + K+ G   A K +   S + LE+++ E+ +++   H  +V+L
Sbjct: 22  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL----YLHR 598
           LG      +  ++ E+ P  ++DA++ +      LD       I+ + R +L    +LH 
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
               RIIHRDLKA N+L+  E + +++DFG++        + D+   +GT  +M+PE  M
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 659 -----EGRFSEKSDVFSFGVLLLEIVS 680
                +  +  K+D++S G+ L+E+  
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQ 217

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 136 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 190
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 141
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 141
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 113/229 (49%), Gaps = 37/229 (16%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
            ++F+  + LGQG FG V   R   D +  A+K++ + + + L   ++EVM+++ L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 539 LVRLLGC------------CVEGEEKMLI-YEYMPNRSL-DALLFDPLKKERLD-WRKRF 583
           +VR                 V+ +  + I  EY  NR+L D +  + L ++R + WR   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD----- 638
            I+E +S    Y+H      IIHRDLK  NI +DE  N KI DFG+AK    + D     
Sbjct: 124 QILEALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 639 -------QADTGRVVGTFGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIV 679
                    +    +GT  Y++ E     G ++EK D++S G++  E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 93/314 (29%), Positives = 154/314 (49%), Gaps = 36/314 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKL 534
           +  +FQ+   LG G FG V+  R + +G+  A+K L K      + +E   +E +++S +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGL 593
            H  ++R+ G   + ++  +I +Y+    L +LL    K +R  +   +F   E +   L
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAE-VCLAL 119
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            YLH      II+RDLK  NILLD+  + KI+DFG AK          T  + GT  Y++
Sbjct: 120 EYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYXLCGTPDYIA 171
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP 713
           PE      +++  D +SFG+L+ E+++G   T F++ + T+  Y   L  E +      P
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDSN-TMKTYEKILNAELRF----PP 224
Query: 714 FLSESSFQL--DMIIRCIHVGLLCVQ---ELVKDRPNMSTVV--SMLNSEIRDLPYPKEP 766
           F +E    L   +I R +   L  +Q   E VK+ P    VV   +L+   R++  P EP
Sbjct: 225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLS---RNIETPYEP 281
Query: 767 AFTERQGADDSESF 780
               +QG  D+  F
Sbjct: 282 PI--QQGQGDTSQF 293

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 141
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 144
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 140
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 140
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 112/202 (55%), Gaps = 20/202 (9%)
Query: 489 LGQGGFGPVYWGR-LKDGQEI----AVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRL 542
           LG G FG VY G  + DG+ +    A+K L +  S +  +E ++E  V++ +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDS 600
           LG C+    + L+ + MP       L D +++ R  L  +   N    I++G+ YL    
Sbjct: 85  LGICLTSTVQ-LVTQLMPY----GCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED-- 137
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAM 658
            +R++HRDL A N+L+    + KI+DFG+A++   ++ +  AD G+V     +M+ E  +
Sbjct: 138 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESIL 194
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
             RF+ +SDV+S+GV + E+++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 144
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 139 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 537
             ++ L   LG+G  G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSG 681
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 146
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 147 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 112/225 (49%), Gaps = 12/225 (5%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHR 537
           NF++  K+G+G F  VY    L DG  +A+K++        +   + + E+ ++ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYL 596
           N+++     +E  E  ++ E      L  ++    K++RL   R  +     +   L ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H  SR R++HRD+K +N+ +      K+ D G+ + F      A +  +VGT  YMSPE 
Sbjct: 153 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 207
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL 701
             E  ++ KSD++S G LL E+ + +  + F+ D + +     K+
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSLCKKI 250

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K E  D  K F  
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE--DLYKDFLT 146
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 147 LEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVIS 532
           A  ++ ++    LG+G FG V   + K  GQE AVK +SK         E  + EV ++ 
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           +L H N+ +L       E+K   Y      +   L  + + ++R        II  +  G
Sbjct: 82  QLDHPNIXKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 593 LLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
           + Y H++   +I+HRDLK  N+LL+   ++ N +I DFG++  F  ++   D    +GT 
Sbjct: 139 ITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IGTA 192
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 482 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQ 535
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG  E   E+  +  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H ++++L       +E +++ EY  N   D ++    +++++  ++     + I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 127
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            HR    +I+HRDLK  N+LLDE LN KI+DFG++ I     D        G+  Y +PE
Sbjct: 128 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPE 181
Query: 656 YAMEGRF--SEKSDVFSFGVLLLEIVSGR 682
             + G+     + DV+S GV+L  ++  R
Sbjct: 182 -VISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    L  G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 482 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQ 535
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG  E   E+  +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H ++++L       +E +++ EY  N   D ++    +++++  ++     + I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 118
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            HR    +I+HRDLK  N+LLDE LN KI+DFG++ I     D        G+  Y +PE
Sbjct: 119 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPE 172
Query: 656 YAMEGRF--SEKSDVFSFGVLLLEIVSGR 682
             + G+     + DV+S GV+L  ++  R
Sbjct: 173 -VISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 110/224 (49%), Gaps = 36/224 (16%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DG--QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 535
           N+ +    +G+G FG V   R+K DG   + A+KR+ + AS     +F  E+ V+ KL  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LD 578
           H N++ LLG C       L  EY P+ +L     D L+K R                 L 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
            ++  +    ++RG+ YL   S+ + IHR+L A NIL+ E    KI+DFG+++       
Sbjct: 138 SQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR-----GQ 189
Query: 639 QADTGRVVGTFG--YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           +    + +G     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 190 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 482 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQ 535
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG  E   E+  +  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H ++++L       +E +++ EY  N   D ++    +++++  ++     + I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 128
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            HR    +I+HRDLK  N+LLDE LN KI+DFG++ I     D        G+  Y +PE
Sbjct: 129 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPE 182
Query: 656 YAMEGRF--SEKSDVFSFGVLLLEIVSGR 682
             + G+     + DV+S GV+L  ++  R
Sbjct: 183 -VISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 108/201 (53%), Gaps = 11/201 (5%)
Query: 488 KLGQGGFGPVYWG-RLKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRNLVRLLGC 545
           ++G+G FG V+ G   +  Q +A+K +  + +   +E+   E+ V+S+     + +  G 
Sbjct: 30  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGS 89
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
            ++G +  +I EY+   S      D L+    D  +   +++ I +GL YLH + +   I
Sbjct: 90  YLKGSKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---I 142
Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           HRD+KA+N+LL E+ + K++DFG+A      Q + +T   VGT  +M+PE   +  +  K
Sbjct: 143 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDSK 200
Query: 666 SDVFSFGVLLLEIVSGRKNTS 686
           +D++S G+  +E+  G    S
Sbjct: 201 ADIWSLGITAIELAKGEPPNS 221

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 482 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQ 535
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG  E   E+  +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H ++++L       +E +++ EY  N   D ++    +++++  ++     + I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 122
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            HR    +I+HRDLK  N+LLDE LN KI+DFG++ I     D        G+  Y +PE
Sbjct: 123 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPE 176
Query: 656 YAMEGRF--SEKSDVFSFGVLLLEIVSGR 682
             + G+     + DV+S GV+L  ++  R
Sbjct: 177 -VISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 123
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 183
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 184 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 240
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 241 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKF---RQIVSAVQYCH 130
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 656
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN  + DT    G+  Y +PE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDT--FCGSPPYAAPEL 183
Query: 657 AMEGRFS-EKSDVFSFGVLLLEIVSG 681
               ++   + DV+S GV+L  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR---QIVSAVQYCH 130
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 656
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN+  A      G   Y +PE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPEL 183
Query: 657 AMEGRFS-EKSDVFSFGVLLLEIVSG 681
               ++   + DV+S GV+L  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR---QIVSAVQYCH 130
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 656
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN  + DT    G+  Y +PE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDT--FCGSPPYAAPEL 183
Query: 657 AMEGRFS-EKSDVFSFGVLLLEIVSG 681
               ++   + DV+S GV+L  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    L  G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 139 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    L  G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 139 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV ++  L H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR---QIVSAVQYCH 131
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 656
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN  + DT    G+  Y +PE 
Sbjct: 132 QKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN--KLDT--FCGSPPYAAPEL 184
Query: 657 AMEGRFS-EKSDVFSFGVLLLEIVSG 681
               ++   + DV+S GV+L  +VSG
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 107/227 (47%), Gaps = 31/227 (13%)
Query: 482 NFQLSSKLGQGGFGPVY----WGRLKDGQ--EIAVKRL-SKASGQGLEEFMNEVMVISKL 534
           N +    LG G FG V     +G  K G   ++AVK L  KA     E  M+E+ ++++L
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 535 -QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK-----------ERLDWRKR 582
             H N+V LLG C       LI+EY     L   L    +K           +RL+  + 
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 583 FNIIE---------GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
            N++           +++G+ +L   S    +HRDL A N+L+      KI DFG+A+  
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 634 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             + +    G       +M+PE   EG ++ KSDV+S+G+LL EI S
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G  + +G+++    A+  L +A S +  +E ++E  V++ +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 165
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 652
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 166 YLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 220
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 221 ALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F      R L   +E A+K L K        +     E  V+S+L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 591
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 141
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV ++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK-EARAKFR---QIVSAVQYCH 123
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 656
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN  + DT    G+  Y +PE 
Sbjct: 124 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDT--FCGSPPYAAPEL 176
Query: 657 AMEGRFS-EKSDVFSFGVLLLEIVSG 681
               ++   + DV+S GV+L  +VSG
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 488 KLGQGGFGPVYWGRLKDGQ-EIAVKRLSKAS-------------GQGLEEFMNEVMVISK 533
           KLG G +G V   + K+G  E A+K + K+               +  EE  NE+ ++  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           L H N+++L     + +   L+ E+     L   +   + + + D     NI++ I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSGI 159
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
            YLH+ +   I+HRD+K  NILL+ +   LN KI DFG++  F  +    D    +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAY 213
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           Y++PE  ++ +++EK DV+S GV++  ++ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
           N++L   +G+G F  V   R +  G+E+AV+ + K   +   L++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR---QIVSAVQYCH 130
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPE 655
           +     I+HRDLKA N+LLD ++N KI+DFG +    FG   D+       G+  Y +PE
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE-----FCGSPPYAAPE 182
Query: 656 YAMEGRFS-EKSDVFSFGVLLLEIVSG 681
                ++   + DV+S GV+L  +VSG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 489 LGQGGFGPVY---WGRLKDG--QEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLVRL 542
           LG+G FG V    +    DG  + +AVK L +  G  L   +  E+ ++  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 543 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
            GCC +  EK   L+ EY+P  SL     D L +  +   +     + I  G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAM 658
               IHR L A N+LLD +   KI DFG+AK    G    +         F Y +PE   
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLK 188
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
           E +F   SDV+SFGV L E+++
Sbjct: 189 ECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 489 LGQGGFGPVY---WGRLKDG--QEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLVRL 542
           LG+G FG V    +    DG  + +AVK L +  G  L   +  E+ ++  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 543 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
            GCC +  EK   L+ EY+P  SL     D L +  +   +     + I  G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAM 658
               IHR L A N+LLD +   KI DFG+AK    G    +         F Y +PE   
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLK 187
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
           E +F   SDV+SFGV L E+++
Sbjct: 188 ECKFYYASDVWSFGVTLYELLT 209

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 119/234 (50%), Gaps = 18/234 (7%)
Query: 456 SATNVNTVKLQDLPLFQFEELATATNN---FQLSSKLGQGGFGPVYWGRLKDGQEIAV-K 511
           S  ++ T  L    + Q+E +    N    +++  +LG G FG VY  + K+   +A  K
Sbjct: 9   SGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK 68
Query: 512 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 571
            +   S + LE++M E+ +++   H N+V+LL          ++ E+    ++DA++   
Sbjct: 69  VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM--- 125
Query: 572 LKKERLDWRKRFNII-EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
           L+ ER     +  ++ +     L YLH +   +IIHRDLKA NIL   + + K++DFG++
Sbjct: 126 LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 631 KIFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIV 679
                   + D+   +GT  +M+PE  M     +  +  K+DV+S G+ L+E+ 
Sbjct: 183 AKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
           N++L   +G+G F  V   R +  G+E+AV+ + K   +   L++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR---QIVSAVQYCH 130
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 656
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN  + DT    G+  Y +PE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDT--FCGSPPYAAPEL 183
Query: 657 AMEGRFS-EKSDVFSFGVLLLEIVSG 681
               ++   + DV+S GV+L  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEFMNEVMVISKLQHRNLV 540
           F    ++G+G FG VY G     +E+ A+K +  + +   +E+   E+ V+S+     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 541 RLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           R  G  ++  +  +I EY+   S LD L   PL++  +       I+  I +GL YLH +
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 135
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              R IHRD+KA+N+LL E+ + K++DFG+A      Q + +    VGT  +M+PE   +
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 190
Query: 660 GRFSEKSDVFSFGVLLLEIVSGRKNTS 686
             +  K+D++S G+  +E+  G    S
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPPNS 217

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 36/225 (16%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--VMVISKLQHRN 538
           +N +L   +G+G +G VY G L D + +AVK  S A+ Q    F+NE  +  +  ++H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDN 68
Query: 539 LVRLL----GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           + R +        +G  E +L+ EY PN SL   L         DW     +   ++RGL
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGL 124
Query: 594 LYLHRD------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ----DQADTG 643
            YLH +       +  I HRDL + N+L+  +    ISDFG++    GN+     + D  
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 644 RV--VGTFGYMSPEYAMEGRFS--------EKSDVFSFGVLLLEI 678
            +  VGT  YM+PE  +EG  +        ++ D+++ G++  EI
Sbjct: 185 AISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
              +T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 119/234 (50%), Gaps = 18/234 (7%)
Query: 456 SATNVNTVKLQDLPLFQFEELATATNN---FQLSSKLGQGGFGPVYWGRLKDGQEIAV-K 511
           S  ++ T  L    + Q+E +    N    +++  +LG G FG VY  + K+   +A  K
Sbjct: 9   SGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK 68
Query: 512 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 571
            +   S + LE++M E+ +++   H N+V+LL          ++ E+    ++DA++   
Sbjct: 69  VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM--- 125
Query: 572 LKKERLDWRKRFNII-EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
           L+ ER     +  ++ +     L YLH +   +IIHRDLKA NIL   + + K++DFG++
Sbjct: 126 LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 631 KIFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIV 679
                   + D+   +GT  +M+PE  M     +  +  K+DV+S G+ L+E+ 
Sbjct: 183 AKNTRXIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK-EARAKFR---QIVSAVQYCH 130
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 656
           +     I+HRDLKA N+LLD + N KI+DFG +  F  GN+  A      G   Y +PE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPEL 183
Query: 657 AMEGRFS-EKSDVFSFGVLLLEIVSG 681
               ++   + DV+S GV+L  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +   L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPE-DLYKDFLT 146
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 485 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 534
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 581
           +H+N++ LLG C +     +I EY    +L   L           F+P    +E+L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 117/244 (47%), Gaps = 31/244 (12%)
Query: 460 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVK 511
           V+  +L + P ++F       +   L   LG+G FG V           + K+   +AVK
Sbjct: 19  VSEYELPEDPKWEF-----PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 512 RLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL- 568
            L   A+ + L + ++E+ ++  + +H+N++ LLG C +     +I EY    +L   L 
Sbjct: 74  MLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 133
Query: 569 ------------FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
                        + + +E++ ++   +    ++RG+ YL   +  + IHRDL A N+L+
Sbjct: 134 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV 190
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
            E    KI+DFG+A+          T        +M+PE   +  ++ +SDV+SFGVL+ 
Sbjct: 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250
Query: 677 EIVS 680
           EI +
Sbjct: 251 EIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 118/234 (50%), Gaps = 18/234 (7%)
Query: 456 SATNVNTVKLQDLPLFQFEELATATNN---FQLSSKLGQGGFGPVYWGRLKDGQEIAV-K 511
           S  ++ T  L    + Q+E +    N    +++  +LG G FG VY  + K+   +A  K
Sbjct: 9   SGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK 68
Query: 512 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 571
            +   S + LE++M E+ +++   H N+V+LL          ++ E+    ++DA++   
Sbjct: 69  VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM--- 125
Query: 572 LKKERLDWRKRFNII-EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
           L+ ER     +  ++ +     L YLH +   +IIHRDLKA NIL   + + K++DFG++
Sbjct: 126 LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 631 KIFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIV 679
                   + D    +GT  +M+PE  M     +  +  K+DV+S G+ L+E+ 
Sbjct: 183 AKNTRXIQRRDX--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 114/213 (53%), Gaps = 11/213 (5%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLS-KASGQGLEEF-MNEVMVISKLQHRNL 539
            +Q   K+G+G +G VY  +   G+ +A+KR+   A  +G+    + E+ ++ +L H N+
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V L+          L++E+M  + L  +L D  K    D + +  + + + RG+ + H+ 
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQH 138
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM- 658
              RI+HRDLK  N+L++ +   K++DFG+A+ FG    ++ T  VV T  Y +P+  M 
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVV-TLWYRAPDVLMG 193
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
             ++S   D++S G +  E+++G+       DD
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 114/213 (53%), Gaps = 11/213 (5%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLS-KASGQGLEEF-MNEVMVISKLQHRNL 539
            +Q   K+G+G +G VY  +   G+ +A+KR+   A  +G+    + E+ ++ +L H N+
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V L+          L++E+M  + L  +L D  K    D + +  + + + RG+ + H+ 
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQH 138
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM- 658
              RI+HRDLK  N+L++ +   K++DFG+A+ FG    ++ T  VV T  Y +P+  M 
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVV-TLWYRAPDVLMG 193
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
             ++S   D++S G +  E+++G+       DD
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 489 LGQGGFGPVY---WGRLKDG--QEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
           LG+G FG V    +    DG  + +AVK L    G Q    +  E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 543 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
            GCC +  EK   L+ EY+P  SL     D L +  +   +     + I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHAQ- 136
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAM 658
               IHR+L A N+LLD +   KI DFG+AK    G    +         F Y +PE   
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLK 193
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
           E +F   SDV+SFGV L E+++
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 489 LGQGGFGPVY---WGRLKDG--QEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
           LG+G FG V    +    DG  + +AVK L    G Q    +  E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 543 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
            GCC +  EK   L+ EY+P  SL     D L +  +   +     + I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHSQ- 136
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAM 658
               IHR+L A N+LLD +   KI DFG+AK    G    +         F Y +PE   
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLK 193
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
           E +F   SDV+SFGV L E+++
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 112/229 (48%), Gaps = 37/229 (16%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
            ++F+  + LGQG FG V   R   D +  A+K++ + + + L   ++EVM+++ L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 539 LVRLLGC------------CVEGEEKMLI-YEYMPNRSL-DALLFDPLKKERLD-WRKRF 583
           +VR                 V+ +  + I  EY  N +L D +  + L ++R + WR   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD----- 638
            I+E +S    Y+H      IIHRDLK  NI +DE  N KI DFG+AK    + D     
Sbjct: 124 QILEALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 639 -------QADTGRVVGTFGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIV 679
                    +    +GT  Y++ E     G ++EK D++S G++  E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +   L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK----DLYKDFLT 142
Query: 586 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 143 LEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 199
Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G+S 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLS- 117
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 169
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 489 LGQGGFGPVYWGR-LKDGQEI----AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
           LG G FG V+ G  + +G+ I     +K +   SG Q  +   + ++ I  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDS 600
           LG C  G    L+ +Y+P  SL     D +++ R  L  +   N    I++G+ YL    
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
              ++HR+L A N+LL      +++DFG+A +   +  Q           +M+ E    G
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +++ +SDV+S+GV + E+++
Sbjct: 193 KYTHQSDVWSYGVTVWELMT 212

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQ-GLEEFMNEVMVISKLQHRN 538
           ++++L   +G G    V        +E +A+KR++    Q  ++E + E+  +S+  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKER----LDWRKRFNIIEGISRGL 593
           +V      V  +E  L+ + +   S LD +     K E     LD      I+  +  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRV-VGTFG 650
            YLH++ +   IHRD+KA NILL E+ + +I+DFG++     GG+  +    +  VGT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 651 YMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG 681
           +M+PE   + R +  K+D++SFG+  +E+ +G
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V     K  G+++AVK++     Q  E   NEV+++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ E++   +L     D +   R++  +   +   + R L YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++++E++ G
Sbjct: 222 VDIWSLGIMVIEMIDG 237

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 115/215 (53%), Gaps = 20/215 (9%)
Query: 476 LATATNNFQLSSKLGQGGFGPVYWGR-LKDGQE-IAVKRLSKASGQ-GLE-EFMNEVMVI 531
           L  A   ++  +++G+G +G V+  R LK+G   +A+KR+   +G+ G+    + EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 532 SKLQ---HRNLVRLLGCCV----EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
             L+   H N+VRL   C     + E K+ L++E++ ++ L   L D + +  +      
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
           +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+     Q    
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 177
Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 678
            VV T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 117/244 (47%), Gaps = 31/244 (12%)
Query: 460 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVK 511
           V+  +L + P ++F       +   L   LG+G FG V           + K+   +AVK
Sbjct: 8   VSEYELPEDPKWEF-----PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 62
Query: 512 RLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL- 568
            L   A+ + L + ++E+ ++  + +H+N++ LLG C +     +I EY    +L   L 
Sbjct: 63  MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 122
Query: 569 ------------FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
                        + + +E++ ++   +    ++RG+ YL   +  + IHRDL A N+L+
Sbjct: 123 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV 179
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
            E    KI+DFG+A+          T        +M+PE   +  ++ +SDV+SFGVL+ 
Sbjct: 180 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 239
Query: 677 EIVS 680
           EI +
Sbjct: 240 EIFT 243

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 489 LGQGGFGPVYWGR-LKDGQEI----AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
           LG G FG V+ G  + +G+ I     +K +   SG Q  +   + ++ I  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDS 600
           LG C  G    L+ +Y+P  SL     D +++ R  L  +   N    I++G+ YL    
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
              ++HR+L A N+LL      +++DFG+A +   +  Q           +M+ E    G
Sbjct: 154 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +++ +SDV+S+GV + E+++
Sbjct: 211 KYTHQSDVWSYGVTVWELMT 230

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +   L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 585
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D+    ++
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 586 IE---GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
           I     +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    
Sbjct: 147 IXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 485 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 534
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 581
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 137 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQ-GLEEFMNEVMVISKLQHRN 538
           ++++L   +G G    V        +E +A+KR++    Q  ++E + E+  +S+  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKER----LDWRKRFNIIEGISRGL 593
           +V      V  +E  L+ + +   S LD +     K E     LD      I+  +  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRV-VGTFG 650
            YLH++ +   IHRD+KA NILL E+ + +I+DFG++     GG+  +    +  VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 651 YMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG 681
           +M+PE   + R +  K+D++SFG+  +E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEFMNEVMVISKLQHRNLV 540
           F    K+G+G FG V+ G     Q++ A+K +  + +   +E+   E+ V+S+     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +  G  ++  +  +I EY+   S      D L+   LD  +   I+  I +GL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
           +   IHRD+KA+N+LL E    K++DFG+A      Q + +T   VGT  +M+PE   + 
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 179
Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTS 686
            +  K+D++S G+  +E+  G    S
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHS 205

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 485 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 534
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 581
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 145 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 117/244 (47%), Gaps = 31/244 (12%)
Query: 460 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVK 511
           V+  +L + P ++F       +   L   LG+G FG V           + K+   +AVK
Sbjct: 19  VSEYELPEDPKWEF-----PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 512 RLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL- 568
            L   A+ + L + ++E+ ++  + +H+N++ LLG C +     +I EY    +L   L 
Sbjct: 74  MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 133
Query: 569 ------------FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
                        + + +E++ ++   +    ++RG+ YL   +  + IHRDL A N+L+
Sbjct: 134 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV 190
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
            E    +I+DFG+A+          T        +M+PE   +  ++ +SDV+SFGVL+ 
Sbjct: 191 TENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250
Query: 677 EIVS 680
           EI +
Sbjct: 251 EIFT 254

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEFMNEVMVISKLQHRNLV 540
           F    K+G+G FG V+ G     Q++ A+K +  + +   +E+   E+ V+S+     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +  G  ++  +  +I EY+   S      D L+   LD  +   I+  I +GL YLH + 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
           +   IHRD+KA+N+LL E    K++DFG+A      Q + +T   VGT  +M+PE   + 
Sbjct: 145 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 199
Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTS 686
            +  K+D++S G+  +E+  G    S
Sbjct: 200 AYDSKADIWSLGITAIELARGEPPHS 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 115/215 (53%), Gaps = 20/215 (9%)
Query: 476 LATATNNFQLSSKLGQGGFGPVYWGR-LKDGQE-IAVKRLSKASGQ-GLE-EFMNEVMVI 531
           L  A   ++  +++G+G +G V+  R LK+G   +A+KR+   +G+ G+    + EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 532 SKLQ---HRNLVRLLGCCV----EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
             L+   H N+VRL   C     + E K+ L++E++ ++ L   L D + +  +      
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
           +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+     Q    
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 177
Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 678
            VV T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 117
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 169
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 489 LGQGGFGPVY---WGRLKDG--QEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
           LG+G FG V    +    DG  + +AVK L   +G Q    +  E+ ++  L H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 543 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
            GCC +       L+ EY+P  SL     D L +  +   +     + I  G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAM 658
               IHRDL A N+LLD +   KI DFG+AK    G    +         F Y +PE   
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLK 210
Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
           E +F   SDV+SFGV L E+++
Sbjct: 211 EYKFYYASDVWSFGVTLYELLT 232

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 115/215 (53%), Gaps = 20/215 (9%)
Query: 476 LATATNNFQLSSKLGQGGFGPVYWGR-LKDGQE-IAVKRLSKASGQ-GLE-EFMNEVMVI 531
           L  A   ++  +++G+G +G V+  R LK+G   +A+KR+   +G+ G+    + EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 532 SKLQ---HRNLVRLLGCCV----EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
             L+   H N+VRL   C     + E K+ L++E++ ++ L   L D + +  +      
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
           +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+     Q    
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 177
Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 678
            VV T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 485 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 534
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 581
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 141 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 485 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 534
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 581
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 485 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 534
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 581
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 489 LGQGGFGPVYWGRLKDGQE----IAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLL 543
           +G+G FG VY G   D  +     A+K LS+ +  Q +E F+ E +++  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 544 GCCV--EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           G  +  EG   +L+  YM +  L   +  P +   +     F +   ++RG+ YL   + 
Sbjct: 89  GIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYL---AE 142
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ----DQADTGRVVGTFGYMSPEYA 657
            + +HRDL A N +LDE    K++DFG+A+     +     Q    R+     + + E  
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PVKWTALESL 200
Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
              RF+ KSDV+SFGVLL E+++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 485 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 534
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 581
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 485 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 534
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 581
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 144 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T
Sbjct: 117 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-T 167
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 117
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 169
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 116
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 117 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 168
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 116
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 117 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 168
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 21/217 (9%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQHR 537
           ++ L   LG G FG V  G+ +  G ++AVK L++   + L+   +   E+  +   +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYL 596
           ++++L        +  ++ EY+        LFD + K  RLD ++   + + I  G+ Y 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSG----GELFDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           HR     ++HRDLK  N+LLD  +N KI+DFG++ +     D        G+  Y +PE 
Sbjct: 133 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRXSCGSPNYAAPE- 185
Query: 657 AMEGRF--SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
            + GR     + D++S GV+L  ++ G   T  F+DD
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCG---TLPFDDD 219

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 485 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 534
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 581
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 117
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 169
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 124
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 125 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 176
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 177 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVIS 532
           E L   +   QL     +G FG V+  +L + + +AVK       Q  + E+  EV  + 
Sbjct: 17  ENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLP 73
Query: 533 KLQHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
            ++H N+++ +G    G     +  LI  +    SL     D LK   + W +  +I E 
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLS----DFLKANVVSWNELCHIAET 129
Query: 589 ISRGLLYLHRD-------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
           ++RGL YLH D        +  I HRD+K+ N+LL   L   I+DFG+A  F   +   D
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVF------SFGVLLLEIVS 680
           T   VGT  YM+PE  +EG  + + D F      + G++L E+ S
Sbjct: 190 THGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 124
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 125 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 176
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 177 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 37/229 (16%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
            ++F+  + LGQG FG V   R   D +  A+K++ + + + L   ++EV +++ L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQY 63
Query: 539 LVRLLGC------------CVEGEEKMLI-YEYMPNRSL-DALLFDPLKKERLD-WRKRF 583
           +VR                 V+ +  + I  EY  NR+L D +  + L ++R + WR   
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD----- 638
            I+E +S    Y+H      IIHR+LK  NI +DE  N KI DFG+AK    + D     
Sbjct: 124 QILEALS----YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 639 -------QADTGRVVGTFGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIV 679
                    +    +GT  Y++ E     G ++EK D +S G++  E +
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 121
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 122 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 173
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEF-MNEVMVISKLQ 535
           ++++ F+   KLG G +  VY G  K  G  +A+K +   S +G     + E+ ++ +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS----- 590
           H N+VRL        +  L++E+M N            K+ +D R   N   G+      
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDL----------KKYMDSRTVGNTPRGLELNLVK 111
Query: 591 -------RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
                  +GL + H +   +I+HRDLK  N+L+++    K+ DFG+A+ FG   +   + 
Sbjct: 112 YFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 644 RVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            V  T  Y +P+  M  R +S   D++S G +L E+++G+
Sbjct: 169 VV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I  Y    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL---SKASGQGLE-EFMNEVMVISKLQH 536
           ++F++   LG+G FG VY  R K    I   ++   S+   +G+E +   E+ + + L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLY 595
            N++RL     +     LI EY P       L+  L+K    D ++   I+E ++  L+Y
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPR----GELYKELQKSCTFDEQRTATIMEELADALMY 138
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            H     ++IHRD+K  N+LL  +   KI+DFG    +  +        + GT  Y+ PE
Sbjct: 139 CHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPPE 191
Query: 656 YAMEGRF-SEKSDVFSFGVLLLEIVSG 681
             +EGR  +EK D++  GVL  E++ G
Sbjct: 192 -MIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 43/235 (18%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC-- 545
           +G GGFG V+  + + DG+   ++R+   +    E+   EV  ++KL H N+V   GC  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 75
Query: 546 -----CVEGEEKMLIYEYMP------NRSLDALLF---------------DPLKKERLDW 579
                    ++ +   +Y P      +RS    LF               +  + E+LD 
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
                + E I++G+ Y+H     ++IHRDLK SNI L +    KI DFG+       ++ 
Sbjct: 136 VLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL---KND 189
Query: 640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV----SGRKNTSFFED 690
               R  GT  YMSPE      + ++ D+++ G++L E++    +  + + FF D
Sbjct: 190 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 244

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H N+V+LL       +  L++E++     D +    L    L   K +  +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 118
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPE 173
Query: 656 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             +  + +S   D++S G +  E+V+ R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 533
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 589
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 72  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 124
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVG 647
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 125 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 180
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 118/252 (46%), Gaps = 36/252 (14%)
Query: 457 ATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPV-----YWGRLKDG-QEIAV 510
           + +V+  K+ + P ++F        N  L   LG+G FG V     +  + + G   +AV
Sbjct: 4   SLSVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAV 58
Query: 511 KRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF 569
           K L + AS   L + ++E  V+ ++ H ++++L G C +    +LI EY    SL   L 
Sbjct: 59  KMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
Query: 570 DPLK-------------KERLDWRKRFNIIEG--------ISRGLLYLHRDSRLRIIHRD 608
           +  K                LD      +  G        IS+G+ YL   + ++++HRD
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRD 175
Query: 609 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDV 668
           L A NIL+ E    KISDFG+++            +      +M+ E   +  ++ +SDV
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 669 FSFGVLLLEIVS 680
           +SFGVLL EIV+
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 489 LGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM-NEVMVISKLQHRNLVRLLGCC 546
           LG G F  V     K  Q+ +A+K ++K + +G E  M NE+ V+ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 547 VEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
             G    LI + +    L D ++      ER   R  F +++ +     YLH    L I+
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLHD---LGIV 138
Query: 606 HRDLKASNIL---LDEELNPKISDFGMAKIFGGNQDQADTGRVV----GTFGYMSPEYAM 658
           HRDLK  N+L   LDE+    ISDFG++K+        D G V+    GT GY++PE   
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYVAPEVLA 191
Query: 659 EGRFSEKSDVFSFGVLLLEIVSG 681
           +  +S+  D +S GV+   ++ G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 533
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 589
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 120
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA--DTGRVVG 647
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 121 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV- 176
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 30/212 (14%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQ-EIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNL 539
           +Q   KLG G +G V   R K    E A+K  R +  S     + + EV V+  L H N+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 540 VRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRG 592
           ++L     +     L+ E Y      D ++           R +FN      II+ +  G
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIH----------RMKFNEVDAAVIIKQVLSG 148
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTF 649
           + YLH+ +   I+HRDLK  N+LL+ +      KI DFG++ +F   ++Q      +GT 
Sbjct: 149 VTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTA 202
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y++PE  +  ++ EK DV+S GV+L  +++G
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 118/252 (46%), Gaps = 36/252 (14%)
Query: 457 ATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPV-----YWGRLKDG-QEIAV 510
           + +V+  K+ + P ++F        N  L   LG+G FG V     +  + + G   +AV
Sbjct: 4   SLSVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAV 58
Query: 511 KRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF 569
           K L + AS   L + ++E  V+ ++ H ++++L G C +    +LI EY    SL   L 
Sbjct: 59  KMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
Query: 570 DPLK-------------KERLDWRKRFNIIEG--------ISRGLLYLHRDSRLRIIHRD 608
           +  K                LD      +  G        IS+G+ YL   + ++++HRD
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRD 175
Query: 609 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDV 668
           L A NIL+ E    KISDFG+++            +      +M+ E   +  ++ +SDV
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 669 FSFGVLLLEIVS 680
           +SFGVLL EIV+
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 489 LGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM-NEVMVISKLQHRNLVRLLGCC 546
           LG G F  V     K  Q+ +A+K ++K + +G E  M NE+ V+ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 547 VEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
             G    LI + +    L D ++      ER   R  F +++ +     YLH    L I+
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLHD---LGIV 138
Query: 606 HRDLKASNIL---LDEELNPKISDFGMAKIFGGNQDQADTGRVV----GTFGYMSPEYAM 658
           HRDLK  N+L   LDE+    ISDFG++K+        D G V+    GT GY++PE   
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYVAPEVLA 191
Query: 659 EGRFSEKSDVFSFGVLLLEIVSG 681
           +  +S+  D +S GV+   ++ G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 166
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 489 LGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM-NEVMVISKLQHRNLVRLLGCC 546
           LG G F  V     K  Q+ +A+K ++K + +G E  M NE+ V+ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 547 VEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
             G    LI + +    L D ++      ER   R  F +++ +     YLH    L I+
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLHD---LGIV 138
Query: 606 HRDLKASNIL---LDEELNPKISDFGMAKIFGGNQDQADTGRVV----GTFGYMSPEYAM 658
           HRDLK  N+L   LDE+    ISDFG++K+        D G V+    GT GY++PE   
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYVAPEVLA 191
Query: 659 EGRFSEKSDVFSFGVLLLEIVSG 681
           +  +S+  D +S GV+   ++ G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 166
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 166
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I  Y    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H N+V+LL       +  L++E++     D +    L    L   K +  +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 120
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPE 175
Query: 656 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             +  + +S   D++S G +  E+V+ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMP---NRSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 119 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 169
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMP---NRSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 117 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 167
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM-NEVMVISKLQHRNLV 540
           +     LG G F  V     K  Q+ +A+K ++K + +G E  M NE+ V+ K++H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
            L      G    LI + +    L D ++      ER   R  F +++ +     YLH  
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLHD- 134
Query: 600 SRLRIIHRDLKASNIL---LDEELNPKISDFGMAKIFGGNQDQADTGRVV----GTFGYM 652
             L I+HRDLK  N+L   LDE+    ISDFG++K+        D G V+    GT GY+
Sbjct: 135 --LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYV 185
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +PE   +  +S+  D +S GV+   ++ G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 27/213 (12%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 539 LVRLLGCCVEGEEKMLIYE--------YMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
           +V+LL       +  L++E        +M   +L  +   PL K  L     F +++G++
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPL-PLIKSYL-----FQLLQGLA 116
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
               + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLW 167
Query: 651 YMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
           Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 166
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 533
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 589
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 130
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA--DTGRVVG 647
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 131 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV- 186
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 533
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 589
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 120
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVG 647
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 121 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 176
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 117
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 118 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 168
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H N+V+LL       +  L++E++     D +    L    L   K +  +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 121
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPE 176
Query: 656 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             +  + +S   D++S G +  E+V+ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 116
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y
Sbjct: 117 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWY 168
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 117 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 167
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEFMNEVMVISKLQHRNLV 540
           F    K+G+G FG V+ G     Q++ A+K +  + +   +E+   E+ V+S+     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +  G  ++  +  +I EY+   S      D L+   LD  +   I+  I +GL YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
           +   IHRD+KA+N+LL E    K++DFG+A      Q + +    VGT  +M+PE   + 
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 194
Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTS 686
            +  K+D++S G+  +E+  G    S
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHS 220

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEFMNEVMVISKLQHRNLV 540
           F    K+G+G FG V+ G     Q++ A+K +  + +   +E+   E+ V+S+     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +  G  ++  +  +I EY+   S      D L+   LD  +   I+  I +GL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
           +   IHRD+KA+N+LL E    K++DFG+A      Q + +    VGT  +M+PE   + 
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 179
Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTS 686
            +  K+D++S G+  +E+  G    S
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHS 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 117
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 118 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 168
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 108/229 (47%), Gaps = 44/229 (19%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           +G GGFG V+  + + DG+   +KR+   +    E+   EV  ++KL H N+V   GC  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCW- 73
Query: 548 EGEEKMLIYEYMP-------NRSLDALLF---------------DPLKKERLDWRKRFNI 585
           +G      ++Y P       +RS    LF               +  + E+LD      +
Sbjct: 74  DG------FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
            E I++G+ Y+H     ++I+RDLK SNI L +    KI DFG+       ++     R 
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXRS 181
Query: 646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV----SGRKNTSFFED 690
            GT  YMSPE      + ++ D+++ G++L E++    +  + + FF D
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 169
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 117
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 118 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 168
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 116
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y
Sbjct: 117 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWY 168
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 117 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 167
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 118
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y
Sbjct: 119 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWY 170
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 119
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 120 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 170
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 533
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 589
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 120
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVG 647
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 121 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 176
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 169
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK---ASGQGLEEFMNEVMV 530
           ++     +F+L   LG+G FG V+    K   Q  A+K L K        +E  M E  V
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 531 ISKLQHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
           +S       +  + C  + +E +  + EY+    L   ++      + D  +       I
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 128
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVG 647
             GL +LH      I++RDLK  NILLD++ + KI+DFGM K  + G     A T    G
Sbjct: 129 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNEFCG 181
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           T  Y++PE  +  +++   D +SFGVLL E++ G+
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++++E+V G
Sbjct: 197 VDIWSLGIMVIEMVDG 212

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+   RL   +       + E+ ++ +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 117
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 169
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 25/212 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+   RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 591
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 116
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 117 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 168
Query: 652 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 533
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 589
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 72  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 124
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVG 647
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 125 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 180
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 533
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 589
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 130
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVG 647
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 131 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 186
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + QL     +G FG V+  +L +   +AVK       Q  +    E+     ++H NL++
Sbjct: 16  SLQLLEIKARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQ 73
Query: 542 LLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
            +     G     E  LI  +    SL     D LK   + W +  ++ E +SRGL YLH
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLT----DYLKGNIITWNELCHVAETMSRGLSYLH 129
Query: 598 RD--------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
            D         +  I HRD K+ N+LL  +L   ++DFG+A  F   +   DT   VGT 
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 650 GYMSPEYAMEGRFSEKSDVF------SFGVLLLEIVS 680
            YM+PE  +EG  + + D F      + G++L E+VS
Sbjct: 190 RYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 535
           ++ ++L   LG GG   V+  R L+D +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 536 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA-DTGRVVGTFG 650
            L + H++    IIHRD+K +NIL+      K+ DFG+A+    + +    T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYW----GRLKDGQEIAVKRLSKASGQGLEEFMNEVM--VISKL 534
           ++F+L   LGQG FG V+      R   G   A+K L KA+ +  +    ++   +++ +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRG 592
            H  +V+L        +  LI +++  R  D  LF  L KE +  +   +F + E ++ G
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAE-LALG 142
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L +LH    L II+RDLK  NILLDEE + K++DFG++K    ++ +A +    GT  YM
Sbjct: 143 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYM 197
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +PE       S  +D +S+GVL+ E+++G
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++++E+V G
Sbjct: 201 VDIWSLGIMVIEMVDG 216

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++++E+V G
Sbjct: 206 VDIWSLGIMVIEMVDG 221

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ-GLE-EFMNEVMVISKLQ 535
           AT+ ++  +++G G +G VY  R    G  +A+K +   +G+ GL    + EV ++ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 536 ---HRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
              H N+VRL+  C         +  L++E++ ++ L   L D      L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
              RGL +LH +    I+HRDLK  NIL+      K++DFG+A+I+     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALAPVVV 173
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 678
           T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++++E+V G
Sbjct: 208 VDIWSLGIMVIEMVDG 223

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 117/252 (46%), Gaps = 36/252 (14%)
Query: 457 ATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPV-----YWGRLKDG-QEIAV 510
           + +V+  K+ + P ++F        N  L   LG+G FG V     +  + + G   +AV
Sbjct: 4   SLSVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAV 58
Query: 511 KRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF 569
           K L + AS   L + ++E  V+ ++ H ++++L G C +    +LI EY    SL   L 
Sbjct: 59  KMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
Query: 570 DPLK-------------KERLDWRKRFNIIEG--------ISRGLLYLHRDSRLRIIHRD 608
           +  K                LD      +  G        IS+G+ YL   + + ++HRD
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRD 175
Query: 609 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDV 668
           L A NIL+ E    KISDFG+++            +      +M+ E   +  ++ +SDV
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 669 FSFGVLLLEIVS 680
           +SFGVLL EIV+
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 169
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR-LSKASGQGLE-EFMNEVMVISKLQH 536
            + ++  +K+GQG FG V+  R  K GQ++A+K+ L +   +G     + E+ ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 537 RNLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
            N+V L+  C               L++++     L  LL + L K  L   KR  +++ 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---GNQDQADTGRV 645
           +  GL Y+HR+   +I+HRD+KA+N+L+  +   K++DFG+A+ F     +Q      RV
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 646 VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 678
           V T  Y  PE  +  R +    D++  G ++ E+
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR-LSKASGQGLE-EFMNEVMVISKLQH 536
            + ++  +K+GQG FG V+  R  K GQ++A+K+ L +   +G     + E+ ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 537 RNLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
            N+V L+  C               L++++     L  LL + L K  L   KR  +++ 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---GNQDQADTGRV 645
           +  GL Y+HR+   +I+HRD+KA+N+L+  +   K++DFG+A+ F     +Q      RV
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 646 VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 678
           V T  Y  PE  +  R +    D++  G ++ E+
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKR-LSKASGQGLE-EFMNEVMVISKLQH 536
            + ++  +K+GQG FG V+  R  K GQ++A+K+ L +   +G     + E+ ++  L+H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 537 RNLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
            N+V L+  C               L++++     L  LL + L K  L   KR  +++ 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR--VMQM 132
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---GNQDQADTGRV 645
           +  GL Y+HR+   +I+HRD+KA+N+L+  +   K++DFG+A+ F     +Q      RV
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 189
Query: 646 VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 678
           V T  Y  PE  +  R +    D++  G ++ E+
Sbjct: 190 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKR-LSKASGQGLE-EFMNEVMVISKLQH 536
            + ++  +K+GQG FG V+  R  K GQ++A+K+ L +   +G     + E+ ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 537 RNLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
            N+V L+  C               L++++     L  LL + L K  L   KR  +++ 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---GNQDQADTGRV 645
           +  GL Y+HR+   +I+HRD+KA+N+L+  +   K++DFG+A+ F     +Q      RV
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 646 VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 678
           V T  Y  PE  +  R +    D++  G ++ E+
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 535
           ++ ++L   LG GG   V+  R L+D +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 536 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-ADTGRVVGTFG 650
            L + H++    IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 535
           ++ ++L   LG GG   V+  R L+D +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 536 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-ADTGRVVGTFG 650
            L + H++    IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 535
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 588
           H N+V+LL       +  L++E++       +DA        PL K  L     F +++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 169
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 129/278 (46%), Gaps = 19/278 (6%)
Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ E++        L D +   R++  +   +   + + L  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEG----GALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 666 SDVFSFGVLLLEIVSGRKNTSFFEDDLTIL-----GYAWKLWNENKILALVDPFLSESSF 720
            D++S G++++E+V G +   F E  L  +         +L N +K+   +  FL     
Sbjct: 328 VDIWSLGIMVIEMVDG-EPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 386
Query: 721 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 758
           + D   R     LL    L K  P  S V  M  +  R
Sbjct: 387 R-DPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 423

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 483 FQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLV 540
           +++  +LG GGFG V  W     G+++A+K+  +  S +  E +  E+ ++ KL H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN---------------I 585
                  +G +K+      PN   D  L      E  D RK  N               +
Sbjct: 76  SAREV-PDGLQKL-----APN---DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQAD- 641
           +  IS  L YLH +   RIIHRDLK  NI+L    + L  KI D G AK      DQ + 
Sbjct: 127 LSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL----DQGEL 179
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
               VGT  Y++PE   + +++   D +SFG L  E ++G
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 483 FQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLV 540
           +++  +LG GGFG V  W     G+++A+K+  +  S +  E +  E+ ++ KL H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN---------------I 585
                  +G +K+      PN   D  L      E  D RK  N               +
Sbjct: 77  SAREV-PDGLQKL-----APN---DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 127
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQAD- 641
           +  IS  L YLH +   RIIHRDLK  NI+L    + L  KI D G AK      DQ + 
Sbjct: 128 LSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL----DQGEL 180
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
               VGT  Y++PE   + +++   D +SFG L  E ++G
Sbjct: 181 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ-GLE-EFMNEVMVISKLQ 535
           AT+ ++  +++G G +G VY  R    G  +A+K +   +G+ GL    + EV ++ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 536 ---HRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
              H N+VRL+  C         +  L++E++ ++ L   L D      L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
              RGL +LH +    I+HRDLK  NIL+      K++DFG+A+I+     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVVV 173
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 678
           T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFM-NEVMVISKLQHRNLV 540
           F+    LG G F  V     K  G+  AVK + K + +G E  + NE+ V+ K++H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN-IIEGISRGLLYLHRD 599
            L           L+ + +        LFD + ++     K  + +I  +   + YLHR 
Sbjct: 84  ALEDIYESPNHLYLVMQLVSG----GELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHR- 138
Query: 600 SRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
             + I+HRDLK  N+L    DEE    ISDFG++K+  G  D   T    GT GY++PE 
Sbjct: 139 --MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-EGKGDVMSTA--CGTPGYVAPEV 193
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSG 681
             +  +S+  D +S GV+   ++ G
Sbjct: 194 LAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 469 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 521
           P F  +ELA         +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 2   PTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 580
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K  +L   
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDD 121
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 174
Query: 641 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 175 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 665
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 666 SDVFSFGVLLLEIVSG 681
            D++S G++++E+V G
Sbjct: 251 VDIWSLGIMVIEMVDG 266

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
              ++   +G+G FG VY GR      I +  + + +   L+ F  EVM   + +H N+V
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
             +G C+      +I      R+L +++ D   K  LD  K   I + I +G+ YLH   
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 601 RLRIIHRDLKASNILLDEELNPK--ISDFGMAKIFGGNQ--DQADTGRVV-GTFGYMSPE 655
              I+H+DLK+ N+  D   N K  I+DFG+  I G  Q   + D  R+  G   +++PE
Sbjct: 151 ---ILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 656 YAMEGR---------FSEKSDVFSFGVLLLEI 678
              +           FS+ SDVF+ G +  E+
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRN 538
            +F+    LG+GGFG V+  + K D    A+KR+   + +   E+ M EV  ++KL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DW---------RKR---FNI 585
           +VR     +E      +    P   L  +     +KE L DW         R+R    +I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYL-YIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA----- 640
              I+  + +LH      ++HRDLK SNI    +   K+ DFG+      ++++      
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 641 ------DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 679
                  TG+V GT  YMSPE      +S K D+FS G++L E++
Sbjct: 181 MPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK---ASGQGLEEFMNEVMV 530
           ++     +F L   LG+G FG V+    K   Q  A+K L K        +E  M E  V
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 531 ISKLQHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
           +S       +  + C  + +E +  + EY+    L   ++      + D  +       I
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 127
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVG 647
             GL +LH      I++RDLK  NILLD++ + KI+DFGM K  + G     A T    G
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNXFCG 180
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           T  Y++PE  +  +++   D +SFGVLL E++ G+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 28/216 (12%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLV 540
           F+L   +G G +G VY GR +K GQ  A+K +   +G   EE   E+ ++ K   HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 541 RLLGCCVE------GEEKMLIYEYMPNRSLDALLFDP----LKKERLDWRKRFNIIEGIS 590
              G  ++       ++  L+ E+    S+  L+ +     LK+E + +     I   I 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-----ICREIL 139
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
           RGL +LH+    ++IHRD+K  N+LL E    K+ DFG++        + +T   +GT  
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 194
Query: 651 YMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSG 681
           +M+PE        +  +  KSD++S G+  +E+  G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ-GLE-EFMNEVMVISKLQ 535
           AT+ ++  +++G G +G VY  R    G  +A+K +   +G+ GL    + EV ++ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 536 ---HRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
              H N+VRL+  C         +  L++E++ ++ L   L D      L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
              RGL +LH +    I+HRDLK  NIL+      K++DFG+A+I+     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVVV 173
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 678
           T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 68
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 181
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 182 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 21/222 (9%)
Query: 465 LQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRL--SKASGQGL 521
           L ++P  +F       ++F +   LG+G FG VY  R K  + I A+K L  S+   +G+
Sbjct: 4   LAEMPKRKF-----TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV 58
Query: 522 E-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDW 579
           E +   E+ + S L+H N++R+     + +   L+ E+ P       L+  L+K  R D 
Sbjct: 59  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR----GELYKELQKHGRFDE 114
Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
           ++    +E ++  L Y H     ++IHRD+K  N+L+  +   KI+DFG    +  +   
Sbjct: 115 QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPS 167
Query: 640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
                + GT  Y+ PE        EK D++  GVL  E + G
Sbjct: 168 LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 22  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 81
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 82  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 142 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 194
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 195 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 23  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 82
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 195
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 196 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 12/227 (5%)
Query: 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ----EIAVKRLSK-ASGQGLEEFMNEVM 529
           +   A  +  L+  LG+G FG VY G   + +     +AVK   K  +    E+FM+E +
Sbjct: 2   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 61
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
           ++  L H ++V+L+G  +E E   +I E  P   L   L     K  L           I
Sbjct: 62  IMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQI 118
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
            + + YL     +  +HRD+   NIL+      K+ DFG+++ +  ++D           
Sbjct: 119 CKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPI 174
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG 696
            +MSPE     RF+  SDV+ F V + EI+S  K   F+ ++  ++G
Sbjct: 175 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 221

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 475 ELATATNNFQLSSK------LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--FM 525
           +L T    FQ   K      +G+G +G V   R KD G+ +A+K+  ++    + +   M
Sbjct: 13  DLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM 72
Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW----RK 581
            E+ ++ +L+H NLV LL  C + +   L++E++ +  LD L   P     LD+    + 
Sbjct: 73  REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP---NGLDYQVVQKY 129
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
            F II GI  G  + H      IIHRD+K  NIL+ +    K+ DFG A+      +  D
Sbjct: 130 LFQIINGI--GFCHSH-----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 642 TGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 681
               V T  Y +PE  + + ++ +  DV++ G L+ E+  G
Sbjct: 183 DE--VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 115/236 (48%), Gaps = 17/236 (7%)
Query: 456 SATNVNTVKLQDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAV 510
           SA    T+  ++ P F  +EL          +Q  S +G G +G V     +K G +IAV
Sbjct: 22  SAAAPFTMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAV 81
Query: 511 KRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDAL 567
           K+LS+   S    +    E+ ++  ++H N++ LL             + Y+    + A 
Sbjct: 82  KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGAD 141
Query: 568 LFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627
           L + +K ++L       +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DF
Sbjct: 142 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF 198
Query: 628 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           G+A+    + D   TG  V T  Y +PE  +    ++   D++S G ++ E+++GR
Sbjct: 199 GLAR----HTDDEMTG-YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 21/222 (9%)
Query: 465 LQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRL--SKASGQGL 521
           L ++P  +F       ++F +   LG+G FG VY  R K  + I A+K L  S+   +G+
Sbjct: 3   LAEMPKRKF-----TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV 57
Query: 522 E-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDW 579
           E +   E+ + S L+H N++R+     + +   L+ E+ P       L+  L+K  R D 
Sbjct: 58  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR----GELYKELQKHGRFDE 113
Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
           ++    +E ++  L Y H     ++IHRD+K  N+L+  +   KI+DFG    +  +   
Sbjct: 114 QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPS 166
Query: 640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
                + GT  Y+ PE        EK D++  GVL  E + G
Sbjct: 167 LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LSK   S 
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSI 74
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 187
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 188 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 12/227 (5%)
Query: 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ----EIAVKRLSK-ASGQGLEEFMNEVM 529
           +   A  +  L+  LG+G FG VY G   + +     +AVK   K  +    E+FM+E +
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
           ++  L H ++V+L+G  +E E   +I E  P   L   L     K  L           I
Sbjct: 66  IMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQI 122
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
            + + YL     +  +HRD+   NIL+      K+ DFG+++ +  ++D           
Sbjct: 123 CKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPI 178
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG 696
            +MSPE     RF+  SDV+ F V + EI+S  K   F+ ++  ++G
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 225

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 12/227 (5%)
Query: 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ----EIAVKRLSK-ASGQGLEEFMNEVM 529
           +   A  +  L+  LG+G FG VY G   + +     +AVK   K  +    E+FM+E +
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 77
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
           ++  L H ++V+L+G  +E E   +I E  P   L   L     K  L           I
Sbjct: 78  IMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQI 134
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
            + + YL     +  +HRD+   NIL+      K+ DFG+++ +  ++D           
Sbjct: 135 CKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPI 190
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG 696
            +MSPE     RF+  SDV+ F V + EI+S  K   F+ ++  ++G
Sbjct: 191 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 237

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 545
           K+G+G +G VY  +   G+  A+K  RL K         + E+ ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
               +  +L++E++ ++ L  LL   + +  L+     + +  +  G+ Y H     R++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSE 664
           HRDLK  N+L++ E   KI+DFG+A+ FG    +  T  VV T  Y +P+  M   ++S 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVV-TLWYRAPDVLMGSKKYST 180
Query: 665 KSDVFSFGVLLLEIVSG 681
             D++S G +  E+V+G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 37/210 (17%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 545
           K+G+G +G VY  +   G+  A+K  RL K         + E+ ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG-------------ISRG 592
               +  +L++E++                  D +K  ++ EG             +  G
Sbjct: 69  IHTKKRLVLVFEHLDQ----------------DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           + Y H     R++HRDLK  N+L++ E   KI+DFG+A+ FG    +  T  VV T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVV-TLWYR 167
Query: 653 SPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 681
           +P+  M   ++S   D++S G +  E+V+G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMN 526
            E      N F+    LG+GGFG V        G++   +++  KR+ K  G+ +   +N
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LN 233
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 586
           E  ++ K+  R +V L       +   L+   M    L   ++   +    + R  F   
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
           E I  GL  LHR+   RI++RDLK  NILLD+  + +ISD G+A      + Q   GR V
Sbjct: 294 E-ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-V 346
Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           GT GYM+PE     R++   D ++ G LL E+++G+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 115/230 (50%), Gaps = 42/230 (18%)
Query: 483 FQLSSKLGQGGFGPVYWGRL--KDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQ-HR 537
           ++L  KLG+G +G + W  +  + G+ +AVK++  A  +    +    E+M++++L  H 
Sbjct: 11  YELVKKLGKGAYG-IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 538 NLVRLLGCCVEGEEK--MLIYEYMP---NRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           N+V LL       ++   L+++YM    +  + A + +P+ K+         ++  + + 
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY--------VVYQLIKV 121
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG----------------- 635
           + YLH      ++HRD+K SNILL+ E + K++DFG+++ F                   
Sbjct: 122 IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 636 --NQDQADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 682
             + DQ      V T  Y +PE  +   ++++  D++S G +L EI+ G+
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 469 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 521
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 580
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 174
Query: 641 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 175 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HT 180
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 181 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  + +G G +G V      K G  +AVK+LS+   S 
Sbjct: 13  QERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 72
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 73  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 132
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 133 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 185
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 186 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 180
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 181 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 2   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 61
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 62  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 121
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 122 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 174
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 175 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMN 526
            E      N F+    LG+GGFG V        G++   +++  KR+ K  G+ +   +N
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LN 233
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 586
           E  ++ K+  R +V L       +   L+   M    L   ++   +    + R  F   
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
           E I  GL  LHR+   RI++RDLK  NILLD+  + +ISD G+A      + Q   GR V
Sbjct: 294 E-ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-V 346
Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           GT GYM+PE     R++   D ++ G LL E+++G+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 177
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 178 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 182
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 183 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 177
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 178 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 37/210 (17%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 545
           K+G+G +G VY  +   G+  A+K  RL K         + E+ ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG-------------ISRG 592
               +  +L++E++                  D +K  ++ EG             +  G
Sbjct: 69  IHTKKRLVLVFEHLDQ----------------DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           + Y H     R++HRDLK  N+L++ E   KI+DFG+A+ FG    +  T  +V T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYR 167
Query: 653 SPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 681
           +P+  M   ++S   D++S G +  E+V+G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HT 180
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 181 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 180
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 181 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 177
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 178 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 187
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 188 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 14  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 74  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 134 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 186
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 187 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 187
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 188 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 22  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 81
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 82  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 142 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 194
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 195 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 14  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 74  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 134 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HT 186
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 187 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 181
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 182 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 21/232 (9%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQ--EIAVKRLSK--ASGQGLEEFM 525
           + E++      F L   LG+G FG V   +LK  DG   ++AVK L     +   +EEF+
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEK------MLIYEYMPNRSLDALLFDPLKKER--- 576
            E   + +  H ++ +L+G  +    K      M+I  +M +  L A L      E    
Sbjct: 74  REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 577 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGG 635
           L  +     +  I+ G+ YL   S    IHRDL A N +L E++   ++DFG++ KI+ G
Sbjct: 134 LPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 687
           +  +      +    +++ E   +  ++  SDV++FGV + EI++ R  T +
Sbjct: 191 DYYRQGCASKL-PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT-RGQTPY 240

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 181
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 182 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 23  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 82
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 195
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 196 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 113/256 (44%), Gaps = 32/256 (12%)
Query: 450 EVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY----WGRLKD- 504
           +V+ +++  N   +    LP     E     N       LG G FG V     +G +K  
Sbjct: 10  KVVEEINGNNXVXIDPTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSD 67
Query: 505 -GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEY--- 558
               +AVK L  ++     E  M+E+ V+S L  H N+V LLG C  G   ++I EY   
Sbjct: 68  AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 127
Query: 559 --------------MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                         + +++  A++ D      L+    F+    +++G+ +L   +    
Sbjct: 128 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY--QVAKGMAFLASKN---C 182
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDL A NILL      KI DFG+A+    + +    G       +M+PE      ++ 
Sbjct: 183 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 242
Query: 665 KSDVFSFGVLLLEIVS 680
           +SDV+S+G+ L E+ S
Sbjct: 243 ESDVWSYGIFLWELFS 258

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 26  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 86  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 146 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 198
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 199 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D    G  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMAG-FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D    G  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMAG-FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 113/256 (44%), Gaps = 32/256 (12%)
Query: 450 EVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY----WGRLKD- 504
           +V+ +++  N   +    LP     E     N       LG G FG V     +G +K  
Sbjct: 17  KVVEEINGNNYVYIDPTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSD 74
Query: 505 -GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEY--- 558
               +AVK L  ++     E  M+E+ V+S L  H N+V LLG C  G   ++I EY   
Sbjct: 75  AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 134
Query: 559 --------------MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                         + +++  A++ D      L+    F+    +++G+ +L   +    
Sbjct: 135 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY--QVAKGMAFLASKN---C 189
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDL A NILL      KI DFG+A+    + +    G       +M+PE      ++ 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 665 KSDVFSFGVLLLEIVS 680
           +SDV+S+G+ L E+ S
Sbjct: 250 ESDVWSYGIFLWELFS 265

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR----HT 177
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 178 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 113/256 (44%), Gaps = 32/256 (12%)
Query: 450 EVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY----WGRLKD- 504
           +V+ +++  N   +    LP     E     N       LG G FG V     +G +K  
Sbjct: 17  KVVEEINGNNYVYIDPTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSD 74
Query: 505 -GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEY--- 558
               +AVK L  ++     E  M+E+ V+S L  H N+V LLG C  G   ++I EY   
Sbjct: 75  AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 134
Query: 559 --------------MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                         + +++  A++ D      L+    F+    +++G+ +L   +    
Sbjct: 135 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY--QVAKGMAFLASKN---C 189
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDL A NILL      KI DFG+A+    + +    G       +M+PE      ++ 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 665 KSDVFSFGVLLLEIVS 680
           +SDV+S+G+ L E+ S
Sbjct: 250 ESDVWSYGIFLWELFS 265

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 113/256 (44%), Gaps = 32/256 (12%)
Query: 450 EVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY----WGRLKD- 504
           +V+ +++  N   +    LP     E     N       LG G FG V     +G +K  
Sbjct: 12  KVVEEINGNNYVYIDPTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSD 69
Query: 505 -GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEY--- 558
               +AVK L  ++     E  M+E+ V+S L  H N+V LLG C  G   ++I EY   
Sbjct: 70  AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 129
Query: 559 --------------MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                         + +++  A++ D      L+    F+    +++G+ +L   +    
Sbjct: 130 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY--QVAKGMAFLASKN---C 184
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDL A NILL      KI DFG+A+    + +    G       +M+PE      ++ 
Sbjct: 185 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 244
Query: 665 KSDVFSFGVLLLEIVS 680
           +SDV+S+G+ L E+ S
Sbjct: 245 ESDVWSYGIFLWELFS 260

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR----HT 181
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 182 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSKASGQGLEEFMNEVM--VISKL 534
           + F+L   LGQG FG V+  +   G    Q  A+K L KA+ +  +    ++   ++ ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK--RFNIIEGISRG 592
            H  +V+L        +  LI +++  R  D  LF  L KE +   +  +F + E ++  
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAE-LALA 138
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L +LH    L II+RDLK  NILLDEE + K++DFG++K    ++ +A +    GT  YM
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +PE       ++ +D +SFGVL+ E+++G
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 535
           ++ ++L   LG GG   V+  R L+  +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 536 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-ADTGRVVGTFG 650
            L + H++    IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 469 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 521
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 580
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 174
Query: 641 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 175 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI D+G+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 30/225 (13%)
Query: 481 NNFQLSSKLGQGGFGPVY----WGRLKD--GQEIAVKRLSKASG-QGLEEFMNEVMVISK 533
           N       LG G FG V     +G +K      +AVK L  ++     E  M+E+ V+S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG---- 588
           L  H N+V LLG C  G   ++I EY      D L F   K++     K    I      
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 589 -------------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635
                        +++G+ +L   +    IHRDL A NILL      KI DFG+A+    
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           + +    G       +M+PE      ++ +SDV+S+G+ L E+ S
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 469 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 521
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 580
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 122
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 123 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 175
Query: 641 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSKASGQGLEEFMNEVM--VISKL 534
           + F+L   LGQG FG V+  +   G    Q  A+K L KA+ +  +    ++   ++ ++
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK--RFNIIEGISRG 592
            H  +V+L        +  LI +++  R  D  LF  L KE +   +  +F + E ++  
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAE-LALA 139
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L +LH    L II+RDLK  NILLDEE + K++DFG++K    ++ +A +    GT  YM
Sbjct: 140 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 194
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +PE       ++ +D +SFGVL+ E+++G
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 23  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 82
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 195
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D    G  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 196 DDEMXG-XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 469 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 521
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 4   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 63
Query: 522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 580
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 64  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 123
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 124 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 176
Query: 641 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 177 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 483 FQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQHRNL 539
           +QL  +LG+G F  V    ++  GQE A K ++  K S +  ++   E  +   L+H N+
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           VRL     E     LI++ +       L  D + +E        + I+ I   +L+ H+ 
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTG---GELFEDIVAREYYSEADASHCIQQILEAVLHCHQ- 139
Query: 600 SRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
             + ++HRDLK  N+LL  +L     K++DFG+A    G Q QA  G   GT GY+SPE 
Sbjct: 140 --MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFG-FAGTPGYLSPEV 195
Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSG 681
             +  + +  D+++ GV+L  ++ G
Sbjct: 196 LRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 469 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 521
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 580
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 122
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 123 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 175
Query: 641 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLS--KASGQGLEEFMNEVMVISKLQH 536
           ++N+ +  +LG+G F  V     K  G E A K ++  K S +  ++   E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
            N+VRL     E     L+++ +    L     D + +E        + I+ I   + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 597 HRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           H +    I+HR+LK  N+LL  +      K++DFG+A     N  +A  G   GT GY+S
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLS 174
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           PE   +  +S+  D+++ GV+L  ++ G
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLS--KASGQGLEEFMNEVMVISKLQH 536
           ++N+ +  +LG+G F  V     K  G E A K ++  K S +  ++   E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
            N+VRL     E     L+++ +    L     D + +E        + I+ I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 597 HRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           H +    I+HR+LK  N+LL  +      K++DFG+A     N  +A  G   GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLS 175
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           PE   +  +S+  D+++ GV+L  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQHR 537
           ++ L   LG G FG V  G  +  G ++AVK L++   + L+   +   E+  +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++++L        +  ++ EY+    L   +    + E ++ R+ F   + I   + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVDYCH 128
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           R     ++HRDLK  N+LLD  +N KI+DFG++ +    +   D+    G+  Y +PE  
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPE-V 181
Query: 658 MEGRF--SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
           + GR     + D++S GV+L  ++ G   T  F+D+
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCG---TLPFDDE 214

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 480 TNNFQLSSKLGQGGFGPVYWG-RLKDGQEIA-----VKRLSKASGQGLEEFMNEVMVISK 533
           T  +QL  +LG+G F  V    ++  GQE A      K+LS    Q LE    E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           L+H N+VRL     E     LI++ +       L  D + +E        + I+ I   +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTG---GELFEDIVAREYYSEADASHCIQQILEAV 123
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFG 650
           L+ H+   + ++HR+LK  N+LL  +L     K++DFG+A    G Q QA  G   GT G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFG-FAGTPG 178
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           Y+SPE   +  + +  D+++ GV+L  ++ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKL 534
           + T+ +QL   +G+G F  V    +L  G E A K ++  K S +  ++   E  +   L
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N+VRL     E     L+++ +       L  D + +E        + I+ I   +L
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTG---GELFEDIVAREYYSEADASHCIQQILEAVL 117
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
           + H+   + ++HRDLK  N+LL  +      K++DFG+A    G+Q QA  G   GT GY
Sbjct: 118 HCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFG-FAGTPGY 172
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   +  + +  D+++ GV+L  ++ G
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSKASGQGLEEFMNEVM--VISKL 534
           + F+L   LGQG FG V+  +   G    Q  A+K L KA+ +  +    ++   ++ ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK--RFNIIEGISRG 592
            H  +V+L        +  LI +++  R  D  LF  L KE +   +  +F + E ++  
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAE-LALA 138
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L +LH    L II+RDLK  NILLDEE + K++DFG++K    ++ +A +    GT  YM
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +PE       ++ +D +SFGVL+ E+++G
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLS--KASGQGLEEFMNEVMVISKLQH 536
           ++N+ +  +LG+G F  V     K  G E A K ++  K S +  ++   E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
            N+VRL     E     L+++ +    L     D + +E        + I+ I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 597 HRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           H +    I+HR+LK  N+LL  +      K++DFG+A     N  +A  G   GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLS 175
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           PE   +  +S+  D+++ GV+L  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 487 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 544
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 49  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                  + +   Y+    + A L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 165
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 661
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 662 -FSEKSDVFSFGVLLLEIVSGR 682
            +++  D++S G +L E++S R
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 17/223 (7%)
Query: 469 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 521
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 580
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 174
Query: 641 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
             G  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 175 MAG-FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+ +    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQH 536
           T     Q+  ++G+G +G V+ G+ + G+++AVK   +        E   E+     ++H
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRH 90
Query: 537 RNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
            N++  +   ++G     +  LI +Y  N SL    +D LK   LD +    +      G
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSG 146
Query: 593 LLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT--GRV 645
           L +LH +      +  I HRDLK+ NIL+ +     I+D G+A  F  + ++ D      
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 646 VGTFGYMSPEYAMEG----RFSE--KSDVFSFGVLLLEIV 679
           VGT  YM PE   E      F     +D++SFG++L E+ 
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE---FMNEVMVISKLQ 535
           ++ +Q   KLG G +G V   + K  G E A+K + K+S          ++EV V+ +L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 536 HRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           H N+++L     +     L+ E Y      D ++     +++        I++ +  G  
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSGTT 135
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIF--GGNQDQADTGRVVGTF 649
           YLH+ +   I+HRDLK  N+LL+ +      KI DFG++  F  GG   +      +GT 
Sbjct: 136 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER-----LGTA 187
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y++PE  +  ++ EK DV+S GV+L  ++ G
Sbjct: 188 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 535
           ++ ++L   LG GG   V+  R L+  +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 536 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-ADTGRVVGTFG 650
            L + H++    IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DF +A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 488 KLGQGGFG-PVYWGRLKDGQEIAVKRL--SKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           K+G+G FG  +     +DG++  +K +  S+ S +  EE   EV V++ ++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 545 CCVEGEEKMLIYEYMPNRSL-------DALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
              E     ++ +Y     L         +LF   + + LDW         I   L ++H
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ--EDQILDW------FVQICLALKHVH 142
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
                +I+HRD+K+ NI L ++   ++ DFG+A++     + A     +GT  Y+SPE  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
               ++ KSD+++ G +L E+ +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCT 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
               TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 187 ----TG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 34  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 149
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 207
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 35  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 150
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 208
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 209 KGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 26  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 141
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 199
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 200 KGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
               TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 187 ----TG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 34  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 149
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 535
           ++ ++L   LG GG   V+  R L+  +++AVK L     +       F  E    + L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 536 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 144
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-ADTGRVVGTFG 650
            L + H++    IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 145 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 26  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 86  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 146 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 198
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D    G  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 199 DDEMXG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 27  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 142
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
               TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 187 ----TG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 35/218 (16%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE---FMNEVMVISKLQ 535
           ++ +Q   KLG G +G V   + K  G E A+K + K+S          ++EV V+ +L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 536 HRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFN------IIEG 588
           H N+++L     +     L+ E Y      D ++           R++F+      I++ 
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----------RQKFSEVDAAVIMKQ 112
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIF--GGNQDQADTG 643
           +  G  YLH+ +   I+HRDLK  N+LL+ +      KI DFG++  F  GG   +    
Sbjct: 113 VLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER--- 166
Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
             +GT  Y++PE  +  ++ EK DV+S GV+L  ++ G
Sbjct: 167 --LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 27  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 142
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 487 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 544
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 661
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 662 -FSEKSDVFSFGVLLLEIVSGR 682
            +++  D++S G +L E++S R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLS--KASGQGLEEFMNEVMVISKLQH 536
           ++N+ +  +LG+G F  V     K  G E A K ++  K S +  ++   E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
            N+VRL     E     L+++ +       L  D + +E        + I+ I   + Y 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTG---GELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 597 HRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           H +    I+HR+LK  N+LL  +      K++DFG+A     N  +A  G   GT GY+S
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLS 198
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           PE   +  +S+  D+++ GV+L  ++ G
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 18/246 (7%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 142
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDLK  N+ L+E+L  KI DFG+A     + ++  T  + GT  Y++PE   +   S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 665 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF---LSESSFQ 721
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P    L +   Q
Sbjct: 201 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 257
Query: 722 LDMIIR 727
            D   R
Sbjct: 258 TDPTAR 263

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 487 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 544
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 147
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 661
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 662 -FSEKSDVFSFGVLLLEIVSGR 682
            +++  D++S G +L E++S R
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 89/165 (53%), Gaps = 10/165 (6%)
Query: 521 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
           +E+   E+ ++ KL H N+V+L+    +  E  L Y      +   ++  P  K   + +
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
            RF   + + +G+ YLH     +IIHRD+K SN+L+ E+ + KI+DFG++  F G+   A
Sbjct: 139 ARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--DA 192
Query: 641 DTGRVVGTFGYMSPEYAMEGR--FSEKS-DVFSFGVLLLEIVSGR 682
                VGT  +M+PE   E R  FS K+ DV++ GV L   V G+
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 18/246 (7%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 138
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDLK  N+ L+E+L  KI DFG+A     + ++  T  + GT  Y++PE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 665 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF---LSESSFQ 721
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P    L +   Q
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 253
Query: 722 LDMIIR 727
            D   R
Sbjct: 254 TDPTAR 259

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 18/246 (7%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 138
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDLK  N+ L+E+L  KI DFG+A     + ++  T  + GT  Y++PE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 665 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF---LSESSFQ 721
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P    L +   Q
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 253
Query: 722 LDMIIR 727
            D   R
Sbjct: 254 TDPTAR 259

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 483 FQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN---EVMVISKLQHRN 538
           + +   LG+G FG V      K  Q++A+K +S+   +  +  M    E+  +  L+H +
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYL 596
           +++L        + +++ EY      D ++    +K+R+  D  +RF   + I   + Y 
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIV----EKKRMTEDEGRRF--FQQIICAIEYC 124
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPE 655
           HR    +I+HRDLK  N+LLD+ LN KI+DFG++ I   GN  +       G+  Y +PE
Sbjct: 125 HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPE 177
Query: 656 YAMEGRF--SEKSDVFSFGVLLLEIVSGR 682
             + G+     + DV+S G++L  ++ GR
Sbjct: 178 -VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 487 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 544
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 661
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 662 -FSEKSDVFSFGVLLLEIVSGR 682
            +++  D++S G +L E++S R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 487 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 544
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 661
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 146 LHRDLKPSNLLLNTTXDLKIXDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 662 -FSEKSDVFSFGVLLLEIVSGR 682
            +++  D++S G +L E++S R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 487 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 544
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 661
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 662 -FSEKSDVFSFGVLLLEIVSGR 682
            +++  D++S G +L E++S R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 487 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 544
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 37  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 153
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 661
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 154 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 662 -FSEKSDVFSFGVLLLEIVSGR 682
            +++  D++S G +L E++S R
Sbjct: 212 GYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 487 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 544
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 661
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 662 -FSEKSDVFSFGVLLLEIVSGR 682
            +++  D++S G +L E++S R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 487 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 544
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 49  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 165
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 661
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 662 -FSEKSDVFSFGVLLLEIVSGR 682
            +++  D++S G +L E++S R
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFM-----NEVMV 530
           + AT+ ++  +++G G +G VY  R    G  +A+K +   +G G    +      EV +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 531 ISKLQ---HRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 582
           + +L+   H N+VRL+  C         +  L++E++ ++ L   L D      L     
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETI 122
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
            +++    RGL +LH +    I+HRDLK  NIL+      K++DFG+A+I+     Q   
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMAL 176
Query: 643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 678
             VV T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGR----LKDGQEIAVKRLSKA----SGQGLEEFMNEVMVISKL 534
           F+L   LG+GG+G V+  R       G+  A+K L KA    + +       E  ++ ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR--FNIIEGISRG 592
           +H  +V L+     G +  LI EY+    L    F  L++E +       F + E IS  
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAE-ISMA 133
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L +LH+     II+RDLK  NI+L+ + + K++DFG+ K      D   T    GT  YM
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYM 188
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +PE  M    +   D +S G L+ ++++G
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI D G+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI  FG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--FMNEVMVISKLQHRN 538
            ++   K+G+G +G V+  R +D GQ +A+K+  ++    + +   + E+ ++ +L+H N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS----RGLL 594
           LV LL          L++EY  +  L  L       +R       ++++ I+    + + 
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDHTVLHEL-------DRYQRGVPEHLVKSITWQTLQAVN 116
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           + H+ +    IHRD+K  NIL+ +    K+ DFG A++  G  D  D    V T  Y SP
Sbjct: 117 FCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSP 171
Query: 655 EYAM-EGRFSEKSDVFSFGVLLLEIVSG 681
           E  + + ++    DV++ G +  E++SG
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGR----LKDGQEIAVKRLSKA----SGQGLEEFMNEVMVISKL 534
           F+L   LG+GG+G V+  R       G+  A+K L KA    + +       E  ++ ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR--FNIIEGISRG 592
           +H  +V L+     G +  LI EY+    L    F  L++E +       F + E IS  
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAE-ISMA 133
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L +LH+     II+RDLK  NI+L+ + + K++DFG+ K      D   T    GT  YM
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYM 188
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +PE  M    +   D +S G L+ ++++G
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 487 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
           S +G+G +G V   +  L +   +A++++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 660
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 661 R-FSEKSDVFSFGVLLLEIVSGR 682
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 489 LGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLGC 545
           +G+G +G V   +  ++  + +A+K++S    Q   +  + E+ ++ + +H N++ +   
Sbjct: 51  IGEGAYGMVSSAYDHVRKTR-VAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDI 109
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
                 + +   Y+    ++  L+  LK ++L        +  I RGL Y+H  +   ++
Sbjct: 110 LRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VL 166
Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-TGRVVGTFGYMSPEYAMEGR-FS 663
           HRDLK SN+L++   + KI DFG+A+I     D        V T  Y +PE  +  + ++
Sbjct: 167 HRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYT 226
Query: 664 EKSDVFSFGVLLLEIVSGR 682
           +  D++S G +L E++S R
Sbjct: 227 KSIDIWSVGCILAEMLSNR 245

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI D G+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 487 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 544
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++ +  
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 147
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 661
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 662 -FSEKSDVFSFGVLLLEIVSGR 682
            +++  D++S G +L E++S R
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 466 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 518
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 577
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI D G+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR----HT 175
Query: 638 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQHR 537
           ++ L   LG G FG V  G  +  G ++AVK L++   + L+   +   E+  +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++++L        +  ++ EY+    L   +    + E ++ R+ F   + I   + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVDYCH 128
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           R     ++HRDLK  N+LLD  +N KI+DFG++ +    +    +    G+  Y +PE  
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE-V 181
Query: 658 MEGRF--SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
           + GR     + D++S GV+L  ++ G   T  F+D+
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCG---TLPFDDE 214

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 17/218 (7%)
Query: 473 FEELATAT---NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLS--KASGQGLEEFMN 526
           F+ +AT T   +++QL  +LG+G F  V     K   QE A K ++  K S +  ++   
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 586
           E  +   L+H N+VRL     E     L+++ +       L  D + +E        + I
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTG---GELFEDIVAREYYSEADASHCI 136
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTG 643
             I   + ++H+     I+HRDLK  N+LL  +      K++DFG+A    G Q QA  G
Sbjct: 137 HQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ-QAWFG 192
Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
              GT GY+SPE   +  + +  D+++ GV+L  ++ G
Sbjct: 193 -FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 536
           N+F +   +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 537 RN--LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
            +   +  +       +K+  I + M    L   L         D R  F   E I  GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR--FYAAE-IILGL 305
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++H  +R  +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GYM+
Sbjct: 306 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMA 358
Query: 654 PEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 682
           PE   +G  +   +D FS G +L +++ G 
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 536
           N+F +   +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 537 RN--LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
            +   +  +       +K+  I + M    L   L         D R  F   E I  GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR--FYAAE-IILGL 305
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++H  +R  +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GYM+
Sbjct: 306 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMA 358
Query: 654 PEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 682
           PE   +G  +   +D FS G +L +++ G 
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 478 TATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKL 534
           + T+ +QL  +LG+G F  V    ++  GQE A K ++  K S +  ++   E  +   L
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N+VRL     E     L+++ +       L  D + +E        + I+ I   + 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTG---GELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 595 YLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
           + H +    I+HRDLK  N+LL  +      K++DFG+A    G+Q QA  G   GT GY
Sbjct: 118 HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFG-FAGTPGY 172
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   +  + +  D+++ GV+L  ++ G
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 536
           N+F +   +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +  
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 537 RN--LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
            +   +  +       +K+  I + M    L   L         D R  F   E I  GL
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR--FYAAE-IILGL 304
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++H  +R  +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GYM+
Sbjct: 305 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMA 357
Query: 654 PEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 682
           PE   +G  +   +D FS G +L +++ G 
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 387

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 536
           N+F +   +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 537 RN--LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
            +   +  +       +K+  I + M    L   L         D R  F   E I  GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR--FYAAE-IILGL 305
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++H  +R  +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GYM+
Sbjct: 306 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMA 358
Query: 654 PEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 682
           PE   +G  +   +D FS G +L +++ G 
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 478 TATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKL 534
           + T+ +QL  +LG+G F  V    ++  GQE A K ++  K S +  ++   E  +   L
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N+VRL     E     L+++ +       L  D + +E        + I+ I   + 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTG---GELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 595 YLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
           + H +    I+HRDLK  N+LL  +      K++DFG+A    G+Q QA  G   GT GY
Sbjct: 118 HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFG-FAGTPGY 172
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +SPE   +  + +  D+++ GV+L  ++ G
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLS-KASGQGLE-EFMNEVMVISK 533
           AT+ + ++  +KLG+G +G VY        + +A+KR+  +   +G+    + EV ++ +
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           LQHRN++ L           LI+EY  N     +  +P    R+     + +I G++   
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN--- 146
Query: 594 LYLHRDSRLRIIHRDLKASNILL---DEELNP--KISDFGMAKIFGGNQDQADTGRVVGT 648
            + H  SR R +HRDLK  N+LL   D    P  KI DFG+A+ FG    Q  T  ++ T
Sbjct: 147 -FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-T 200
Query: 649 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIV 679
             Y  PE  +  R +S   D++S   +  E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 21/229 (9%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 534
           T  +   L   +G+G +G V+ G  + G+ +AVK  S    +      E  N VM    L
Sbjct: 5   TVAHQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----L 59
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++  +   +           + +      L+D L+   LD      I+  I+ GL 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLA 119
Query: 595 YLH-----RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR--VVG 647
           +LH        +  I HRDLK+ NIL+ +     I+D G+A +   + +Q D G    VG
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 648 TFGYMSPEYAMEG------RFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           T  YM+PE   E          ++ D+++FG++L E+     +    ED
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 454 KLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKR 512
           K  + N++ VKL D               F     LG+G FG V     K  +E+ A+K 
Sbjct: 7   KQPSNNLDRVKLTD---------------FNFLMVLGKGSFGKVMLADRKGTEELYAIKI 51
Query: 513 LSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALL 568
           L K        +E  M E  V++ L     +  L  C +  +++  + EY+    L   +
Sbjct: 52  LKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---M 108
Query: 569 FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628
           +   +  +    +       IS GL +LH+     II+RDLK  N++LD E + KI+DFG
Sbjct: 109 YHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFG 165
Query: 629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           M K      D   T    GT  Y++PE      + +  D +++GVLL E+++G+
Sbjct: 166 MCK--EHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 185 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 238
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 487 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 544
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++ +  
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 147
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 661
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 148 LHRDLKPSNLLLNTTSDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 662 -FSEKSDVFSFGVLLLEIVSGR 682
            +++  D++S G +L E++S R
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 21/229 (9%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 534
           T   +  L   +G+G +G V+ G  + G+ +AVK  S    +      E  N VM    L
Sbjct: 5   TVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----L 59
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           +H N++  +   +           + +      L+D L+   LD      I+  I+ GL 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLA 119
Query: 595 YLH-----RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR--VVG 647
           +LH        +  I HRDLK+ NIL+ +     I+D G+A +   + +Q D G    VG
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 648 TFGYMSPEYAMEG------RFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           T  YM+PE   E          ++ D+++FG++L E+     +    ED
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 542
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 205
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +FS KSDV+SFGVL+ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 542
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 205
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +FS KSDV+SFGVL+ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 18/246 (7%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 162
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDLK  N+ L+E+L  KI DFG+A     + ++     + GT  Y++PE   +   S 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 220
Query: 665 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF---LSESSFQ 721
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P    L +   Q
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277
Query: 722 LDMIIR 727
            D   R
Sbjct: 278 TDPTAR 283

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 18/246 (7%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 160
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDLK  N+ L+E+L  KI DFG+A     + ++     + GT  Y++PE   +   S 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 218
Query: 665 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF---LSESSFQ 721
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P    L +   Q
Sbjct: 219 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 275
Query: 722 LDMIIR 727
            D   R
Sbjct: 276 TDPTAR 281

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 542
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 127
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 185
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +FS KSDV+SFGVL+ E  S
Sbjct: 186 KFSSKSDVWSFGVLMWEAFS 205

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 542
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY-KAQTHGKWPVKWYAPECINYY 189
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +FS KSDV+SFGVL+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 122/273 (44%), Gaps = 18/273 (6%)
Query: 451 VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSK---LGQGGFGPVYWGRLKDGQE 507
            IAK SA     V  +  PL +  ++       +   +   LG+GGF   Y     D +E
Sbjct: 9   AIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKE 68
Query: 508 IAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRS 563
           +   ++   S        E+   E+ +   L + ++V   G   + +   ++ E    RS
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 564 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK 623
           L  L     +K   +   R+ + + I +G+ YLH +   R+IHRDLK  N+ L+++++ K
Sbjct: 129 L--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVK 182
Query: 624 ISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 683
           I DFG+A     + ++  T  + GT  Y++PE   +   S + D++S G +L  ++ G+ 
Sbjct: 183 IGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKP 240
Query: 684 NTSFFEDDLTILGYAWKLWNENKILALVDPFLS 716
               FE       Y     NE  +   ++P  S
Sbjct: 241 P---FETSCLKETYIRIKKNEYSVPRHINPVAS 270

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 542
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 145
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 146 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 203
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +FS KSDV+SFGVL+ E  S
Sbjct: 204 KFSSKSDVWSFGVLMWEAFS 223

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 102/233 (43%), Gaps = 29/233 (12%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 534
           T      L   +G+G +G V+ G  + G+ +AVK  S    +      E  N VM    L
Sbjct: 34  TVARQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----L 88
Query: 535 QHRNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
           +H N++  +   +          LI  Y    SL    +D L+   LD      I+  I+
Sbjct: 89  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIA 144
Query: 591 RGLLYLH-----RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR- 644
            GL +LH        +  I HRDLK+ NIL+ +     I+D G+A +   + +Q D G  
Sbjct: 145 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 204
Query: 645 -VVGTFGYMSPEYAMEG------RFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
             VGT  YM+PE   E          ++ D+++FG++L E+     +    ED
Sbjct: 205 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 257

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 542
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 189
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +FS KSDV+SFGVL+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 15/229 (6%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 136
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
           IHRDLK  N+ L+E+L  KI DFG+A     + ++     + GT  Y++PE   +   S 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 194
Query: 665 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP 713
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P
Sbjct: 195 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINP 240

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 542
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 125
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 126 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 183
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +FS KSDV+SFGVL+ E  S
Sbjct: 184 KFSSKSDVWSFGVLMWEAFS 203

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 10/161 (6%)
Query: 522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK 581
           +E + E  V+ +L +  +VR++G C E E  ML+ E      L+  L    +   +  + 
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 471
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
              ++  +S G+ YL   +    +HRDL A N+LL  +   KISDFG++K    +++   
Sbjct: 472 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 528
Query: 642 TGRVVGTF--GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +  G +   + +PE     +FS KSDV+SFGVL+ E  S
Sbjct: 529 A-QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 542
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 660
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 195
Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           +FS KSDV+SFGVL+ E  S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 203
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 10/161 (6%)
Query: 522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK 581
           +E + E  V+ +L +  +VR++G C E E  ML+ E      L+  L    +   +  + 
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 470
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
              ++  +S G+ YL   +    +HRDL A N+LL  +   KISDFG++K    +++   
Sbjct: 471 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY- 526
Query: 642 TGRVVGTF--GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +  G +   + +PE     +FS KSDV+SFGVL+ E  S
Sbjct: 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 11/204 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G          VGT  YMSPE   
Sbjct: 126 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDEMANEFVGTRSYMSPERLQ 179
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 22/275 (8%)
Query: 451 VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSK---LGQGGFGPVYWGRLKDGQE 507
            IAK SA     V  +  PL +  ++       +   +   LG+GGF   Y     D +E
Sbjct: 9   AIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKE 68
Query: 508 IAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRS 563
           +   ++   S        E+   E+ +   L + ++V   G   + +   ++ E    RS
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 564 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK 623
           L  L     +K   +   R+ + + I +G+ YLH +   R+IHRDLK  N+ L+++++ K
Sbjct: 129 L--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVK 182
Query: 624 ISDFGMA-KI-FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           I DFG+A KI F G + +     + GT  Y++PE   +   S + D++S G +L  ++ G
Sbjct: 183 IGDFGLATKIEFDGERKKX----LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238
Query: 682 RKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 716
           +     FE       Y     NE  +   ++P  S
Sbjct: 239 KPP---FETSCLKETYIRIKKNEYSVPRHINPVAS 270

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 20/274 (7%)
Query: 451 VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSK---LGQGGFGPVYWGRLKDGQE 507
            IAK SA     V  +  PL +  ++       +   +   LG+GGF   Y     D +E
Sbjct: 9   AIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKE 68
Query: 508 IAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRS 563
           +   ++   S        E+   E+ +   L + ++V   G   + +   ++ E    RS
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 564 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK 623
           L  L     +K   +   R+ + + I +G+ YLH +   R+IHRDLK  N+ L+++++ K
Sbjct: 129 L--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVK 182
Query: 624 ISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           I DFG+A KI    + + D   + GT  Y++PE   +   S + D++S G +L  ++ G+
Sbjct: 183 IGDFGLATKIEFDGERKKD---LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239
Query: 683 KNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 716
                FE       Y     NE  +   ++P  S
Sbjct: 240 PP---FETSCLKETYIRIKKNEYSVPRHINPVAS 270

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 142 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 195
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 487 SKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRLL 543
           + +G G +G V      + G+++A+K+LS+     +  +    E++++  +QH N++ LL
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 544 GCCVEGEEKMLIYEY---MP--NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
                       Y++   MP     L  ++     +E++ +     ++  + +GL Y+H 
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIHS 144
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
                ++HRDLK  N+ ++E+   KI DFG+A+    + D   TG VV T  Y +PE  +
Sbjct: 145 AG---VVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV-TRWYRAPEVIL 196
Query: 659 E-GRFSEKSDVFSFGVLLLEIVSGR 682
               +++  D++S G ++ E+++G+
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 489 LGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLL 543
           +G G +G V   Y  RL+  Q++AVK+LS+   S         E+ ++  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 544 GCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
                        E Y+    + A L + +K + L       ++  + RGL Y+H     
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GR 661
            IIHRDLK SN+ ++E+   +I DFG+A+      D+  TG  V T  Y +PE  +    
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTG-YVATRWYRAPEIMLNWMH 205
Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +++  D++S G ++ E++ G+
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 24/225 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI--AVKRLSKAS---GQGLEEFMNEVMVISK-L 534
           ++F     +G+G FG V   R K  +E+  AVK L K +    +  +  M+E  V+ K +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 592
           +H  LV L       ++   + +Y+    L    F  L++ER  L+ R RF   E I+  
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAE-IASA 151
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L YLH    L I++RDLK  NILLD + +  ++DFG+ K     +  + T    GT  Y+
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYL 206
Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG-----RKNTSFFEDDL 692
           +PE   +  +    D +  G +L E++ G      +NT+   D++
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 487 SKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRLL 543
           + +G G +G V      + G+++A+K+LS+     +  +    E++++  +QH N++ LL
Sbjct: 48  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 544 GCCVEGEEKMLIYEY---MP--NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
                       Y++   MP     L  ++     +E++ +     ++  + +GL Y+H 
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIHS 162
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
                ++HRDLK  N+ ++E+   KI DFG+A+    + D   TG VV T  Y +PE  +
Sbjct: 163 AG---VVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV-TRWYRAPEVIL 214
Query: 659 E-GRFSEKSDVFSFGVLLLEIVSGR 682
               +++  D++S G ++ E+++G+
Sbjct: 215 SWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 489 LGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLL 543
           +G G +G V   Y  RL+  Q++AVK+LS+   S         E+ ++  L+H N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 544 GCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
                        E Y+    + A L + +K + L       ++  + RGL Y+H     
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 143
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GR 661
            IIHRDLK SN+ ++E+   +I DFG+A+      D+  TG  V T  Y +PE  +    
Sbjct: 144 -IIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTG-YVATRWYRAPEIMLNWMH 197
Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +++  D++S G ++ E++ G+
Sbjct: 198 YNQTVDIWSVGCIMAELLQGK 218

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
           N F+    LG+G FG V   + K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANG----GELFFHLSRERVFSEDRARFYGAEIVS-ALD 262
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH  S   +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++P
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 318
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           E   +  +    D +  GV++ E++ GR
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
           N F+    LG+G FG V   + K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANG----GELFFHLSRERVFSEDRARFYGAEIVS-ALD 265
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH  S   +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++P
Sbjct: 266 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 321
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           E   +  +    D +  GV++ E++ GR
Sbjct: 322 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAV----KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGFG V+  ++K   ++       +      +G +  M E  +++K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
                 +  L+   M    +   ++  D       + R  F   + +S GL +LH+ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS-GLEHLHQRN-- 309
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            II+RDLK  N+LLD++ N +ISD G+A      Q +  T    GT G+M+PE  +   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEY 366
Query: 663 SEKSDVFSFGVLLLEIVSGR 682
               D F+ GV L E+++ R
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 536
            +F L   +G+G +  V   RLK    I   R+ K       + ++    E  V  +  +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 537 RNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLL 594
              +  L  C + E ++  + EY+    L   +F   ++ +L +   RF   E IS  L 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 167
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH      II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++P
Sbjct: 168 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 222
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           E      +    D ++ GVL+ E+++GR
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFYGAEIVS-ALE 119
Query: 595 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 120 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 173
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFYGAEIVS-ALE 122
Query: 595 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 123 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 176
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE   +  +    D +  GV++ E++ GR
Sbjct: 177 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY     L    F  L +ER+  + R RF   E +S  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS-ALE 119
Query: 595 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 120 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 173
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
           N F+    LG+G FG V   + K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANG----GELFFHLSRERVFSEDRARFYGAEIVS-ALD 122
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH  S   +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++P
Sbjct: 123 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAP 178
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           E   +  +    D +  GV++ E++ GR
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
           N F+    LG+G FG V   + K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANG----GELFFHLSRERVFSEDRARFYGAEIVS-ALD 123
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH  S   +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++P
Sbjct: 124 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAP 179
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           E   +  +    D +  GV++ E++ GR
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
           N F+    LG+G FG V   + K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANG----GELFFHLSRERVFSEDRARFYGAEIVS-ALD 124
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH  S   +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++P
Sbjct: 125 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAP 180
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           E   +  +    D +  GV++ E++ GR
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-----EVMVISKLQHRNLVRL 542
           LG+G F  VY  R K+  Q +A+K++        ++ +N     E+ ++ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           L          L++++M    L+ ++ D          K + ++    +GL YLH+    
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW-- 132
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR- 661
            I+HRDLK +N+LLDE    K++DFG+AK F G+ ++A   +VV T  Y +PE     R 
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVV-TRWYRAPELLFGARM 189
Query: 662 FSEKSDVFSFGVLLLEIV 679
           +    D+++ G +L E++
Sbjct: 190 YGVGVDMWAVGCILAELL 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFYGAEIVS-ALE 119
Query: 595 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 120 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 173
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           LG G F  V+  + +  G+  A+K + K+         NE+ V+ K++H N+V L     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN-IIEGISRGLLYLHRDSRLRIIH 606
                 L+ + +    L    FD + +  +   K  + +I+ +   + YLH +    I+H
Sbjct: 77  STTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 607 RDLKASNIL-LDEELNPKI--SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 663
           RDLK  N+L L  E N KI  +DFG++K+    +         GT GY++PE   +  +S
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 664 EKSDVFSFGVLLLEIVSG 681
           +  D +S GV+   ++ G
Sbjct: 186 KAVDCWSIGVITYILLCG 203

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFYGAEIVS-ALE 119
Query: 595 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 120 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 173
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAV----KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGFG V+  ++K   ++       +      +G +  M E  +++K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
                 +  L+   M    +   ++  D       + R  F   + +S GL +LH+ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS-GLEHLHQRN-- 309
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            II+RDLK  N+LLD++ N +ISD G+A      Q +  T    GT G+M+PE  +   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEY 366
Query: 663 SEKSDVFSFGVLLLEIVSGR 682
               D F+ GV L E+++ R
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAV----KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGFG V+  ++K   ++       +      +G +  M E  +++K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
                 +  L+   M    +   ++  D       + R  F   + +S GL +LH+ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS-GLEHLHQRN-- 309
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            II+RDLK  N+LLD++ N +ISD G+A      Q +  T    GT G+M+PE  +   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEY 366
Query: 663 SEKSDVFSFGVLLLEIVSGR 682
               D F+ GV L E+++ R
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY     L    F  L +ER+  + R RF   E +S  L 
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS-ALE 124
Query: 595 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 125 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 178
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE   +  +    D +  GV++ E++ GR
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAV----KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGFG V+  ++K   ++       +      +G +  M E  +++K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
                 +  L+   M    +   ++  D       + R  F   + +S GL +LH+ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS-GLEHLHQRN-- 309
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 662
            II+RDLK  N+LLD++ N +ISD G+A      Q +  T    GT G+M+PE  +   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEY 366
Query: 663 SEKSDVFSFGVLLLEIVSGR 682
               D F+ GV L E+++ R
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVM---VISKLQH 536
           N+F     LG+G FG V   R K  G+  A+K L K      +E  + V    V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFYGAEIVS-ALE 119
Query: 595 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 120 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 173
Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
           ++F+  S+LG G  G V   + +    I  ++L     +     + + E+ V+ +     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V   G      E  +  E+M   SLD +L +    +R+       +   + RGL YL  
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE 132
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YM+PE   
Sbjct: 133 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMAPERLQ 186
Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +S +SD++S G+ L+E+  GR
Sbjct: 187 GTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 489 LGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLL 543
           +G G +G V   Y  RL+  Q++AVK+LS+   S         E+ ++  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 544 GCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
                        E Y+    + A L + +K + L       ++  + RGL Y+H     
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GR 661
            IIHRDLK SN+ ++E+   +I DFG+A+      D+  TG  V T  Y +PE  +    
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTG-YVATRWYRAPEIMLNWMH 205
Query: 662 FSEKSDVFSFGVLLLEIVSGR 682
           +++  D++S G ++ E++ G+
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 11  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 55
Query: 503 KD-GQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 56  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 115
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 116 VPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 167
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 168 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 222
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 223 EMAAGY--PPFFAD 234

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/92 (43%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           ++RG+ +L   S  + IHRDL A NILL E    KI DFG+A+    N D    G     
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +M+PE   +  +S KSDV+S+GVLL EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 20/227 (8%)
Query: 476 LATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS--GQGLEEFMNEVMVIS 532
           L     ++ +   +G+G FG V   R K  Q++ A+K LSK     +    F  E   I 
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 533 KLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
              +   V  L C  + ++ + ++ EYMP   L  L+ +    E+  W K +      + 
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAKFYT-----AE 182
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFG 650
            +L L     + +IHRD+K  N+LLD+  + K++DFG   K+        DT   VGT  
Sbjct: 183 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA--VGTPD 240
Query: 651 YMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 693
           Y+SPE       +G +  + D +S GV L E++ G  +T F+ D L 
Sbjct: 241 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFYADSLV 285

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 536
            +F L   +G+G +  V   RLK    I   ++ K       + ++    E  V  +  +
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 537 RNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLL 594
              +  L  C + E ++  + EY+    L   +F   ++ +L +   RF   E IS  L 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 120
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH      II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++P
Sbjct: 121 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 175
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           E      +    D ++ GVL+ E+++GR
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 536
            +F L   +G+G +  V   RLK    I   ++ K       + ++    E  V  +  +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 537 RNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLL 594
              +  L  C + E ++  + EY+    L   +F   ++ +L +   RF   E IS  L 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 124
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH      II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++P
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 179
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           E      +    D ++ GVL+ E+++GR
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 536
            +F L   +G+G +  V   RLK    I   ++ K       + ++    E  V  +  +
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 537 RNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLL 594
              +  L  C + E ++  + EY+    L   +F   ++ +L +   RF   E IS  L 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 135
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH      II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++P
Sbjct: 136 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 190
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           E      +    D ++ GVL+ E+++GR
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           F++ S+LG+G    VY  + K  Q+  A+K L K   + +     E+ V+ +L H N+++
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIK 112
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDS 600
           L        E  L+ E +    L    FD + +K     R   + ++ I   + YLH + 
Sbjct: 113 LKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 601 RLRIIHRDLKASNILL-----DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
              I+HRDLK  N+L      D  L  KI+DFG++KI    + Q     V GT GY +PE
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPL--KIADFGLSKIV---EHQVLMKTVCGTPGYCAPE 220
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSG 681
                 +  + D++S G++   ++ G
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 109/214 (50%), Gaps = 24/214 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK-----RLSKAS-GQGLEEFMNEVMVISK 533
           +++++  +LG G F  V   R K  G+E A K     RLS +  G   EE   EV ++ +
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRG 592
           ++H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSG----GELFDFLAEKESLTEDEATQFLKQILDG 127
Query: 593 LLYLHRDSRLRIIHRDLKASNI-LLDEEL-NPKIS--DFGMA-KIFGGNQDQADTGRVVG 647
           + YLH     RI H DLK  NI LLD+ + NP+I   DFG+A KI  GN+ +     + G
Sbjct: 128 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFG 180
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           T  +++PE         ++D++S GV+   ++SG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 537
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 72  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 656
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL--PIKWMAPES 183
Query: 657 AMEGRFSEKSDVFSFGVLLLEIV 679
               RF+  SDV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    +G G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EYMP   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   K++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    +G G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EYMP   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   K++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 110/218 (50%), Gaps = 24/218 (11%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK-----RLSKAS-GQGLEEFMNEVM 529
           +   +++++  +LG G F  V   R K  G+E A K     RLS +  G   EE   EV 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEG 588
           ++ +++H N++ L        + +LI E +        LFD L +KE L   +    ++ 
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSG----GELFDFLAEKESLTEDEATQFLKQ 116
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNI-LLDEEL-NPKIS--DFGMA-KIFGGNQDQADTG 643
           I  G+ YLH     RI H DLK  NI LLD+ + NP+I   DFG+A KI  GN+ +    
Sbjct: 117 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---- 169
Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            + GT  +++PE         ++D++S GV+   ++SG
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 11  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 55
Query: 503 KD-GQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 56  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 115
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +P       +F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 116 VPG----GEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 167
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 168 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 222
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 223 EMAAGY--PPFFAD 234

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 537
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 40  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 99
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 100 HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 656
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 157 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 211
Query: 657 AMEGRFSEKSDVFSFGVLLLEIV 679
               RF+  SDV+ FGV + EI+
Sbjct: 212 INFRRFTSASDVWMFGVCMWEIL 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 537
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 17  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 77  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 656
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 188
Query: 657 AMEGRFSEKSDVFSFGVLLLEIV 679
               RF+  SDV+ FGV + EI+
Sbjct: 189 INFRRFTSASDVWMFGVCMWEIL 211

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 537
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 72  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 656
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 183
Query: 657 AMEGRFSEKSDVFSFGVLLLEIV 679
               RF+  SDV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 537
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 72  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 656
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 183
Query: 657 AMEGRFSEKSDVFSFGVLLLEIV 679
               RF+  SDV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 537
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 69  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 656
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 180
Query: 657 AMEGRFSEKSDVFSFGVLLLEIV 679
               RF+  SDV+ FGV + EI+
Sbjct: 181 INFRRFTSASDVWMFGVCMWEIL 203

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
           KLG+G +  VY G+ K     +A+K +     +G     + EV ++  L+H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
               +   L++EY+ ++ L   L D      +   K F  +  + RGL Y HR    +++
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHRQ---KVL 122
Query: 606 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSE 664
           HRDLK  N+L++E    K++DFG+A+         D   V  T  Y  P+  +    +S 
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYST 180
Query: 665 KSDVFSFGVLLLEIVSGR 682
           + D++  G +  E+ +GR
Sbjct: 181 QIDMWGVGCIFYEMATGR 198

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 537
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 15  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 74
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 75  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 131
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 656
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 132 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 186
Query: 657 AMEGRFSEKSDVFSFGVLLLEIV 679
               RF+  SDV+ FGV + EI+
Sbjct: 187 INFRRFTSASDVWMFGVCMWEIL 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 537
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 14  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 73
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 74  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 130
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 656
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 131 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 185
Query: 657 AMEGRFSEKSDVFSFGVLLLEIV 679
               RF+  SDV+ FGV + EI+
Sbjct: 186 INFRRFTSASDVWMFGVCMWEIL 208

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 115/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 124 APGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMI 175
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + K+ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 17/233 (7%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 544
           LG+GGF   Y     D +E+   ++   S        E+   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
              + +   ++ E    RSL  L     +K   +   R+ + + I +G+ YLH +   R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 605 IHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 663
           IHRDLK  N+ L+++++ KI DFG+A KI    + + D   + GT  Y++PE   +   S
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD---LCGTPNYIAPEVLCKKGHS 204
Query: 664 EKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 716
            + D++S G +L  ++ G+     FE       Y     NE  +   ++P  S
Sbjct: 205 FEVDIWSLGCILYTLLVGKPP---FETSCLKETYIRIKKNEYSVPRHINPVAS 254

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPK----ISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   PK    I DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 AFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + K+ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + K+ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 39  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 83
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 84  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 144 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 195
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 196 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 250
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 251 EMAAGY--PPFFAD 262

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 24/218 (11%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK----ASGQGL--EEFMNEVM 529
           +   +++++  +LG G F  V   R K  G+E A K + K    +S +G+  EE   EV 
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEG 588
           ++ +++H N++ L        + +LI E +        LFD L +KE L   +    ++ 
Sbjct: 82  ILREIRHPNIITLHDIFENKTDVVLILELVSG----GELFDFLAEKESLTEDEATQFLKQ 137
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNI-LLDEEL-NPKIS--DFGMA-KIFGGNQDQADTG 643
           I  G+ YLH     RI H DLK  NI LLD+ + NP+I   DFG+A KI  GN+ +    
Sbjct: 138 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---- 190
Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            + GT  +++PE         ++D++S GV+   ++SG
Sbjct: 191 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K     L+E    +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+++D++   K++DFG+AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 537
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 72  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 656
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 129 SK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 183
Query: 657 AMEGRFSEKSDVFSFGVLLLEIV 679
               RF+  SDV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI----AVKRLSKAS----GQGLEEFMNEVMVIS 532
            NF+L   LG G +G V+  R   G +     A+K L KA+     +  E    E  V+ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 533 KLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
            ++    +  L    + E K+ LI +Y+    L   L    ++ER    +    +  I  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVL 170
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L +LH+   L II+RD+K  NILLD   +  ++DFG++K F  ++ +       GT  Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEY 226
Query: 652 MSPEYAMEGRFSEKSDV--FSFGVLLLEIVSG 681
           M+P+    G       V  +S GVL+ E+++G
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 156
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 242

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 100/233 (42%), Gaps = 29/233 (12%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 534
           T      L   +G+G +G V W  L  G+ +AVK  S    Q      E  N V+    L
Sbjct: 5   TVARQVALVECVGKGRYGEV-WRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVL----L 59
Query: 535 QHRNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
           +H N++  +   +          LI  Y  + SL    +D L+++ L+      +    +
Sbjct: 60  RHDNILGFIASDMTSRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAA 115
Query: 591 RGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR- 644
            GL +LH +      +  I HRD K+ N+L+   L   I+D G+A +     D  D G  
Sbjct: 116 CGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNN 175
Query: 645 -VVGTFGYMSPEYAMEGRFSEK------SDVFSFGVLLLEIVSGRKNTSFFED 690
             VGT  YM+PE   E   ++       +D+++FG++L EI          ED
Sbjct: 176 PRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVED 228

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 128 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 180
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 128 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 180
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 489 LGQGGFGPV---YWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRLL 543
           +G G +G V     GR   G ++A+K+L +     L  +    E+ ++  ++H N++ LL
Sbjct: 33  VGSGAYGAVCSAVDGRT--GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 544 GCCVEGE---EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
                 E   +    Y  MP    D  L   +K E+L   +   ++  + +GL Y+H   
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTD--LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME- 659
              IIHRDLK  N+ ++E+   KI DFG+A+      D    G VV T  Y +PE  +  
Sbjct: 149 ---IIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMXGXVV-TRWYRAPEVILNW 200
Query: 660 GRFSEKSDVFSFGVLLLEIVSGR 682
            R+++  D++S G ++ E+++G+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+++D++   K++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 117/252 (46%), Gaps = 28/252 (11%)
Query: 446 AKRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-D 504
           A+     A ++A N+  +K +      F+      + +++   +G G +G V   R +  
Sbjct: 25  AEPAHTAASVAAKNLALLKARS-----FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLT 79
Query: 505 GQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVR----LLGCCVEGEEK--MLIY 556
           GQ++A+K++  A       +  + E+ ++   +H N++     L      GE K   ++ 
Sbjct: 80  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 139
Query: 557 EYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 614
           + M    L  ++    PL  E + +      +  + RGL Y+H     ++IHRDLK SN+
Sbjct: 140 DLM-ESDLHQIIHSSQPLTLEHVRY-----FLYQLLRGLKYMHS---AQVIHRDLKPSNL 190
Query: 615 LLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSF 671
           L++E    KI DFGMA+       + Q      V T  Y +PE  +    +++  D++S 
Sbjct: 191 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 250
Query: 672 GVLLLEIVSGRK 683
           G +  E+++ R+
Sbjct: 251 GCIFGEMLARRQ 262

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    +G G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   K++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEE-F 524
           DLP+         ++ ++L   +G G FG     R K   E +AVK + +  G+ ++E  
Sbjct: 11  DLPIMH------DSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIER--GEKIDENV 62
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF- 583
             E++    L+H N+VR     +      ++ EY     L   + +  +    + R  F 
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 122
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQAD 641
            +I G+S    Y H    +++ HRDLK  N LLD    P  KI+DFG +K    +   + 
Sbjct: 123 QLISGVS----YAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQ 172
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 681
               VGT  Y++PE  ++  +  K +DV+S GV L  ++ G
Sbjct: 173 PKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 141
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEYLAP 193
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 227

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 91/182 (50%), Gaps = 21/182 (11%)
Query: 507 EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDA 566
           E AVK + K+     EE     +++   QH N++ L     +G+   L+ E M       
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRG---GE 107
Query: 567 LLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL-LDEELNP--- 622
           LL   L+++    R+   ++  I + + YLH      ++HRDLK SNIL +DE  NP   
Sbjct: 108 LLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 623 KISDFGMAKIFGGNQDQADTGRVVG---TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 679
           +I DFG AK     Q +A+ G ++    T  +++PE      + E  D++S G+LL  ++
Sbjct: 165 RICDFGFAK-----QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219
Query: 680 SG 681
           +G
Sbjct: 220 AG 221

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 114/254 (44%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIRT----------LGTGSFGRVMLVKH 63
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  +   +    LV+L     +     ++ EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEY 123
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 APGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +    L    FD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 156
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 242

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+P   +    F  L++     +   RF   + I     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 156
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEYLAP 208
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 242

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+++D++   K++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +    L    FD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 479 ATNNFQLSSK---LGQGGFGPVY-WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL 534
           A N+F   SK   LG G FG V+       G ++A K +     +  EE  NE+ V+++L
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII--EGISRG 592
            H NL++L        + +L+ EY+        LFD +  E  +  +   I+  + I  G
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDG----GELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 593 LLYLHRDSRLRIIHRDLKASNILL--DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
           + ++H   ++ I+H DLK  NIL    +    KI DFG+A+ +   + +       GT  
Sbjct: 200 IRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPE 253
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +++PE       S  +D++S GV+   ++SG
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 91/182 (50%), Gaps = 21/182 (11%)
Query: 507 EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDA 566
           E AVK + K+     EE     +++   QH N++ L     +G+   L+ E M       
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRG---GE 107
Query: 567 LLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL-LDEELNP--- 622
           LL   L+++    R+   ++  I + + YLH      ++HRDLK SNIL +DE  NP   
Sbjct: 108 LLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 623 KISDFGMAKIFGGNQDQADTGRVVG---TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 679
           +I DFG AK     Q +A+ G ++    T  +++PE      + E  D++S G+LL  ++
Sbjct: 165 RICDFGFAK-----QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219
Query: 680 SG 681
           +G
Sbjct: 220 AG 221

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K     L+E    +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+++D++   +++DFG+AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +    L    FD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 15/228 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR 537
           +++ +  +LG G FG V+  R+ +   G   A K +        E    E+  +S L+H 
Sbjct: 157 DHYDIHEELGTGAFGVVH--RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
            LV L     +  E ++IYE+M    L   + D   K   D  +    +  + +GL ++H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMH 272
Query: 598 RDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            ++    +H DLK  NI+   + +   K+ DFG+       Q    T    GT  + +PE
Sbjct: 273 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPE 326
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
            A        +D++S GVL   ++SG        DD T+       WN
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 374

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 537
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 452 HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 656
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 563
Query: 657 AMEGRFSEKSDVFSFGVLLLEIV 679
               RF+  SDV+ FGV + EI+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 537
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 452 HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 656
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 509 SK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 563
Query: 657 AMEGRFSEKSDVFSFGVLLLEIV 679
               RF+  SDV+ FGV + EI+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 116/250 (46%), Gaps = 22/250 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 527
           +  +L     ++++   +G+G FG V   R K  +++ A+K LSK       +   F  E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
             +++      +V+L     +     ++ EYMP   L  L+ +    E+  W  RF   E
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--W-ARFYTAE 181
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 646
            +    L L     +  IHRD+K  N+LLD+  + K++DFG   K+      + DT   V
Sbjct: 182 VV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--V 235
Query: 647 GTFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
           GT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D  +++G   K+ 
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYAD--SLVGTYSKIM 291
Query: 703 NENKILALVD 712
           N    L   D
Sbjct: 292 NHKNSLTFPD 301

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 650
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 117/252 (46%), Gaps = 28/252 (11%)
Query: 446 AKRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-D 504
           A+     A ++A N+  +K +      F+      + +++   +G G +G V   R +  
Sbjct: 24  AEPAHTAASVAAKNLALLKARS-----FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLT 78
Query: 505 GQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVR----LLGCCVEGEEK--MLIY 556
           GQ++A+K++  A       +  + E+ ++   +H N++     L      GE K   ++ 
Sbjct: 79  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138
Query: 557 EYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 614
           + M    L  ++    PL  E + +      +  + RGL Y+H     ++IHRDLK SN+
Sbjct: 139 DLM-ESDLHQIIHSSQPLTLEHVRY-----FLYQLLRGLKYMHS---AQVIHRDLKPSNL 189
Query: 615 LLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSF 671
           L++E    KI DFGMA+       + Q      V T  Y +PE  +    +++  D++S 
Sbjct: 190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 249
Query: 672 GVLLLEIVSGRK 683
           G +  E+++ R+
Sbjct: 250 GCIFGEMLARRQ 261

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 116/250 (46%), Gaps = 22/250 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 527
           +  +L     ++++   +G+G FG V   R K  +++ A+K LSK       +   F  E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
             +++      +V+L     +     ++ EYMP   L  L+ +    E+  W  RF   E
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--W-ARFYTAE 181
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 646
            +    L L     +  IHRD+K  N+LLD+  + K++DFG   K+      + DT   V
Sbjct: 182 VV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--V 235
Query: 647 GTFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
           GT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D  +++G   K+ 
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYAD--SLVGTYSKIM 291
Query: 703 NENKILALVD 712
           N    L   D
Sbjct: 292 NHKNSLTFPD 301

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 5   FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 49
Query: 503 KD-GQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 50  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 109
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 110 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 161
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           DE+   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 162 DEQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 216
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 217 EMAAGY--PPFFAD 228

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 649
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 116/250 (46%), Gaps = 22/250 (8%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 527
           +  +L     ++++   +G+G FG V   R K  +++ A+K LSK       +   F  E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
             +++      +V+L     +     ++ EYMP   L  L+ +    E+  W  RF   E
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--W-ARFYTAE 176
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 646
            +    L L     +  IHRD+K  N+LLD+  + K++DFG   K+      + DT   V
Sbjct: 177 VV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--V 230
Query: 647 GTFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
           GT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D  +++G   K+ 
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYAD--SLVGTYSKIM 286
Query: 703 NENKILALVD 712
           N    L   D
Sbjct: 287 NHKNSLTFPD 296

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 650
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL----- 542
           LG GG G V+     D  + +A+K++     Q ++  + E+ +I +L H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 543 ---------LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
                    +G   E     ++ EYM     + L   PL    L+   R  + + + RGL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL----LEEHARLFMYQ-LLRGL 133
Query: 594 LYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFGGN-QDQADTGRVVGTFGY 651
            Y+H  +   ++HRDLK +N+ ++ E+L  KI DFG+A+I   +   +      + T  Y
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 652 MSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
            SP   +    +++  D+++ G +  E+++G+
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM 525
           DLP+         ++ ++L   +G G FG     R K   E +AVK + +  G+ ++E +
Sbjct: 10  DLPIMH------DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENV 61
Query: 526 N-EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF- 583
             E++    L+H N+VR     +      ++ EY     L   + +  +    + R  F 
Sbjct: 62  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 121
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQAD 641
            +I G+S    Y H    +++ HRDLK  N LLD    P  KI DFG +K    +   + 
Sbjct: 122 QLISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 171
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 681
               VGT  Y++PE  ++  +  K +DV+S GV L  ++ G
Sbjct: 172 PKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQ 535
           T  + F    KLG G FG V+    +  G E  +K ++K   Q  +E+   E+ V+  L 
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           H N++++     +     ++ E       L+ ++    + + L       +++ +   L 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 650
           Y H      ++H+DLK  NIL  ++ +P    KI DFG+A++F  ++   +     GT  
Sbjct: 139 YFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTAL 191
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           YM+PE   +   + K D++S GV++  +++G
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 103/233 (44%), Gaps = 45/233 (19%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA----------------- 516
           +E     N++++   L QG F  +     KD +  A+K+  K+                 
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKIS 82
Query: 517 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL------------ 564
                ++F NE+ +I+ +++   +   G     +E  +IYEYM N S+            
Sbjct: 83  IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624
           +   F P++  +        II+ +     Y+H +    I HRD+K SNIL+D+    K+
Sbjct: 143 NYTCFIPIQVIKC-------IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKL 193
Query: 625 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-YAMEGRFS-EKSDVFSFGVLL 675
           SDFG ++     + +       GT+ +M PE ++ E  ++  K D++S G+ L
Sbjct: 194 SDFGESEYMVDKKIKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 650
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 650
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 650
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 535
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 594
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 650
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             L +L     +     ++ EY P   +    F  L++     +   RF   + I     
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 156
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+++D++   K++DFG AK   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 242

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY P   +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+++D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQH 536
           ++L   +G+G F  V     ++ GQ+ AVK     + + + G   E+   E  +   L+H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL-- 594
            ++V LL          +++E+M    L    F+ +K+    +     +     R +L  
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 595 --YLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTF 649
             Y H ++   IIHRD+K  N+LL  + N    K+ DFG+A I  G       GRV GT 
Sbjct: 143 LRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVAGGRV-GTP 197
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +M+PE      + +  DV+  GV+L  ++SG
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 11/226 (4%)
Query: 481 NNFQLSSKLGQGGFGPVYW-GRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
           +++ +  +LG G FG V+       G   A K +        E    E+  +S L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V L     +  E ++IYE+M    L   + D   K   D  +    +  + +GL ++H +
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 168
Query: 600 SRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           +    +H DLK  NI+   + +   K+ DFG+       Q    T    GT  + +PE A
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVA 222
Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 703
                   +D++S GVL   ++SG        DD T+       WN
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 268

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 110/272 (40%), Gaps = 75/272 (27%)
Query: 481 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 20  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 79
Query: 534 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLK------------ 573
           +  H N+V LLG C + G   M+I E+    +L   L      F P K            
Sbjct: 80  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 139
Query: 574 --------KERLDWR------------------------------KRFNIIEGI------ 589
                   K RLD                                K F  +E +      
Sbjct: 140 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 199
Query: 590 -SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
            ++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    G     
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFAEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 117/255 (45%), Gaps = 37/255 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFEDD 691
           E+ +G     FF D+
Sbjct: 230 EMAAGY--PPFFADE 242

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 13  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 57
Query: 503 KD-GQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 58  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 117
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 118 VAGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 169
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 170 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 224
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 225 EMAAGY--PPFFAD 236

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 483 FQLSSKL-GQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNL 539
           ++L+S+L G+G +  V     L++G+E AVK + K +G        EV  + + Q ++N+
Sbjct: 14  YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNI 73
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           + L+    +     L++E +   S+ A +    K++  + R+   ++  ++  L +LH  
Sbjct: 74  LELIEFFEDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTK 130
Query: 600 SRLRIIHRDLKASNILLD--EELNP-KISDFGMAKIFGGNQD-----QADTGRVVGTFGY 651
               I HRDLK  NIL +  E+++P KI DF +      N         +     G+  Y
Sbjct: 131 G---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEY 187
Query: 652 MSPE----YAMEGRFSEK-SDVFSFGVLLLEIVSG 681
           M+PE    +  +  F +K  D++S GV+L  ++SG
Sbjct: 188 MAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 39  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 83
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 84  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 144 VAGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 195
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 196 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 250
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 251 EMAAGY--PPFFAD 262

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             L +L     +     ++ EY P   +    F  L++     +   RF   + I     
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 156
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+++D++   K++DFG AK   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 242

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             L +L     +     ++ EY P   +    F  L++     +   RF   + I     
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 156
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+++D++   K++DFG AK   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 242

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM 525
           DLP+         ++ ++L   +G G FG     R K   E +AVK + +  G+ ++E +
Sbjct: 11  DLPIMH------DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENV 62
Query: 526 N-EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF- 583
             E++    L+H N+VR     +      ++ EY     L   + +  +    + R  F 
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 122
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQAD 641
            +I G+S    Y H    +++ HRDLK  N LLD    P  KI  FG +K    +    D
Sbjct: 123 QLISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKD 175
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 681
           T   VGT  Y++PE  ++  +  K +DV+S GV L  ++ G
Sbjct: 176 T---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 113/244 (46%), Gaps = 31/244 (12%)
Query: 462 TVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ---EIAVKRLSKASG 518
           T KL+ +     EE+  AT+      +LG+G FG V+  R++D Q   + AVK++     
Sbjct: 59  TEKLKPVDYEYREEVHWATHQL----RLGRGSFGEVH--RMEDKQTGFQCAVKKVR---- 108
Query: 519 QGLEEF-MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER- 576
             LE F   E+M  + L    +V L G   EG    +  E +   SL  L+     KE+ 
Sbjct: 109 --LEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQG 161
Query: 577 -LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIF- 633
            L   +    +     GL YLH  SR RI+H D+KA N+LL  +  +  + DFG A    
Sbjct: 162 CLPEDRALYYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQ 218
Query: 634 --GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFED 690
             G  +D      + GT  +M+PE  +      K DV+S   ++L +++G    T FF  
Sbjct: 219 PDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG 278
Query: 691 DLTI 694
            L +
Sbjct: 279 PLCL 282

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 72/268 (26%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRN 538
            +F+    +G+GGFG V+  + K D    A+KR+   + +   E+ M EV  ++KL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 539 LVRLLGCCVEGEEKMLIYEY-------------------MPNRSLDALLFDPL------- 572
           +VR     +E   +    E                    M   S+     DP        
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 573 ------------------KKERL-DWRKR------------FNIIEGISRGLLYLHRDSR 601
                             +KE L DW  R             +I   I+  + +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ----------ADTGRVVGTFGY 651
             ++HRDLK SNI    +   K+ DFG+      ++++          A     VGT  Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLY 242
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIV 679
           MSPE      +S K D+FS G++L E++
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H    L+IIHRD+K SNILLD   N K+ DFG++   G   D     R  G   YM+PE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPER 196
Query: 657 ----AMEGRFSEKSDVFSFGVLLLEIVSGR 682
               A    +  +SDV+S G+ L E+ +GR
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 63
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F     LG+G FG V     K   E+ AVK L K        +E  M E  V++    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
              +  L  C +  +++  + EY+    L   ++   +  R            I+ GL +
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           L       II+RDLK  N++LD E + KI+DFGM K      D   T    GT  Y++PE
Sbjct: 137 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPE 191
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                 + +  D ++FGVLL E+++G+
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
           T+ +++   +G G +        K    E AVK + K+     EE     +++   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           ++ L     +G+   ++ E M       LL   L+++    R+   ++  I++ + YLH 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKG---GELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 599 DSRLRIIHRDLKASNIL-LDEELNP---KISDFGMAKIFGGNQDQADTGRVVG---TFGY 651
                ++HRDLK SNIL +DE  NP   +I DFG AK     Q +A+ G ++    T  +
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK-----QLRAENGLLMTPCYTANF 186
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           ++PE      +    D++S GVLL  +++G
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG-QGLEEFMNEVMVISKL 534
           +T+ + + LS  LGQG    V+ GR K  G   A+K  +  S  + ++  M E  V+ KL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 535 QHRNLVRLLGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
            H+N+V+L     E     K+LI E+ P  SL  +L +P     L   +   ++  +  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 593 LLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           + +L  +    I+HR++K  NI+     D +   K++DFG A+     +D      + GT
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVXLYGT 178
Query: 649 FGYMSPEYA--------MEGRFSEKSDVFSFGVLLLEIVSG 681
             Y+ P+           + ++    D++S GV      +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +F     LG+G FG V     K   E+ AVK L K        +E  M E  V++    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
              +  L  C +  +++  + EY+   +   L++   +  R            I+ GL +
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYV---NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           L       II+RDLK  N++LD E + KI+DFGM K      D   T    GT  Y++PE
Sbjct: 458 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPE 512
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                 + +  D ++FGVLL E+++G+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCC 546
           K+G+G +G VY  + KDG++     L +  G G+      E+ ++ +L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 547 VEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRD 599
           +   ++   L+++Y  +     + F    K     +K   +  G+ + LLY     +H  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 600 SRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGN-QDQADTGRVVGTFGYMSP 654
               ++HRDLK +NIL+     E    KI+D G A++F    +  AD   VV TF Y +P
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 655 EYAMEGRFSEKS-DVFSFGVLLLEIVSG 681
           E  +  R   K+ D+++ G +  E+++ 
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG-QGLEEFMNEVMVISKL 534
           +T+ + + LS  LGQG    V+ GR K  G   A+K  +  S  + ++  M E  V+ KL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 535 QHRNLVRLLGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
            H+N+V+L     E     K+LI E+ P  SL  +L +P     L   +   ++  +  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 593 LLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           + +L  +    I+HR++K  NI+     D +   K++DFG A+     +D      + GT
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGT 178
Query: 649 FGYMSPEYA--------MEGRFSEKSDVFSFGVLLLEIVSG 681
             Y+ P+           + ++    D++S GV      +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHR 537
           +++FQL S LG+G +G V     K  G+ +A+K++            + E+ ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 538 NLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           N++ +             E  +I E M       +    L  + + +      I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ--------DQADTGR 644
           +  LH  +   +IHRDLK SN+L++   + K+ DFG+A+I   +          Q+    
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 645 VVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 682
            V T  Y +PE  +   ++S   DV+S G +L E+   R
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHR 537
           +++FQL S LG+G +G V     K  G+ +A+K++            + E+ ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 538 NLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           N++ +             E  +I E M       +    L  + + +      I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ--------DQADTGR 644
           +  LH  +   +IHRDLK SN+L++   + K+ DFG+A+I   +          Q+    
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 645 VVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 682
            V T  Y +PE  +   ++S   DV+S G +L E+   R
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 39  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 83
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 84  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 144 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 195
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 196 DQQGYIQVTDFGFAKRVKGA-----TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 250
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 251 EMAAGY--PPFFAD 262

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL 534
           T    +Q    +G G  G V        G  +AVK+LS+   +    +    E++++  +
Sbjct: 19  TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 78
Query: 535 QHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
            H+N++ LL          E ++  L+ E M + +L  ++   L  ER+ +     ++  
Sbjct: 79  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-----LLYQ 132
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+    N     T  VV  
Sbjct: 133 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMM--TPYVVTR 187
Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           + Y +PE  +   + E  D++S G ++ E+V G
Sbjct: 188 Y-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
           ++ +     +G G FG     R K  +E +AVK + + +    E    E++    L+H N
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPN 77
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRG 592
           +VR     +      +I EY     L          ER+    RF+        + +  G
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGEL---------YERICNAGRFSEDEARFFFQQLLSG 128
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFG 650
           + Y H    ++I HRDLK  N LLD    P  KI DFG +K    +   +     VGT  
Sbjct: 129 VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA 182
Query: 651 YMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 681
           Y++PE  +   +  K +DV+S GV L  ++ G
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    G     
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    G     
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    G     
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHR 537
           +++FQL S LG+G +G V     K  G+ +A+K++            + E+ ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 538 NLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           N++ +             E  +I E M       +    L  + + +      I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGR------ 644
           +  LH  +   +IHRDLK SN+L++   + K+ DFG+A+I       +   TG+      
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 645 VVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 682
            V T  Y +PE  +   ++S   DV+S G +L E+   R
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y +PE  +   + E  D++S GV++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 20/219 (9%)
Query: 467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN 526
           DLP+         ++ ++L   +G G FG     R K   E+   +  +   +       
Sbjct: 11  DLPIMH------DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKR 64
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF-NI 585
           E++    L+H N+VR     +      ++ EY     L   + +  +    + R  F  +
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 124
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTG 643
           I G+S    Y H    +++ HRDLK  N LLD    P  KI DFG +K    +   +   
Sbjct: 125 ISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPK 174
Query: 644 RVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 681
             VGT  Y++PE  ++  +  K +DV+S GV L  ++ G
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +        +F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 123 VAG----GEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLII 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 108/205 (52%), Gaps = 12/205 (5%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGL-EEFMNEVMVISKLQHRNL 539
           ++   K+G+G +G V+  + ++  EI A+KR+      +G+    + E+ ++ +L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           VRL       ++  L++E+  ++ L    FD    + LD     + +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCH-- 118
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           SR  ++HRDLK  N+L++     K++DFG+A+ FG    +  +  VV T  Y  P+    
Sbjct: 119 SR-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEVV-TLWYRPPDVLFG 175
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGRK 683
            + +S   D++S G +  E+ +  +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 473 FEELATATNNFQLSSK-LGQGGFGPVYWGRLKD-GQEIAVKRLSKAS-GQGLE-EFMNEV 528
           F+ +    N + L+SK LG+G F  V     K  GQE A K L K   GQ    E ++E+
Sbjct: 20  FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEI 79
Query: 529 MVISKLQH-RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
            V+   +    ++ L        E +LI EY     + +L   P   E +       +I+
Sbjct: 80  AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIK 138
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTG 643
            I  G+ YLH+++   I+H DLK  NILL   + P    KI DFGM++  G      +  
Sbjct: 139 QILEGVYYLHQNN---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRKIG---HACELR 191
Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVL 674
            ++GT  Y++PE       +  +D+++ G++
Sbjct: 192 EIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           ++ +G     FF D
Sbjct: 230 QMAAGY--PPFFAD 241

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQH 536
           + F+    LG G FG V   + ++ G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLL 594
             LV+L     +     ++ EY+    +    F  L++     +   RF   + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFE 155
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH    L +I+RDLK  N+L+D++   +++DFG AK   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
           E  +   +++  D ++ GVL+ E+ +G     FF D
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY--PPFFAD 241

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y +PE  +   + E  D++S GV++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKX 79
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQME-LDHERMSYLLY 133
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 134 QMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVT 188
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEE--FMNEVMVISKLQHR 537
           N+ +   ++G G  G V+  R  K G  IAVK++ ++  +   +   M+  +V+      
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPN--RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
            +V+  G  +   +  +  E M      L   +  P+  ER+  +    I+    + L Y
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP-ERILGKMTVAIV----KALYY 139
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           L    +  +IHRD+K SNILLDE    K+ DFG   I G   D     R  G   YM+PE
Sbjct: 140 LK--EKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRSAGCAAYMAPE 194
Query: 656 Y-----AMEGRFSEKSDVFSFGVLLLEIVSGR 682
                   +  +  ++DV+S G+ L+E+ +G+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM 525
           DLP+         ++ ++L   +G G FG     R K   E +AVK + +  G+ ++E +
Sbjct: 11  DLPIMH------DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENV 62
Query: 526 N-EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF- 583
             E++    L+H N+VR     +      ++ EY     L   + +  +    + R  F 
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 122
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQAD 641
            +I G+S    Y H    +++ HRDLK  N LLD    P  KI  FG +K    +   + 
Sbjct: 123 QLISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQ 172
Query: 642 TGRVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 681
               VGT  Y++PE  ++  +  K +DV+S GV L  ++ G
Sbjct: 173 PKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 115/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT  Y++P   +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 112/244 (45%), Gaps = 31/244 (12%)
Query: 462 TVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ---EIAVKRLSKASG 518
           T KL+ +     EE+  AT+      +LG+G FG V+  R++D Q   + AVK++     
Sbjct: 78  TEKLKPVDYEYREEVHWATHQL----RLGRGSFGEVH--RMEDKQTGFQCAVKKVR---- 127
Query: 519 QGLEEF-MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER- 576
             LE F   E+M  + L    +V L G   EG    +  E +   SL  L+     KE+ 
Sbjct: 128 --LEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQG 180
Query: 577 -LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIF- 633
            L   +    +     GL YLH  SR RI+H D+KA N+LL  +  +  + DFG A    
Sbjct: 181 CLPEDRALYYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQ 237
Query: 634 --GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFED 690
             G  +       + GT  +M+PE  +      K DV+S   ++L +++G    T FF  
Sbjct: 238 PDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG 297
Query: 691 DLTI 694
            L +
Sbjct: 298 PLCL 301

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQME-LDHERMSYLLY 126
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 127 QMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVT 181
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL 534
           T    +Q    +G G  G V        G  +AVK+LS+   +    +    E++++  +
Sbjct: 21  TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 80
Query: 535 QHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
            H+N++ LL          E ++  L+ E M + +L  ++   L  ER+ +     ++  
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-----LLYQ 134
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+    N     T  VV  
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTR 189
Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           + Y +PE  +   ++   D++S G ++ E+V G
Sbjct: 190 Y-YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKX 79
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQME-LDHERMSYLLY 133
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVT 188
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQME-LDHERMSYLLY 133
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 134 QMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVT 188
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 110/234 (47%), Gaps = 41/234 (17%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMV 530
           F+ ++     + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 531 ISKLQHRN--LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-W-RKRF--N 584
           ++KLQ  +  ++RL    +  +   ++ E   N  L++ L    KK+ +D W RK +  N
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKN 135
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++E +       H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  
Sbjct: 136 MLEAV-------HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTS 182
Query: 645 V-----VGTFGYMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 682
           V     VGT  YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPEVVTRY 190
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKX 79
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 133
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVT 188
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI--AVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
           + L + +G+G +G V    ++ G  I  A K++ K   + ++ F  E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR--FNIIEGISRGLLYLHR 598
           RL     +  +  L+ E          LF+ +  +R+ +R+     I++ +   + Y H 
Sbjct: 70  RLYETFEDNTDIYLVMEL----CTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH- 123
Query: 599 DSRLRIIHRDLKASNILL--DEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
             +L + HRDLK  N L   D   +P K+ DFG+A  F   +        VGT  Y+SP+
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ 178
Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSG 681
             +EG +  + D +S GV++  ++ G
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 117
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 171
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 172 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 226
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 227 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 113/250 (45%), Gaps = 46/250 (18%)
Query: 464 KLQDLPLFQFEELATATNNFQLSSK-LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
           ++ ++P F+      +  N  +S K LG G  G V +     G+ +AVKR+       L 
Sbjct: 20  RIANIPNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LI 67
Query: 523 EFMNEVMVISKL-----QHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDP-LKKE 575
           +F +  ++  KL      H N++R    C E  ++ L I   + N +L  L+    +  E
Sbjct: 68  DFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDE 125
Query: 576 RLDWRKRFN---IIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-------------EE 619
            L  +K +N   ++  I+ G+ +LH    L+IIHRDLK  NIL+              E 
Sbjct: 126 NLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAEN 182
Query: 620 LNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYMSPEYAMEG---RFSEKSDVFSFGVL 674
           L   ISDFG+ K     Q   + +     GT G+ +PE   E    R +   D+FS G +
Sbjct: 183 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242
Query: 675 LLEIVSGRKN 684
              I+S  K+
Sbjct: 243 FYYILSKGKH 252

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 113/250 (45%), Gaps = 46/250 (18%)
Query: 464 KLQDLPLFQFEELATATNNFQLSSK-LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
           ++ ++P F+      +  N  +S K LG G  G V +     G+ +AVKR+       L 
Sbjct: 20  RIANIPNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LI 67
Query: 523 EFMNEVMVISKL-----QHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDP-LKKE 575
           +F +  ++  KL      H N++R    C E  ++ L I   + N +L  L+    +  E
Sbjct: 68  DFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDE 125
Query: 576 RLDWRKRFN---IIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-------------EE 619
            L  +K +N   ++  I+ G+ +LH    L+IIHRDLK  NIL+              E 
Sbjct: 126 NLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAEN 182
Query: 620 LNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYMSPEYAMEG---RFSEKSDVFSFGVL 674
           L   ISDFG+ K     Q   + +     GT G+ +PE   E    R +   D+FS G +
Sbjct: 183 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242
Query: 675 LLEIVSGRKN 684
              I+S  K+
Sbjct: 243 FYYILSKGKH 252

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 50/254 (19%)
Query: 464 KLQDLPLFQFEELATATNNFQLSSK-LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
           ++ ++P F+      +  N  +S K LG G  G V +     G+ +AVKR+       L 
Sbjct: 2   RIANIPNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LI 49
Query: 523 EFMNEVMVISKL-----QHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDP-LKKE 575
           +F +  ++  KL      H N++R    C E  ++ L I   + N +L  L+    +  E
Sbjct: 50  DFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDE 107
Query: 576 RLDWRKRFN---IIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-------------EE 619
            L  +K +N   ++  I+ G+ +LH    L+IIHRDLK  NIL+              E 
Sbjct: 108 NLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 620 LNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYMSPEYAMEG-------RFSEKSDVFS 670
           L   ISDFG+ K     Q   + +     GT G+ +PE   E        R +   D+FS
Sbjct: 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 671 FGVLLLEIVSGRKN 684
            G +   I+S  K+
Sbjct: 225 MGCVFYYILSKGKH 238

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI--AVKRLSKASGQGLEEFMNEV 528
           FQ          + L + +G+G +G V    ++ G  I  A K++ K   + ++ F  E+
Sbjct: 16  FQGSTKGDINQYYTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEI 74
Query: 529 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR--FNII 586
            ++  L H N++RL     +  +  L+ E          LF+ +  +R+ +R+     I+
Sbjct: 75  EIMKSLDHPNIIRLYETFEDNTDIYLVMEL----CTGGELFERVVHKRV-FRESDAARIM 129
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILL--DEELNP-KISDFGMAKIFGGNQDQADTG 643
           + +   + Y H   +L + HRDLK  N L   D   +P K+ DFG+A  F   +      
Sbjct: 130 KDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK- 185
Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
             VGT  Y+SP+  +EG +  + D +S GV++  ++ G
Sbjct: 186 --VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMN---EVMVISKLQH 536
           ++F++   +G+G FG V   +  D +++ A+K ++K       E  N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
             LV L     + E+  ++ + +    L   L     ++ + +++   +   I   ++ L
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFKEE-TVKLFICELVMAL 128
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
                 RIIHRD+K  NILLDE  +  I+DF +A +      +     + GT  YM+PE 
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYMAPEM 185
Query: 657 AMEGR---FSEKSDVFSFGVLLLEIVSGRK 683
               +   +S   D +S GV   E++ GR+
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 73
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 127
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 128 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 182
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 183 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 136
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 191
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 192 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 133
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 188
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 126
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 181
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 134
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 189
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 190 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 20  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 78
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 132
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 133 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 187
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 188 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 73
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 127
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 128 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 182
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 183 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGL-EEFMNEVMVISKLQHRNL 539
           ++   K+G+G +G V+  + ++  EI A+KR+      +G+    + E+ ++ +L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           VRL       ++  L++E+  ++ L    FD    + LD     + +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCH-- 118
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
           SR  ++HRDLK  N+L++     K+++FG+A+ FG    +  +  VV T  Y  P+    
Sbjct: 119 SR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVV-TLWYRPPDVLFG 175
Query: 660 GR-FSEKSDVFSFGVLLLEIVSG 681
            + +S   D++S G +  E+ + 
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANA 198

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 117
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 171
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 172 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 226
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 227 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 115/254 (45%), Gaps = 37/254 (14%)
Query: 444 WIAKRKE-VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 502
           ++AK KE  + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 503 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 559 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D++   +++DFG AK   G      T  + GT   ++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229
Query: 677 EIVSGRKNTSFFED 690
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 101/234 (43%), Gaps = 33/234 (14%)
Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVM 529
           FQ   +     ++    KLG+GGF  V     L DG   A+KR+     Q  EE   E  
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREAD 78
Query: 530 VISKLQHRNLVRLLGCCVE----GEEKMLIYEYMPNRSL--------DALLFDPLKKERL 577
           +     H N++RL+  C+       E  L+  +    +L        D   F  L ++++
Sbjct: 79  MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF--LTEDQI 136
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG---MAKIFG 634
            W     ++ GI RGL  +H        HRDLK +NILL +E  P + D G    A I  
Sbjct: 137 LW-----LLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188
Query: 635 GNQDQA----DTGRVVGTFGYMSPE-YAMEGR--FSEKSDVFSFGVLLLEIVSG 681
               QA    D      T  Y +PE ++++      E++DV+S G +L  ++ G
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 40/234 (17%)
Query: 485 LSSKLGQGGFGPVYWGRLKD----GQ----EIAVKRLSKASGQGLEEFMNEVMVISKLQH 536
            +  LGQG F  ++ G  ++    GQ    E+ +K L KA     E F     ++SKL H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
           ++LV   G CV G+E +L+ E++   SLD  L        + W  +  + + ++  + +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFL 129
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF------- 649
             ++   +IH ++ A NILL  E + K  +    K+       +D G  +          
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL-------SDPGISITVLPKDILQE 179
Query: 650 --GYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG----------RKNTSFFED 690
              ++ PE     +  +  +D +SFG  L EI SG          ++   F+ED
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 133
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 188
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 478 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 533
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 534 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 134
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 189
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 190 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRL-LGC 545
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 546 CVEGEEKMLIY-----EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
              GE+K ++Y     +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 196
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 41/213 (19%)
Query: 488 KLGQGGFGPVYWGRLKDGQ------EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           ++G+G F  VY G   +        E+  ++L+K+  Q    F  E   +  LQH N+VR
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 542 LLGC---CVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---------G 588
                   V+G++ + L+ E   + +L   L            KRF + +          
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYL------------KRFKVXKIKVLRSWCRQ 137
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVG 647
           I +GL +LH  +   IIHRDLK  NI +       KI D G+A +   +  +A    V+G
Sbjct: 138 ILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIG 192
Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           T  + +PE   E ++ E  DV++FG   LE  +
Sbjct: 193 TPEFXAPE-XYEEKYDESVDVYAFGXCXLEXAT 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 50/254 (19%)
Query: 464 KLQDLPLFQFEELATATNNFQLSSK-LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
           ++ ++P F+      +  N  +S K LG G  G V +     G+ +AVKR+       L 
Sbjct: 2   RIANIPNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LI 49
Query: 523 EFMNEVMVISKL-----QHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDP-LKKE 575
           +F +  ++  KL      H N++R    C E  ++ L I   + N +L  L+    +  E
Sbjct: 50  DFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDE 107
Query: 576 RLDWRKRFN---IIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-------------EE 619
            L  +K +N   ++  I+ G+ +LH    L+IIHRDLK  NIL+              E 
Sbjct: 108 NLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 620 LNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYMSPEYAMEG-------RFSEKSDVFS 670
           L   ISDFG+ K     Q   + +     GT G+ +PE   E        R +   D+FS
Sbjct: 165 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 671 FGVLLLEIVSGRKN 684
            G +   I+S  K+
Sbjct: 225 MGCVFYYILSKGKH 238

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +        F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRAPELIFG 196
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +        F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFG 196
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +        F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YRAPELIFG 196
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
           T+ +++   +G G +        K    E AVK + K+     EE     +++   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           ++ L     +G+   ++ E         LL   L+++    R+   ++  I++ + YLH 
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKG---GELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 599 DSRLRIIHRDLKASNIL-LDEELNP---KISDFGMAKIFGGNQDQADTGRVVG---TFGY 651
                ++HRDLK SNIL +DE  NP   +I DFG AK     Q +A+ G +     T  +
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK-----QLRAENGLLXTPCYTANF 186
Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
           ++PE      +    D++S GVLL   ++G
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 531
           + + +S  LG G  G V      K  +++A+K +SK      S +  +  +N   E+ ++
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 590
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 128 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 177
Query: 648 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG------RKNTSFFEDDLTILGYA 698
           T  Y++PE  +      ++   D +S GV+L   +SG       +     +D +T   Y 
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 237
Query: 699 W--KLWNE--NKILALVDPFL 715
           +  ++W E   K L LV   L
Sbjct: 238 FIPEVWAEVSEKALDLVKKLL 258

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 531
           + + +S  LG G  G V      K  +++A+K +SK      S +  +  +N   E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 590
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 178
Query: 648 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG------RKNTSFFEDDLTILGYA 698
           T  Y++PE  +      ++   D +S GV+L   +SG       +     +D +T   Y 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 699 W--KLWNE--NKILALVDPFL 715
           +  ++W E   K L LV   L
Sbjct: 239 FIPEVWAEVSEKALDLVKKLL 259

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 531
           + + +S  LG G  G V      K  +++A+K +SK      S +  +  +N   E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 590
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 178
Query: 648 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG------RKNTSFFEDDLTILGYA 698
           T  Y++PE  +      ++   D +S GV+L   +SG       +     +D +T   Y 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 699 W--KLWNE--NKILALVDPFL 715
           +  ++W E   K L LV   L
Sbjct: 239 FIPEVWAEVSEKALDLVKKLL 259

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 23  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 80
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 81  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 137
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +         V T 
Sbjct: 138 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVP---FVVTR 191
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 192 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 531
           + + +S  LG G  G V      K  +++A+K +SK      S +  +  +N   E+ ++
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 590
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 135 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 184
Query: 648 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG------RKNTSFFEDDLTILGYA 698
           T  Y++PE  +      ++   D +S GV+L   +SG       +     +D +T   Y 
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 244
Query: 699 W--KLWNE--NKILALVDPFL 715
           +  ++W E   K L LV   L
Sbjct: 245 FIPEVWAEVSEKALDLVKKLL 265

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 110
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 168
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 169 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YRAPELIFG 224
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 225 ATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 531
           + + +S  LG G  G V      K  +++A+K +SK      S +  +  +N   E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 590
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 178
Query: 648 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG------RKNTSFFEDDLTILGYA 698
           T  Y++PE  +      ++   D +S GV+L   +SG       +     +D +T   Y 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 699 W--KLWNE--NKILALVDPFL 715
           +  ++W E   K L LV   L
Sbjct: 239 FIPEVWAEVSEKALDLVKKLL 259

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 87
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 145
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 146 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YRAPELIFG 201
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 202 ATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 148
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 149 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 204
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 205 ATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 174
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 175 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRAPELIFG 230
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 152
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 153 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 208
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 159
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 160 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 215
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 216 ATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 174
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 175 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFG 230
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 141
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 142 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 197
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 198 ATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISK 533
           +T      L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    
Sbjct: 5   STIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM---- 59
Query: 534 LQHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
           L+H N++  +    +      +  L+ +Y  + SL    FD L +  +       +    
Sbjct: 60  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALST 115
Query: 590 SRGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG- 643
           + GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A       D  D   
Sbjct: 116 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 175
Query: 644 -RVVGTFGYMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 679
              VGT  YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 176 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 196
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 20/169 (11%)
Query: 522 EEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDW 579
           E  + EV ++ K+  H N+++L           L+++ M    L    FD L +K  L  
Sbjct: 55  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSE 110
Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
           ++   I+  +   +  LH+   L I+HRDLK  NILLD+++N K++DFG    F    D 
Sbjct: 111 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDP 163
Query: 640 ADTGR-VVGTFGYMSPEY---AMEGR---FSEKSDVFSFGVLLLEIVSG 681
            +  R V GT  Y++PE    +M      + ++ D++S GV++  +++G
Sbjct: 164 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 118
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 176
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 177 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFG 232
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 233 ATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 20/169 (11%)
Query: 522 EEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDW 579
           E  + EV ++ K+  H N+++L           L+++ M        LFD L +K  L  
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK----GELFDYLTEKVTLSE 123
Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
           ++   I+  +   +  LH+   L I+HRDLK  NILLD+++N K++DFG    F    D 
Sbjct: 124 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDP 176
Query: 640 ADTGR-VVGTFGYMSPEY---AMEGR---FSEKSDVFSFGVLLLEIVSG 681
            +  R V GT  Y++PE    +M      + ++ D++S GV++  +++G
Sbjct: 177 GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 120
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 178
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 179 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFG 234
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 235 ATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 538
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 595
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 74  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 124
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 650
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VGT  
Sbjct: 125 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVN 177
Query: 651 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 682
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 178 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 196
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 531
           + + +S  LG G  G V      K  +++A++ +SK      S +  +  +N   E+ ++
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 590
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 209 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 268 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 317
Query: 648 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG 681
           T  Y++PE  +      ++   D +S GV+L   +SG
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 534
           T      L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    L
Sbjct: 1   TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----L 55
Query: 535 QHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
           +H N++  +    +      +  L+ +Y  + SL    FD L +  +       +    +
Sbjct: 56  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTA 111
Query: 591 RGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG-- 643
            GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A       D  D    
Sbjct: 112 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 171
Query: 644 RVVGTFGYMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 679
             VGT  YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 172 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 152
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 153 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 208
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 153
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     +        + +  Y +PE    
Sbjct: 154 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPELIFG 209
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 210 ATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 161
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 219
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 220 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFG 275
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 276 ATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 144
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 145 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRAPELIFG 200
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 201 ATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 547 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 601 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              I HRD+K  N+LLD +    K+ DFG AK     +        + +  Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPELIFG 196
Query: 660 GR-FSEKSDVFSFGVLLLEIVSGR 682
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 531
           + + +S  LG G  G V      K  +++A++ +SK      S +  +  +N   E+ ++
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 590
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 195 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 254 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 303
Query: 648 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG 681
           T  Y++PE  +      ++   D +S GV+L   +SG
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 20/169 (11%)
Query: 522 EEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDW 579
           E  + EV ++ K+  H N+++L           L+++ M        LFD L +K  L  
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK----GELFDYLTEKVTLSE 123
Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
           ++   I+  +   +  LH+   L I+HRDLK  NILLD+++N K++DFG    F    D 
Sbjct: 124 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDP 176
Query: 640 ADTGR-VVGTFGYMSPEY---AMEGR---FSEKSDVFSFGVLLLEIVSG 681
            +  R V GT  Y++PE    +M      + ++ D++S GV++  +++G
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 538
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 595
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 70  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 120
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 650
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VGT  
Sbjct: 121 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVN 173
Query: 651 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 682
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISK 533
            T      L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    
Sbjct: 2   GTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM---- 56
Query: 534 LQHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
           L+H N++  +    +      +  L+ +Y  + SL    FD L +  +       +    
Sbjct: 57  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALST 112
Query: 590 SRGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG- 643
           + GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A       D  D   
Sbjct: 113 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 172
Query: 644 -RVVGTFGYMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 679
              VGT  YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 173 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 538
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 595
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 71  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 121
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 650
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VGT  
Sbjct: 122 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVN 174
Query: 651 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 682
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 538
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 595
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 168
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 650
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VGT  
Sbjct: 169 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVN 221
Query: 651 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 682
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 534
           T      L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    L
Sbjct: 39  TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----L 93
Query: 535 QHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
           +H N++  +    +      +  L+ +Y  + SL    FD L +  +       +    +
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTA 149
Query: 591 RGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG-- 643
            GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A       D  D    
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 644 RVVGTFGYMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 679
             VGT  YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 534
           T      L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    L
Sbjct: 26  TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----L 80
Query: 535 QHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
           +H N++  +    +      +  L+ +Y  + SL    FD L +  +       +    +
Sbjct: 81  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTA 136
Query: 591 RGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG-- 643
            GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A       D  D    
Sbjct: 137 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 196
Query: 644 RVVGTFGYMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 679
             VGT  YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 197 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 41/234 (17%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMV 530
           F+ ++     + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 531 ISKLQHRN--LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-W-RKRF--N 584
           ++KLQ  +  ++RL    +  +   ++ E   N  L++ L    KK+ +D W RK +  N
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKN 135
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++E +       H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q D   
Sbjct: 136 MLEAV-------HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDXXX 182
Query: 645 V-----VGTFGYMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 682
           V     VGT  YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 489 LGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCC 546
           LG+G    V     L   QE AVK + K  G        EV ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
            E +   L++E M   S+ + +    K+   +  +   +++ ++  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 607 RDLKASNILLDE--ELNP-KISDFGMAKIFGGNQDQADTG-----RVVGTFGYMSPE--- 655
           RDLK  NIL +   +++P KI DFG+      N D +           G+  YM+PE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 656 -YAMEGR-FSEKSDVFSFGVLLLEIVSG 681
            ++ E   + ++ D++S GV+L  ++SG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 73  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 129
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 184
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 185 -YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 26  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 83
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 84  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 140
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 141 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 195
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 196 -YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +         V T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE---VVTR 189
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKLQHRNLVR 541
           L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    L+H N++ 
Sbjct: 7   LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LRHENILG 61
Query: 542 LLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
            +    +      +  L+ +Y  + SL    FD L +  +       +    + GL +LH
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 598 RD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG--RVVGTFG 650
            +      +  I HRDLK+ NIL+ +     I+D G+A       D  D      VGT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 651 YMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 679
           YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 538
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 595
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 168
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 650
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VGT  
Sbjct: 169 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVN 221
Query: 651 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 682
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 86/165 (52%), Gaps = 13/165 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLE--EFMNEVMVISKLQHR 537
           +N+++   +G+G +G VY    K+  + +A+K++++     ++    + E+ ++++L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 538 NLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
            ++RL    +  +    +++ I   + +  L  L   P+    L  +    I+  +  G 
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPI---FLTEQHVKTILYNLLLGE 144
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
            ++H      IIHRDLK +N LL+++ + KI DFG+A+    ++D
Sbjct: 145 KFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 485 LSSKLGQGGFGPVYWGRLKD----GQ----EIAVKRLSKASGQGLEEFMNEVMVISKLQH 536
            +  LGQG F  ++ G  ++    GQ    E+ +K L KA     E F     ++SKL H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
           ++LV   G C  G+E +L+ E++   SLD  L        + W  +  + + ++  + +L
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFL 129
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF------- 649
             ++   +IH ++ A NILL  E + K  +    K+       +D G  +          
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL-------SDPGISITVLPKDILQE 179
Query: 650 --GYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG----------RKNTSFFED 690
              ++ PE     +  +  +D +SFG  L EI SG          ++   F+ED
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQH 536
           ++L   +G+G F  V     ++ GQ+ AVK     + + + G   E+   E  +   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL-- 594
            ++V LL          +++E+M    L    F+ +K+    +     +     R +L  
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 595 --YLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTF 649
             Y H ++   IIHRD+K   +LL  + N    K+  FG+A I  G       GRV GT 
Sbjct: 143 LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVAGGRV-GTP 197
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +M+PE      + +  DV+  GV+L  ++SG
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 478 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 532
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 533 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +         V T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE---VVTR 189
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 190 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQH 536
           ++L   +G+G F  V     ++ GQ+ AVK     + + + G   E+   E  +   L+H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL-- 594
            ++V LL          +++E+M    L    F+ +K+    +     +     R +L  
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 595 --YLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTF 649
             Y H ++   IIHRD+K   +LL  + N    K+  FG+A I  G       GRV GT 
Sbjct: 145 LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVAGGRV-GTP 199
Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
            +M+PE      + +  DV+  GV+L  ++SG
Sbjct: 200 HFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCV 547
           LG G  G + +  + D +++AVKR+        +    EV ++ +  +H N++R    C 
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYF--CT 86
Query: 548 EGEEKM----------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           E + +            + EY+  +    L  +P+            +++  + GL +LH
Sbjct: 87  EKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI-----------TLLQQTTSGLAHLH 135
Query: 598 RDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGY 651
               L I+HRDLK  NIL+       ++   ISDFG+ K    G    +    V GT G+
Sbjct: 136 S---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 652 MSPEYAMEGRFSEKS---DVFSFGVLLLEIVS 680
           ++PE   E      +   D+FS G +   ++S
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 87/334 (26%), Positives = 138/334 (41%), Gaps = 60/334 (17%)
Query: 452 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAV 510
           +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D   +A+
Sbjct: 10  LAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 511 KRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562
           K + K       E  N      EV+++ K+      ++RLL      +  +LI E  P  
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEP 126
Query: 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLD 617
             D  LFD +        +R  + E ++R   +     +       ++HRD+K  NIL+D
Sbjct: 127 VQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 177
Query: 618 EELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGV 673
             LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+S G+
Sbjct: 178 --LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 674 LLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGL 733
           LL ++V G      FE D  I+G                    +  F+  +   C H+  
Sbjct: 232 LLYDMVCGDIP---FEHDEEIIG-------------------GQVFFRQRVSXECQHLIR 269
Query: 734 LCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 767
            C+     DRP    + +  +  ++D+  P+E A
Sbjct: 270 WCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 301

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 87/334 (26%), Positives = 138/334 (41%), Gaps = 60/334 (17%)
Query: 452 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAV 510
           +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D   +A+
Sbjct: 9   LAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 511 KRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562
           K + K       E  N      EV+++ K+      ++RLL      +  +LI E  P  
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEP 125
Query: 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLD 617
             D  LFD +        +R  + E ++R   +     +       ++HRD+K  NIL+D
Sbjct: 126 VQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 176
Query: 618 EELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGV 673
             LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+S G+
Sbjct: 177 --LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 674 LLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGL 733
           LL ++V G      FE D  I+G                    +  F+  +   C H+  
Sbjct: 231 LLYDMVCGDIP---FEHDEEIIG-------------------GQVFFRQRVSXECQHLIR 268
Query: 734 LCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 767
            C+     DRP    + +  +  ++D+  P+E A
Sbjct: 269 WCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 300

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 87/334 (26%), Positives = 138/334 (41%), Gaps = 60/334 (17%)
Query: 452 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAV 510
           +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D   +A+
Sbjct: 10  LAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 511 KRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562
           K + K       E  N      EV+++ K+      ++RLL      +  +LI E  P  
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEP 126
Query: 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLD 617
             D  LFD +        +R  + E ++R   +     +       ++HRD+K  NIL+D
Sbjct: 127 VQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 177
Query: 618 EELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGV 673
             LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+S G+
Sbjct: 178 --LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 674 LLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGL 733
           LL ++V G      FE D  I+G                    +  F+  +   C H+  
Sbjct: 232 LLYDMVCGDIP---FEHDEEIIG-------------------GQVFFRQRVSXECQHLIR 269
Query: 734 LCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 767
            C+     DRP    + +  +  ++D+  P+E A
Sbjct: 270 WCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 301

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 20/218 (9%)
Query: 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG-----------LEE 523
           EL    + + +   +  G +G V  G   +G  +A+KR+      G            + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 524 FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
            + E+ +++   H N++ L    V  EE  +   Y+    +   L   +  +R+    + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ- 134
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
           +I   +   LL LH      ++HRDL   NILL +  +  I DF +A+     +D AD  
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-----EDTADAN 189
Query: 644 RV--VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 678
           +   V    Y +PE  M+ + F++  D++S G ++ E+
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 20/218 (9%)
Query: 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG-----------LEE 523
           EL    + + +   +  G +G V  G   +G  +A+KR+      G            + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 524 FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
            + E+ +++   H N++ L    V  EE  +   Y+    +   L   +  +R+    + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ- 134
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
           +I   +   LL LH      ++HRDL   NILL +  +  I DF +A+     +D AD  
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-----EDTADAN 189
Query: 644 RV--VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 678
           +   V    Y +PE  M+ + F++  D++S G ++ E+
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 115/263 (43%), Gaps = 39/263 (14%)
Query: 452 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAV 510
           +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D   +A+
Sbjct: 10  LAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 511 KRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562
           K + K       E  N      EV+++ K+      ++RLL      +  +LI E  P  
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEP 126
Query: 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLD 617
             D  LFD +        +R  + E ++R   +     +       ++HRD+K  NIL+D
Sbjct: 127 VQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 177
Query: 618 EELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGV 673
             LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+S G+
Sbjct: 178 --LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 674 LLLEIVSGRKNTSFFEDDLTILG 696
           LL ++V G      FE D  I+G
Sbjct: 232 LLYDMVCGDIP---FEHDEEIIG 251

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 488 KLGQGGFGPVYWGRLKDGQ---EIAVKRLSKASGQGLEEF-MNEVMVISKLQHRNLVRLL 543
           +LG+G FG V+  R+KD Q   + AVK++       LE F + E++  + L    +V L 
Sbjct: 79  RLGRGSFGEVH--RMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLY 130
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           G   EG    +  E +   SL  L+     L ++R         +     GL YLH    
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-----LYYLGQALEGLEYLHTR-- 183
Query: 602 LRIIHRDLKASNILLDEELN-PKISDFGMAKIF---GGNQDQADTGRVVGTFGYMSPEYA 657
            RI+H D+KA N+LL  + +   + DFG A      G  +       + GT  +M+PE  
Sbjct: 184 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 242
Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFEDDLTI 694
           M      K D++S   ++L +++G    T +F   L +
Sbjct: 243 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 280

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 115/263 (43%), Gaps = 39/263 (14%)
Query: 452 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAV 510
           +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D   +A+
Sbjct: 10  LAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 511 KRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562
           K + K       E  N      EV+++ K+      ++RLL      +  +LI E  P  
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEP 126
Query: 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLD 617
             D  LFD +        +R  + E ++R   +     +       ++HRD+K  NIL+D
Sbjct: 127 VQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 177
Query: 618 EELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGV 673
             LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+S G+
Sbjct: 178 --LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 674 LLLEIVSGRKNTSFFEDDLTILG 696
           LL ++V G      FE D  I+G
Sbjct: 232 LLYDMVCGDIP---FEHDEEIIG 251

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 115/263 (43%), Gaps = 39/263 (14%)
Query: 452 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAV 510
           +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D   +A+
Sbjct: 9   LAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 511 KRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562
           K + K       E  N      EV+++ K+      ++RLL      +  +LI E  P  
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEP 125
Query: 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLD 617
             D  LFD +        +R  + E ++R   +     +       ++HRD+K  NIL+D
Sbjct: 126 VQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 176
Query: 618 EELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGV 673
             LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+S G+
Sbjct: 177 --LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 674 LLLEIVSGRKNTSFFEDDLTILG 696
           LL ++V G      FE D  I+G
Sbjct: 231 LLYDMVCGDIP---FEHDEEIIG 250

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 115/263 (43%), Gaps = 39/263 (14%)
Query: 452 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAV 510
           +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D   +A+
Sbjct: 9   LAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 511 KRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562
           K + K       E  N      EV+++ K+      ++RLL      +  +LI E  P  
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEP 125
Query: 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLD 617
             D  LFD +        +R  + E ++R   +     +       ++HRD+K  NIL+D
Sbjct: 126 VQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 176
Query: 618 EELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGV 673
             LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+S G+
Sbjct: 177 --LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 674 LLLEIVSGRKNTSFFEDDLTILG 696
           LL ++V G      FE D  I+G
Sbjct: 231 LLYDMVCGDIP---FEHDEEIIG 250

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 86/334 (25%), Positives = 138/334 (41%), Gaps = 60/334 (17%)
Query: 452 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAV 510
           +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D   +A+
Sbjct: 29  LAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 86
Query: 511 KRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562
           K + K       E  N      EV+++ K+      ++RLL      +  +LI E  P  
Sbjct: 87  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEP 145
Query: 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLD 617
             D  LFD +        +R  + E ++R   +     +       ++HRD+K  NIL+D
Sbjct: 146 VQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 196
Query: 618 EELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGV 673
             LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+S G+
Sbjct: 197 --LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 250
Query: 674 LLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGL 733
           LL ++V G  +  F  D+  I G  +                    F+  +   C H+  
Sbjct: 251 LLYDMVCG--DIPFEHDEEIIRGQVF--------------------FRQRVSXECQHLIR 288
Query: 734 LCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 767
            C+     DRP    + +  +  ++D+  P+E A
Sbjct: 289 WCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 320

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 108/234 (46%), Gaps = 23/234 (9%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 527
           + +++     +F++   +G+G FG V   +LK+  ++ A+K L+K       E   F  E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNI 585
             V+     + +  L     +     L+ +Y     L  LL  F+    E +    RF +
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYL 181
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGR 644
            E +    + +    +L  +HRD+K  NIL+D   + +++DFG   K+      Q+    
Sbjct: 182 AEMV----IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA- 236
Query: 645 VVGTFGYMSPEY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 693
            VGT  Y+SPE   AME   GR+  + D +S GV + E++ G   T F+ + L 
Sbjct: 237 -VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESLV 287

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 86/334 (25%), Positives = 138/334 (41%), Gaps = 60/334 (17%)
Query: 452 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAV 510
           +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D   +A+
Sbjct: 9   LAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 511 KRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562
           K + K       E  N      EV+++ K+      ++RLL      +  +LI E  P  
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEP 125
Query: 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLD 617
             D  LFD +        +R  + E ++R   +     +       ++HRD+K  NIL+D
Sbjct: 126 VQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 176
Query: 618 EELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGV 673
             LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+S G+
Sbjct: 177 --LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 674 LLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGL 733
           LL ++V G  +  F  D+  I G  +                    F+  +   C H+  
Sbjct: 231 LLYDMVCG--DIPFEHDEEIIRGQVF--------------------FRQRVSSECQHLIR 268
Query: 734 LCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 767
            C+     DRP    + +  +  ++D+  P+E A
Sbjct: 269 WCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 300

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 86/334 (25%), Positives = 138/334 (41%), Gaps = 60/334 (17%)
Query: 452 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAV 510
           +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D   +A+
Sbjct: 24  LAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 81
Query: 511 KRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562
           K + K       E  N      EV+++ K+      ++RLL      +  +LI E  P  
Sbjct: 82  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEP 140
Query: 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLD 617
             D  LFD +        +R  + E ++R   +     +       ++HRD+K  NIL+D
Sbjct: 141 VQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 191
Query: 618 EELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGV 673
             LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+S G+
Sbjct: 192 --LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 245
Query: 674 LLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGL 733
           LL ++V G  +  F  D+  I G  +                    F+  +   C H+  
Sbjct: 246 LLYDMVCG--DIPFEHDEEIIRGQVF--------------------FRQRVSXECQHLIR 283
Query: 734 LCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 767
            C+     DRP    + +  +  ++D+  P+E A
Sbjct: 284 WCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 315

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 86/334 (25%), Positives = 138/334 (41%), Gaps = 60/334 (17%)
Query: 452 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAV 510
           +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D   +A+
Sbjct: 24  LAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 81
Query: 511 KRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562
           K + K       E  N      EV+++ K+      ++RLL      +  +LI E  P  
Sbjct: 82  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEP 140
Query: 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLD 617
             D  LFD +        +R  + E ++R   +     +       ++HRD+K  NIL+D
Sbjct: 141 VQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 191
Query: 618 EELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGV 673
             LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+S G+
Sbjct: 192 --LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 245
Query: 674 LLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGL 733
           LL ++V G  +  F  D+  I G  +                    F+  +   C H+  
Sbjct: 246 LLYDMVCG--DIPFEHDEEIIRGQVF--------------------FRQRVSSECQHLIR 283
Query: 734 LCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 767
            C+     DRP    + +  +  ++D+  P+E A
Sbjct: 284 WCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 315

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 132
Query: 592 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 643
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 133 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 187
Query: 644 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 188 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 241
Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 242 -----------------FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 282
Query: 763 PKEPA 767
           P+E A
Sbjct: 283 PQETA 287

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 133
Query: 592 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 643
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 188
Query: 644 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 189 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 242
Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 243 -----------------FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 283
Query: 763 PKEPA 767
           P+E A
Sbjct: 284 PQETA 288

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 113
Query: 592 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 643
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 114 SFFWQVLEAVRHCHNXGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 168
Query: 644 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 169 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 222
Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 223 -----------------FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 263
Query: 763 PKEPA 767
           P+E A
Sbjct: 264 PQETA 268

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 83/319 (26%), Positives = 134/319 (42%), Gaps = 61/319 (19%)
Query: 470 LFQ---FEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFM 525
           LFQ    +E     + +Q+   LG GGFG VY G R+ D   +A+K + K       E  
Sbjct: 17  LFQGPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 76
Query: 526 N------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL 577
           N      EV+++ K+      ++RLL      +  +LI E  P    D  LFD +     
Sbjct: 77  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT---- 129
Query: 578 DWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGM 629
              +R  + E ++R   +     +       ++HRD+K  NIL+D  LN    K+ DFG 
Sbjct: 130 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGS 184
Query: 630 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFF 688
             +    +D   T    GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F 
Sbjct: 185 GALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFE 238
Query: 689 EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMST 748
            D+  I G  +                    F+  +   C H+   C+     DRP    
Sbjct: 239 HDEEIIRGQVF--------------------FRQRVSXECQHLIRWCLALRPSDRPTFEE 278
Query: 749 VVSMLNSEIRDLPYPKEPA 767
           + +  +  ++D+  P+E A
Sbjct: 279 IQN--HPWMQDVLLPQETA 295

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 96/194 (49%), Gaps = 28/194 (14%)
Query: 505 GQEIAVKRLS----KASGQGLEEFMN----EVMVISKLQ-HRNLVRLLGCCVEGEEKMLI 555
           G E AVK +     + S + LEE       E  ++ ++  H +++ L+          L+
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 556 YEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 614
           ++ M        LFD L +K  L  ++  +I+  +   + +LH ++   I+HRDLK  NI
Sbjct: 179 FDLMRK----GELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENI 231
Query: 615 LLDEELNPKISDFGMAKIFGGNQDQADTGR-VVGTFGYMSPEY------AMEGRFSEKSD 667
           LLD+ +  ++SDFG    F  + +  +  R + GT GY++PE            + ++ D
Sbjct: 232 LLDDNMQIRLSDFG----FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 668 VFSFGVLLLEIVSG 681
           +++ GV+L  +++G
Sbjct: 288 LWACGVILFTLLAG 301

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 39/223 (17%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 538
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 595
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 168
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 650
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VG   
Sbjct: 169 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGAVN 221
Query: 651 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 682
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCCV 547
           +G G FG V+  +L +  E+A+K++ +      + F N E+ ++  ++H N+V L     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 548 EGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
              +K       L+ EY+P     A       K+ +        +  + R L Y+H    
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---S 159
Query: 602 LRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
           + I HRD+K  N+LLD      K+ DFG AKI    +        + +  Y +PE     
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX---ICSRYYRAPELIFGA 216
Query: 661 -RFSEKSDVFSFGVLLLEIVSGR 682
             ++   D++S G ++ E++ G+
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 130/302 (43%), Gaps = 52/302 (17%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYM-PNRSL-DALLFDPLKKERLDWRKRFNIIEGI 589
           +      ++RLL      +  +LI E M P + L D +      +E L     + ++E +
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVV 646
                + H      ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T    
Sbjct: 128 R----HCH---NCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD-FD 174
Query: 647 GTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN 705
           GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +      
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF------ 226
Query: 706 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKE 765
                         F+  +   C H+   C+     DRP    + +  +  ++D+  P+E
Sbjct: 227 --------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLLPQE 270
Query: 766 PA 767
            A
Sbjct: 271 TA 272

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 488 KLGQGGFGPVYWGRLKDGQ---EIAVKRLSKASGQGLEEF-MNEVMVISKLQHRNLVRLL 543
           ++G+G FG V+  R+KD Q   + AVK++       LE F + E++  + L    +V L 
Sbjct: 65  RVGRGSFGEVH--RMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           G   EG    +  E +   SL  L+     L ++R         +     GL YLH    
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-----LYYLGQALEGLEYLHTR-- 169
Query: 602 LRIIHRDLKASNILLDEELN-PKISDFGMAKIF---GGNQDQADTGRVVGTFGYMSPEYA 657
            RI+H D+KA N+LL  + +   + DFG A      G  +       + GT  +M+PE  
Sbjct: 170 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFEDDLTI 694
           M      K D++S   ++L +++G    T +F   L +
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 266

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 133
Query: 592 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 643
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 188
Query: 644 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 189 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 242
Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 243 -----------------FRQRVSXECQHLIRWCLALRPXDRPTFEEIQN--HPWMQDVLL 283
Query: 763 PKEPA 767
           P+E A
Sbjct: 284 PQETA 288

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 489 LGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCC 546
           LG+G    V     L   QE AVK + K  G        EV ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
            E +   L++E M   S+ + +    K+   +  +   +++ ++  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 607 RDLKASNILLDE--ELNP-KISDFGMAKIFGGNQDQADTG-----RVVGTFGYMSPE--- 655
           RDLK  NIL +   +++P KI DF +      N D +           G+  YM+PE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 656 -YAMEGR-FSEKSDVFSFGVLLLEIVSG 681
            ++ E   + ++ D++S GV+L  ++SG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 133
Query: 592 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 643
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 188
Query: 644 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 189 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 242
Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 243 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 283
Query: 763 PKEPA 767
           P+E A
Sbjct: 284 PQETA 288

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 113
Query: 592 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 643
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 168
Query: 644 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
              GT  Y  PE+    R+  +S  V+S G+LL ++V G      FE D  I+G      
Sbjct: 169 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIG------ 218
Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
                         +  F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 219 -------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 263
Query: 763 PKEPA 767
           P+E A
Sbjct: 264 PQETA 268

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 132
Query: 592 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 643
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 133 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 187
Query: 644 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 188 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 241
Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 242 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 282
Query: 763 PKEPA 767
           P+E A
Sbjct: 283 PQETA 287

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 116
Query: 592 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 643
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 117 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 171
Query: 644 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 172 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 225
Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 226 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 266
Query: 763 PKEPA 767
           P+E A
Sbjct: 267 PQETA 271

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 118
Query: 592 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 643
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 173
Query: 644 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 174 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 227
Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 228 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 268
Query: 763 PKEPA 767
           P+E A
Sbjct: 269 PQETA 273

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/241 (21%), Positives = 113/241 (46%), Gaps = 40/241 (16%)
Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLE--EFMNE 527
           FQ  +     +N+ +   +G+G +G VY    K+ ++ +A+K++++     ++    + E
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 528 VMVISKLQHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDP--LKKERLDWRK 581
           + ++++L+   ++RL    +  +    +++ I   + +  L  L   P  L +E +    
Sbjct: 76  ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK--- 132
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--- 638
              I+  +  G  ++H      IIHRDLK +N LL+++ + K+ DFG+A+     +D   
Sbjct: 133 --TILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 639 ------------------QADTGRVVGTFGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIV 679
                             +  T  VV T  Y +PE   ++  +++  D++S G +  E++
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 680 S 680
           +
Sbjct: 247 N 247

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 131/313 (41%), Gaps = 58/313 (18%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN----- 526
            +E     + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N     
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 527 -EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
            EV+++ K+      ++RLL      +  +LI E  P    D  LFD +        +R 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERG 110
Query: 584 NIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGG 635
            + E ++R   +     +       ++HRD+K  NIL+D  LN    K+ DFG   +   
Sbjct: 111 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL-- 166
Query: 636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTI 694
            +D   T    GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I
Sbjct: 167 -KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEII 222
Query: 695 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 754
            G  +                    F+  +   C H+   C+     DRP    + +  +
Sbjct: 223 RGQVF--------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--H 260
Query: 755 SEIRDLPYPKEPA 767
             ++D+  P+E A
Sbjct: 261 PWMQDVLLPQETA 273

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 131/312 (41%), Gaps = 58/312 (18%)
Query: 474 EELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------ 526
           +E     + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 527 EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           EV+++ K+      ++RLL      +  +LI E  P    D  LFD +        +R  
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGA 110
Query: 585 IIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGN 636
           + E ++R   +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    
Sbjct: 111 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL--- 165
Query: 637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTIL 695
           +D   T    GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I 
Sbjct: 166 KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIR 222
Query: 696 GYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 755
           G  +                    F+  +   C H+   C+     DRP    + +  + 
Sbjct: 223 GQVF--------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HP 260
Query: 756 EIRDLPYPKEPA 767
            ++D+  P+E A
Sbjct: 261 WMQDVLLPQETA 272

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 131/313 (41%), Gaps = 58/313 (18%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN----- 526
            +E     + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N     
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 527 -EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
            EV+++ K+      ++RLL      +  +LI E  P    D  LFD +        +R 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERG 110
Query: 584 NIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGG 635
            + E ++R   +     +       ++HRD+K  NIL+D  LN    K+ DFG   +   
Sbjct: 111 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL-- 166
Query: 636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTI 694
            +D   T    GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I
Sbjct: 167 -KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEII 222
Query: 695 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 754
            G  +                    F+  +   C H+   C+     DRP    + +  +
Sbjct: 223 RGQVF--------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--H 260
Query: 755 SEIRDLPYPKEPA 767
             ++D+  P+E A
Sbjct: 261 PWMQDVLLPQETA 273

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 488 KLGQGGFGPVYWGRLKDGQ---EIAVKRLSKASGQGLEEF-MNEVMVISKLQHRNLVRLL 543
           ++G+G FG V+  R+KD Q   + AVK++       LE F + E++  + L    +V L 
Sbjct: 81  RVGRGSFGEVH--RMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLY 132
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           G   EG    +  E +   SL  L+     L ++R         +     GL YLH    
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-----LYYLGQALEGLEYLHTR-- 185
Query: 602 LRIIHRDLKASNILLDEELN-PKISDFGMAKIF---GGNQDQADTGRVVGTFGYMSPEYA 657
            RI+H D+KA N+LL  + +   + DFG A      G  +       + GT  +M+PE  
Sbjct: 186 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 244
Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFEDDLTI 694
           M      K D++S   ++L +++G    T +F   L +
Sbjct: 245 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 282

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 113
Query: 592 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 643
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 168
Query: 644 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 169 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 222
Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 223 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 263
Query: 763 PKEPA 767
           P+E A
Sbjct: 264 PQETA 268

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 32/228 (14%)
Query: 465 LQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKASGQGLEE 523
           ++D P +Q  +L            LG+G F         K  Q  AVK +SK      ++
Sbjct: 1   MKDSPFYQHYDLDLK------DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK 54
Query: 524 FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
            +  + +     H N+V+L     +     L+ E +    L          ER+  +K F
Sbjct: 55  EITALKLCEG--HPNIVKLHEVFHDQLHTFLVMELLNGGEL---------FERIKKKKHF 103
Query: 584 NIIEG--ISRGLL----YLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFG 634
           +  E   I R L+    ++H    + ++HRDLK  N+L  +E   L  KI DFG A++  
Sbjct: 104 SETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160
Query: 635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            +     T     T  Y +PE   +  + E  D++S GV+L  ++SG+
Sbjct: 161 PDNQPLKTP--CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 533
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 534 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 152
Query: 592 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 643
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 207
Query: 644 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 208 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 261
Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 262 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 302
Query: 763 PKEPA 767
           P+E A
Sbjct: 303 PQETA 307

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 24/238 (10%)
Query: 469 PLFQF-EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE--- 523
           P  Q  +E+     +F++   +G+G FG V   ++K+ + I A+K L+K       E   
Sbjct: 61  PFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC 120
Query: 524 FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRK 581
           F  E  V+     + +  L     +     L+ +Y     L  LL  F+    E +    
Sbjct: 121 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM---A 177
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD-QA 640
           RF I E +    L +    +L  +HRD+K  N+LLD   + +++DFG       N D   
Sbjct: 178 RFYIGEMV----LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTV 231
Query: 641 DTGRVVGTFGYMSPEY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 693
            +   VGT  Y+SPE   AME   G++  + D +S GV + E++ G   T F+ + L 
Sbjct: 232 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLV 287

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 105/234 (44%), Gaps = 39/234 (16%)
Query: 482 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISKL 534
            ++L   LG+GGFG V+ G RL D  ++A+K + +    G     +      EV ++ K+
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 535 Q----HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDAL-LFDPLKKERLDWRKRFNIIEGI 589
                H  ++RLL      E  ML+ E    R L A  LFD + +       +  + EG 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLE----RPLPAQDLFDYITE-------KGPLGEGP 140
Query: 590 SRGLL------YLHRDSRLRIIHRDLKASNILLDEELN-PKISDFGMAKIFGGNQDQADT 642
           SR           H  SR  ++HRD+K  NIL+D      K+ DFG   +     D+  T
Sbjct: 141 SRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYT 196
Query: 643 GRVVGTFGYMSPEYAMEGRFSE-KSDVFSFGVLLLEIVSGRKNTSFFEDDLTIL 695
               GT  Y  PE+    ++    + V+S G+LL ++V G      FE D  IL
Sbjct: 197 D-FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP---FERDQEIL 246

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 24/238 (10%)
Query: 469 PLFQF-EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE--- 523
           P  Q  +E+     +F++   +G+G FG V   ++K+ + I A+K L+K       E   
Sbjct: 77  PFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC 136
Query: 524 FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRK 581
           F  E  V+     + +  L     +     L+ +Y     L  LL  F+    E +    
Sbjct: 137 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM---A 193
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD-QA 640
           RF I E +    L +    +L  +HRD+K  N+LLD   + +++DFG       N D   
Sbjct: 194 RFYIGEMV----LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTV 247
Query: 641 DTGRVVGTFGYMSPEY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 693
            +   VGT  Y+SPE   AME   G++  + D +S GV + E++ G   T F+ + L 
Sbjct: 248 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLV 303

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 476 LATATNNFQLSS-------KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE---F 524
           ++    NF++ +       +LG+G +G V   R +  GQ +AVKR+ +A+    E+    
Sbjct: 39  ISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLL 97
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRF 583
           M+  + +  +     V   G      +  +  E M + SLD      + K + +      
Sbjct: 98  MDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG 156
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
            I   I + L +LH  S+L +IHRD+K SN+L++     K+ DFG++   G   D     
Sbjct: 157 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDSVAKT 211
Query: 644 RVVGTFGYMSPEYA----MEGRFSEKSDVFSFGVLLLEIV 679
              G   YM+PE       +  +S KSD++S G+ ++E+ 
Sbjct: 212 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 251
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	807
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-148
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-147
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-126
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-91
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-75
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-57
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-49
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-49
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-49
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-48
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-48
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-47
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-47
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-47
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-46
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-46
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-46
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-45
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-45
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-45
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-45
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-45
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-45
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-45
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-45
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-44
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-44
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-44
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-44
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-43
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-43
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-43
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-43
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-43
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-43
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-43
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-43
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-43
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-43
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-42
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-42
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-42
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-42
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-42
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-42
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-42
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-42
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-42
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-42
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-41
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-41
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-41
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-41
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-41
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-41
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-40
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-40
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-39
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-39
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-39
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-36
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-35
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-33
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-33
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-32
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-32
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-31
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-31
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-31
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-31
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-29
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-28
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-27
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-25
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-11
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-10
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	9e-10
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	1e-09
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	1e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-09
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	1e-08
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	1e-08
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	2e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-08
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	9e-08
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	2e-06
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	2e-04
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	4e-06
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	8e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	5e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	9e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	1e-04
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	2e-05
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	2e-05
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	1e-04
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	4e-05
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	8e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  435 bits (1122), Expect = e-148
 Identities = 126/292 (43%), Positives = 177/292 (60%), Gaps = 8/292 (2%)

Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVM 529
           F   EL  A++NF   + LG+GGFG VY GRL DG  +AVKRL +   QG E +F  EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEG 588
           +IS   HRNL+RL G C+   E++L+Y YM N S+ + L +  + +  LDW KR  I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
            +RGL YLH     +IIHRD+KA+NILLDEE    + DFG+AK+         T  V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF----EDDLTILGYAWKLWNE 704
            G+++PEY   G+ SEK+DVF +GV+LLE+++G++         +DD+ +L +   L  E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 705 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 756
            K+ ALVD  L + +++ + + + I V LLC Q    +RP MS VV ML  +
Sbjct: 259 KKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  434 bits (1118), Expect = e-147
 Identities = 102/300 (34%), Positives = 155/300 (51%), Gaps = 18/300 (6%)

Query: 467 DLPLFQFEELATATNNF------QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSK----A 516
               F F EL   TNNF         +K+G+GGFG VY G + +   +AVK+L+      
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69

Query: 517 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER 576
           + +  ++F  E+ V++K QH NLV LLG   +G++  L+Y YMPN SL   L        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 577 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
           L W  R  I +G + G+ +LH +     IHRD+K++NILLDE    KISDFG+A+     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG 696
                T R+VGT  YM+PE  + G  + KSD++SFGV+LLEI++G        +   +L 
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245

Query: 697 YAWKLWNENKIL-ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 755
              ++ +E K +   +D  +++       +     V   C+ E    RP++  V  +L  
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  379 bits (975), Expect = e-126
 Identities = 111/287 (38%), Positives = 163/287 (56%), Gaps = 9/287 (3%)

Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMV 530
               +L  ATNNF     +G G FG VY G L+DG ++A+KR +  S QG+EEF  E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGI 589
           +S  +H +LV L+G C E  E +LIY+YM N +L   L+   L    + W +R  I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGT 648
           +RGL YLH  +   IIHRD+K+ NILLDE   PKI+DFG++K     +Q    T  V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204

Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK--NTSFFEDDLTILGYAWKLWNENK 706
            GY+ PEY ++GR +EKSDV+SFGV+L E++  R     S   + + +  +A +  N  +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264

Query: 707 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 753
           +  +VDP L     + + + +     + C+    +DRP+M  V+  L
Sbjct: 265 LEQIVDPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  289 bits (742), Expect = 1e-91
 Identities = 72/309 (23%), Positives = 120/309 (38%), Gaps = 31/309 (10%)

Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMV 530
              E L   +   QL     +G FG V+  +L   + +AVK       Q   +   EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 531 ISKLQHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 586
           +  ++H N+++ +G    G     +  LI  +    SL     D LK   + W +  +I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL----SDFLKANVVSWNELCHIA 127

Query: 587 EGISRGLLYLHRD-------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
           E ++RGL YLH D        +  I HRD+K+ N+LL   L   I+DFG+A  F   +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 640 ADTGRVVGTFGYMSPEYAMEG-----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTI 694
            DT   VGT  YM+PE              + D+++ G++L E+ S         D+   
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM- 246

Query: 695 LGYAWKLWNENKILAL--------VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNM 746
           L +  ++     +  +          P L +   +   +         C     + R + 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 747 STVVSMLNS 755
             V   +  
Sbjct: 307 GCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  247 bits (631), Expect = 3e-75
 Identities = 72/336 (21%), Positives = 128/336 (38%), Gaps = 44/336 (13%)

Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--V 528
               E +   +N +L   +G+G +G VY G L D + +AVK  S A+ Q    F+NE  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 529 MVISKLQHRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
             +  ++H N+ R +            E +L+ EY PN SL       L     DW    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLX----KYLSLHTSDWVSSC 114

Query: 584 NIIEGISRGLLYLHRD------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN- 636
            +   ++RGL YLH +       +  I HRDL + N+L+  +    ISDFG++    GN 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 637 -----QDQADTGRVVGTFGYMSPEYAME-------GRFSEKSDVFSFGVLLLEIVSGRKN 684
                ++       VGT  YM+PE               ++ D+++ G++  EI     +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 685 TSFFEDDLTI-LGYAWKLWNENKILALVDPFLSE-------SSFQLDMIIRCIHVGLL-- 734
               E      + +  ++ N      +      E        +++ + +        +  
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 735 CVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTE 770
           C  +  + R         +   +      K  + T 
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  211 bits (540), Expect = 1e-62
 Identities = 78/319 (24%), Positives = 150/319 (47%), Gaps = 27/319 (8%)

Query: 456 SATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-- 513
                 T  L        +++     +  +  K+G G FG V+      G ++AVK L  
Sbjct: 12  DYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILME 70

Query: 514 SKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK 573
                + + EF+ EV ++ +L+H N+V  +G   +     ++ EY+   SL  LL     
Sbjct: 71  QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130

Query: 574 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
           +E+LD R+R ++   +++G+ YLH      I+HR+LK+ N+L+D++   K+ DFG++++ 
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189

Query: 634 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 693
                 + +    GT  +M+PE   +   +EKSDV+SFGV+L E+ + ++    +  +L 
Sbjct: 190 ASTFLSSKSA--AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ---PWG-NLN 243

Query: 694 ILGYAWKLWNENKILAL---VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVV 750
                  +  + K L +   ++P ++       +I  C              RP+ +T++
Sbjct: 244 PAQVVAAVGFKCKRLEIPRNLNPQVA------AIIEGCWT-------NEPWKRPSFATIM 290

Query: 751 SMLNSEIRD-LPYPKEPAF 768
            +L   I+  +P P     
Sbjct: 291 DLLRPLIKSAVPPPNRSDL 309

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  206 bits (525), Expect = 2e-60
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
                 LG+G FG       ++ G+ + +K L +   +    F+ EV V+  L+H N+++
Sbjct: 12  LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
            +G   + +    I EY+   +L  ++       +  W +R +  + I+ G+ YLH    
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---S 126

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR------------VVGTF 649
           + IIHRDL + N L+ E  N  ++DFG+A++    + Q +  R            VVG  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 683
            +M+PE      + EK DVFSFG++L EI+    
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  204 bits (520), Expect = 1e-59
 Identities = 73/290 (25%), Positives = 127/290 (43%), Gaps = 30/290 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
              ++   +G+G FG V   + +  +++A+K++   S    + F+ E+  +S++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L G C+      L+ EY    SL  +L               +     S+G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 601 RLRIIHRDLKASNILLDEELN-PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              +IHRDLK  N+LL       KI DFG A     +     T    G+  +M+PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVFEG 177

Query: 660 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFED-DLTILGYAWKLWNEN--KILALVDPFLS 716
             +SEK DVFS+G++L E+++ RK    F++         W + N     ++  +   + 
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234

Query: 717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 766
                  ++ RC         +    RP+M  +V ++   +R  P   EP
Sbjct: 235 S------LMTRCWS-------KDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  201 bits (513), Expect = 3e-59
 Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 48/298 (16%)

Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGLEEFMNEV 528
           F EL        L   +G GGFG VY      G E+AVK       +   Q +E    E 
Sbjct: 6   FAEL-------TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57

Query: 529 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
            + + L+H N++ L G C++     L+ E+     L       L  +R+      N    
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPL----NRVLSGKRIPPDILVNWAVQ 113

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--------KISDFGMAKIFGGNQDQA 640
           I+RG+ YLH ++ + IIHRDLK+SNIL+ +++          KI+DFG+A+       + 
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRT 169

Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK 700
                 G + +M+PE      FS+ SDV+S+GVLL E+++G      F   +  L  A+ 
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV---PFR-GIDGLAVAYG 225

Query: 701 LWNENK---ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 755
           +        I +      ++       ++        C       RP+ + ++  L +
Sbjct: 226 VAMNKLALPIPSTCPEPFAK-------LME------DCWNPDPHSRPSFTNILDQLTT 270

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  200 bits (511), Expect = 1e-58
 Identities = 69/287 (24%), Positives = 135/287 (47%), Gaps = 29/287 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
               +  ++G G FG VY G+     ++AVK L+    + Q L+ F NEV V+ K +H N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           ++  +G      +  ++ ++    SL   L     + + + +K  +I    +RG+ YLH 
Sbjct: 82  ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA 138

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE--- 655
                IIHRDLK++NI L E+   KI DFG+A             ++ G+  +M+PE   
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR---KNTSFFEDDLTILGYAWKLWNENKILALVD 712
                 +S +SDV++FG++L E+++G+    N +  +  + ++G      + +K+ +   
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255

Query: 713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
             +        ++  C+        +   +RP+   +++ +    R+
Sbjct: 256 KRMK------RLMAECLK-------KKRDERPSFPRILAEIEELARE 289

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  197 bits (504), Expect = 1e-57
 Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 37/290 (12%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQG-------LEEFMNEVMVIS 532
           N  +   ++G+GGFG V+ GRL  D   +A+K L     +G        +EF  EV ++S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
            L H N+V+L G         ++ E++P   L   L D  K   + W  +  ++  I+ G
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKIFGGNQDQADTGRVVG 647
           + Y+  +    I+HRDL++ NI L        +  K++DFG+++             ++G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLG 188

Query: 648 TFGYMSPE--YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN 705
            F +M+PE   A E  ++EK+D +SF ++L  I++G      F+ + +     +      
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PFD-EYSYGKIKFINMIRE 244

Query: 706 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 755
           + L        +   +L  +I       LC     K RP+ S +V  L+ 
Sbjct: 245 EGLRP--TIPEDCPPRLRNVIE------LCWSGDPKKRPHFSYIVKELSE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  195 bits (497), Expect = 7e-57
 Identities = 62/286 (21%), Positives = 119/286 (41%), Gaps = 39/286 (13%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL--SKASGQGLEEFMNEVMVISKLQHRN 538
                 +KL +   G ++ GR + G +I VK L     S +   +F  E   +    H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 539 LVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
           ++ +LG C         LI  +MP  SL  +L +      +D  +       ++RG+ +L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFL 127

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H    L I    L + ++++DE++  +IS   +   F        +   +    +++PE 
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178

Query: 657 AMEGR----FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL-- 710
           A++ +        +D++SF VLL E+V+       F  DL+ +    K+  E     +  
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREV---PFA-DLSNMEIGMKVALEGLRPTIPP 234

Query: 711 -VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 755
            + P +S+       +++      +C+ E    RP    +V +L  
Sbjct: 235 GISPHVSK-------LMK------ICMNEDPAKRPKFDMIVPILEK 267

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  185 bits (471), Expect = 5e-53
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 27/232 (11%)

Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--VMVISKLQ 535
           T   +  L   +G+G +G V+ G  + G+ +AVK  S    +  + +  E  +     L+
Sbjct: 5   TVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLR 60

Query: 536 HRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           H N++  +   +          LI  Y    SL    +D L+   LD      I+  I+ 
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIAS 116

Query: 592 GLLYLHRDSRLR-----IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR-- 644
           GL +LH +         I HRDLK+ NIL+ +     I+D G+A +   + +Q D G   
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176

Query: 645 VVGTFGYMSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
            VGT  YM+PE              ++ D+++FG++L E+     +    ED
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  185 bits (472), Expect = 8e-53
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 29/224 (12%)

Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL--SKASGQGLEEFMNEVMV 530
           FE+L       ++   +G+G FG VY GR     E+A++ +   + +   L+ F  EVM 
Sbjct: 32  FEQL-------EIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMA 82

Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
             + +H N+V  +G C+      +I      R+L +++ D   K  LD  K   I + I 
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIV 140

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VVG 647
           +G+ YLH      I+H+DLK+ N+  D      I+DFG+  I G  Q      +     G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNG 196

Query: 648 TFGYMSPE---------YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
              +++PE            +  FS+ SDVF+ G +  E+ +  
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  180 bits (459), Expect = 6e-51
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 27/232 (11%)

Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--VMVISKLQ 535
           T     Q+  ++G+G +G V+ G+ + G+++AVK            +  E  +     ++
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMR 89

Query: 536 HRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           H N++  +   ++G        LI +Y  N SL    +D LK   LD +    +      
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVS 145

Query: 592 GLLYLHRDSRLR-----IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD--TGR 644
           GL +LH +         I HRDLK+ NIL+ +     I+D G+A  F  + ++ D     
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 645 VVGTFGYMSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 690
            VGT  YM PE           +    +D++SFG++L E+     +    E+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (450), Expect = 1e-49
 Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 32/243 (13%)

Query: 468 LPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE 527
           LPL     +A       L   +G+G FG V+ G+ + G+E+AVK  S    +    +  E
Sbjct: 32  LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFRE 84

Query: 528 --VMVISKLQHRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRK 581
             +     L+H N++  +    +         L+ +Y  + SL    FD L +  +    
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEG 140

Query: 582 RFNIIEGISRGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
              +    + GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A      
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200

Query: 637 QDQADTGR--VVGTFGYMSPEYAMEG-------RFSEKSDVFSFGVLLLEIVSGRKNTSF 687
            D  D      VGT  YM+PE  ++           +++D+++ G++  EI         
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259

Query: 688 FED 690
            ED
Sbjct: 260 HED 262

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  175 bits (446), Expect = 3e-49
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 28/290 (9%)

Query: 481 NNFQLSSKLGQGGFGPVY---WGRLKDGQEI--AVKRL-SKASGQGLEEFMNEVMVISKL 534
              +    LG+G FG V    +    DG     AVK L + A  Q    +  E+ ++  L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 535 QHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
            H ++++  GCC +       L+ EY+P  SL     D L +  +   +     + I  G
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEG 146

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFG 650
           + YLH       IHRDL A N+LLD +   KI DFG+AK      +  +         F 
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF- 202

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILA 709
           + +PE   E +F   SDV+SFGV L E+++    + S     L ++G A       ++  
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262

Query: 710 LVDPFLSESSFQLDMIIRC---IH-VGLLCVQELVKDRPNMSTVVSMLNS 755
           L+     E   +L    +C   ++ +   C +     RP    ++ +L +
Sbjct: 263 LL-----ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  175 bits (447), Expect = 9e-49
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 11/204 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRN 538
            +  L  ++G+G FG V+ GRL+ D   +AVK            +F+ E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +VRL+G C + +   ++ E +        L    +  RL  +    ++   + G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE- 230

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEY 656
                 IHRDL A N L+ E+   KISDFGM++        A  G           +PE 
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL--RQVPVKWTAPEA 286

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVS 680
              GR+S +SDV+SFG+LL E  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  173 bits (440), Expect = 2e-48
 Identities = 73/226 (32%), Positives = 114/226 (50%), Gaps = 16/226 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 535
            + +   +LG+G FG V   R        G+ +AVK+L  ++ + L +F  E+ ++  LQ
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 536 HRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           H N+V+  G C     +   LI EY+P  SL   L     KER+D  K       I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGY 651
            YL      R IHRDL   NIL++ E   KI DFG+ K+   +++  +         F +
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF-W 214

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILG 696
            +PE   E +FS  SDV+SFGV+L E+ +   K+ S   + + ++G
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  171 bits (435), Expect = 5e-48
 Identities = 73/226 (32%), Positives = 114/226 (50%), Gaps = 16/226 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 535
            + +   +LG+G FG V   R        G+ +AVK+L  ++ + L +F  E+ ++  LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 536 HRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           H N+V+  G C     +   LI EY+P  SL   L     KER+D  K       I +G+
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGY 651
            YL      R IHRDL   NIL++ E   KI DFG+ K+   +++  +         F +
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-W 183

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILG 696
            +PE   E +FS  SDV+SFGV+L E+ +   K+ S   + + ++G
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  171 bits (435), Expect = 1e-47
 Identities = 83/304 (27%), Positives = 138/304 (45%), Gaps = 25/304 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 535
            + +  S+LG+G FG V   R        G  +AVK+L  +      +F  E+ ++  L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 536 HRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
              +V+  G       +   L+ EY+P+  L   L     + RLD  +       I +G+
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGY 651
            YL      R +HRDL A NIL++ E + KI+DFG+AK+   ++D            F +
Sbjct: 141 EYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-W 196

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILAL 710
            +PE   +  FS +SDV+SFGV+L E+ +   K+ S   + L ++G    +   +++L L
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256

Query: 711 VDPFLSESSFQLDMIIRC---IH-VGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 766
           +     E   +L     C   +H +  LC     +DRP+ S +   L+         +  
Sbjct: 257 L-----EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH 311

Query: 767 AFTE 770
           AFT 
Sbjct: 312 AFTA 315

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  168 bits (428), Expect = 5e-47
 Identities = 70/293 (23%), Positives = 133/293 (45%), Gaps = 26/293 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRL-SKASGQGLEEFMNEVMVISKL 534
              +    LG+G FG V   R        G+++AVK L  ++ G  + +   E+ ++  L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 535 QHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
            H N+V+  G C E       LI E++P+ SL   L  P  K +++ +++      I +G
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFG 650
           + YL      + +HRDL A N+L++ E   KI DFG+ K    +++       R    F 
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILA 709
           + +PE  M+ +F   SDV+SFGV L E+++    ++S     L ++G         +++ 
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254

Query: 710 LVDPFLSESSFQLDMIIRC---IH-VGLLCVQELVKDRPNMSTVVSMLNSEIR 758
            +     +   +L     C   ++ +   C +    +R +   ++    + ++
Sbjct: 255 TL-----KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  166 bits (424), Expect = 9e-47
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 12/206 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
               L  +LG G FG V  G+ K   ++AVK + K      +EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +  G C +     ++ EY+ N  L   L      + L+  +   +   +  G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAM 658
             + IHRDL A N L+D +L  K+SDFGM +    +Q  +  G     F     +PE   
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG---TKFPVKWSAPEVFH 178

Query: 659 EGRFSEKSDVFSFGVLLLEIVS-GRK 683
             ++S KSDV++FG+L+ E+ S G+ 
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKM 204

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  167 bits (425), Expect = 1e-46
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 11/202 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            +     +LG G FG V +G+ +   ++A+K + K      +EF+ E  V+  L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L G C +     +I EYM N  L   L +   + R   ++   + + +   + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYL---E 137

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAM 658
             + +HRDL A N L++++   K+SDFG+++    ++  +  G     F      PE  M
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG---SKFPVRWSPPEVLM 194

Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
             +FS KSD+++FGVL+ EI S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  166 bits (422), Expect = 2e-46
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 12/206 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
           +      ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L G C+E     L+ E+M +  L   L    ++          +   +  G+ YL    
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL---E 121

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAM 658
              +IHRDL A N L+ E    K+SDFGM +    +Q  + TG     F     SPE   
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG---TKFPVKWASPEVFS 178

Query: 659 EGRFSEKSDVFSFGVLLLEIVS-GRK 683
             R+S KSDV+SFGVL+ E+ S G+ 
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKI 204

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  166 bits (422), Expect = 7e-46
 Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 47/231 (20%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRLSKASGQGLEEFMNEVMVISKL 534
            +  L  +LG+G FG V+     +         +AVK L +AS    ++F  E  +++ L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL------------FDPLKKERLDWRKR 582
           QH+++VR  G C EG   ++++EYM +  L+  L             + +    L   + 
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
             +   ++ G++YL   + L  +HRDL   N L+ + L  KI DFGM+            
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------------ 205

Query: 643 GRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            R + +  Y             M PE  +  +F+ +SDV+SFGV+L EI +
Sbjct: 206 -RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  164 bits (418), Expect = 1e-45
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 48/232 (20%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSKASGQGLEEFMNEVMVISKL 534
            +  L  +LG+G FG V+     +         +AVK L   +    ++F  E  +++ L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLDWRK 581
           QH ++V+  G C +G+  ++++EYM +  L+  L                  K  L   +
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
             +I   I+ G++YL   +    +HRDL   N L+   L  KI DFGM+           
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS----------- 180

Query: 642 TGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             R V +  Y             M PE  M  +F+ +SDV+SFGV+L EI +
Sbjct: 181 --RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  164 bits (417), Expect = 1e-45
 Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 11/203 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL   
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYA 657
            +   IHRDL A N L+ E    K++DFG++++  G+   A  G     F     +PE  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG---AKFPIKWTAPESL 184

Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
              +FS KSDV++FGVLL EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  168 bits (428), Expect = 2e-45
 Identities = 68/202 (33%), Positives = 103/202 (50%), Gaps = 11/202 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLG G FG V+        ++AVK + K     +E F+ E  V+  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L     + E   +I E+M   SL   L    +  +    K  +    I+ G+ ++    
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAM 658
           +   IHRDL+A+NIL+   L  KI+DFG+A++   N+  A  G     F     +PE   
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG---AKFPIKWTAPEAIN 358

Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
            G F+ KSDV+SFG+LL+EIV+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  169 bits (431), Expect = 2e-45
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 7/201 (3%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL   
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
            +   IHR+L A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393

Query: 660 GRFSEKSDVFSFGVLLLEIVS 680
            +FS KSDV++FGVLL EI +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  164 bits (418), Expect = 2e-45
 Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 17/212 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSK-ASGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G      E     +A+K L +  S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+      LI + MP   L   + +   K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYM 652
           YL      R++HRDL A N+L+    + KI+DFG+AK+ G  +    A+ G+V     +M
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 683
           + E  +   ++ +SDV+S+GV + E+++ G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  164 bits (418), Expect = 2e-45
 Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 14/211 (6%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRL-SKASGQGLEEFMNEVMVISKLQ 535
           +   +   +G G  G V +GRL+    +++  A+K L +  + +   +F++E  ++ +  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H N++RL G    G   M++ EYM N SLD  L       +    +   ++ G+  G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRY 166

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MS 653
           L   S L  +HRDL A N+L+D  L  K+SDFG++++   + D A T    G       +
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-TTGGKIPIRWTA 222

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 683
           PE      FS  SDV+SFGV++ E+++ G +
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  163 bits (414), Expect = 3e-45
 Identities = 72/202 (35%), Positives = 107/202 (52%), Gaps = 11/202 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
              +L  +LG G FG V+ G      ++AVK L K      + F+ E  ++ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           RL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+ ++    
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---E 126

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAM 658
               IHRDL+A+NIL+ + L+ KI+DFG+A++    +D   T R    F     +PE   
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAIN 183

Query: 659 EGRFSEKSDVFSFGVLLLEIVS 680
            G F+ KSDV+SFG+LL EIV+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  163 bits (414), Expect = 3e-45
 Identities = 69/233 (29%), Positives = 106/233 (45%), Gaps = 49/233 (21%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
           +  +   +LG+  FG VY G L         Q +A+K L   A G   EEF +E M+ ++
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLDWR 580
           LQH N+V LLG   + +   +I+ Y  +  L   L              D   K  L+  
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
              +++  I+ G+ YL   S   ++H+DL   N+L+ ++LN KISD G+           
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF---------- 175

Query: 641 DTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
              R V    Y             M+PE  M G+FS  SD++S+GV+L E+ S
Sbjct: 176 ---REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  163 bits (415), Expect = 6e-45
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSK-ASGQGLEEFMNEVMVISKL 534
           +       +G G FG VY G LK         +A+K L    + +   +F+ E  ++ + 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            H N++RL G   + +  M+I EYM N +LD  L +  K       +   ++ GI+ G+ 
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 161

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--M 652
           YL   + +  +HRDL A NIL++  L  K+SDFG++++   + + A      G       
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-ATYTTSGGKIPIRWT 217

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 683
           +PE     +F+  SDV+SFG+++ E+++ G +
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  163 bits (414), Expect = 2e-44
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 14/211 (6%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQ 535
            N  +   +G G FG V  GRLK    +EI  A+K L    + +   +F+ E  ++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H N++RL G   + +  M++ EYM N SLD+ L       +    +   ++ GI+ G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKY 162

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MS 653
           L   S +  +HRDL A NIL++  L  K+SDFG+ ++   + + A T    G       S
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-TRGGKIPIRWTS 218

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 683
           PE     +F+  SDV+S+G++L E++S G +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  165 bits (419), Expect = 3e-44
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
              +L   +G+G FG V  G  + G ++AVK +   +    + F+ E  V+++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249

Query: 541 RLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           +LLG  VE +    ++ EYM   SL   L     +  L           +   + YL   
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYA 657
                +HRDL A N+L+ E+   K+SDFG+ K               G       +PE  
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT---GKLPVKWTAPEAL 358

Query: 658 MEGRFSEKSDVFSFGVLLLEIVS 680
            E +FS KSDV+SFG+LL EI S
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS 381

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  159 bits (404), Expect = 5e-44
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
              +L   +G+G FG V  G  + G ++AVK +   +    + F+ E  V+++L+H NLV
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 77

Query: 541 RLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           +LLG  VE +    ++ EYM   SL   L     +  L           +   + YL   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYA 657
                +HRDL A N+L+ E+   K+SDFG+ K               G       +PE  
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT---GKLPVKWTAPEAL 186

Query: 658 MEGRFSEKSDVFSFGVLLLEIVS-GRK 683
            E +FS KSDV+SFG+LL EI S GR 
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRV 213

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  160 bits (407), Expect = 7e-44
 Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 43/227 (18%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRLSK-ASGQGLEEFMNEVMVISK 533
               +S +LGQG FG VY G  K   +      +A+K +++ AS +   EF+NE  V+ +
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDWRKRFNII 586
               ++VRLLG   +G+  ++I E M         RSL   + +          K   + 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
             I+ G+ YL   +  + +HRDL A N ++ E+   KI DFGM              R +
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMT-------------RDI 188

Query: 647 GTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
               Y             MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  158 bits (403), Expect = 1e-43
 Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 17/213 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRL---SKASGQGLEEFMNEVMVISK 533
            + +L  KLG G FG V  G      G+ +  AVK L     +  + +++F+ EV  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           L HRNL+RL G  +      ++ E  P  SL   L     +              ++ G+
Sbjct: 78  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGM 134

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY-- 651
            YL      R IHRDL A N+LL      KI DFG+ +    N D     +      +  
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAW 190

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 683
            +PE      FS  SD + FGV L E+ + G++
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  158 bits (403), Expect = 1e-43
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 21/209 (10%)

Query: 484 QLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 538
             +  +G+G FG VY G L D        AVK L++      + +F+ E +++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 539 LVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++ LLG C+  E   +++  YM +  L   + +         +        +++G+ YL 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL- 144

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG------Y 651
             +  + +HRDL A N +LDE+   K++DFG+A+         +   V    G      +
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAKLPVKW 198

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           M+ E     +F+ KSDV+SFGVLL E+++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  158 bits (402), Expect = 2e-43
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 484 QLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 538
                +G+G FG VY G   D  +     A+K LS+    Q +E F+ E +++  L H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 539 LVRLLGCCVEGEE-KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++ L+G  +  E    ++  YM +  L   +  P  +     +   +    ++RG+ YL 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL- 140

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPE 655
             +  + +HRDL A N +LDE    K++DFG+A+     +  +            + + E
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVS 680
                RF+ KSDV+SFGVLL E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  163 bits (415), Expect = 3e-43
 Identities = 71/200 (35%), Positives = 108/200 (54%), Gaps = 7/200 (3%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L     E E   ++ EYM   SL   L      + L   +  ++   I+ G+ Y+    
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
           R+  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439

Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           RF+ KSDV+SFG+LL E+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  158 bits (402), Expect = 4e-43
 Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 17/212 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRL-SKASGQGLEEFMNEVMVISKL 534
             F+    LG G FG VY G      E     +A+K L    S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            + ++ RLLG C+      LI + MP   L   + +   K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYM 652
           YL      R++HRDL A N+L+    + KI+DFG+AK+ G  +    A+ G+V     +M
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 683
           + E  +   ++ +SDV+S+GV + E+++ G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  161 bits (410), Expect = 4e-43
 Identities = 71/200 (35%), Positives = 108/200 (54%), Gaps = 7/200 (3%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L     E E   ++ EYM   SL   L      + L   +  ++   I+ G+ Y+    
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
           R+  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356

Query: 661 RFSEKSDVFSFGVLLLEIVS 680
           RF+ KSDV+SFG+LL E+ +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  157 bits (400), Expect = 4e-43
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 43/227 (18%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSK--ASGQGLEEFMNEVMVISKL 534
           N   L   LG+G FG V  G LK        +AVK +    +S + +EEF++E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 535 QHRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNII 586
            H N++RLLG C+E       + M+I  +M    L   L         + +  +     +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
             I+ G+ YL   S    +HRDL A N +L +++   ++DFG++             + +
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLS-------------KKI 197

Query: 647 GTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
            +  Y             ++ E   +  ++ KSDV++FGV + EI +
Sbjct: 198 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  157 bits (398), Expect = 5e-43
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 14/203 (6%)

Query: 488 KLGQGGFGPVYWGRLKDGQE---IAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           +LG G FG V  G  +  ++   +A+K L +       EE M E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           G C + E  ML+ E      L   L    K+E +       ++  +S G+ YL       
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEGR 661
            +HRDL A N+LL      KISDFG++K  G + D   T R  G +   + +PE     +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRK 189

Query: 662 FSEKSDVFSFGVLLLEIVS-GRK 683
           FS +SDV+S+GV + E +S G+K
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQK 212

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  158 bits (401), Expect = 5e-43
 Identities = 72/219 (32%), Positives = 101/219 (46%), Gaps = 27/219 (12%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
            N  L   LG G FG VY G++          ++AVK L +  S Q   +F+ E ++ISK
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGI 589
             H+N+VR +G  ++   + ++ E M    L + L      P +   L      ++   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVV 646
           + G  YL        IHRD+ A N LL         KI DFGMA+    +  +A   R  
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-K 201

Query: 647 GTFGY-----MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           G         M PE  MEG F+ K+D +SFGVLL EI S
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  156 bits (397), Expect = 6e-43
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 43/228 (18%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASGQGLEEFMNEVMVIS 532
            +   +  LGQG F  ++ G  ++          E+ +K L KA     E F     ++S
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           KL H++LV   G CV G+E +L+ E++   SLD  L     K  ++   +  + + ++  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAA 125

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNP--------KISDFGMAKIFGGNQDQADTGR 644
           + +L       +IH ++ A NILL  E +         K+SD G++              
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------------I 169

Query: 645 VVGTFGY-------MSPEYAMEGR-FSEKSDVFSFGVLLLEIVS-GRK 683
            V            + PE     +  +  +D +SFG  L EI S G K
Sbjct: 170 TVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  157 bits (399), Expect = 1e-42
 Identities = 70/223 (31%), Positives = 103/223 (46%), Gaps = 34/223 (15%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE---IAVKRL-SKASGQGLEEFMNEVMVISKL-Q 535
           N+ +    +G+G FG V   R+K        A+KR+   AS     +F  E+ V+ KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------FDPLKKERLDWRKRFNIIE- 587
           H N++ LLG C       L  EY P+ +L   L        DP            +  + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 588 -----GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
                 ++RG+ YL   S+ + IHRDL A NIL+ E    KI+DFG+++     Q+    
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY-- 195

Query: 643 GRVVGTFG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             V  T G     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 196 --VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  157 bits (400), Expect = 1e-42
 Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 41/266 (15%)

Query: 448 RKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDG-- 505
             E++      N    ++  L   +   L    NN +    +G+G FG V+  R      
Sbjct: 14  PSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLP 73

Query: 506 ----QEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560
                 +AVK L  +AS     +F  E  ++++  + N+V+LLG C  G+   L++EYM 
Sbjct: 74  YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133

Query: 561 NRSLDALL---------------------FDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
              L+  L                             L   ++  I   ++ G+ YL   
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--- 190

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY-----MSP 654
           S  + +HRDL   N L+ E +  KI+DFG+++    N   AD  +            M P
Sbjct: 191 SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NIYSADYYK-ADGNDAIPIRWMPP 245

Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVS 680
           E     R++ +SDV+++GV+L EI S
Sbjct: 246 ESIFYNRYTTESDVWAYGVVLWEIFS 271

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  157 bits (398), Expect = 1e-42
 Identities = 59/249 (23%), Positives = 107/249 (42%), Gaps = 44/249 (17%)

Query: 460 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSK 515
           ++++ + D    + E++      F L   LG+G FG V   +LK       ++AVK L  
Sbjct: 2   LDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61

Query: 516 --ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK------MLIYEYMPNRSLDAL 567
              +   +EEF+ E   + +  H ++ +L+G  +    K      M+I  +M +  L A 
Sbjct: 62  DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121

Query: 568 LFD---PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624
           L           L  +     +  I+ G+ YL   S    IHRDL A N +L E++   +
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCV 178

Query: 625 SDFGMAKIFGGNQDQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSF 671
           +DFG++             R + +  Y             ++ E   +  ++  SDV++F
Sbjct: 179 ADFGLS-------------RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225

Query: 672 GVLLLEIVS 680
           GV + EI++
Sbjct: 226 GVTMWEIMT 234

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  155 bits (394), Expect = 1e-42
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 17/211 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQ 535
            +  L+  LG+G FG VY G      G++I  AVK   K  +    E+FM+E +++  L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H ++V+L+G   E E   +I E  P   L   L     K  L           I + + Y
Sbjct: 72  HPHIVKLIGII-EEEPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAY 128

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMS 653
           L     +  +HRD+   NIL+      K+ DFG+++     +D+      V      +MS
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIKWMS 182

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 683
           PE     RF+  SDV+ F V + EI+S G++
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  155 bits (394), Expect = 2e-42
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 20/206 (9%)

Query: 488 KLGQGGFGPVYWGRLKDG---QEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRL 542
           +LG G FG V  G  +     + +AVK L          +E + E  V+ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL      
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTF--GYMSPEYAM 658
             +HRDL A N+LL  +   KISDFG++K    +++  +A T    G +   + +PE   
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH---GKWPVKWYAPECIN 193

Query: 659 EGRFSEKSDVFSFGVLLLEIVS-GRK 683
             +FS KSDV+SFGVL+ E  S G+K
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  157 bits (400), Expect = 2e-42
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 21/209 (10%)

Query: 484 QLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 538
             +  +G+G FG VY G L D        AVK L++      + +F+ E +++    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 539 LVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++ LLG C+  E   +++  YM +  L   + +         +        +++G+ +L 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL- 208

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFG-----Y 651
             +  + +HRDL A N +LDE+   K++DFG+A+ ++    D                 +
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG----AKLPVKW 262

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           M+ E     +F+ KSDV+SFGVLL E+++
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  157 bits (399), Expect = 2e-42
 Identities = 72/219 (32%), Positives = 101/219 (46%), Gaps = 27/219 (12%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
            N  L   LG G FG VY G++          ++AVK L +  S Q   +F+ E ++ISK
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGI 589
             H+N+VR +G  ++   + ++ E M    L + L      P +   L      ++   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVV 646
           + G  YL        IHRD+ A N LL         KI DFGMA+    +  +A   R  
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-K 242

Query: 647 GTFGY-----MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           G         M PE  MEG F+ K+D +SFGVLL EI S
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  156 bits (396), Expect = 2e-42
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 17/212 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSKASG-QGLEEFMNEVMVISKL 534
              +    LG G FG V+ G      E     + +K +   SG Q  +   + ++ I  L
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            H ++VRLLG C  G    L+ +Y+P  SL   +     +  L  +   N    I++G+ 
Sbjct: 73  DHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMY 129

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYM 652
           YL       ++HR+L A N+LL      +++DFG+A +   +         +      +M
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT--PIKWM 184

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 683
           + E    G+++ +SDV+S+GV + E+++ G +
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  154 bits (391), Expect = 4e-42
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 17/211 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQ 535
              +L   +G+G FG V+ G     +   +  A+K      S    E+F+ E + + +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H ++V+L+G   E     +I E      L + L    +K  LD          +S  L Y
Sbjct: 75  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 131

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMS 653
           L      R +HRD+ A N+L+      K+ DFG+++     +D        G     +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMA 185

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 683
           PE     RF+  SDV+ FGV + EI+  G K
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  154 bits (392), Expect = 8e-42
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 52/236 (22%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRL-SKASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V                  +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A       
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA------- 204

Query: 638 DQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                 R +    Y             M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 205 ------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  155 bits (394), Expect = 1e-41
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 52/236 (22%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRL-SKASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V                  +AVK L   A+ + L + ++E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A       
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA------- 250

Query: 638 DQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                 R +    Y             M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 251 ------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  153 bits (390), Expect = 2e-41
 Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 24/220 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRL-SKASGQGLEEFMNEVMVISK 533
           NN Q    LG G FG V         +      +AVK L S A     E  M+E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPN-----------RSLDALLFDPLKKERLDWRK 581
           L QH N+V LLG C  G   ++I EY              R L+      +       R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQA 640
             +    +++G+ +L   +    IHRD+ A N+LL      KI DFG+A  I   +    
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                +    +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 223 KGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  153 bits (388), Expect = 2e-41
 Identities = 63/241 (26%), Positives = 97/241 (40%), Gaps = 57/241 (23%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRL-SKASGQGLEEFMNEVMVISK 533
            N  L   LG+G FG V                +AVK L   AS   L + ++E  V+ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDWRKRFNII 586
           + H ++++L G C +    +LI EY          R    +    L           +  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 587 EG--------------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
           +               IS+G+ YL   + ++++HRDL A NIL+ E    KISDFG++  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS-- 197

Query: 633 FGGNQDQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIV 679
                      R V                  M+ E   +  ++ +SDV+SFGVLL EIV
Sbjct: 198 -----------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

Query: 680 S 680
           +
Sbjct: 247 T 247

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  154 bits (390), Expect = 2e-41
 Identities = 50/205 (24%), Positives = 99/205 (48%), Gaps = 9/205 (4%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHR 537
             +    K+G+G FG     +  +DG++  +K   +S+ S +  EE   EV V++ ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V+      E     ++ +Y     L   + +  K       +  +    I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
                +I+HRD+K+ NI L ++   ++ DFG+A++     + A     +GT  Y+SPE  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGR 682
               ++ KSD+++ G +L E+ + +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  152 bits (386), Expect = 3e-41
 Identities = 69/316 (21%), Positives = 122/316 (38%), Gaps = 48/316 (15%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 538
            +F+    LG+GGFG V+  + K D    A+KR+         E+ M EV  ++KL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 539 LVRLLGCCVEGEE---------KMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNII 586
           +VR     +E            K+ +Y   +     +L   +      E  +     +I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV- 645
             I+  + +LH      ++HRDLK SNI    +   K+ DFG+      ++++       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 646 ---------VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG 696
                    VGT  YMSPE      +S K D+FS G++L E++       F      +  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMERVR- 235

Query: 697 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 756
                    K      P  ++      ++++     +L       +RP    +   + + 
Sbjct: 236 -TLTDVRNLKF----PPLFTQKYPCEYVMVQ----DMLSPSP--MERPEAINI---IENA 281

Query: 757 -IRDLPYPKEPAFTER 771
              DL +P +    +R
Sbjct: 282 VFEDLDFPGKTVLRQR 297

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  152 bits (385), Expect = 5e-41
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRL---SKASGQGLEEFMNEVMVISKLQH 536
            NF++  K+G+G F  VY    L DG  +A+K++        +   + + E+ ++ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 590
            N+++     +E  E  ++ E      L  ++     K     ++             + 
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTVWKYFVQLC 146

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
             L ++H     R++HRD+K +N+ +      K+ D G+ + F      A +  +VGT  
Sbjct: 147 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 201

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           YMSPE   E  ++ KSD++S G LL E+ + +
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  151 bits (384), Expect = 6e-41
 Identities = 63/236 (26%), Positives = 89/236 (37%), Gaps = 52/236 (22%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRL-SKASGQGLEEFMNEVMVISK 533
           N       LG G FG V         +      +AVK L   A     E  M+E+ V+S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL---------------FDPLKKERL 577
           L  H N+V LLG C  G   ++I EY     L   L                    +  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
           D     +    +++G+ +L   +    IHRDL A NILL      KI DFG+A       
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA------- 192

Query: 638 DQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                 R +                  M+PE      ++ +SDV+S+G+ L E+ S
Sbjct: 193 ------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  158 bits (401), Expect = 7e-41
 Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 14/203 (6%)

Query: 488 KLGQGGFGPVYWGRLKDGQE---IAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
           +LG G FG V  G  +  ++   +A+K L         EE M E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
           G C + E  ML+ E      L   L    K+E +       ++  +S G+ YL       
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAMEGR 661
            +HR+L A N+LL      KISDFG++K   G  D   T R  G +     +PE     +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRK 515

Query: 662 FSEKSDVFSFGVLLLEIVS-GRK 683
           FS +SDV+S+GV + E +S G+K
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK 538

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  152 bits (386), Expect = 2e-40
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 52/236 (22%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRL-SKASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V                 ++AVK L S A+ + L + ++E+ ++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-------------DALLFDPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L              +       +E+L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
             +   +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A       
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA------- 238

Query: 638 DQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                 R +    Y             M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 239 ------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  149 bits (379), Expect = 4e-40
 Identities = 65/235 (27%), Positives = 98/235 (41%), Gaps = 51/235 (21%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V              + +AVK L   A+       M+E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 534 L-QHRNLVRLLGCC-VEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLD 578
           +  H N+V LLG C   G   M+I E+    +L   L              + L K+ L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
                     +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A        
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 195

Query: 639 QADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
                R +                  M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 196 -----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  147 bits (373), Expect = 1e-39
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 30/231 (12%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            +F+    +G GGFG V+  +   DG+   +KR+   +    E+   EV  ++KL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 540 VRLLGCCVEGEEKM----------------LIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
           V   GC    +                   +  E+    +L+  + +  + E+LD     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
            + E I++G+ Y+H     ++I+RDLK SNI L +    KI DFG+      +  +    
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--- 179

Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTI 694
           R  GT  YMSPE      + ++ D+++ G++L E++      + FE     
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--TAFETSKFF 228

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  154 bits (391), Expect = 2e-39
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 16/207 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRL-SKASGQGLEEFMNEVMVISKLQ 535
              +L   +G+G FG V+ G     +   +  A+K   +  S    E+F+ E + + +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H ++V+L+G   E     +I E      L + L    +K  LD          +S  L Y
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 506

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMS 653
           L      R +HRD+ A N+L+      K+ DFG+++     +D        G     +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMA 560

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVS 680
           PE     RF+  SDV+ FGV + EI+ 
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  146 bits (370), Expect = 2e-39
 Identities = 67/286 (23%), Positives = 122/286 (42%), Gaps = 37/286 (12%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHR 537
            ++++   +G G +G     R   DG+ +  K       +    +  ++EV ++ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 538 NLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGI 589
           N+VR     ++     L  + EY     L +++      +    R+         ++  +
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQL 120

Query: 590 SRGLLYLH--RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
           +  L   H   D    ++HRDLK +N+ LD + N K+ DFG+A+I   +   A T   VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVG 178

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI 707
           T  YMSPE      ++EKSD++S G LL E+ +      F       L          KI
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP--PFTAFSQKELA--------GKI 228

Query: 708 LALVDPFLSES-SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM 752
                  +    S +L+ II      +L +++    RP++  ++  
Sbjct: 229 REGKFRRIPYRYSDELNEIIT----RMLNLKD--YHRPSVEEILEN 268

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  147 bits (374), Expect = 3e-39
 Identities = 63/241 (26%), Positives = 96/241 (39%), Gaps = 57/241 (23%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRL-SKASGQGLEEFMNEVMVISK 533
            N +    LG G FG V         +      +AVK L  KA     E  M+E+ ++++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSL--------DALLFDPLKKERLDWRKRFN 584
           L  H N+V LLG C       LI+EY     L        +    D ++ E     +   
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 585 IIEG------------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
            +              +++G+ +L        +HRDL A N+L+      KI DFG+A  
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA-- 219

Query: 633 FGGNQDQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIV 679
                      R + +                M+PE   EG ++ KSDV+S+G+LL EI 
Sbjct: 220 -----------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

Query: 680 S 680
           S
Sbjct: 269 S 269

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  146 bits (370), Expect = 4e-39
 Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 37/231 (16%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
            ++F+  + LGQG FG V   R   D +  A+K++     + L   ++EVM+++ L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 539 LVRLLGCCVEG----------EEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRF-- 583
           +VR     +E           ++K  ++   EY  N +L    +D +  E L+ ++    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119

Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
            +   I   L Y+H      IIHRDLK  NI +DE  N KI DFG+AK    + D     
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 644 R------------VVGTFGYMSPE-YAMEGRFSEKSDVFSFGVLLLEIVSG 681
                         +GT  Y++ E     G ++EK D++S G++  E++  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  146 bits (370), Expect = 4e-39
 Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 11/199 (5%)

Query: 489 LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
           LG+G +G VY GR L +   IA+K + +   +  +    E+ +   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 548 EGEEKMLIY-EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
           E    + I+ E +P  SL ALL       + + +      + I  GL YLH +   +I+H
Sbjct: 90  E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 607 RDLKASNILLDEEL-NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR--FS 663
           RD+K  N+L++      KISDFG +K   G     +T    GT  YM+PE   +G   + 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYG 203

Query: 664 EKSDVFSFGVLLLEIVSGR 682
           + +D++S G  ++E+ +G+
Sbjct: 204 KAADIWSLGCTIIEMATGK 222

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  144 bits (366), Expect = 2e-38
 Identities = 68/309 (22%), Positives = 119/309 (38%), Gaps = 50/309 (16%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
           ++    KLG+GGF  V     L DG   A+KR+     Q  EE   E  +     H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 541 RLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 590
           RL+  C+          L+  +    +L    ++ +++   D            ++ GI 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIER-LKDKGNFLTEDQILWLLLGIC 144

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV---- 646
           RGL  +H        HRDLK +NILL +E  P + D G       + + +     +    
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201

Query: 647 ---GTFGYMSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY 697
               T  Y +PE      + +     E++DV+S G +L  ++ G     +          
Sbjct: 202 AQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGE--GPYDMVFQKGDSV 256

Query: 698 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI 757
           A  + N+  I     P     S  L  ++      ++ V      RP++  ++S L   +
Sbjct: 257 ALAVQNQLSI-----PQSPRHSSALWQLLN----SMMTVD--PHQRPHIPLLLSQL-EAL 304

Query: 758 RDLPYPKEP 766
           +  P P + 
Sbjct: 305 QP-PAPGQH 312

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  142 bits (360), Expect = 6e-38
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
           ++G+G F  VY G   +   E+A    +  K +    + F  E  ++  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 545 CCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
                 +      L+ E M + +L   L    + + +  +   +    I +GL +LH   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 601 RLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
              IIHRDLK  NI +     + KI D G+A +   +  +A    V+GT  +M+PE   E
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEE 204

Query: 660 GRFSEKSDVFSFGVLLLEIVSGR 682
             + E  DV++FG+ +LE+ +  
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  141 bits (357), Expect = 2e-37
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 18/208 (8%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL-QHR 537
           +FQ  S+LG G +G V+  R K DG+  AVKR        +     + EV    K+ QH 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE--RLDWRKRFNIIEGISRGLLY 595
             VRL     EG    L  E          L    +     L   + +  +      L +
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-----GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           LH      ++H D+K +NI L      K+ DFG+     G     +     G   YM+PE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QEGDPRYMAPE 226

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGRK 683
             ++G +   +DVFS G+ +LE+    +
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNME 253

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  140 bits (355), Expect = 5e-37
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 23/225 (10%)

Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR--LSKASGQGLEEFMNEVMV 530
           F+ ++     + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79

Query: 531 ISKLQHRNL--VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
           ++KLQ  +   +RL    +  +   ++ E   N  L++ L    KK+ +D  +R +  + 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKN 135

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           +   +  +H+     I+H DLK +N L+ +    K+ DFG+A     +         VGT
Sbjct: 136 MLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 649 FGYMSPE-----------YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
             YM PE              + + S KSDV+S G +L  +  G+
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  139 bits (351), Expect = 3e-36
 Identities = 58/249 (23%), Positives = 104/249 (41%), Gaps = 23/249 (9%)

Query: 442 WRWIAKRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR 501
           W   + + + +   +  N   +  + L    +E      +      ++G+G FG V+  +
Sbjct: 20  WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREE-VHWMTHQPRVGRGSFGEVHRMK 78

Query: 502 -LKDGQEIAVKRLSKASGQGLEEF-MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559
             + G + AVK++       LE F + E++  + L    +V L G   EG    +  E +
Sbjct: 79  DKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132

Query: 560 PNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617
              SL  L+     L ++R         +     GL YLH     RI+H D+KA N+LL 
Sbjct: 133 EGGSLGQLIKQMGCLPEDRAL-----YYLGQALEGLEYLHTR---RILHGDVKADNVLLS 184

Query: 618 EELNP-KISDFGMAKIFGGNQDQADTGR---VVGTFGYMSPEYAMEGRFSEKSDVFSFGV 673
            + +   + DFG A     +           + GT  +M+PE  M      K D++S   
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 244

Query: 674 LLLEIVSGR 682
           ++L +++G 
Sbjct: 245 MMLHMLNGC 253

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (353), Expect = 4e-36
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 23/217 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 538
             + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 539 L--VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
              +RL    +  +   ++ E   N  L++ L    KK+ +D  +R +  + +   +  +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 171

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE- 655
           H+     I+H DLK +N L+ +    K+ DFG+A     +         VG   YM PE 
Sbjct: 172 HQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227

Query: 656 ----------YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                        + + S KSDV+S G +L  +  G+
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  138 bits (350), Expect = 5e-36
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 23/217 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRN 538
             + +  ++G GG   V+    +  Q  A+K ++   A  Q L+ + NE+  ++KLQ  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 539 L--VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
              +RL    +  +   ++ E   N  L++ L    KK+ +D  +R +  + +   +  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE- 655
           H+     I+H DLK +N L+ +    K+ DFG+A     +         VGT  YM PE 
Sbjct: 125 HQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 656 ----------YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                        + + S KSDV+S G +L  +  G+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  136 bits (345), Expect = 7e-36
 Identities = 56/200 (28%), Positives = 106/200 (53%), Gaps = 10/200 (5%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           +    K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
            L   + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
            ++IHRD+K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE      
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192

Query: 662 FSEKSDVFSFGVLLLEIVSG 681
           +  K D++S G++ +E++ G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  135 bits (343), Expect = 2e-35
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 10/200 (5%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
                K+G+G  G V   R    G+++AVK +     Q  E   NEV+++   QH N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           +    + GEE  ++ E++   +L     D + + RL+  +   + E + + L YLH    
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
             +IHRD+K+ +ILL  +   K+SDFG       +  +  +  +VGT  +M+PE      
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217

Query: 662 FSEKSDVFSFGVLLLEIVSG 681
           ++ + D++S G++++E+V G
Sbjct: 218 YATEVDIWSLGIMVIEMVDG 237

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  138 bits (349), Expect = 3e-35
 Identities = 60/265 (22%), Positives = 108/265 (40%), Gaps = 34/265 (12%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLV 540
           +F     LG G  G + +  + D +++AVKR+        +    EV ++ +  +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVI 81

Query: 541 RLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLY 595
           R    C E +++   Y   E        A L + +  K       +   +++  + GL +
Sbjct: 82  RYF--CTE-KDRQFQYIAIELCA-----ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133

Query: 596 LHRDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKIFGGNQD-QADTGRVVGTF 649
           LH    L I+HRDLK  NIL+       ++   ISDFG+ K     +   +    V GT 
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 650 GYMSPEY---AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK 706
           G+++PE      +   +   D+FS G +   ++S   +   F   L              
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--PFGKSLQRQANILL---GAC 245

Query: 707 ILALVDPFLSESSFQLDMIIRCIHV 731
            L  + P   E     ++I + I +
Sbjct: 246 SLDCLHPEKHEDVIARELIEKMIAM 270

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  134 bits (339), Expect = 6e-35
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 11/201 (5%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLV 540
           F    K+G+G FG V+ G   +  + +A+K +     +  +E+   E+ V+S+     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +  G  ++  +  +I EY+   S      D L+   LD  +   I+  I +GL YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE- 138

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
             + IHRD+KA+N+LL E    K++DFG+A      Q + +T   VGT  +M+PE   + 
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194

Query: 661 RFSEKSDVFSFGVLLLEIVSG 681
            +  K+D++S G+  +E+  G
Sbjct: 195 AYDSKADIWSLGITAIELARG 215

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  133 bits (337), Expect = 1e-34
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 24/222 (10%)

Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ 535
           T+ + + LS  LGQG    V+ GR K  G   A+K  +  S  + ++  M E  V+ KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 536 HRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           H+N+V+L     E           E+ P  SL  +L +P     L   +   ++  +  G
Sbjct: 66  HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 593 LLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           + +L       I+HR++K  NI+     D +   K++DFG A+    ++ Q  +  + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGT 178

Query: 649 FGYMSPE--------YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
             Y+ P+           + ++    D++S GV      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  133 bits (337), Expect = 5e-34
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 24/222 (10%)

Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ 535
           T+ + + LS  LGQG    V+ GR K  G   A+K  +  S  + ++  M E  V+ KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 536 HRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           H+N+V+L     E           E+ P  SL  +L +P     L   +   ++  +  G
Sbjct: 66  HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 593 LLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           + +L       I+HR++K  NI+     D +   K++DFG A+    ++ Q  +  + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGT 178

Query: 649 FGYMSPE--------YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
             Y+ P+           + ++    D++S GV      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  130 bits (329), Expect = 1e-33
 Identities = 54/205 (26%), Positives = 104/205 (50%), Gaps = 13/205 (6%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           +++  +LG G FG VY  +  + G   A K +   S + LE+++ E+ +++   H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           LLG      +  ++ E+ P  ++DA++        L   +   +   +   L +LH    
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHSK-- 136

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-----Y 656
            RIIHRDLKA N+L+  E + +++DFG++        + D+   +GT  +M+PE      
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCET 193

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSG 681
             +  +  K+D++S G+ L+E+   
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQI 218

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  129 bits (327), Expect = 1e-33
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 31/216 (14%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQH 536
            +F++ + LG+G F  VY    +  G E+A+K + K +    G+ +   NEV +  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGI 589
            +++ L     E    + L+ E   N  +       LK       K F+       +  I
Sbjct: 71  PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRV----KPFSENEARHFMHQI 121

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VV 646
             G+LYLH      I+HRDL  SN+LL   +N KI+DFG+A      Q +    +   + 
Sbjct: 122 ITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLC 173

Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           GT  Y+SPE A       +SDV+S G +   ++ GR
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  130 bits (329), Expect = 2e-33
 Identities = 64/230 (27%), Positives = 121/230 (52%), Gaps = 16/230 (6%)

Query: 459 NVNTVKLQDLPLFQFEELATATNN------FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK 511
           ++ TV+L++ P  Q ++L   +        F +  KLG+G +G VY     + GQ +A+K
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 512 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 571
           ++       L+E + E+ ++ +    ++V+  G   +  +  ++ EY    S+  ++   
Sbjct: 61  QVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--R 116

Query: 572 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
           L+ + L   +   I++   +GL YLH     R IHRD+KA NILL+ E + K++DFG+A 
Sbjct: 117 LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG 173

Query: 632 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 681
                  + +T  V+GT  +M+PE   E  ++  +D++S G+  +E+  G
Sbjct: 174 QLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  130 bits (330), Expect = 2e-33
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 32/215 (14%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQHR 537
            +     LG+GGF   +        +  A K + K+        E    E+ +   L H+
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 590
           ++V   G   E  + + ++ E    RSL     +  K+     RK          +  I 
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIV 151

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VVG 647
            G  YLHR    R+IHRDLK  N+ L+E+L  KI DFG+A      + + D  R   + G
Sbjct: 152 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCG 203

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           T  Y++PE   +   S + DV+S G ++  ++ G+
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  129 bits (326), Expect = 3e-33
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 32/215 (14%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQHR 537
            +     LG+GGF   +        +  A K + K+        E    E+ +   L H+
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 590
           ++V   G   E  + + ++ E    RSL     +  K+     RK          +  I 
Sbjct: 76  HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIV 125

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VVG 647
            G  YLHR    R+IHRDLK  N+ L+E+L  KI DFG+A      + + D  R   + G
Sbjct: 126 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCG 177

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           T  Y++PE   +   S + DV+S G ++  ++ G+
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (339), Expect = 7e-33
 Identities = 42/209 (20%), Positives = 85/209 (40%), Gaps = 26/209 (12%)

Query: 483 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRN 538
           +++   +  GG G +Y      + +G+ + +K L  +     +   M E   ++++ H +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140

Query: 539 LVRLL--GCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           +V++       +     + Y   EY+  +SL          ++L   +    +  I   L
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPAL 195

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            YLH    + +++ DLK  NI+L EE   K+ D G              G + GT G+ +
Sbjct: 196 SYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGTPGFQA 245

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE       +  +D+++ G  L  +    
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDL 273

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (326), Expect = 7e-33
 Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 21/237 (8%)

Query: 448 RKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQ 506
            ++   +L A      K+ +L    FE++          S+LG G  G V+    K  G 
Sbjct: 10  DEQQRKRLEAFLTQKQKVGELKDDDFEKI----------SELGAGNGGVVFKVSHKPSGL 59

Query: 507 EIAVKRLS-KASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD 565
            +A K +  +       + + E+ V+ +     +V   G      E  +  E+M   SLD
Sbjct: 60  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119

Query: 566 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625
            +L    K  R+  +    +   + +GL YL    + +I+HRD+K SNIL++     K+ 
Sbjct: 120 QVL---KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLC 174

Query: 626 DFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           DFG++         A++   VGT  YMSPE      +S +SD++S G+ L+E+  GR
Sbjct: 175 DFGVSGQL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  127 bits (321), Expect = 9e-33
 Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEE-FMNEVMVISKLQH 536
            +F++   LG+G FG VY  R K     +A+K L KA     G+E     EV + S L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLY 595
            N++RL G   +     LI EY P  ++    +  L+K  + D ++    I  ++  L Y
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSY 124

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            H     R+IHRD+K  N+LL      KI+DFG +     +  +     + GT  Y+ PE
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTD--LCGTLDYLPPE 177

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                   EK D++S GVL  E + G+
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  132 bits (333), Expect = 9e-33
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 28/215 (13%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
           +  +Q   KLG G +G V   R K    E A+K + K   S     + + EV V+  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 590
            N+++L     +     L+ E          LFD      +  R +FN      II+ + 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGE----LFD-----EIIHRMKFNEVDAAVIIKQVL 146

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G+ YLH   +  I+HRDLK  N+LL   +++   KI DFG++ +F   +   +    +G
Sbjct: 147 SGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---RLG 200

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           T  Y++PE  +  ++ EK DV+S GV+L  +++G 
Sbjct: 201 TAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  127 bits (321), Expect = 1e-32
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQG-LEEFMNEVMVISKLQHRN 538
           +++  KLG GG   VY         ++A+K   +     +  L+ F  EV   S+L H+N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 539 LVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           +V ++      EE    Y   EY+   +L   +        L      N    I  G+ +
Sbjct: 73  IVSMI---DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKH 126

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            H    +RI+HRD+K  NIL+D     KI DFG+AK          T  V+GT  Y SPE
Sbjct: 127 AHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPE 182

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            A      E +D++S G++L E++ G 
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  128 bits (323), Expect = 1e-32
 Identities = 71/312 (22%), Positives = 118/312 (37%), Gaps = 48/312 (15%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNL 539
             ++   L +GGF  VY  + +  G+E A+KRL     +     + EV  + KL  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 540 VRLLGCCVEGEEKM-------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           V+       G+E+        L+   +    L   L     +  L       I     R 
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR-------- 644
           + ++HR  +  IIHRDLK  N+LL  +   K+ DFG A       D + + +        
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 645 --VVGTFGYMSPE-YAMEGRF--SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW 699
                T  Y +PE   +   F   EK D+++ G +L  +         FED         
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR---QHPFEDG-------- 256

Query: 700 KLWNENKIL--ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN--S 755
               + +I+      P           +IR        +Q   ++R +++ VV  L   +
Sbjct: 257 ---AKLRIVNGKYSIPPHDTQYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQEIA 307

Query: 756 EIRDLPYPKEPA 767
             R++  PK P 
Sbjct: 308 AARNVN-PKSPI 318

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  131 bits (331), Expect = 1e-32
 Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 29/216 (13%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ 535
           ++ ++    LG+G FG V   + K  GQE AVK +SK         E  + EV ++ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGI 589
           H N+++L     +     L+ E          LFD      +  RKRF+      II  +
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFD-----EIISRKRFSEVDAARIIRQV 135

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVV 646
             G+ Y+H   + +I+HRDLK  N+LL    ++ N +I DFG++  F  ++   D    +
Sbjct: 136 LSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KI 189

Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           GT  Y++PE  + G + EK DV+S GV+L  ++SG 
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  126 bits (318), Expect = 3e-32
 Identities = 54/234 (23%), Positives = 83/234 (35%), Gaps = 46/234 (19%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKL-Q 535
           T  F    K+G G FG V+      DG   A+KR     A     +  + EV   + L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 536 HRNLVRLLGCCVEGEEKMLIY-EYMPNRSLDALLFDPLKKERLDWRKRF------NIIEG 588
           H ++VR      E +  MLI  EY    SL   +      E       F      +++  
Sbjct: 70  HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAI-----SENYRIMSYFKEAELKDLLLQ 123

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-------------------KISDFGM 629
           + RGL Y+H      ++H D+K SNI +     P                   KI D G 
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 630 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
                  Q +       G   +++ E   E      K+D+F+  + ++      
Sbjct: 181 VTRISSPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  132 bits (334), Expect = 3e-32
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 19/213 (8%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNL 539
            +++  +LG GGFG V     +D G+++A+K+  +       E +  E+ ++ KL H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 540 VRLLGCCVEGEEKM-------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           V       +G +K+       L  EY     L   L        L       ++  IS  
Sbjct: 75  VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 593 LLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
           L YLH     RIIHRDLK  NI+L    + L  KI D G AK     +        VGT 
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTE--FVGTL 187

Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            Y++PE   + +++   D +SFG L  E ++G 
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  129 bits (325), Expect = 9e-32
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 28/215 (13%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
              + +   LG+G FG V   + +   QE AVK ++KA    +     + EV ++ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 590
            N+++L     +     ++ E          LFD      +  RKRF+      II+ + 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFD-----EIIKRKRFSEHDAARIIKQVF 131

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G+ Y+H   +  I+HRDLK  NILL   +++ + KI DFG++  F  N    D    +G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIG 185

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           T  Y++PE  + G + EK DV+S GV+L  ++SG 
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  124 bits (313), Expect = 1e-31
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 16/214 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 538
           ++++L   +G G    V         +++A+KR++ +     ++E + E+  +S+  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRG 592
           +V      V  +E  L+ + +   S+  ++   +  +        +      I+  +  G
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDII-KHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGR--VVGTF 649
           L YLH++     IHRD+KA NILL E+ + +I+DFG+ A +  G     +  R   VGT 
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 650 GYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            +M+PE   + R +  K+D++SFG+  +E+ +G 
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  123 bits (311), Expect = 2e-31
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 19/205 (9%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHR 537
            + F    KLG G FG V+    +  G E  +K ++K   Q  +E+   E+ V+  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 538 NLVRLLGCCVEGEEKMLIY---EYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGL 593
           N++++       E+   +Y   E      L + ++    + + L       +++ +   L
Sbjct: 81  NIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 594 LYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
            Y H      ++H+DLK  NIL          KI DFG+A++F  ++   +     GT  
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTAL 191

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLL 675
           YM+PE   +   + K D++S GV++
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVM 215

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  123 bits (311), Expect = 2e-31
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 32/209 (15%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
              + L + +G+G +G V     K      A K++ K   + ++ F  E+ ++  L H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 539 LVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGI 589
           ++RL       E+   IY   E          LF+     R+  ++ F       I++ +
Sbjct: 68  IIRLYETF---EDNTDIYLVMELCTGGE----LFE-----RVVHKRVFRESDAARIMKDV 115

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVV 646
              + Y H   +L + HRDLK  N L      +   K+ DFG+A  F   +        V
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KV 169

Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
           GT  Y+SP+  +EG +  + D +S GV++
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (312), Expect = 2e-31
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQG-LEEFMNEVMVISKLQHRN 538
           ++L   LG GG   V+  R L+D +++AVK  R   A        F  E    + L H  
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 539 LVRLL--GCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           +V +   G   E     L Y   EY+   +L  ++     +  +  ++   +I    + L
Sbjct: 74  IVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQAL 129

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYM 652
            + H+     IIHRD+K +NI++      K+ DFG+A+ I         T  V+GT  Y+
Sbjct: 130 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           SPE A       +SDV+S G +L E+++G 
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  123 bits (311), Expect = 7e-31
 Identities = 54/244 (22%), Positives = 98/244 (40%), Gaps = 46/244 (18%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA-----------------SGQGLEE 523
           N++++   L QG F  +     KD +  A+K+  K+                      ++
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 524 FMNEVMVISKLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERLDWRK 581
           F NE+ +I+ +++   +   G  +   +++ +IYEYM N S+             LD   
Sbjct: 90  FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNY 144

Query: 582 RFNIIEGISR--------GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
              I   + +           Y+H  +   I HRD+K SNIL+D+    K+SDFG ++  
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202

Query: 634 GGNQDQADTGRVVGTFGYMSPEYAMEGRFS---EKSDVFSFGVLLLEIVSGRKNTSFFED 690
                +       GT+ +M PE       S    K D++S G+ L  +         F  
Sbjct: 203 VDK--KIKG--SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV---VPFSL 254

Query: 691 DLTI 694
            +++
Sbjct: 255 KISL 258

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  121 bits (307), Expect = 7e-31
 Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 28/208 (13%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
              + +   LG+G FG V   + +   QE AVK ++KA    +     + EV ++ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 590
            N+++L     +     ++ E          LFD      +  RKRF+      II+ + 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFD-----EIIKRKRFSEHDAARIIKQVF 131

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            G+ Y+H   +  I+HRDLK  NILL   +++ + KI DFG++  F  N    D    +G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIG 185

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
           T  Y++PE  + G + EK DV+S GV+L
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  121 bits (306), Expect = 9e-31
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKL-QHR 537
           ++ +   +LG+G +G V   R    GQ +AVKR+ +  + Q  +  + ++ +  +     
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISR 591
             V   G      +  +  E M + SLD        K+ +D  +         I   I +
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L +LH  S+L +IHRD+K SN+L++     K+ DFG++   G   D        G   Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKPY 175

Query: 652 MSPE----YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           M+PE       +  +S KSD++S G+ ++E+   R
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  125 bits (317), Expect = 1e-30
 Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 39/226 (17%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-------------SGQGLEEFM 525
             ++    KLG G +G V   + K    E A+K + K+               +  EE  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN- 584
           NE+ ++  L H N+++L     + +   L+ E+     L    F+     ++  R +F+ 
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FE-----QIINRHKFDE 145

Query: 585 -----IIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGN 636
                I++ I  G+ YLH+     I+HRD+K  NILL   +  LN KI DFG++  F  +
Sbjct: 146 CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202

Query: 637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
               D    +GT  Y++PE  ++ +++EK DV+S GV++  ++ G 
Sbjct: 203 YKLRD---RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  122 bits (309), Expect = 1e-30
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 19/206 (9%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRN 538
           F    ++G G FG VY+ R +++ + +A+K++S   K S +  ++ + EV  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
            ++  GC +      L+ EY    + D L    + K+ L   +   +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS 172

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE--- 655
                +IHRD+KA NILL E    K+ DFG A         A++   VGT  +M+PE   
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPEVIL 223

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSG 681
              EG++  K DV+S G+  +E+   
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAER 249

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  122 bits (307), Expect = 2e-30
 Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 28/241 (11%)

Query: 455 LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL 513
           +S  +   +K+     + F        + +   ++G+G +G V     K  GQ +AVKR+
Sbjct: 1   MSIESSGKLKISPEQHWDFT-----AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI 55

Query: 514 -SKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 571
            S    +  ++ + ++ V+ +      +V+  G      +  +  E M + S D      
Sbjct: 56  RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY--- 111

Query: 572 LKKERLDWRKRFN------IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625
            K                 I     + L +L     L+IIHRD+K SNILLD   N K+ 
Sbjct: 112 -KYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLC 168

Query: 626 DFGMAKIFGGNQDQADTGRVVGTFGYMSPE----YAMEGRFSEKSDVFSFGVLLLEIVSG 681
           DFG++     +  +       G   YM+PE     A    +  +SDV+S G+ L E+ +G
Sbjct: 169 DFGISGQLVDSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

Query: 682 R 682
           R
Sbjct: 226 R 226

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (309), Expect = 2e-30
 Identities = 43/215 (20%), Positives = 85/215 (39%), Gaps = 16/215 (7%)

Query: 480 TNNFQLSSKLGQG--GFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKL 534
              ++L + +G+G      V   R    G+ + V+R  L   S + +     E+ V    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            H N+V      +   E  ++  +M   S   L+      + ++      I++G+ + L 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYILQGVLKALD 142

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT-----GRVVGTF 649
           Y+H       +HR +KAS+IL+  +    +S          +  +           V   
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 650 GYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGR 682
            ++SPE   +    +  KSD++S G+   E+ +G 
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (312), Expect = 2e-30
 Identities = 57/235 (24%), Positives = 91/235 (38%), Gaps = 48/235 (20%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNL 539
           N       LG G  G V +     G+ +AVKR+        +  + E+ ++++   H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 540 VRLLGCCVEGEEKMLIY---EYMPNRSLDALLFD--------PLKKERLDWRKRFNIIEG 588
           +R    C E      +Y   E       +  L D            +        +++  
Sbjct: 72  IRYY--CSE-TTDRFLYIALELC-----NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLD-------------EELNPKISDFGMAKIFGG 635
           I+ G+ +LH    L+IIHRDLK  NIL+              E L   ISDFG+ K    
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 636 NQD--QADTGRVVGTFGYMSPE-------YAMEGRFSEKSDVFSFGVLLLEIVSG 681
            Q   + +     GT G+ +PE          + R +   D+FS G +   I+S 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  122 bits (307), Expect = 3e-30
 Identities = 27/253 (10%), Positives = 60/253 (23%), Gaps = 45/253 (17%)

Query: 466 QDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK---ASGQGL 521
           Q+        L+      +L   L  G    V+  R  +  ++ A+K  +     S   L
Sbjct: 47  QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106

Query: 522 EEFMNEVMVISKLQHRNLVRLLGCC----------VEGEEKM----------------LI 555
           E         ++L   +                  V+ +                   L+
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166

Query: 556 YEYMP---NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKAS 612
                         L F  + +          +   + R    L       ++H      
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPD 223

Query: 613 NILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR---FSEKSDVF 669
           N+ +  +    + D       G        G         +P   +      F+   + +
Sbjct: 224 NLFIMPDGRLMLGDVSALWKVG------TRGPASSVPVTYAPREFLNASTATFTHALNAW 277

Query: 670 SFGVLLLEIVSGR 682
             G+ +  +    
Sbjct: 278 QLGLSIYRVWCLF 290

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (304), Expect = 3e-30
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 17/207 (8%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK--ASGQG-LEEFMNEVMVISKLQHRN 538
           ++L   +G+GG G VY        + +A+K +S+  +S          E     +LQ  +
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 539 LVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           +V +      GE    +Y     +    L A+L    ++  L   +   I+  I   L  
Sbjct: 96  VVPIHD---FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDA 149

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
            H        HRD+K  NIL+  +    + DFG+A      +     G  VGT  YM+PE
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPE 205

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
              E   + ++D+++   +L E ++G 
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGS 232

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  120 bits (302), Expect = 3e-30
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 22/210 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEE-FMNEVMVISKLQH 536
           ++F +   LG+G FG VY  R K     +A+K L K+    +G+E     E+ + S L+H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLY 595
            N++R+     + +   L+ E+ P   L    +  L+K  R D ++    +E ++  L Y
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHY 129

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VVGTFGYM 652
            H     ++IHRD+K  N+L+  +   KI+DFG +         A + R   + GT  Y+
Sbjct: 130 CHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV-------HAPSLRRRTMCGTLDYL 179

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            PE        EK D++  GVL  E + G 
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  119 bits (299), Expect = 2e-29
 Identities = 57/263 (21%), Positives = 88/263 (33%), Gaps = 66/263 (25%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 538
            +F+    +G+GGFG V+  + K D    A+KR+         E+ M EV  ++KL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII------------ 586
           +VR     +E   +    E       D     PL            I             
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 587 ---------------EGISRGLLYLHRDSRL---------------------------RI 604
                          +   +  L    + R                             +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG----------RVVGTFGYMSP 654
           +HRDLK SNI    +   K+ DFG+      ++++                VGT  YMSP
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 655 EYAMEGRFSEKSDVFSFGVLLLE 677
           E      +S K D+FS G++L E
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFE 268

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  118 bits (297), Expect = 2e-29
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 26/206 (12%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
              F     LG G F  V+  + +  G+  A+K + K+         NE+ V+ K++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGISRG 592
           +V L           L+ + +        LFD     R+  R  +       +I+ +   
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGE----LFD-----RILERGVYTEKDASLVIQQVLSA 118

Query: 593 LLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
           + YLH      I+HRDLK  N+L    +E     I+DFG++K+              GT 
Sbjct: 119 VKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTP 171

Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLL 675
           GY++PE   +  +S+  D +S GV+ 
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  121 bits (305), Expect = 5e-29
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 14/209 (6%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
           + F     LG+GGFG V+  ++K   ++ A K+L+K      +G +  M E  +++K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 593
           R +V L     E +  + L+   M    +   +++  +      + R  F   + I  GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGL 302

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            +LH+     II+RDLK  N+LLD++ N +ISD G+A      Q +       GT G+M+
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMA 357

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE  +   +    D F+ GV L E+++ R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  116 bits (292), Expect = 8e-29
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 28/214 (13%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGL---------EEFMNEVM 529
             N++    LG+G    V     K   +E AVK +    G            E  + EV 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 530 VISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIE 587
           ++ K+  H N+++L           L+++ M    L    FD L +K  L  ++   I+ 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMR 131

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +   +  LH+   L I+HRDLK  NILLD+++N K++DFG +      +   +   V G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCG 185

Query: 648 TFGYMSPE------YAMEGRFSEKSDVFSFGVLL 675
           T  Y++PE            + ++ D++S GV++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  117 bits (294), Expect = 8e-29
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 20/234 (8%)

Query: 461 NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ 519
           +    + L       L      F+L   +G G +G VY GR +K GQ  A+K +   +G 
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGD 62

Query: 520 GLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPL 572
             EE   E+ ++ K   HRN+    G  ++           L+ E+    S+  L+    
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNT 121

Query: 573 KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
           K   L       I   I RGL +LH+    ++IHRD+K  N+LL E    K+ DFG++  
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178

Query: 633 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE-----KSDVFSFGVLLLEIVSG 681
                 + +T   +GT  +M+PE        +     KSD++S G+  +E+  G
Sbjct: 179 LDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  118 bits (297), Expect = 1e-28
 Identities = 33/233 (14%), Positives = 64/233 (27%), Gaps = 43/233 (18%)

Query: 489 LGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH-------- 536
           LGQ            + G+   V             +++   EV+ +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 537 --------RNLVRLLGCC-----VEGEEKMLIYEY---MPNRS------LDALLFDPLKK 574
                    +LV+             E  M +       P          + LL      
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
           + L    R  +   + R L  LH      ++H  L+  +I+LD+     ++ F      G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 635 GNQDQADTGRVVGTFGYMSPE-----YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            +   +  GR        +              +   D ++ G+ +  I    
Sbjct: 263 ASA-VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  114 bits (289), Expect = 2e-28
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
           ++N+ +  +LG+G F  V     K  G E A K ++    S +  ++   E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLY 595
            N+VRL     E     L+++ +        LF+ +  +E        + I+ I   + Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 120

Query: 596 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
            H      I+HR+LK  N+LL    +    K++DFG+A     ++         GT GY+
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 174

Query: 653 SPEYAMEGRFSEKSDVFSFGVLL 675
           SPE   +  +S+  D+++ GV+L
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVIL 197

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  115 bits (290), Expect = 2e-28
 Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 16/217 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS---GQGLEEFMNEVMVISKLQH 536
            +F+    LG+G F  V   R        A+K L K        +     E  V+S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLL 594
              V+L     + E+      Y  N  L       ++K     +   RF   E I   L 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAE-IVSALE 144

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y+SP
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
           E   E    + SD+++ G ++ ++V+G     F   +
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGL--PPFRAGN 236

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  115 bits (291), Expect = 5e-28
 Identities = 45/201 (22%), Positives = 85/201 (42%), Gaps = 15/201 (7%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
            + + +  +LG G FG V+    K  G+    K ++           NE+ ++++L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYL 596
           L+ L     +  E +LI E++        LFD +  +  ++   +  N +     GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 597 HRDSRLRIIHRDLKASNILL--DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           H      I+H D+K  NI+    +  + KI DFG+A     ++          T  + +P
Sbjct: 166 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAP 219

Query: 655 EYAMEGRFSEKSDVFSFGVLL 675
           E          +D+++ GVL 
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (287), Expect = 6e-28
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 16/210 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKL-QHR 537
           N+ +   ++G G  G V+  R +  G  IAVK++    + +  +  + ++ V+ K     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
            +V+  G  +   +  +  E M     +        +  +  R    +   I + L YL 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRMQGPIPERILGKMTVAIVKALYYLK 141

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-- 655
              +  +IHRD+K SNILLDE    K+ DFG++   G   D     R  G   YM+PE  
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERI 196

Query: 656 ---YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                 +  +  ++DV+S G+ L+E+ +G+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  115 bits (289), Expect = 8e-28
 Identities = 48/213 (22%), Positives = 92/213 (43%), Gaps = 27/213 (12%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQG--------LEEFMNEVMV 530
              +     +G+G    V     +  G E AVK +   + +          E    E  +
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 531 ISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEG 588
           + ++  H +++ L+          L+++ M    L    FD L +K  L  ++  +I+  
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRS 208

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           +   + +LH      I+HRDLK  NILLD+ +  ++SDFG +      +   +   + GT
Sbjct: 209 LLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGT 262

Query: 649 FGYMSPE------YAMEGRFSEKSDVFSFGVLL 675
            GY++PE            + ++ D+++ GV+L
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  113 bits (286), Expect = 2e-27
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 25/208 (12%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQH 536
           ++L   +G+G F  V     ++ GQ+ AVK     + + + G   E+   E  +   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 590
            ++V LL          +++E+M      A L   +  +R D    +      + +  I 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDG----ADLCFEI-VKRADAGFVYSEAVASHYMRQIL 140

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
             L Y H      IIHRD+K   +LL   +     K+  FG+A   G +   A     VG
Sbjct: 141 EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVG 195

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
           T  +M+PE      + +  DV+  GV+L
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  113 bits (285), Expect = 2e-27
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
           ++N+ +  +LG+G F  V     K  G E A K ++    S +  ++   E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLY 595
            N+VRL     E     L+++ +    L    F+ +  +E        + I+ I   + Y
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAY 143

Query: 596 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
            H      I+HR+LK  N+LL    +    K++DFG+A     ++         GT GY+
Sbjct: 144 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 197

Query: 653 SPEYAMEGRFSEKSDVFSFGVLL 675
           SPE   +  +S+  D+++ GV+L
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVIL 220

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  116 bits (293), Expect = 2e-27
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
           N F+    LG+GGFG V   +++   ++ A K+L K      +G    +NE  ++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW----RKRFNIIEGISR 591
           R +V L     E ++ + L+   M    L       +           R  F   E I  
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDL----KFHIYHMGQAGFPEARAVFYAAE-ICC 297

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
           GL  LHR    RI++RDLK  NILLD+  + +ISD G+A      Q        VGT GY
Sbjct: 298 GLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGY 351

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           M+PE     R++   D ++ G LL E+++G+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  111 bits (280), Expect = 3e-27
 Identities = 63/239 (26%), Positives = 103/239 (43%), Gaps = 51/239 (21%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK-------------------ASGQG 520
           N + L  ++G+G +G V       D    A+K LSK                    +  G
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 521 LEEFMN-------EVMVISKLQHRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFD 570
             +          E+ ++ KL H N+V+L+   ++   +  +Y   E +    +     +
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----ME 127

Query: 571 PLKKERLD---WRKRFN-IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISD 626
               + L     R  F  +I+GI     YLH     +IIHRD+K SN+L+ E+ + KI+D
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIE----YLHY---QKIIHRDIKPSNLLVGEDGHIKIAD 180

Query: 627 FGMAKIFGGNQDQADTGRVVGTFGYMSPE--YAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
           FG++  F G+         VGT  +M+PE        FS +  DV++ GV L   V G+
Sbjct: 181 FGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  111 bits (281), Expect = 3e-27
 Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 27/212 (12%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--------FMNEVMV 530
            + + +S  LG G  G V     +   +++A+K +SK                   E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGI 589
           + KL H  ++++     + E+  ++ E M    L    FD +   +RL           +
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 123

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVV 646
              + YLH      IIHRDLK  N+LL   +E+   KI+DFG +KI G          + 
Sbjct: 124 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LC 177

Query: 647 GTFGYMSPE---YAMEGRFSEKSDVFSFGVLL 675
           GT  Y++PE         ++   D +S GV+L
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  112 bits (282), Expect = 4e-27
 Identities = 51/252 (20%), Positives = 85/252 (33%), Gaps = 52/252 (20%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISK 533
              + L   +GQG +G V            A+K     ++ + + + +E    EV ++ K
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYM-------------------------------PNR 562
           L H N+ RL     + +   L+ E                                    
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 563 SLDALLFDPLKKERLDWRKRFN------IIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
             +  +   +   R              I+  I   L YLH      I HRD+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 617 --DEELNPKISDFGMAKIFGGNQ--DQADTGRVVGTFGYMSPE--YAMEGRFSEKSDVFS 670
             ++    K+ DFG++K F      +        GT  +++PE        +  K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 671 FGVLLLEIVSGR 682
            GVLL  ++ G 
Sbjct: 262 AGVLLHLLLMGA 273

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  113 bits (284), Expect = 4e-27
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 15/199 (7%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
               +  LG G FG V+       G ++A K +     +  EE  NE+ V+++L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYLHR 598
           +L        + +L+ EY+        LFD +  +   L        ++ I  G+ ++H 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMH- 204

Query: 599 DSRLRIIHRDLKASNILL-DEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
             ++ I+H DLK  NIL  + +    KI DFG+A+ +   +         GT  +++PE 
Sbjct: 205 --QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEV 259

Query: 657 AMEGRFSEKSDVFSFGVLL 675
                 S  +D++S GV+ 
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  116 bits (293), Expect = 4e-27
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 24/213 (11%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMV---ISK 533
           N+F +   +G+GGFG VY  R  D  ++ A+K L K      QG    +NE ++   +S 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 534 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGIS 590
                +V +        +K+  I + M    L       L +  +  +   RF   E I 
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAAE-II 302

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
            GL ++H      +++RDLK +NILLDE  + +ISD G+A  F   +        VGT G
Sbjct: 303 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHG 355

Query: 651 YMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 682
           YM+PE   +G   + S D FS G +L +++ G 
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  112 bits (282), Expect = 4e-27
 Identities = 31/226 (13%), Positives = 62/226 (27%), Gaps = 30/226 (13%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASGQGLEEFMNEVMVISK 533
           +    +   LG+G F  VY     D       Q+  +K    A+          +  +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIE 587
                 ++     +     +L+ E     +    L + +   +    K            
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGT----LLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILL-----------DEELNPKISDFGMAKIFGGN 636
            +   +  +H      IIH D+K  N +L           D      + D G +      
Sbjct: 180 RMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236

Query: 637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                      T G+   E      ++ + D F     +  ++ G 
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  116 bits (291), Expect = 4e-27
 Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 15/201 (7%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
            +++ +  +LG G FG V+    +  G   A K +        E    E+  +S L+H  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYL 596
           LV L     +  E ++IYE+M        LF+ +  +  ++   +    +  + +GL ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 597 HRDSRLRIIHRDLKASNILL--DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           H       +H DLK  NI+         K+ DFG+       Q         GT  + +P
Sbjct: 272 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAP 325

Query: 655 EYAMEGRFSEKSDVFSFGVLL 675
           E A        +D++S GVL 
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  110 bits (277), Expect = 1e-26
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 27/224 (12%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 536
            + +   LG+G +G V      +     AVK L K        G      E+ ++ +L+H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 537 RNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERL---DWRKRFN-IIEGI 589
           +N+++L+   +  EEK  +Y   EY      +  + D + ++R         F  +I+G+
Sbjct: 66  KNVIQLVDV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGL 122

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
                YLH      I+H+D+K  N+LL      KIS  G+A+               G+ 
Sbjct: 123 E----YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 650 GYMSPEYAMEGRFSE--KSDVFSFGVLLLEIVSGRKNTSFFEDD 691
            +  PE A         K D++S GV L  I +G      FE D
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP---FEGD 216

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  112 bits (282), Expect = 1e-26
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 27/212 (12%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--------FMNEVMV 530
            + + +S  LG G  G V     +   +++A++ +SK                   E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGI 589
           + KL H  ++++     + E+  ++ E M    L    FD +   +RL           +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 248

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVV 646
              + YLH      IIHRDLK  N+LL   +E+   KI+DFG +KI G          + 
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LC 302

Query: 647 GTFGYMSPE---YAMEGRFSEKSDVFSFGVLL 675
           GT  Y++PE         ++   D +S GV+L
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (278), Expect = 2e-26
 Identities = 31/239 (12%), Positives = 66/239 (27%), Gaps = 54/239 (22%)

Query: 489 LGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQ--------- 535
           LGQ            + G+   V             +++   EV+ +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 536 ----------------HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-----KK 574
                            + ++R+     +       + Y   +S      + L       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
           + L    R  +   + R L  LH      ++H  L+  +I+LD+     ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 635 GNQDQADTGRVVGTFGYMSPEY-----------AMEGRFSEKSDVFSFGVLLLEIVSGR 682
                        + G+  PE                  +   D ++ G+++  I    
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  112 bits (282), Expect = 2e-26
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--FMNEVMVISKLQH 536
           T  +QL  +LG+G F  V        GQE A   ++       +      E  +   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 590
            N+VRL     E     LI++ +    L    F+      +  R+ +      + I+ I 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGEL----FE-----DIVAREYYSEADASHCIQQIL 120

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
             +L+ H+   + ++HR+LK  N+LL    +    K++DFG+A    G Q         G
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAG 175

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
           T GY+SPE   +  + +  D+++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  108 bits (273), Expect = 2e-26
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 22/208 (10%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA------SGQGLEEFMNEVMVIS 532
            +++++  +LG G F  V   R K  G+E A K + K        G   EE   EV ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 591
           +++H N++ L        + +LI E +        LFD L +KE L   +    ++ I  
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILD 119

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 647
           G+ YLH     RI H DLK  NI+L ++  P    K+ DFG+A       +  +   + G
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFG 173

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
           T  +++PE         ++D++S GV+ 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  109 bits (275), Expect = 2e-26
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 33/208 (15%)

Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCC 546
           LG+G    V         QE AVK + K  G        EV ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRGLLYLHRDS 600
            E +   L++E M   S+            +  R+ FN      +++ ++  L +LH   
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LS-----HIHKRRHFNELEASVVVQDVASALDFLHN-- 129

Query: 601 RLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGR-----VVGTFGYM 652
              I HRDLK  NIL    ++    KI DF +      N D +           G+  YM
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 653 SPE-----YAMEGRFSEKSDVFSFGVLL 675
           +PE           + ++ D++S GV+L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  109 bits (274), Expect = 3e-26
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA------SGQGLEEFMNEVMVIS 532
            + + +  +LG G F  V   R K  G E A K + K        G   EE   EV ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 591
           ++ H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 647
           G+ YLH     +I H DLK  NI+L ++  P    K+ DFG+A       +  +   + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
           T  +++PE         ++D++S GV+ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  110 bits (276), Expect = 4e-26
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS------GQGLEEFMNEVMVIS 532
            + + +  +LG G F  V   R K  G E A K + K        G   EE   EV ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 591
           ++ H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 647
           G+ YLH     +I H DLK  NI+L ++  P    K+ DFG+A       +  +   + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
           T  +++PE         ++D++S GV+ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  109 bits (274), Expect = 5e-26
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 27/206 (13%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
           ++ F++ S+LG+G    VY  + K   +  A+K L K   +  +    E+ V+ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGISRG 592
           +++L        E  L+ E +    L    FD     R+  +  +      + ++ I   
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FD-----RIVEKGYYSERDAADAVKQILEA 160

Query: 593 LLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
           + YLH      I+HRDLK  N+L      +   KI+DFG++KI            V GT 
Sbjct: 161 VAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGTP 214

Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLL 675
           GY +PE      +  + D++S G++ 
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIIT 240

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  107 bits (270), Expect = 1e-25
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA------SGQGLEEFMNEVMVIS 532
            + +    +LG G F  V   R K  G + A K + K        G   E+   EV ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 591
           ++QH N++ L        + +LI E +        LFD L +KE L   +    ++ I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILN 125

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 647
           G+ YLH    L+I H DLK  NI+L +   P    KI DFG+A       +  +   + G
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFG 179

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
           T  +++PE         ++D++S GV+ 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  106 bits (268), Expect = 2e-25
 Identities = 70/217 (32%), Positives = 111/217 (51%), Gaps = 37/217 (17%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
           N++L   +G+G F  V   R +  G+E+A+K + K   +   L++   EV ++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 539 LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISRG 592
           +V+L    +E E+ + LI EY     +    FD L    R+   + R +F  I+  +   
Sbjct: 76  IVKLFEV-IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ-- 128

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF-GY 651
             Y H+    RI+HRDLKA N+LLD ++N KI+DFG +  F         G  +  F G 
Sbjct: 129 --YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF-------TVGGKLDAFCG- 175

Query: 652 MSPEYA----MEGRFSE--KSDVFSFGVLLLEIVSGR 682
            +P YA     +G+  +  + DV+S GV+L  +VSG 
Sbjct: 176 -APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  106 bits (268), Expect = 2e-25
 Identities = 41/201 (20%), Positives = 82/201 (40%), Gaps = 16/201 (7%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
              + ++  LG+G FG V+        +    K +    G        E+ +++  +HRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYL 596
           ++ L       EE ++I+E++        +F+ +      L+ R+  + +  +   L +L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 597 HRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           H      I H D++  NI+     +   KI +FG A+      +      +     Y +P
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172

Query: 655 EYAMEGRFSEKSDVFSFGVLL 675
           E       S  +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  106 bits (267), Expect = 3e-25
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 32/218 (14%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN------EVMVISKL 534
            +Q+   LG GGFG VY G  + D   +A+K + K       E  N      EV+++ K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 535 QHR--NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLD---WRKRFN-IIE 587
                 ++RLL      +  +LI E  P    D  LFD + ++  L     R  F  ++E
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLE 160

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQA-DTGRV 645
            +     + H      ++HRD+K  NIL+D      K+ DFG   +    +D        
Sbjct: 161 AVR----HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD--F 208

Query: 646 VGTFGYMSPEYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
            GT  Y  PE+    R+    + V+S G+LL ++V G 
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  105 bits (264), Expect = 3e-25
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 35/217 (16%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNL 539
           ++ L   LG+G +G V         + +AVK +         E    E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 540 VRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 591
           V+  G      E  + Y   EY     L    FD +     +   D ++ F+ ++ G+  
Sbjct: 68  VKFYGHR---REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV- 119

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              YLH    + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y
Sbjct: 120 ---YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

Query: 652 MSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           ++PE      +      +E  DV+S G++L  +++G 
Sbjct: 174 VAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGE 205

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  106 bits (267), Expect = 3e-25
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 28/227 (12%)

Query: 460 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG 518
           + TV +  +           T+ +++   +G G +        K    E AVK + K+  
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60

Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 578
              EE   E++ +   QH N++ L     +G+   ++ E M    L     D     ++ 
Sbjct: 61  DPTEE--IEIL-LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LD-----KIL 108

Query: 579 WRKRFN------IIEGISRGLLYLHRDSRLRIIHRDLKASNILL-DEELNP---KISDFG 628
            +K F+      ++  I++ + YLH      ++HRDLK SNIL  DE  NP   +I DFG
Sbjct: 109 RQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFG 165

Query: 629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
            AK          T     T  +++PE      +    D++S GVLL
Sbjct: 166 FAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  105 bits (265), Expect = 6e-25
 Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 30/217 (13%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--------SGQGLEEFMNEVMVIS 532
            +   S LG G FG V+     +  +E+ VK + K             L +   E+ ++S
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLD---WRKRFN-IIE 587
           +++H N++++L      E +      M        LF  + +  RLD       F  ++ 
Sbjct: 85  RVEHANIIKVLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141

Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
            +     YL       IIHRD+K  NI++ E+   K+ DFG A      +    T    G
Sbjct: 142 AVG----YLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT--FCG 191

Query: 648 TFGYMSPEYAMEGRFSE--KSDVFSFGVLLLEIVSGR 682
           T  Y +PE  + G      + +++S GV L  +V   
Sbjct: 192 TIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  105 bits (263), Expect = 8e-25
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 35/217 (16%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNL 539
           ++ L   LG+G +G V         + +AVK +         E    E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 540 VRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 591
           V+  G      E  + Y   EY     L    FD +     +   D ++ F+ ++ G+  
Sbjct: 68  VKFYGHR---REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV- 119

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
              YLH    + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y
Sbjct: 120 ---YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

Query: 652 MSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           ++PE      +      +E  DV+S G++L  +++G 
Sbjct: 174 VAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGE 205

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  104 bits (262), Expect = 1e-24
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 28/199 (14%)

Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGC 545
            LG+G F        K   Q  AVK +SK           E+  +   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74

Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRGLLYLHRD 599
             +     L+ E +    L    F+     R+  +K F+      I+  +   + ++H  
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FE-----RIKKKKHFSETEASYIMRKLVSAVSHMHD- 124

Query: 600 SRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
             + ++HRDLK  N+L    ++ L  KI DFG A++   +     T     T  Y +PE 
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPEL 180

Query: 657 AMEGRFSEKSDVFSFGVLL 675
             +  + E  D++S GV+L
Sbjct: 181 LNQNGYDESCDLWSLGVIL 199

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  103 bits (258), Expect = 4e-24
 Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 34/220 (15%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN------EV----MV 530
            ++L   LG+GGFG V+ G  L D  ++A+K + +    G     +      EV     V
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLD---WRKRFN-I 585
            +   H  ++RLL      E  ML+ E  P  + D  LFD + +K  L     R  F  +
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQV 148

Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQA-DTG 643
           +  I     + H      ++HRD+K  NIL+D      K+ DFG   +     D+     
Sbjct: 149 VAAIQ----HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD- 197

Query: 644 RVVGTFGYMSPEYAMEGRFS-EKSDVFSFGVLLLEIVSGR 682
              GT  Y  PE+    ++    + V+S G+LL ++V G 
Sbjct: 198 -FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  103 bits (259), Expect = 7e-24
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 22/212 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 536
           ++F++   +G+G FG V   +  D +++ A+K ++K       E      E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 593
             LV L     + EE M ++ + +    L       L++     +   +  I E +   L
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFKEETVKLFICE-LVMAL 128

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            YL      RIIHRD+K  NILLDE  +  I+DF +A +      Q  T  + GT  YM+
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT--MAGTKPYMA 182

Query: 654 PE--YAMEGRFSEKS-DVFSFGVLLLEIVSGR 682
           PE   + +G     + D +S GV   E++ GR
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  101 bits (255), Expect = 1e-23
 Identities = 59/240 (24%), Positives = 97/240 (40%), Gaps = 32/240 (13%)

Query: 447 KRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSK-LGQGGFGPVYWGRLKD- 504
                   L   N+    +++             N + L+SK LG+G F  V     K  
Sbjct: 5   HHHSSGVDLGTENLYFQSMENF-----------NNFYILTSKELGRGKFAVVRQCISKST 53

Query: 505 GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHR-NLVRLLGCCVEGEEKMLIYEYMPN 561
           GQE A K L K         E ++E+ V+   +    ++ L        E +LI EY   
Sbjct: 54  GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113

Query: 562 RSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL-- 616
             +    F     E  +         +I+ I  G+ YLH+     I+H DLK  NILL  
Sbjct: 114 GEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSS 166

Query: 617 -DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
                + KI DFGM++  G   +  +   ++GT  Y++PE       +  +D+++ G++ 
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  102 bits (256), Expect = 3e-23
 Identities = 62/264 (23%), Positives = 107/264 (40%), Gaps = 28/264 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 536
            ++++   +G+G FG V   R K  +++ A+K LSK       +   F  E  +++    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLY 595
             +V+L     +     ++ EYMP   L     + +    +     RF   E +   L  
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL----VNLMSNYDVPEKWARFYTAEVVL-ALDA 183

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           +H    +  IHRD+K  N+LLD+  + K++DFG                 VGT  Y+SPE
Sbjct: 184 IHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPE 239

Query: 656 ----YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV 711
                  +G +  + D +S GV L E++ G   T F+ D L    Y       +KI+   
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFYADSLVGT-Y-------SKIMNHK 289

Query: 712 DPFLSESSFQLDMIIRCIHVGLLC 735
           +         +    + +    L 
Sbjct: 290 NSLTFPDDNDISKEAKNLICAFLT 313

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.9 bits (249), Expect = 2e-22
 Identities = 52/216 (24%), Positives = 102/216 (47%), Gaps = 25/216 (11%)

Query: 485 LSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLV 540
              K+G+G +G VY  + KD    ++ A+K++      G+      E+ ++ +L+H N++
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVI 81

Query: 541 RLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRG 592
            L    +   ++   L+++Y     L  ++      +      +        ++  I  G
Sbjct: 82  SLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGG-NQDQADTGRVVG 647
           + YLH +    ++HRDLK +NIL+  E       KI+D G A++F    +  AD   VV 
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 648 TFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
           TF Y +PE  +  R  ++  D+++ G +  E+++  
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 62/251 (24%), Positives = 110/251 (43%), Gaps = 36/251 (14%)

Query: 447 KRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ 506
            +++ + K    + NT +L       F+ + T          LG G FG V   + K+  
Sbjct: 22  AKEDFLKKWETPSQNTAQLDQ-----FDRIKT----------LGTGSFGRVMLVKHKESG 66

Query: 507 EI-AVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562
              A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY+   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 563 SLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620
            +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+D++ 
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQG 178

Query: 621 NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +++DFG AK   G      T  + GT   ++PE  +   +++  D ++ GVL+ E+ +
Sbjct: 179 YIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233

Query: 681 GRKNTSFFEDD 691
           G     FF D 
Sbjct: 234 GY--PPFFADQ 242

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 23/207 (11%), Positives = 59/207 (28%), Gaps = 47/207 (22%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRL---SKASGQGLEEFMNEVMVISKLQH 536
           ++L    G       +     D    +++A+  +          L+E ++  + +S++  
Sbjct: 33  YRLLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
             + R+L         +++ E++   SL  +                  ++ ++      
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAA 145

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV-GTFGYMSPE 655
           HR     +       S + +                       +  G VV      M   
Sbjct: 146 HRAG---VALSIDHPSRVRV-----------------------SIDGDVVLAYPATMPDA 179

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                  + + D+   G  L  ++  R
Sbjct: 180 -------NPQDDIRGIGASLYALLVNR 199

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 17/209 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 536
           N F+    LG+G FG V   + K      A+K L K      +E    + E  V+   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 593
             L  L     +  +++  + EY     L    F  L +ER+  + R RF   E +S  L
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS-AL 261

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            YLH  S   +++RDLK  N++LD++ + KI+DFG+ K    +     T    GT  Y++
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 317

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE   +  +    D +  GV++ E++ GR
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 38/218 (17%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
           ++ L   LG G FG V  G     G ++AVK L++    S   + +   E+  +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 591
           ++++L    +       ++ EY+    L    FD + K  R+   + R+ F  I+  +  
Sbjct: 72  HIIKLYQV-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD- 125

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF-G 650
              Y HR     ++HRDLK  N+LLD  +N KI+DFG++ +          G  + T  G
Sbjct: 126 ---YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------SDGEFLRTSCG 172

Query: 651 YMSPEYA----MEGRFSE--KSDVFSFGVLLLEIVSGR 682
             SP YA    + GR     + D++S GV+L  ++ G 
Sbjct: 173 --SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 97.6 bits (244), Expect = 2e-22
 Identities = 56/211 (26%), Positives = 106/211 (50%), Gaps = 23/211 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEF--------MNEVMVIS 532
             +Q   K+G+G +G VY  +   G+ +A+KR+       L+          + E+ ++ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74

Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           +L H N+V L+          L++E+M    L  +L +     +    K +  +  + RG
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY--LYQLLRG 131

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           + + H+    RI+HRDLK  N+L++ +   K++DFG+A+ F G   ++ T  VV T  Y 
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186

Query: 653 SPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
           +P+  M  +  S   D++S G +  E+++G+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 99.0 bits (247), Expect = 4e-22
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 21/224 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
           ++F++   +G+G F  V   ++K   ++ A+K ++K        +  F  E  V+     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           R + +L     + E  + L+ EY     L  LL    ++   +   RF + E +   +  
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-MARFYLAEIVM-AIDS 177

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           +HR   L  +HRD+K  NILLD   + +++DFG       +     +   VGT  Y+SPE
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPE 233

Query: 656 -------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 692
                      G +  + D ++ GV   E+  G+  T F+ D  
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPFYADST 275

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 96.4 bits (241), Expect = 4e-22
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 23/211 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEF--------MNEVMVIS 532
             +    K+G+G +G VY  +   G+  A+K++       LE+         + E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
           +L+H N+V+L       +  +L++E++    L  LL            K F  +  +  G
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLLNG 112

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           + Y H     R++HRDLK  N+L++ E   KI+DFG+A+ F G   +  T  +V T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167

Query: 653 SPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
           +P+  M  +  S   D++S G +  E+V+G 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 97.7 bits (244), Expect = 4e-22
 Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 30/221 (13%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEF----MNEVMVISK 533
           + ++  +K+GQG FG V+  R  K GQ++A+K   +        E F    + E+ ++  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK----EGFPITALREIKILQL 72

Query: 534 LQHRNLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
           L+H N+V L+  C               L++++  +  L  LL + L K  L   KR   
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV-- 129

Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD---T 642
           ++ +  GL Y+HR+   +I+HRD+KA+N+L+  +   K++DFG+A+ F   ++      T
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186

Query: 643 GRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 682
            RVV T  Y  PE  + E  +    D++  G ++ E+ +  
Sbjct: 187 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 98.7 bits (246), Expect = 6e-22
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 23/224 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 536
            +F++   +G+G FG V   +LK+  ++ A+K L+K       E   F  E  V+     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 593
           + +  L     + +  + L+ +Y     L  LL    K E    +   RF + E +   +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVI-AI 188

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
             +H+   L  +HRD+K  NIL+D   + +++DFG       +     +   VGT  Y+S
Sbjct: 189 DSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYIS 244

Query: 654 PE-----YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 692
           PE        +GR+  + D +S GV + E++ G   T F+ + L
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESL 286

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 96.9 bits (242), Expect = 8e-22
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN-----EVMVISKL 534
             ++    LG+G F  VY  R     Q +A+K++        ++ +N     E+ ++ +L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            H N++ LL          L++++M    L+ ++ D          K +  +    +GL 
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLE 126

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH+     I+HRDLK +N+LLDE    K++DFG+AK F G+ ++A T +VV T  Y +P
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRAP 181

Query: 655 EYAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
           E     R      D+++ G +L E++   
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRV 210

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 21/217 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 536
            +FQ+   LG G FG V+  R +      A+K L K     L++     +E +++S + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
             ++R+ G   + ++  +I +Y+    L    F  L+K +   +   +F   E +   L 
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAE-VCLALE 120

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           YLH      II+RDLK  NILLD+  + KI+DFG AK      D   T  + GT  Y++P
Sbjct: 121 YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYT--LCGTPDYIAP 172

Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 691
           E      +++  D +SFG+L+ E+++G   T F++ +
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDSN 207

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 94.9 bits (237), Expect = 1e-21
 Identities = 47/213 (22%), Positives = 99/213 (46%), Gaps = 24/213 (11%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF--------MNEVMVI 531
             ++   K+G+G +G V+  +  +  + +A+KR+       L++         + E+ ++
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
            +L+H+N+VRL       ++  L++E+     L             +  K F  +  + +
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF--LFQLLK 112

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
           GL + H      ++HRDLK  N+L++     K+++FG+A+ F G   +  +  VV T  Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWY 167

Query: 652 MSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRK 683
             P+     +  S   D++S G +  E+ +  +
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 95.8 bits (239), Expect = 2e-21
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 39/218 (17%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
            + +   LG+G FG V      K  Q++A+K +S+              E+  +  L+H 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 591
           ++++L    +     + ++ EY         LFD + +K+R+   + R+ F  II  I  
Sbjct: 70  HIIKLYDV-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE- 122

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF-G 650
              Y HR    +I+HRDLK  N+LLD+ LN KI+DFG++ I          G  + T  G
Sbjct: 123 ---YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-------TDGNFLKTSCG 169

Query: 651 YMSPEYA----MEGRFSE--KSDVFSFGVLLLEIVSGR 682
             SP YA    + G+     + DV+S G++L  ++ GR
Sbjct: 170 --SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 97.9 bits (244), Expect = 2e-21
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 38/218 (17%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
           ++ L   LG G FG V  G+    G ++AVK L++    S   + +   E+  +   +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 591
           ++++L    +     + ++ EY+    L    FD + K  RL   + R+ F  I+ G+  
Sbjct: 77  HIIKLYQV-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD- 130

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF-G 650
              Y HR     ++HRDLK  N+LLD  +N KI+DFG++ +          G  + T  G
Sbjct: 131 ---YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------SDGEFLRTSCG 177

Query: 651 YMSPEYA----MEGRFSE--KSDVFSFGVLLLEIVSGR 682
             SP YA    + GR     + D++S GV+L  ++ G 
Sbjct: 178 --SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 95.3 bits (238), Expect = 2e-21
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 42/226 (18%)

Query: 478 TATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMN-----EVM 529
           ++++ F+   KLG G +  VY G     G  +A+K  +L        EE        E+ 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS------EEGTPSTAIREIS 55

Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
           ++ +L+H N+VRL        +  L++E+M     D      LKK  +D R   N   G+
Sbjct: 56  LMKELKHENIVRLYDVIHTENKLTLVFEFM---DND------LKKY-MDSRTVGNTPRGL 105

Query: 590 S------------RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
                        +GL + H +   +I+HRDLK  N+L+++    K+ DFG+A+ F G  
Sbjct: 106 ELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIP 161

Query: 638 DQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
               +  VV T  Y +P+  M  R  S   D++S G +L E+++G+
Sbjct: 162 VNTFSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 536
           N+F     LG+G FG V   R K      A+K L K      +E    + E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 593
             L  L     +  +++  + EY     L    F  L +ER+  + R RF   E I   L
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAE-IVSAL 118

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            YLH      +++RD+K  N++LD++ + KI+DFG+ K    +     T    GT  Y++
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 173

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 94.6 bits (236), Expect = 3e-21
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-------FMNEVMVIS 532
             +    KLG+G +  VY G+ K     +A+K +       LE         + EV ++ 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR------LEHEEGAPCTAIREVSLLK 55

Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
            L+H N+V L       +   L++EY+ ++ L   L D      +   K F  +  + RG
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRG 112

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L Y HR    +++HRDLK  N+L++E    K++DFG+A+       +     VV T  Y 
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYR 167

Query: 653 SPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
            P+  +    +S + D++  G +  E+ +GR
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 96.0 bits (239), Expect = 3e-21
 Identities = 44/203 (21%), Positives = 78/203 (38%), Gaps = 27/203 (13%)

Query: 485 LSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRL 542
            S  LG G  G V     K   ++ A+K L         +   EV +  +     ++VR+
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120

Query: 543 LGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLY 595
           +              ++ E +    L    F  ++         R+   I++ I   + Y
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 596 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           LH    + I HRD+K  N+L          K++DFG AK    +           T  Y+
Sbjct: 177 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYV 230

Query: 653 SPEYAMEGRFSEKSDVFSFGVLL 675
           +PE     ++ +  D++S GV++
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIM 253

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.9 bits (234), Expect = 6e-21
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 35/212 (16%)

Query: 480 TNNFQLSSK-LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H 536
           T+++QLS + LG G  G V     +  GQ+ A+K L  +      +   EV    +    
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81

Query: 537 RNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------II 586
            ++V +L              +I E M    L    F  +++      + F       I+
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERG---DQAFTEREAAEIM 134

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTG 643
             I   + +LH      I HRD+K  N+L    +++   K++DFG AK    N  Q    
Sbjct: 135 RDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ---- 187

Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLL 675
               T  Y++PE     ++ +  D++S GV++
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 94.3 bits (235), Expect = 9e-21
 Identities = 51/222 (22%), Positives = 97/222 (43%), Gaps = 40/222 (18%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRN 538
              +     +G G FG V+  +L +  E+A+K++ +      + F N E+ ++  ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93

Query: 539 LVRLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG---- 588
           +V L        +K       L+ EY+P         + + +    + K    +      
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVP---------ETVYRASRHYAKLKQTMPMLLIK 144

Query: 589 -----ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADT 642
                + R L Y+H    + I HRD+K  N+LLD      K+ DFG AKI      + + 
Sbjct: 145 LYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNV 199

Query: 643 GRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGR 682
             +  +  Y +PE  + G   ++   D++S G ++ E++ G+
Sbjct: 200 SYIC-SRYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 93.0 bits (232), Expect = 1e-20
 Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 22/213 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR---LKDGQEI-AVKRLSKAS----GQGLEEFMNEVMVIS 532
             F+L   LG+GG+G V+  R     +  +I A+K L KA      +       E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 533 KLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGI 589
           +++H  +V L+    +   K+ LI EY+    L    F  L++E +  +    F + E I
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAE-I 130

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
           S  L +LH+     II+RDLK  NI+L+ + + K++DFG+ K    +     T    GT 
Sbjct: 131 SMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTI 185

Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            YM+PE  M    +   D +S G L+ ++++G 
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 93.0 bits (232), Expect = 1e-20
 Identities = 67/211 (31%), Positives = 114/211 (54%), Gaps = 20/211 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR---LKDGQEI-AVKRLSKAS--GQGLEEFMNEVMVISKL 534
           + F+L   LGQG FG V+  +     D +++ A+K L KA+   +       E  ++ ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 535 QHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISR 591
            H  +V+L     + E K+ LI +++    L    F  L KE +  +   +F + E ++ 
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE-LAL 137

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L +LH    L II+RDLK  NILLDEE + K++DFG++K    ++ +A +    GT  Y
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           M+PE       ++ +D +SFGVL+ E+++G 
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 20/210 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVK--RLSKASGQGLEEF----MNEVMVISK 533
             ++    +G+G +G V   R KD G+ +A+K    S       +      M E+ ++ +
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           L+H NLV LL  C + +   L++E++ + ++   L        LD++     +  I  G+
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLEL--FPNGLDYQVVQKYLFQIINGI 137

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            + H      IIHRD+K  NIL+ +    K+ DFG A+       +     V  T  Y +
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRA 192

Query: 654 PEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 682
           PE  +      K+ DV++ G L+ E+  G 
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 22/218 (10%)

Query: 479 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEF----MNEVMVIS 532
           AT+ ++  +++G G +G VY  R    G  +A+K +     G G        + EV ++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 533 KLQ---HRNLVRLLGCCVEGEEK-----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
           +L+   H N+VRL+  C            L++E++ ++ L   L D      L      +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124

Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
           ++    RGL +LH +    I+HRDLK  NIL+      K++DFG+A+I+        T  
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPV 179

Query: 645 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           VV T  Y +PE  ++  ++   D++S G +  E+   +
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 36/216 (16%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNL 539
            +     +G G FG     R     + +AVK + +  G  ++E +  E++    L+H N+
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNI 78

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISRGLL 594
           VR     +      +I EY     L    ++ +    R    + R  F  ++ G+S    
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS---- 130

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           Y H    ++I HRDLK  N LLD    P  KI DFG +K    +  Q  +   VGT  Y+
Sbjct: 131 YCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS--TVGTPAYI 184

Query: 653 SPE------YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           +PE      Y   G+    +DV+S GV L  ++ G 
Sbjct: 185 APEVLLRQEYD--GK---IADVWSCGVTLYVMLVGA 215

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 42/223 (18%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF--------MNEVMVI 531
           + ++  +KLG+G +G VY        + +A+KR+       LE          + EV ++
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87

Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS- 590
            +LQHRN++ L           LI+EY      D      LKK  +D     ++    S 
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA---END------LKK-YMDKNPDVSMRVIKSF 137

Query: 591 -----RGLLYLHRDSRLRIIHRDLKASNILLDEELNP-----KISDFGMAKIFGGNQDQA 640
                 G+ + H     R +HRDLK  N+LL           KI DFG+A+ F G   + 
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193

Query: 641 DTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 682
            T  ++ T  Y  PE  +    +S   D++S   +  E++   
Sbjct: 194 FTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 12/206 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN--EVMVISKLQHR 537
             ++   K+G+G +G V+  R +D GQ +A+K+  ++    + + +   E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           NLV LL          L++EY  + ++   L     +  +      +I     + + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
           +      IHRD+K  NIL+ +    K+ DFG A++  G         V  T  Y SPE  
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPELL 174

Query: 658 MEGRF-SEKSDVFSFGVLLLEIVSGR 682
           +         DV++ G +  E++SG 
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 94.0 bits (234), Expect = 2e-20
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 41/223 (18%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHR 537
             ++  +  +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 538 NLVRLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG--- 588
           N+VRL        EK       L+ +Y+P         + + +    + +    +     
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYSRAKQTLPVIYV 158

Query: 589 ------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQAD 641
                 + R L Y+H      I HRD+K  N+LLD +    K+ DFG AK     + + +
Sbjct: 159 KLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPN 213

Query: 642 TGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGR 682
              +  +  Y +PE  + G   ++   DV+S G +L E++ G+
Sbjct: 214 VSYIC-SRYYRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 91.9 bits (229), Expect = 5e-20
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 19/210 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISK-LQ 535
           ++F     +G+G FG V   R K  +   AVK L K +    +E    M+E  V+ K ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 592
           H  LV L     +  +K+  + +Y+    L    F  L++ER  L+ R RF   E I+  
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAE-IASA 151

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L YLH    L I++RDLK  NILLD + +  ++DFG+ K    +     T    GT  Y+
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYL 206

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           +PE   +  +    D +  G +L E++ G 
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 91.1 bits (227), Expect = 6e-20
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 535
            +F L   +G+G +  V   RLK    I A+K + K      + ++    E  V  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 592
           H  LV L   C + E ++  + EY+    L       ++++R   +   RF   E IS  
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAE-ISLA 122

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L YLH      II+RDLK  N+LLD E + K++D+GM K      D   T    GT  Y+
Sbjct: 123 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYI 177

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           +PE      +    D ++ GVL+ E+++GR
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 91.1 bits (227), Expect = 8e-20
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 19/210 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 535
           +NF+    LG+G FG V   R+K+  ++ AVK L K        +E  M E  ++S    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 592
           H  L +L  CC +  +++  + E++    L       ++K R   + R RF   E I   
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAE-IISA 136

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L++LH      II+RDLK  N+LLD E + K++DFGM K    N     T    GT  Y+
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYI 191

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           +PE   E  +    D ++ GVLL E++ G 
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 90.4 bits (225), Expect = 1e-19
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISK-LQ 535
            +F L   LG+G FG V+    K   +  A+K L K      ++    M E  V+S   +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 592
           H  L  +  C  + +E +  + EY+    L       ++        R  F   E I  G
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFDLSRATFYAAE-IILG 130

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L +LH      I++RDLK  NILLD++ + KI+DFGM K       + +T    GT  Y+
Sbjct: 131 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYI 185

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           +PE  +  +++   D +SFGVLL E++ G+
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 90.9 bits (226), Expect = 1e-19
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 535
            +F L   +G+G +  V   RLK    I A++ + K      + ++    E  V  +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRG 592
           H  LV L   C + E ++  + EY+    L       ++++R   +   RF   E IS  
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAE-ISLA 165

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L YLH      II+RDLK  N+LLD E + K++D+GM K      D   T    GT  Y+
Sbjct: 166 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYI 220

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           +PE      +    D ++ GVL+ E+++GR
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 92.8 bits (230), Expect = 2e-19
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 535
            +F     LG+G FG V     K   E+ AVK L K        +E  M E  V++   +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 592
              L +L   C +  +++  + EY+    L       +++     +    F   E I+ G
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAE-IAIG 454

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L +L       II+RDLK  N++LD E + KI+DFGM K    +     T    GT  Y+
Sbjct: 455 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYI 509

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           +PE      + +  D ++FGVLL E+++G+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 89.2 bits (222), Expect = 3e-19
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 535
            +F     LG+G FG V     K   E+ AVK L K        +E  M E  V++   +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRG 592
              L +L   C +  +++  + EY+    L       +++     +    F   E I+ G
Sbjct: 80  PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAE-IAIG 133

Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           L +L       II+RDLK  N++LD E + KI+DFGM K    +     T    GT  Y+
Sbjct: 134 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYI 188

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           +PE      + +  D ++FGVLL E+++G+
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 87.6 bits (218), Expect = 7e-19
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 32/220 (14%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI-AVKRLSKASGQGLEEFMN--------EVMV 530
             ++  +++G+G +G V+  R LK+G    A+KR+       ++            EV V
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64

Query: 531 ISKLQ---HRNLVRLLGCCVEGEEK-----MLIYEYMPNRSLDALLFDPLKKERLDWRKR 582
           +  L+   H N+VRL   C            L++E++ ++ L   L D + +  +     
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122

Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
            +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+        T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177

Query: 643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
             VV T  Y +PE  ++  ++   D++S G +  E+   +
Sbjct: 178 SVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 35/219 (15%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
              +Q    +G G  G V         + +A+K+LS+        F N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76

Query: 530 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
           ++  + H+N++ LL          E ++  ++ E M     DA L   ++ E    R  +
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSY 131

Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
            ++  +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T 
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TP 185

Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            VV T  Y +PE  +   + E  D++S G ++ E++ G 
Sbjct: 186 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 87.2 bits (216), Expect = 4e-18
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
              +Q    +G G  G V         + +A+K+LS+        F N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113

Query: 530 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
           ++  + H+N++ LL          E ++  L+ E M     DA L   ++ E    R  +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSY 168

Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
            + + +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G       T 
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTP 222

Query: 644 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            VV T  Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 85.4 bits (212), Expect = 6e-18
 Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 32/223 (14%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE--FMN---------EV 528
            + + +   +  G +G V  G   +G  +A+KR+      G       +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 529 MVISKLQHRNLVRLLGC-CVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL---DWR 580
            +++   H N++ L        E  M    L+ E M        L   +  +R+      
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQH 135

Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
            ++  +  I  GL  LH      ++HRDL   NILL +  +  I DF +A+      D  
Sbjct: 136 IQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--EDTADAN 189

Query: 641 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
            T  V     Y +PE  M+   F++  D++S G ++ E+ + +
Sbjct: 190 KTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 85.0 bits (211), Expect = 7e-18
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 26/217 (11%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR---LKDGQEI-AVKRLSKAS----GQGLEEFMNEVMVIS 532
            NF+L   LG G +G V+  R     D  ++ A+K L KA+     +  E    E  V+ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 533 KLQHRN-LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEG 588
            ++    LV L     + E K+ LI +Y+    L    F  L +     +   +  + E 
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGE- 167

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVG 647
           I   L +LH+   L II+RD+K  NILLD   +  ++DFG++K F     ++A      G
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCG 222

Query: 648 TFGYMSPEYAMEGRFSEKSDV--FSFGVLLLEIVSGR 682
           T  YM+P+    G       V  +S GVL+ E+++G 
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 85.0 bits (210), Expect = 7e-18
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    G     
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 680
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.0 bits (166), Expect = 3e-12
 Identities = 37/168 (22%), Positives = 62/168 (36%), Gaps = 19/168 (11%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
           +  +L   LG+G FG V              + +AVK L   A+       M+E+ ++  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 534 L-QHRNLVRLLGCC-VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +  H N+V LLG C   G   M+I E+    +L   L            KR   +   ++
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
           G  +      +  I  DLK     +    +   S F   K     +++
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 50/220 (22%), Positives = 104/220 (47%), Gaps = 38/220 (17%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
              +   + +G G +G V      + G+++A+K+LS+        F +         E++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 530 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
           ++  +QH N++ LL             +  L+  +M        L   +  +  + + ++
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY 130

Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
            ++  + +GL Y+H      ++HRDLK  N+ ++E+   KI DFG+A+      D   TG
Sbjct: 131 -LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH----ADAEMTG 182

Query: 644 RVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
            VV T  Y +PE  +    +++  D++S G ++ E+++G+
Sbjct: 183 YVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 83.5 bits (207), Expect = 3e-17
 Identities = 53/223 (23%), Positives = 96/223 (43%), Gaps = 35/223 (15%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
            + FQ+    GQG FG V  G+ K  G  +A+K++ +       E    +  ++ L H N
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80

Query: 539 LVRLLGC-CVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG--- 588
           +V+L       GE         ++ EY+P         D L +   ++ +R         
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVP---------DTLHRCCRNYYRRQVAPPPILI 131

Query: 589 ------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQAD 641
                 + R +  LH  S + + HRD+K  N+L++E     K+ DFG AK    +  + +
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPN 188

Query: 642 TGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGR 682
              +   + Y +PE  + G   ++   D++S G +  E++ G 
Sbjct: 189 VAYICSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.5 bits (202), Expect = 7e-17
 Identities = 48/210 (22%), Positives = 101/210 (48%), Gaps = 21/210 (10%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HR 537
            +++QL  KLG+G +  V+    + + +++ VK L     +   +   E+ ++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91

Query: 538 NLVRLLGCCVEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           N++ L     +   +   L++E++ N     L +  L    +    RF + E I + L Y
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQL-YQTLTDYDI----RFYMYE-ILKALDY 145

Query: 596 LHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
            H  S   I+HRD+K  N+++D E    ++ D+G+A+    +  Q    RV  +  +  P
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVA-SRYFKGP 199

Query: 655 EYAMEGRFSEKS-DVFSFGVLLLEIVSGRK 683
           E  ++ +  + S D++S G +L  ++  ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 37/222 (16%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
              +   S +G+G +G V       +   +A+K++S         F +         E+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 530 VISKLQHRNLVRLLGCCV-EGEEKM----LIYEYMPNRSLDALLFDPLKKERL-DWRKRF 583
           ++ + +H N++ +         E+M    ++ + M     +  L+  LK + L +    +
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICY 132

Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-- 641
             +  I RGL Y+H  S   ++HRDLK SN+LL+   + KI DFG+A++   + D     
Sbjct: 133 -FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188

Query: 642 TGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           T  V  T  Y +PE  +    +++  D++S G +L E++S R
Sbjct: 189 TEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 39/221 (17%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
              ++    +G G +G V      + G ++A+K+L +        F +         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76

Query: 530 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKR 582
           ++  ++H N++ LL          +  +  L+  +M        L   +K E+L + R +
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQ 131

Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
           F ++  + +GL Y+H      IIHRDLK  N+ ++E+   KI DFG+A+      D   T
Sbjct: 132 F-LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMT 183

Query: 643 GRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           G VV T  Y +PE  +   R+++  D++S G ++ E+++G+
Sbjct: 184 GYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 52/232 (22%), Positives = 102/232 (43%), Gaps = 48/232 (20%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
            + +     LG GG G V+        + +A+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 530 VISKLQHRNLVRLL--------------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE 575
           +I +L H N+V++               G   E     ++ EYM     +  L + L++ 
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQG 115

Query: 576 RL-DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIF 633
            L +   R   +  + RGL Y+H  +   ++HRDLK +N+ ++ E+L  KI DFG+A+I 
Sbjct: 116 PLLEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 634 GGNQDQAD--TGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
             +       +  +V T  Y SP   +    +++  D+++ G +  E+++G+
Sbjct: 172 DPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 39/221 (17%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
              +Q  S +G G +G V      K G  +AVK+LS+        F +         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 530 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKR 582
           ++  ++H N++ LL          E  +  L+   M      A L + +K ++L D   +
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQ 135

Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
           F +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+          T
Sbjct: 136 F-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH----TADEMT 187

Query: 643 GRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
           G V  T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 188 GYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.2 bits (190), Expect = 5e-15
 Identities = 35/203 (17%), Positives = 85/203 (41%), Gaps = 33/203 (16%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
            + +++   +G G +G V       + + +A+K++ +        F +         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-------FEDLIDCKRILREIA 104

Query: 530 VISKLQHRNLVRLLG-CCVEGEEKM----LIYEYMPNRSLDALL--FDPLKKERLDWRKR 582
           ++++L H ++V++L     +  EK     ++ E         L      L +       +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELH----IK 159

Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
             ++  +  G+ Y+H  S   I+HRDLK +N L++++ + K+ DFG+A+     ++    
Sbjct: 160 T-LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 643 GRVVGTFGYMSPEYAMEGRFSEK 665
             +      M+       +  ++
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKR 238

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 45/247 (18%), Positives = 91/247 (36%), Gaps = 53/247 (21%)

Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQ 535
           T++  + L   LG G FG V      + G+  A+K++ +        + N E+ ++  L 
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58

Query: 536 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------- 584
           H N+++L+        E  +     +            +   K  +    +         
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 585 --------IIEGIS-------------------RGLLYLHRDSRLRIIHRDLKASNILLD 617
                   +++                      R + ++H    L I HRD+K  N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175

Query: 618 EELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLL 675
            + N  K+ DFG AK       +     +   F Y +PE  +    ++   D++S G + 
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 676 LEIVSGR 682
            E++ G+
Sbjct: 233 GELILGK 239

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 44/229 (19%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
           +++FQL S LG+G +G V        G+ +A+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 530 VISKLQHRNLVRLLGC-CVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL-DWRKRF 583
           ++   +H N++ +      +  E      +I E M        L   +  + L D   ++
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQY 116

Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-- 641
             I    R +  LH  +   +IHRDLK SN+L++   + K+ DFG+A+I   +       
Sbjct: 117 -FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

Query: 642 -------TGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 682
                     V  T  Y +PE  +   ++S   DV+S G +L E+   R
Sbjct: 173 TGQQSGMVEFVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 42/203 (20%), Positives = 75/203 (36%), Gaps = 48/203 (23%)

Query: 485 LSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRL 542
            S  LG G  G V     K   ++ A+K L         +   EV +  +  Q  ++VR+
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76

Query: 543 LGCC---VEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLY 595
           +        G + + ++ E +        LF  ++         R+   I++ I   + Y
Sbjct: 77  VDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 596 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 652
           LH    + I HRD+K  N+L          K++DFG AK                     
Sbjct: 133 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET------------------- 170

Query: 653 SPEYAMEGRFSEKSDVFSFGVLL 675
                   ++ +  D++S GV++
Sbjct: 171 -----TGEKYDKSCDMWSLGVIM 188

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 40/211 (18%), Positives = 87/211 (41%), Gaps = 33/211 (15%)

Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN--- 526
           FQ  +     +N+ +   +G+G +G VY        + +A+K++++        F +   
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLID 68

Query: 527 ------EVMVISKLQHRNLVRLLGCCV-EGEEKM----LIYEYMPNRSLDALL--FDPLK 573
                 E+ ++++L+   ++RL    + +   K     ++ E      L  L      L 
Sbjct: 69  CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLT 127

Query: 574 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
           +E      +  I+  +  G  ++H      IIHRDLK +N LL+++ + K+ DFG+A+  
Sbjct: 128 EEH----IKT-ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 634 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 664
              +D      +            ++ + + 
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 47/190 (24%), Positives = 92/190 (48%), Gaps = 30/190 (15%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
              ++L  KLG+G +G V+     + G+ +AVK++  A       F N         E+M
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60

Query: 530 VISKLQ-HRNLVRLLGCCV--EGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNI 585
           ++++L  H N+V LL         +  L+++YM     +  L   ++   L    K++ +
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQY-V 114

Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
           +  + + + YLH  S   ++HRD+K SNILL+ E + K++DFG+++ F   +   +   +
Sbjct: 115 VYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

Query: 646 VGTFGYMSPE 655
                  + +
Sbjct: 172 SINENTENFD 181

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 50/228 (21%), Positives = 98/228 (42%), Gaps = 44/228 (19%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ------ 535
           + L  KLG G F  V+  + + +   +A+K + +      E   +E+ ++ ++       
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 536 -----HRNLVRLLGC-CVEGEEKM---LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI- 585
                  ++++LL     +G   +   +++E      L   L   +KK      +   + 
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEH---RGIPLI 131

Query: 586 -IEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEELNP------KISDFGMAKIFG 634
            ++ IS+    GL Y+HR  R  IIH D+K  N+L++   +P      KI+D G A  + 
Sbjct: 132 YVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWY 188

Query: 635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                      + T  Y SPE  +   +   +D++S   L+ E+++G 
Sbjct: 189 DEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.1 bits (160), Expect = 1e-11
 Identities = 35/199 (17%), Positives = 67/199 (33%), Gaps = 46/199 (23%)

Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL--------SKASGQGLEEFMNEVMV 530
            T   Q   K+G+G FG V+         +A+K +        + +  +  EE + E+++
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 531 ISKLQ---------HRNLVRLLGC-CVEG---EEKMLIYEYM----------PNRSLDAL 567
             +L              + L    CV+G      +  +++           P+   D  
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 568 LF------------DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615
           LF            + ++ +        +I+  ++  L        LR  HRDL   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 616 LDEELNPKISDFGMAKIFG 634
           L +    K+      K   
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 67.2 bits (163), Expect = 2e-11
 Identities = 85/658 (12%), Positives = 191/658 (29%), Gaps = 207/658 (31%)

Query: 191 QNIPEIFVWNVSRP-Y-WRSGPWNGQIFIGIPELKSV-YLFRHNFTFGFANDWTFFA--- 244
           + + + FV  V R  Y +   P   +     P + +  Y+ + +  +   ND   FA   
Sbjct: 76  EEMVQKFVEEVLRINYKFLMSPIKTEQ--RQPSMMTRMYIEQRDRLY---NDNQVFAKYN 130

Query: 245 LT-AQGILEERIWIKWKDNWEVGFLNLRTECDV--YGKCGAFGICNSQEKPICSCL---- 297
           ++  Q  L+ R  +          L LR   +V   G  G  G      K   + +    
Sbjct: 131 VSRLQPYLKLRQAL----------LELRPAKNVLIDGVLG-SG------K---TWVALDV 170

Query: 298 ---EGFEPKNAEEWNRGNW-TSGCIRRSKLQCER-RNITGKVGKEDGFSKLNKMKVPDFT 352
                 + K      +  W         +   E  + +  ++         +   +    
Sbjct: 171 CLSYKVQCKMD---FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227

Query: 353 EWTSPATEDECREQCLKNC---------SCIAYAFDGGIGC---MVWRSINLIDI----- 395
                      + +  +NC         +    AF+  + C   +  R   + D      
Sbjct: 228 HSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFN--LSCKILLTTRFKQVTDFLSAAT 285

Query: 396 --------QRLPFG---GTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRW 444
                     +         L ++  +    +  ++ +  +P    + A       L  W
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA-ESIRDGLATW 344

Query: 445 IAKRKEVIAKLSATNVNTVKLQDLPLFQ--FEELATATNNFQLSSKLGQGGFGP-----V 497
              +     KL+    +++ + +   ++  F+ L+     F  S+ +      P     +
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV----FPPSAHI------PTILLSL 394

Query: 498 YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVI-SKLQHRNLVRLLGCCVEGEEKMLIY 556
            W  +                       ++VMV+ +KL   +L       VE + K    
Sbjct: 395 IWFDVIK---------------------SDVMVVVNKLHKYSL-------VEKQPKESTI 426

Query: 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
                 S+ ++  + LK +  +                 LHR     I+           
Sbjct: 427 ------SIPSIYLE-LKVKLEN--------------EYALHR----SIVDHYNIPKTFDS 461

Query: 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 676
           D+ + P +  +     +                G+    +       E+  +F   ++ L
Sbjct: 462 DDLIPPYLDQY----FY-------------SHIGH----HLKNIEHPERMTLFR--MVFL 498

Query: 677 EIVSGRKNTSFFEDDLTILGYAWK----LWNENKILALVDPFLSESSFQLDMIIRCIHVG 732
                  +  F E  +     AW     + N  + L    P++ ++  + + ++      
Sbjct: 499 -------DFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVN----- 546

Query: 733 LLCVQELVKDRPNMSTVVSMLNSEIRD-----LPYPKEPAFTERQGADDSESFKQIQQ 785
                 ++   P +    +++ S+  D     L    E  F         E+ KQ+Q+
Sbjct: 547 -----AILDFLPKIEE--NLICSKYTDLLRIALMAEDEAIF--------EEAHKQVQR 589

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 60.2 bits (146), Expect = 3e-11
 Identities = 22/121 (18%), Positives = 46/121 (38%), Gaps = 17/121 (14%)

Query: 24  SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLK 83
           +S++S   +      L  G +++L      +       + YD       +W +N      
Sbjct: 2   NSLSSPNSLF-TGHSLEVGPSYRLIMQGDCNF------VLYD---SGKPVWASNTGG--L 49

Query: 84  DSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWE 143
            S   +T+  +GNLV+ +    V+W +  +    +     L    N+V+       +VW 
Sbjct: 50  GSGCRLTLHNNGNLVIYDQSNRVIWQTKTNG-KEDHYVLVLQQDRNVVIYGP----VVWA 104

Query: 144 S 144
           +
Sbjct: 105 T 105

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.0 bits (158), Expect = 5e-11
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 36/221 (16%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 538
           N F+L  K+G G FG +Y G  ++  +E+A+K  + K     L     E  +   LQ   
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL---YESKIYRILQGGT 63

Query: 539 LV-RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 590
            +  +    VEG+  +L+ + +   SL+  LF+          ++ ++        + I+
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCS-------RKLSLKTVLMLADQMIN 114

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK---ISDFGMAKIFGGNQDQA-----DT 642
           R + ++H  S    +HRD+K  N L+          I DFG+AK +            + 
Sbjct: 115 R-VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170

Query: 643 GRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
             + GT  Y S      G   S + D+ S G +L+  + G 
Sbjct: 171 KNLTGTARYASV-NTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.3 bits (157), Expect = 5e-11
 Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 42/224 (18%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK------RLSKASGQGLEEFMNEVMVIS 532
            + +++ S +G+G FG V       + + +A+K           +         EV ++ 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVRLLE 105

Query: 533 KLQHR------NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI- 585
            +          +V L    +      L++E      L   L+D L+       +  ++ 
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTN---FRGVSLN 157

Query: 586 -IEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQD 638
                ++     LL+L     L IIH DLK  NILL        KI DFG +        
Sbjct: 158 LTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LG 212

Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           Q     +   F Y SPE  +   +    D++S G +L+E+ +G 
Sbjct: 213 QRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQH-R 537
           N ++L  K+G G FG +Y G  +  G+E+A+K    K     L     E  +   +Q   
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH---IESKIYKMMQGGV 65

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 590
            +  +  C  EG+  +++ E +   SL+  LF+          ++F++        + IS
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCS-------RKFSLKTVLLLADQMIS 116

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK---ISDFGMAKIF----GGNQDQADTG 643
           R + Y+H  +    IHRD+K  N L+          I DFG+AK +              
Sbjct: 117 R-IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

Query: 644 R-VVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
           + + GT  Y S      G   S + D+ S G +L+    G 
Sbjct: 173 KNLTGTARYASI-NTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 46/227 (20%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQH-R 537
            NF++  K+G G FG +  G+ L   + +A+K    K+    L     E     +L    
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQL---HLEYRFYKQLGSGD 65

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 590
            + ++      G+   ++ E +   SL+  LFD          + F++       I+ IS
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCD-------RTFSLKTVLMIAIQLIS 116

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK-----ISDFGMAKIFGGNQDQADTGR- 644
           R + Y+H  +   +I+RD+K  N L+    N       I DF +AK +    D  +T + 
Sbjct: 117 R-MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY---ID-PETKKH 168

Query: 645 --------VVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
                   + GT  YMS      G+  S + D+ + G + +  + G 
Sbjct: 169 IPYREHKSLTGTARYMSI-NTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 60/229 (26%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK------RLSKASGQGLEEFMNEVMVISKLQ 535
           +++   +G+G FG V      K  Q +A+K      R  + +         E+ ++  L+
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIRILEHLR 151

Query: 536 HR------NLVRLLGC-------CVEGEEKMLIYEYM-PNRSLDALLFDPLKKERLDWRK 581
            +      N++ +L         C       + +E +  N      L++ +KK +    +
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHIC-------MTFELLSMN------LYELIKKNKF---Q 195

Query: 582 RFNI--IEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIF 633
            F++  +   +      L  LH+    RIIH DLK  NILL ++     K+ DFG +   
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY- 251

Query: 634 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
              + Q     +   F Y +PE  +  R+    D++S G +L E+++G 
Sbjct: 252 ---EHQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 54/273 (19%), Positives = 99/273 (36%), Gaps = 88/273 (32%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ--- 535
              + +  KLG G F  V+    ++  + +A+K + K++    E  ++E+ ++  ++   
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94

Query: 536 -----HRNLVRLLGC-CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN----- 584
                   +V+LL    + G           N +   ++F+ L    L W  + N     
Sbjct: 95  PNDPNREMVVQLLDDFKISG----------VNGTHICMVFEVLGHHLLKWIIKSNYQGLP 144

Query: 585 ------IIEGISRGLLYLHRDSRLRIIHRDLKASNILL---------------------- 616
                 II+ + +GL YLH  ++ RIIH D+K  NILL                      
Sbjct: 145 LPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202

Query: 617 ---------------------------DEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 649
                                       E+L  KI+D G A  +       D    + T 
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA-CWVHKHFTED----IQTR 257

Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            Y S E  +   ++  +D++S   +  E+ +G 
Sbjct: 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 44/223 (19%), Positives = 93/223 (41%), Gaps = 38/223 (17%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQH-R 537
            ++++  ++G+G FG ++ G  L + Q++A+K    ++    L    +E      L    
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR---DEYRTYKLLAGCT 66

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 590
            +  +     EG   +L+ + +   SL+  L D          ++F++        + ++
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCG-------RKFSVKTVAMAAKQMLA 117

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK-----ISDFGMAKIFGGNQDQA----- 640
           R +  +H  S   +++RD+K  N L+    +       + DFGM K +     +      
Sbjct: 118 R-VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173

Query: 641 DTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
           +   + GT  YMS      GR  S + D+ + G + +  + G 
Sbjct: 174 EKKNLSGTARYMSI-NTHLGREQSRRDDLEALGHVFMYFLRGS 215

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 56.1 bits (135), Expect = 9e-10
 Identities = 23/127 (18%), Positives = 40/127 (31%), Gaps = 17/127 (13%)

Query: 23  DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMG-----IWYDMPSEKAVIWVAN 77
           ++ I S Q   +   IL    +  L            M      + YD       IW  N
Sbjct: 1   NNIIFSKQPDDNHPQILHATES--LEILFGTHVYRFIMQTDCNLVLYD---NNNPIWATN 55

Query: 78  RDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNIN 137
                  +     +  DG LV++  +   +W S V+          L    N+V+  +  
Sbjct: 56  TGG--LGNGCRAVLQPDGVLVVITNENVTVWQSPVAG-KAGHYVLVLQPDRNVVIYGD-- 110

Query: 138 RAIVWES 144
              +W +
Sbjct: 111 --ALWAT 115

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 55.3 bits (133), Expect = 1e-09
 Identities = 27/123 (21%), Positives = 45/123 (36%), Gaps = 18/123 (14%)

Query: 22  IDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNP 81
           +D+ + S Q +   D  L  G  + L   N  +       + Y        IW +N D  
Sbjct: 1   MDNVLLSGQTLH-ADHSLQAG-AYTLTIQNKCNL------VKYQ---NGRQIWASNTDR- 48

Query: 82  LKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIV 141
            + S   +T+  DGNLV+ +     +W S      N   +  L   G  V+       ++
Sbjct: 49  -RGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG-DNGKYALVLQKDGRFVIYGP----VL 102

Query: 142 WES 144
           W  
Sbjct: 103 WSL 105

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 44.1 bits (104), Expect = 1e-05
 Identities = 18/76 (23%), Positives = 32/76 (42%), Gaps = 2/76 (2%)

Query: 77  NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
           + D+ L+  +  +TI    NLV     +  +W+SN     +      LL  GNLV+ D+ 
Sbjct: 12  HADHSLQAGAYTLTIQNKCNLVKYQNGR-QIWASNTDRRGSGCR-LTLLSDGNLVIYDHN 69

Query: 137 NRAIVWESFQEPTDSF 152
           N  +   +       +
Sbjct: 70  NNDVWGSACWGDNGKY 85

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 32/214 (14%), Positives = 66/214 (30%), Gaps = 60/214 (28%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR---------LKDGQEIAVKRLSKASGQGLEEFMNEVMVI 531
             ++L S   +   G +Y                Q+ ++K L    G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 532 SKLQHRNLVRLLGC------------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW 579
             LQ     +L                 + + + L+   +  RSL + L        +  
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSAL-------DVSP 152

Query: 580 RKRFNI-------IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI--SDFGMA 630
           +   +           +   L +LH +     +H ++ A NI +D E   ++  + +G A
Sbjct: 153 KHVLSERSVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

Query: 631 KIFGGNQDQADTGRVV-----------GTFGYMS 653
             +        +G+ V           G   ++S
Sbjct: 209 FRY------CPSGKHVAYVEGSRSPHEGDLEFIS 236

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.1 bits (141), Expect = 5e-09
 Identities = 48/248 (19%), Positives = 88/248 (35%), Gaps = 76/248 (30%)

Query: 480 TNNFQLSSKLGQGGFGPVY--WGRLKDGQEIAVK------RLSKASGQGLEEFMNEVMVI 531
              +++   LG+G FG V       +   ++A+K      +  +A+         E+ V+
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEINVL 70

Query: 532 SKLQHR------NLVRLLGC-------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 578
            K++ +        V +          C       + +E      L    F+ LK+    
Sbjct: 71  KKIKEKDKENKFLCVLMSDWFNFHGHMC-------IAFE-----LLGKNTFEFLKENN-- 116

Query: 579 WRKRFNI--IEGISRGLL----YLHRDSRLRIIHRDLKASNILLDEELNP---------- 622
             + + +  +  ++  L     +LH     ++ H DLK  NIL                 
Sbjct: 117 -FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172

Query: 623 ---------KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGV 673
                    +++DFG A  F    D      +V T  Y  PE  +E  +++  DV+S G 
Sbjct: 173 EKSVKNTSIRVADFGSA-TF----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGC 227

Query: 674 LLLEIVSG 681
           +L E   G
Sbjct: 228 ILFEYYRG 235

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 43/238 (18%), Positives = 91/238 (38%), Gaps = 50/238 (21%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI------AVKRLSKASGQ-----------GLEE 523
             +++   +GQGGFG +Y   +   + +       VK     +G               E
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 524 FMNEVMVISKLQHRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDW 579
            + + +   KL++  + +  G  +  +       +I +      L  + ++   K     
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKI-YEANAK----- 147

Query: 580 RKRFNI-------IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI--SDFGMA 630
             RF+        +  +   L Y+H       +H D+KASN+LL+ +   ++   D+G+A
Sbjct: 148 --RFSRKTVLQLSLRILDI-LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

Query: 631 KIF---GGNQD--QADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 682
             +   G ++           GT  + S + A  G   S + D+   G  +++ ++G 
Sbjct: 202 YRYCPEGVHKAYAADPKRCHDGTIEFTSID-AHNGVAPSRRGDLEILGYCMIQWLTGH 258

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 39/206 (18%), Positives = 73/206 (35%), Gaps = 47/206 (22%)

Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIA---VKRLSKASGQGLEEF-----MNEVMVI 531
           N + L  K+G GGFG +Y        ++ A   VK   + +G    E      + +   I
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 532 SKLQHRNLVRLLG----------CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK 581
            K   R  +  LG                 + ++ E +    L  +              
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKI---------SGQNG 146

Query: 582 RFNI-------IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI--SDFGMAKI 632
            F         I  +   L Y+H +     +H D+KA+N+LL  +   ++  +D+G++  
Sbjct: 147 TFKKSTVLQLGIRMLDV-LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202

Query: 633 F---GGNQD--QADTGRVVGTFGYMS 653
           +   G ++   +       GT  + S
Sbjct: 203 YCPNGNHKQYQENPRKGHNGTIEFTS 228

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 52.5 bits (126), Expect = 1e-08
 Identities = 16/74 (21%), Positives = 31/74 (41%), Gaps = 6/74 (8%)

Query: 72  VIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLV 131
            +W +N     K       +  DGN V+ + +   LW+S+     N +    L + GN+V
Sbjct: 39  SVWASNTGILGKKGC-KAVLQSDGNFVVYDAEGRSLWASHSVR-GNGNYVLVLQEDGNVV 96

Query: 132 LRDNINRAIVWESF 145
           +  +     +W + 
Sbjct: 97  IYGS----DIWSTG 106

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 52.5 bits (126), Expect = 1e-08
 Identities = 20/68 (29%), Positives = 27/68 (39%), Gaps = 2/68 (2%)

Query: 77  NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
                L        + ED NLVL +     +W+SN   L      A L   GN V+ D  
Sbjct: 11  YAGQSLDVEPYHFIMQEDCNLVLYDHST-SVWASNTGILGKKGCKAVLQSDGNFVVYDAE 69

Query: 137 NRAIVWES 144
            R+ +W S
Sbjct: 70  GRS-LWAS 76

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 51.8 bits (124), Expect = 2e-08
 Identities = 25/122 (20%), Positives = 45/122 (36%), Gaps = 18/122 (14%)

Query: 23  DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPL 82
           D+ + S + +  P   L+NG  +        +       + YD       IW  N     
Sbjct: 1   DNILYSGETLS-PGEFLNNG-RYVFIMQEDCNL------VLYD---VDKPIWATNTGG-- 47

Query: 83  KDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVW 142
            D    +++  DGNLV+ + +   +W+SN     N +    L    N+V+         W
Sbjct: 48  LDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG-ENGNYVCVLQKDRNVVIYGT----ARW 102

Query: 143 ES 144
            +
Sbjct: 103 AT 104

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 52/248 (20%), Positives = 90/248 (36%), Gaps = 76/248 (30%)

Query: 480 TNNFQLSSKLGQGGFGPVY--WGRLKDGQEIAVK------RLSKASGQGLEEFMNEVMVI 531
           +  +++   LG+G FG V         G+ +AVK      R  +A+        +E+ V+
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVL 65

Query: 532 SKLQHR------NLVRLLGC-------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 578
             L           V++L         C       +++E      L    +D +K+    
Sbjct: 66  EHLNTTDPNSTFRCVQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFIKENG-- 111

Query: 579 WRKRFNI--IEGISRGLL----YLHRDSRLRIIHRDLKASNILLDEELNP---------- 622
               F +  I  ++  +     +LH     ++ H DLK  NIL  +              
Sbjct: 112 -FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167

Query: 623 ---------KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGV 673
                    K+ DFG A  +    D      +V T  Y +PE  +   +S+  DV+S G 
Sbjct: 168 ERTLINPDIKVVDFGSA-TY----DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGC 222

Query: 674 LLLEIVSG 681
           +L+E   G
Sbjct: 223 ILIEYYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 54/247 (21%), Positives = 92/247 (37%), Gaps = 70/247 (28%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK------RLSKASGQGLEEFMNEVMVIS 532
            N F +  K+G G FG V   + + + +  AVK      + ++++         E  ++ 
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------KIEADILK 86

Query: 533 KLQHR-----NLVRLLGC-------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
           K+Q+      N+V+  G        C       LI+E      L   L++ + +      
Sbjct: 87  KIQNDDINNNNIVKYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITRNN---Y 131

Query: 581 KRFNI--IEGISRGLL----YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
             F+I  I+     +L    YL +   + + H DLK  NILLD+    K          G
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188

Query: 635 GNQDQADTGRV---VGTFG-----------------YMSPEYAMEGRFSEKSDVFSFGVL 674
                  T      +  FG                 Y +PE  +   +   SD++SFG +
Sbjct: 189 KKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248

Query: 675 LLEIVSG 681
           L E+ +G
Sbjct: 249 LAELYTG 255

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 49.9 bits (119), Expect = 9e-08
 Identities = 28/119 (23%), Positives = 50/119 (42%), Gaps = 16/119 (13%)

Query: 26  ITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDS 85
           + S   +      L+ G  +     N  +       + YD       +W +  +   K S
Sbjct: 4   LNSGHQLD-TGGSLAEG-GYLFIIQNDCNL------VLYD---NNRAVWASGTNG--KAS 50

Query: 86  SGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144
             ++ +  DGNLV+ +G +  +W+SN +   N +    L    N+V+ DN N AI W +
Sbjct: 51  GCVLKMQNDGNLVIYSGSR-AIWASNTNR-QNGNYYLILQRDRNVVIYDNSNNAI-WAT 106

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 46.4 bits (110), Expect = 2e-06
 Identities = 19/82 (23%), Positives = 34/82 (41%), Gaps = 12/82 (14%)

Query: 74  WVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLR 133
           W +N  N        +T+++ G LV+ NG    +W S   + V  + +A +   G LV+ 
Sbjct: 40  WQSNTAN--NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQS-VKGNYAAVVHPDGRLVVF 96

Query: 134 DNINRAIVWESFQEPTDSFLPG 155
                  V+       D ++ G
Sbjct: 97  GP----SVF-----KIDPWVRG 109

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 40.6 bits (95), Expect = 2e-04
 Identities = 21/68 (30%), Positives = 32/68 (47%), Gaps = 6/68 (8%)

Query: 77  NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
           + +  LK+    + + +D NLVL NG     W SN +N         L D G LV+++  
Sbjct: 13  DTEGHLKNGDFDLVMQDDCNLVLYNGN----WQSNTANN-GRDCKLTLTDYGELVIKNGD 67

Query: 137 NRAIVWES 144
               VW+S
Sbjct: 68  GST-VWKS 74

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 45.6 bits (108), Expect = 4e-06
 Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 4/68 (5%)

Query: 77  NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
             D  L   +  + +  D NLVL     +  W SN      +    +L   G L+++D+ 
Sbjct: 16  YGDGRLTAKNHQLVMQGDCNLVLYG--GKYGWQSNTHGNGEHCF-LRLNHKGELIIKDDD 72

Query: 137 NRAIVWES 144
            + I W S
Sbjct: 73  FKTI-WSS 79

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 44.5 bits (105), Expect = 8e-06
 Identities = 17/110 (15%), Positives = 38/110 (34%), Gaps = 15/110 (13%)

Query: 23  DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPL 82
           ++ + S Q++     + +   N +L      +       + Y         W +N     
Sbjct: 6   NNLLFSGQVLYGDGRLTA--KNHQLVMQGDCNL------VLYGG----KYGWQSNTHG-- 51

Query: 83  KDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVL 132
                 + ++  G L++ +   + +WSS  S+         L D G  V+
Sbjct: 52  NGEHCFLRLNHKGELIIKDDDFKTIWSSR-SSSKQGEYVLILQDDGFGVI 100

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 47.6 bits (112), Expect = 5e-06
 Identities = 18/142 (12%), Positives = 40/142 (28%), Gaps = 8/142 (5%)

Query: 71  AVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNL 130
             +W +N       +     +  DG LV++  Q  + WSS        +    L     +
Sbjct: 45  VRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKG-SIGNYVLVLQPDRTV 100

Query: 131 VLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIH 190
                I    +W+S      S +   +      + +          +  S       L  
Sbjct: 101 T----IYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSM 156

Query: 191 QNIPEIFVWNVSRPYWRSGPWN 212
           +    + +++     W +    
Sbjct: 157 ETDCNLVLFDRDDRVWSTNTAG 178

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 46.8 bits (110), Expect = 9e-06
 Identities = 30/153 (19%), Positives = 47/153 (30%), Gaps = 10/153 (6%)

Query: 62  IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
           I + +  E +     +    L+ SS   T+  D NLVL +     +W+SN +        
Sbjct: 3   ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDV-RVWASNTAG--ATGCR 59

Query: 122 AQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPST 181
           A L   G LV+       I W S          G +  + Q             L D  T
Sbjct: 60  AVLQSDGLLVILTA-QNTIRWSS----GTKGSIGNYVLVLQPDRTVT--IYGPGLWDSGT 112

Query: 182 GSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQ 214
            +  + ++  N   I                 Q
Sbjct: 113 SNKGSVVVANNGNSILYSTQGNDNHPQTLHATQ 145

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 43.4 bits (101), Expect = 1e-04
 Identities = 11/75 (14%), Positives = 23/75 (30%), Gaps = 7/75 (9%)

Query: 70  KAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGN 129
              +W  N          ++    +G + ++  Q   +W+S  S          L    N
Sbjct: 168 DDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSRSAGRYV-FVLQPDRN 224

Query: 130 LVLRDNINRAIVWES 144
           L +        +W +
Sbjct: 225 LAIYGG----ALWTT 235

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 46.6 bits (109), Expect = 2e-05
 Identities = 29/144 (20%), Positives = 46/144 (31%), Gaps = 17/144 (11%)

Query: 35  PDAILSNGSNFKLGFFNPADSPYRYMGIWYDM---PSEKAVIWVANRDNPLKDSSGIITI 91
              +L+ GS    G    A +         ++       A  W A         +     
Sbjct: 145 DSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGK---GAVRAVF 201

Query: 92  SEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDS 151
             DGNLV+      VLW S+     + S   +L  +G++ + D      VW  F      
Sbjct: 202 QGDGNLVVYGAGNAVLWHSHTGG--HASAVLRLQANGSIAILDE---KPVWARF-----G 251

Query: 152 FLPGMHHG-IDQRTGKKVQLTSWK 174
           F P   H        K + + +W 
Sbjct: 252 FQPTYRHIRKINPDQKPIDIWTWH 275

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 46.2 bits (108), Expect = 2e-05
 Identities = 20/123 (16%), Positives = 36/123 (29%), Gaps = 5/123 (4%)

Query: 24  SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAV--IWVANRDNP 81
           S+ TS+        +L +  N  L       +    + +         +       +   
Sbjct: 101 STFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVV 160

Query: 82  LKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIV 141
               +  +    DGNLV         W++        +  A     GNLV+    N  + 
Sbjct: 161 YGAGASKLVFQGDGNLVAYGPNGAATWNAGTQG--KGAVRAVFQGDGNLVVYGAGNAVL- 217

Query: 142 WES 144
           W S
Sbjct: 218 WHS 220

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 43.9 bits (102), Expect = 1e-04
 Identities = 30/202 (14%), Positives = 62/202 (30%), Gaps = 18/202 (8%)

Query: 15  CLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSP--YRYMGIWYDMPSEKAV 72
            + F     S + + Q +     +LS    FKL      +         +W     +   
Sbjct: 6   RIPFNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFS 65

Query: 73  IWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVL 132
             +  R+         +         L +  +  +W ++ S   +N       +  +LVL
Sbjct: 66  STIPLRNKK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQW----NRTHLVL 116

Query: 133 RDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSL-SDPSTGSFSAGLIHQ 191
           +D+ N  +V           +P +   ID        L     L      G+ ++ L+ Q
Sbjct: 117 QDDGNIVLVDSLALWNGTPAIPLVPGAIDSL-----LLAPGSELVQGVVYGAGASKLVFQ 171

Query: 192 NIPEIFVWNVS-RPYWRSGPWN 212
               +  +  +    W +G   
Sbjct: 172 GDGNLVAYGPNGAATWNAGTQG 193

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111

 Score = 42.9 bits (101), Expect = 4e-05
 Identities = 17/68 (25%), Positives = 25/68 (36%), Gaps = 3/68 (4%)

Query: 77  NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
           + DN L   S    +  D NLVL N      + SN         + +L + G L +    
Sbjct: 12  HTDNQLSYESAAFVMQGDCNLVLYNEA--GGFQSNTHGR-GVDCTLRLNNRGQLEIHSAN 68

Query: 137 NRAIVWES 144
           +   VW  
Sbjct: 69  SNTPVWVY 76

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 41.7 bits (98), Expect = 8e-05
 Identities = 11/77 (14%), Positives = 26/77 (33%), Gaps = 7/77 (9%)

Query: 68  SEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDS 127
           S+  ++W +      +     + +   G L + + +   ++ SN            L  +
Sbjct: 42  SKTNIVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVG-QEGDYVLILQIN 98

Query: 128 GNLVLRDNINRAIVWES 144
           G  V+        VW +
Sbjct: 99  GQAVVYGP----AVWST 111

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	807
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-74
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-23
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	4e-18
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	7e-16
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	3e-04
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	5e-15
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	1e-10
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	1e-09
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	1e-09
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	8e-05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (613), Expect = 6e-74
 Identities = 66/284 (23%), Positives = 130/284 (45%), Gaps = 19/284 (6%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
               +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
             +G      +  ++ ++    SL   L     + + +  K  +I    ++G+ YLH  S
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-- 658
              IIHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 659 -EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE 717
            +  +S +SDV++FG++L E+++G+        ++        +     +   +    S 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY----SNINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 761
               +  ++        C+++   +RP    +++ +    R LP
Sbjct: 238 CPKAMKRLMA------ECLKKKRDERPLFPQILASIELLARSLP 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 1e-66
 Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 21/273 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           RL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+ ++   +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
               IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +PE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185

Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 720
            F+ KSDV+SFG+LL EIV+  +       +  ++    +       +   D    E   
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI----QNLERGYRMVRPDNCPEE--- 238

Query: 721 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 753
                     +  LC +E  +DRP    + S+L
Sbjct: 239 -------LYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 5e-65
 Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 22/279 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
           +      ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L G C+E     L++E+M +  L   L    ++          +   +  G+ YL    
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLE--- 118

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
              +IHRDL A N L+ E    K+SDFGM +    +Q    +        + SPE     
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 720
           R+S KSDV+SFGVL+ E+ S  K       +  ++           I      +      
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---------EDISTGFRLYKPR--- 225

Query: 721 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
                     +   C +E  +DRP  S ++  L +EI +
Sbjct: 226 --LASTHVYQIMNHCWKERPEDRPAFSRLLRQL-AEIAE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 4e-64
 Identities = 66/273 (24%), Positives = 121/273 (44%), Gaps = 21/273 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            +     +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L G C +     +I EYM N  L   L +   + R   ++   + + +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
             + +HRDL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176

Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 720
           +FS KSD+++FGVL+ EI S  K               ++ +  ++    +   L     
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK-------------MPYERFTNSETAEHIAQGL-RLYR 222

Query: 721 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 753
                 +   +   C  E   +RP    ++S +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 9e-64
 Identities = 62/298 (20%), Positives = 111/298 (37%), Gaps = 29/298 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
               L   +G+G FG V+ G+ + G+E+AVK  S    +       E+     L+H N++
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60

Query: 541 RLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
             +    +         L+ +Y  + S    LFD L +  +       +    + GL +L
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHL 116

Query: 597 HRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD--TGRVVGTF 649
           H +      +  I HRDLK+ NIL+ +     I+D G+A       D  D      VGT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 650 GYMSPEYAME------GRFSEKSDVFSFGVLLLEIVSGRKNTSFFED------DLTILGY 697
            YM+PE   +          +++D+++ G++  EI          ED      DL     
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 698 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 755
           + +   +      + P +       + +     +   C       R     +   L+ 
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  212 bits (541), Expect = 1e-63
 Identities = 75/300 (25%), Positives = 131/300 (43%), Gaps = 21/300 (7%)

Query: 467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFM 525
           D     +++      +  +  KLG G +G VY G  K     +AVK L + + + +EEF+
Sbjct: 3   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFL 61

Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
            E  V+ +++H NLV+LLG C       +I E+M   +L   L +   ++ +       +
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYM 120

Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
              IS  + YL    +   IHRDL A N L+ E    K++DFG++++  G+   A  G  
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-A 176

Query: 646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN 705
                + +PE     +FS KSDV++FGVLL EI +     S +              + +
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM--SPYPG-----------IDLS 223

Query: 706 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKE 765
           ++  L++              +   +   C Q    DRP+ + +     +  ++     E
Sbjct: 224 QVYELLEKDY-RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  211 bits (539), Expect = 4e-63
 Identities = 71/306 (23%), Positives = 131/306 (42%), Gaps = 36/306 (11%)

Query: 471 FQFEELATATNNF---------QLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA- 516
           F FE+   A   F         ++   +G G FG V  G LK        +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 517 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER 576
           + +   +F++E  ++ +  H N++ L G   +    M+I E+M N SLD+ L       +
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124

Query: 577 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
               +   ++ GI+ G+ YL     +  +HRDL A NIL++  L  K+SDFG+++    +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 637 QDQADTGRVVG---TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 693
                    +G      + +PE     +F+  SDV+S+G+++ E++S  +          
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 694 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 753
                +       ++  ++         +D       + L C Q+    RP    +V+ L
Sbjct: 232 ---RPYWDMTNQDVINAIEQDY-RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

Query: 754 NSEIRD 759
           +  IR+
Sbjct: 288 DKMIRN 293

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 5e-63
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQH 536
             ++F+  S+LG G  G V+    K  G  +A K +       +  + + E+ V+ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
             +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
               + +I+HRD+K SNIL++     K+ DFG++     +         VGT  YMSPE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGR 682
                +S +SD++S G+ L+E+  GR
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 6e-63
 Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 21/287 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + +L  KLGQG FG V+ G       +A+K L   +    E F+ E  V+ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
           +L       E   ++ EYM   SL   L      + L   +  ++   I+ G+ Y+ R  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 660
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 661 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 720
           RF+ KSDV+SFG+LL E+ +  +    +                 ++L  V+        
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPG-----------MVNREVLDQVERGY-RMPC 235

Query: 721 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 767
             +       +   C ++  ++RP    + + L           +P 
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 6e-62
 Identities = 74/306 (24%), Positives = 128/306 (41%), Gaps = 36/306 (11%)

Query: 474 EELATATNNFQLSS-KLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQG-LEEFMNEV 528
           ++L    +N  ++  +LG G FG V  G  +      ++A+K L + + +   EE M E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 529 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
            ++ +L +  +VRL+G C + E  ML+ E      L   L    K+E +       ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQ 117

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-TGRVVG 647
           +S G+ YL        +HRDL A N+LL      KISDFG++K  G +            
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 648 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI 707
              + +PE     +FS +SDV+S+GV + E +S  +               +K     ++
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-------------KPYKKMKGPEV 221

Query: 708 LALVD-----PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 762
           +A ++         E   +L  ++        C     +DRP+  TV   + +    L  
Sbjct: 222 MAFIEQGKRMECPPECPPELYALMS------DCWIYKWEDRPDFLTVEQRMRACYYSLAS 275

Query: 763 PKEPAF 768
             E   
Sbjct: 276 KVEGHH 281

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  208 bits (530), Expect = 8e-62
 Identities = 71/310 (22%), Positives = 125/310 (40%), Gaps = 45/310 (14%)

Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSK-ASGQGLEEF 524
           +   L    NN +    +G+G FG V+  R            +AVK L + AS     +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-------------- 570
             E  ++++  + N+V+LLG C  G+   L++EYM    L+  L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 571 -------PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK 623
                        L   ++  I   ++ G+ YL      + +HRDL   N L+ E +  K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180

Query: 624 ISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 683
           I+DFG+++           G       +M PE     R++ +SDV+++GV+L EI S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 684 NTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDR 743
              +      ++        +  ILA  +          +  +   ++  LC  +L  DR
Sbjct: 241 QPYYGMAHEEVI----YYVRDGNILACPE----------NCPLELYNLMRLCWSKLPADR 286

Query: 744 PNMSTVVSML 753
           P+  ++  +L
Sbjct: 287 PSFCSIHRIL 296

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 2e-60
 Identities = 72/274 (26%), Positives = 113/274 (41%), Gaps = 27/274 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
              +L   +G+G FG V  G  + G ++AVK +   +    + F+ E  V+++L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 541 RLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           +LLG  VE +  + ++ EYM   SL   L     +  L           +   + YL  +
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 659
                +HRDL A N+L+ E+   K+SDFG+ K     QD            + +PE   E
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALRE 174

Query: 660 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS 719
            +FS KSDV+SFG+LL EI S  +          ++        +   +   D       
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRVEKGYKMDAPDGCPPA-- 228

Query: 720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 753
                      V   C       RP+   +   L
Sbjct: 229 --------VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 1e-59
 Identities = 70/302 (23%), Positives = 109/302 (36%), Gaps = 39/302 (12%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQG-LEEFMNEVMVISK 533
           N       LG G FG V                +AVK L  ++     E  M+E+ V+S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---------------RL 577
           L  H N+V LLG C  G   ++I EY     L   L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
           D     +    +++G+ +L        IHRDL A NILL      KI DFG+A+    + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY 697
           +    G       +M+PE      ++ +SDV+S+G+ L E+ S   +        +    
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-- 257

Query: 698 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI 757
            +K+  E   + L                    +   C       RP    +V ++  +I
Sbjct: 258 -YKMIKEGFRM-LSPEHAPA---------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

Query: 758 RD 759
            +
Sbjct: 307 SE 308

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-59
 Identities = 66/286 (23%), Positives = 121/286 (42%), Gaps = 27/286 (9%)

Query: 484 QLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRN 538
             +  +G+G FG VY G L D        AVK L++ +  G + +F+ E +++    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 539 LVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           ++ LLG C+  E   +++  YM +  L   + +      +     F +          + 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK-----GMK 144

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR--VVGTFGYMSPE 655
             +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 715
                +F+ KSDV+SFGVLL E+++          D+        L    ++  L   + 
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVNTFDITVYLLQGRRL--LQPEYC 259

Query: 716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 761
            +             V L C     + RP+ S +VS +++      
Sbjct: 260 PDP---------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 7e-59
 Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 44/305 (14%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASGQG-LEEFMNEVMVISK 533
            N +    LG G FG V               ++AVK L + +     E  M+E+ ++++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK------------------ 574
           L  H N+V LLG C       LI+EY     L   L    +K                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 575 --ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
               L +         +++G+ +L        +HRDL A N+L+      KI DFG+A+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 633 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 692
              + +    G       +M+PE   EG ++ KSDV+S+G+LL EI S   N       +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGI 270

Query: 693 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM 752
            +    +KL      +     + +E             +   C     + RP+   + S 
Sbjct: 271 PVDANFYKLIQNGFKMDQ-PFYATE---------EIYIIMQSCWAFDSRKRPSFPNLTSF 320

Query: 753 LNSEI 757
           L  ++
Sbjct: 321 LGCQL 325

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 8e-59
 Identities = 69/289 (23%), Positives = 117/289 (40%), Gaps = 30/289 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRN 538
            ++ L   LG+G +G V     +   + +AVK +         E    E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V+  G   EG  + L  EY     L   +        +           +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
              + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 659 EGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE 717
              F +E  DV+S G++L  +++G        D        +  W E K    ++P+   
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----YSDWKEKKT--YLNPWKKI 232

Query: 718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 766
            S  L ++ + +             R  +         +I+   +  +P
Sbjct: 233 DSAPLALLHKILVEN-------PSARITI--------PDIKKDRWYNKP 266

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (510), Expect = 9e-59
 Identities = 85/324 (26%), Positives = 143/324 (44%), Gaps = 38/324 (11%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRN 538
           F    ++G G FG VY+ R +++ + +A+K++S +  Q     ++ + EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
            ++  GC +      L+ EY    + D L    + K+ L   +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH- 132

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
                +IHRD+KA NILL E    K+ DFG A I       A     VGT  +M+PE  +
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184

Query: 659 ---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 715
              EG++  K DV+S G+  +E+   +     F  +     Y      +N+  AL     
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSALYHIA---QNESPALQSGHW 239

Query: 716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGAD 775
           SE     + +  C+       Q++ +DRP    ++   +  +     P       ++  D
Sbjct: 240 SEYF--RNFVDSCL-------QKIPQDRPTSEVLLK--HRFVLRERPPTVIMDLIQRTKD 288

Query: 776 DSESFKQIQQRILLMILLLHSQQA 799
                  +Q R +  IL    Q+A
Sbjct: 289 AVRELDNLQYRKMKKIL---FQEA 309

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-58
 Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 26/291 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSKASGQG-LEEFMNEVMVISKL 534
           +       +G G FG VY G LK         +A+K L     +    +F+ E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
            H N++RL G   + +  M+I EYM N +LD  L +  K       +   ++ GI+ G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT-GRVVGTFGYMS 653
           YL     +  +HRDL A NIL++  L  K+SDFG++++   + +   T         + +
Sbjct: 125 YLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP 713
           PE     +F+  SDV+SFG+++ E+++  +               W+L N   + A+ D 
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGER------------PYWELSNHEVMKAINDG 229

Query: 714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPK 764
           F       +D       + + C Q+    RP  + +VS+L+  IR     K
Sbjct: 230 FRLP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-58
 Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 27/279 (9%)

Query: 488 KLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQG--LEEFMNEVMVISKLQHRNLVRL 542
           +LG G FG V  G  +     + +AVK L   +      +E + E  V+ +L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL      
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES--- 126

Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG-RVVGTFGYMSPEYAMEGR 661
             +HRDL A N+LL  +   KISDFG++K    +++             + +PE     +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 662 FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ 721
           FS KSDV+SFGVL+ E  S  +               ++    +++ A+++         
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ-------------KPYRGMKGSEVTAMLEKGERM-GCP 232

Query: 722 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL 760
                    +  LC    V++RP  + V   L +   D+
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 5e-58
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 33/302 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
               +S +LGQG FG VY G  K          +A+K +++ AS +   EF+NE  V+ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------DPLKKERLDWRKRFNII 586
               ++VRLLG   +G+  ++I E M    L + L        +          K   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
             I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +           G+ +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 647 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK 706
               +MSPE   +G F+  SDV+SFGV+L EI +  +       +  +L    +   E  
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL----RFVMEGG 252

Query: 707 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 766
           +L   D                  +  +C Q   K RP+   ++S +  E+   P  +E 
Sbjct: 253 LLDKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIKEEME--PGFREV 300

Query: 767 AF 768
           +F
Sbjct: 301 SF 302

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-57
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 13/209 (6%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
            + +++  +LG G FG VY  + K+     A K +   S + LE++M E+ +++   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V+LL          ++ E+    ++DA++ +   +  L   +   + +     L YLH 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH- 127

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
               +IIHRDLKA NIL   + + K++DFG++        + D+   +GT  +M+PE  M
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183

Query: 659 -----EGRFSEKSDVFSFGVLLLEIVSGR 682
                +  +  K+DV+S G+ L+E+    
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE 212

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 2e-57
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 25/277 (9%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRN 538
           ++++   +G G +G     R K DG+ +  K L   S      +  ++EV ++ +L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 539 LVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGISRGLLY 595
           +VR     ++     L  + EY     L +++    K ++ LD      ++  ++  L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 596 LHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            HR  D    ++HRDLK +N+ LD + N K+ DFG+A+I   +   A     VGT  YMS
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP 713
           PE      ++EKSD++S G LL E+ +      F       L    +     +I      
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFTAFSQKELAGKIREGKFRRIPYRYSD 240

Query: 714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVV 750
            L       ++I R +             RP++  ++
Sbjct: 241 EL------NEIITRML-------NLKDYHRPSVEEIL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 5e-57
 Identities = 64/277 (23%), Positives = 117/277 (42%), Gaps = 30/277 (10%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNL 539
            +   ++G+G F  VY G   +   E+A   L     +    + F  E  ++  LQH N+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 540 VRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           VR         +     +L+ E M + +L   L    + + +  +   +    I +GL +
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127

Query: 596 LHRDSRLRIIHRDLKASNILLDEELN-PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
           LH  +   IIHRDLK  NI +       KI D G+A +   +        V+GT  +M+P
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAP 182

Query: 655 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF 714
           E   E ++ E  DV++FG+ +LE+ +      + E             N  +I   V   
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYP--YSEC-----------QNAAQIYRRVTSG 228

Query: 715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS 751
           +  +SF    I     +   C+++   +R ++  +++
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-56
 Identities = 75/281 (26%), Positives = 109/281 (38%), Gaps = 27/281 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSK---ASGQGLEEFMNEVMVISK 533
            + +L  KLG G FG V  G           +AVK L     +  + +++F+ EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           L HRNL+RL G  +    KM + E  P  SL   L     +              ++ G+
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-TGRVVGTFGYM 652
            YL      R IHRDL A N+LL      KI DFG+ +    N D           F + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 653 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD 712
           +PE      FS  SD + FGV L E+ +  +      +   IL    K+  E + L   +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HKIDKEGERLPRPE 238

Query: 713 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 753
                     D      +V + C     +DRP    +   L
Sbjct: 239 ----------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-56
 Identities = 69/303 (22%), Positives = 126/303 (41%), Gaps = 26/303 (8%)

Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSKA-SGQGLEEFMNEVMVISKLQH 536
           F+    LG G FG VY G      E     +A+K L +A S +  +E ++E  V++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
            ++ RLLG C+      LI + MP   L  L +    K+ +  +   N    I++G+ YL
Sbjct: 71  PHVCRLLGICLTSTV-QLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
                 R++HRDL A N+L+    + KI+DFG+AK+ G  + +           +M+ E 
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 716
            +   ++ +SDV+S+GV + E+++                  +     ++I ++++    
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS-------------KPYDGIPASEISSILEKGER 231

Query: 717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADD 776
                    I    + + C       RP    ++   +   RD          ER     
Sbjct: 232 LPQPP-ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPS 290

Query: 777 SES 779
              
Sbjct: 291 PTD 293

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-56
 Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 38/299 (12%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG---QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 535
           N+ +    +G+G FG V   R+K      + A+KR+ + AS     +F  E+ V+ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLDWRKR 582
           H N++ LLG C       L  EY P+ +L   L                     L  ++ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
            +    ++RG+ YL +    + IHRDL A NIL+ E    KI+DFG+++   G +     
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 643 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 702
                   +M+ E      ++  SDV+S+GVLL EIVS           +T      KL 
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLP 240

Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 761
              ++              L+       +   C +E   +RP+ + ++  LN  + +  
Sbjct: 241 QGYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-55
 Identities = 73/275 (26%), Positives = 114/275 (41%), Gaps = 30/275 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
            +F++   LG+G FG VY  R K     +A+K L KA         +   EV + S L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
            N++RL G   +     LI EY P  ++   L    K  + D ++    I  ++  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H     R+IHRD+K  N+LL      KI+DFG +     ++       + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 716
                  EK D++S GVL  E + G+     FE +     Y        +I  +   F  
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY-------KRISRVEFTFPD 225

Query: 717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS 751
             +     +I         ++     RP +  V+ 
Sbjct: 226 FVTEGARDLISR------LLKHNPSQRPMLREVLE 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-54
 Identities = 56/204 (27%), Positives = 105/204 (51%), Gaps = 10/204 (4%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
              +    K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V  L   + G+E  ++ EY+   S    L D + +  +D  +   +     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQALEFLH- 133

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
               ++IHRD+K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE   
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189

Query: 659 EGRFSEKSDVFSFGVLLLEIVSGR 682
              +  K D++S G++ +E++ G 
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 3e-53
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 38/297 (12%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQG-LEEFMNEVMVISK 533
           +  +L   LG+G FG V              + +AVK L + +        M+E+ ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 534 -LQHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALLF-------------DPLKKERLD 578
              H N+V LLG C + G   M+I E+    +L   L              + L K+ L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
                     +++G+ +L      + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA 698
               G       +M+PE   +  ++ +SDV+SFGVLL EI S   +       + I    
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEF 246

Query: 699 WKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 755
            +   E   +   D    E               L C       RP  S +V  L +
Sbjct: 247 CRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-51
 Identities = 59/284 (20%), Positives = 112/284 (39%), Gaps = 26/284 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQGL-EEFMNEVMVISKLQ 535
              +L   +G+G FG V+ G           +A+K     +   + E+F+ E + + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H ++V+L+G   E     +I E      L + L    +K  LD          +S  L Y
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 123

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           L      R +HRD+ A N+L+      K+ DFG+++    +       +      +M+PE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPE 179

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 715
                RF+  SDV+ FGV + EI+           +  ++    ++ N  ++     P  
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGERL-----PMP 231

Query: 716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 759
                 L  ++        C       RP  + + + L++ + +
Sbjct: 232 PNCPPTLYSLMTK------CWAYDPSRRPRFTELKAQLSTILEE 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 6e-51
 Identities = 70/255 (27%), Positives = 110/255 (43%), Gaps = 21/255 (8%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
           +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
             V+L     + E+      Y  N  L   +    K    D          I   L YLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
                 IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y+SPE  
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE 717
            E    + SD+++ G ++ ++V+G     F   +  ++          KI+ L   F  +
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL--PPFRAGNEYLI--------FQKIIKLEYDFPEK 232

Query: 718 SSFQL-DMIIRCIHV 731
              +  D++ + + +
Sbjct: 233 FFPKARDLVEKLLVL 247

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-50
 Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 40/297 (13%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
           +   L   LG+G FG V                 ++AVK L   A+ + L + ++E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DPLKKERL 577
             + +H+N++ LLG C +     +I EY    +L   L                  +E+L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
             +   +    ++RG+ YL      + IHRDL A N+L+ E+   KI+DFG+A+      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 638 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY 697
               T        +M+PE   +  ++ +SDV+SFGVLL EI +    + +    +  L  
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-SPYPGVPVEEL-- 246

Query: 698 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 754
            +KL  E   +       +E             +   C   +   RP    +V  L+
Sbjct: 247 -FKLLKEGHRMDKPSNCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  177 bits (451), Expect = 3e-50
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 11/205 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
           +++ +  +LG G FG V+       G   A K +        E    E+  +S L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           V L     +  E ++IYE+M    L   + D  +  ++   +    +  + +GL ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141

Query: 600 SRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
                +H DLK  NI+   + +   K+ DFG+         +       GT  + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197

Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGR 682
                   +D++S GVL   ++SG 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  172 bits (438), Expect = 2e-48
 Identities = 44/205 (21%), Positives = 86/205 (41%), Gaps = 11/205 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
           + + +  +LG G FG V+       G+    K ++           NE+ ++++L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           + L     +  E +LI E++    L   +    +  ++   +  N +     GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 600 SRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               I+H D+K  NI+ + +     KI DFG+A     ++          T  + +PE  
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV 200

Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGR 682
                   +D+++ GVL   ++SG 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 2e-47
 Identities = 60/285 (21%), Positives = 119/285 (41%), Gaps = 21/285 (7%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHR 537
              +   S +G+G +G V       +   +A+K++S    Q   +  + E+ ++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N++ +         + +   Y+    + A L+  LK + L        +  I RGL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT-GRVVGTFGYMSPEY 656
                 ++HRDLK SN+LL+   + KI DFG+A++   + D        V T  Y +PE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 657 AMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 715
            +  + +++  D++S G +L E++S R                +   +    L  +   L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR--------------PIFPGKHYLDQLNHILGIL 229

Query: 716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL 760
              S +    I  +      +    K++   + +    +S+  DL
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 274

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  164 bits (417), Expect = 2e-46
 Identities = 58/261 (22%), Positives = 111/261 (42%), Gaps = 20/261 (7%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQ 535
           ++ ++L   LG GG   V+  R L+  +++AVK L     +       F  E    + L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 536 HRNLVRLLGCCVE----GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-TGRVVGTFG 650
            L + H+     IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL 710
           Y+SPE A       +SDV+S G +L E+++G      F  D  +      +  +    + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE---PPFTGDSPVSVAYQHVREDPIPPSA 236

Query: 711 VDPFLSESSFQLDMIIRCIHV 731
               LS       ++++ +  
Sbjct: 237 RHEGLSADL--DAVVLKALAK 255

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  165 bits (419), Expect = 3e-46
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 15/207 (7%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
            +FQ+   LG G FG V+  R + +G+  A+K L K      + +E   +E +++S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
             ++R+ G   + ++  +I +Y+    L +LL    +      +     +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
                  II+RDLK  NILLD+  + KI+DFG AK             + GT  Y++PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGRK 683
                +++  D +SFG+L+ E+++G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 1e-44
 Identities = 52/298 (17%), Positives = 105/298 (35%), Gaps = 26/298 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
           N ++L  K+G G FG +Y G  +  G+E+A+K     +     +   E  +   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 540 VRLLG-CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +  +  C  EG+  +++ E +     D          +   +    + + +   + Y+H 
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 599 DSRLRIIHRDLKASNIL---LDEELNPKISDFGMAKIFGGNQDQAD-----TGRVVGTFG 650
                 IHRD+K  N L     +     I DFG+AK +   +            + GT  
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL 710
           Y S    +    S + D+ S G +L+    G     +           ++  +E K+   
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYERISEKKMSTP 236

Query: 711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF 768
           ++        +    +        C      D+P+ S +  +  +      +  +  F
Sbjct: 237 IEVLCKGYPSEFATYLNF------CRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  162 bits (411), Expect = 1e-44
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 18/210 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ- 535
           N+F +   +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 536 --HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
                +V +       ++   I + M    L   L    +               I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
            ++H      +++RDLK +NILLDE  + +ISD G+A  F   +        VGT GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 654 PEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
           PE   +G  +   +D FS G +L +++ G 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 2e-44
 Identities = 57/254 (22%), Positives = 103/254 (40%), Gaps = 13/254 (5%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHR 537
            + +     LG G F  V      +  + +A+K ++K + +G E    NE+ V+ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+V L      G    LI + +    L   +   ++K     R    +I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
               +    +        LDE+    ISDFG++K+              GT GY++PE  
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVL 181

Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE 717
            +  +S+  D +S GV+   ++ G      F D+     +   L  E +  +     +S+
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGY---PPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238

Query: 718 SSFQLDMIIRCIHV 731
           S+   D I   +  
Sbjct: 239 SA--KDFIRHLMEK 250

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 3e-44
 Identities = 48/253 (18%), Positives = 98/253 (38%), Gaps = 17/253 (6%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
            + ++  LG+G FG V+        +    K + K  G        E+ +++  +HRN++
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64

Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
            L       EE ++I+E++    +   +        L+ R+  + +  +   L +LH   
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH--- 119

Query: 601 RLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
              I H D++  NI+     +   KI +FG A+         +   +     Y +PE   
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176

Query: 659 EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES 718
               S  +D++S G L+  ++SG    + F  +         +  E          +S  
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGI---NPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 719 SFQLDMIIRCIHV 731
           +  +D + R +  
Sbjct: 234 A--MDFVDRLLVK 244

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  158 bits (399), Expect = 1e-43
 Identities = 42/299 (14%), Positives = 102/299 (34%), Gaps = 26/299 (8%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
            ++++  ++G+G FG ++ G  L + Q++A+K   + S     +  +E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
           +  +    +     ++   +   SL+ LL       +   +      + +   +  +H  
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119

Query: 600 SRLRIIHRDLKASNILLDEELNP-----KISDFGMAKIF-----GGNQDQADTGRVVGTF 649
               +++RD+K  N L+    +       + DFGM K +       +    +   + GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA 709
            YMS    +    S + D+ + G + +  + G       +       Y  +   E K   
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY--ERIGEKKQST 235

Query: 710 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF 768
            +    +    +    +                 P+   +  + +  +  L   ++  F
Sbjct: 236 PLRELCAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 1e-43
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 13/207 (6%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISK-LQ 535
            +F L   LG+G FG V+    K   Q  A+K L K        +E  M E  V+S   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
           H  L  +       E    + EY+    L   +       + D  +       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           LH      I++RDLK  NILLD++ + KI+DFGM K       + +T    GT  Y++PE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
             +  +++   D +SFGVLL E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-43
 Identities = 63/335 (18%), Positives = 137/335 (40%), Gaps = 35/335 (10%)

Query: 481 NNFQLSSK-LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHR 537
           ++++++S+ LG G  G V      +  ++ A+K L         +   EV +  +  Q  
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65

Query: 538 NLVRLLGCC----VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           ++VR++          +  +++ E +    L + + D    +    R+   I++ I   +
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAI 124

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFG 650
            YLH    + I HRD+K  N+L   +      K++DFG AK    +           T  
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPY 178

Query: 651 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL 710
           Y++PE     ++ +  D++S GV++  ++ G     F+ +    +    K          
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY--PPFYSNHGLAISPGMKTRIRMGQYEF 236

Query: 711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE--IRDLPYPKEPAF 768
            +P  SE S ++ M+IR        ++     R  ++     +N    ++    P+ P  
Sbjct: 237 PNPEWSEVSEEVKMLIRN------LLKTEPTQRMTITEF---MNHPWIMQSTKVPQTPLH 287

Query: 769 TERQGADDSESFKQIQQRILLMILLLHSQQAEIRR 803
           T R   +D E ++ +++ +   +  +     +I+ 
Sbjct: 288 TSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKI 322

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  155 bits (394), Expect = 3e-43
 Identities = 60/267 (22%), Positives = 111/267 (41%), Gaps = 31/267 (11%)

Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGL---------EEFMNEVMVI 531
           N++    LG+G    V         +E AVK +    G            E  + EV ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 532 SKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
            K+  H N+++L           L+++ M    L   L    +K  L  ++   I+  + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALL 120

Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
             +  LH+   L I+HRDLK  NILLD+++N K++DFG +      +       V GT  
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174

Query: 651 YMSPEYAMEGR------FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE 704
           Y++PE            + ++ D++S GV++  +++G      F     +L     +   
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---PPFWHRKQMLMLRMIMSGN 231

Query: 705 NKILALVDPFLSESSFQLDMIIRCIHV 731
            +  +      S++    D++ R + V
Sbjct: 232 YQFGSPEWDDYSDTV--KDLVSRFLVV 256

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 8e-42
 Identities = 66/309 (21%), Positives = 127/309 (41%), Gaps = 31/309 (10%)

Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASGQG--LEEFMNEVMVISKL 534
           A   ++  +++G+G +G V+  R     G+ +A+KR+   +G+       + EV V+  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 535 ---QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD---ALLFDPLKKERLDWRKRFNIIEG 588
              +H N+VRL   C            +    +D       D + +  +      +++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
           + RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+           VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178

Query: 649 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR------KNTSFFEDDLTILGYAWKLW 702
             Y +PE  ++  ++   D++S G +  E+   +       +       L ++G   +  
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 703 NENKILALVDPFLSESSFQLDMIIRCIHVGLL-----CVQELVKDRPNMSTVVSMLNSE- 756
               +      F S+S+  ++  +  I          C+      R +  +    L+   
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA---LSHPY 295

Query: 757 IRDLPYPKE 765
            +DL   KE
Sbjct: 296 FQDLERCKE 304

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  150 bits (380), Expect = 3e-41
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
             +    K+G+G +G VY  +   G+  A+K  RL K         + E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V+L       +  +L++E++       L      +  L+     + +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH- 117

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 658
               R++HRDLK  N+L++ E   KI+DFG+A+ FG    +      + T  Y +P+  M
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 659 -EGRFSEKSDVFSFGVLLLEIVSGR 682
              ++S   D++S G +  E+V+G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 7e-41
 Identities = 68/299 (22%), Positives = 112/299 (37%), Gaps = 46/299 (15%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE------FMNEVMVISK 533
           + +Q+   LG GGFG VY G  + D   +A+K + K       E         EV+++ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 534 LQ--HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           +      ++RLL      +  +LI E               ++  L      +    +  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLE 121

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRVVGTFG 650
            + + H      ++HRD+K  NIL+D      K+ DFG   +              GT  
Sbjct: 122 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174

Query: 651 YMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA 709
           Y  PE+    R+    + V+S G+LL ++V G      FE D              +I+ 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD---IPFEHD-------------EEIIR 218

Query: 710 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE-IRDLPYPKEPA 767
               F    S +   +IR       C+     DRP    +    N   ++D+  P+E A
Sbjct: 219 GQVFFRQRVSSECQHLIRW------CLALRPSDRPTFEEI---QNHPWMQDVLLPQETA 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-40
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 17/209 (8%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
           ++  +  +G G FG VY  +L D G+ +A+K++ +           E+ ++ KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76

Query: 541 RLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           RL        EK       L+ +Y+P             K+ L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 595 YLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 653
           Y+H      I HRD+K  N+LLD +    K+ DFG AK     + + +   +   +    
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 191

Query: 654 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                   ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 6e-40
 Identities = 69/303 (22%), Positives = 110/303 (36%), Gaps = 37/303 (12%)

Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE-----FMNEVMVISKLQHRNLVR 541
            LG+G F  VY  R K   Q +A+K++        ++      + E+ ++ +L H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
           LL          L++++M                 L        +    +GL YLH+   
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119

Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 661
             I+HRDLK +N+LLDE    K++DFG+AK FG           V T  Y +PE     R
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGAR 176

Query: 662 -FSEKSDVFSFGVLLLEIVSGRKNTSFFEDD----------LTILGYAWKLWNENKILAL 710
            +    D+++ G +L E++       F   D           T+     + W +   L  
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV---PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 711 VDPFLSESSFQLDMIIRCIHVGLL-----CVQELVKDRPNMSTVVSMLNSE-IRDLPYPK 764
              F S     L  I       LL             R   +     L  +   + P P 
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA---LKMKYFSNRPGPT 290

Query: 765 EPA 767
              
Sbjct: 291 PGC 293

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 6e-40
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)

Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
           +V+LL       +  L++E++          D      +      + +  + +GL + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-YA 657
               R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y +PE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175

Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGR 682
               +S   D++S G +  E+V+ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 20/213 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS------GQGLEEFMNEVMVISK 533
           + +    +LG G F  V   R K  G + A K + K        G   E+   EV ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
           +QH N++ L        + +LI E +       L     +KE L   +    ++ I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAG---GELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTF 649
            YLH    L+I H DLK  NI+L +   P    KI DFG+A          +   + GT 
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTP 180

Query: 650 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            +++PE         ++D++S GV+   ++SG 
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-38
 Identities = 49/216 (22%), Positives = 102/216 (47%), Gaps = 20/216 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG--LEEFMNEVMVISKLQHR 537
           + ++  +K+GQG FG V+  R  K GQ++A+K++   + +       + E+ ++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 538 NLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
           N+V L+  C               L++++  +     L    +K    + ++   ++   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126

Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR--VVG 647
              L  L+   R +I+HRD+KA+N+L+  +   K++DFG+A+ F   ++         V 
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 648 TFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
           T  Y  PE  +  R +    D++  G ++ E+ +  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-38
 Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 12/206 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
             L  L       +    + EY     L   L    ++      +       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H      +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++PE 
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEV 176

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGR 682
             +  +    D +  GV++ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (350), Expect = 1e-36
 Identities = 58/255 (22%), Positives = 104/255 (40%), Gaps = 24/255 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
           + F     LG G FG V   +  + G   A+K L K      + +E  +NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
             LV+L     +     ++ EY+    + + L    +  R            I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H    L +I+RDLK  N+L+D++   +++DFG AK   G         + GT   ++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 716
            +   +++  D ++ GVL+ E+ +G      F  D  I  Y   +  + +  +     L 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY---PPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266

Query: 717 ESSFQLDMIIRCIHV 731
                 D++   + V
Sbjct: 267 ------DLLRNLLQV 275

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-36
 Identities = 49/206 (23%), Positives = 96/206 (46%), Gaps = 11/206 (5%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHR 537
             ++    +G G +G V      + G ++A+K+L +   S    +    E+ ++  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 538 NLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
           N++ LL      E      + Y+    +   L   +K E+L   +   ++  + +GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 656
           H      IIHRDLK  N+ ++E+   KI DFG+A+          TG VV  +       
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVVTRWYRAPEVI 190

Query: 657 AMEGRFSEKSDVFSFGVLLLEIVSGR 682
               R+++  D++S G ++ E+++G+
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 1e-35
 Identities = 42/206 (20%), Positives = 93/206 (45%), Gaps = 10/206 (4%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHR 537
             ++   K+G+G +G V+  + +   + +A+KR+             + E+ ++ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
           N+VRL       ++  L++E+          +       LD     + +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 657
                 ++HRDLK  N+L++     K+++FG+A+ FG    +  +  VV  +        
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174

Query: 658 MEGRFSEKSDVFSFGVLLLEIVSGRK 683
               +S   D++S G +  E+ +  +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  127 bits (320), Expect = 7e-33
 Identities = 42/208 (20%), Positives = 95/208 (45%), Gaps = 21/208 (10%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRN 538
           +++QL  KLG+G +  V+    + + +++ VK L        ++   E+ ++  L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 539 LVRLLGCCVEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
           ++ L     +   +   L++E++ N     L       + L        +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 597 HRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           H    + I+HRD+K  N+++D E    ++ D+G+A+ +   Q+       V +  +  PE
Sbjct: 146 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199

Query: 656 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 682
             ++ + +    D++S G +L  ++  +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-32
 Identities = 71/263 (26%), Positives = 113/263 (42%), Gaps = 25/263 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS----GQGLEEFMNEVMVIS 532
            NF+L   LG G +G V+  R       G+  A+K L KA+     +  E    E  V+ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 533 KLQHR-NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
            ++    LV L        +  LI +Y+    L   L    ++ER    +    +  I  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVL 140

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
            L +LH+   L II+RD+K  NILLD   +  ++DFG++K F  ++ +       GT  Y
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 652 MSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA 709
           M+P+    G     +  D +S GVL+ E+++G   + F  D               +IL 
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQAEIS----RRILK 250

Query: 710 LVDPFLSESSFQL-DMIIRCIHV 731
              P+  E S    D+I R +  
Sbjct: 251 SEPPYPQEMSALAKDLIQRLLMK 273

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-31
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 21/211 (9%)

Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHR 537
             +Q    +G G  G V         + +A+K+LS+   +    +    E++++  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 538 NLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
           N++ LL          E ++  L+ E M       +      +  LD  +   ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130

Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 651
           G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +         V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 184

Query: 652 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
            +PE  +   + E  D++S G ++ E+V  +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 5e-31
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 11/207 (5%)

Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
              +Q  S +G G +G V      K G  +AVK+LS+   S    +    E+ ++  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 537 RNLVRLLGCCVEGEEKMLI-YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
            N++ LL               Y+    + A L + +K ++L       +I  I RGL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 655
           +H      IIHRDLK SN+ ++E+   KI DFG+A+      D   TG V   +      
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEI 189

Query: 656 YAMEGRFSEKSDVFSFGVLLLEIVSGR 682
                 +++  D++S G ++ E+++GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (283), Expect = 1e-27
 Identities = 42/217 (19%), Positives = 85/217 (39%), Gaps = 22/217 (10%)

Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
           + L  KLG G F  V+  + + +   +A+K +        E   +E+ ++ ++   +  +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73

Query: 542 LLGCCVEGEEKMLIY---------------EYMPNRSLDALLFDPLKKERLDWRKRFNII 586
                     K+L +               E +    L  +     +   L + K+  I 
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--IS 131

Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRV 645
           + +  GL Y+HR  R  IIH D+K  N+L++       +    +A +             
Sbjct: 132 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 646 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 682
           + T  Y SPE  +   +   +D++S   L+ E+++G 
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 95.2 bits (236), Expect = 5e-23
 Identities = 36/203 (17%), Positives = 67/203 (33%), Gaps = 25/203 (12%)

Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQ--------GLEEFMNEVMVISKL 534
           +   +G+G    V+    +   E  VK  ++   S +        G   F    +  ++ 
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
           + R L +L G  V       +Y +  N  L  L+                +++ I   + 
Sbjct: 64  EFRALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVA 117

Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 654
             +      I+H DL   N+L+ EE    I DF  +   G    +    R V        
Sbjct: 118 KFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITY-- 171

Query: 655 EYAMEGRFSEKSDVFSFGVLLLE 677
                  +  + D+ S    +L+
Sbjct: 172 ---FSRTYRTEKDINSAIDRILQ 191

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 78.1 bits (192), Expect = 4e-18
 Identities = 18/107 (16%), Positives = 40/107 (37%), Gaps = 10/107 (9%)

Query: 39  LSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLV 98
           L  G +  +  ++        + ++         +W +N     K       +  DGN V
Sbjct: 10  LYAGQSLDVEPYHFIMQEDCNLVLYDH----STSVWASNTGILGKKGCKA-VLQSDGNFV 64

Query: 99  LVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF 145
           + + +   LW+S+     N +    L + GN+V+  +     +W + 
Sbjct: 65  VYDAEGRSLWASHSVR-GNGNYVLVLQEDGNVVIYGS----DIWSTG 106

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 72.3 bits (177), Expect = 7e-16
 Identities = 18/84 (21%), Positives = 29/84 (34%), Gaps = 3/84 (3%)

Query: 62  IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
           I Y            +    L+ S   +++  D NLVL +    V  ++           
Sbjct: 12  ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGK--GTGCR 69

Query: 122 AQLLDSGNLVLRDNINRAIVWESF 145
           A L  +G + +  N N   VW S 
Sbjct: 70  AVLQPNGRMDVLTNQNI-AVWTSG 92

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 38.8 bits (90), Expect = 3e-04
 Identities = 20/108 (18%), Positives = 38/108 (35%), Gaps = 10/108 (9%)

Query: 87  GIITISEDGNLVLVNGQKE--VLWSSNVSN-LVNNSTSAQLLDSGNLVLRDNINRAIVWE 143
           G + ++ +GN +L + Q       + + +  L  +     +    NLVL D  +R     
Sbjct: 1   GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTN 60

Query: 144 SFQEPTDSFLPGMHHG---IDQRTGKKVQLTSWKSLSDPSTGSFSAGL 188
           +  + T        +G   +       V    W S +  S G +   L
Sbjct: 61  TAGKGTGCRAVLQPNGRMDVLTNQNIAV----WTSGNSRSAGRYVFVL 104

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 69.6 bits (170), Expect = 5e-15
 Identities = 24/84 (28%), Positives = 34/84 (40%), Gaps = 4/84 (4%)

Query: 62  IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
           I + +  E +     +    L+ SS   T+  D NLVL +    V W+SN +        
Sbjct: 3   ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRV-WASNTAG--ATGCR 59

Query: 122 AQLLDSGNLVLRDNINRAIVWESF 145
           A L   G LV+    N  I W S 
Sbjct: 60  AVLQSDGLLVILTAQNT-IRWSSG 82

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 56.9 bits (137), Expect = 1e-10
 Identities = 20/111 (18%), Positives = 35/111 (31%), Gaps = 17/111 (15%)

Query: 35  PDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISED 94
               L+ G +F        +     +             W  N        S  +++  D
Sbjct: 12  TGEFLNYG-SFVFIMQEDCNLVLYDVDKPI---------WATNTGGL--SRSCFLSMQTD 59

Query: 95  GNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF 145
           GNLV+ N   + +W+SN     N +    L    N+V+         W + 
Sbjct: 60  GNLVVYNPSNKPIWASNTGG-QNGNYVCILQKDRNVVIYGT----DRWATG 105

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 54.4 bits (130), Expect = 1e-09
 Identities = 23/116 (19%), Positives = 44/116 (37%), Gaps = 15/116 (12%)

Query: 35  PDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISED 94
               L+ G  +     N  +       + YD       +W +  +        ++ +  D
Sbjct: 12  TGGSLAEG-GYLFIIQNDCNL------VLYDN---NRAVWASGTNGKASGC--VLKMQND 59

Query: 95  GNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTD 150
           GNLV+ +G + +    + +N  N +    L    N+V+ DN N AI W +     +
Sbjct: 60  GNLVIYSGSRAIWA--SNTNRQNGNYYLILQRDRNVVIYDNSNNAI-WATHTNVGN 112

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 54.6 bits (131), Expect = 1e-09
 Identities = 13/73 (17%), Positives = 23/73 (31%), Gaps = 7/73 (9%)

Query: 72  VIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLV 131
            IW  N             +  DG LV++  +   +W S             L    N+V
Sbjct: 50  PIWATNTGGLGNGC--RAVLQPDGVLVVITNENVTVWQSP-VAGKAGHYVLVLQPDRNVV 106

Query: 132 LRDNINRAIVWES 144
           +  +     +W +
Sbjct: 107 IYGD----ALWAT 115

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 40.8 bits (95), Expect = 8e-05
 Identities = 18/52 (34%), Positives = 24/52 (46%), Gaps = 3/52 (5%)

Query: 93  EDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144
            D NLVL +     +W++N   L N    A L   G LV+  N     VW+S
Sbjct: 38  TDCNLVLYDNNN-PIWATNTGGLGNGCR-AVLQPDGVLVVITN-ENVTVWQS 86

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	807
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.79
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.77
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.76
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.6
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.55
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.46
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.3
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.07
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.9
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.83
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.82
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.73
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.51
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.33
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.93
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.59
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.46
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.14
d2qj2a1	91	Hepatocyte growth factor {Human (Homo sapiens) [Ta	80.07

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=370.92  Aligned_cols=264  Identities=28%  Similarity=0.461  Sum_probs=213.9

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEECCCCEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             2387645854437971389999359959999991554--72058999999999983368834678638873886799998
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  557 (807)
                      .++|.+.+.||+|+||.||+|+.+  ..||||+++..  ..+..+.|.+|+.++++++||||+++++++.+ ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf             451899889830788589999999--989999997346998999999999999984799878645679715-58999996


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf             24899811000388888778902268899998966576540588848907789998242589981221146620138999
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~  637 (807)
                      |+++|+|.+++..  ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             CCCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCC
T ss_conf             5899888999852--3578999999999999999988875099---9516147899798189978875002213335567


Q ss_pred             CCCCCCEEECCCCCCCHHHHCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             8642110222678558111125---9889655455025878997849989876677301544443300122210002765
Q 003628          638 DQADTGRVVGTFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~---~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      .........||+.|+|||++.+   ..++.++||||||+++|||+||+.||........+.......        ...+.
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~--------~~~p~  230 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG--------YLSPD  230 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT--------SCCCC
T ss_pred             CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC--------CCCCC
T ss_conf             7631256655743179999950568999953151635999999997889989989699999999658--------88986


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf             55784318999999999976554885899998899999720237899
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP  761 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~~~~  761 (807)
                      +.  ..+.+.+.++.+++.+||+.||++|||+.||++.|+.+.+.+|
T Consensus       231 ~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         231 LS--KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             GG--GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CH--HCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf             00--0365554999999999758897689299999999999997098

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=368.89  Aligned_cols=263  Identities=27%  Similarity=0.382  Sum_probs=216.1

Q ss_pred             HHHHCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             997238764585443797138999935-9959999991554720589999999999833688346786388738867999
Q 003628          477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       477 ~~~~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      +...++|++.++||+|+||.||+|++. +++.||||++... ....++|.+|++++++++||||+++++++.+++..++|
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEE
T ss_conf             74579939865982088808999999999969999997776-10399999999999867999882677527457854787


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf             98248998110003888887789022688999989665765405888489077899982425899812211466201389
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~  635 (807)
                      |||+++|+|..++... ....+++..++.++.|+++||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        92 ~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          92 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             EECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf             6314676067775303-5541579999999999999788898789---30576045768998999289832445465378


Q ss_pred             CCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             99864211022267855811112598896554550258789978499898766773015444433001222100027655
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      .... ......|+..|+|||++.+..++.++||||||+++|||++|+.|+....+...+.....    .+     ..+  
T Consensus       168 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~----~~-----~~~--  235 (287)
T d1opja_         168 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----KD-----YRM--  235 (287)
T ss_dssp             SSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH----TT-----CCC--
T ss_pred             CCCE-EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH----CC-----CCC--
T ss_conf             8722-10355665466692787279998104302178999999867998877425999999985----58-----888--


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             57843189999999999765548858999988999997202378
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  759 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~~  759 (807)
                         +.+...+.++.+++.+||+.||++|||+.||++.|+.+.++
T Consensus       236 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         236 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             ---CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             ---88743309999999997577976893999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.49  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=210.8

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf             38764585443797138999935995999999155472058999999999983368834678638873886799998248
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  560 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  560 (807)
                      ++|.+.+.||+|+||.||+|++.++..||||++... ....++|.+|++++++++||||++++|++...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf             995888898208882999999889999999998788-6768999999999996689975653524315993379998369


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf             99811000388888778902268899998966576540588848907789998242589981221146620138999864
Q 003628          561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  640 (807)
Q Consensus       561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~~~~  640 (807)
                      +|+|.+++..  ....+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++........ 
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE-
T ss_conf             9918997520--1347889999999999999877653164---310443153266668877686553210023688733-


Q ss_pred             CCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf             21102226785581111259889655455025878997849989876677301544443300122210002765557843
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  720 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  720 (807)
                      ......||..|+|||++.+..++.++||||||+++|||+|++.|+........+.....    .+.  ...        .
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~----~~~--~~~--------~  223 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----TGF--RLY--------K  223 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH----HTC--CCC--------C
T ss_pred             EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----HCC--CCC--------C
T ss_conf             50430017666785786079998403321059999999878988877899999999998----068--889--------9


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             1899999999997655488589999889999972023
Q 003628          721 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       721 ~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~  757 (807)
                      +...+.++.+++.+||+.||++||||+||++.|+.+.
T Consensus       224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             5436799999999976579768919999999999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=369.04  Aligned_cols=259  Identities=26%  Similarity=0.435  Sum_probs=210.4

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEECC-C---CEEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             387645854437971389999359-9---59999991554-720589999999999833688346786388738867999
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-G---QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ++|++.+.||+|+||.||+|+... +   ..||||.+... .....+.|.+|+++|++++||||++++|++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf             04278569802788299999995799788999999978445989999999999999857998886189999628877999


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf             98248998110003888887789022688999989665765405888489077899982425899812211466201389
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~  635 (807)
                      |||+++|+|.+++..  ....+++.+++.++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEECCCCCCEEEECC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf             972279853002104--5679999999999999999889885279---83576150448988999199888443157567


Q ss_pred             CCCCC---CCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf             99864---2110222678558111125988965545502587899784-9989876677301544443300122210002
Q 003628          636 NQDQA---DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       636 ~~~~~---~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      .....   ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......... ...   . .+      
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~-~~i---~-~~------  249 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI-NAI---E-QD------  249 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHH---H-TT------
T ss_pred             CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHH-HHH---H-CC------
T ss_conf             777653650256668830038788836997861214453578999986799999999999999-999---7-37------


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             765557843189999999999765548858999988999997202378
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  759 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~~  759 (807)
                       ..   .+.+.+.+.++.+++.+||+.||++||++.||++.|+.++++
T Consensus       250 -~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         250 -YR---LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             -CC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -CC---CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             -88---999742269999999997587976892999999999998418

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.77  Aligned_cols=256  Identities=30%  Similarity=0.447  Sum_probs=208.9

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             23876458544379713899993599599999915547205899999999998336883467863887388679999824
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  559 (807)
                      .++|++.+.||+|+||.||+|+++++..||||++... ....+.|.+|++++++++||||++++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf             8993886798107982899999999999999998647-6888999999999986799988578731045-9769999957


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf             89981100038888877890226889999896657654058884890778999824258998122114662013899986
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~~~  639 (807)
                      ++|+|.+++... ....+++..+++++.||++||+|||+.+   |+||||||+||||++++.+||+|||+++.+......
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCC
T ss_conf             898288887514-7898878899999999999999997489---546756422515620244042341014773588644


Q ss_pred             CCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf             42110222678558111125988965545502587899784998987667730154444330012221000276555784
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       ......|++.|+|||++.+..++.++||||||+++|||+||+.|+..............    .+     ..+.     
T Consensus       166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~----~~-----~~~~-----  230 (272)
T d1qpca_         166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE----RG-----YRMV-----  230 (272)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----TT-----CCCC-----
T ss_pred             -CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----HC-----CCCC-----
T ss_conf             -20356774444582898379998245645257999999968988888889999999997----06-----8888-----


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             3189999999999765548858999988999997202
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       720 ~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~  756 (807)
                      .+...+.++.+++.+||+.||++||||++|+++|+..
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             9655719999999997588976893999999986113

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.73  Aligned_cols=259  Identities=27%  Similarity=0.385  Sum_probs=213.1

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEECC------CCEEEEEEECCC-CCCCHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCE
Q ss_conf             2387645854437971389999359------959999991554-720589999999999833-68834678638873886
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE  551 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  551 (807)
                      .++|.+.+.||+|+||.||+|+...      ...||+|.+... .......+.+|+.++.++ +||||+++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf             89939701983078819999998578855420499999966335878999999999999971589968687788862995


Q ss_pred             EEEEEEECCCCCCCCCCCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf             7999982489981100038888--------------------87789022688999989665765405888489077899
Q 003628          552 KMLIYEYMPNRSLDALLFDPLK--------------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKA  611 (807)
Q Consensus       552 ~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp  611 (807)
                      .++||||+++|+|.+++.....                    ...+++..++.++.||++||+|||+.+   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCH
T ss_conf             899997279995999998625777510221000012220012577899999999999999999997399---05052703


Q ss_pred             CCEEECCCCCCEEECCCCCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCC
Q ss_conf             982425899812211466201389998642110222678558111125988965545502587899784-9989876677
Q 003628          612 SNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFED  690 (807)
Q Consensus       612 ~NIll~~~~~~kI~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~ellt-G~~p~~~~~~  690 (807)
                      +|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf             21443459828985142222045778615623435787657838872799996330300039999998389999999898


Q ss_pred             CCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             30154444330012221000276555784318999999999976554885899998899999720
Q 003628          691 DLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       691 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~  755 (807)
                      ...+.....    .+.     .+     +.+...+.++.+++.+||+.||++|||++||+++|.-
T Consensus       273 ~~~~~~~~~----~~~-----~~-----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         273 DANFYKLIQ----NGF-----KM-----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             SHHHHHHHH----TTC-----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHH----CCC-----CC-----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             999999985----699-----89-----9887678999999999758896689399999999748

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.47  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=209.2

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             38764585443797138999935-99599999915547205899999999998336883467863887388679999824
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  559 (807)
                      ++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf             05388789812858299999998999899999984301727999999999998679998805857798899989999703


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf             89981100038888877890226889999896657654058884890778999824258998122114662013899986
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~~~  639 (807)
                      ++|+|.+++.    ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++++||+|||+++.+..... 
T Consensus       100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-
T ss_conf             7980898864----159999999999999999999999879---72267768886887899686425156413213666-


Q ss_pred             CCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf             42110222678558111125988965545502587899784998987667730154444330012221000276555784
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||........+...    ...+      .+..   .
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~------~~~~---~  237 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----ATNG------TPEL---Q  237 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHHC------SCCC---S
T ss_pred             -CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHH----HHCC------CCCC---C
T ss_conf             -444444477736826644799880120313729999980488998997999999999----8579------9988---8


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             31899999999997655488589999889999
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       720 ~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                      .+...+.++.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             85537999999999986699668909999964

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.27  Aligned_cols=253  Identities=25%  Similarity=0.341  Sum_probs=207.8

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             238764585443797138999935-99599999915547-2058999999999983368834678638873886799998
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  557 (807)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... .+..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf             74608998972174809999999999979999998456641279999999999985799888469654046743679886


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf             24899811000388888778902268899998966576540588848907789998242589981221146620138999
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~  637 (807)
                      |+++|+|.+++.   ....+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             CCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf             458980899975---3799999999999999999999999759---8357546899788789987983231422404688


Q ss_pred             CCCCCCEEECCCCCCCHHHHCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             8642110222678558111125988-965545502587899784998987667730154444330012221000276555
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~~-s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      ........+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+........    .....        .
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~----~~~~~--------~  225 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----KEKKT--------Y  225 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH----HTTCT--------T
T ss_pred             CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----HCCCC--------C
T ss_conf             65311132557474287286189999971016173799999982997888898599999998----63888--------7


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             78431899999999997655488589999889999
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       717 ~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                       .......+.++.+++.+|++.||++|||++|+++
T Consensus       226 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -8864469999999999976799668909999961

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.83  Aligned_cols=266  Identities=28%  Similarity=0.422  Sum_probs=216.4

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             23876458544379713899993599599999915547205899999999998336883467863887388679999824
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  559 (807)
                      .++|++.+.||+|+||.||+|+++++..||||++... ....+.|.+|+.++++++|+||++++|++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf             7997984699307980999999999999999998804-4888999999999986666788689999823-9759999944


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf             89981100038888877890226889999896657654058884890778999824258998122114662013899986
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~~~  639 (807)
                      ++|+|..++... ....+++.+++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCE
T ss_conf             799435420000-3553059999999999999999875411---433531230799989992998442555425688733


Q ss_pred             CCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf             42110222678558111125988965545502587899784998987667730154444330012221000276555784
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                       ......||+.|+|||++..+.++.++||||||+++|||++|+.|+...............    +     ..     .+
T Consensus       170 -~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~----~-----~~-----~~  234 (285)
T d1fmka3         170 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----G-----YR-----MP  234 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----T-----CC-----CC
T ss_pred             -EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHH----C-----CC-----CC
T ss_conf             -524545566545808983799891774132358999998689999988889999999982----6-----89-----99


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             31899999999997655488589999889999972023789999999
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP  766 (807)
Q Consensus       720 ~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p  766 (807)
                      .+...+.++.+++.+||+.||++||+|++|+++|+......+.+..|
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p  281 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  281 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCCCCCC
T ss_conf             98323799999999975669758919999999876662389999999

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=353.53  Aligned_cols=254  Identities=22%  Similarity=0.303  Sum_probs=210.6

Q ss_pred             HHCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             7238764585443797138999935-995999999155472058999999999983368834678638873886799998
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       479 ~~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  557 (807)
                      ..++|.+.+.||+|+||.||+++.. +|..||||++........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf             86575898898407681999999889998999999845243169999999999986799799929999998999999998


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCCEEECCCCCCCCCC
Q ss_conf             2489981100038888877890226889999896657654058884890778999824258--99812211466201389
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE--ELNPKISDFGMAKIFGG  635 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~--~~~~kI~DFGla~~~~~  635 (807)
                      |+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+..
T Consensus       104 ~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         104 FMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCCHHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCC
T ss_conf             5799889999976--2378999999999999999999997569---7600015467364168898699954521044256


Q ss_pred             CCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             99864211022267855811112598896554550258789978499898766773015444433001222100027655
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ..   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+....+........           ..
T Consensus       179 ~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-----------~~  244 (350)
T d1koaa2         179 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW-----------NM  244 (350)
T ss_dssp             TS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----------CS
T ss_pred             CC---CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC-----------CC
T ss_conf             54---32000686242188997589987267655465999999859899899799999999984788-----------98


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             5784318999999999976554885899998899999
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~  752 (807)
                      . .......+.++.+++.+||+.||++|||++|+++.
T Consensus       245 ~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 D-DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             C-CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             C-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             9-42235899999999999756896679089998629

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.45  Aligned_cols=259  Identities=27%  Similarity=0.452  Sum_probs=209.9

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEECCC-----CEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf             3876458544379713899993599-----599999915547-2058999999999983368834678638873886799
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDG-----QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ..|+..+.||+|+||.||+|.++..     ..||||++.... .....+|.+|++++++++||||++++|++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf             99686159811779099999996899878799999998844596899999999999985689878323677833880389


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCC
Q ss_conf             99824899811000388888778902268899998966576540588848907789998242589981221146620138
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~  634 (807)
                      ||||+.++++.+++..  ....+++.++++++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEECCCCCCHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf             9972135740222102--3454208999999999998541212123---4257656442788899849984551030035


Q ss_pred             CCCCC-CCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             99986-42110222678558111125988965545502587899784998987667730154444330012221000276
Q 003628          635 GNQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       635 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ..... .......||..|+|||++.+..++.++||||||+++|||++++.|+........+...    ..++.     . 
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~----i~~~~-----~-  231 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA----INDGF-----R-  231 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTTC-----C-
T ss_pred             CCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHH----HHCCC-----C-
T ss_conf             7876526742677773434888870499997355634489899999679886556899999999----86357-----8-


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             555784318999999999976554885899998899999720237
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~  758 (807)
                          .+.+.+.+.++.+++.+||+.||++||+|.||+++|+.+++
T Consensus       232 ----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         232 ----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             ----99850457999999999776797689399999999999866

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.64  Aligned_cols=254  Identities=26%  Similarity=0.445  Sum_probs=212.3

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             23876458544379713899993599599999915547205899999999998336883467863887388679999824
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  559 (807)
                      .++|++.++||+|+||.||+|+.+++..||||.++... ...++|.+|+.++++++||||++++|++.+....++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf             69979968982078839999998899899999987475-77899999999999668986015889985078169999704


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf             89981100038888877890226889999896657654058884890778999824258998122114662013899986
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~~~  639 (807)
                      ++|+|..++..  ....+++..+.+++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++........
T Consensus        82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             CCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE
T ss_conf             89938886410--2467768999999999999999875468---434665413588769984798861442023578722


Q ss_pred             CCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCC
Q ss_conf             42110222678558111125988965545502587899784-99898766773015444433001222100027655578
Q 003628          640 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  718 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  718 (807)
                       ......||..|+|||++.+..++.++||||||+++|||+| |+.||...........    .. .+.  ...       
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~----i~-~~~--~~~-------  221 (258)
T d1k2pa_         157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IA-QGL--RLY-------  221 (258)
T ss_dssp             -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----HH-TTC--CCC-------
T ss_pred             -EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHH----HH-HCC--CCC-------
T ss_conf             -524657887757807863799885210336432467397559999889999999999----98-079--789-------


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             4318999999999976554885899998899999720
Q 003628          719 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  755 (807)
Q Consensus       719 ~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~  755 (807)
                       .+...+.++.+++.+||+.||++|||+++|++.|..
T Consensus       222 -~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 -RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             -965465999999999766897689399999987418

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.32  Aligned_cols=257  Identities=27%  Similarity=0.432  Sum_probs=207.6

Q ss_pred             CCCCCCC-CCCCCCCCCEEEEEEC---CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             3876458-5443797138999935---99599999915547-20589999999999833688346786388738867999
Q 003628          481 NNFQLSS-KLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~f~~~~-~Lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      +++.+.+ +||+|+||.||+|...   ++..||||.+.... ....++|.+|++++++++||||++++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf             4718878487306080999999960897689999998820397899999999999986799888068656036-807999


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf             98248998110003888887789022688999989665765405888489077899982425899812211466201389
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~  635 (807)
                      |||+++|+|.+++..  ....+++..+.+++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCC
T ss_conf             980789968997521--2569999999999999999878998688---10576764660454688542033134211554


Q ss_pred             CCCC-CCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             9986-42110222678558111125988965545502587899784-998987667730154444330012221000276
Q 003628          636 NQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       636 ~~~~-~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      .... .......||+.|+|||++....++.++||||||+++|||+| |+.||.......... .    ...+..     +
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~-~----i~~~~~-----~  231 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-F----IEQGKR-----M  231 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-H----HHTTCC-----C
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHH-H----HHCCCC-----C
T ss_conf             34321135621137433586887279999541232201789999938999999979999999-9----981899-----9


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             555784318999999999976554885899998899999720237
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~  758 (807)
                           +.+...+.++.+++.+||+.||++||++.+|++.|+....
T Consensus       232 -----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         232 -----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             -----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             -----9997678999999999757797689099999999999999

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.57  Aligned_cols=251  Identities=25%  Similarity=0.377  Sum_probs=207.4

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             38764585443797138999935-99599999915547205899999999998336883467863887388679999824
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  559 (807)
                      +.|++.+.||+|+||.||+|+.. ++..||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf             37598479930778199999999999399999987289999999999999998679999884988980099589999627


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf             89981100038888877890226889999896657654058884890778999824258998122114662013899986
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~~~  639 (807)
                      ++|+|.+++..  ....+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  .
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~  164 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I  164 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred             CCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCC--C
T ss_conf             99818899986--2899999999999999999999999889---887140700314878999899716123035778--6


Q ss_pred             CCCCEEECCCCCCCHHHHC-----CCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             4211022267855811112-----59889655455025878997849989876677301544443300122210002765
Q 003628          640 ADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~-----~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      .......||+.|+|||++.     ...++.++||||+||++|||++|+.||........+.....    ..      .+.
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~----~~------~~~  234 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK----SE------PPT  234 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH----SC------CCC
T ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHC----CC------CCC
T ss_conf             41001025626479999832025788888066578789999998208899999899999999970----79------987


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             5578431899999999997655488589999889999
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                      +   ..+...+.++.+++.+||+.||++|||++|+++
T Consensus       235 ~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 L---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             C---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             7---765669999999999976699668919999962

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.17  Aligned_cols=246  Identities=28%  Similarity=0.374  Sum_probs=206.7

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             238764585443797138999935-9959999991554---720589999999999833688346786388738867999
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+.+.   .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf             53769988985177858999999899949999998168856768999999999999856888888599999989998999


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf             98248998110003888887789022688999989665765405888489077899982425899812211466201389
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~  635 (807)
                      |||+++|+|.+++.   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 mEy~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          85 LEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EEECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf             85047985898875---0489999999999999999999999889---46522023441466899871155563354488


Q ss_pred             CCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             99864211022267855811112598896554550258789978499898766773015444433001222100027655
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ..    .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+........    . ..      ++  
T Consensus       159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----~-~~------~~--  221 (263)
T d2j4za1         159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----S-RV------EF--  221 (263)
T ss_dssp             CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H-TT------CC--
T ss_pred             CC----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----H-CC------CC--
T ss_conf             85----23557887634999975899893144046759999983299998889999999999----7-18------99--


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             578431899999999997655488589999889999
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                         ..+...+.++.+++.+|++.||++|||++|+++
T Consensus       222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ---998668999999999976479768909999971

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=349.81  Aligned_cols=256  Identities=21%  Similarity=0.251  Sum_probs=210.6

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             238764585443797138999935-9959999991554720589999999999833688346786388738867999982
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  558 (807)
                      .++|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|++++++++||||+++++++.++...++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             40359989993177829999999899979999998872646799999999999867997989199999989999999982


Q ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCCEEECCCCCCCCCCC
Q ss_conf             48998110003888887789022688999989665765405888489077899982425--8998122114662013899
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD--EELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~--~~~~~kI~DFGla~~~~~~  636 (807)
                      +++|+|.+++..  ....+++.++..++.||+.||+|||+.+   |+||||||+|||++  .++.+||+|||+++.+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf             899808888986--3899899999999999999999999779---26513144553113467884899525630343788


Q ss_pred             CCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             98642110222678558111125988965545502587899784998987667730154444330012221000276555
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      .   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+....+.....     .      +....
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~-----~------~~~~~  248 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-----C------DWEFD  248 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH-----C------CCCCC
T ss_pred             C---CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-----C------CCCCC
T ss_conf             7---20100476453489997479989763338989999999968899899799999999984-----7------88989


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHH
Q ss_conf             784318999999999976554885899998899999--720
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNS  755 (807)
Q Consensus       717 ~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~--L~~  755 (807)
                      . ......+.++.+++.+||+.||.+|||+.|+++.  +++
T Consensus       249 ~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         249 E-DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             S-STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             C-CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             3-002479999999999975699668918999960973488

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.77  Aligned_cols=258  Identities=24%  Similarity=0.322  Sum_probs=206.0

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             238764585443797138999935-99599999915547-2058999999999983368834678638873886799998
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  557 (807)
                      .++|++.++||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf             56888978971277809999999899969999998754097899999999999986799999949999998999999997


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf             248998110003888887789022688999989665765405-8884890778999824258998122114662013899
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~  636 (807)
                      |+++|+|.+++..   ...+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf             6799868998742---4999999999999999999999998599---971445779946878998999548776256788


Q ss_pred             CCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCC-----------
Q ss_conf             986421102226785581111259889655455025878997849989876677301544443300122-----------
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN-----------  705 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~-----------  705 (807)
                          .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+................           
T Consensus       159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ----CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf             ----6211137714119468758998948889989999999998889989988789999998875177545774212333


Q ss_pred             --------------CCCC-------CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             --------------2100-------027655578431899999999997655488589999889999
Q 003628          706 --------------KILA-------LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       706 --------------~~~~-------~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                                    ...+       ...+.+.    ......++.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP----SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCC----BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             22111122235413477887665026876676----4448999999999986899467908999960

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.22  Aligned_cols=249  Identities=27%  Similarity=0.342  Sum_probs=209.1

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             38764585443797138999935-9959999991554---7205899999999998336883467863887388679999
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+.+.   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999899889999


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf             82489981100038888877890226889999896657654058884890778999824258998122114662013899
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~  636 (807)
                      ||+++|+|.+++.   ..+.+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             ECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf             7048987777653---1599999999999999999997621650---884767741236688853886032102422567


Q ss_pred             CCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             98642110222678558111125988965545502587899784998987667730154444330012221000276555
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......    ... ..      .   
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~----i~~-~~------~---  227 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIK-LE------Y---  227 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHT-TC------C---
T ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHC-CC------C---
T ss_conf             764333555677552584400268989666230456999998038899899599999999----971-89------9---


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             78431899999999997655488589999889999
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       717 ~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                        .++.....++.+++.+||+.||++|||++|++.
T Consensus       228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf             --998547999999999985579768919789737

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=353.50  Aligned_cols=262  Identities=26%  Similarity=0.442  Sum_probs=213.1

Q ss_pred             HHHHCCCCCCCCCCCCCCCCEEEEEEC------CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
Q ss_conf             997238764585443797138999935------995999999155472-0589999999999833688346786388738
Q 003628          477 ATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG  549 (807)
Q Consensus       477 ~~~~~~f~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  549 (807)
                      +...++|++.+.||+|+||.||+|+..      ++..||||++..... +..++|.+|++++++++||||+++++++...
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCC
T ss_conf             38988938867982078839999998887657788299999988210857999999999999966899765524666059


Q ss_pred             CEEEEEEEECCCCCCCCCCCCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
Q ss_conf             86799998248998110003888---------------------887789022688999989665765405888489077
Q 003628          550 EEKMLIYEYMPNRSLDALLFDPL---------------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRD  608 (807)
Q Consensus       550 ~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D  608 (807)
                      ...++|+||+++|+|.++++...                     ....+++..++.++.|++.||+|||+.+   ++|||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD  165 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  165 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEEEE
T ss_conf             803899981589929999985275542100001110012103467889899999999999999855413578---68548


Q ss_pred             CCCCCEEECCCCCCEEECCCCCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCC-CCCC
Q ss_conf             899982425899812211466201389998642110222678558111125988965545502587899784998-9876
Q 003628          609 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK-NTSF  687 (807)
Q Consensus       609 Ikp~NIll~~~~~~kI~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~-p~~~  687 (807)
                      |||+|||++.++.+||+|||+++.+.............|++.|+|||.+.+..++.++||||||+++|||++|.. |+..
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCC
T ss_conf             84011689899928983314421136776411157777676767989972688980563025236299998068999999


Q ss_pred             CCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             677301544443300122210002765557843189999999999765548858999988999997202
Q 003628          688 FEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       688 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~  756 (807)
                      .++..... .    ...+..     +     +.+...+.++.+|+.+||+.+|++||||.||+++|+.+
T Consensus       246 ~~~~e~~~-~----v~~~~~-----~-----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         246 MAHEEVIY-Y----VRDGNI-----L-----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             SCHHHHHH-H----HHTTCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCHHHHHH-H----HHCCCC-----C-----CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             89999999-9----973997-----8-----88732529999999997488965793999999999984

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.57  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=209.7

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEEC-CCC----EEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf             38764585443797138999935-995----9999991554-72058999999999983368834678638873886799
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      ++|++.+.||+|+||.||+|+.. +++    .||+|++... ..+..++|.+|++++++++||||++++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf             999783198208992999999958998898999999965134979999999999999867998881589999619-8369


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCC
Q ss_conf             99824899811000388888778902268899998966576540588848907789998242589981221146620138
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~  634 (807)
                      ++|++.+|+|.+++..  ....+++..+++++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEECCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf             9984268740101113--3457999999999999999999998769---5047621203116799875860255222335


Q ss_pred             CCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             9998642110222678558111125988965545502587899784-998987667730154444330012221000276
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ............||+.|+|||++.++.++.++||||||+++|||+| |+.||...+..... ..    ...+.       
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~----i~~~~-------  230 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI----LEKGE-------  230 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HH----HHHTC-------
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HH----HHCCC-------
T ss_conf             4445322365105864467088746999835654407999999997799999999989999-99----97599-------


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             555784318999999999976554885899998899999720237
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~  758 (807)
                      +.   +.+...+.++.+++.+||+.||.+|||+.||++.|+....
T Consensus       231 ~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         231 RL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             CC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             89---9985568999999998478993469199999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.91  Aligned_cols=248  Identities=27%  Similarity=0.398  Sum_probs=201.9

Q ss_pred             CCCCCCCCCCEEEEEECC---CCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf             854437971389999359---9599999915547--20589999999999833688346786388738867999982489
Q 003628          487 SKLGQGGFGPVYWGRLKD---GQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  561 (807)
Q Consensus       487 ~~Lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  561 (807)
                      ++||+|+||.||+|.+..   ++.||||++....  ....++|.+|++++++++||||++++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCCC-
Q ss_conf             9811000388888778902268899998966576540588848907789998242589981221146620138999864-
Q 003628          562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA-  640 (807)
Q Consensus       562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~~~~-  640 (807)
                      |+|.+++.   ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....... 
T Consensus        92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf             96899975---2257899999999999999976687479---55677761131023567512341345331343234432


Q ss_pred             CCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf             2110222678558111125988965545502587899784-998987667730154444330012221000276555784
Q 003628          641 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  719 (807)
Q Consensus       641 ~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  719 (807)
                      ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ..    ....+..          .+
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-~~----~i~~~~~----------~~  230 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TA----MLEKGER----------MG  230 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HH----HHHTTCC----------CC
T ss_pred             CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHH-HH----HHHCCCC----------CC
T ss_conf             244567784203916653799984344303403132896589999999899999-99----9982899----------99


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             3189999999999765548858999988999997202
Q 003628          720 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       720 ~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~  756 (807)
                      .+...+.++.+++.+||+.||++||++++|+++|+..
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf             9865679999999997588976890989999985288

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=347.90  Aligned_cols=253  Identities=23%  Similarity=0.283  Sum_probs=206.5

Q ss_pred             HHCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             7238764585443797138999935-99599999915547-205899999999998336883467863887388679999
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       479 ~~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ..+.|.+.+.||+|+||.||+++.. +++.||||.+.+.. ......+.+|+.++++++||||+++++++.+++..++||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             76666998899406583999999999998999999815773128999999999998679989991989999899888988


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCCEEECCCCCCCC
Q ss_conf             8248998110003888887789022688999989665765405888489077899982425---8998122114662013
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIF  633 (807)
Q Consensus       557 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~---~~~~~kI~DFGla~~~  633 (807)
                      ||+++|+|.+++.   ....+++.++..++.|++.||.|||+.+   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             ECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf             5268984888653---0367887899999999999987524130---556870463001104688824998315435872


Q ss_pred             CCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             89998642110222678558111125988965545502587899784998987667730154444330012221000276
Q 003628          634 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       634 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      ....   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...........    ... ..      .
T Consensus       161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~----i~~-~~------~  226 (307)
T d1a06a_         161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ----ILK-AE------Y  226 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHT-TC------C
T ss_pred             CCCC---EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHC-CC------C
T ss_conf             5897---04400328422591887379998078734515999999859799999899999999----861-68------7


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             555784318999999999976554885899998899999
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~  752 (807)
                      ... .+...+.+.++.+++.+|++.||++|||++|+++.
T Consensus       227 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         227 EFD-SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CCC-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             778-76666789999999999760897579189998629

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.61  Aligned_cols=255  Identities=25%  Similarity=0.359  Sum_probs=206.3

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEE
Q ss_conf             238764585443797138999935-99599999915547--2058999999999983368834678638873--886799
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKML  554 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l  554 (807)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+....  ....+.+.+|++++++++||||+++++++.+  ....++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             33379967983088919999999999979999998746579799999999999999778999824899999178998999


Q ss_pred             EEEECCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf             99824899811000388-88877890226889999896657654058--8848907789998242589981221146620
Q 003628          555 IYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDS--RLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       555 V~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~DIkp~NIll~~~~~~kI~DFGla~  631 (807)
                      ||||+++|+|.+++... .....+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf             99568999389999851545789999999999999999999999716778878858676542574788857980010003


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf             13899986421102226785581111259889655455025878997849989876677301544443300122210002
Q 003628          632 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       632 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      .+.....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.......     ...+..    
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~-----i~~~~~----  231 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-----IREGKF----  231 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----HHHTCC----
T ss_pred             ECCCCCC--CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHH-----HHCCCC----
T ss_conf             2245777--55667788232799998399999389887527899998018899899899999999-----971899----


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             7655578431899999999997655488589999889999
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                       +.     .+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       232 -~~-----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 -RR-----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CC-----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             -88-----97435999999999976799557918999972

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.09  Aligned_cols=247  Identities=26%  Similarity=0.392  Sum_probs=197.7

Q ss_pred             CCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE----CCEEEEE
Q ss_conf             764585443797138999935-9959999991554--72058999999999983368834678638873----8867999
Q 003628          483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEKMLI  555 (807)
Q Consensus       483 f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV  555 (807)
                      |++.++||+|+||+||+|+.. ++..||+|.+...  .....+.+.+|++++++++||||+++++++..    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf             88516970082849999999999959999998512279899999999999998579998506999984033458889999


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCCEEECCCCCCCCC
Q ss_conf             98248998110003888887789022688999989665765405888489077899982425-89981221146620138
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFG  634 (807)
Q Consensus       556 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~-~~~~~kI~DFGla~~~~  634 (807)
                      |||+++|+|.+++.   +...+++..+..++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf             95789894899975---1355469999999999999999999789-9799687674351166799988980057654236


Q ss_pred             CCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             99986421102226785581111259889655455025878997849989876677301544443300122210002765
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  714 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  714 (807)
                      ..    ......||+.|+|||++.+ .++.++||||+||++|||++|+.||....+...+.....    .+     ..+ 
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~----~~-----~~~-  231 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT----SG-----VKP-  231 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT----TT-----CCC-
T ss_pred             CC----CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----CC-----CCC-
T ss_conf             87----6677553813008988478-999867110079999999878899987655999999997----38-----998-


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             5578431899999999997655488589999889999
Q 003628          715 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       715 l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                         ...+.....++.+++.+|++.||++|||++|+++
T Consensus       232 ---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ---6567557899999999976379758929999967

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.58  Aligned_cols=267  Identities=27%  Similarity=0.376  Sum_probs=213.4

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEECC-CC--EEEEEEECCC-CCCCHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCEEEEE
Q ss_conf             387645854437971389999359-95--9999991554-720589999999999833-688346786388738867999
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD-GQ--EIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ++|++.+.||+|+||.||+|++.+ +.  .||||++... ..+..+.|.+|++++.++ +||||++++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf             99688779820788289999998999699999999782338579999999999998622899883678888418736999


Q ss_pred             EEECCCCCCCCCCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCC
Q ss_conf             9824899811000388-------------888778902268899998966576540588848907789998242589981
Q 003628          556 YEYMPNRSLDALLFDP-------------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  622 (807)
Q Consensus       556 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~  622 (807)
                      |||+++|+|.++++..             .....+++..+.+++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf             9802898699998640355555123101234578999999999999999987663089---5455505204898688763


Q ss_pred             EEECCCCCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHH
Q ss_conf             2211466201389998642110222678558111125988965545502587899784998-987667730154444330
Q 003628          623 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK-NTSFFEDDLTILGYAWKL  701 (807)
Q Consensus       623 kI~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~-p~~~~~~~~~l~~~~~~~  701 (807)
                      ||+|||+++......   ......||..|+|||.+.+..++.++||||||+++|||++|.. |+...+ ...+.....  
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-~~~~~~~i~--  240 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLP--  240 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHGG--
T ss_pred             EECCCCCCCCCCCCC---CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHH--
T ss_conf             874344322444223---45530137755553875269999622153138899999836899999999-999999998--


Q ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             0122210002765557843189999999999765548858999988999997202378999999985
Q 003628          702 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF  768 (807)
Q Consensus       702 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~  768 (807)
                        .+     ..+     +.+...+.++.+++.+||+.||++||+|+||++.|+.++++.+....+..
T Consensus       241 --~~-----~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~~~~  295 (309)
T d1fvra_         241 --QG-----YRL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTL  295 (309)
T ss_dssp             --GT-----CCC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBC
T ss_pred             --HC-----CCC-----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf             --26-----888-----88766789999999997678966894999999999999861867789750

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=348.60  Aligned_cols=245  Identities=28%  Similarity=0.454  Sum_probs=200.8

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCC---CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             38764585443797138999935-995999999155472---05899999999998336883467863887388679999
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      +.|+..++||+|+||.||+|+.. ++..||||++.....   ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             85676279701888099999998999399999984444358899999999999999778999823899999899889999


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf             82489981100038888877890226889999896657654058884890778999824258998122114662013899
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~  636 (807)
                      ||+++|+|..++.   ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf             8069994578997---3799999999999999999999998689---76667884217987999789844365334677-


Q ss_pred             CCCCCCCEEECCCCCCCHHHHCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             98642110222678558111125---988965545502587899784998987667730154444330012221000276
Q 003628          637 QDQADTGRVVGTFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~---~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                           .....||+.|+|||++.+   ..++.++|||||||++|||++|+.||........+..    ...      ...+
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~----i~~------~~~~  232 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQ------NESP  232 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHH------SCCC
T ss_pred             -----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHH------CCCC
T ss_conf             -----8731347663688998346788867214545589999999878899999799999999----982------8999


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             55578431899999999997655488589999889999
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                      ...    +...+.++.+++.+||+.||.+|||++|+++
T Consensus       233 ~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 ALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             888----7888999999999977379657918999971

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=347.36  Aligned_cols=267  Identities=27%  Similarity=0.348  Sum_probs=211.4

Q ss_pred             HHHHHHHCCCCCCCCCCCCCCCCEEEEEEC------CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHC-CCCCEEEEEEE
Q ss_conf             899997238764585443797138999935------99599999915547-20589999999999833-68834678638
Q 003628          474 EELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGC  545 (807)
Q Consensus       474 ~~l~~~~~~f~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~  545 (807)
                      .+.+...++|++.++||+|+||.||+|+..      +++.||||++.... ....+.+.+|...+.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf             25261679979844984167839999998677755578399999986001717899999999998861499849974115


Q ss_pred             EEECC-EEEEEEEECCCCCCCCCCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf             87388-6799998248998110003888-------------887789022688999989665765405888489077899
Q 003628          546 CVEGE-EKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKA  611 (807)
Q Consensus       546 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp  611 (807)
                      +...+ ..++||||+++|+|.+++....             ....+++.++..++.||++||.|||+.+   |+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred             ECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCC
T ss_conf             404797579999845899299999853666665322202332146899999999999999999887379---71786773


Q ss_pred             CCEEECCCCCCEEECCCCCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCC
Q ss_conf             98242589981221146620138999864211022267855811112598896554550258789978499-89876677
Q 003628          612 SNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR-KNTSFFED  690 (807)
Q Consensus       612 ~NIll~~~~~~kI~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~-~p~~~~~~  690 (807)
                      +|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++|. .||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             CCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCH
T ss_conf             10657799828984575200113566522247516672102036864688996632213678999998688999989998


Q ss_pred             CCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             3015444433001222100027655578431899999999997655488589999889999972023
Q 003628          691 DLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       691 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~  757 (807)
                      ...+....    ..+.     .+.     .+...+.++.+++.+||+.||++|||+.||+++|+.++
T Consensus       243 ~~~~~~~~----~~~~-----~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         243 DEEFCRRL----KEGT-----RMR-----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             SHHHHHHH----HHTC-----CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHH----HCCC-----CCC-----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             99999999----6389-----888-----88657899999999976779667919999999997998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.85  Aligned_cols=248  Identities=23%  Similarity=0.282  Sum_probs=207.3

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             238764585443797138999935-9959999991554---720589999999999833688346786388738867999
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      .++|.+.+.||+|+||.||+++.. +++.||||++.+.   .....+.+.+|+.+|++++||||+++++.+.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47428988983176849999999899989999998156544979999999999999867999887787640356421110


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf             98248998110003888887789022688999989665765405888489077899982425899812211466201389
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~  635 (807)
                      |||+++|+|..++.   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf             00357986055553---2567759999999999965211343159---62246477784765899888820565200356


Q ss_pred             CCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             99864211022267855811112598896554550258789978499898766773015444433001222100027655
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ..  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......    .. .+.      .  
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~----i~-~~~------~--  222 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----IL-MEE------I--  222 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HCC------C--
T ss_pred             CC--CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHH----HH-CCC------C--
T ss_conf             78--620551008899666650489888333102230678899878999999699999999----85-289------9--


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             578431899999999997655488589999-----889999
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVS  751 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt-----~~evl~  751 (807)
                         .++...+.++.+++.+||+.||.+||+     ++|+++
T Consensus       223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf             ---89866899999999866638934422565234999972

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.20  Aligned_cols=252  Identities=23%  Similarity=0.290  Sum_probs=206.1

Q ss_pred             HHCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC------CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
Q ss_conf             7238764585443797138999935-99599999915547------2058999999999983368834678638873886
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  551 (807)
Q Consensus       479 ~~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  551 (807)
                      ..++|.+.+.||+|+||.||+|+.. +|+.||||++.+..      ....+.+.+|+.++++++||||+++++++.+...
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf             55677982798117895999999999998999999875663213406899999999999986799899938899997998


Q ss_pred             EEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CCEEECC
Q ss_conf             799998248998110003888887789022688999989665765405888489077899982425899----8122114
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL----NPKISDF  627 (807)
Q Consensus       552 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~----~~kI~DF  627 (807)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          88 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEECCCCCCCCCHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCH
T ss_conf             9999986778643100103---564215578999999999987666254---2211333012798258986664696433


Q ss_pred             CCCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf             66201389998642110222678558111125988965545502587899784998987667730154444330012221
Q 003628          628 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI  707 (807)
Q Consensus       628 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~  707 (807)
                      |+++.......   .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+....+.....     .. 
T Consensus       162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~-----~~-  232 (293)
T d1jksa_         162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-----VN-  232 (293)
T ss_dssp             TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT-----TC-
T ss_pred             HHHHHCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH-----CC-
T ss_conf             44210577763---1224777743099998189999766522140999999708899889999999999981-----68-


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             00027655578431899999999997655488589999889999
Q 003628          708 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       708 ~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                           .... .......+..+.+++.+||+.||++|||++|+++
T Consensus       233 -----~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 -----YEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -----CCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CCCC-CHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -----8887-0104788999999999986389668919999961

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.00  Aligned_cols=256  Identities=25%  Similarity=0.412  Sum_probs=206.1

Q ss_pred             CCCCCCCCCCCEEEEEECCC----CEEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CEEEEEEEEC
Q ss_conf             58544379713899993599----59999991554-720589999999999833688346786388738-8679999824
Q 003628          486 SSKLGQGGFGPVYWGRLKDG----QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-EEKMLIYEYM  559 (807)
Q Consensus       486 ~~~Lg~G~~g~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~  559 (807)
                      .++||+|+||+||+|++..+    ..||||++... .....++|.+|++++++++||||++++|++... ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf             66981368809999999779987999999998843697899999999999986789998678678980699438999874


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf             89981100038888877890226889999896657654058884890778999824258998122114662013899986
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~~~  639 (807)
                      ++|+|.+++..  ....+++..+++++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ECCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf             06741442101--3454048999999999887652003367---625776687576779998899106523225566555


Q ss_pred             --CCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf             --421102226785581111259889655455025878997849989876677301544443300122210002765557
Q 003628          640 --ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       640 --~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                        .......||..|+|||.+....++.++||||||+++|||++|+.|+..............    .+..  ..      
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~----~g~~--~~------  254 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QGRR--LL------  254 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH----TTCC--CC------
T ss_pred             CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----CCCC--CC------
T ss_conf             31002565556455676887437999745746619999999978999988899999999998----0898--89------


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf             8431899999999997655488589999889999972023789
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  760 (807)
Q Consensus       718 ~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~~~  760 (807)
                        .+...+.++.+++.+||+.||++||+|.||++.|+.+....
T Consensus       255 --~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         255 --QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             --CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf             --96447599999999976889768939999999999999752

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.44  Aligned_cols=264  Identities=26%  Similarity=0.377  Sum_probs=213.9

Q ss_pred             HHCCCCCCCCCCCCCCCCEEEEEEC------CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC
Q ss_conf             7238764585443797138999935------995999999155472-0589999999999833-6883467863887388
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE  550 (807)
Q Consensus       479 ~~~~f~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  550 (807)
                      ..++|.+.+.||+|+||.||+|++.      .+..||||+++.... .....|.+|+.++.++ +||||+++++++.+..
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf             78996985498206882999999806644778869999998742487799999999999876269998878998983199


Q ss_pred             EEEEEEEECCCCCCCCCCCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf             6799998248998110003888---------------8877890226889999896657654058884890778999824
Q 003628          551 EKMLIYEYMPNRSLDALLFDPL---------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL  615 (807)
Q Consensus       551 ~~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIl  615 (807)
                      ..++||||+++|+|.++++...               ....+++..+..++.||++||+|||.++   ++||||||+||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCC
T ss_conf             78999973799879999985356654444453322233458899999999999999999887579---266624102100


Q ss_pred             ECCCCCCEEECCCCCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCC-CCCCCCCCHH
Q ss_conf             258998122114662013899986421102226785581111259889655455025878997849989-8766773015
Q 003628          616 LDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFEDDLTI  694 (807)
Q Consensus       616 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p-~~~~~~~~~l  694 (807)
                      ++.++.+|++|||+++...............||+.|+|||.+....++.++||||||+++|||+|++.| +........+
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf             00257521023401023367886158620135968767788617999974001025899999985899887789989999


Q ss_pred             HHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             44443300122210002765557843189999999999765548858999988999997202378
Q 003628          695 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  759 (807)
Q Consensus       695 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~~  759 (807)
                      .....    .+     ..+.     .+...+.++.+++.+||+.||.+||||++|+++|++.+.+
T Consensus       258 ~~~i~----~~-----~~~~-----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         258 YKMIK----EG-----FRML-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHH----HT-----CCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHH----CC-----CCCC-----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             99986----68-----9889-----8543659999999997577965792999999999876534

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.85  Aligned_cols=270  Identities=21%  Similarity=0.285  Sum_probs=203.8

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEECCCCEEEEEEECCCCCCCHHHHHH--HHHHHHHCCCCCEEEEEEEEEECC----EEE
Q ss_conf             23876458544379713899993599599999915547205899999--999998336883467863887388----679
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN--EVMVISKLQHRNLVRLLGCCVEGE----EKM  553 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~g~~~~~~----~~~  553 (807)
                      .++|.+.+.||+|+||.||+|++. |..||||++....   .+.+..  |+..+.+++||||+++++++.+.+    ..+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
T ss_conf             868999889820788199999999-9899999987200---467999999999962799868326889983798604899


Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCCEEECCC
Q ss_conf             9998248998110003888887789022688999989665765405-----88848907789998242589981221146
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       554 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~DIkp~NIll~~~~~~kI~DFG  628 (807)
                      +||||+++|+|.++++.    ..++|..+++++.+++.||.|||..     ...+|+||||||+||||+.++.+||+|||
T Consensus        78 lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEECCCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECC
T ss_conf             99964669898999865----89998999999999999999988766520468986615317313578688776887638


Q ss_pred             CCCCCCCCCCCC--CCCEEECCCCCCCHHHHCCCC------CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCH-HHH---
Q ss_conf             620138999864--211022267855811112598------89655455025878997849989876677301-544---
Q 003628          629 MAKIFGGNQDQA--DTGRVVGTFGYMSPEYAMEGR------FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT-ILG---  696 (807)
Q Consensus       629 la~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~------~s~~sDV~SlGvil~elltG~~p~~~~~~~~~-l~~---  696 (807)
                      +++.........  ......||+.|+|||++.+..      ++.++||||||+++|||+||..|+........ ...   
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
T ss_conf             66234677762001355250354767822105654546777675012201599999996289988766311241012255


Q ss_pred             --HHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             --4433001222100027655578431899999999997655488589999889999972023
Q 003628          697 --YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       697 --~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~  757 (807)
                        ................|.+.......+....+.+++.+||+.||++|||+.||+++|+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             643099999987502468887765577689999999999976069858959999999999888

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=338.53  Aligned_cols=245  Identities=27%  Similarity=0.357  Sum_probs=204.7

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             238764585443797138999935-9959999991554---720589999999999833688346786388738867999
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      .++|++.+.||+|+||.||+++.. +|+.||||++.+.   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf             54708888972076808999999899979999998457754889999999999999863696753303568528800567


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf             98248998110003888887789022688999989665765405888489077899982425899812211466201389
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~  635 (807)
                      |||+++|+|..++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        83 mE~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          83 MDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             ECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EEECCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf             65037863223432---2221110079999999987655412476---77055681050386899889831752167124


Q ss_pred             CCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             99864211022267855811112598896554550258789978499898766773015444433001222100027655
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      .     .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......    ... +.      .  
T Consensus       157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----i~~-~~------~--  218 (316)
T d1fota_         157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILN-AE------L--  218 (316)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHH-CC------C--
T ss_pred             C-----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHH----HHC-CC------C--
T ss_conf             5-----6434576343599998389998043046533368999759899999699999999----970-89------8--


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             57843189999999999765548858999-----9889999
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  751 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~ii~~Cl~~dP~~RP-----t~~evl~  751 (807)
                         ..+...+.++.+++.+|++.||.+||     +++++++
T Consensus       219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf             ---89977899999999999544997666431021999981

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.73  Aligned_cols=262  Identities=28%  Similarity=0.427  Sum_probs=212.2

Q ss_pred             HHCCCCCCCCCCCCCCCCEEEEEEC------CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
Q ss_conf             7238764585443797138999935------99599999915547-2058999999999983368834678638873886
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  551 (807)
Q Consensus       479 ~~~~f~~~~~Lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  551 (807)
                      ..++|.+.++||+|+||.||+|.+.      .+..||||+++... .+....|.+|++++++++||||++++|++.....
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf             68991883598207881899999878644778968999998701286899999999999997699988412547842881


Q ss_pred             EEEEEEECCCCCCCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEE
Q ss_conf             79999824899811000388-------88877890226889999896657654058884890778999824258998122
Q 003628          552 KMLIYEYMPNRSLDALLFDP-------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  624 (807)
Q Consensus       552 ~~lV~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI  624 (807)
                      .++||||+++|+|.+++...       .....+++..+.+++.|+++||.|||..+   |+||||||+|||++.++.+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEE
T ss_conf             06777604899889998750332113444688799999999999999999876479---654328677540359964999


Q ss_pred             ECCCCCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHCC
Q ss_conf             1146620138999864211022267855811112598896554550258789978499-898766773015444433001
Q 003628          625 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR-KNTSFFEDDLTILGYAWKLWN  703 (807)
Q Consensus       625 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~-~p~~~~~~~~~l~~~~~~~~~  703 (807)
                      +|||+++.+.............|++.|+|||.+.+..++.++||||||+++|||+||+ .|+........+. ..   . 
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~-~i---~-  249 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-FV---M-  249 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH-HH---H-
T ss_pred             EECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH-HH---H-
T ss_conf             424542023577630313402316323788887369988333444378999999968999999989999999-99---8-


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             2221000276555784318999999999976554885899998899999720237
Q 003628          704 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       704 ~~~~~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~  758 (807)
                      .+..          .+.+...+..+.+++.+||+.+|.+||||++|+++|+..++
T Consensus       250 ~~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 EGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HCCC----------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             0888----------88863353999999999757796589399999999787617

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=338.60  Aligned_cols=244  Identities=23%  Similarity=0.286  Sum_probs=205.1

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             38764585443797138999935-9959999991554---7205899999999998336883467863887388679999
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  556 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  556 (807)
                      ++|++.+.||+|+||.||+++.. +|+.||||++.+.   .....+.+.+|+++++.++||||+++++++.+....++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443222223222


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf             82489981100038888877890226889999896657654058884890778999824258998122114662013899
Q 003628          557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  636 (807)
Q Consensus       557 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~  636 (807)
                      ||+.+|+|..++.   ..+.+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf             2334662266675---1589899999999999999899998599---861767999936077897886101033322566


Q ss_pred             CCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             98642110222678558111125988965545502587899784998987667730154444330012221000276555
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                           .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......    ... +.      +   
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----i~~-~~------~---  255 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVS-GK------V---  255 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHH-CC------C---
T ss_pred             -----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHH----HHC-CC------C---
T ss_conf             -----6433676356788997179988533114500789999758899899599999999----861-79------8---


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             7843189999999999765548858999-----9889999
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  751 (807)
Q Consensus       717 ~~~~~~~~~~~l~~ii~~Cl~~dP~~RP-----t~~evl~  751 (807)
                        ..+...+.++.+++.+||+.||.+|+     +++++++
T Consensus       256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf             --89766899999999998340998606553454999971

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.74  Aligned_cols=260  Identities=26%  Similarity=0.396  Sum_probs=212.9

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEECC--------CCEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCEEEEEEEEEEC
Q ss_conf             2387645854437971389999359--------95999999155472-0589999999999833-688346786388738
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG  549 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  549 (807)
                      .++|.+.+.||+|+||.||+|+...        +..||||+++.... ....++.+|+..+.++ +||||+++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf             89969700985167828999998578755566754999999881128688999999999999813999697346522018


Q ss_pred             CEEEEEEEECCCCCCCCCCCCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf             867999982489981100038888-------------8778902268899998966576540588848907789998242
Q 003628          550 EEKMLIYEYMPNRSLDALLFDPLK-------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL  616 (807)
Q Consensus       550 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll  616 (807)
                      ...++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEE
T ss_conf             8689999736999099999860677643222334574346799999999999999998766379---7863022102245


Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHH
Q ss_conf             5899812211466201389998642110222678558111125988965545502587899784-998987667730154
Q 003628          617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTIL  695 (807)
Q Consensus       617 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~ellt-G~~p~~~~~~~~~l~  695 (807)
                      +.++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+....... +.
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-~~  247 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LF  247 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HH
T ss_pred             CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH-HH
T ss_conf             47897676221110113555554314667888466326675179888255547758888874017989899999999-99


Q ss_pred             HHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             44433001222100027655578431899999999997655488589999889999972023
Q 003628          696 GYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  757 (807)
Q Consensus       696 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~  757 (807)
                      .    ....+.     .+.     .+...+.++.+++.+||+.||++|||+.||+++|++++
T Consensus       248 ~----~i~~~~-----~~~-----~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         248 K----LLKEGH-----RMD-----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             H----HHHTTC-----CCC-----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----HHHCCC-----CCC-----CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             9----997288-----889-----87435299999999976679767939999999998886

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=335.52  Aligned_cols=253  Identities=19%  Similarity=0.221  Sum_probs=199.3

Q ss_pred             HHCCCCCCC-CCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCEEEEEEEEEE----CCE
Q ss_conf             723876458-5443797138999935-9959999991554720589999999999833-68834678638873----886
Q 003628          479 ATNNFQLSS-KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE----GEE  551 (807)
Q Consensus       479 ~~~~f~~~~-~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~  551 (807)
                      ..++|.+.. .||+|+||.||+|+.. +++.||||++..     ...+.+|++++.++ +||||+++++++.+    ...
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             CCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCE
T ss_conf             014879810796545486999999889998999999897-----477999999999866999978298999503468978


Q ss_pred             EEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCCEEECCC
Q ss_conf             7999982489981100038888877890226889999896657654058884890778999824258---9981221146
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFG  628 (807)
Q Consensus       552 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~---~~~~kI~DFG  628 (807)
                      .++||||+++|+|.+++... ....+++.++..++.|++.||+|||+.+   |+||||||+|||++.   .+.+||+|||
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEECCCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             99999778998499999862-7877579999999999999999999769---8644410022011355556631135455


Q ss_pred             CCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf             62013899986421102226785581111259889655455025878997849989876677301544443300122210
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  708 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~  708 (807)
                      +++.......   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.................      
T Consensus       160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~------  230 (335)
T d2ozaa1         160 FAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR------  230 (335)
T ss_dssp             TCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC------
T ss_pred             EEEECCCCCC---CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH------
T ss_conf             1233368886---4322677563792777489888888887645167788658899889887788999999985------


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             0027655578431899999999997655488589999889999
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                       ....... .+.....+.++.+++.+|++.||++|||+.|+++
T Consensus       231 -~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         231 -MGQYEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -SCSSSCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -CCCCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -3888889-8543469999999999975699657909999970

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=336.72  Aligned_cols=249  Identities=25%  Similarity=0.284  Sum_probs=198.4

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC---CCCHHHHHHH---HHHHHHCCCCCEEEEEEEEEECCEE
Q ss_conf             238764585443797138999935-99599999915547---2058999999---9999833688346786388738867
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNE---VMVISKLQHRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~  552 (807)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++.+..   ......+.+|   +.+++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf             77685101884288909999999999979999998458754266799999999999998508998588999999989988


Q ss_pred             EEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf             99998248998110003888887789022688999989665765405888489077899982425899812211466201
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~  632 (807)
                      ++||||+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf             99999148983899987---3255327899999999999999999779---62204442216785889679822010233


Q ss_pred             CCCCCCCCCCCEEECCCCCCCHHHHCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf             389998642110222678558111125-9889655455025878997849989876677301544443300122210002
Q 003628          633 FGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       633 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      +....    .....||+.|+|||++.. ..++.++||||+||++|||++|+.||.......... ......         
T Consensus       157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~---------  222 (364)
T d1omwa3         157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL---------  222 (364)
T ss_dssp             CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSS---------
T ss_pred             CCCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHHHCC---------
T ss_conf             37886----4331134554216876038999844104677899999985999888899899999-998604---------


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             7655578431899999999997655488589999-----889999
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVS  751 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt-----~~evl~  751 (807)
                      ...   ...+...+.++.+++.+||+.||++|||     ++|+++
T Consensus       223 ~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 TMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SCC---CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCC---CCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf             688---878877899999999998566988808874357999974

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.04  Aligned_cols=257  Identities=22%  Similarity=0.327  Sum_probs=208.6

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEECC----CCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf             2387645854437971389999359----9599999915547-2058999999999983368834678638873886799
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  554 (807)
                      .++|++.+.||+|+||.||+|+...    +..||||.+.... ....+.|.+|++++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf             8996987799307882999999936996449999999365668799999999999998689999856988995-374799


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCC
Q ss_conf             99824899811000388888778902268899998966576540588848907789998242589981221146620138
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  634 (807)
Q Consensus       555 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~  634 (807)
                      ||||+++|+|.+++..  ....+++..++.++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECC
T ss_conf             9984069807765422--4789999999999999987752302267---4414102655320678967876503421336


Q ss_pred             CCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             9998642110222678558111125988965545502587899784-998987667730154444330012221000276
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  713 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  713 (807)
                      .... .......||+.|+|||++....++.++||||||+++|||++ |..|+...........     ...+..      
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~-----i~~~~~------  227 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-----IENGER------  227 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----HHTTCC------
T ss_pred             CCCC-EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHCCCC------
T ss_conf             7762-3305400583103266751699887452444247899998269999888999999999-----981899------


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             555784318999999999976554885899998899999720237
Q 003628          714 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  758 (807)
Q Consensus       714 ~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~  758 (807)
                          .+.+...+.++.+++.+||+.||++|||++||++.|+.+++
T Consensus       228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             ----98987779999999999768797689299999999999977

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=333.02  Aligned_cols=251  Identities=19%  Similarity=0.247  Sum_probs=205.0

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             238764585443797138999935-9959999991554720589999999999833688346786388738867999982
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  558 (807)
                      .++|.+.+.||+|+||+||+|+.. +++.||||.+.... .....+.+|+++|++++||||+++++++.+.+..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf             010588789831778399999998999699999975786-6599999999999857997989098999889988999953


Q ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCCEEECCCCCCCCCCC
Q ss_conf             4899811000388888778902268899998966576540588848907789998242589--98122114662013899
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE--LNPKISDFGMAKIFGGN  636 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~--~~~kI~DFGla~~~~~~  636 (807)
                      +++|+|.+++..  ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf             899808899875--3899999999999999999999998769---97513554443443788518997644111003467


Q ss_pred             CCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             98642110222678558111125988965545502587899784998987667730154444330012221000276555
Q 003628          637 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  716 (807)
Q Consensus       637 ~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  716 (807)
                         .......+++.|+|||...+..++.++||||+||++|+|++|+.||............    ....       ....
T Consensus       158 ---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i----~~~~-------~~~~  223 (321)
T d1tkia_         158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI----MNAE-------YTFD  223 (321)
T ss_dssp             ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HHTC-------CCCC
T ss_pred             ---CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHH----HHCC-------CCCC
T ss_conf             ---7532122332223402104877784011302799999998289999998999999999----8389-------9988


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             78431899999999997655488589999889999
Q 003628          717 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       717 ~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                       .......+.++.+++..|++.||.+|||+.|+++
T Consensus       224 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 -EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -0223678999999999986699668909999963

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.41  Aligned_cols=256  Identities=27%  Similarity=0.387  Sum_probs=207.3

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEECC--C--CEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf             387645854437971389999359--9--59999991554---7205899999999998336883467863887388679
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKD--G--QEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  553 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  553 (807)
                      ++|++.+.||+|+||.||+|+...  +  ..||||++.+.   ..+..+.|.+|++++++++||||++++|++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf             891997898038883999999988999079999999983555798999999999999986899998789877740-1001


Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf             99982489981100038888877890226889999896657654058884890778999824258998122114662013
Q 003628          554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  633 (807)
Q Consensus       554 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~  633 (807)
                      +||||+++|++.+.+..  ....+++..+++++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEECCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf             14654238612544421--2689999999999999999998752178---752056688815655654332561155530


Q ss_pred             CCCCCCC-CCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf             8999864-2110222678558111125988965545502587899784-9989876677301544443300122210002
Q 003628          634 GGNQDQA-DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALV  711 (807)
Q Consensus       634 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~  711 (807)
                      ....... ......|+..|+|||++.+..++.++||||||+++|||++ |+.||...+.......    ....+..    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~----i~~~~~~----  233 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK----IDKEGER----  233 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTSCCC----
T ss_pred             CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHHCCCC----
T ss_conf             35887526547632573107999983799994215661489999999689999999699999999----9847999----


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             765557843189999999999765548858999988999997202
Q 003628          712 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       712 d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~  756 (807)
                            .+.+...+..+.+++.+||+.||++|||+.||+++|++.
T Consensus       234 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 ------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf             ------998544539999999997688966792999999999964

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.85  Aligned_cols=250  Identities=28%  Similarity=0.394  Sum_probs=204.6

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CEEEEEEEE
Q ss_conf             2387645854437971389999359959999991554720589999999999833688346786388738-867999982
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-EEKMLIYEY  558 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~  558 (807)
                      .++|++.+.||+|+||.||+|+.+ |..||||+++..  ...+.|.+|++++++++||||++++|++.+. +..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf             899488579820798089999999-909999998857--77999999999998678989854987887238928999963


Q ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf             48998110003888887789022688999989665765405888489077899982425899812211466201389998
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~~  638 (807)
                      +++|+|.+++... ....+++..+++++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCC--
T ss_conf             6999899998745-7888899999999999985232113376---553666567601468997763245600344787--


Q ss_pred             CCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf             642110222678558111125988965545502587899784-9989876677301544443300122210002765557
Q 003628          639 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  717 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  717 (807)
                         .....++..|+|||++.+..++.++||||||+++|||+| |+.|+...+... +....    ..+     ..+    
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-~~~~i----~~~-----~~~----  219 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRV----EKG-----YKM----  219 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HHHHH----TTT-----CCC----
T ss_pred             ---CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHH----HCC-----CCC----
T ss_conf             ---7655666467781787279888588777579999999978999999999999-99999----808-----999----


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             843189999999999765548858999988999997202
Q 003628          718 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  756 (807)
Q Consensus       718 ~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~  756 (807)
                       +.+...+.++.+++.+||+.||++|||+.+++++|+.+
T Consensus       220 -~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         220 -DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -99765799999999997566976893999999999999

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=334.51  Aligned_cols=259  Identities=23%  Similarity=0.316  Sum_probs=209.4

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----E
Q ss_conf             238764585443797138999935-99599999915547---205899999999998336883467863887388----6
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----E  551 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~  551 (807)
                      .++|++.+.||+|+||.||+++.. +++.||||.+....   ....+.+.+|++++++++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf             62069868996089929999999999989999998556646989999999999999856999887311435432688766


Q ss_pred             EEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf             79999824899811000388888778902268899998966576540588848907789998242589981221146620
Q 003628          552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       552 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~  631 (807)
                      .++||||+++++|..++.   ..+.+++.++..++.|++.||.|||+.+   |+||||||+|||++.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEEHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf             999997788987101120---3589999999999999999999998579---5276346755665754320100344432


Q ss_pred             CCCCCC-CCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf             138999-8642110222678558111125988965545502587899784998987667730154444330012221000
Q 003628          632 IFGGNQ-DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  710 (807)
Q Consensus       632 ~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~  710 (807)
                      ...... .........||+.|+|||++.+..++.++||||+|+++|||++|+.||........+..    .......   
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----~~~~~~~---  232 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ----HVREDPI---  232 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHCCCC---
T ss_pred             HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHH----HHHCCCC---
T ss_conf             212354433334642576243699998399999663202652899999769799899699999999----9846999---


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHC
Q ss_conf             2765557843189999999999765548858999-988999997202
Q 003628          711 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP-NMSTVVSMLNSE  756 (807)
Q Consensus       711 ~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RP-t~~evl~~L~~~  756 (807)
                       .+..    ...+.+.++.+++.+|++.||.+|| +++++++.|..+
T Consensus       233 -~~~~----~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         233 -PPSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             -CGGG----TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -CCCH----HCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf             -9710----03478999999999986679767773999999999997

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=335.53  Aligned_cols=247  Identities=27%  Similarity=0.387  Sum_probs=203.5

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHH-HCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             38764585443797138999935-9959999991554---7205899999999998-33688346786388738867999
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVIS-KLQHRNLVRLLGCCVEGEEKMLI  555 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV  555 (807)
                      ++|.+.+.||+|+||+||+|+.. +++.||||++.+.   .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             97188658940878289999999999899999980555338489999999999999847999687898897049831677


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf             98248998110003888887789022688999989665765405888489077899982425899812211466201389
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  635 (807)
Q Consensus       556 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~  635 (807)
                      |||+++|+|.+++.   ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEECCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf             75037980899864---0478999999999999999999998689---34034765404444899630155530232356


Q ss_pred             CCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             99864211022267855811112598896554550258789978499898766773015444433001222100027655
Q 003628          636 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  715 (807)
Q Consensus       636 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  715 (807)
                      ..  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......    .. .+      .+. 
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~-~~------~~~-  221 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IR-MD------NPF-  221 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HC------CCC-
T ss_pred             CC--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HH-CC------CCC-
T ss_conf             65--334545787776899998279988323201122789898738899999899999999----97-18------998-


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf             57843189999999999765548858999988-9999
Q 003628          716 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMS-TVVS  751 (807)
Q Consensus       716 ~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~-evl~  751 (807)
                          ++...+.++.+++.+|++.||++||++. ++++
T Consensus       222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf             ----975679999999999654489878388999980

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=329.13  Aligned_cols=258  Identities=22%  Similarity=0.233  Sum_probs=197.6

Q ss_pred             CCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCC-----CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             585443797138999935-9959999991554720-----5899999999998336883467863887388679999824
Q 003628          486 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-----GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  559 (807)
Q Consensus       486 ~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  559 (807)
                      .+.||+|+||+||+|+.. +++.||||++......     ..+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf             63851272829999999999969999998420212456799999999999998679999868985422587402204553


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf             89981100038888877890226889999896657654058884890778999824258998122114662013899986
Q 003628          560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  639 (807)
Q Consensus       560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~~~  639 (807)
                      +++++..+..   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus        83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             CCHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             4507765541---2667789999999999999998863163---550357762588537784114657610005787554


Q ss_pred             CCCCEEECCCCCCCHHHHCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH-------CCCC-CCCCC
Q ss_conf             421102226785581111259-88965545502587899784998987667730154444330-------0122-21000
Q 003628          640 ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------WNEN-KILAL  710 (807)
Q Consensus       640 ~~~~~~~gt~~y~APE~~~~~-~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~-------~~~~-~~~~~  710 (807)
                        ....+||+.|+|||++... .++.++||||+||++|||++|+.||....+...+.......       +... .....
T Consensus       157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             --CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHH
T ss_conf             --330204733363999726778880564363042899998596999999999999999985189972545210002134


Q ss_pred             C-CCCCCCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             2-76555784---31899999999997655488589999889999
Q 003628          711 V-DPFLSESS---FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       711 ~-d~~l~~~~---~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                      . .......+   .......++.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             430347898867856568999999999976389456908999967

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=327.47  Aligned_cols=250  Identities=23%  Similarity=0.300  Sum_probs=203.8

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCC---------CCHHHHHHHHHHHHHCC-CCCEEEEEEEEEEC
Q ss_conf             38764585443797138999935-995999999155472---------05899999999998336-88346786388738
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---------QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG  549 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  549 (807)
                      ++|.+.+.||+|+||+||+++.. +++.||||++.+...         ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf             63888528841768499999999999899999996244641147888999999999999999850799747997621467


Q ss_pred             CEEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCC
Q ss_conf             86799998248998110003888887789022688999989665765405888489077899982425899812211466
Q 003628          550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  629 (807)
Q Consensus       550 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGl  629 (807)
                      +..++||||+++|+|.+++.   ....+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEECCCCCHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf             60599997689866899998---6599999999999999999999998759---94323462548986899838712403


Q ss_pred             CCCCCCCCCCCCCCEEECCCCCCCHHHHCC------CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             201389998642110222678558111125------98896554550258789978499898766773015444433001
Q 003628          630 AKIFGGNQDQADTGRVVGTFGYMSPEYAME------GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN  703 (807)
Q Consensus       630 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~  703 (807)
                      ++.+.....   .....||..|+|||++.+      ..++.++||||+|+++|||++|+.||...+.......    .. 
T Consensus       157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~----i~-  228 (277)
T d1phka_         157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IM-  228 (277)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-
T ss_pred             EEECCCCCC---EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHH----HH-
T ss_conf             167268872---1345246788898886053445678899233185656023103228889889999999999----98-


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             222100027655578431899999999997655488589999889999
Q 003628          704 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       704 ~~~~~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                      .+..      ... .+.....+.++.+++.+||+.||++||+++|+++
T Consensus       229 ~~~~------~~~-~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 SGNY------QFG-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HTCC------CCC-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HCCC------CCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             1898------889-8543468999999999976589668919999973

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=325.89  Aligned_cols=269  Identities=21%  Similarity=0.311  Sum_probs=203.9

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             38764585443797138999935-99599999915547--2058999999999983368834678638873886799998
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  557 (807)
                      ++|++.+.||+|+||+||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99776517723768099999999999799999980222575899999999999986799838874453322432037886


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf             24899811000388888778902268899998966576540588848907789998242589981221146620138999
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~  637 (807)
                      |+.++.+......  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ECCCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf             2377445554420--2568888999999999999999865288---9921357114011346762103578613436886


Q ss_pred             CCCCCCEEECCCCCCCHHHHCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH-------CCCCCCCC
Q ss_conf             864211022267855811112598-8965545502587899784998987667730154444330-------01222100
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------WNENKILA  709 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~-~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~-------~~~~~~~~  709 (807)
                      .  ......||+.|+|||++.... ++.++||||+|+++|+|++|+.||...+....+.......       +.......
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             C--CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCC
T ss_conf             4--10010365215411221366577742210333313427966879989889999999999832898333144422242


Q ss_pred             CCCCC---CCCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHC
Q ss_conf             02765---55784---318999999999976554885899998899999--7202
Q 003628          710 LVDPF---LSESS---FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSE  756 (807)
Q Consensus       710 ~~d~~---l~~~~---~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~--L~~~  756 (807)
                      .....   .....   .......++.+++.+|++.||++|||++|+++.  ++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             1243454322220444166789999999999763995579189999678701469

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=322.19  Aligned_cols=263  Identities=21%  Similarity=0.310  Sum_probs=205.1

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEECCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             3876458544379713899993599599999915547--20589999999999833688346786388738867999982
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  558 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  558 (807)
                      ++|.+.++||+|+||+||+|+.++++.||||++....  ....+.+.+|+.+|++++||||+++++.+...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf             99634318722778189999968999999999812326858999999999999867998687660120467731589974


Q ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf             48998110003888887789022688999989665765405888489077899982425899812211466201389998
Q 003628          559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  638 (807)
Q Consensus       559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~~  638 (807)
                      +.++.+..+..   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||.+........
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             EHHHHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf             00456789986---0477514456899999999999860574---88267877505686899787323664301146765


Q ss_pred             CCCCCEEECCCCCCCHHHHCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH-------HCCC----CC
Q ss_conf             6421102226785581111259-8896554550258789978499898766773015444433-------0012----22
Q 003628          639 QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-------LWNE----NK  706 (807)
Q Consensus       639 ~~~~~~~~gt~~y~APE~~~~~-~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~-------~~~~----~~  706 (807)
                        ......+++.|+|||.+... .++.++||||+|+++|||++|+.||....+...+......       .+..    ..
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             --CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             --410102431101378871788888410021117589999779799898898999999998638997110421233322


Q ss_pred             CCCCCCC--CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             1000276--55578431899999999997655488589999889999
Q 003628          707 ILALVDP--FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       707 ~~~~~d~--~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                      .......  ..............+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             14333335676466651258999999999986689668909999856

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=320.64  Aligned_cols=271  Identities=20%  Similarity=0.258  Sum_probs=201.0

Q ss_pred             HHCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----EE
Q ss_conf             7238764585443797138999935-99599999915547-205899999999998336883467863887388----67
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----EK  552 (807)
Q Consensus       479 ~~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~  552 (807)
                      ..++|++.++||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+++|++++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf             38985997899406480999999999994999999803109589999999999999768989885888995056455414


Q ss_pred             EEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf             99998248998110003888887789022688999989665765405888489077899982425899812211466201
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       553 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~  632 (807)
                      +++++++.+|+|.+++.    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEECCCCHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf             99999625986566440----589999999999999999999999789---86777876437887999778754570565


Q ss_pred             CCCCCCC-CCCCEEECCCCCCCHHHHCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCC------
Q ss_conf             3899986-42110222678558111125-988965545502587899784998987667730154444330012------
Q 003628          633 FGGNQDQ-ADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE------  704 (807)
Q Consensus       633 ~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~------  704 (807)
                      ....... .......|++.|+|||++.. ..++.++||||+|+++|||++|+.||...................      
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             CCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHH
T ss_conf             04777641010110265200038786047888741010046701337766979978888899999876520699756642


Q ss_pred             ------CCCCCCCCCCCCCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHC
Q ss_conf             ------221000276555784---318999999999976554885899998899999--7202
Q 003628          705 ------NKILALVDPFLSESS---FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSE  756 (807)
Q Consensus       705 ------~~~~~~~d~~l~~~~---~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~--L~~~  756 (807)
                            ........+.....+   .......++.+++.+|++.||.+|||++|+++.  ++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             343322220244677557787778378999999999999764895679089998619865558

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=319.17  Aligned_cols=265  Identities=22%  Similarity=0.283  Sum_probs=197.9

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-C-CCEEEEEEECCCC--CCCHHHHHHHHHHHHHC---CCCCEEEEEEEEEE----
Q ss_conf             238764585443797138999935-9-9599999915547--20589999999999833---68834678638873----
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-D-GQEIAVKRLSKAS--GQGLEEFMNEVMVISKL---QHRNLVRLLGCCVE----  548 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----  548 (807)
                      .++|++.++||+|+||+||+|+.. + ++.||||++....  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf             58979888992155869999999888998999999802324516799999999999987425898802366322146666


Q ss_pred             -CCEEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECC
Q ss_conf             -8867999982489981100038888877890226889999896657654058884890778999824258998122114
Q 003628          549 -GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  627 (807)
Q Consensus       549 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DF  627 (807)
                       ....++++|+++++.+......  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCEEEEEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf             67469999974058714444430--3789998999999999999999997588---983579862789858997542100


Q ss_pred             CCCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCC---
Q ss_conf             66201389998642110222678558111125988965545502587899784998987667730154444330012---
Q 003628          628 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE---  704 (807)
Q Consensus       628 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~---  704 (807)
                      |+++....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||...++...+..........   
T Consensus       161 g~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             HHHHHHCC---CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHH
T ss_conf             01011002---345777654851148310017988811100032899999987879989989899999999840799611


Q ss_pred             -----CCCCCCCC---CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             -----22100027---6555784318999999999976554885899998899999
Q 003628          705 -----NKILALVD---PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       705 -----~~~~~~~d---~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~  752 (807)
                           ........   ...............+.+++.+|++.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             05321111033302234564544044589999999999874896679189999669

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-45  Score=314.62  Aligned_cols=263  Identities=22%  Similarity=0.317  Sum_probs=201.5

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECC------
Q ss_conf             238764585443797138999935-9959999991554--7205899999999998336883467863887388------
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------  550 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  550 (807)
                      .++|++.++||+|+||+||+|+.. +++.||||++...  .....+.+.+|+++|++++||||+++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf             77189988980177819999999999989999998522259699999999999998668987547999863576555541


Q ss_pred             EEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCC
Q ss_conf             67999982489981100038888877890226889999896657654058884890778999824258998122114662
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       551 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla  630 (807)
                      ..++||||+ +.+|..++    +...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEECC-CCCHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf             599998405-52189998----7402269999999999999999987378---764566851111210012211343102


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCHHHHCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCC------
Q ss_conf             013899986421102226785581111259-8896554550258789978499898766773015444433001------
Q 003628          631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN------  703 (807)
Q Consensus       631 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~------  703 (807)
                      +......     ....||+.|+|||++.+. .++.++||||+||++|||++|+.||...+....+.........      
T Consensus       169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         169 RQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             EECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ECCCCCC-----CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHH
T ss_conf             2068763-----10245533358899817878996501030038999999786998889768999999850378848888


Q ss_pred             ----C---CCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHC
Q ss_conf             ----2---2210002765557---84318999999999976554885899998899999--7202
Q 003628          704 ----E---NKILALVDPFLSE---SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSE  756 (807)
Q Consensus       704 ----~---~~~~~~~d~~l~~---~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~--L~~~  756 (807)
                          .   ......+ +....   ..........+.+++.+||+.||.+|||+.|+++.  ++.+
T Consensus       244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HTCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHCCHHHHHHHCCC-CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             653000344331157-8666556677556899999999999772995579299999639623758

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-45  Score=315.39  Aligned_cols=265  Identities=22%  Similarity=0.258  Sum_probs=195.3

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEEC------CEEEE
Q ss_conf             8764585443797138999935-9959999991554720589999999999833688346786388738------86799
Q 003628          482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------EEKML  554 (807)
Q Consensus       482 ~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l  554 (807)
                      +|...++||+|+||+||+|+.. +++.||||++.....    ...+|+++|++++|+||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             76751698217683999999999997999999881606----89999999986689898738789974476577318999


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CCEEECCCCCCCC
Q ss_conf             998248998110003888887789022688999989665765405888489077899982425899-8122114662013
Q 003628          555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIF  633 (807)
Q Consensus       555 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kI~DFGla~~~  633 (807)
                      ||||++++.+..+.........+++.++..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf             9841688607888863103689999999999999999999998668---7645788603787358971167336605440


Q ss_pred             CCCCCCCCCCEEECCCCCCCHHHHCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH-------CCC-
Q ss_conf             89998642110222678558111125-988965545502587899784998987667730154444330-------012-
Q 003628          634 GGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------WNE-  704 (807)
Q Consensus       634 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~-------~~~-  704 (807)
                      .....   .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||........+.......       +.. 
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf             47765---320025555568277640468882100024652778550287998987999999999997489817765430


Q ss_pred             -CCCCCCCCCCCCCC----CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf             -22100027655578----431899999999997655488589999889999--97202
Q 003628          705 -NKILALVDPFLSES----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS--MLNSE  756 (807)
Q Consensus       705 -~~~~~~~d~~l~~~----~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~--~L~~~  756 (807)
                       .......-+.....    ........++.+++.+||+.||++|||+.|+++  .++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             CCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             62101103554456744443156899999999999765895579299999669845246

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-44  Score=308.72  Aligned_cols=267  Identities=18%  Similarity=0.286  Sum_probs=200.8

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE--------
Q ss_conf             238764585443797138999935-9959999991554--72058999999999983368834678638873--------
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--------  548 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------  548 (807)
                      .++|++.++||+|+||+||+|+.. +++.||||++...  .......+.+|+.+|++++|+|++++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf             27988999972274829999999899979999998422246378999999999999835999660676540246544445


Q ss_pred             CCEEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCC
Q ss_conf             88679999824899811000388888778902268899998966576540588848907789998242589981221146
Q 003628          549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  628 (807)
Q Consensus       549 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFG  628 (807)
                      ....++||||++++.+.....   ....++...+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEECCCCCCCCHHHH---CCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECC
T ss_conf             763899985357874101222---0344330899999999999998852299---8856767222036689968763135


Q ss_pred             CCCCCCCCCCC--CCCCEEECCCCCCCHHHHCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHC---
Q ss_conf             62013899986--421102226785581111259-889655455025878997849989876677301544443300---
Q 003628          629 MAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW---  702 (807)
Q Consensus       629 la~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~---  702 (807)
                      +++.+......  .......||+.|+|||++.+. .++.++||||+|+++|||++|+.||...++...+........   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf             00223554443211356602497874289970799989178700678646617448799899899999999998418998


Q ss_pred             -------CCCCCCCCCCCCCCCCC-CC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             -------12221000276555784-31-----8999999999976554885899998899999
Q 003628          703 -------NENKILALVDPFLSESS-FQ-----LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  752 (807)
Q Consensus       703 -------~~~~~~~~~d~~l~~~~-~~-----~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~  752 (807)
                             ........+........ ..     ......+++++.+||+.||++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             255344320344433201334455503340444599899999999873896589099999749

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=322.30  Aligned_cols=240  Identities=25%  Similarity=0.404  Sum_probs=194.1

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCC------CCHHHHHHHHHHHHHCC--CCCEEEEEEEEEECC
Q ss_conf             238764585443797138999935-995999999155472------05899999999998336--883467863887388
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG------QGLEEFMNEVMVISKLQ--HRNLVRLLGCCVEGE  550 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~  550 (807)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.+...      ....++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf             88379967984087839999999999979999998568844334556799999999999974358988127999983099


Q ss_pred             EEEEEEEECCC-CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCCEEECCC
Q ss_conf             67999982489-9811000388888778902268899998966576540588848907789998242589-981221146
Q 003628          551 EKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFG  628 (807)
Q Consensus       551 ~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kI~DFG  628 (807)
                      ..++||||+.+ +++.+++.   ....+++.++..++.|+++||+|||+.+   |+||||||+|||++.+ +.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEEECCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf             68999983368622899986---1589999999999999999999998779---75566761114774478848977546


Q ss_pred             CCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf             6201389998642110222678558111125988-965545502587899784998987667730154444330012221
Q 003628          629 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI  707 (807)
Q Consensus       629 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~  707 (807)
                      +++.....    ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+.   ..       . +..
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---i~-------~-~~~  221 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---II-------R-GQV  221 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---HH-------H-CCC
T ss_pred             CCEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH---HH-------H-CCC
T ss_conf             53532444----556656587747999984899788653325540345367568899887367---76-------1-544


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             00027655578431899999999997655488589999889999
Q 003628          708 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       708 ~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                            .     ++...+.++.+++.+|++.||++|||++|+++
T Consensus       222 ------~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 ------F-----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ------C-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------C-----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ------7-----78779999999999976089758939999853

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-43  Score=304.51  Aligned_cols=257  Identities=19%  Similarity=0.275  Sum_probs=197.4

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEEEEEEEEC--CEEEEE
Q ss_conf             238764585443797138999935-99599999915547205899999999998336-88346786388738--867999
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG--EEKMLI  555 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV  555 (807)
                      .++|++.++||+|+||+||+|+.. +++.||||++...   ..+.+.+|+.+|++++ ||||+++++++...  ...++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEE
T ss_conf             86718978983174819999998899979999998889---999999999999851579987679999981687712688


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CCEEECCCCCCCCC
Q ss_conf             98248998110003888887789022688999989665765405888489077899982425899-81221146620138
Q 003628          556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFG  634 (807)
Q Consensus       556 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kI~DFGla~~~~  634 (807)
                      |||+++++|..+.      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EEECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf             8631798589974------68999999999999999998876433---44345644123774899836641565426646


Q ss_pred             CCCCCCCCCEEECCCCCCCHHHHCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCC----------
Q ss_conf             999864211022267855811112598-896554550258789978499898766773015444433001----------
Q 003628          635 GNQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN----------  703 (807)
Q Consensus       635 ~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~----------  703 (807)
                      ....   .....+|+.|+|||.+.+.. ++.++||||+|+++|||++|+.||....+.............          
T Consensus       182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf             8874---4432248642476102688888845232335455587604889998876018999999998788415555542


Q ss_pred             -----CCCCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             -----222100027-------655578431899999999997655488589999889999
Q 003628          704 -----ENKILALVD-------PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       704 -----~~~~~~~~d-------~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                           .........       ..............++.+++.+|++.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             254447430000033343311211552112448999999999986699568908999964

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.9e-44  Score=309.36  Aligned_cols=274  Identities=16%  Similarity=0.236  Sum_probs=212.0

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCEEEEEEE
Q ss_conf             238764585443797138999935-995999999155472058999999999983368-834678638873886799998
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e  557 (807)
                      .++|++.+.||+|+||.||+|+.. +++.||||.+.....  ...+.+|++.+..+.| +|++.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf             9806997998417882999999988997999999750258--29999999999996489998779999601881179999


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCCEEECCCCCCC
Q ss_conf             2489981100038888877890226889999896657654058884890778999824258-----99812211466201
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKI  632 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~-----~~~~kI~DFGla~~  632 (807)
                      |+ +++|.+++..  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EC-CCCHHHHHHH--HCCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf             64-8887999975--2031106899999999999999999779---6626677131523475434479568723660577


Q ss_pred             CCCCCCC-----CCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf             3899986-----42110222678558111125988965545502587899784998987667730154444330012221
Q 003628          633 FGGNQDQ-----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI  707 (807)
Q Consensus       633 ~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~  707 (807)
                      +......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.............. . .+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~-i-~~~~~  233 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-I-GEKKQ  233 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-H-HHHHH
T ss_pred             CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-H-HHCCC
T ss_conf             146766541110246762775102679896488888699989831999999869876788530219999999-9-70567


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             00027655578431899999999997655488589999889999972023789999999854
Q 003628          708 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFT  769 (807)
Q Consensus       708 ~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~  769 (807)
                        ......    .....+.++.+++..|++.+|++||+++.+.+.|+..++.........+.
T Consensus       234 --~~~~~~----l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~D  289 (293)
T d1csna_         234 --STPLRE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD  289 (293)
T ss_dssp             --HSCHHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCG
T ss_pred             --CCCHHH----HCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf             --999589----65799899999999984399300859999999999999975999999989

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-44  Score=311.71  Aligned_cols=264  Identities=21%  Similarity=0.324  Sum_probs=200.9

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCC-EEEEEEEEEECCEEEEEEE
Q ss_conf             238764585443797138999935-99599999915547205899999999998336883-4678638873886799998
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e  557 (807)
                      .++|++.+.||+|+||.||+|+.. +++.||||.+......  .++..|+++++.++|+| |+.+.++..+....++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf             88899968985078809999999889989999997210058--8899999999970389960179999951987789998


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCCEEECCCCCCCCC
Q ss_conf             248998110003888887789022688999989665765405888489077899982425---89981221146620138
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFG  634 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~---~~~~~kI~DFGla~~~~  634 (807)
                      |+. ++|...+..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+++.+.
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             ECC-CCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf             738-713332443--0688768999999999999999999799---4426678766064335777615650467513425


Q ss_pred             CCCCC-----CCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf             99986-----4211022267855811112598896554550258789978499898766773015444433001222100
Q 003628          635 GNQDQ-----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA  709 (807)
Q Consensus       635 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~  709 (807)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...............  .....  
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~--~~~~~--  233 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI--SEKKM--  233 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH--HHHHH--
T ss_pred             CCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHH--HCCCC--
T ss_conf             54455410001357767873532999991899898321886177899998498766553057799999985--23567--


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             02765557843189999999999765548858999988999997202378
Q 003628          710 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  759 (807)
Q Consensus       710 ~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~L~~~~~~  759 (807)
                       ..+ .  .......+.++.+++..|++.+|++||+++++.+.|+.....
T Consensus       234 -~~~-~--~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         234 -STP-I--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             -HSC-H--HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -CCC-H--HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             -898-3--575347889999999998439955791999999999999997

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=305.50  Aligned_cols=263  Identities=19%  Similarity=0.265  Sum_probs=204.7

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             38764585443797138999935-99599999915547--2058999999999983368834678638873886799998
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  557 (807)
                      ++|++.++||+|+||+||+|+.. +++.||||+++...  ......+.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99786269712868199999999999699999980321786899999999999985675788821354444431158863


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf             24899811000388888778902268899998966576540588848907789998242589981221146620138999
Q 003628          558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  637 (807)
Q Consensus       558 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~~~~~~~  637 (807)
                      ++.+++|..++.   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ECCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf             023322211212---3565403678999999999987743399---8600146761211337826652046011046887


Q ss_pred             CCCCCCEEECCCCCCCHHHHCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCC------------
Q ss_conf             864211022267855811112598-8965545502587899784998987667730154444330012------------
Q 003628          638 DQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE------------  704 (807)
Q Consensus       638 ~~~~~~~~~gt~~y~APE~~~~~~-~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~------------  704 (807)
                      ..  .....++..|+|||++.... ++.++||||+||++|||++|+.|+....+..............            
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             CC--CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf             51--0010344310146675069888804440265418899851899998899999999999861189973551344322


Q ss_pred             --CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             --22100027655578431899999999997655488589999889999
Q 003628          705 --NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  751 (807)
Q Consensus       705 --~~~~~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~  751 (807)
                        .......................+.+++.+|++.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             2113344454431043306568999999999986499668909999964

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=305.11  Aligned_cols=297  Identities=20%  Similarity=0.213  Sum_probs=213.1

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE------CC
Q ss_conf             238764585443797138999935-99599999915547--2058999999999983368834678638873------88
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE------GE  550 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~  550 (807)
                      .++|++.++||+|+||+||+|+.. +++.||||++....  ......+.+|+.++++++||||+++++.+..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf             37759988962175859999999999989999998823369799999999999998648987648998970256434576


Q ss_pred             EEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCC
Q ss_conf             67999982489981100038888877890226889999896657654058884890778999824258998122114662
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       551 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla  630 (807)
                      ..++||||+.++.+. .+     ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~-~~-----~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQ-VI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHH-HH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             EEEEEEECCCHHHHH-HH-----HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf             269998414467787-65-----038999999999999999998865221---124567763211365443132010232


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH-------C-
Q ss_conf             01389998642110222678558111125988965545502587899784998987667730154444330-------0-
Q 003628          631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------W-  702 (807)
Q Consensus       631 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~-------~-  702 (807)
                      +......   ......+|+.|+|||++.+..++.++||||+||+++||++|+.||...++...........       + 
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             HCCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHH
T ss_conf             1146665---5332214655558133147777877433356625789865989988897788999999720589879998


Q ss_pred             ----------CC------CCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHCCCCCC-
Q ss_conf             ----------12------221000276555--784318999999999976554885899998899999--720237899-
Q 003628          703 ----------NE------NKILALVDPFLS--ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSEIRDLP-  761 (807)
Q Consensus       703 ----------~~------~~~~~~~d~~l~--~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~~--L~~~~~~~~-  761 (807)
                                ..      ............  ...........+.+++.+|++.||++|||++|+++.  ++....... 
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~  323 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEV  323 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCCCCCC
T ss_conf             76566777764175435666421264333543210133379999999999876994579089999669420878881004


Q ss_pred             CCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             999998544789999021899999999
Q 003628          762 YPKEPAFTERQGADDSESFKQIQQRIL  788 (807)
Q Consensus       762 ~p~~p~~~~~~~~~~~~~~~~~~~~~~  788 (807)
                      ....|........+......++.+.+.
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (355)
T d2b1pa1         324 EAPPPQIYDKQLDEREHTIEEWKELIY  350 (355)
T ss_dssp             TCCCC-------CCCCCCHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHCCHHHHHHHHH
T ss_conf             589998777023324159999999999

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=310.55  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=203.1

Q ss_pred             HCCCCCCCCCCCCCCCCEEEEEEC----CCCEEEEEEECCC----CCCCHHHHHHHHHHHHHCCC-CCEEEEEEEEEECC
Q ss_conf             238764585443797138999935----9959999991554----72058999999999983368-83467863887388
Q 003628          480 TNNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA----SGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGE  550 (807)
Q Consensus       480 ~~~f~~~~~Lg~G~~g~Vy~~~~~----~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~  550 (807)
                      .++|++.++||+|+||+||+++..    +|+.||||.+.+.    .....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf             10259998983287839999998765887948999998367721016899999999999986467983999620002487


Q ss_pred             EEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCC
Q ss_conf             67999982489981100038888877890226889999896657654058884890778999824258998122114662
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       551 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla  630 (807)
                      ..++|+||+.+|+|.+++.   ....+....+..++.|++.|+.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CEEEEEECCCCCHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCH
T ss_conf             3001231234117999987---3045437888888999999998851499---896547732012469998887413202


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCHHHHCCC--CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf             013899986421102226785581111259--889655455025878997849989876677301544443300122210
Q 003628          631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  708 (807)
Q Consensus       631 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~~~~~  708 (807)
                      +.+...... ......|++.|+|||.+...  .++.++||||+||+||||++|+.||...................    
T Consensus       177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~----  251 (322)
T d1vzoa_         177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----  251 (322)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----
T ss_pred             HHHCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC----
T ss_conf             220344443-221222333331068760577688713251777799999976899988887777999999833568----


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             0027655578431899999999997655488589999-----889999
Q 003628          709 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVS  751 (807)
Q Consensus       709 ~~~d~~l~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt-----~~evl~  751 (807)
                           .   .+.+...+.++.+++.+|++.||++||+     ++|+++
T Consensus       252 -----~---~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -----E---PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -----C---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -----C---CCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf             -----9---988654799999999997445898819997450999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-44  Score=305.96  Aligned_cols=266  Identities=20%  Similarity=0.267  Sum_probs=200.4

Q ss_pred             HHCCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-----C
Q ss_conf             7238764585443797138999935-99599999915547--20589999999999833688346786388738-----8
Q 003628          479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----E  550 (807)
Q Consensus       479 ~~~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~  550 (807)
                      ..++|++.++||+|+||+||+|+.. +++.||||++.+..  ....+.+.+|++++++++|+|++++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf             89871888898317883999999999997999999882002868999999999999866898742599999634645668


Q ss_pred             EEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCC
Q ss_conf             67999982489981100038888877890226889999896657654058884890778999824258998122114662
Q 003628          551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  630 (807)
Q Consensus       551 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla  630 (807)
                      ..+++++++.+|+|.+++.    ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             CEEEEEEEECCCCHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf             6499999625886232002----245309999999999999999997388---765166776334554322001321000


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCHHHHCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCC-----
Q ss_conf             0138999864211022267855811112598-8965545502587899784998987667730154444330012-----
Q 003628          631 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE-----  704 (807)
Q Consensus       631 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~~sDV~SlGvil~elltG~~p~~~~~~~~~l~~~~~~~~~~-----  704 (807)
                      .....     ......|+..|+|||...+.. ++.++||||+|+++|+|++|+.||...+...............     
T Consensus       169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CCCCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf             12575-----4444345435558355337756785512432058999997688997889889999999973079975773


Q ss_pred             -----CCCCCCCC--CCCCCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf             -----22100027--6555784---31899999999997655488589999889999--97202
Q 003628          705 -----NKILALVD--PFLSESS---FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS--MLNSE  756 (807)
Q Consensus       705 -----~~~~~~~d--~~l~~~~---~~~~~~~~l~~ii~~Cl~~dP~~RPt~~evl~--~L~~~  756 (807)
                           ........  +......   .......++.+++.+|++.||++|||+.|+++  .+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             2001024454443035578755566267899999999999775883459389998559954879

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.4e-39  Score=275.72  Aligned_cols=281  Identities=19%  Similarity=0.246  Sum_probs=200.9

Q ss_pred             CCCCCCCCCCCCCCCCEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-----------CCCEEEEEEEEEE
Q ss_conf             38764585443797138999935-99599999915547205899999999998336-----------8834678638873
Q 003628          481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-----------HRNLVRLLGCCVE  548 (807)
Q Consensus       481 ~~f~~~~~Lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~  548 (807)
                      .+|++.++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             85799899750778189999999999799999983431-33689999999999840145555542276764789987631


Q ss_pred             --CCEEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCC----
Q ss_conf             --88679999824899811000388888778902268899998966576540-58884890778999824258998----
Q 003628          549 --GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELN----  621 (807)
Q Consensus       549 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~DIkp~NIll~~~~~----  621 (807)
                        ....+++++++..+..............+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf             2565202343200035420000012234678689999999999999888764058---6465677057056305765644


Q ss_pred             --CEEECCCCCCCCCCCCCCCCCCEEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCC------H
Q ss_conf             --12211466201389998642110222678558111125988965545502587899784998987667730------1
Q 003628          622 --PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL------T  693 (807)
Q Consensus       622 --~kI~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDV~SlGvil~elltG~~p~~~~~~~~------~  693 (807)
                        ++++|||.+......     .....||+.|+|||++....++.++||||+|+++++|++|+.||...+...      .
T Consensus       169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             CEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf             30567531442123445-----4223665210571321466777643201237899999878899898755432102689


Q ss_pred             HHHHHHH-----------------HCCCCCCCCCCCCCC---------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf             5444433-----------------001222100027655---------57843189999999999765548858999988
Q 003628          694 ILGYAWK-----------------LWNENKILALVDPFL---------SESSFQLDMIIRCIHVGLLCVQELVKDRPNMS  747 (807)
Q Consensus       694 l~~~~~~-----------------~~~~~~~~~~~d~~l---------~~~~~~~~~~~~l~~ii~~Cl~~dP~~RPt~~  747 (807)
                      +......                 ..........+....         ...........++.+++.+|++.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf             99999983799878862453220001320122024323577644421000156743589999999998779945790899


Q ss_pred             HHHHH--HHHC--CCCCCCCCCCCCCC
Q ss_conf             99999--7202--37899999998544
Q 003628          748 TVVSM--LNSE--IRDLPYPKEPAFTE  770 (807)
Q Consensus       748 evl~~--L~~~--~~~~~~p~~p~~~~  770 (807)
                      |+++.  ++..  .++...|..+....
T Consensus       324 e~L~Hp~f~~~~~~~~~~~p~~~~~~~  350 (362)
T d1q8ya_         324 GLVNHPWLKDTLGMEEIRVPDRELYGS  350 (362)
T ss_dssp             HHHTCGGGTTCTTCTTCCCTTSCTTCB
T ss_pred             HHHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             996693407898744477998666788

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=2.9e-21  Score=156.15  Aligned_cols=163  Identities=17%  Similarity=0.172  Sum_probs=119.5

Q ss_pred             CCCCCCCCCCCCCEEEEEECCCCEEEEEEECCCCC------------------CCHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf             64585443797138999935995999999155472------------------058999999999983368834678638
Q 003628          484 QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG------------------QGLEEFMNEVMVISKLQHRNLVRLLGC  545 (807)
Q Consensus       484 ~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~  545 (807)
                      .+.++||+|+||.||+|+..+|+.||||.++....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf             22778024856599999979999999999860443466655656300088899999977899999998169991449986


Q ss_pred             EEECCEEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEE
Q ss_conf             87388679999824899811000388888778902268899998966576540588848907789998242589981221
Q 003628          546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS  625 (807)
Q Consensus       546 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~DIkp~NIll~~~~~~kI~  625 (807)
                      .    ..+++||++++..+..          ++......++.|+++++.|||+.+   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             C----CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEE
T ss_conf             2----8889999504565420----------015789999999999999982688---8983689036114289-89998


Q ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCC------HHHHCCCCCCCCCCEEEHHHHH
Q ss_conf             1466201389998642110222678558------1111259889655455025878
Q 003628          626 DFGMAKIFGGNQDQADTGRVVGTFGYMS------PEYAMEGRFSEKSDVFSFGVLL  675 (807)
Q Consensus       626 DFGla~~~~~~~~~~~~~~~~gt~~y~A------PE~~~~~~~s~~sDV~SlGvil  675 (807)
                      |||.++........          .|..      .+ +....|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR----------EILERDVRNIIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH----------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCCCCCCCCCCH----------HHHHHHHHHHHH-HHCCCCCCCCCHHHHHHHH
T ss_conf             77884308998709----------999877999999-9757899844689999987

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.79  E-value=9.9e-19  Score=139.29  Aligned_cols=112  Identities=17%  Similarity=0.419  Sum_probs=92.0

Q ss_pred             CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECC
Q ss_conf             36545886458999398389913898755899996399999505999528999459998778965599932876899739
Q 003628           23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG  102 (807)
Q Consensus        23 ~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~  102 (807)
                      .|+|.|||.|.+|+.|+  +|.|.|.|+.+++     |.++.    ..++||.||++.|..  ++.+.|+.||+|+|+++
T Consensus         1 tDtL~~gq~L~~g~~l~--~g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~   67 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLA--EGGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG   67 (112)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET
T ss_pred             CCEECCCCEECCCCEEE--ECCEEEEECCCCC-----EEEEC----CCCEEEECCCCCCCC--CCEEEEECCCCEEEEEC
T ss_conf             98906999955999998--7879999817998-----89873----983899846734788--85799961534999934


Q ss_pred             CCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCCCCC
Q ss_conf             971799630235544634899903888799825566157333467766
Q 003628          103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTD  150 (807)
Q Consensus       103 ~~~~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTD  150 (807)
                      + ..+|++++... .+..+|+|+|+|||||++. +++++|||+.+|++
T Consensus        68 ~-~~~w~s~t~~~-~~~~~l~L~ddGNlvly~~-~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          68 S-RAIWASNTNRQ-NGNYYLILQRDRNVVIYDN-SNNAIWATHTNVGN  112 (112)
T ss_dssp             T-EEEEECCCCCS-CCCCEEEECTTSCEEEECT-TSCEEEECCCCCCC
T ss_pred             C-CEEEEEEECCC-CCCEEEEECCCCCEEEECC-CCCEEECCCCCCCC
T ss_conf             8-74999830368-8725999967899999989-99679618885698

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.77  E-value=2.2e-18  Score=137.02  Aligned_cols=107  Identities=20%  Similarity=0.330  Sum_probs=90.7

Q ss_pred             CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECC
Q ss_conf             36545886458999398389913898755899996399999505999528999459998778965599932876899739
Q 003628           23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG  102 (807)
Q Consensus        23 ~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~  102 (807)
                      +|+|.+|+.|.+|+.|.  +|.|.|.|+.+++     |.++.    ..++||.||++.|.  ..+.+.++.+|+|+|+++
T Consensus         1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~   67 (108)
T d1jpca_           1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNP   67 (108)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred             CCCCCCCCEECCCCEEE--CCCEEEEECCCCE-----EEEEE----CCCEEEEECCCCCC--CCCEEEEECCCEEEEECC
T ss_conf             99956997726999897--2888999878980-----99970----99021570788998--754799812603999779


Q ss_pred             CCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCC
Q ss_conf             971799630235544634899903888799825566157333467
Q 003628          103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE  147 (807)
Q Consensus       103 ~~~~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~  147 (807)
                      ++.++|+|++... ....+|+|+|+|||||++.    .+||||+|
T Consensus        68 ~g~~vWsS~t~~~-~~~~~l~L~ddGNlVly~~----~~W~S~t~  107 (108)
T d1jpca_          68 SNKPIWASNTGGQ-NGNYVCILQKDRNVVIYGT----DRWATGTH  107 (108)
T ss_dssp             TCCEEEECCCCCS-CSCEEEEECTTSCEEEEEC----CCCCCCCC
T ss_pred             CCCCEEECCCCCC-CCCEEEEECCCCCEEEECC----CCCCCCCC
T ss_conf             8551277045588-8767999968889999699----84568888

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.76  E-value=8e-18  Score=133.26  Aligned_cols=107  Identities=18%  Similarity=0.326  Sum_probs=89.8

Q ss_pred             CCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECCC
Q ss_conf             65458864589993983899138987558999963999995059995289994599987789655999328768997399
Q 003628           24 SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQ  103 (807)
Q Consensus        24 ~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~  103 (807)
                      |+|.+|+.|.+|+.|.  +|.|.|+|+.+++     |.+ |.   ..++||+||++.|+.. .+.|.|+.||+|||++++
T Consensus         2 ~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl-~~---~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~   69 (109)
T d1kj1a_           2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVL-YD---HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAE   69 (109)
T ss_dssp             CEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEE-EE---TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSS
T ss_pred             CCCCCCCEEECCCEEE--ECCEEEEECCCCE-----EEE-EE---CCEEEEEECCCCCCCE-EEEEEECCCCEEEEEECC
T ss_conf             8925999882899898--3788999448986-----999-86---9989998378998751-079999379609999089


Q ss_pred             CCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCC
Q ss_conf             71799630235544634899903888799825566157333467
Q 003628          104 KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE  147 (807)
Q Consensus       104 ~~~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~  147 (807)
                      +.++|+|+++.. .+...|+|+|+|||||+++    .+|||+-|
T Consensus        70 g~~vW~s~t~~~-~~~~~l~L~ddGNlvly~~----~~W~S~t~  108 (109)
T d1kj1a_          70 GRSLWASHSVRG-NGNYVLVLQEDGNVVIYGS----DIWSTGTY  108 (109)
T ss_dssp             SCEEEECCCCCC-SSCCEEEECTTSCEEEECC----EEEECCCC
T ss_pred             CCEEEEEEEECC-CCCEEEEEECCCCEEEECC----CEECCCCC
T ss_conf             867999730889-9977999947975999799----87217985

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.60  E-value=1.5e-15  Score=118.15  Aligned_cols=109  Identities=21%  Similarity=0.325  Sum_probs=87.0

Q ss_pred             EEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCE
Q ss_conf             99950599952899945999877896559993287689973997179963023554463489990388879982556615
Q 003628           61 GIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAI  140 (807)
Q Consensus        61 ~iw~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~  140 (807)
                      .|||.++++++.+|++|++.|+....-+|.++.||||||++. +.++|++++.+. .....|.|+++|||||++. ++++
T Consensus        11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~-~~~~~~~l~~~GnLvl~d~-~~~~   87 (120)
T d1dlpa2          11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGK-GTGCRAVLQPNGRMDVLTN-QNIA   87 (120)
T ss_dssp             EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSS-CSSCEEEEETTTEEEEEET-TTEE
T ss_pred             EEEECCCCCCCCCCEECCCCEEECCCEEEEECCCCCEEEECC-CCEEEEECCCCC-CCCEEEEEECCEEEEEECC-CCCE
T ss_conf             699828988885628839972174887999968983899649-968999752247-7747999907764999929-9988


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCEEEEEEECCCCCEEEEECCCEEEEE
Q ss_conf             7333467766557998323212479704898703589999831485210267760699618811880
Q 003628          141 VWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWR  207 (807)
Q Consensus       141 ~WqSFd~PTDtllpg~~lg~~~~~~~~~~L~S~~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~y~~  207 (807)
                      +||||.                               +.+.|.|.+.++++|..  .+|.  .++|.
T Consensus        88 lW~S~t-------------------------------~~~~~~~~l~Lq~DGnl--vlY~--~~~W~  119 (120)
T d1dlpa2          88 VWTSGN-------------------------------SRSAGRYVFVLQPDRNL--AIYG--GALWT  119 (120)
T ss_dssp             EEECCC-------------------------------CCSSSCCEEEECSSSCE--EEEC--CCCCB
T ss_pred             EEEECC-------------------------------CCCCCCEEEEECCCCCE--EEEC--CCCCC
T ss_conf             998199-------------------------------99998489998889869--9968--97434

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.55  E-value=5.5e-14  Score=107.66  Aligned_cols=104  Identities=17%  Similarity=0.345  Sum_probs=80.7

Q ss_pred             CCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECCC
Q ss_conf             65458864589993983899138987558999963999995059995289994599987789655999328768997399
Q 003628           24 SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQ  103 (807)
Q Consensus        24 ~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~  103 (807)
                      .+|.++|.|    .+.+..|.|.|.|+.+|+     |.+ |.   ..++||.+|+..+..  .+.|.|+.+|+|+|.+++
T Consensus        15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~   79 (119)
T d1b2pa_          15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNE   79 (119)
T ss_dssp             CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTT
T ss_pred             CEEECCCEE----EEECCCCEEEEEECCCCC-----EEE-EE---CCEEEEEECCCCCCC--CEEEEEEECCCEEEECCC
T ss_conf             888289758----870478538999889982-----999-97---996799946788774--169999837779998999


Q ss_pred             CCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCC
Q ss_conf             71799630235544634899903888799825566157333467
Q 003628          104 KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE  147 (807)
Q Consensus       104 ~~~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~  147 (807)
                      +.++|++++.+. .+..+|+|+|+|||||++.    ++|||..+
T Consensus        80 g~~vWsS~t~~~-~~~~~l~Lq~DGNlvlYg~----~~W~S~T~  118 (119)
T d1b2pa_          80 NVTVWQSPVAGK-AGHYVLVLQPDRNVVIYGD----ALWATQTV  118 (119)
T ss_dssp             CCEEEECSCCCC-SSCEEEEECTTSCEEEEES----EEEECCCC
T ss_pred             CCEEEECCCCCC-CCCEEEEECCCCCEEEECC----CEECCCCC
T ss_conf             857997887699-8865999969988999799----88416974

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.46  E-value=1.7e-14  Score=111.07  Aligned_cols=80  Identities=28%  Similarity=0.354  Sum_probs=39.7

Q ss_pred             EEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEE
Q ss_conf             99505999528999459998778965599932876899739971799630235544634899903888799825566157
Q 003628           62 IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIV  141 (807)
Q Consensus        62 iw~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~  141 (807)
                      |||...++.+..|+.+.+.++.....+|.++.||||||+++ +.++|++++.+  ..+..+.|+++|||||++. +++++
T Consensus         3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~--~~~~~l~l~~dGNLvl~d~-~~~~v   78 (115)
T d1dlpa1           3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAG--ATGCRAVLQSDGLLVILTA-QNTIR   78 (115)
T ss_dssp             CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCS--CSCCBCCBCSSSCBCCBCT-TTCCS
T ss_pred             EEEECCCCCCCCCEECCCCCEECCCEEEEECCCCEEEEECC-CEEEEECCCCC--CCCEEEEEECCCCEEEECC-CCCEE
T ss_conf             77864789988212469981775988999979983999819-90689711689--9756899944678999905-89789


Q ss_pred             ECCC
Q ss_conf             3334
Q 003628          142 WESF  145 (807)
Q Consensus       142 WqSF  145 (807)
                      |||+
T Consensus        79 WsS~   82 (115)
T d1dlpa1          79 WSSG   82 (115)
T ss_dssp             CCCC
T ss_pred             EECC
T ss_conf             9818

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.30  E-value=2.4e-12  Score=96.80  Aligned_cols=109  Identities=17%  Similarity=0.337  Sum_probs=82.0

Q ss_pred             HHHHHHHHHCCCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEE
Q ss_conf             75222220013654588645899939838991389875589999639999950599952899945999877896559993
Q 003628           13 CFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITIS   92 (807)
Q Consensus        13 ~~~~~~~~a~~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~l~~~   92 (807)
                      +|++..      -.+..|+|.+++.|  .+|.|.|.|..+|+     |.++ .   ...+||.+|...+   ..+++.|+
T Consensus         4 ~~~~~~------~~~~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~-~---~~~~vW~s~t~~~---~~~~l~l~   63 (115)
T d1dlpa1           4 LFGLSH------EGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLF-D---SDVRVWASNTAGA---TGCRAVLQ   63 (115)
T ss_dssp             CBCSSS------SSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEE-E---SSSEEECCCCCSC---SCCBCCBC
T ss_pred             EEECCC------CCCCCCEECCCCCE--ECCCEEEEECCCCE-----EEEE-C---CCEEEEECCCCCC---CCEEEEEE
T ss_conf             786478------99882124699817--75988999979983-----9998-1---9906897116899---75689994


Q ss_pred             CCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCC
Q ss_conf             287689973997179963023554463489990388879982556615733346
Q 003628           93 EDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQ  146 (807)
Q Consensus        93 ~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd  146 (807)
                      .+|||||++.++.++|++++... .+...++|+++|||||++.    ++|+|-.
T Consensus        64 ~dGNLvl~d~~~~~vWsS~t~~~-~g~y~l~Lq~DGNlvlY~~----~~Wssgt  112 (115)
T d1dlpa1          64 SDGLLVILTAQNTIRWSSGTKGS-IGNYVLVLQPDRTVTIYGP----GLWDSGT  112 (115)
T ss_dssp             SSSCBCCBCTTTCCSCCCCCCCC-SSCCEEEECSSSCEEEECS----EEEECSC
T ss_pred             CCCCEEEECCCCCEEEECCCCCC-CCCEEEEECCCCCEEEECC----CEECCCC
T ss_conf             46789999058978998188899-9978999989986999689----7643889

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.07  E-value=2.8e-10  Score=82.96  Aligned_cols=101  Identities=16%  Similarity=0.330  Sum_probs=75.3

Q ss_pred             CCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECCCCC
Q ss_conf             45886458999398389913898755899996399999505999528999459998778965599932876899739971
Q 003628           26 ITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKE  105 (807)
Q Consensus        26 l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~  105 (807)
                      -.+.+.|..++.|.  .|.|.|.|...++     |.++ .   ...+||.+|...  .+..+.+.|+.+|||||++.++.
T Consensus        20 ~~~~~~l~~~q~l~--~g~y~L~~q~DGN-----LvL~-~---~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~   86 (120)
T d1dlpa2          20 DNHPQTLHATQSLQ--LSPYRLSMETDCN-----LVLF-D---RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNI   86 (120)
T ss_dssp             CCCCCEECSSCCCB--CSSCEEEEETTTE-----EEEE-B---TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTE
T ss_pred             CCCCCEECCCCEEE--CCCEEEEECCCCC-----EEEE-C---CCCEEEEECCCC--CCCCEEEEEECCEEEEEECCCCC
T ss_conf             88562883997217--4887999968983-----8996-4---996899975224--77747999907764999929998


Q ss_pred             EEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECC
Q ss_conf             799630235544634899903888799825566157333
Q 003628          106 VLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES  144 (807)
Q Consensus       106 ~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqS  144 (807)
                      ++|+|++... .+..++.|+++||||||+.    .+|.|
T Consensus        87 ~lW~S~t~~~-~~~~~l~Lq~DGnlvlY~~----~~W~t  120 (120)
T d1dlpa2          87 AVWTSGNSRS-AGRYVFVLQPDRNLAIYGG----ALWTT  120 (120)
T ss_dssp             EEEECCCCCS-SSCCEEEECSSSCEEEECC----CCCBC
T ss_pred             EEEEECCCCC-CCCEEEEECCCCCEEEECC----CCCCC
T ss_conf             8998199999-9848999888986999689----74349

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.90  E-value=2.1e-08  Score=70.46  Aligned_cols=149  Identities=15%  Similarity=0.063  Sum_probs=105.1

Q ss_pred             HHHHHHHCCCCCCCCCCCCCCCCEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCEE
Q ss_conf             89999723876458544379713899993599599999915547205899999999998336-88346786388738867
Q 003628          474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEK  552 (807)
Q Consensus       474 ~~l~~~~~~f~~~~~Lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~  552 (807)
                      .++......|+..+..+.+....||+... ++..+++|+...........+.+|...+..+. +-.+.+++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf             99997513527997678998771899990-89869999848876532556999999999876069987289997508964


Q ss_pred             EEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-------------------------------
Q ss_conf             9999824899811000388888778902268899998966576540588-------------------------------
Q 003628          553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR-------------------------------  601 (807)
Q Consensus       553 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-------------------------------  601 (807)
                      ++||+++++.++......        ......++.++++.++.||+...                               
T Consensus        86 ~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEECCCCCCCCCCCC--------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf             999986043343543344--------026999999899999998556842143576446565557789987765555430


Q ss_pred             -------------------------CCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf             -------------------------848907789998242589981221146620
Q 003628          602 -------------------------LRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       602 -------------------------~~ivH~DIkp~NIll~~~~~~kI~DFGla~  631 (807)
                                               ..++|+|+.|.||+++++....|+||+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf             3323200579999999984498678178986004764236499659996023144

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.83  E-value=2.7e-08  Score=69.78  Aligned_cols=88  Identities=26%  Similarity=0.459  Sum_probs=64.5

Q ss_pred             CEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             55999328768997399717996302355446348999038887998255661573334677665579983232124797
Q 003628           87 GIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK  166 (807)
Q Consensus        87 ~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDtllpg~~lg~~~~~~~  166 (807)
                      -.|.|+.||||||+. .+.++|++++......+..+.|+++|||||++. +++++|+|-     |               
T Consensus        21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~s~-----t---------------   78 (109)
T d1kj1a_          21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA-EGRSLWASH-----S---------------   78 (109)
T ss_dssp             EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS-SSCEEEECC-----C---------------
T ss_pred             EEEEECCCCEEEEEE-CCEEEEEECCCCCCCEEEEEEECCCCEEEEEEC-CCCEEEEEE-----E---------------
T ss_conf             899944898699986-998999837899875107999937960999908-986799973-----0---------------


Q ss_pred             EEEEEECCCCCCCCCCEEEEEEECCCCCEEEEECCCEEEEECCCC
Q ss_conf             048987035899998314852102677606996188118803999
Q 003628          167 KVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPW  211 (807)
Q Consensus       167 ~~~L~S~~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~y~~s~~~  211 (807)
                                 ..+.|.|.+.++++|..  ++++  .+.|.|+.+
T Consensus        79 -----------~~~~~~~~l~L~ddGNl--vly~--~~~W~S~t~  108 (109)
T d1kj1a_          79 -----------VRGNGNYVLVLQEDGNV--VIYG--SDIWSTGTY  108 (109)
T ss_dssp             -----------CCCSSCCEEEECTTSCE--EEEC--CEEEECCCC
T ss_pred             -----------ECCCCCEEEEEECCCCE--EEEC--CCEECCCCC
T ss_conf             -----------88999779999479759--9979--987217985

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.82  E-value=2.6e-08  Score=69.82  Aligned_cols=85  Identities=25%  Similarity=0.438  Sum_probs=63.1

Q ss_pred             EEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCE
Q ss_conf             59993287689973997179963023554463489990388879982556615733346776655799832321247970
Q 003628           88 IITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKK  167 (807)
Q Consensus        88 ~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDtllpg~~lg~~~~~~~~  167 (807)
                      .|.++.||||||+++ +.++|++++.+. .....+.++++|||||++. +++++|+|.-                     
T Consensus        33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~-~~~~~l~l~~dGnLvL~d~-~g~~vWsS~t---------------------   88 (119)
T d1b2pa_          33 RFIMQTDCNLVLYDN-NNPIWATNTGGL-GNGCRAVLQPDGVLVVITN-ENVTVWQSPV---------------------   88 (119)
T ss_dssp             EEEECTTSCEEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECT-TCCEEEECSC---------------------
T ss_pred             EEEECCCCCEEEEEC-CEEEEEECCCCC-CCCEEEEEEECCCEEEECC-CCCEEEECCC---------------------
T ss_conf             999889982999979-967999467887-7416999983777999899-9857997887---------------------


Q ss_pred             EEEEECCCCCCCCCCEEEEEEECCCCCEEEEECCCEEEEECCC
Q ss_conf             4898703589999831485210267760699618811880399
Q 003628          168 VQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP  210 (807)
Q Consensus       168 ~~L~S~~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~y~~s~~  210 (807)
                                .-+.|.|.+.++++|..  +++.  .+.|.|+.
T Consensus        89 ----------~~~~~~~~l~Lq~DGNl--vlYg--~~~W~S~T  117 (119)
T d1b2pa_          89 ----------AGKAGHYVLVLQPDRNV--VIYG--DALWATQT  117 (119)
T ss_dssp             ----------CCCSSCEEEEECTTSCE--EEEE--SEEEECCC
T ss_pred             ----------CCCCCCEEEEECCCCCE--EEEC--CCEECCCC
T ss_conf             ----------69988659999699889--9979--98841697

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.73  E-value=5.1e-08  Score=67.91  Aligned_cols=86  Identities=23%  Similarity=0.456  Sum_probs=61.1

Q ss_pred             CEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             55999328768997399717996302355446348999038887998255661573334677665579983232124797
Q 003628           87 GIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK  166 (807)
Q Consensus        87 ~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDtllpg~~lg~~~~~~~  166 (807)
                      -+|.++.||||||++. +.++|++++.+. .....+.|+++|||||++. +++++|+|=     |               
T Consensus        21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~-~~~~~l~l~~~Gnlvl~~~-~g~~vWsS~-----t---------------   77 (108)
T d1jpca_          21 FVFIMQEDCNLVLYDV-DKPIWATNTGGL-SRSCFLSMQTDGNLVVYNP-SNKPIWASN-----T---------------   77 (108)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECT-TCCEEEECC-----C---------------
T ss_pred             EEEEECCCCEEEEEEC-CCEEEEECCCCC-CCCCEEEEECCCEEEEECC-CCCCEEECC-----C---------------
T ss_conf             8999878980999709-902157078899-8754799812603999779-855127704-----5---------------


Q ss_pred             EEEEEECCCCCCCCCCEEEEEEECCCCCEEEEECCCEEEEECCC
Q ss_conf             04898703589999831485210267760699618811880399
Q 003628          167 KVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP  210 (807)
Q Consensus       167 ~~~L~S~~s~~dps~G~fs~~~~~~~~~~~~~~~~~~~y~~s~~  210 (807)
                                 ..+.+.|.+.++++|..  +++.  .+.|.|+.
T Consensus        78 -----------~~~~~~~~l~L~ddGNl--Vly~--~~~W~S~t  106 (108)
T d1jpca_          78 -----------GGQNGNYVCILQKDRNV--VIYG--TDRWATGT  106 (108)
T ss_dssp             -----------CCSCSCEEEEECTTSCE--EEEE--CCCCCCCC
T ss_pred             -----------CCCCCCEEEEECCCCCE--EEEC--CCCCCCCC
T ss_conf             -----------58887679999688899--9969--98456888

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.51  E-value=1.2e-06  Score=58.87  Aligned_cols=88  Identities=19%  Similarity=0.426  Sum_probs=59.1

Q ss_pred             CCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             65599932876899739971799630235544634899903888799825566157333467766557998323212479
Q 003628           86 SGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTG  165 (807)
Q Consensus        86 ~~~l~~~~~g~l~l~~~~~~~~ws~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDtllpg~~lg~~~~~~  165 (807)
                      .-.|.|+.||||||++. +.++|++++.+. .....+.|+.+|||||++.  ++.+|.|=                    
T Consensus        20 ~~~l~~q~DGNLvly~~-~~~vW~s~~~~~-~~~~~l~l~~dGnLvl~~~--~~~~w~s~--------------------   75 (112)
T d1xd5a_          20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGK-ASGCVLKMQNDGNLVIYSG--SRAIWASN--------------------   75 (112)
T ss_dssp             TEEEEECTTSCEEEEET-TEEEEECCCTTS-CSSEEEEECTTSCEEEEET--TEEEEECC--------------------
T ss_pred             CEEEEECCCCCEEEECC-CCEEEECCCCCC-CCCCEEEEECCCCEEEEEC--CCEEEEEE--------------------
T ss_conf             79999817998898739-838998467347-8885799961534999934--87499983--------------------


Q ss_pred             CEEEEEECCCCCCCCCCEEEEEEECCCCCEEEEECC-CEEEEECCC
Q ss_conf             704898703589999831485210267760699618-811880399
Q 003628          166 KKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNV-SRPYWRSGP  210 (807)
Q Consensus       166 ~~~~L~S~~s~~dps~G~fs~~~~~~~~~~~~~~~~-~~~y~~s~~  210 (807)
                                 ..-..+.+.+.++.+|..  ++++. ..+.|.|+.
T Consensus        76 -----------t~~~~~~~~l~L~ddGNl--vly~~~~~~~W~S~t  108 (112)
T d1xd5a_          76 -----------TNRQNGNYYLILQRDRNV--VIYDNSNNAIWATHT  108 (112)
T ss_dssp             -----------CCCSCCCCEEEECTTSCE--EEECTTSCEEEECCC
T ss_pred             -----------ECCCCCCEEEEECCCCCE--EEECCCCCEEECCCC
T ss_conf             -----------036887259999678999--999899967961888

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.33  E-value=4.1e-06  Score=55.19  Aligned_cols=130  Identities=18%  Similarity=0.147  Sum_probs=86.2

Q ss_pred             CCCCCCC-CCEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC--CCCEEEEEEEEEECCEEEEEEEECCCCCC
Q ss_conf             5443797-13899993599599999915547205899999999998336--88346786388738867999982489981
Q 003628          488 KLGQGGF-GPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ--HRNLVRLLGCCVEGEEKMLIYEYMPNRSL  564 (807)
Q Consensus       488 ~Lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gsL  564 (807)
                      .+..|.. ..||+....++..+++|.......   ..+..|...++.+.  .-.++++++...+++..++||+++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf             76786547758999938987899995896677---689999999999986599988613222456615999874413554


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q ss_conf             10003888887789022688999989665765405---------------------------------------------
Q 003628          565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD---------------------------------------------  599 (807)
Q Consensus       565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------------  599 (807)
                      ....        ..   ....+.++++.+..||..                                             
T Consensus        94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             CCCC--------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf             3221--------26---899999999999987368854488755412468899999987541101134011213799999


Q ss_pred             ----------CCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf             ----------88848907789998242589981221146620
Q 003628          600 ----------SRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       600 ----------~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~  631 (807)
                                ..+.++|+|+.|.|||++.+..+.|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf             999871876579567867888763577379658999853326

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.93  E-value=4e-05  Score=48.61  Aligned_cols=77  Identities=12%  Similarity=0.176  Sum_probs=51.1

Q ss_pred             CCCCCCCCCCCEEEEEECC-CCEEEEEEECCC-------CCCCHHHHHHHHHHHHHCC-C--CCEEEEEEEEEECCEEEE
Q ss_conf             5854437971389999359-959999991554-------7205899999999998336-8--834678638873886799
Q 003628          486 SSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA-------SGQGLEEFMNEVMVISKLQ-H--RNLVRLLGCCVEGEEKML  554 (807)
Q Consensus       486 ~~~Lg~G~~g~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~l  554 (807)
                      .+.||.|....||+....+ ++.++||.-...       ......+...|.+.|+.+. +  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf             99807985276899995799848999617713034677788877899999999998650579885528998--5988779


Q ss_pred             EEEECCCCCC
Q ss_conf             9982489981
Q 003628          555 IYEYMPNRSL  564 (807)
Q Consensus       555 V~e~~~~gsL  564 (807)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEECCCCCCC
T ss_conf             8713577653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.59  E-value=0.0002  Score=43.91  Aligned_cols=136  Identities=14%  Similarity=0.126  Sum_probs=74.6

Q ss_pred             CCCEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCE--EEEEE-----EEEECCEEEEEEEECCCCCCCC
Q ss_conf             7138999935995999999155472058999999999983368834--67863-----8873886799998248998110
Q 003628          494 FGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL--VRLLG-----CCVEGEEKMLIYEYMPNRSLDA  566 (807)
Q Consensus       494 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~e~~~~gsL~~  566 (807)
                      --.||+.+..+|..+++|..+.. ....+++..|...+..|....+  +..+.     ........+.++++++|..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             CCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf             20269998389997999984787-78899999999999999855998787520689805665347999986527768899


Q ss_pred             C------------------CCC--CCCCCCCC-------------------HHHH---HHHHHHHHHHHHHH-HHCCCCC
Q ss_conf             0------------------038--88887789-------------------0226---88999989665765-4058884
Q 003628          567 L------------------LFD--PLKKERLD-------------------WRKR---FNIIEGISRGLLYL-HRDSRLR  603 (807)
Q Consensus       567 ~------------------l~~--~~~~~~l~-------------------~~~~---~~i~~~ia~~L~yL-H~~~~~~  603 (807)
                      .                  ...  .......+                   ...+   ...+..+...+.-. .......
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf             99999999899999988630357865567789788766568999874769988989999999999999998454568712


Q ss_pred             EEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf             89077899982425899812211466201
Q 003628          604 IIHRDLKASNILLDEELNPKISDFGMAKI  632 (807)
Q Consensus       604 ivH~DIkp~NIll~~~~~~kI~DFGla~~  632 (807)
                      ++|+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             0247888042878389--35886520146

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.46  E-value=0.00097  Score=39.38  Aligned_cols=73  Identities=18%  Similarity=0.286  Sum_probs=45.1

Q ss_pred             CCCCCCCCCCEEEEEECC--------CCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCEEEEEEE
Q ss_conf             854437971389999359--------9599999915547205899999999998336-8834678638873886799998
Q 003628          487 SKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYE  557 (807)
Q Consensus       487 ~~Lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  557 (807)
                      +.|+.|-.-.+|+....+        ...+.++....  ........+|..+++.+. +.-.+++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf             9917853343489996887754457898179996599--61165899999999999757999808998189----56999


Q ss_pred             ECCCCCCC
Q ss_conf             24899811
Q 003628          558 YMPNRSLD  565 (807)
Q Consensus       558 ~~~~gsL~  565 (807)
                      |+++..+.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EECCCCCC
T ss_conf             73455488

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.14  E-value=0.0066  Score=33.83  Aligned_cols=158  Identities=12%  Similarity=0.019  Sum_probs=79.2

Q ss_pred             CCHHHHHHHHCCCCCCCCCC-----CCCCCCEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCC--EEEEE
Q ss_conf             49889999723876458544-----379713899993599599999915547205899999999998336883--46786
Q 003628          471 FQFEELATATNNFQLSSKLG-----QGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN--LVRLL  543 (807)
Q Consensus       471 ~~~~~l~~~~~~f~~~~~Lg-----~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~  543 (807)
                      .+.+++.....+|.+++...     .|---+.|+....+| .+++|+.....  ..+++..|++.+..+...+  ++..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             8999999999867999856852378885267389997897-28999807899--98899999999875430255545564


Q ss_pred             E------EEEECCEEEEEEEECCCCCCCCCCCC-----------------CCCC---------------------CCCCH
Q ss_conf             3------88738867999982489981100038-----------------8888---------------------77890
Q 003628          544 G------CCVEGEEKMLIYEYMPNRSLDALLFD-----------------PLKK---------------------ERLDW  579 (807)
Q Consensus       544 g------~~~~~~~~~lV~e~~~~gsL~~~l~~-----------------~~~~---------------------~~l~~  579 (807)
                      .      ..........++.+..+......-..                 ....                     .....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf             10489762134125502453114655333204678888899876454443202453101110120024567777653114


Q ss_pred             HHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf             2268899998966576540-588848907789998242589981221146620
Q 003628          580 RKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAK  631 (807)
Q Consensus       580 ~~~~~i~~~ia~~L~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kI~DFGla~  631 (807)
                      ......+......+...+. .-+.+++|+|+.+.||+++.+...-|+||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf             12799999998764204855454503337863656402045412674222123

>d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Hairpin loop containing domain-like
superfamily: Hairpin loop containing domain-like
family: Hairpin loop containing domain
domain: Hepatocyte growth factor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=80.07  E-value=0.94  Score=19.50  Aligned_cols=32  Identities=31%  Similarity=0.769  Sum_probs=24.4

Q ss_pred             CCHHHHHHHHHCC----CCEEEEEECCCEEEEEEEE
Q ss_conf             2477899997202----9803576218803789541
Q 003628          358 ATEDECREQCLKN----CSCIAYAFDGGIGCMVWRS  389 (807)
Q Consensus       358 ~s~~~C~~~Cl~n----CsC~a~~~~~~~~c~~~~~  389 (807)
                      .|.++|...|+++    =.|.+|.|+...+.|++..
T Consensus        30 ~s~eeCA~rC~~~~~~~f~CrSF~y~~~~~~C~Ls~   65 (91)
T d2qj2a1          30 NTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFP   65 (91)
T ss_dssp             SCHHHHHHHHHTTTTCSSCCCEEEEETTTTEEEEES
T ss_pred             CCHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEECC
T ss_conf             899999999872679870677689877898278726